data_1p8g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p8g _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.209 0.052 . . . . 10.0 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.59 91.21 4.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.405 1.882 . . . . 10.0 111.016 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -117.78 175.37 5.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.488 0.661 . . . . 10.0 112.024 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -118.76 102.33 8.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.362 1.065 . . . . 10.0 110.516 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.54 74.57 3.26 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -34.38 110.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.749 1.619 . . . . 10.0 111.24 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.9 t . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 125.712 1.605 . . . . 10.0 110.221 -179.035 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 119.804 -0.141 . . . . 10.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -79.79 -69.67 0.57 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 m -43.52 -44.55 6.1 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 126.668 1.987 . . . . 10.0 111.44 -173.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -49.23 -55.33 12.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.037 0.922 . . . . 10.0 111.186 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.4 -41.87 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.83 -14.06 5.02 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.389 1.471 . . . . 10.0 114.911 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -81.77 -23.95 36.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.712 1.756 . . . . 10.0 108.442 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.6 mt -71.05 120.09 16.12 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 122.013 -0.429 . . . . 10.0 110.728 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.1 -34.67 14.42 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 10.0 112.168 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.45 -0.84 90.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.121 1.343 . . . . 10.0 114.627 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.66 160.29 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 120.327 2.063 . . . . 10.0 111.682 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -131.0 -42.56 1.1 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.214 1.006 . . . . 10.0 112.377 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.41 147.25 35.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.826 0.85 . . . . 10.0 108.966 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.3 59.12 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.784 1.234 . . . . 10.0 111.128 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 71.47 5.55 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.675 -1.266 . . . . 10.0 109.856 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.24 123.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.936 0.895 . . . . 10.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -150.01 58.69 0.98 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -56.54 -29.53 62.04 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.572 -0.705 . . . . 10.0 111.004 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -60.08 -35.67 75.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.313 1.045 . . . . 10.0 110.698 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.02 59.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.939 0.896 . . . . 10.0 111.393 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.83 55.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.092 0.853 . . . . 10.0 111.535 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -154.53 154.31 32.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.501 1.151 . . . . 10.0 110.154 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.42 102.66 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.73 93.35 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.89 114.03 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.187 1.395 . . . . 10.0 108.609 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -102.27 120.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.42 160.47 43.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 123.981 0.801 . . . . 10.0 111.804 -175.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -90.96 80.32 5.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.002 0.906 . . . . 10.0 112.659 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -36.95 -39.13 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.813 2.045 . . . . 10.0 113.684 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.62 -57.19 9.85 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.608 1.163 . . . . 10.0 111.76 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -41.74 15.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 -171.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.5 110.97 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -69.66 155.46 40.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.495 0.664 . . . . 10.0 109.746 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.91 -40.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.076 1.35 . . . . 10.0 113.095 171.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -57.62 -58.33 8.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -47.44 -46.17 26.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.767 0.827 . . . . 10.0 110.096 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.94 -45.35 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 O-C-N 121.691 -0.631 . . . . 10.0 111.019 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.23 91.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.674 0.749 . . . . 10.0 108.987 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -60.44 -36.44 78.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.86 -0.793 . . . . 10.0 108.86 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.61 70.13 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.468 -0.77 . . . . 10.0 112.398 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.59 -48.44 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.288 -1.375 . . . . 10.0 107.288 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.52 -26.95 67.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.043 0.838 . . . . 10.0 112.464 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -26.56 59.69 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.303 0.483 . . . . 10.0 112.303 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -120.13 -63.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.766 1.226 . . . . 10.0 111.183 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.51 -153.72 25.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.185 -1.566 . . . . 10.0 109.185 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -162.79 52.98 0.19 Allowed 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.476 -1.305 . . . . 10.0 107.476 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.91 62.19 1.66 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.165 -1.791 . . . . 10.0 106.165 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.74 88.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.56 1.172 . . . . 10.0 108.663 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.74 -70.44 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.43 -1.259 . . . . 10.0 109.397 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 163.07 -174.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.344 1.858 . . . . 10.0 113.53 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.2 mm . . . . . 0 N--CA 1.438 -1.051 0 C-N-CA 123.674 0.79 . . . . 10.0 109.784 -176.119 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -72.64 100.45 2.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.608 1.563 . . . . 10.0 109.686 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -128.82 178.93 6.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.562 0.345 . . . . 10.0 110.179 172.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -118.17 114.22 22.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.064 0.546 . . . . 10.0 110.505 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mt -79.54 92.76 5.33 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 106.689 -1.597 . . . . 10.0 106.689 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 119.89 5.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.451 -0.421 0 C-N-CA 126.818 2.047 . . . . 10.0 110.837 178.606 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -70.39 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.718 1.207 . . . . 10.0 108.764 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -48.11 -44.46 31.9 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.692 1.197 . . . . 10.0 110.941 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -59.8 -58.95 6.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.586 0.708 . . . . 10.0 110.57 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.16 -41.41 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -13.81 7.77 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.171 -1.349 . . . . 10.0 115.289 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.8 -21.39 34.54 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.289 2.045 . . . . 10.0 108.87 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -66.23 121.81 16.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.455 0.645 . . . . 10.0 111.834 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -45.17 -39.61 6.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.266 1.427 . . . . 10.0 111.776 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.58 7.62 81.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.249 1.404 . . . . 10.0 114.69 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.81 160.59 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 120.599 2.199 . . . . 10.0 111.202 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 t -133.24 -44.57 0.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.63 1.172 . . . . 10.0 111.095 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.9 148.34 35.28 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.786 0.834 . . . . 10.0 108.768 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -141.11 58.31 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.157 0.983 . . . . 10.0 111.292 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.02 67.36 7.99 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.787 -1.196 . . . . 10.0 111.508 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.29 134.9 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.85 1.26 . . . . 10.0 111.576 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.55 55.86 0.69 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -63.41 -23.53 67.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.792 -1.193 . . . . 10.0 111.755 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.32 -32.37 72.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.672 0.789 . . . . 10.0 110.45 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.87 -23.98 44.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.1 29.59 9.55 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.876 1.227 . . . . 10.0 110.275 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -146.34 169.4 18.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.424 1.107 . . . . 10.0 109.964 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.23 118.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.856 -3.016 . . . . 10.0 102.856 169.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.88 99.27 10.84 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.87 112.38 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 125.818 1.647 . . . . 10.0 108.803 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 t -94.81 114.96 26.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.693 -1.225 . . . . 10.0 107.693 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -144.7 154.79 43.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.01 79.31 8.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.242 1.02 . . . . 10.0 111.354 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -35.98 -44.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 112.941 -1.936 . . . . 10.0 112.284 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -44.84 -54.14 6.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.213 1.405 . . . . 10.0 112.299 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.22 -40.42 14.56 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.97 -0.381 . . . . 10.0 109.97 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.69 104.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.4 150.05 48.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.591 -0.693 . . . . 10.0 110.248 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 t -33.85 -51.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 125.569 1.548 . . . . 10.0 113.485 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -49.04 -59.98 3.17 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.53 -42.62 33.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.411 1.485 . . . . 10.0 110.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mm -65.81 -45.38 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.514 -0.742 . . . . 10.0 110.459 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.78 96.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.23 -39.25 75.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.07 69.96 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.5 -46.83 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -59.27 -30.19 68.12 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.716 0.689 . . . . 10.0 111.675 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.86 -24.5 67.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.568 -0.707 . . . . 10.0 112.211 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -112.87 -66.84 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.092 1.757 . . . . 10.0 111.362 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 -148.55 9.99 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.096 1.807 . . . . 10.0 108.754 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -161.98 55.16 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.989 1.394 . . . . 10.0 108.266 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.51 61.91 1.67 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 -168.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 p -149.69 85.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.779 0.799 . . . . 10.0 109.518 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.59 -66.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.382 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt 168.74 172.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.962 2.505 . . . . 10.0 110.266 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 O-C-N 121.598 -0.689 . . . . 10.0 111.645 173.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 104.332 -2.47 . . . . 10.0 104.332 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -71.0 107.07 3.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -131.25 176.2 8.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.732 0.777 . . . . 10.0 111.471 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -112.06 102.5 10.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.585 1.554 . . . . 10.0 110.54 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tt -82.09 94.67 7.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.07 1.348 . . . . 10.0 107.856 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.43 119.39 7.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.591 -0.892 . . . . 10.0 108.591 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 126.799 2.04 . . . . 10.0 109.178 177.437 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 119.204 -0.427 . . . . 10.0 111.437 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -50.41 12.82 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 m -54.93 -36.86 65.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.728 1.211 . . . . 10.0 111.76 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -56.7 -49.91 73.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.232 0.924 . . . . 10.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.04 -43.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.5 8.57 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.014 1.292 . . . . 10.0 115.167 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.56 -21.49 28.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.343 1.572 . . . . 10.0 109.094 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.2 mt -67.05 125.32 25.64 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 122.024 -0.422 . . . . 10.0 110.909 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -48.18 -38.15 17.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.303 1.049 . . . . 10.0 111.783 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.92 -1.43 87.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.018 1.294 . . . . 10.0 114.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 166.09 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.753 2.276 . . . . 10.0 112.273 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 t -141.0 -45.43 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.923 1.289 . . . . 10.0 111.385 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.4 147.59 34.86 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.507 1.123 . . . . 10.0 108.483 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 58.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.618 1.167 . . . . 10.0 112.193 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 87.11 5.49 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.123 -1.611 . . . . 10.0 109.874 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.52 115.28 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 10.0 111.259 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.58 62.95 1.44 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -21.24 32.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.614 -0.679 . . . . 10.0 111.839 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.68 -37.99 89.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.009 0.924 . . . . 10.0 109.001 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.03 -24.7 43.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 23.45 43.23 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.151 -1.579 . . . . 10.0 109.151 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -155.7 116.15 3.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.42 146.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.301 -2.111 . . . . 10.0 105.301 167.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.27 96.31 6.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.938 -1.505 . . . . 10.0 106.938 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 1.6 m -119.76 106.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 122.316 1.055 . . . . 10.0 108.849 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 t -99.62 121.22 40.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.275 -1.379 . . . . 10.0 107.275 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.404 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.5 p90 -148.87 172.06 15.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.033 0.933 . . . . 10.0 111.013 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.41 83.32 2.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.547 1.165 . . . . 10.0 113.301 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.2 -31.73 9.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.011 -1.904 . . . . 10.0 112.607 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -51.36 -60.7 2.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.269 1.028 . . . . 10.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -82.55 -46.57 13.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.368 -0.604 . . . . 10.0 109.368 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.17 94.18 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -60.81 153.36 24.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.116 0.484 . . . . 10.0 110.395 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 t -42.56 -42.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 121.353 -0.842 . . . . 10.0 112.749 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -50.57 -61.83 1.95 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -47.15 -39.61 14.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.111 0.964 . . . . 10.0 111.063 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mm -70.28 -48.53 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.82 89.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.951 0.9 . . . . 10.0 109.826 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.05 -26.48 67.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.786 -0.571 . . . . 10.0 112.077 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -67.59 -49.08 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.886 -1.524 . . . . 10.0 106.886 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -36.14 62.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.05 0.54 . . . . 10.0 110.778 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -51.56 -37.77 51.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.071 0.549 . . . . 10.0 112.327 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.45 -62.11 1.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.91 1.284 . . . . 10.0 111.785 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.95 -152.36 9.16 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.692 1.615 . . . . 10.0 109.631 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.15 51.43 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 10.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.46 68.39 0.85 Allowed 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 107.234 -1.395 . . . . 10.0 107.234 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.22 100.34 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.168 0.987 . . . . 10.0 108.873 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.8 -34.35 77.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 10.0 109.677 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 tttm 117.87 169.79 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 129.186 2.995 . . . . 10.0 110.501 171.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 O-C-N 121.347 -0.846 . . . . 10.0 109.254 175.303 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.417 0.525 . . . . 10.0 112.417 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -83.34 99.72 10.21 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.346 2.258 . . . . 10.0 110.053 169.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -136.96 177.26 8.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.217 0.462 . . . . 10.0 111.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.4 m -114.05 110.37 19.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.035 1.334 . . . . 10.0 109.302 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mt -83.44 93.12 7.72 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.57 118.37 2.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.015 0.926 . . . . 10.0 109.443 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t . . . . . 0 C--O 1.231 0.107 0 C-N-CA 124.62 1.168 . . . . 10.0 111.523 178.529 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 t . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.405 0.621 . . . . 10.0 109.981 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.71 -68.41 0.41 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.749 1.619 . . . . 10.0 109.114 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 m -48.51 -43.78 35.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.943 1.697 . . . . 10.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -56.94 -60.89 2.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 10.0 110.147 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -60.48 -40.23 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.65 -17.66 28.09 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.641 1.591 . . . . 10.0 114.789 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.03 -21.73 36.82 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.645 1.723 . . . . 10.0 108.416 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.1 mt -66.97 122.1 16.98 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.108 0.48 . . . . 10.0 111.373 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.5 -37.54 5.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.985 1.314 . . . . 10.0 112.107 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.07 90.44 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.086 1.327 . . . . 10.0 114.692 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.21 163.49 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 120.555 2.178 . . . . 10.0 111.909 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 t -133.82 -47.34 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.336 1.455 . . . . 10.0 110.633 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.03 148.46 35.25 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.54 59.1 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.32 1.048 . . . . 10.0 110.991 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.54 69.47 8.2 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.079 -1.013 . . . . 10.0 110.408 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.12 124.81 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.009 0.924 . . . . 10.0 110.939 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.8 58.03 1.23 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.32 -1.363 . . . . 10.0 107.32 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -57.76 -26.71 62.25 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.562 -0.711 . . . . 10.0 111.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.16 -38.65 73.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.165 1.386 . . . . 10.0 110.746 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.49 2.77 46.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.769 1.228 . . . . 10.0 111.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.24 98.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.8 -1.32 . . . . 10.0 109.8 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 157.91 35.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.821 0.81 . . . . 10.0 109.21 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.21 102.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.1 97.82 10.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.01 110.61 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.372 1.069 . . . . 10.0 109.042 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 t -95.02 117.12 29.62 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -148.96 154.06 38.84 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.256 1.027 . . . . 10.0 113.712 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -82.55 81.0 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.879 -1.055 . . . . 10.0 112.411 -170.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.31 -44.73 0.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.002 1.321 . . . . 10.0 111.519 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -52.12 64.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.762 2.025 . . . . 10.0 111.369 -174.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.79 -41.78 25.81 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.731 0.696 . . . . 10.0 109.937 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.91 107.7 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.141 0.976 . . . . 10.0 108.63 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.48 152.01 39.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.788 -0.57 . . . . 10.0 110.354 -171.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -39.72 -45.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.489 1.116 . . . . 10.0 112.553 170.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -52.23 -58.15 7.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.393 -0.337 . . . . 10.0 110.386 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.98 -41.09 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.568 0.747 . . . . 10.0 109.625 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.3 -53.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.79 79.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.18 -1.045 . . . . 10.0 108.18 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.67 -32.58 73.67 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.751 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.31 74.41 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.899 -1.126 . . . . 10.0 112.605 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.57 -36.19 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.275 -1.516 . . . . 10.0 108.412 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.62 -49.31 68.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.994 0.815 . . . . 10.0 109.896 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -51.3 -49.5 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.089 0.471 . . . . 10.0 111.819 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.47 -19.9 27.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 -171.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.79 99.79 0.22 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.534 -1.426 . . . . 10.0 109.534 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -67.89 54.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.109 2.263 . . . . 10.0 117.109 -167.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.81 74.41 2.67 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 120.145 -1.597 . . . . 10.0 108.027 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.54 110.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.366 -0.834 . . . . 10.0 108.913 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.45 -73.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.942 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 175.8 174.91 0.28 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.467 1.907 . . . . 10.0 110.643 169.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 O-C-N 121.778 -0.576 . . . . 10.0 111.041 174.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -88.63 106.53 18.38 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 125.449 1.5 . . . . 10.0 110.608 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -136.39 176.29 8.83 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.1 0.864 . . . . 10.0 112.475 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 m -116.0 108.34 16.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.879 0.872 . . . . 10.0 109.189 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.87 79.8 3.45 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.43 122.12 0.89 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.013 1.325 . . . . 10.0 109.003 172.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 C-N-CA 127.773 2.429 . . . . 10.0 107.74 -170.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 119.705 -0.188 . . . . 10.0 110.999 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -91.01 -69.82 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.36 1.064 . . . . 10.0 109.274 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.3 m -36.45 -53.36 0.86 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.181 2.192 . . . . 10.0 111.495 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -51.2 -55.61 17.13 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.301 1.441 . . . . 10.0 110.959 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.0 -19.8 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.559 1.144 . . . . 10.0 110.326 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.47 73.11 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.777 1.18 . . . . 10.0 112.169 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -89.13 -40.24 13.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.023 1.411 . . . . 10.0 108.136 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.69 123.78 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.471 0.545 . . . . 10.0 112.471 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -51.74 -34.86 41.0 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.896 1.278 . . . . 10.0 111.779 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.5 0.64 87.63 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.328 1.442 . . . . 10.0 114.234 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.37 156.26 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 119.849 -1.971 . . . . 10.0 111.54 169.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 t -128.59 -44.3 1.37 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 10.0 110.902 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.06 149.1 33.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.792 -1.099 . . . . 10.0 108.457 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.4 58.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.859 0.864 . . . . 10.0 112.062 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.73 74.06 7.68 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.306 -1.496 . . . . 10.0 111.432 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.23 121.81 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.584 1.153 . . . . 10.0 111.578 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.29 56.61 1.0 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.882 -1.155 . . . . 10.0 107.882 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -59.65 -21.88 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.631 -0.668 . . . . 10.0 111.338 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.98 -39.69 94.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.358 1.463 . . . . 10.0 108.865 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.41 -27.17 41.77 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.79 0.436 . . . . 10.0 110.42 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.32 22.8 9.47 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.128 1.347 . . . . 10.0 111.081 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -147.16 168.52 21.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.634 1.174 . . . . 10.0 108.123 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -157.18 102.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.011 -2.218 . . . . 10.0 105.011 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.23 95.76 6.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.455 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -112.86 108.75 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 122.5 1.143 . . . . 10.0 109.133 -174.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 t -103.18 120.92 41.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -152.36 155.63 37.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.412 1.264 . . . . 10.0 114.412 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.13 84.0 5.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.944 -1.025 . . . . 10.0 111.735 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.46 1.53 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.022 1.329 . . . . 10.0 110.142 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.75 -44.75 9.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.505 2.722 . . . . 10.0 112.595 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -46.76 10.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.041 0.382 . . . . 10.0 110.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.21 115.37 18.12 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.079 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.04 144.67 50.32 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 -170.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -25.53 -55.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.16 2.184 . . . . 10.0 113.661 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -47.95 -62.47 1.45 Allowed 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.6 -39.08 72.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.515 1.526 . . . . 10.0 110.27 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.417 HG22 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mm -61.45 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 119.152 0.887 . . . . 10.0 108.802 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.46 85.75 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -58.46 -34.09 70.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 122.926 0.49 . . . . 10.0 109.978 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -33.13 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mp -64.47 -49.77 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -31.71 64.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.248 0.477 . . . . 10.0 111.245 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.12 -23.14 66.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.226 0.61 . . . . 10.0 112.099 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -113.39 -63.64 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.452 1.501 . . . . 10.0 111.306 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.16 -146.09 9.56 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.219 1.866 . . . . 10.0 109.344 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -164.8 51.22 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.023 1.411 . . . . 10.0 109.554 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.98 66.11 1.36 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.424 -1.695 . . . . 10.0 106.424 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -147.35 99.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.8 -66.51 0.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.64 -0.695 . . . . 10.0 109.663 168.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt 165.86 179.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.31 1.444 . . . . 10.0 113.507 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 mm . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 174.888 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 119.678 -0.201 . . . . 10.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -78.3 103.88 8.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.095 0.958 . . . . 10.0 109.383 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -127.03 176.57 7.25 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -118.14 119.4 34.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.995 -0.742 . . . . 10.0 108.995 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 13.1 mt -77.55 107.67 10.18 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.66 116.75 2.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.342 -1.725 . . . . 10.0 106.342 168.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 126.967 2.107 . . . . 10.0 106.867 177.345 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 119.619 -0.229 . . . . 10.0 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -58.46 3.21 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -46.65 -50.54 17.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.829 1.651 . . . . 10.0 111.793 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -52.39 -60.94 2.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 122.594 1.188 . . . . 10.0 110.501 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.79 -40.42 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.41 -17.46 1.91 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.416 1.484 . . . . 10.0 114.495 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -24.37 30.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.952 1.876 . . . . 10.0 108.757 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.28 125.7 27.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.67 -0.644 . . . . 10.0 110.602 -172.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -48.51 -38.53 20.44 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.446 1.098 . . . . 10.0 112.019 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.06 75.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 114.132 -1.395 . . . . 10.0 114.042 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.35 158.27 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.02 1.91 . . . . 10.0 111.76 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.4 t -133.41 -47.66 0.83 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.907 0.883 . . . . 10.0 110.887 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.41 145.5 41.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.251 -0.88 . . . . 10.0 108.873 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.96 59.27 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.861 1.264 . . . . 10.0 110.918 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -78.41 76.3 4.92 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.36 -1.463 . . . . 10.0 109.263 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.55 133.34 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.393 1.077 . . . . 10.0 111.132 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -154.9 58.2 0.67 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -61.53 -19.8 62.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.131 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -69.42 -36.13 76.4 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.037 0.935 . . . . 10.0 110.372 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.01 50.46 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 109.673 -0.492 . . . . 10.0 109.673 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.72 32.35 8.12 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.489 -1.445 . . . . 10.0 109.489 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -152.31 171.09 18.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.557 1.143 . . . . 10.0 107.937 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -156.34 125.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 103.062 -2.94 . . . . 10.0 103.062 175.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.67 104.08 15.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.486 -1.302 . . . . 10.0 107.486 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -116.58 107.46 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 124.462 1.105 . . . . 10.0 109.16 -172.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.6 t -95.68 113.67 25.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.6 p90 -138.36 154.07 48.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.866 -1.061 . . . . 10.0 112.089 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -80.49 77.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.959 -1.019 . . . . 10.0 112.506 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.65 -38.59 0.41 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.937 1.695 . . . . 10.0 112.902 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.23 -39.02 78.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.793 0.837 . . . . 10.0 110.641 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -80.87 -50.13 10.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.87 0.868 . . . . 10.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.72 137.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.337 0.04 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.77 142.16 34.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 122.0 -0.437 . . . . 10.0 110.479 -168.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.8 t -35.36 -48.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 126.222 1.809 . . . . 10.0 112.458 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -51.7 -65.83 0.49 Allowed 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.429 -0.952 . . . . 10.0 108.429 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -42.56 -41.88 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.693 1.197 . . . . 10.0 111.682 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.2 mm -66.0 -43.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.037 0.835 . . . . 10.0 111.153 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.06 -50.68 69.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.1 -37.22 74.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.823 0.849 . . . . 10.0 109.368 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.68 -29.8 64.95 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.647 0.98 . . . . 10.0 113.647 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -42.85 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.598 -1.314 . . . . 10.0 108.423 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.86 -30.63 71.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.461 0.573 . . . . 10.0 111.115 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.7 -50.97 64.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.992 0.425 . . . . 10.0 110.957 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -49.64 6.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.558 0.947 . . . . 10.0 113.558 -168.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.53 94.23 0.11 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -66.61 102.01 0.86 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.818 1.247 . . . . 10.0 111.711 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.22 74.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 p -156.79 77.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -33.88 -61.8 0.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.38 1.072 . . . . 10.0 112.99 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mttt 157.0 176.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.523 2.329 . . . . 10.0 113.092 169.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mm . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 179.844 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.843 2.057 . . . . 10.0 110.408 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.04 176.63 4.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.169 0.509 . . . . 10.0 110.023 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.9 m -114.59 109.39 18.18 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.312 1.045 . . . . 10.0 109.297 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.35 83.42 3.8 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.959 0.903 . . . . 10.0 109.267 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.98 116.46 0.45 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.461 1.104 . . . . 10.0 109.76 169.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 C-N-CA 128.77 2.828 . . . . 10.0 109.241 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 119.877 -0.106 . . . . 10.0 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -79.31 -72.31 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.336 1.054 . . . . 10.0 109.404 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -44.35 -49.97 9.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.103 2.161 . . . . 10.0 111.63 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.0 m -54.56 -56.18 21.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.771 0.829 . . . . 10.0 110.47 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -67.77 -39.85 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -14.46 17.74 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.964 1.269 . . . . 10.0 114.612 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -81.55 -21.47 38.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.599 1.7 . . . . 10.0 108.935 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.9 mt -69.14 120.74 15.45 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 123.185 0.594 . . . . 10.0 111.31 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.97 -39.93 4.37 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.99 1.316 . . . . 10.0 111.94 169.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.63 -4.72 90.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.031 1.301 . . . . 10.0 114.617 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.85 162.55 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.286 2.043 . . . . 10.0 112.103 175.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -135.33 -45.22 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 10.0 111.038 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.73 146.94 29.42 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.265 1.026 . . . . 10.0 108.437 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.5 57.47 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.744 0.818 . . . . 10.0 111.381 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -80.79 75.13 7.72 Favored 'General case' 0 N--CA 1.46 0.057 0 O-C-N 120.726 -1.234 . . . . 10.0 110.254 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.78 127.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.16 0.984 . . . . 10.0 110.742 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -146.81 58.45 1.18 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.31 -24.2 64.81 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.006 -0.434 . . . . 10.0 110.961 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.44 -33.5 72.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.571 1.548 . . . . 10.0 110.151 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.23 -3.24 55.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.209 1.403 . . . . 10.0 111.728 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.62 41.07 25.42 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -156.35 165.68 35.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.028 0.918 . . . . 10.0 110.885 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.42 107.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 104.726 -2.324 . . . . 10.0 104.726 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.1 98.71 11.69 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.215 -1.402 . . . . 10.0 107.215 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -114.08 110.18 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.962 -170.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -93.78 114.35 26.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.401 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -145.48 158.93 43.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.833 0.825 . . . . 10.0 112.366 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -79.75 83.05 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.145 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.12 -29.74 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.936 -1.484 . . . . 10.0 113.549 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.82 -52.34 21.08 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.365 0.984 . . . . 10.0 110.402 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -78.38 -38.02 42.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.86 102.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.505 1.122 . . . . 10.0 108.425 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -64.33 152.77 40.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.198 -0.939 . . . . 10.0 110.638 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.42 -39.35 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.867 0.867 . . . . 10.0 112.794 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -56.44 21.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.917 0.887 . . . . 10.0 109.469 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.88 -44.11 66.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.039 0.936 . . . . 10.0 110.624 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 mm -60.58 -51.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.307 -0.998 . . . . 10.0 108.307 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.4 88.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.58 -42.02 77.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.124 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -33.33 67.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.143 -0.456 . . . . 10.0 112.208 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mp -66.48 -45.26 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 119.864 1.211 . . . . 10.0 108.806 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -61.07 -22.9 65.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.388 0.994 . . . . 10.0 112.075 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.05 -39.95 79.72 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 10.0 110.689 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.85 -65.94 1.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.428 1.491 . . . . 10.0 112.222 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.41 -159.05 28.98 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.247 -1.541 . . . . 10.0 109.247 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -151.76 56.78 0.86 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.888 1.344 . . . . 10.0 108.567 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.87 53.03 1.38 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.1 t -142.25 92.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.93 -62.88 1.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.878 -1.056 . . . . 10.0 109.581 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tttp 169.54 179.79 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.005 1.322 . . . . 10.0 112.53 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 tp . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 169.771 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 40.4 mt-10 . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 111.607 0.225 . . . . 10.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -91.84 107.85 19.5 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.521 2.329 . . . . 10.0 110.407 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 17.8 mttt -128.89 173.74 10.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.399 0.619 . . . . 10.0 111.126 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -112.42 111.56 22.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.416 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 3.9 mt -78.51 99.86 6.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 121.46 9.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.208 -0.932 . . . . 10.0 108.918 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 127.719 2.407 . . . . 10.0 108.698 -177.115 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 110.739 -0.097 . . . . 10.0 110.739 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -70.32 -66.22 0.63 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.098 1.359 . . . . 10.0 108.775 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.1 m -46.44 -51.16 15.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.481 1.912 . . . . 10.0 111.8 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -55.83 -54.9 38.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.41 1.005 . . . . 10.0 110.957 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.37 -40.87 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.03 -13.15 8.2 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.366 -1.241 . . . . 10.0 115.513 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.22 -24.93 46.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.006 1.903 . . . . 10.0 108.534 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.3 mt -69.33 119.21 13.24 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.458 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.13 -42.78 3.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.263 1.425 . . . . 10.0 111.7 169.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.1 -4.29 89.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.109 -1.405 . . . . 10.0 115.138 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 162.01 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.526 2.163 . . . . 10.0 111.713 174.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -133.08 -46.56 0.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.717 1.207 . . . . 10.0 111.108 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.81 38.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 118.172 -0.918 . . . . 10.0 108.724 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.77 57.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.642 1.177 . . . . 10.0 111.504 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 69.16 4.57 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.691 -1.256 . . . . 10.0 111.499 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.2 126.78 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.815 1.246 . . . . 10.0 112.151 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -148.44 58.18 1.07 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.78 -21.53 66.51 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.751 -1.218 . . . . 10.0 111.869 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -61.32 -37.84 84.73 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.378 1.071 . . . . 10.0 109.642 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.51 -28.32 41.38 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.34 12.58 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.752 1.644 . . . . 10.0 110.827 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -142.11 167.08 22.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.996 0.918 . . . . 10.0 109.503 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -158.47 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.617 -1.994 . . . . 10.0 105.617 -178.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.57 99.43 6.52 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.368 0.985 . . . . 10.0 108.514 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 1.3 m -108.49 109.48 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 125.09 1.356 . . . . 10.0 109.461 -175.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -95.96 115.05 26.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -145.23 154.7 42.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -76.75 82.0 3.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.055 -0.975 . . . . 10.0 112.525 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.04 -28.07 0.65 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.709 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.62 -48.75 18.13 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.949 1.249 . . . . 10.0 110.188 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -82.26 -34.28 28.85 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.056 -0.402 . . . . 10.0 110.276 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.15 104.1 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 10.0 108.556 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 150.35 48.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.195 -0.94 . . . . 10.0 110.24 -171.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -40.64 -40.14 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.921 0.889 . . . . 10.0 113.148 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 3.7 ttpp -58.14 -54.86 42.17 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 123.002 0.521 . . . . 10.0 109.773 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.87 -44.78 63.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.145 0.978 . . . . 10.0 110.17 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mm -62.57 -43.41 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 121.534 -0.729 . . . . 10.0 110.24 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.81 93.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 54' ' ' LYS . 10.0 m-20 -53.36 -42.23 66.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.315 -0.624 . . . . 10.0 109.315 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.61 -36.92 74.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.5 -49.11 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 168.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.41 -22.36 66.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.59 -39.26 88.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.223 0.535 . . . . 10.0 110.552 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.34 -57.65 2.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.442 1.497 . . . . 10.0 111.136 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.09 -152.42 8.65 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.506 2.003 . . . . 10.0 108.59 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -150.36 55.71 0.92 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.388 1.094 . . . . 10.0 108.449 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.66 57.35 1.77 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.212 -1.033 . . . . 10.0 108.212 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.266 14.5 p -147.81 82.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.596 1.189 . . . . 10.0 111.57 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.21 -60.31 1.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.321 -1.763 . . . . 10.0 110.574 168.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.383 24.0 mttp 140.96 -176.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.39 3.076 . . . . 10.0 114.026 169.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm . . . . . 0 N--CA 1.442 -0.861 0 O-C-N 121.839 -0.538 . . . . 10.0 110.136 -167.288 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -88.81 101.99 14.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 125.441 1.497 . . . . 10.0 110.26 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -137.08 176.62 8.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.325 0.511 . . . . 10.0 111.136 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -116.39 116.57 27.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.526 0.73 . . . . 10.0 109.64 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.1 mt -78.41 109.82 12.92 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.038 -1.838 . . . . 10.0 106.038 169.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.06 119.32 4.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.963 1.256 . . . . 10.0 107.904 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 125.24 1.416 . . . . 10.0 108.164 178.525 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 110.078 -0.341 . . . . 10.0 110.078 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -68.83 0.32 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.266 1.426 . . . . 10.0 107.555 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 m -48.18 -45.44 33.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.548 1.539 . . . . 10.0 111.194 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 m -52.4 -58.41 6.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 122.106 0.955 . . . . 10.0 110.808 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.68 -42.76 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.09 -11.9 10.17 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.429 1.49 . . . . 10.0 115.321 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.73 -26.35 37.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.804 1.802 . . . . 10.0 108.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.72 122.35 17.45 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.005 -0.434 . . . . 10.0 111.037 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -50.35 -35.23 26.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.29 1.043 . . . . 10.0 111.853 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.73 -3.78 89.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.196 1.379 . . . . 10.0 114.617 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.36 163.39 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.435 2.117 . . . . 10.0 111.312 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -137.7 -44.75 0.53 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.776 1.231 . . . . 10.0 111.313 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.6 149.82 36.41 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.927 . . . . 10.0 108.501 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.09 57.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 10.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.22 67.82 5.04 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.67 -1.269 . . . . 10.0 110.478 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.87 123.5 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.435 1.094 . . . . 10.0 110.913 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -144.52 57.86 1.31 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.485 -0.759 . . . . 10.0 111.099 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -61.55 -39.0 89.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.797 1.239 . . . . 10.0 109.804 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.71 -26.97 44.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.221 0.608 . . . . 10.0 109.59 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.43 32.36 7.02 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.78 -1.328 . . . . 10.0 109.78 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -149.55 162.62 39.8 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -144.0 120.3 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 102.649 -3.093 . . . . 10.0 102.649 169.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -96.24 96.24 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.43 104.84 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -170.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -92.06 117.55 29.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.411 -1.7 . . . . 10.0 106.411 171.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.63 154.75 41.83 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.675 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.7 89.0 7.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.866 0.841 . . . . 10.0 112.681 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.12 -24.91 1.25 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.661 -1.609 . . . . 10.0 114.074 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.48 -56.17 25.41 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.898 1.227 . . . . 10.0 110.278 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -86.16 -40.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.184 -0.916 . . . . 10.0 109.827 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.48 99.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 p -64.97 154.69 36.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.429 -0.795 . . . . 10.0 110.521 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.92 -40.22 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.273 1.029 . . . . 10.0 113.152 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -53.88 -65.58 0.54 Allowed 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 108.697 -0.853 . . . . 10.0 108.697 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -43.58 -43.83 5.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.84 0.856 . . . . 10.0 110.613 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.82 -44.51 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.517 -0.739 . . . . 10.0 111.156 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.65 92.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.97 -38.67 79.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.53 -0.915 . . . . 10.0 108.53 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.15 69.47 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.753 -0.592 . . . . 10.0 112.311 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.41 -48.37 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 167.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.6 -29.77 68.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.122 0.874 . . . . 10.0 112.737 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.28 -36.46 61.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.671 0.669 . . . . 10.0 111.86 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -56.39 2.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.535 1.134 . . . . 10.0 112.752 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.33 -145.95 6.31 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.206 1.86 . . . . 10.0 109.176 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -165.71 56.9 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.572 1.686 . . . . 10.0 109.977 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.6 66.54 1.55 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.59 68.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 113.383 0.882 . . . . 10.0 113.383 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -29.75 -71.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.997 1.11 . . . . 10.0 113.997 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 167.95 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.775 1.63 . . . . 10.0 113.338 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 106.921 -1.511 . . . . 10.0 106.921 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.92 106.81 4.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.965 -1.124 . . . . 10.0 107.965 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -128.8 161.93 28.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.781 0.801 . . . . 10.0 111.126 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 m -112.02 93.76 4.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.216 1.406 . . . . 10.0 108.067 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tt -78.02 94.23 4.61 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.81 1.244 . . . . 10.0 108.309 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 117.84 6.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.452 -0.35 0 C-N-CA 126.725 2.01 . . . . 10.0 111.004 175.494 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.598 0.713 . . . . 10.0 109.16 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -61.94 -57.43 11.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.231 1.812 . . . . 10.0 108.364 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 m -48.15 -53.95 15.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.181 0.992 . . . . 10.0 110.172 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 m -67.62 -54.13 22.28 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.76 0.314 . . . . 10.0 111.726 -168.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.54 -44.14 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.771 -0.825 . . . . 10.0 108.771 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.28 -2.46 7.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.015 -1.436 . . . . 10.0 114.817 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -81.5 -31.32 32.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 120.123 1.962 . . . . 10.0 108.5 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 123.37 21.28 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 122.095 -0.378 . . . . 10.0 111.002 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.78 -35.14 56.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.2 1.0 . . . . 10.0 111.787 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.64 -12.7 59.7 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.393 -1.276 . . . . 10.0 113.673 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.81 161.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.73 1.765 . . . . 10.0 112.027 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.1 t -138.7 -46.78 0.49 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.44 1.096 . . . . 10.0 110.929 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.42 44.23 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.31 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.268 1.027 . . . . 10.0 110.631 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -83.0 77.1 9.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 120.976 -1.077 . . . . 10.0 108.22 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.71 112.63 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 123.494 0.718 . . . . 10.0 110.113 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -136.23 56.83 1.8 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.246 -1.761 . . . . 10.0 106.246 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.88 -23.43 63.44 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.34 -0.85 . . . . 10.0 111.344 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.24 -31.14 72.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.567 0.621 . . . . 10.0 111.034 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.03 -4.62 53.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.617 0.767 . . . . 10.0 111.586 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.83 19.62 79.74 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.339 1.447 . . . . 10.0 111.131 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -156.06 133.22 10.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.855 0.827 . . . . 10.0 109.274 -168.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.23 120.62 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.04 94.85 9.34 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 m -108.16 109.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -96.31 120.81 37.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.222 -1.769 . . . . 10.0 106.222 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.95 171.99 14.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.767 0.427 . . . . 10.0 111.272 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.4 82.52 2.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.22 -43.26 10.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.755 -1.566 . . . . 10.0 112.233 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -53.96 19.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.812 0.845 . . . . 10.0 111.505 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -38.3 20.53 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.141 -0.349 . . . . 10.0 110.614 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 101.9 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.678 1.591 . . . . 10.0 108.216 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 148.36 38.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.272 0.629 . . . . 10.0 110.234 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.44 -41.21 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.065 -1.022 . . . . 10.0 113.616 172.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.24 -52.62 64.58 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 10.0 110.653 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -52.01 -45.65 64.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.459 1.104 . . . . 10.0 110.08 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mm -61.6 -48.94 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.17 84.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.03 -33.4 75.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.666 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.66 69.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.321 -0.862 . . . . 10.0 111.721 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mp -68.87 -47.87 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.92 -1.511 . . . . 10.0 106.92 168.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.76 -30.71 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.04 0.836 . . . . 10.0 111.529 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.95 -37.59 77.1 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.984 -0.447 . . . . 10.0 112.007 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 -66.89 0.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.062 1.345 . . . . 10.0 112.043 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.48 -152.14 12.17 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 126.426 1.965 . . . . 10.0 109.224 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -165.67 55.63 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.378 1.089 . . . . 10.0 110.357 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.91 61.65 1.67 Allowed 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.63 97.94 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 C-N-CA 123.82 0.848 . . . . 10.0 108.841 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.03 -73.11 0.06 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.865 -1.061 . . . . 10.0 108.929 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.69 172.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.506 1.522 . . . . 10.0 111.457 169.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp . . . . . 0 N--CA 1.445 -0.698 0 O-C-N 122.128 -0.358 . . . . 10.0 111.124 171.69 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.84 97.93 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.04 0.936 . . . . 10.0 109.53 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -131.85 173.27 11.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.039 0.447 . . . . 10.0 110.415 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -112.56 104.31 12.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.045 0.938 . . . . 10.0 109.251 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.77 86.24 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.8 123.09 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.874 0.87 . . . . 10.0 108.882 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.723 0 C-N-CA 128.353 2.661 . . . . 10.0 108.33 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 CA--C 1.542 0.656 0 CA-C-O 119.205 -0.426 . . . . 10.0 111.503 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -76.83 -74.9 0.22 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 m -40.94 -53.26 2.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.713 2.405 . . . . 10.0 111.903 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -65.76 -52.36 51.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.182 0.438 . . . . 10.0 112.182 -167.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t -56.94 -44.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.699 -1.223 . . . . 10.0 107.699 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -9.61 17.24 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.32 1.914 . . . . 10.0 116.136 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.68 -24.91 49.19 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.938 1.869 . . . . 10.0 108.687 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.82 122.49 20.81 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.375 0.67 . . . . 10.0 110.753 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.37 -41.8 20.4 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.453 1.121 . . . . 10.0 112.091 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.2 -21.76 68.47 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.047 -1.433 . . . . 10.0 113.793 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.27 150.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.567 1.684 . . . . 10.0 112.258 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.2 t -131.14 -42.6 1.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.493 1.117 . . . . 10.0 110.941 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.57 153.11 40.72 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.82 0.848 . . . . 10.0 108.917 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.75 57.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.89 1.676 . . . . 10.0 111.349 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -83.51 72.16 10.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.719 -1.238 . . . . 10.0 110.563 -169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.74 129.32 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 123.421 0.688 . . . . 10.0 111.43 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -150.32 56.22 0.93 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.995 -1.483 . . . . 10.0 106.995 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.63 -29.05 67.74 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.737 -0.602 . . . . 10.0 111.334 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -63.33 -30.87 71.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.245 1.018 . . . . 10.0 110.811 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.22 -7.16 59.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.09 0.956 . . . . 10.0 111.587 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 25.65 42.08 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 124.952 1.263 . . . . 10.0 110.834 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.22 171.8 19.57 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.4 1.095 . . . . 10.0 110.86 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.92 141.79 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 102.712 -3.07 . . . . 10.0 102.712 173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.57 91.4 3.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.83 108.15 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -169.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 106.6 18.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.43 170.35 16.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.939 0.399 . . . . 10.0 111.852 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 0.8 OUTLIER -91.04 73.23 6.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 113.016 0.747 . . . . 10.0 113.016 -168.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.94 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.922 1.289 . . . . 10.0 112.792 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.1 t70 -53.88 -57.27 11.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.697 0.799 . . . . 10.0 111.417 173.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -80.52 -39.04 28.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.105 -0.372 . . . . 10.0 110.52 -172.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.79 104.31 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 127.021 2.128 . . . . 10.0 106.638 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -64.46 157.9 25.35 Favored 'General case' 0 C--O 1.226 -0.175 0 O-C-N 121.51 -0.744 . . . . 10.0 110.383 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.25 -45.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.833 0.853 . . . . 10.0 113.207 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -61.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 175.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.77 -36.45 36.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.483 1.513 . . . . 10.0 111.449 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mm -66.09 -55.07 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.77 71.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -171.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -60.78 -37.21 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.171 0.988 . . . . 10.0 110.531 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.239 -0.913 . . . . 10.0 111.373 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.44 -34.5 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.841 -1.162 . . . . 10.0 109.335 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -45.69 76.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.281 0.946 . . . . 10.0 110.05 173.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -60.25 -38.3 83.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -126.08 79.16 1.82 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.95 0.9 . . . . 10.0 111.537 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.74 81.12 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.449 -0.66 . . . . 10.0 111.449 169.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -67.23 89.4 0.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.981 1.312 . . . . 10.0 112.142 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -134.36 58.41 1.77 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.99 97.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 O-C-N 120.821 -1.174 . . . . 10.0 110.763 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.13 -68.92 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.351 -0.841 . . . . 10.0 110.222 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.25 171.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.624 1.17 . . . . 10.0 113.925 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.222 0 O-C-N 121.461 -0.774 . . . . 10.0 110.582 172.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 106.541 -1.652 . . . . 10.0 106.541 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -101.12 111.52 23.75 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 117.453 -1.26 . . . . 10.0 108.599 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -136.4 172.74 12.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.07 1.305 . . . . 10.0 112.668 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -113.38 97.38 6.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.194 1.398 . . . . 10.0 109.226 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.59 87.8 5.74 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -177.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 119.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.276 1.03 . . . . 10.0 109.684 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.7 t . . . . . 0 C--O 1.232 0.183 0 C-N-CA 126.182 1.793 . . . . 10.0 111.177 -179.301 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.2 t . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 110.567 -0.161 . . . . 10.0 110.567 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -57.66 5.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -44.67 -55.31 5.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.869 1.267 . . . . 10.0 111.324 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 m -63.46 -58.59 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.103 0.411 . . . . 10.0 111.71 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.08 -40.0 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.87 -6.53 24.78 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 118.082 -1.399 . . . . 10.0 114.802 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.48 -20.16 44.32 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 120.365 2.083 . . . . 10.0 108.878 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.7 mt -66.22 117.71 8.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.448 0.642 . . . . 10.0 112.191 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -40.82 -43.55 2.05 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.0 2.12 . . . . 10.0 111.186 167.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.22 6.27 83.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.685 1.612 . . . . 10.0 115.405 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.02 160.54 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 120.883 2.342 . . . . 10.0 111.092 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -132.34 -42.28 0.96 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.42 1.088 . . . . 10.0 111.964 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.32 149.76 29.73 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.311 -1.366 . . . . 10.0 107.311 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.62 60.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 122.079 0.942 . . . . 10.0 110.301 -173.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.39 61.41 5.56 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.311 -0.868 . . . . 10.0 110.398 -169.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.24 121.69 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.242 1.417 . . . . 10.0 110.102 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -142.13 54.57 1.46 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 173.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.65 -26.8 67.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.548 -0.72 . . . . 10.0 111.007 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -69.03 -30.84 69.29 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.398 1.079 . . . . 10.0 110.489 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.21 -28.92 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.126 0.571 . . . . 10.0 110.116 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.45 5.4 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.906 1.241 . . . . 10.0 110.949 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -155.91 158.08 37.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.416 1.486 . . . . 10.0 107.43 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.43 94.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.029 -2.952 . . . . 10.0 103.029 -168.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.83 94.15 8.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.651 -1.611 . . . . 10.0 106.651 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 112.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 125.808 1.643 . . . . 10.0 108.038 -171.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.19 115.37 27.33 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 125.985 1.714 . . . . 10.0 106.558 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -149.13 155.76 41.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 113.248 0.833 . . . . 10.0 113.248 -173.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -77.04 82.05 3.56 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.555 0.946 . . . . 10.0 113.555 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.79 -25.63 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.128 -1.396 . . . . 10.0 113.666 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.03 -60.14 2.47 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.081 0.855 . . . . 10.0 110.479 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.83 -0.544 . . . . 10.0 110.083 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.43 103.1 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -72.02 157.66 37.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.661 -1.274 . . . . 10.0 109.065 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -32.15 -48.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 126.315 1.846 . . . . 10.0 112.301 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -62.42 1.55 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.78 -41.18 61.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.419 1.488 . . . . 10.0 109.356 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.12 -52.6 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 119.502 -0.879 . . . . 10.0 108.886 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.37 87.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -58.06 -39.33 78.21 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.627 1.171 . . . . 10.0 109.452 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.81 71.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.916 -0.49 . . . . 10.0 112.183 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mp -70.46 -40.34 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 O-C-N 120.786 -1.196 . . . . 10.0 108.368 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -60.34 -28.38 68.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.329 1.422 . . . . 10.0 112.669 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.79 -23.9 67.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 10.0 112.001 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -108.64 -68.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.299 1.84 . . . . 10.0 111.148 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 -144.58 8.42 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.9 2.19 . . . . 10.0 108.806 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -162.5 58.9 0.22 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.666 1.233 . . . . 10.0 108.275 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -137.97 54.2 1.81 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 120.91 0.386 . . . . 10.0 110.398 -166.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 92.1 t -145.86 84.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.306 -1.368 . . . . 10.0 107.306 -172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.55 -72.77 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.709 -1.132 . . . . 10.0 110.698 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 173.39 174.37 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.256 1.022 . . . . 10.0 113.549 169.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.9 mm . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 103.752 -2.684 . . . . 10.0 103.752 168.209 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -61.3 97.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.414 1.486 . . . . 10.0 111.018 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -134.54 171.37 14.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.905 0.859 . . . . 10.0 112.543 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 m -108.29 101.03 10.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.435 ' HG ' ' CG2' ' A' ' 67' ' ' VAL . 12.3 tp -84.34 72.71 10.56 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.079 1.351 . . . . 10.0 107.537 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.3 123.23 0.62 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.919 1.688 . . . . 10.0 111.497 -169.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 128.248 2.619 . . . . 10.0 109.182 -177.078 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 111.496 0.184 . . . . 10.0 111.496 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.92 -62.7 1.6 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.448 1.099 . . . . 10.0 108.471 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -50.47 -44.45 55.77 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.642 1.577 . . . . 10.0 111.99 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -54.11 -65.57 0.55 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.069 1.347 . . . . 10.0 110.627 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.43 -43.37 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 123.777 0.831 . . . . 10.0 108.787 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.43 -19.37 6.05 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.58 1.562 . . . . 10.0 115.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.26 -23.53 32.65 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 120.041 1.92 . . . . 10.0 108.873 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.6 mt -66.42 121.38 15.16 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.092 0.473 . . . . 10.0 111.151 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -44.9 -37.79 4.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.204 1.402 . . . . 10.0 112.397 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.12 -5.9 89.29 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.103 1.335 . . . . 10.0 114.684 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.63 166.52 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.245 2.023 . . . . 10.0 111.782 175.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -140.93 -49.26 0.43 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.857 0.863 . . . . 10.0 111.134 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.62 144.73 51.05 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -143.57 56.86 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.253 1.021 . . . . 10.0 111.224 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -86.11 70.29 10.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.524 -1.36 . . . . 10.0 109.017 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.15 130.98 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.402 0.681 . . . . 10.0 110.088 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.26 67.74 0.73 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.61 -21.17 65.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.581 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.27 -35.33 73.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.969 0.508 . . . . 10.0 109.651 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.27 45.68 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.0 25.81 30.72 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.954 1.264 . . . . 10.0 109.969 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -149.71 109.74 4.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.439 0.62 . . . . 10.0 109.569 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.46 148.05 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 165.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -119.12 95.79 4.96 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -112.63 109.59 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.177 1.391 . . . . 10.0 107.944 -172.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.0 t -99.6 109.93 22.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -140.76 150.67 43.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 124.411 1.07 . . . . 10.0 111.701 -174.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.24 83.35 7.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.244 -0.889 . . . . 10.0 112.958 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.54 -36.22 1.29 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.931 -1.486 . . . . 10.0 112.99 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -61.39 -53.34 57.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.343 0.657 . . . . 10.0 110.134 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.87 -40.26 28.77 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.816 -0.553 . . . . 10.0 110.792 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.15 102.74 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.081 1.352 . . . . 10.0 108.598 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.16 148.33 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.636 -0.665 . . . . 10.0 111.054 -170.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -39.09 -45.74 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.556 1.142 . . . . 10.0 113.803 173.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -58.36 -52.39 65.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.99 -43.46 50.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.713 1.205 . . . . 10.0 109.83 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mm -64.3 -46.22 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 121.561 -0.712 . . . . 10.0 110.711 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.17 90.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.863 0.84 . . . . 10.0 109.446 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -66.27 -37.49 85.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.32 82.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.949 -1.094 . . . . 10.0 111.753 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.69 -41.26 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.876 -1.14 . . . . 10.0 109.265 169.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -44.28 90.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.86 -53.95 34.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.778 0.323 . . . . 10.0 111.288 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -48.08 12.39 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.406 0.891 . . . . 10.0 113.406 -169.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.35 90.79 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 10.0 108.828 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -65.98 108.22 2.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.009 1.323 . . . . 10.0 111.156 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -166.56 78.71 0.23 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 104.091 -2.559 . . . . 10.0 104.091 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.435 ' CG2' ' HG ' ' A' ' 6' ' ' LEU . 13.9 p -155.5 83.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.16 -50.31 0.71 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.961 2.104 . . . . 10.0 113.361 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 128.16 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.338 3.055 . . . . 10.0 113.308 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.0 mm . . . . . 0 N--CA 1.441 -0.923 0 O-C-N 121.211 -0.931 . . . . 10.0 108.999 -171.588 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 44.6 mt-10 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 119.717 -0.182 . . . . 10.0 110.781 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.33 107.49 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.234 1.413 . . . . 10.0 109.918 169.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 64.6 mttt -136.69 119.72 16.5 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 121.5 24.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.859 0.464 . . . . 10.0 110.34 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.2 114.47 17.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 169.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 125.92 28.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 C-N-CA 127.811 2.444 . . . . 10.0 108.817 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.182 0.039 . . . . 10.0 110.933 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 -73.03 0.42 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.81 1.244 . . . . 10.0 109.337 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -49.62 -44.6 47.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.5 2.32 . . . . 10.0 111.267 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 t -47.04 -64.08 0.87 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.866 1.317 . . . . 10.0 109.776 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.5 t -66.66 -38.0 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.729 -1.123 . . . . 10.0 108.013 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.56 -15.29 8.3 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 117.99 -1.45 . . . . 10.0 114.81 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.32 -22.02 38.82 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.45 2.125 . . . . 10.0 109.103 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.0 mt -70.07 120.58 15.99 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.076 0.465 . . . . 10.0 110.893 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.37 -39.25 10.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.374 1.083 . . . . 10.0 111.874 169.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.15 0.88 86.79 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 114.213 -1.358 . . . . 10.0 114.753 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.72 157.86 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.334 2.067 . . . . 10.0 111.725 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -127.31 -42.92 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.666 1.186 . . . . 10.0 111.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.34 150.08 34.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.53 58.18 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.758 0.823 . . . . 10.0 111.495 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 72.39 7.18 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.67 -1.269 . . . . 10.0 110.667 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.01 124.77 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.168 0.987 . . . . 10.0 110.787 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.93 56.81 1.26 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.6 pp -62.46 -23.93 67.17 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.525 -0.734 . . . . 10.0 112.244 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.02 -31.37 72.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.287 0.494 . . . . 10.0 111.19 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.39 -7.52 58.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.397 0.679 . . . . 10.0 111.101 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.96 57.87 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.396 1.474 . . . . 10.0 109.97 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -150.96 162.07 41.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.21 1.005 . . . . 10.0 111.137 -168.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.0 t -153.37 111.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.078 -2.564 . . . . 10.0 104.078 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.45 85.08 6.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.91 126.99 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.3 t -116.08 120.81 40.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -152.34 158.48 42.79 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 123.776 0.673 . . . . 10.0 112.451 -175.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -85.56 88.99 7.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.69 -25.18 0.67 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.485 -1.689 . . . . 10.0 113.75 168.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.04 -61.86 2.32 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.655 1.116 . . . . 10.0 111.086 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -80.12 -50.92 9.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.17 95.06 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.44 -1.689 . . . . 10.0 106.44 -170.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 153.03 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.869 0.842 . . . . 10.0 109.596 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.8 t -34.99 -48.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 125.988 1.715 . . . . 10.0 112.009 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -55.17 -58.55 7.21 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -48.02 -42.88 29.29 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.601 0.76 . . . . 10.0 110.054 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 46' ' ' PHE . 2.1 mm -64.63 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.057 -0.657 . . . . 10.0 110.381 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.66 80.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -52.01 -40.86 61.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.527 0.731 . . . . 10.0 109.403 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.87 -40.04 72.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.85 -45.85 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.4 -24.78 67.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.743 0.701 . . . . 10.0 111.944 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.54 -33.89 74.61 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.984 -0.448 . . . . 10.0 111.568 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.73 -70.25 0.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.867 1.267 . . . . 10.0 112.112 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.85 -147.38 18.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.831 -1.708 . . . . 10.0 108.831 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -163.03 53.01 0.18 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 174.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.56 59.13 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -144.75 85.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.92 -62.54 1.36 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.784 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.06 177.13 0.06 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.21 2.204 . . . . 10.0 109.717 169.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 mm . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 123.473 0.709 . . . . 10.0 110.267 169.096 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 102.96 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.194 1.798 . . . . 10.0 111.001 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -144.66 176.24 9.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.936 0.789 . . . . 10.0 111.953 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 m -111.38 108.22 17.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.594 1.158 . . . . 10.0 108.745 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.22 83.23 5.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.55 126.54 2.35 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 10.0 110.796 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 128.537 2.735 . . . . 10.0 111.437 -171.721 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 119.765 -0.16 . . . . 10.0 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -71.79 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 10.0 109.119 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -49.41 -42.16 41.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.933 2.093 . . . . 10.0 112.884 -174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.6 p -50.35 -61.41 2.19 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.648 1.179 . . . . 10.0 110.201 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.457 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 89.7 t -61.9 -47.9 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 124.063 0.945 . . . . 10.0 108.524 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.92 -1.57 0.26 Allowed Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.991 -1.449 . . . . 10.0 115.828 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.92 -31.42 19.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.133 1.967 . . . . 10.0 108.688 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.6 125.01 25.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 121.403 -0.811 . . . . 10.0 111.02 -171.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.32 -36.57 32.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 122.45 1.119 . . . . 10.0 111.85 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.88 -12.99 75.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 114.23 -1.35 . . . . 10.0 114.153 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.24 146.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 120.085 1.943 . . . . 10.0 111.177 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -123.0 -47.11 2.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.891 1.676 . . . . 10.0 111.016 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.64 147.56 51.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 118.237 -0.887 . . . . 10.0 108.771 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.1 58.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.584 1.154 . . . . 10.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -79.39 75.04 5.99 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.221 -1.549 . . . . 10.0 109.501 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.59 122.73 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.362 0.665 . . . . 10.0 110.1 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -147.63 59.74 1.14 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.71 -21.38 65.73 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.695 -0.628 . . . . 10.0 111.946 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -66.47 -32.85 74.47 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.556 0.742 . . . . 10.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.87 -34.57 33.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.81 -1.96 41.72 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.26 1.886 . . . . 10.0 110.611 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -129.9 100.08 5.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.046 0.938 . . . . 10.0 108.746 -170.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -78.02 137.95 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.534 -2.024 . . . . 10.0 105.534 168.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -104.79 97.85 7.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.983 1.265 . . . . 10.0 107.812 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.81 106.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.12 1.368 . . . . 10.0 108.94 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -96.55 114.27 25.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.15 152.28 51.95 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.015 1.326 . . . . 10.0 111.649 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -82.95 84.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 122.425 1.107 . . . . 10.0 112.353 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.95 1.21 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.239 -1.801 . . . . 10.0 113.801 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.3 -49.56 76.72 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.524 0.602 . . . . 10.0 110.594 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -87.09 -48.62 7.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.86 102.63 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.39 154.55 38.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.402 0.62 . . . . 10.0 109.805 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.51 -42.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.184 1.394 . . . . 10.0 112.601 175.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -57.01 -54.44 46.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.246 0.618 . . . . 10.0 109.776 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.35 -40.68 49.91 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.907 0.883 . . . . 10.0 111.178 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.68 -49.49 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.23 -39.69 95.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -62.28 -41.68 98.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.51 79.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.385 -0.822 . . . . 10.0 110.977 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.457 ' CD1' ' CG2' ' A' ' 24' ' ' VAL . 1.9 mp -61.0 -44.2 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 O-C-N 120.981 -1.074 . . . . 10.0 108.789 168.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.91 -33.56 67.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.013 1.279 . . . . 10.0 112.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.89 -39.35 81.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.997 0.369 . . . . 10.0 111.997 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -133.93 84.4 2.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.623 1.569 . . . . 10.0 108.903 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.28 76.5 1.21 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.495 0.569 . . . . 10.0 112.116 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -68.0 55.22 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.71 2.404 . . . . 10.0 114.739 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.5 56.19 0.63 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.718 -1.238 . . . . 10.0 107.707 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 m -133.38 94.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.319 1.448 . . . . 10.0 111.398 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.65 -66.38 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.263 168.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt 160.38 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.53 1.932 . . . . 10.0 113.086 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 mm . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 179.951 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 106.822 -1.547 . . . . 10.0 106.822 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.36 89.21 1.22 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.452 1.101 . . . . 10.0 110.14 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -139.18 175.18 9.78 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.843 0.682 . . . . 10.0 112.843 -172.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -115.63 117.06 29.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.544 1.538 . . . . 10.0 108.885 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mt -86.57 97.34 10.47 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.8 118.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 t . . . . . 0 N--CA 1.454 -0.233 0 C-N-CA 124.76 1.224 . . . . 10.0 108.438 179.818 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.4 t . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 111.276 0.102 . . . . 10.0 111.276 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -77.01 -66.11 0.86 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.827 0.851 . . . . 10.0 109.048 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -51.7 -47.91 63.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.307 1.843 . . . . 10.0 111.289 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -53.04 -67.83 0.22 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 10.0 110.753 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.46 -42.33 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 124.512 1.125 . . . . 10.0 108.996 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.6 -14.04 13.53 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.07 -1.406 . . . . 10.0 115.085 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.01 -22.13 36.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 120.301 2.051 . . . . 10.0 108.697 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -67.69 117.68 9.94 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.44 0.638 . . . . 10.0 111.498 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -40.79 -40.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.594 1.958 . . . . 10.0 112.251 168.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.14 -8.5 87.56 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.285 1.421 . . . . 10.0 115.2 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.83 158.35 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.022 1.911 . . . . 10.0 111.855 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -132.27 -48.72 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.221 1.009 . . . . 10.0 110.662 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.62 146.09 51.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.099 -1.075 . . . . 10.0 108.099 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.99 57.37 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.328 1.051 . . . . 10.0 110.59 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -82.44 66.15 7.9 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.968 -1.083 . . . . 10.0 110.367 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.09 126.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.038 1.335 . . . . 10.0 110.976 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -144.27 56.14 1.3 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.12 -28.74 66.82 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.551 -0.718 . . . . 10.0 110.986 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -61.85 -31.37 71.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.921 1.289 . . . . 10.0 110.749 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.0 -4.68 56.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.769 1.228 . . . . 10.0 111.771 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.74 40.05 65.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.913 0.768 . . . . 10.0 111.233 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -155.74 160.13 40.06 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 117.901 0.851 . . . . 10.0 109.981 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.31 101.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.45 103.16 11.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.38 96.55 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.714 1.206 . . . . 10.0 107.785 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 t -88.15 105.76 17.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.86 152.39 50.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.696 0.999 . . . . 10.0 113.696 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.38 84.24 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.61 -0.723 . . . . 10.0 112.824 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.87 -30.87 10.81 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.75 -51.87 65.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.012 0.525 . . . . 10.0 110.503 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -78.82 -42.62 27.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.8 98.63 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.179 0.992 . . . . 10.0 109.426 -169.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.69 152.48 26.52 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.48 -0.762 . . . . 10.0 110.617 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -36.81 -44.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.788 1.033 . . . . 10.0 113.788 171.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -55.25 -58.21 8.65 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.36 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -46.79 -44.38 19.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.993 0.917 . . . . 10.0 110.232 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -66.99 -45.19 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.542 -0.724 . . . . 10.0 110.669 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.49 99.71 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.383 -0.969 . . . . 10.0 108.383 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.29 -38.95 88.62 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.33 71.88 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.526 -0.733 . . . . 10.0 111.653 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.3 -49.8 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.19 -30.4 68.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.563 1.074 . . . . 10.0 112.446 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.94 -29.86 69.87 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.81 -0.556 . . . . 10.0 111.342 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.51 -62.95 1.21 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.109 1.764 . . . . 10.0 111.786 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.54 -143.59 6.66 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.382 1.944 . . . . 10.0 109.18 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.28 57.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.775 1.287 . . . . 10.0 109.978 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.22 70.3 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.725 -1.954 . . . . 10.0 105.725 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.23 92.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 121.647 -0.658 . . . . 10.0 112.159 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.17 -71.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.512 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 171.03 176.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.527 1.531 . . . . 10.0 113.959 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.589 -0.523 . . . . 10.0 109.589 177.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -78.17 106.67 10.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.82 1.648 . . . . 10.0 109.945 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -128.07 174.72 8.98 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -120.75 114.99 22.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.658 -0.651 . . . . 10.0 109.593 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.09 82.07 3.6 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.76 -1.57 . . . . 10.0 106.76 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -40.34 120.27 1.19 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.439 -1.01 0 C-N-CA 126.172 1.789 . . . . 10.0 107.717 -169.451 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 t . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 119.647 -0.216 . . . . 10.0 110.909 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -78.68 -76.18 0.21 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.167 -1.419 . . . . 10.0 107.167 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -42.09 -49.96 4.75 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.573 2.749 . . . . 10.0 112.152 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -54.33 -58.24 8.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 122.253 1.025 . . . . 10.0 110.63 -177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.45 -38.66 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.29 -1.004 . . . . 10.0 108.29 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.47 -11.32 40.63 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.181 1.372 . . . . 10.0 114.531 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.94 -21.7 40.23 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.923 1.861 . . . . 10.0 108.123 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -67.37 117.25 9.1 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.45 0.643 . . . . 10.0 111.525 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -46.96 -35.27 6.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.984 1.313 . . . . 10.0 111.716 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.77 5.69 84.4 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 125.338 1.447 . . . . 10.0 114.93 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.24 159.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 120.532 2.166 . . . . 10.0 111.939 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -126.81 -44.64 1.64 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.07 1.348 . . . . 10.0 112.004 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.65 146.81 34.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.66 -1.162 . . . . 10.0 108.862 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.12 56.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.224 1.01 . . . . 10.0 112.469 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -82.6 70.85 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.158 -1.589 . . . . 10.0 111.147 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.57 126.29 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.541 0.736 . . . . 10.0 111.383 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -144.41 56.97 1.3 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.61 -24.52 67.62 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.659 -0.65 . . . . 10.0 111.529 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.1 -32.27 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.348 0.659 . . . . 10.0 110.518 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.12 44.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.33 9.35 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.118 1.342 . . . . 10.0 111.078 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -141.62 174.41 10.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 122.325 1.06 . . . . 10.0 109.276 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.1 115.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 102.996 -2.964 . . . . 10.0 102.996 174.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -91.95 101.24 13.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 120.337 1.426 . . . . 10.0 108.092 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -116.64 107.97 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.637 1.175 . . . . 10.0 109.045 -172.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -98.71 116.56 31.22 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -148.06 161.1 42.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 -176.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.33 81.8 5.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.302 -0.863 . . . . 10.0 112.97 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.47 -40.87 0.9 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.687 1.595 . . . . 10.0 112.87 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -54.88 18.82 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.31 1.044 . . . . 10.0 111.806 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -83.38 -40.72 19.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -135.43 105.2 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 148.67 49.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.588 -0.695 . . . . 10.0 110.222 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.1 t -29.31 -52.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 126.871 2.068 . . . . 10.0 112.242 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -50.32 -60.78 2.64 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.423 0.689 . . . . 10.0 109.331 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -44.76 -44.64 9.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.858 1.663 . . . . 10.0 110.192 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mm -67.15 -45.56 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.098 -1.001 . . . . 10.0 110.904 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.45 94.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -54.69 -39.69 68.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.234 1.014 . . . . 10.0 108.681 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.32 69.83 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.1 0.778 . . . . 10.0 113.1 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mp -66.26 -47.61 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.32 -26.39 68.4 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -61.97 -33.94 75.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.652 -0.655 . . . . 10.0 111.577 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -98.6 -54.29 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.316 1.446 . . . . 10.0 111.819 -169.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.12 -140.36 3.82 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.155 -1.978 . . . . 10.0 108.155 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -164.83 53.38 0.12 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.685 1.242 . . . . 10.0 110.604 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 78.4 1.48 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.918 -1.512 . . . . 10.0 106.918 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.05 108.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.33 0.14 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.5 tttt 177.75 176.85 0.4 Allowed 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 113.863 1.061 . . . . 10.0 113.863 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm . . . . . 0 CA--C 1.533 0.305 0 O-C-N 121.871 -0.518 . . . . 10.0 110.76 174.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.848 . . . . 10.0 106.012 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.34 89.7 1.61 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.529 1.132 . . . . 10.0 109.691 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -131.77 173.58 11.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.513 0.673 . . . . 10.0 111.751 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -111.91 112.92 24.92 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.542 1.537 . . . . 10.0 108.148 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -80.64 95.0 6.43 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.611 -1.996 . . . . 10.0 105.611 172.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.4 121.56 5.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.378 -1.341 . . . . 10.0 107.378 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.438 -1.074 0 C-N-CA 128.431 2.692 . . . . 10.0 108.192 -169.214 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.5 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 119.544 -0.265 . . . . 10.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -55.73 4.19 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.4 m -50.06 -53.07 29.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.753 0.821 . . . . 10.0 110.159 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -60.62 -59.95 4.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 122.583 1.183 . . . . 10.0 111.1 -168.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.82 -41.47 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.351 -0.84 . . . . 10.0 108.831 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.67 -13.28 7.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.598 1.57 . . . . 10.0 114.546 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.89 -23.0 33.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.984 1.892 . . . . 10.0 108.575 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.9 123.16 20.24 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.733 -0.604 . . . . 10.0 111.085 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -43.4 -43.06 5.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.1 1.36 . . . . 10.0 112.297 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.2 -17.61 74.17 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 113.961 -1.472 . . . . 10.0 114.016 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.4 147.84 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.732 1.766 . . . . 10.0 111.616 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -123.88 -43.23 2.13 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 10.0 110.795 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.6 154.56 44.51 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.794 0.837 . . . . 10.0 109.358 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.64 57.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.079 1.752 . . . . 10.0 111.101 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.17 66.14 7.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.919 -1.113 . . . . 10.0 111.522 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.47 132.4 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 124.618 1.167 . . . . 10.0 111.871 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -152.97 58.17 0.79 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.79 -26.12 67.05 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.179 -0.951 . . . . 10.0 111.248 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -34.54 71.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.571 1.148 . . . . 10.0 110.433 173.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.71 -4.19 58.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.104 . . . . 10.0 111.583 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.98 34.74 55.22 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.601 1.096 . . . . 10.0 111.274 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -156.98 160.56 39.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.274 1.037 . . . . 10.0 111.134 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.69 104.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.417 -2.438 . . . . 10.0 104.417 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.15 95.26 9.9 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.677 -1.601 . . . . 10.0 106.677 -175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -110.9 91.84 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.336 1.065 . . . . 10.0 109.93 -169.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 m -77.83 84.51 4.14 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.933 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -106.26 178.36 4.58 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.457 0.703 . . . . 10.0 111.372 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.05 83.78 2.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 114.246 1.202 . . . . 10.0 114.246 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -36.0 4.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.904 -1.498 . . . . 10.0 113.036 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -65.72 -54.9 21.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.267 0.485 . . . . 10.0 110.74 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -82.02 -28.08 32.71 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.83 -0.544 . . . . 10.0 111.125 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.63 105.85 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.37 1.468 . . . . 10.0 108.948 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.34 152.28 29.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.404 -0.81 . . . . 10.0 109.663 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.4 -42.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.959 0.903 . . . . 10.0 112.496 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -47.93 83.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.607 0.763 . . . . 10.0 110.567 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.66 -44.57 73.41 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.078 0.951 . . . . 10.0 109.709 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.64 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 122.177 0.989 . . . . 10.0 109.587 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.29 77.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.157 -0.929 . . . . 10.0 108.677 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.54 -43.44 97.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.676 -0.64 . . . . 10.0 109.711 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.94 83.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.725 -0.609 . . . . 10.0 110.451 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -51.13 -46.41 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.489 -0.757 . . . . 10.0 109.157 170.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.11 -42.74 60.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.963 0.801 . . . . 10.0 111.762 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.37 -41.56 93.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.192 0.52 . . . . 10.0 111.13 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -114.11 66.44 0.67 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.204 1.402 . . . . 10.0 110.606 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 103.5 0.63 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.45 -1.06 . . . . 10.0 110.45 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -74.33 54.3 0.56 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.496 1.518 . . . . 10.0 113.723 -169.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -106.04 79.31 1.4 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.441 -1.318 . . . . 10.0 107.441 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -156.18 104.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.711 -0.618 . . . . 10.0 110.653 172.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.18 -67.63 0.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.027 -0.987 . . . . 10.0 110.514 167.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt 160.03 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.162 2.185 . . . . 10.0 114.098 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.243 0 O-C-N 121.23 -0.919 . . . . 10.0 111.178 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.27 99.92 12.61 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.818 0.847 . . . . 10.0 109.493 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -134.35 175.62 9.35 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.963 0.347 . . . . 10.0 110.111 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -117.69 119.38 34.78 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -75.95 111.83 11.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.857 -2.275 . . . . 10.0 104.857 169.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.32 121.62 14.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t . . . . . 0 N--CA 1.446 -0.643 0 C-N-CA 127.156 2.182 . . . . 10.0 108.5 -177.967 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 118.924 -0.56 . . . . 10.0 111.258 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -89.63 -56.95 3.05 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.9 m -60.48 -59.91 4.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.706 1.202 . . . . 10.0 111.48 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -53.91 50.61 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.68 0.673 . . . . 10.0 110.435 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.35 -44.26 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.06 -14.79 3.05 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.034 -1.426 . . . . 10.0 114.876 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -87.22 -20.2 27.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.095 1.947 . . . . 10.0 109.293 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.27 128.59 37.13 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.706 -0.622 . . . . 10.0 111.004 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -46.99 -39.41 12.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.912 1.285 . . . . 10.0 111.901 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.37 -9.24 86.94 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 113.857 -1.519 . . . . 10.0 114.556 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.47 161.32 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 120.385 2.093 . . . . 10.0 112.048 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -140.96 -45.22 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.626 1.17 . . . . 10.0 111.421 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.49 42.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.4 58.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.138 . . . . 10.0 110.516 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -80.05 79.77 6.55 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.757 -1.214 . . . . 10.0 110.44 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.79 118.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.61 0.764 . . . . 10.0 110.584 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -144.65 64.67 1.29 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.054 -1.461 . . . . 10.0 107.054 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.04 -26.82 50.65 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.185 -0.947 . . . . 10.0 111.874 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -63.34 -31.55 72.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.815 0.846 . . . . 10.0 110.195 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.26 -10.9 59.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.25 0.62 . . . . 10.0 111.351 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.44 20.72 79.51 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.743 -1.343 . . . . 10.0 109.743 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -151.63 117.79 5.58 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.703 0.801 . . . . 10.0 109.708 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.27 126.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 104.604 -2.369 . . . . 10.0 104.604 167.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.84 93.52 8.88 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -109.43 108.07 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.759 1.266 . . . . 10.0 109.013 -173.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 m -99.5 112.92 25.05 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.426 1.49 . . . . 10.0 107.379 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p90 -148.87 159.26 44.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.277 1.037 . . . . 10.0 113.558 -171.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.82 79.77 9.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.234 1.016 . . . . 10.0 112.337 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.09 -27.98 1.58 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.321 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.24 -56.6 10.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.346 0.521 . . . . 10.0 110.618 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -79.95 -39.23 30.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.798 -0.564 . . . . 10.0 110.639 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 107.67 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -68.16 152.81 44.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.49 0.662 . . . . 10.0 109.809 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.7 t -41.18 -44.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.103 1.361 . . . . 10.0 112.539 175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -49.78 67.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -58.84 -41.03 85.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.217 1.007 . . . . 10.0 109.972 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.3 mm -63.3 -45.09 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 121.684 -0.635 . . . . 10.0 109.636 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.92 97.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.602 -0.888 . . . . 10.0 108.602 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.06 -38.52 79.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.51 63.44 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.27 -48.83 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.59 -29.82 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.208 0.913 . . . . 10.0 111.91 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.95 -35.64 69.34 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.005 0.431 . . . . 10.0 110.689 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -100.0 -69.67 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.802 1.241 . . . . 10.0 112.732 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.26 -143.27 8.27 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.123 1.821 . . . . 10.0 109.314 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.9 51.99 0.11 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.085 1.443 . . . . 10.0 109.995 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.8 68.15 1.32 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 -172.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.54 78.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.428 0.558 . . . . 10.0 112.18 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.48 -66.55 0.24 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.637 0.775 . . . . 10.0 112.875 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt 162.04 171.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.907 2.083 . . . . 10.0 113.023 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 O-C-N 122.194 -0.316 . . . . 10.0 110.647 -179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -62.04 108.18 1.0 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -127.59 173.13 10.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.852 0.751 . . . . 10.0 110.129 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -119.01 116.52 26.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.074 0.55 . . . . 10.0 109.932 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -78.34 110.83 13.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 116.82 3.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.211 -1.774 . . . . 10.0 106.211 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 125.328 1.451 . . . . 10.0 107.77 177.127 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 t . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.14 -65.92 0.91 Allowed 'General case' 0 C--N 1.338 0.087 0 C-N-CA 122.912 0.485 . . . . 10.0 110.106 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m -52.84 -40.3 63.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.963 1.305 . . . . 10.0 110.134 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 m -59.51 -51.73 68.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.442 1.097 . . . . 10.0 110.671 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.76 -42.52 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.28 -11.8 3.76 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.666 1.603 . . . . 10.0 115.307 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.96 -23.63 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.711 1.756 . . . . 10.0 108.269 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.55 119.07 16.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 121.604 -0.685 . . . . 10.0 110.394 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -48.94 -36.37 17.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.169 0.985 . . . . 10.0 112.18 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 -9.26 77.0 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.934 1.254 . . . . 10.0 114.364 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.57 167.64 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.58 1.69 . . . . 10.0 111.957 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -138.26 -50.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.622 1.169 . . . . 10.0 110.847 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.55 145.03 51.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.163 -0.922 . . . . 10.0 108.643 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 56.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.511 1.124 . . . . 10.0 110.778 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.28 78.79 9.71 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 120.27 -1.519 . . . . 10.0 108.717 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.95 123.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.727 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -145.75 59.78 1.26 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.593 -1.632 . . . . 10.0 106.593 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.79 -21.56 64.69 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.567 -0.708 . . . . 10.0 111.586 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.06 -37.61 83.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.74 0.816 . . . . 10.0 109.563 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.83 -16.81 37.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.514 0.726 . . . . 10.0 110.845 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.52 39.26 61.28 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -158.1 95.71 1.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -86.85 120.09 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.899 -1.519 . . . . 10.0 106.899 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -86.32 99.92 11.93 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.714 1.143 . . . . 10.0 108.266 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.5 m -115.39 106.77 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.102 0.953 . . . . 10.0 108.753 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -99.73 114.72 28.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -146.8 154.01 40.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 124.034 0.834 . . . . 10.0 113.152 -174.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.91 94.43 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.894 0.854 . . . . 10.0 112.095 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.02 22.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.695 -1.139 . . . . 10.0 113.73 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.91 -52.18 61.08 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.229 1.377 . . . . 10.0 110.2 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -87.04 -48.83 7.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 -173.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.83 99.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.55 148.66 32.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.288 -0.634 . . . . 10.0 109.288 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -36.7 -46.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.104 1.362 . . . . 10.0 113.866 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -51.32 -58.58 5.82 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -44.72 -44.8 9.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.486 1.514 . . . . 10.0 109.824 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.0 mm -65.43 -47.41 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.251 -0.906 . . . . 10.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.83 84.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -55.87 -39.47 71.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.128 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -35.57 70.15 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.01 -46.21 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 120.398 1.454 . . . . 10.0 107.616 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.02 -26.19 65.9 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.585 0.63 . . . . 10.0 112.011 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.54 -33.44 68.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.37 0.668 . . . . 10.0 110.766 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -110.39 -63.79 1.34 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.168 1.387 . . . . 10.0 112.086 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.8 -159.16 21.64 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.411 1.482 . . . . 10.0 109.412 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -151.76 57.16 0.86 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.182 1.491 . . . . 10.0 108.196 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.34 61.82 1.6 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.816 -1.179 . . . . 10.0 107.816 -167.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.02 64.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 121.81 -0.556 . . . . 10.0 111.177 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -25.75 -67.89 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.37 1.068 . . . . 10.0 113.224 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 171.65 170.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.373 1.869 . . . . 10.0 111.909 167.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 tp . . . . . 0 N--CA 1.454 -0.234 0 O-C-N 121.847 -0.533 . . . . 10.0 111.103 174.953 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.654 0.264 . . . . 10.0 110.65 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -64.07 108.7 1.6 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 172.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -134.62 168.47 18.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.601 0.715 . . . . 10.0 110.509 174.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -113.54 107.64 16.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.931 -0.577 . . . . 10.0 109.638 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -77.27 79.26 3.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 170.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.74 124.14 0.69 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.855 1.262 . . . . 10.0 110.042 173.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 126.389 1.875 . . . . 10.0 108.011 -178.795 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.8 t . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 119.647 -0.216 . . . . 10.0 110.49 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.89 -71.54 0.46 Allowed 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 173.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -36.39 -47.81 0.62 Allowed 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.44 1.896 . . . . 10.0 112.474 -174.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -56.57 -57.81 10.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.18 0.992 . . . . 10.0 111.561 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.28 -40.74 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.75 0.71 1.48 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.788 1.661 . . . . 10.0 115.197 173.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.1 -32.46 26.73 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.199 1.999 . . . . 10.0 108.608 173.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 mt -72.73 119.22 16.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.992 -0.442 . . . . 10.0 110.753 -171.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.49 -34.47 36.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 122.112 0.958 . . . . 10.0 112.121 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -6.1 71.8 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.828 1.204 . . . . 10.0 114.27 178.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.25 162.75 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.566 1.683 . . . . 10.0 111.771 169.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -134.67 -44.96 0.74 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 10.0 111.563 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.37 148.68 44.8 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.43 1.092 . . . . 10.0 108.289 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.16 55.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.122 0.963 . . . . 10.0 111.504 -174.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 70.55 10.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.383 -1.448 . . . . 10.0 108.948 -177.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.57 124.61 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.742 -0.599 . . . . 10.0 110.078 173.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -141.01 62.18 1.48 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.47 -1.678 . . . . 10.0 106.47 169.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -57.34 -25.35 59.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.699 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.39 -36.51 78.28 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.463 1.105 . . . . 10.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.96 19.9 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.213 1.005 . . . . 10.0 110.729 177.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.03 39.48 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.862 1.22 . . . . 10.0 111.851 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.09 123.61 26.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.641 -1.614 . . . . 10.0 106.641 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.46 105.38 18.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 126.159 1.783 . . . . 10.0 107.909 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.16 93.8 4.62 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.38 -0.97 . . . . 10.0 108.38 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -109.96 109.31 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.426 1.09 . . . . 10.0 109.396 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -100.4 123.29 44.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 174.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -150.08 160.97 43.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.686 -173.923 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.77 86.82 5.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.381 1.086 . . . . 10.0 112.484 -172.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.01 -27.01 6.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.977 -1.465 . . . . 10.0 113.392 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -43.22 -55.68 3.85 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 10.0 111.377 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -99.01 -39.59 8.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.991 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.26 101.64 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.43 149.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.504 -0.748 . . . . 10.0 109.654 -177.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -36.67 -44.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.082 1.353 . . . . 10.0 114.042 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -50.87 72.0 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.645 -0.693 . . . . 10.0 109.663 174.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.54 -43.58 25.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.334 1.053 . . . . 10.0 110.151 175.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mm -65.61 -43.55 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.227 -0.921 . . . . 10.0 111.025 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.27 90.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -59.22 -41.73 89.32 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.97 63.93 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.994 0.738 . . . . 10.0 112.994 172.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.84 -46.02 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 120.647 1.567 . . . . 10.0 108.693 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.85 -28.57 69.58 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.202 0.445 . . . . 10.0 112.202 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -31.77 61.63 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.96 -0.462 . . . . 10.0 111.878 171.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.45 -65.81 1.1 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.781 0.832 . . . . 10.0 111.447 -176.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.19 -155.63 15.12 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 108.438 -1.865 . . . . 10.0 108.438 -175.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -148.72 54.52 1.0 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 119.286 1.543 . . . . 10.0 107.33 172.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.16 65.44 1.56 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.038 -1.468 . . . . 10.0 107.038 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.62 96.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.76 -0.654 . . . . 10.0 109.362 167.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tttt 171.7 -174.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.369 1.068 . . . . 10.0 112.801 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 mm . . . . . 0 N--CA 1.435 -1.193 0 O-C-N 121.801 -0.562 . . . . 10.0 109.722 179.17 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 4' ' ' LYS . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -70.07 98.63 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.746 1.218 . . . . 10.0 109.854 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 2' ' ' GLU . 39.7 mttt -135.7 166.51 23.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.193 0.597 . . . . 10.0 109.733 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -114.21 117.24 30.61 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.093 0.957 . . . . 10.0 108.827 175.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 12.2 mt -78.59 104.37 9.15 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 170.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 118.41 3.86 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.035 1.289 . . . . 10.0 108.564 175.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t . . . . . 0 C--O 1.231 0.114 0 C-N-CA 124.974 1.31 . . . . 10.0 109.869 177.192 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 119.975 -0.06 . . . . 10.0 110.873 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -72.85 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.31 1.044 . . . . 10.0 108.513 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 m -43.0 -44.8 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.991 2.116 . . . . 10.0 111.487 -175.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.7 m -54.1 -51.34 64.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.523 0.678 . . . . 10.0 111.063 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.38 -44.04 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 176.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -12.73 4.32 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.268 1.413 . . . . 10.0 115.163 176.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 -25.63 31.24 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.989 1.394 . . . . 10.0 108.465 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.47 122.71 16.44 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.383 0.611 . . . . 10.0 111.801 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.27 -35.99 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.647 1.579 . . . . 10.0 112.286 169.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.92 -2.18 81.48 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.273 1.416 . . . . 10.0 114.891 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.04 156.99 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 120.55 2.175 . . . . 10.0 111.466 175.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.0 t -130.35 -47.04 1.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 110.912 176.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.6 146.04 35.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 178.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -143.33 58.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.658 1.183 . . . . 10.0 110.91 -176.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -79.28 76.03 5.84 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.589 -1.319 . . . . 10.0 108.87 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 120.7 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.214 1.005 . . . . 10.0 109.732 173.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 57.55 1.36 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 172.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -56.49 -28.55 60.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.83 75.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.737 1.215 . . . . 10.0 110.083 176.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -7.77 58.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.413 1.085 . . . . 10.0 111.523 178.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.82 38.78 60.46 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 -176.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -158.35 155.57 28.98 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.514 0.725 . . . . 10.0 109.263 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 1.3 p -146.38 118.68 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 103.617 -2.734 . . . . 10.0 103.617 172.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -88.34 108.39 19.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.422 -1.695 . . . . 10.0 106.422 172.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -121.09 90.21 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 -176.737 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -83.73 108.66 16.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.982 -1.858 . . . . 10.0 105.982 174.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 1.0 OUTLIER -129.37 178.21 6.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.05 -0.977 . . . . 10.0 110.431 -176.261 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.14 89.88 3.19 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.135 -0.978 . . . . 10.0 113.481 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.88 -33.04 34.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.772 -1.558 . . . . 10.0 112.38 177.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.13 -50.41 64.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.802 0.441 . . . . 10.0 110.602 -178.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -78.23 -37.86 44.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.59 111.08 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.697 1.199 . . . . 10.0 108.104 -177.228 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -70.84 149.84 46.4 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.115 -0.991 . . . . 10.0 110.516 -172.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -31.11 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.8 1.64 . . . . 10.0 114.022 172.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -50.86 -62.32 1.68 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -42.65 -42.26 3.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.104 0.962 . . . . 10.0 110.609 177.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -70.29 -44.22 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.588 -0.695 . . . . 10.0 110.628 -177.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.74 71.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.78 -38.78 70.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.902 1.281 . . . . 10.0 108.997 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.41 71.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.91 -0.493 . . . . 10.0 112.271 175.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.19 -44.35 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.798 1.181 . . . . 10.0 108.141 170.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.82 -30.14 68.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.453 0.569 . . . . 10.0 112.425 -178.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.5 -26.2 68.41 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.529 -0.732 . . . . 10.0 111.971 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -58.19 1.92 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.297 1.439 . . . . 10.0 111.685 -170.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.31 -156.78 8.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.033 -2.027 . . . . 10.0 108.033 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -146.88 56.08 1.13 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.468 1.634 . . . . 10.0 109.812 175.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.64 65.65 1.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -150.07 98.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 171.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.14 -73.01 0.05 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.303 169.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 174.08 173.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.606 1.562 . . . . 10.0 110.795 169.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.284 0 O-C-N 121.59 -0.694 . . . . 10.0 109.793 175.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 120.846 0.355 . . . . 10.0 111.725 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -73.69 104.25 4.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.999 1.319 . . . . 10.0 109.902 169.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 175.45 9.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.641 0.776 . . . . 10.0 110.556 172.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -113.83 108.16 16.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.824 1.25 . . . . 10.0 110.029 175.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 tp -85.63 73.63 10.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.497 1.119 . . . . 10.0 109.054 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.2 119.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.268 1.427 . . . . 10.0 111.88 -173.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t . . . . . 0 N--CA 1.448 -0.564 0 C-N-CA 126.637 1.975 . . . . 10.0 109.987 177.429 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 t . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -61.12 2.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.26 -169.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -48.21 -51.12 26.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.25 1.42 . . . . 10.0 111.056 171.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -59.17 -59.62 5.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.649 1.113 . . . . 10.0 110.481 -169.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.46 -36.78 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.335 -0.848 . . . . 10.0 108.899 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.65 -12.0 25.14 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.141 -1.366 . . . . 10.0 115.113 172.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -81.74 -18.1 45.45 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.434 2.117 . . . . 10.0 109.114 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.41 112.07 6.43 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.228 0.537 . . . . 10.0 110.195 -175.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -41.2 -40.76 1.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.795 1.638 . . . . 10.0 113.152 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.93 -15.79 79.6 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.546 -1.206 . . . . 10.0 114.147 -178.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.09 149.96 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.561 1.681 . . . . 10.0 112.133 -174.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -111.92 -51.12 2.87 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 10.0 110.878 177.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.7 146.79 38.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.443 0.697 . . . . 10.0 109.2 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -146.65 88.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 128.072 2.549 . . . . 10.0 105.108 -173.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -114.54 71.74 0.77 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.011 1.324 . . . . 10.0 110.662 -176.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.5 132.06 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.298 -0.876 . . . . 10.0 111.091 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -143.65 57.1 1.36 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 174.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.16 -28.97 69.5 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.567 -0.708 . . . . 10.0 111.552 -171.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.631 0.772 . . . . 10.0 111.043 174.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 -3.7 58.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.8 0.84 . . . . 10.0 111.5 176.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.39 36.91 78.95 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -175.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.91 161.42 41.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.823 0.82 . . . . 10.0 109.687 -177.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -155.03 121.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 101.665 -3.457 . . . . 10.0 101.665 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -99.6 103.37 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 120.71 1.595 . . . . 10.0 106.754 177.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.46 99.19 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 p -87.84 95.67 10.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 172.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.32 155.85 33.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.982 -1.008 . . . . 10.0 110.69 -176.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 10.6 t0 -91.61 90.84 7.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.036 0.754 . . . . 10.0 113.036 -172.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.81 -30.22 2.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.009 -1.45 . . . . 10.0 113.756 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -64.37 -52.83 56.34 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.13 0.877 . . . . 10.0 110.035 -178.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -37.9 35.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 -174.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.19 104.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.49 1.116 . . . . 10.0 107.996 -175.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.15 150.17 26.05 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 123.453 0.701 . . . . 10.0 111.098 -173.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 m -40.95 -44.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.446 1.099 . . . . 10.0 113.67 173.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -54.5 -56.26 20.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 171.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.69 -42.79 46.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.241 1.416 . . . . 10.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mm -63.32 -47.65 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.411 -0.806 . . . . 10.0 110.522 178.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.89 81.22 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -63.7 -40.37 96.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.721 -0.612 . . . . 10.0 109.468 175.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.14 88.64 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.384 -0.823 . . . . 10.0 111.146 177.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.33 -40.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 120.905 -1.122 . . . . 10.0 109.0 170.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -47.42 72.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.922 0.783 . . . . 10.0 110.282 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.83 -56.7 18.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.478 0.656 . . . . 10.0 109.858 175.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -94.53 67.54 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.353 0.661 . . . . 10.0 110.47 -177.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.99 97.06 0.26 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.023 -0.99 . . . . 10.0 111.38 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -65.95 105.11 1.24 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.728 0.775 . . . . 10.0 110.334 -175.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -148.94 76.63 1.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 169.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.92 105.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 O-C-N 121.152 -0.967 . . . . 10.0 111.129 175.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.46 -67.61 0.38 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.965 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttt 157.25 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.746 2.418 . . . . 10.0 112.949 173.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 N--CA 1.443 -0.793 0 C-N-CA 124.147 0.979 . . . . 10.0 109.576 -173.363 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pm0 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -78.16 117.07 19.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -130.35 166.13 21.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.482 -1.303 . . . . 10.0 107.482 174.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.0 m -129.78 108.85 10.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.573 -0.529 . . . . 10.0 109.573 -174.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -76.86 92.75 3.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.39 111.79 0.46 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.068 -1.086 . . . . 10.0 108.068 172.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m . . . . . 0 N--CA 1.441 -0.89 0 C-N-CA 125.949 1.7 . . . . 10.0 109.493 -178.316 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.3 t . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 110.174 -0.306 . . . . 10.0 110.174 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.92 -73.77 0.16 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.809 0.844 . . . . 10.0 109.704 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.1 m -44.92 -45.1 10.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.926 1.69 . . . . 10.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 m -53.48 -55.14 27.81 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.817 0.818 . . . . 10.0 110.709 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.15 -25.0 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 123.65 0.78 . . . . 10.0 110.701 179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 4.2 69.38 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.061 1.315 . . . . 10.0 112.688 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.66 -45.1 17.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.087 1.444 . . . . 10.0 107.447 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.71 118.82 4.89 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -176.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.66 -35.66 14.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.692 1.197 . . . . 10.0 111.963 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.72 -3.54 83.79 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.883 1.23 . . . . 10.0 114.326 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 158.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.902 1.851 . . . . 10.0 111.527 170.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -133.93 -46.3 0.79 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.253 . . . . 10.0 110.897 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.33 46.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.291 -1.003 . . . . 10.0 108.291 173.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.9 58.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 110.255 -174.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.92 67.7 5.79 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.355 -0.841 . . . . 10.0 109.964 -172.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.5 129.77 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.579 1.152 . . . . 10.0 109.907 178.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -155.61 55.51 0.62 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.69 -18.47 65.39 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.715 -0.615 . . . . 10.0 110.493 -175.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -36.17 82.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.498 1.119 . . . . 10.0 109.711 171.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 -29.02 43.68 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.032 -0.359 . . . . 10.0 110.032 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.94 22.9 7.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 10.0 111.464 174.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -148.67 174.65 11.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.407 1.083 . . . . 10.0 108.255 -178.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.99 99.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -80.94 90.88 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.737 -1.209 . . . . 10.0 107.737 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -103.22 101.19 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.135 1.374 . . . . 10.0 108.733 -174.749 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -89.11 107.61 19.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.89 156.59 45.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.313 0.578 . . . . 10.0 112.447 -176.15 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -81.93 90.7 6.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.869 1.063 . . . . 10.0 113.869 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.72 -27.08 1.79 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.92 -1.491 . . . . 10.0 113.353 169.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.49 -55.22 9.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.607 1.094 . . . . 10.0 110.342 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -77.22 -38.75 50.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 -175.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.99 98.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -176.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.45 148.2 46.32 Favored 'General case' 0 C--O 1.219 -0.52 0 O-C-N 121.497 -0.752 . . . . 10.0 109.091 -175.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.7 t -28.65 -52.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 125.986 1.714 . . . . 10.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -48.29 -54.01 15.24 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 123.364 0.665 . . . . 10.0 109.443 177.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.34 -46.63 62.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.01 2.124 . . . . 10.0 109.132 177.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -67.3 -45.15 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.752 -0.592 . . . . 10.0 110.88 -176.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.66 90.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.877 -0.786 . . . . 10.0 108.877 -178.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.82 -38.88 76.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 175.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.51 73.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.767 -0.635 . . . . 10.0 112.285 172.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.51 -47.29 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 120.203 1.365 . . . . 10.0 107.825 169.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.38 -34.5 66.75 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.607 1.094 . . . . 10.0 111.614 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.48 -30.01 66.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.503 -0.748 . . . . 10.0 112.022 176.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.27 -62.23 1.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.992 1.717 . . . . 10.0 112.108 -169.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.07 -147.03 6.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.437 1.97 . . . . 10.0 108.551 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.48 54.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.152 1.476 . . . . 10.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.47 58.17 1.22 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -139.77 100.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 121.221 -0.924 . . . . 10.0 110.766 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.87 -77.24 0.06 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.252 -0.885 . . . . 10.0 109.77 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.61 175.04 0.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.752 1.39 . . . . 10.0 114.752 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mm . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 123.674 0.79 . . . . 10.0 109.168 178.139 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.49 -0.929 . . . . 10.0 108.49 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -79.53 88.86 5.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.259 1.024 . . . . 10.0 110.282 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -125.21 175.87 7.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.505 0.593 . . . . 10.0 111.965 178.561 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -119.78 109.65 15.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.658 0.783 . . . . 10.0 109.205 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -82.87 101.8 11.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 124.11 20.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.44 -0.948 . . . . 10.0 108.44 -175.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 127.827 2.451 . . . . 10.0 107.275 -175.528 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -58.51 6.77 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.935 0.894 . . . . 10.0 108.695 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 m -48.35 -49.74 33.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.683 0.793 . . . . 10.0 110.879 173.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -59.57 -58.76 7.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.451 0.643 . . . . 10.0 109.51 -170.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 95.1 t -71.15 -18.12 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.809 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.44 82.58 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.702 1.144 . . . . 10.0 112.907 178.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.25 -44.34 16.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.131 1.466 . . . . 10.0 107.654 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.94 122.22 11.77 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.04 -0.527 . . . . 10.0 112.409 -174.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.91 -36.46 38.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.271 1.034 . . . . 10.0 111.538 169.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.35 -3.05 64.69 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.224 -1.353 . . . . 10.0 114.038 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.82 157.85 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 120.165 1.983 . . . . 10.0 111.772 169.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 m -129.84 -44.28 1.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.152 1.381 . . . . 10.0 111.649 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.03 146.57 33.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.777 -1.106 . . . . 10.0 108.328 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.27 58.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.483 1.113 . . . . 10.0 111.172 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.73 74.57 6.42 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.4 -1.437 . . . . 10.0 109.723 -176.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.53 118.05 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 124.517 1.127 . . . . 10.0 111.507 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -142.27 63.35 1.41 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 174.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.51 -22.78 65.43 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.653 -0.655 . . . . 10.0 111.627 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.48 -34.43 77.13 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.028 0.931 . . . . 10.0 110.386 172.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.69 41.88 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 10.0 110.264 171.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.09 21.99 43.57 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.946 1.26 . . . . 10.0 110.667 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -153.63 105.64 2.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 -174.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 m -89.08 128.67 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.006 -1.849 . . . . 10.0 106.006 170.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.24 97.84 10.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 177.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -119.99 99.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 -168.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -92.63 116.45 29.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.426 -1.694 . . . . 10.0 106.426 176.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.05 151.78 37.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.699 1.25 . . . . 10.0 112.103 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -86.97 88.09 7.62 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.063 0.935 . . . . 10.0 112.655 -169.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.13 -30.34 2.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.496 1.518 . . . . 10.0 112.739 175.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.63 -56.94 7.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.122 0.969 . . . . 10.0 111.56 174.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -50.34 6.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -172.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.03 99.04 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.53 148.11 34.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.742 -0.836 . . . . 10.0 108.742 -176.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -32.66 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.823 1.649 . . . . 10.0 111.553 168.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -55.85 -55.61 30.49 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 119.072 -0.489 . . . . 10.0 110.47 175.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -46.78 -46.28 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.464 0.706 . . . . 10.0 110.124 173.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 mm -64.04 -51.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 121.85 -0.531 . . . . 10.0 110.128 -177.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.58 87.37 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -62.5 -35.86 80.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.543 0.737 . . . . 10.0 109.279 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.6 67.3 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.197 -0.939 . . . . 10.0 112.271 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 24' ' ' VAL . 3.5 mp -70.97 -44.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 168.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.92 -36.28 67.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.355 1.434 . . . . 10.0 111.549 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -55.59 -30.79 61.47 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.132 0.424 . . . . 10.0 112.116 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.05 83.48 1.74 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.448 1.099 . . . . 10.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.37 109.36 2.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.899 -0.88 . . . . 10.0 110.899 172.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -77.32 57.51 1.49 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.307 1.043 . . . . 10.0 112.878 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -120.77 65.7 0.85 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 10.0 109.765 -168.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.273 0.9 OUTLIER -142.42 92.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 122.363 1.078 . . . . 10.0 110.337 -174.086 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.59 -23.74 66.24 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.702 -1.135 . . . . 10.0 111.561 169.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.0 tttt 107.15 165.75 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.4 2.28 . . . . 10.0 112.16 168.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.165 0 O-C-N 121.119 -0.988 . . . . 10.0 110.455 -178.494 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.364 0.135 . . . . 10.0 111.364 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.37 114.46 21.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.18 1.792 . . . . 10.0 107.864 169.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -137.91 175.34 9.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.13 0.877 . . . . 10.0 110.083 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -123.83 109.55 13.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.514 -0.755 . . . . 10.0 109.162 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.61 90.78 6.84 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 121.77 6.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 127.256 2.222 . . . . 10.0 108.867 179.267 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.4 t . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.359 0.123 . . . . 10.0 110.758 . . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.75 -57.24 11.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.92 0.888 . . . . 10.0 108.662 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -50.37 -51.89 41.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.163 0.985 . . . . 10.0 110.093 177.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -57.28 -54.26 48.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.091 0.948 . . . . 10.0 111.165 -168.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.85 -41.6 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.189 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.58 -7.93 12.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.152 1.358 . . . . 10.0 114.286 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.73 -24.06 36.35 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.184 1.492 . . . . 10.0 107.823 176.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.18 121.55 15.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.623 -0.673 . . . . 10.0 111.547 -176.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -47.71 -34.32 8.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.077 1.351 . . . . 10.0 112.125 169.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 0.88 87.39 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.317 1.437 . . . . 10.0 114.729 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.46 157.15 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 120.578 2.189 . . . . 10.0 111.768 173.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -126.48 -44.47 1.7 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.714 1.205 . . . . 10.0 111.968 174.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.96 146.87 32.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.041 -0.98 . . . . 10.0 108.439 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.22 59.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 10.0 111.866 -177.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.62 73.84 6.31 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 120.431 -1.418 . . . . 10.0 110.29 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.96 124.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 123.858 0.863 . . . . 10.0 111.298 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -146.74 58.24 1.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 171.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -56.21 -28.33 57.94 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.717 -0.615 . . . . 10.0 111.173 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.62 -27.16 69.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.169 1.388 . . . . 10.0 111.144 177.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.03 -1.76 51.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.201 1.4 . . . . 10.0 111.852 173.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.29 71.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.906 1.241 . . . . 10.0 111.291 -177.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.18 153.39 27.57 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 117.991 0.896 . . . . 10.0 109.387 -177.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.04 101.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.846 -2.279 . . . . 10.0 104.846 -175.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.27 102.09 12.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 -174.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.89 106.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 124.879 1.272 . . . . 10.0 108.386 -172.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -96.56 119.42 35.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.442 -1.688 . . . . 10.0 106.442 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.0 157.34 43.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.065 0.936 . . . . 10.0 113.074 -174.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.13 82.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.711 -1.132 . . . . 10.0 113.706 -172.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.49 -28.57 0.59 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.925 -1.489 . . . . 10.0 113.501 168.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.49 -43.63 26.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.063 0.847 . . . . 10.0 110.266 -172.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -78.96 -47.63 15.99 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.151 0.887 . . . . 10.0 109.169 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 108.86 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 -174.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.91 154.38 41.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -175.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -27.34 -55.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 126.662 1.985 . . . . 10.0 113.288 168.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -48.39 50.2 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 118.437 0.562 . . . . 10.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -42.6 81.52 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.922 1.289 . . . . 10.0 108.46 -179.051 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mm -67.31 -43.99 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 120.365 -0.534 . . . . 10.0 109.734 -178.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.28 84.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 -176.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -54.48 -41.66 69.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.528 1.131 . . . . 10.0 108.848 177.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.911 -0.493 . . . . 10.0 112.029 175.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.55 -43.69 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.773 1.169 . . . . 10.0 108.572 170.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.21 -34.76 68.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.668 1.576 . . . . 10.0 111.693 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.33 69.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.773 0.715 . . . . 10.0 112.447 172.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -133.18 65.44 1.59 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.959 1.704 . . . . 10.0 111.342 -176.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 117.93 4.13 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.424 1.011 . . . . 10.0 110.843 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.24 55.92 2.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.381 1.091 . . . . 10.0 111.47 -169.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.99 64.19 0.86 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.739 1.216 . . . . 10.0 108.406 -170.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.266 0.4 OUTLIER -149.62 93.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 120.593 -1.317 . . . . 10.0 110.694 -178.225 . . . . . . . . 3 3 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.68 -73.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.654 169.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . 0.402 ' CG ' ' H ' ' A' ' 70' ' ' ILE . 1.5 ttmm 172.28 176.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.67 2.388 . . . . 10.0 108.894 171.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.402 ' H ' ' CG ' ' A' ' 69' ' ' LYS . 8.0 mm . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 123.909 0.884 . . . . 10.0 109.803 172.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 1.3 mm-40 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 119.312 -0.375 . . . . 10.0 110.017 . . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -69.13 102.74 1.72 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.124 0.969 . . . . 10.0 109.639 169.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 70.9 mttt -128.33 169.4 14.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 121.466 0.651 . . . . 10.0 110.387 176.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -110.4 115.26 29.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 tp -83.38 107.3 15.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.118 -1.808 . . . . 10.0 106.118 169.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.39 117.1 3.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.482 -1.673 . . . . 10.0 106.482 173.531 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.329 -0.295 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 176.927 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -63.11 -65.86 0.62 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.977 1.311 . . . . 10.0 109.494 -175.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 m -43.6 -47.02 7.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.082 1.753 . . . . 10.0 110.195 174.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 m -67.6 -45.12 76.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 119.029 0.831 . . . . 10.0 111.162 -173.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.22 -20.45 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 121.31 -0.869 . . . . 10.0 110.38 169.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.87 15.42 60.76 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.034 1.302 . . . . 10.0 112.677 -172.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.51 -44.69 11.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 178.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.412 ' CD1' ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -60.39 126.0 25.81 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.193 -0.912 . . . . 10.0 112.352 -174.686 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.01 -35.81 36.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.24 1.416 . . . . 10.0 111.282 172.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.92 -9.14 75.13 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.526 -1.215 . . . . 10.0 113.738 179.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.24 158.93 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 120.115 1.957 . . . . 10.0 112.674 172.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.7 t -133.7 -45.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.832 1.253 . . . . 10.0 111.588 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.31 37.43 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.452 1.101 . . . . 10.0 108.473 177.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.53 55.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.841 0.856 . . . . 10.0 111.042 -173.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -85.91 68.89 10.48 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.702 -1.248 . . . . 10.0 109.257 -170.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.32 118.59 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 10.0 110.221 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -136.02 59.21 1.72 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.93 -28.47 51.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.003 -0.544 . . . . 10.0 111.284 -179.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -62.76 -36.35 82.79 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.951 0.9 . . . . 10.0 110.946 174.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -8.09 59.28 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.048 0.939 . . . . 10.0 111.236 174.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.33 30.27 57.09 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.441 1.02 . . . . 10.0 110.63 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -158.21 161.85 37.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.921 0.867 . . . . 10.0 110.581 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.03 125.98 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.367 -3.197 . . . . 10.0 102.367 -172.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -105.48 93.44 4.67 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 120.056 1.298 . . . . 10.0 107.749 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.2 m -105.15 107.56 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -178.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -97.84 114.91 27.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 172.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -144.8 153.53 41.73 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.379 0.609 . . . . 10.0 110.929 -177.463 . . . . . . . . 3 3 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.19 77.12 6.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.822 -168.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.23 -37.35 0.63 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.168 1.787 . . . . 10.0 113.605 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.88 -55.42 26.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.436 1.095 . . . . 10.0 111.272 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -84.21 -42.52 15.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.501 0.72 . . . . 10.0 109.969 -173.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.7 99.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 143.82 57.17 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 121.47 -0.769 . . . . 10.0 109.15 -175.38 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 m -38.88 -45.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.973 1.309 . . . . 10.0 113.562 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -55.67 29.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.612 0.765 . . . . 10.0 110.692 172.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -47.95 -38.71 17.32 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.25 1.02 . . . . 10.0 111.044 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mm -68.05 -53.15 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.326 -0.99 . . . . 10.0 108.326 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.02 -47.29 53.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 -179.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.43 -38.44 87.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.153 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.73 82.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.645 -0.66 . . . . 10.0 111.004 176.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 mp -65.07 -42.71 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 117.766 -1.111 . . . . 10.0 108.965 169.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -61.15 -21.54 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.201 1.364 . . . . 10.0 113.032 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.44 -33.7 76.57 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 10.0 111.644 169.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 -61.78 1.33 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.987 1.715 . . . . 10.0 112.086 -170.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.22 -151.69 10.04 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 127.104 2.288 . . . . 10.0 109.082 176.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -159.19 66.54 0.41 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.067 1.434 . . . . 10.0 108.981 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -146.47 55.64 1.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 -168.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -153.6 58.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.698 -0.626 . . . . 10.0 110.543 -172.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -26.33 -70.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.789 1.236 . . . . 10.0 112.544 176.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.92 173.0 0.61 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.438 1.095 . . . . 10.0 111.804 169.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 mp . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 122.972 0.509 . . . . 10.0 111.456 178.455 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -91.26 123.86 35.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.746 1.218 . . . . 10.0 109.995 173.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.52 173.03 12.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.834 0.309 . . . . 10.0 111.834 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 m -116.53 107.83 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.431 0.693 . . . . 10.0 110.326 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.68 88.48 6.25 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.19 115.72 1.07 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.434 1.094 . . . . 10.0 109.553 -177.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 125.709 1.604 . . . . 10.0 112.258 178.224 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.176 -0.675 . . . . 10.0 109.176 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.22 -63.85 1.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.137 1.375 . . . . 10.0 109.644 -173.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.5 m -50.87 -48.2 60.27 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.401 1.081 . . . . 10.0 109.526 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 t -58.19 -64.81 0.79 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 122.245 1.021 . . . . 10.0 109.867 -169.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.64 -36.91 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.54 -15.61 18.42 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.066 -1.408 . . . . 10.0 115.496 171.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -23.7 37.98 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.511 2.156 . . . . 10.0 109.165 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 39.3 mt -67.68 121.79 16.67 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 122.926 0.491 . . . . 10.0 110.443 -173.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.01 -41.67 16.86 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 122.659 1.219 . . . . 10.0 111.544 170.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.27 -4.6 74.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 113.689 -1.596 . . . . 10.0 114.441 -179.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.79 159.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 120.69 2.245 . . . . 10.0 111.168 173.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -138.29 -45.06 0.5 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 10.0 110.713 -178.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.19 149.07 39.22 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 173.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 m -142.9 57.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.64 0.776 . . . . 10.0 111.134 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -81.55 74.49 8.55 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.504 -1.373 . . . . 10.0 109.568 -175.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.27 131.26 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 123.902 0.881 . . . . 10.0 111.158 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -155.19 66.85 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.171 0.986 . . . . 10.0 109.004 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.44 -23.53 50.22 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.858 176.539 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.37 -41.91 98.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.716 1.606 . . . . 10.0 108.96 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.47 -26.7 46.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 173.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.18 5.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -153.9 175.01 13.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 173.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.61 125.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 101.578 -3.49 . . . . 10.0 101.578 169.113 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -99.78 97.47 8.39 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.43 106.98 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 114.075 -1.42 . . . . 10.0 107.594 -172.38 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 t -96.7 113.61 25.18 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 175.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -146.72 152.9 39.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 124.588 1.18 . . . . 10.0 111.965 -173.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.274 32.8 t0 -83.48 82.0 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.417 1.103 . . . . 10.0 113.303 -170.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.87 -25.25 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.452 -2.158 . . . . 10.0 114.005 169.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -63.28 -57.25 11.03 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.382 0.992 . . . . 10.0 109.581 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -87.14 -39.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.272 -0.268 . . . . 10.0 110.89 -172.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.65 100.44 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 177.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -63.97 156.97 26.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.889 0.852 . . . . 10.0 110.186 -177.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.1 t -33.69 -49.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 125.573 1.549 . . . . 10.0 111.739 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -52.14 -59.24 4.61 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 175.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -43.41 59.17 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.088 0.955 . . . . 10.0 109.565 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mm -63.59 -51.12 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.535 -0.913 . . . . 10.0 108.535 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.13 87.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 -174.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.65 -37.63 68.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.852 0.861 . . . . 10.0 109.673 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.23 -40.92 74.84 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.622 -0.674 . . . . 10.0 111.187 175.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.26 -38.9 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.029 -1.044 . . . . 10.0 108.269 175.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.89 -38.8 79.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.64 1.109 . . . . 10.0 110.727 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -56.31 22.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.467 0.576 . . . . 10.0 110.064 170.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -99.07 62.03 1.27 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.418 1.487 . . . . 10.0 111.136 -175.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.41 99.67 0.39 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.97 0.795 . . . . 10.0 113.26 169.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.01 103.19 1.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.306 1.042 . . . . 10.0 112.553 -171.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -149.54 66.09 1.0 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.32 1.048 . . . . 10.0 108.549 173.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.9 p -154.49 75.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 120.406 -1.433 . . . . 10.0 112.565 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -31.19 -69.1 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.574 1.15 . . . . 10.0 112.751 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 166.25 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.095 1.758 . . . . 10.0 113.91 168.035 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 O-C-N 121.741 -0.599 . . . . 10.0 110.511 176.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -80.37 104.51 10.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.572 1.149 . . . . 10.0 109.272 169.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -139.26 177.04 8.2 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.591 0.632 . . . . 10.0 110.399 174.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -121.19 110.62 16.4 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.771 1.229 . . . . 10.0 108.112 -173.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.87 89.6 4.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -46.3 127.31 8.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -178.69 . . . . . . . . 3 3 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.4 ' H ' ' NE2' ' A' ' 7' ' ' GLN . 2.1 p . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 128.189 2.595 . . . . 10.0 108.321 -175.476 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 110.446 -0.205 . . . . 10.0 110.446 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.02 -68.86 0.74 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.086 0.555 . . . . 10.0 111.018 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 m -55.25 -39.5 69.83 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.543 1.537 . . . . 10.0 111.262 -170.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -48.16 -68.74 0.16 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.486 1.914 . . . . 10.0 110.491 177.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 124.319 1.048 . . . . 10.0 108.931 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.59 -18.98 5.86 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.299 1.428 . . . . 10.0 115.034 173.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.09 -21.24 29.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.867 1.834 . . . . 10.0 108.72 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.68 121.24 19.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.87 -0.519 . . . . 10.0 109.861 -173.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -47.12 -37.12 9.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.009 1.324 . . . . 10.0 112.416 173.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.67 81.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 114.519 -1.219 . . . . 10.0 114.35 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.32 163.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.86 1.83 . . . . 10.0 112.755 176.107 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -136.82 -49.17 0.63 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.677 1.191 . . . . 10.0 111.032 174.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.81 147.67 51.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.733 -0.839 . . . . 10.0 108.733 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.91 59.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.926 1.29 . . . . 10.0 110.655 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 79.81 5.79 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.329 -1.482 . . . . 10.0 108.54 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 135.03 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 174.15 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.05 58.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 172.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.61 -26.98 68.89 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.771 -0.581 . . . . 10.0 111.12 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.43 -30.41 71.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.353 0.661 . . . . 10.0 110.147 174.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.43 -19.57 24.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.018 0.527 . . . . 10.0 111.21 172.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.52 14.76 55.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.82 1.676 . . . . 10.0 111.542 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -144.38 97.83 3.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.025 0.93 . . . . 10.0 109.35 -169.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -88.97 109.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 N-CA-C 106.699 -1.593 . . . . 10.0 106.699 168.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.65 102.92 15.08 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.33 106.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 125.233 1.413 . . . . 10.0 108.384 -172.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.3 t -92.86 120.95 33.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.667 -1.605 . . . . 10.0 106.667 174.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.14 157.24 40.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.145 0.974 . . . . 10.0 113.355 -173.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.36 80.85 7.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.057 . . . . 10.0 112.497 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.15 -30.19 1.1 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.308 170.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.45 -53.55 27.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.084 0.553 . . . . 10.0 110.925 -177.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.17 -36.23 24.88 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.068 0.547 . . . . 10.0 109.868 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.58 101.63 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.762 1.225 . . . . 10.0 109.106 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 152.31 27.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.538 -0.726 . . . . 10.0 110.35 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.07 -39.84 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.884 0.874 . . . . 10.0 112.777 171.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -59.15 -53.97 52.25 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 118.581 -0.724 . . . . 10.0 109.935 174.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -47.52 -46.84 27.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.521 0.729 . . . . 10.0 109.898 175.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.72 -49.64 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 O-C-N 122.07 -0.394 . . . . 10.0 110.394 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.25 -46.52 88.27 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.088 -1.079 . . . . 10.0 108.088 -175.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -59.99 -38.32 82.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.4 0.68 . . . . 10.0 109.221 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.34 70.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.569 -0.707 . . . . 10.0 112.499 172.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.91 -45.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 168.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.21 -24.79 66.6 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.799 0.727 . . . . 10.0 112.864 -176.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.54 -36.07 77.54 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.677 -0.64 . . . . 10.0 111.301 171.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.55 -55.06 2.85 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.93 1.692 . . . . 10.0 112.164 -169.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.54 -152.2 8.01 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.029 1.776 . . . . 10.0 108.874 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -151.27 59.32 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.925 1.363 . . . . 10.0 107.475 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.02 63.39 1.63 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.155 -1.424 . . . . 10.0 107.155 -167.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 p -155.92 70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.871 0.367 . . . . 10.0 111.642 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -27.65 -71.37 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.319 1.047 . . . . 10.0 113.541 170.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt 165.8 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.28 2.232 . . . . 10.0 112.436 169.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 O-C-N 120.721 -1.237 . . . . 10.0 111.844 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.49 -0.559 . . . . 10.0 109.49 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -93.54 115.12 27.61 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.849 1.66 . . . . 10.0 109.453 170.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -135.55 176.96 8.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.993 0.815 . . . . 10.0 112.02 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -123.14 114.17 19.95 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 174.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.15 125.92 30.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.298 -1.741 . . . . 10.0 106.298 166.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 130.27 40.78 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.442 -0.874 0 C-N-CA 128.133 2.573 . . . . 10.0 110.22 -174.949 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 119.805 -0.141 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -79.37 -71.42 0.45 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -49.82 -39.4 38.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.269 1.827 . . . . 10.0 112.365 -167.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m -49.82 -55.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.259 1.028 . . . . 10.0 110.24 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.43 -41.82 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 124.136 0.975 . . . . 10.0 108.79 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.36 -9.27 3.13 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.892 1.234 . . . . 10.0 114.603 173.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.86 -27.51 40.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 119.65 1.725 . . . . 10.0 108.622 177.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.76 118.99 13.31 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.344 -173.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -45.38 -41.19 8.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.472 1.13 . . . . 10.0 111.925 170.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -3.38 81.13 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 114.04 -1.436 . . . . 10.0 114.674 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.09 163.38 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.411 2.105 . . . . 10.0 112.02 174.36 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -136.61 -43.62 0.6 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.841 1.257 . . . . 10.0 111.612 179.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.49 37.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.438 1.095 . . . . 10.0 108.233 176.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 57.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.14 1.376 . . . . 10.0 110.774 -173.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -81.52 88.87 6.16 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.768 -1.208 . . . . 10.0 109.847 -170.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 110.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.687 0.795 . . . . 10.0 111.231 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -142.07 57.55 1.47 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 175.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.1 -22.51 62.85 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.505 -0.747 . . . . 10.0 112.068 -177.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -61.97 -32.83 73.31 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.631 0.772 . . . . 10.0 110.876 172.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.93 -6.07 56.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.686 0.794 . . . . 10.0 111.554 173.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 15.44 81.56 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.825 1.679 . . . . 10.0 110.794 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -148.82 135.81 19.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.363 1.065 . . . . 10.0 108.296 -167.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.63 131.28 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 102.96 -2.978 . . . . 10.0 102.96 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.61 96.37 6.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.33 1.423 . . . . 10.0 108.326 177.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.5 110.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.341 1.456 . . . . 10.0 109.541 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 t -98.22 123.82 42.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 10.0 106.173 169.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 154.26 32.75 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.605 0.717 . . . . 10.0 112.55 -174.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.52 83.04 4.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.339 -0.846 . . . . 10.0 113.223 -170.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.14 -32.61 0.49 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.031 -1.441 . . . . 10.0 113.411 168.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.1 -40.15 68.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.854 0.752 . . . . 10.0 110.113 -172.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -91.48 -42.42 10.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.634 0.652 . . . . 10.0 111.145 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.39 109.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 146.81 50.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.477 -0.765 . . . . 10.0 109.569 -175.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -38.51 -40.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.306 1.042 . . . . 10.0 113.615 170.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -62.63 -48.87 77.49 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.648 -0.691 . . . . 10.0 111.198 174.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -48.32 -45.11 34.77 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.819 0.736 . . . . 10.0 109.279 175.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mm -66.26 -43.73 91.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 122.071 -0.393 . . . . 10.0 111.015 178.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.84 68.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.42 -34.52 72.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.287 0.635 . . . . 10.0 109.867 -178.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.58 -31.69 66.42 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.947 -1.096 . . . . 10.0 113.188 173.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mp -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 120.477 1.49 . . . . 10.0 108.152 169.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.41 -29.72 67.95 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.646 1.112 . . . . 10.0 111.635 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -59.55 -29.49 67.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.697 0.399 . . . . 10.0 111.647 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -111.02 -64.37 1.29 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.518 1.127 . . . . 10.0 111.228 -177.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.98 -156.46 24.05 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.557 1.551 . . . . 10.0 109.261 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -152.35 56.13 0.82 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.592 1.196 . . . . 10.0 108.174 173.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.04 57.84 1.77 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -168.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -146.86 79.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 122.172 0.987 . . . . 10.0 109.815 -174.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.75 -61.83 1.97 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.63 -1.176 . . . . 10.0 111.727 170.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt 154.53 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.843 2.057 . . . . 10.0 115.122 170.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mm . . . . . 0 N--CA 1.446 -0.628 0 C-N-CA 125.986 1.714 . . . . 10.0 110.988 -177.63 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tmt? . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.137 -1.431 . . . . 10.0 107.137 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.21 114.13 13.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.071 0.149 . . . . 10.0 111.022 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.59 91.21 4.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.405 1.882 . . . . 10.0 111.016 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 20.2 mttp -117.78 175.37 5.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.488 0.661 . . . . 10.0 112.024 -173.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -118.76 102.33 8.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.362 1.065 . . . . 10.0 110.516 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.54 74.57 3.26 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -34.38 110.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.749 1.619 . . . . 10.0 111.24 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 90.9 t -96.29 137.27 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.712 1.605 . . . . 10.0 110.221 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.302 -1.37 . . . . 10.0 107.302 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.71 0.97 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.13 -0.817 . . . . 10.0 111.523 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.62 94.55 3.78 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.526 1.163 . . . . 10.0 111.376 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -175.71 -132.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 105.469 -2.048 . . . . 10.0 105.469 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 t -143.27 -51.5 0.35 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.996 0.816 . . . . 10.0 112.25 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -158.8 -46.86 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.657 0.741 . . . . 10.0 110.489 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -75.09 82.69 2.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 -47.04 0.17 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.537 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -42.48 -53.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.812 . . . . 10.0 110.192 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.98 75.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.91 0.484 . . . . 10.0 112.244 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.4 65.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.944 1.247 . . . . 10.0 110.341 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.86 -26.44 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.371 1.469 . . . . 10.0 111.162 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -79.79 -69.67 0.57 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 m -43.52 -44.55 6.1 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 126.668 1.987 . . . . 10.0 111.44 -173.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -49.23 -55.33 12.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.037 0.922 . . . . 10.0 111.186 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.7 t -70.4 -41.87 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.701 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.83 -14.06 5.02 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.389 1.471 . . . . 10.0 114.911 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -81.77 -23.95 36.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.712 1.756 . . . . 10.0 108.442 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.6 mt -71.05 120.09 16.12 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 122.013 -0.429 . . . . 10.0 110.728 -174.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.1 -34.67 14.42 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 10.0 112.168 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.45 -0.84 90.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.121 1.343 . . . . 10.0 114.627 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.66 160.29 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 120.327 2.063 . . . . 10.0 111.682 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -131.0 -42.56 1.1 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.214 1.006 . . . . 10.0 112.377 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.41 147.25 35.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.826 0.85 . . . . 10.0 108.966 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.3 59.12 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.784 1.234 . . . . 10.0 111.128 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 71.47 5.55 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.675 -1.266 . . . . 10.0 109.856 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.24 123.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.936 0.895 . . . . 10.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -150.01 58.69 0.98 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.7 pp -56.54 -29.53 62.04 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.572 -0.705 . . . . 10.0 111.004 178.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -60.08 -35.67 75.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.313 1.045 . . . . 10.0 110.698 175.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.02 59.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.939 0.896 . . . . 10.0 111.393 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.83 55.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.092 0.853 . . . . 10.0 111.535 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -154.53 154.31 32.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.501 1.151 . . . . 10.0 110.154 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.3 p -142.42 102.66 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 172.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.73 93.35 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -105.89 114.03 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.187 1.395 . . . . 10.0 108.609 -177.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -102.27 120.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -148.42 160.47 43.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 123.981 0.801 . . . . 10.0 111.804 -175.375 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -90.96 80.32 5.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.002 0.906 . . . . 10.0 112.659 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -36.95 -39.13 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.813 2.045 . . . . 10.0 113.684 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.62 -57.19 9.85 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.608 1.163 . . . . 10.0 111.76 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -41.74 15.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 -171.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.5 110.97 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -69.66 155.46 40.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.495 0.664 . . . . 10.0 109.746 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.91 -40.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.076 1.35 . . . . 10.0 113.095 171.74 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -57.62 -58.33 8.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -47.44 -46.17 26.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.767 0.827 . . . . 10.0 110.096 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mm -63.94 -45.35 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 O-C-N 121.691 -0.631 . . . . 10.0 111.019 -178.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.23 91.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.674 0.749 . . . . 10.0 108.987 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -60.44 -36.44 78.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.86 -0.793 . . . . 10.0 108.86 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.61 70.13 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.468 -0.77 . . . . 10.0 112.398 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mp -64.59 -48.44 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.288 -1.375 . . . . 10.0 107.288 168.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.52 -26.95 67.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.043 0.838 . . . . 10.0 112.464 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -26.56 59.69 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.303 0.483 . . . . 10.0 112.303 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -120.13 -63.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.766 1.226 . . . . 10.0 111.183 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.51 -153.72 25.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.185 -1.566 . . . . 10.0 109.185 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -162.79 52.98 0.19 Allowed 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.476 -1.305 . . . . 10.0 107.476 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.91 62.19 1.66 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.165 -1.791 . . . . 10.0 106.165 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.74 88.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.56 1.172 . . . . 10.0 108.663 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.74 -70.44 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.43 -1.259 . . . . 10.0 109.397 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 163.07 -174.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.344 1.858 . . . . 10.0 113.53 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.2 mm -68.29 106.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 123.674 0.79 . . . . 10.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -90.1 99.89 12.82 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.25 158.72 33.84 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.748 0.69 . . . . 10.0 112.171 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 mtm105 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 117.941 -1.028 . . . . 10.0 111.368 -179.204 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 ttp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -104.97 112.77 26.02 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -170.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -72.64 100.45 2.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.608 1.563 . . . . 10.0 109.686 169.584 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 60.8 mttt -128.82 178.93 6.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.562 0.345 . . . . 10.0 110.179 172.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -118.17 114.22 22.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.064 0.546 . . . . 10.0 110.505 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.2 mt -79.54 92.76 5.33 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 106.689 -1.597 . . . . 10.0 106.689 174.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 119.89 5.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -94.65 128.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.818 2.047 . . . . 10.0 110.837 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.46 104.34 16.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.292 -2.484 . . . . 10.0 104.292 166.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.76 102.82 0.87 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.192 -0.763 . . . . 10.0 111.192 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -115.81 -173.19 2.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.425 1.09 . . . . 10.0 110.552 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t 65.64 -170.22 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.126 1.37 . . . . 10.0 111.692 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.5 t -96.14 -49.15 5.36 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.325 1.45 . . . . 10.0 109.96 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.46 178.1 10.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 56.22 34.47 24.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.116 1.366 . . . . 10.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.07 -51.39 2.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.195 0.598 . . . . 10.0 110.196 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.88 -50.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.062 0.945 . . . . 10.0 110.665 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -23.17 61.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.47 -56.13 12.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 10.0 108.33 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t -48.79 -41.45 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.342 0.657 . . . . 10.0 109.791 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -70.39 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.718 1.207 . . . . 10.0 108.764 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -48.11 -44.46 31.9 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.692 1.197 . . . . 10.0 110.941 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -59.8 -58.95 6.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.586 0.708 . . . . 10.0 110.57 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.8 t -61.16 -41.41 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 175.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -13.81 7.77 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.171 -1.349 . . . . 10.0 115.289 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.8 -21.39 34.54 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.289 2.045 . . . . 10.0 108.87 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 61.7 mt -66.23 121.81 16.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.455 0.645 . . . . 10.0 111.834 -174.699 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -45.17 -39.61 6.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.266 1.427 . . . . 10.0 111.776 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.58 7.62 81.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.249 1.404 . . . . 10.0 114.69 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.81 160.59 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 120.599 2.199 . . . . 10.0 111.202 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 t -133.24 -44.57 0.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.63 1.172 . . . . 10.0 111.095 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.9 148.34 35.28 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.786 0.834 . . . . 10.0 108.768 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -141.11 58.31 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.157 0.983 . . . . 10.0 111.292 -175.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.02 67.36 7.99 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.787 -1.196 . . . . 10.0 111.508 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.29 134.9 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.85 1.26 . . . . 10.0 111.576 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.55 55.86 0.69 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -63.41 -23.53 67.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.792 -1.193 . . . . 10.0 111.755 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.32 -32.37 72.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.672 0.789 . . . . 10.0 110.45 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.87 -23.98 44.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.1 29.59 9.55 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.876 1.227 . . . . 10.0 110.275 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -146.34 169.4 18.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.424 1.107 . . . . 10.0 109.964 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -155.23 118.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.856 -3.016 . . . . 10.0 102.856 169.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.88 99.27 10.84 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -111.87 112.38 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 125.818 1.647 . . . . 10.0 108.803 -171.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.1 t -94.81 114.96 26.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.693 -1.225 . . . . 10.0 107.693 170.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.3 p90 -144.7 154.79 43.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 179.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.01 79.31 8.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.242 1.02 . . . . 10.0 111.354 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -35.98 -44.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 112.941 -1.936 . . . . 10.0 112.284 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -44.84 -54.14 6.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.213 1.405 . . . . 10.0 112.299 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.22 -40.42 14.56 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.97 -0.381 . . . . 10.0 109.97 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -134.69 104.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -178.213 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.4 150.05 48.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.591 -0.693 . . . . 10.0 110.248 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.6 t -33.85 -51.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 125.569 1.548 . . . . 10.0 113.485 170.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -49.04 -59.98 3.17 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.53 -42.62 33.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.411 1.485 . . . . 10.0 110.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mm -65.81 -45.38 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.514 -0.742 . . . . 10.0 110.459 179.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.78 96.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.23 -39.25 75.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.07 69.96 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.5 -46.83 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -59.27 -30.19 68.12 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.716 0.689 . . . . 10.0 111.675 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.86 -24.5 67.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.568 -0.707 . . . . 10.0 112.211 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -112.87 -66.84 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.092 1.757 . . . . 10.0 111.362 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 -148.55 9.99 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.096 1.807 . . . . 10.0 108.754 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -161.98 55.16 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.989 1.394 . . . . 10.0 108.266 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.51 61.91 1.67 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 -168.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.4 p -149.69 85.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.779 0.799 . . . . 10.0 109.518 -179.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.59 -66.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.382 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt 168.74 172.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.962 2.505 . . . . 10.0 110.266 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -67.91 133.46 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.598 -0.689 . . . . 10.0 111.645 173.61 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.19 117.43 6.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.38 73.53 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.251 -0.74 . . . . 10.0 111.251 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.234 0 CA-C-O 117.761 -1.114 . . . . 10.0 111.006 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 mtt . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.156 0.503 . . . . 10.0 111.714 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.66 107.75 11.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.332 -2.47 . . . . 10.0 104.332 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -71.0 107.07 3.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.1 mttt -131.25 176.2 8.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.732 0.777 . . . . 10.0 111.471 171.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -112.06 102.5 10.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.585 1.554 . . . . 10.0 110.54 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 3.3 tt -82.09 94.67 7.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.07 1.348 . . . . 10.0 107.856 174.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.43 119.39 7.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.591 -0.892 . . . . 10.0 108.591 -175.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t -94.31 117.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.799 2.04 . . . . 10.0 109.178 177.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.69 90.2 5.78 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.41 111.97 2.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.581 -0.566 . . . . 10.0 112.529 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.47 -152.36 0.41 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.314 1.046 . . . . 10.0 110.081 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -71.4 71.64 0.66 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.327 1.451 . . . . 10.0 111.537 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.2 t -135.74 -48.25 0.68 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.92 1.688 . . . . 10.0 109.929 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.14 -155.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.316 1.046 . . . . 10.0 110.974 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.2 m80 49.09 43.67 22.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.247 0.931 . . . . 10.0 112.53 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.03 38.83 10.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.318 1.047 . . . . 10.0 110.756 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.255 9.8 p 51.89 18.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.237 2.215 . . . . 10.0 113.48 -175.589 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -65.74 -30.62 71.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 120.73 -1.231 . . . . 10.0 110.974 -171.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.7 -36.36 11.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.922 -1.111 . . . . 10.0 112.447 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 1.5 t -84.09 -20.65 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.245 1.418 . . . . 10.0 111.437 179.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -50.41 12.82 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 m -54.93 -36.86 65.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.728 1.211 . . . . 10.0 111.76 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -56.7 -49.91 73.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.232 0.924 . . . . 10.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.1 t -68.04 -43.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 175.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.5 8.57 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.014 1.292 . . . . 10.0 115.167 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.56 -21.49 28.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.343 1.572 . . . . 10.0 109.094 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 45.2 mt -67.05 125.32 25.64 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 122.024 -0.422 . . . . 10.0 110.909 -174.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -48.18 -38.15 17.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.303 1.049 . . . . 10.0 111.783 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.92 -1.43 87.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.018 1.294 . . . . 10.0 114.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 166.09 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.753 2.276 . . . . 10.0 112.273 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 t -141.0 -45.43 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.923 1.289 . . . . 10.0 111.385 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.4 147.59 34.86 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.507 1.123 . . . . 10.0 108.483 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -144.48 58.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.618 1.167 . . . . 10.0 112.193 -178.478 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 87.11 5.49 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.123 -1.611 . . . . 10.0 109.874 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.52 115.28 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 10.0 111.259 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.58 62.95 1.44 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.24 -21.24 32.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.614 -0.679 . . . . 10.0 111.839 172.174 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -64.68 -37.99 89.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.009 0.924 . . . . 10.0 109.001 176.581 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.03 -24.7 43.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 23.45 43.23 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.151 -1.579 . . . . 10.0 109.151 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -155.7 116.15 3.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.7 m -86.42 146.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.301 -2.111 . . . . 10.0 105.301 167.387 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.27 96.31 6.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.938 -1.505 . . . . 10.0 106.938 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.404 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 1.6 m -119.76 106.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 122.316 1.055 . . . . 10.0 108.849 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 t -99.62 121.22 40.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.275 -1.379 . . . . 10.0 107.275 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.404 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.5 p90 -148.87 172.06 15.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.033 0.933 . . . . 10.0 111.013 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.41 83.32 2.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.547 1.165 . . . . 10.0 113.301 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.2 -31.73 9.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.011 -1.904 . . . . 10.0 112.607 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -51.36 -60.7 2.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.269 1.028 . . . . 10.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -82.55 -46.57 13.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.368 -0.604 . . . . 10.0 109.368 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.17 94.18 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -60.81 153.36 24.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.116 0.484 . . . . 10.0 110.395 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 3.7 t -42.56 -42.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 121.353 -0.842 . . . . 10.0 112.749 173.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -50.57 -61.83 1.95 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -47.15 -39.61 14.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.111 0.964 . . . . 10.0 111.063 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.5 mm -70.28 -48.53 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -177.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.82 89.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.951 0.9 . . . . 10.0 109.826 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.05 -26.48 67.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.786 -0.571 . . . . 10.0 112.077 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.0 mp -67.59 -49.08 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.886 -1.524 . . . . 10.0 106.886 168.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -36.14 62.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.05 0.54 . . . . 10.0 110.778 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -51.56 -37.77 51.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.071 0.549 . . . . 10.0 112.327 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.45 -62.11 1.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.91 1.284 . . . . 10.0 111.785 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.95 -152.36 9.16 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.692 1.615 . . . . 10.0 109.631 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.15 51.43 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 10.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -120.46 68.39 0.85 Allowed 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 107.234 -1.395 . . . . 10.0 107.234 176.145 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.5 t -139.22 100.34 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.168 0.987 . . . . 10.0 108.873 -178.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.8 -34.35 77.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 10.0 109.677 168.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 tttm 117.87 169.79 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 129.186 2.995 . . . . 10.0 110.501 171.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -66.19 128.53 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.347 -0.846 . . . . 10.0 109.254 175.303 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -136.18 144.37 44.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.264 0.978 . . . . 10.0 109.819 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.95 -100.79 0.11 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 . . . . . 0 C--O 1.252 1.222 0 N-CA-C 103.384 -2.821 . . . . 10.0 103.384 173.168 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 21.4 ttt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.079 -0.486 . . . . 10.0 112.031 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -126.65 125.83 42.54 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.109 0.963 . . . . 10.0 112.417 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -83.34 99.72 10.21 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.346 2.258 . . . . 10.0 110.053 169.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.2 mttt -136.96 177.26 8.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.217 0.462 . . . . 10.0 111.504 178.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.4 m -114.05 110.37 19.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.035 1.334 . . . . 10.0 109.302 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.1 mt -83.44 93.12 7.72 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 174.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.57 118.37 2.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.015 0.926 . . . . 10.0 109.443 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 37.7 t -93.6 133.59 34.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 124.62 1.168 . . . . 10.0 111.523 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.07 96.23 7.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.352 -1.722 . . . . 10.0 106.352 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.44 100.15 0.25 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.337 -0.705 . . . . 10.0 111.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -77.68 167.47 21.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.332 1.053 . . . . 10.0 109.642 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -68.1 74.38 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.332 1.053 . . . . 10.0 110.25 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.75 114.7 3.8 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -59.08 -42.69 91.03 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.547 -0.721 . . . . 10.0 111.072 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -82.64 46.41 1.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.765 -0.584 . . . . 10.0 110.862 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.88 -35.87 23.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.302 1.041 . . . . 10.0 110.566 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.06 60.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.877 1.322 . . . . 10.0 109.848 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.85 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.189 2.596 . . . . 10.0 110.055 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.23 -52.03 54.79 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.165 0.893 . . . . 10.0 110.961 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 11.3 t -62.8 -41.76 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.981 177.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.71 -68.41 0.41 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.749 1.619 . . . . 10.0 109.114 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 m -48.51 -43.78 35.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.943 1.697 . . . . 10.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -56.94 -60.89 2.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 10.0 110.147 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 86.7 t -60.48 -40.23 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.385 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.65 -17.66 28.09 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.641 1.591 . . . . 10.0 114.789 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.03 -21.73 36.82 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.645 1.723 . . . . 10.0 108.416 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.1 mt -66.97 122.1 16.98 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.108 0.48 . . . . 10.0 111.373 -175.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.5 -37.54 5.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.985 1.314 . . . . 10.0 112.107 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.07 90.44 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.086 1.327 . . . . 10.0 114.692 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.21 163.49 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 120.555 2.178 . . . . 10.0 111.909 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 t -133.82 -47.34 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.336 1.455 . . . . 10.0 110.633 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.03 148.46 35.25 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.5 m -141.54 59.1 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.32 1.048 . . . . 10.0 110.991 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.54 69.47 8.2 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.079 -1.013 . . . . 10.0 110.408 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.12 124.81 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.009 0.924 . . . . 10.0 110.939 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.8 58.03 1.23 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.32 -1.363 . . . . 10.0 107.32 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -57.76 -26.71 62.25 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.562 -0.711 . . . . 10.0 111.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.16 -38.65 73.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.165 1.386 . . . . 10.0 110.746 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.49 2.77 46.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.769 1.228 . . . . 10.0 111.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.24 98.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.8 -1.32 . . . . 10.0 109.8 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 157.91 35.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.821 0.81 . . . . 10.0 109.21 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.21 102.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.1 97.82 10.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -111.01 110.61 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.372 1.069 . . . . 10.0 109.042 -173.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 t -95.02 117.12 29.62 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 170.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.4 p90 -148.96 154.06 38.84 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.256 1.027 . . . . 10.0 113.712 -177.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -82.55 81.0 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.879 -1.055 . . . . 10.0 112.411 -170.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.31 -44.73 0.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.002 1.321 . . . . 10.0 111.519 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -55.11 -52.12 64.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.762 2.025 . . . . 10.0 111.369 -174.374 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.79 -41.78 25.81 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.731 0.696 . . . . 10.0 109.937 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.91 107.7 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.141 0.976 . . . . 10.0 108.63 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.48 152.01 39.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.788 -0.57 . . . . 10.0 110.354 -171.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.7 t -39.72 -45.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.489 1.116 . . . . 10.0 112.553 170.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -52.23 -58.15 7.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.393 -0.337 . . . . 10.0 110.386 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.98 -41.09 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.568 0.747 . . . . 10.0 109.625 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.2 mm -64.3 -53.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.79 79.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.18 -1.045 . . . . 10.0 108.18 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.67 -32.58 73.67 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.751 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.31 74.41 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.899 -1.126 . . . . 10.0 112.605 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.0 mp -60.57 -36.19 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.275 -1.516 . . . . 10.0 108.412 171.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.62 -49.31 68.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.994 0.815 . . . . 10.0 109.896 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -51.3 -49.5 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.089 0.471 . . . . 10.0 111.819 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.47 -19.9 27.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 -171.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.79 99.79 0.22 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.534 -1.426 . . . . 10.0 109.534 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -67.89 54.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.109 2.263 . . . . 10.0 117.109 -167.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.81 74.41 2.67 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 120.145 -1.597 . . . . 10.0 108.027 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -151.54 110.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.366 -0.834 . . . . 10.0 108.913 173.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.45 -73.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.942 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 175.8 174.91 0.28 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.467 1.907 . . . . 10.0 110.643 169.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.48 130.64 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.778 -0.576 . . . . 10.0 111.041 174.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -84.04 -84.52 0.14 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.349 -1.352 . . . . 10.0 107.349 169.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.11 75.9 0.04 OUTLIER Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.687 -1.765 . . . . 10.0 108.687 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.986 1.715 . . . . 10.0 112.258 -171.207 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 24.5 ttm . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.324 -0.846 . . . . 10.0 110.379 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -155.66 144.75 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.318 0.963 . . . . 10.0 111.861 170.148 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 3.3 pm0 -88.63 106.53 18.38 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 125.449 1.5 . . . . 10.0 110.608 175.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 58.4 mttt -136.39 176.29 8.83 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.1 0.864 . . . . 10.0 112.475 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 21.5 m -116.0 108.34 16.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.879 0.872 . . . . 10.0 109.189 -175.428 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.87 79.8 3.45 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.43 122.12 0.89 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.013 1.325 . . . . 10.0 109.003 172.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.62 140.16 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 127.773 2.429 . . . . 10.0 107.74 -170.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -102.61 112.06 24.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.89 107.58 1.73 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.398 -0.668 . . . . 10.0 111.893 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.45 -69.32 0.76 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.859 0.83 . . . . 10.0 110.196 173.367 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.2 t -83.92 156.04 22.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.382 0.61 . . . . 10.0 111.714 -170.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.1 t -76.15 -41.92 48.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.797 1.239 . . . . 10.0 112.045 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -146.4 170.26 17.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.801 0.841 . . . . 10.0 109.148 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.3 t60 59.0 20.1 7.88 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.622 1.569 . . . . 10.0 112.321 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.6 p -104.88 -36.36 7.39 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.83 1.652 . . . . 10.0 111.072 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -69.09 62.17 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.127 1.771 . . . . 10.0 110.029 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.09 -40.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.143 2.177 . . . . 10.0 109.165 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.28 -48.15 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.029 -1.045 . . . . 10.0 110.153 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 t -67.58 -13.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.715 1.206 . . . . 10.0 110.999 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -91.01 -69.82 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.36 1.064 . . . . 10.0 109.274 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.3 m -36.45 -53.36 0.86 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.181 2.192 . . . . 10.0 111.495 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -51.2 -55.61 17.13 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.301 1.441 . . . . 10.0 110.959 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 60.1 t -72.0 -19.8 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.559 1.144 . . . . 10.0 110.326 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.47 73.11 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.777 1.18 . . . . 10.0 112.169 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -89.13 -40.24 13.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.023 1.411 . . . . 10.0 108.136 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -59.69 123.78 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.471 0.545 . . . . 10.0 112.471 -177.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -51.74 -34.86 41.0 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.896 1.278 . . . . 10.0 111.779 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.5 0.64 87.63 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.328 1.442 . . . . 10.0 114.234 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.37 156.26 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 119.849 -1.971 . . . . 10.0 111.54 169.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 t -128.59 -44.3 1.37 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 10.0 110.902 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.06 149.1 33.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.792 -1.099 . . . . 10.0 108.457 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.8 m -143.4 58.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.859 0.864 . . . . 10.0 112.062 -178.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.73 74.06 7.68 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.306 -1.496 . . . . 10.0 111.432 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.23 121.81 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.584 1.153 . . . . 10.0 111.578 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.29 56.61 1.0 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.882 -1.155 . . . . 10.0 107.882 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.4 pp -59.65 -21.88 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.631 -0.668 . . . . 10.0 111.338 177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -63.98 -39.69 94.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.358 1.463 . . . . 10.0 108.865 175.202 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.41 -27.17 41.77 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.79 0.436 . . . . 10.0 110.42 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.32 22.8 9.47 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.128 1.347 . . . . 10.0 111.081 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -147.16 168.52 21.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.634 1.174 . . . . 10.0 108.123 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.1 p -157.18 102.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.011 -2.218 . . . . 10.0 105.011 -178.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.23 95.76 6.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.455 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -112.86 108.75 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 122.5 1.143 . . . . 10.0 109.133 -174.815 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 t -103.18 120.92 41.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.455 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -152.36 155.63 37.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.412 1.264 . . . . 10.0 114.412 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.13 84.0 5.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.944 -1.025 . . . . 10.0 111.735 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.46 1.53 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.022 1.329 . . . . 10.0 110.142 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -44.75 -44.75 9.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.505 2.722 . . . . 10.0 112.595 176.45 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -46.76 10.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.041 0.382 . . . . 10.0 110.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.21 115.37 18.12 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.079 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.04 144.67 50.32 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 -170.074 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.1 t -25.53 -55.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.16 2.184 . . . . 10.0 113.661 168.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -47.95 -62.47 1.45 Allowed 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 173.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.6 -39.08 72.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.515 1.526 . . . . 10.0 110.27 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.417 HG22 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mm -61.45 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 119.152 0.887 . . . . 10.0 108.802 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.46 85.75 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -58.46 -34.09 70.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 122.926 0.49 . . . . 10.0 109.978 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -33.13 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.6 mp -64.47 -49.77 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 169.366 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -31.71 64.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.248 0.477 . . . . 10.0 111.245 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.12 -23.14 66.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.226 0.61 . . . . 10.0 112.099 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -113.39 -63.64 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.452 1.501 . . . . 10.0 111.306 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.16 -146.09 9.56 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.219 1.866 . . . . 10.0 109.344 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -164.8 51.22 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.023 1.411 . . . . 10.0 109.554 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.98 66.11 1.36 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.424 -1.695 . . . . 10.0 106.424 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -147.35 99.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.8 -66.51 0.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.64 -0.695 . . . . 10.0 109.663 168.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt 165.86 179.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.31 1.444 . . . . 10.0 113.507 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 mm -66.11 114.57 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 174.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.99 -43.46 73.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.149 1.379 . . . . 10.0 109.311 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.23 -116.11 1.67 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 104.893 -3.283 . . . . 10.0 104.893 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 116.022 -1.942 . . . . 10.0 111.038 -174.163 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.56 119.99 29.63 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.374 0.669 . . . . 10.0 110.46 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -78.3 103.88 8.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.095 0.958 . . . . 10.0 109.383 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 31.8 mttm -127.03 176.57 7.25 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 176.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -118.14 119.4 34.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.995 -0.742 . . . . 10.0 108.995 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 13.1 mt -77.55 107.67 10.18 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.66 116.75 2.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.342 -1.725 . . . . 10.0 106.342 168.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.28 130.93 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.967 2.107 . . . . 10.0 106.867 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.257 1.4 pm0 -86.93 -46.32 9.99 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 122.38 1.086 . . . . 10.0 113.386 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.99 118.2 1.37 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.102 2.287 . . . . 10.0 112.508 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.1 ttt -120.5 170.25 9.57 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.431 1.493 . . . . 10.0 111.217 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p 61.78 -137.8 0.5 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.028 1.731 . . . . 10.0 111.819 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.2 m -153.56 128.1 9.31 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 125.245 1.418 . . . . 10.0 107.475 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 54.17 29.61 10.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.459 1.103 . . . . 10.0 112.021 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.71 177.64 7.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.381 1.872 . . . . 10.0 106.09 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.5 m 74.63 -50.05 0.67 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.909 1.284 . . . . 10.0 111.83 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -35.32 -51.42 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 C-N-CA 126.607 1.963 . . . . 10.0 110.142 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -42.42 8.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.78 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.502 1.501 . . . . 10.0 111.615 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -61.21 -25.38 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.501 1.12 . . . . 10.0 110.99 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -58.46 3.21 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -46.65 -50.54 17.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.829 1.651 . . . . 10.0 111.793 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -52.39 -60.94 2.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 122.594 1.188 . . . . 10.0 110.501 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 54.1 t -65.79 -40.42 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.41 -17.46 1.91 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.416 1.484 . . . . 10.0 114.495 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -24.37 30.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.952 1.876 . . . . 10.0 108.757 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.28 125.7 27.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.67 -0.644 . . . . 10.0 110.602 -172.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -48.51 -38.53 20.44 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.446 1.098 . . . . 10.0 112.019 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.06 75.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 114.132 -1.395 . . . . 10.0 114.042 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.35 158.27 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.02 1.91 . . . . 10.0 111.76 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.4 t -133.41 -47.66 0.83 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.907 0.883 . . . . 10.0 110.887 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.41 145.5 41.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.251 -0.88 . . . . 10.0 108.873 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.7 m -142.96 59.27 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.861 1.264 . . . . 10.0 110.918 -178.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -78.41 76.3 4.92 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.36 -1.463 . . . . 10.0 109.263 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.55 133.34 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.393 1.077 . . . . 10.0 111.132 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -154.9 58.2 0.67 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -61.53 -19.8 62.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.131 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -69.42 -36.13 76.4 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.037 0.935 . . . . 10.0 110.372 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.01 50.46 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 109.673 -0.492 . . . . 10.0 109.673 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.72 32.35 8.12 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.489 -1.445 . . . . 10.0 109.489 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -152.31 171.09 18.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.557 1.143 . . . . 10.0 107.937 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 0.4 OUTLIER -156.34 125.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 103.062 -2.94 . . . . 10.0 103.062 175.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.67 104.08 15.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.486 -1.302 . . . . 10.0 107.486 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.417 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -116.58 107.46 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 124.462 1.105 . . . . 10.0 109.16 -172.81 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.6 t -95.68 113.67 25.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.417 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.6 p90 -138.36 154.07 48.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.866 -1.061 . . . . 10.0 112.089 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -80.49 77.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.959 -1.019 . . . . 10.0 112.506 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.65 -38.59 0.41 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.937 1.695 . . . . 10.0 112.902 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 1' ' ' MET . 4.6 m-20 -69.23 -39.02 78.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.793 0.837 . . . . 10.0 110.641 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -80.87 -50.13 10.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.87 0.868 . . . . 10.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.72 137.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.337 0.04 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.77 142.16 34.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 122.0 -0.437 . . . . 10.0 110.479 -168.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.8 t -35.36 -48.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 126.222 1.809 . . . . 10.0 112.458 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -51.7 -65.83 0.49 Allowed 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.429 -0.952 . . . . 10.0 108.429 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -42.56 -41.88 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.693 1.197 . . . . 10.0 111.682 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.2 mm -66.0 -43.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.037 0.835 . . . . 10.0 111.153 178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.06 -50.68 69.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.1 -37.22 74.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.823 0.849 . . . . 10.0 109.368 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.68 -29.8 64.95 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.647 0.98 . . . . 10.0 113.647 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -42.85 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.598 -1.314 . . . . 10.0 108.423 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.86 -30.63 71.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.461 0.573 . . . . 10.0 111.115 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.7 -50.97 64.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.992 0.425 . . . . 10.0 110.957 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -49.64 6.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.558 0.947 . . . . 10.0 113.558 -168.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.53 94.23 0.11 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -66.61 102.01 0.86 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.818 1.247 . . . . 10.0 111.711 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.22 74.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 p -156.79 77.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -33.88 -61.8 0.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.38 1.072 . . . . 10.0 112.99 169.504 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mttt 157.0 176.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.523 2.329 . . . . 10.0 113.092 169.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 2.8 mm -64.71 123.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 179.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.74 -56.01 27.48 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 121.42 0.629 . . . . 10.0 109.591 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.09 -172.58 30.69 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.83 -1.308 . . . . 10.0 109.83 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 128.019 2.528 . . . . 10.0 104.406 167.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.297 0.639 . . . . 10.0 109.642 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.3 pm0 -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.843 2.057 . . . . 10.0 110.408 174.815 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -114.04 176.63 4.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.169 0.509 . . . . 10.0 110.023 176.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.9 m -114.59 109.39 18.18 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.312 1.045 . . . . 10.0 109.297 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.35 83.42 3.8 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.959 0.903 . . . . 10.0 109.267 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.98 116.46 0.45 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.461 1.104 . . . . 10.0 109.76 169.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.33 131.26 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 128.77 2.828 . . . . 10.0 109.241 -171.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -101.88 56.79 0.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.856 1.262 . . . . 10.0 107.807 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 118.69 6.51 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.239 -1.144 . . . . 10.0 110.239 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ttt -90.15 147.76 23.39 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.331 0.565 . . . . 10.0 110.622 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -64.48 69.54 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.775 1.63 . . . . 10.0 112.129 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.7 t -149.34 -57.19 0.2 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.153 0.581 . . . . 10.0 110.931 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.44 ' CG ' ' H ' ' A' ' 15' ' ' HIS . 0.2 OUTLIER -162.37 -148.63 0.14 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 173.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.44 ' H ' ' CG ' ' A' ' 14' ' ' GLN . 44.5 m170 64.89 1.42 1.44 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.178 1.791 . . . . 10.0 114.567 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.3 m -21.22 -70.74 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 128.48 2.712 . . . . 10.0 114.628 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.96 80.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.74 -57.26 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.057 0.762 . . . . 10.0 113.057 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.57 65.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.104 1.32 . . . . 10.0 110.755 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.92 -25.16 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.579 1.551 . . . . 10.0 110.87 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -79.31 -72.31 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.336 1.054 . . . . 10.0 109.404 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -44.35 -49.97 9.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.103 2.161 . . . . 10.0 111.63 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.0 m -54.56 -56.18 21.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.771 0.829 . . . . 10.0 110.47 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.2 t -67.77 -39.85 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 177.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -14.46 17.74 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.964 1.269 . . . . 10.0 114.612 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -81.55 -21.47 38.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.599 1.7 . . . . 10.0 108.935 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 57.9 mt -69.14 120.74 15.45 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 123.185 0.594 . . . . 10.0 111.31 -174.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.97 -39.93 4.37 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.99 1.316 . . . . 10.0 111.94 169.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.63 -4.72 90.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.031 1.301 . . . . 10.0 114.617 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.85 162.55 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.286 2.043 . . . . 10.0 112.103 175.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -135.33 -45.22 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 10.0 111.038 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.73 146.94 29.42 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.265 1.026 . . . . 10.0 108.437 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.8 m -142.5 57.47 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.744 0.818 . . . . 10.0 111.381 -175.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -80.79 75.13 7.72 Favored 'General case' 0 N--CA 1.46 0.057 0 O-C-N 120.726 -1.234 . . . . 10.0 110.254 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.78 127.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.16 0.984 . . . . 10.0 110.742 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -146.81 58.45 1.18 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.31 -24.2 64.81 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.006 -0.434 . . . . 10.0 110.961 -176.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -60.44 -33.5 72.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.571 1.548 . . . . 10.0 110.151 175.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.23 -3.24 55.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.209 1.403 . . . . 10.0 111.728 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.62 41.07 25.42 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -156.35 165.68 35.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.028 0.918 . . . . 10.0 110.885 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -157.42 107.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 104.726 -2.324 . . . . 10.0 104.726 172.523 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.1 98.71 11.69 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.215 -1.402 . . . . 10.0 107.215 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.1 OUTLIER -114.08 110.18 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.962 -170.557 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.0 t -93.78 114.35 26.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 169.862 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.401 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -145.48 158.93 43.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.833 0.825 . . . . 10.0 112.366 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -79.75 83.05 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.145 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.12 -29.74 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.936 -1.484 . . . . 10.0 113.549 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.82 -52.34 21.08 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.365 0.984 . . . . 10.0 110.402 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -78.38 -38.02 42.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.86 102.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.505 1.122 . . . . 10.0 108.425 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -64.33 152.77 40.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.198 -0.939 . . . . 10.0 110.638 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.42 -39.35 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.867 0.867 . . . . 10.0 112.794 173.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -56.44 21.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.917 0.887 . . . . 10.0 109.469 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.88 -44.11 66.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.039 0.936 . . . . 10.0 110.624 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 mm -60.58 -51.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.307 -0.998 . . . . 10.0 108.307 178.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.4 88.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.58 -42.02 77.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.124 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -33.33 67.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.143 -0.456 . . . . 10.0 112.208 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mp -66.48 -45.26 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 119.864 1.211 . . . . 10.0 108.806 169.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -61.07 -22.9 65.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.388 0.994 . . . . 10.0 112.075 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.05 -39.95 79.72 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 10.0 110.689 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.85 -65.94 1.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.428 1.491 . . . . 10.0 112.222 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.41 -159.05 28.98 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.247 -1.541 . . . . 10.0 109.247 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -151.76 56.78 0.86 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.888 1.344 . . . . 10.0 108.567 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.87 53.03 1.38 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 54.1 t -142.25 92.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 169.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.93 -62.88 1.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.878 -1.056 . . . . 10.0 109.581 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tttp 169.54 179.79 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.005 1.322 . . . . 10.0 112.53 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 tp -67.04 140.83 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 169.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.09 158.98 34.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.199 0.904 . . . . 10.0 111.71 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptt85 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.013 -1.47 . . . . 10.0 108.338 168.76 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 117.791 -1.1 . . . . 10.0 108.244 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 40.4 mt-10 -152.4 160.33 43.3 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.835 0.743 . . . . 10.0 111.607 -169.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -91.84 107.85 19.5 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.521 2.329 . . . . 10.0 110.407 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 17.8 mttt -128.89 173.74 10.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.399 0.619 . . . . 10.0 111.126 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -112.42 111.56 22.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.416 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 3.9 mt -78.51 99.86 6.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 121.46 9.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.208 -0.932 . . . . 10.0 108.918 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.5 t -112.38 129.75 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.719 2.407 . . . . 10.0 108.698 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.92 82.85 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.66 -23.41 68.86 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.849 -0.614 . . . . 10.0 113.316 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.1 ttt 61.01 -69.45 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.231 2.213 . . . . 10.0 113.524 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -64.75 -28.54 69.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.221 1.409 . . . . 10.0 111.988 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.3 m 71.04 -58.9 0.56 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.469 1.907 . . . . 10.0 111.063 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -58.07 138.38 56.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.783 -0.573 . . . . 10.0 110.801 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.7 m170 53.95 -147.75 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.322 1.049 . . . . 10.0 108.331 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t 68.49 -50.98 0.56 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.889 1.44 . . . . 10.0 114.889 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.59 -49.77 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 10.0 110.643 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -35.63 80.41 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.658 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -54.15 48.56 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.366 0.984 . . . . 10.0 108.795 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t -51.42 -36.15 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.975 0.91 . . . . 10.0 110.739 175.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -70.32 -66.22 0.63 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.098 1.359 . . . . 10.0 108.775 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.1 m -46.44 -51.16 15.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.481 1.912 . . . . 10.0 111.8 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -55.83 -54.9 38.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.41 1.005 . . . . 10.0 110.957 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 53.3 t -66.37 -40.87 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 175.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.03 -13.15 8.2 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.366 -1.241 . . . . 10.0 115.513 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.22 -24.93 46.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.006 1.903 . . . . 10.0 108.534 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 65.3 mt -69.33 119.21 13.24 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.458 -172.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.13 -42.78 3.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.263 1.425 . . . . 10.0 111.7 169.124 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.1 -4.29 89.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.109 -1.405 . . . . 10.0 115.138 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 162.01 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.526 2.163 . . . . 10.0 111.713 174.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -133.08 -46.56 0.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.717 1.207 . . . . 10.0 111.108 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.81 38.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 118.172 -0.918 . . . . 10.0 108.724 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.77 57.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.642 1.177 . . . . 10.0 111.504 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 69.16 4.57 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.691 -1.256 . . . . 10.0 111.499 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.2 126.78 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.815 1.246 . . . . 10.0 112.151 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -148.44 58.18 1.07 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.78 -21.53 66.51 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.751 -1.218 . . . . 10.0 111.869 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -61.32 -37.84 84.73 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.378 1.071 . . . . 10.0 109.642 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.51 -28.32 41.38 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.34 12.58 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.752 1.644 . . . . 10.0 110.827 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -142.11 167.08 22.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.996 0.918 . . . . 10.0 109.503 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.416 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 0.5 OUTLIER -158.47 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.617 -1.994 . . . . 10.0 105.617 -178.392 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.57 99.43 6.52 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.368 0.985 . . . . 10.0 108.514 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.433 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 1.3 m -108.49 109.48 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 125.09 1.356 . . . . 10.0 109.461 -175.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -95.96 115.05 26.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -145.23 154.7 42.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -76.75 82.0 3.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.055 -0.975 . . . . 10.0 112.525 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.04 -28.07 0.65 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.709 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.62 -48.75 18.13 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.949 1.249 . . . . 10.0 110.188 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -82.26 -34.28 28.85 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.056 -0.402 . . . . 10.0 110.276 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.15 104.1 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 10.0 108.556 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 150.35 48.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.195 -0.94 . . . . 10.0 110.24 -171.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.2 m -40.64 -40.14 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.921 0.889 . . . . 10.0 113.148 172.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 3.7 ttpp -58.14 -54.86 42.17 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 123.002 0.521 . . . . 10.0 109.773 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.87 -44.78 63.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.145 0.978 . . . . 10.0 110.17 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mm -62.57 -43.41 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 121.534 -0.729 . . . . 10.0 110.24 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.81 93.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 54' ' ' LYS . 10.0 m-20 -53.36 -42.23 66.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.315 -0.624 . . . . 10.0 109.315 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.61 -36.92 74.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.5 -49.11 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 168.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.41 -22.36 66.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.59 -39.26 88.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.223 0.535 . . . . 10.0 110.552 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.34 -57.65 2.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.442 1.497 . . . . 10.0 111.136 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.09 -152.42 8.65 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.506 2.003 . . . . 10.0 108.59 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -150.36 55.71 0.92 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.388 1.094 . . . . 10.0 108.449 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.66 57.35 1.77 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.212 -1.033 . . . . 10.0 108.212 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.266 14.5 p -147.81 82.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.596 1.189 . . . . 10.0 111.57 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.21 -60.31 1.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.321 -1.763 . . . . 10.0 110.574 168.527 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.383 24.0 mttp 140.96 -176.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.39 3.076 . . . . 10.0 114.026 169.16 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.4 mm -64.74 129.3 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 121.839 -0.538 . . . . 10.0 110.136 -167.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.77 -51.48 63.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.348 1.059 . . . . 10.0 111.011 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.12 173.18 44.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.666 -2.574 . . . . 10.0 106.666 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.714 -1.612 . . . . 10.0 110.283 179.513 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 117.925 -1.036 . . . . 10.0 108.661 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -134.9 122.39 21.9 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.147 0.979 . . . . 10.0 110.074 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -88.81 101.99 14.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 125.441 1.497 . . . . 10.0 110.26 177.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -137.08 176.62 8.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.325 0.511 . . . . 10.0 111.136 176.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -116.39 116.57 27.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.526 0.73 . . . . 10.0 109.64 177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.462 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 4.1 mt -78.41 109.82 12.92 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.038 -1.838 . . . . 10.0 106.038 169.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.06 119.32 4.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.963 1.256 . . . . 10.0 107.904 174.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 16.0 t -123.28 115.84 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 125.24 1.416 . . . . 10.0 108.164 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -92.87 125.11 37.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.416 1.486 . . . . 10.0 107.956 173.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.16 90.54 0.52 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.064 -1.214 . . . . 10.0 110.064 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mtt -143.87 73.27 1.38 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.552 1.176 . . . . 10.0 110.923 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -149.3 -74.33 0.17 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.1 t -167.97 -167.51 0.85 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.8 164.01 3.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.883 0.765 . . . . 10.0 109.91 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 76.44 -3.67 2.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.764 1.226 . . . . 10.0 112.773 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -46.07 76.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.702 0.683 . . . . 10.0 112.051 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.32 -2.2 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.843 1.257 . . . . 10.0 112.588 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -114.98 -43.08 3.13 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.152 -0.967 . . . . 10.0 110.039 167.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.33 -56.27 8.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.586 1.085 . . . . 10.0 111.117 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 59.3 t -57.09 -34.75 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.792 0.837 . . . . 10.0 110.078 178.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -68.83 0.32 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.266 1.426 . . . . 10.0 107.555 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 m -48.18 -45.44 33.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.548 1.539 . . . . 10.0 111.194 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 m -52.4 -58.41 6.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 122.106 0.955 . . . . 10.0 110.808 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 64.4 t -66.68 -42.76 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.09 -11.9 10.17 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.429 1.49 . . . . 10.0 115.321 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.73 -26.35 37.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.804 1.802 . . . . 10.0 108.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.0 mt -66.72 122.35 17.45 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.005 -0.434 . . . . 10.0 111.037 -174.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -50.35 -35.23 26.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.29 1.043 . . . . 10.0 111.853 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.73 -3.78 89.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.196 1.379 . . . . 10.0 114.617 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.36 163.39 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.435 2.117 . . . . 10.0 111.312 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -137.7 -44.75 0.53 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.776 1.231 . . . . 10.0 111.313 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.6 149.82 36.41 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.927 . . . . 10.0 108.501 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.09 57.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 10.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.22 67.82 5.04 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.67 -1.269 . . . . 10.0 110.478 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.87 123.5 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.435 1.094 . . . . 10.0 110.913 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -144.52 57.86 1.31 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.485 -0.759 . . . . 10.0 111.099 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -61.55 -39.0 89.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.797 1.239 . . . . 10.0 109.804 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.71 -26.97 44.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.221 0.608 . . . . 10.0 109.59 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.43 32.36 7.02 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.78 -1.328 . . . . 10.0 109.78 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -149.55 162.62 39.8 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.462 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 1.0 OUTLIER -144.0 120.3 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 102.649 -3.093 . . . . 10.0 102.649 169.84 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -96.24 96.24 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -111.43 104.84 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -170.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.8 t -92.06 117.55 29.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.411 -1.7 . . . . 10.0 106.411 171.429 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -146.63 154.75 41.83 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.675 -177.477 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.7 89.0 7.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.866 0.841 . . . . 10.0 112.681 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.12 -24.91 1.25 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.661 -1.609 . . . . 10.0 114.074 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.48 -56.17 25.41 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.898 1.227 . . . . 10.0 110.278 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -86.16 -40.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.184 -0.916 . . . . 10.0 109.827 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 m -135.48 99.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 -175.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 p -64.97 154.69 36.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.429 -0.795 . . . . 10.0 110.521 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.92 -40.22 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.273 1.029 . . . . 10.0 113.152 174.552 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -53.88 -65.58 0.54 Allowed 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 108.697 -0.853 . . . . 10.0 108.697 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -43.58 -43.83 5.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.84 0.856 . . . . 10.0 110.613 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.3 mm -66.82 -44.51 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.517 -0.739 . . . . 10.0 111.156 179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.65 92.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.97 -38.67 79.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.53 -0.915 . . . . 10.0 108.53 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.15 69.47 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.753 -0.592 . . . . 10.0 112.311 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.6 mp -64.41 -48.37 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 167.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.6 -29.77 68.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.122 0.874 . . . . 10.0 112.737 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.28 -36.46 61.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.671 0.669 . . . . 10.0 111.86 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -56.39 2.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.535 1.134 . . . . 10.0 112.752 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.33 -145.95 6.31 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.206 1.86 . . . . 10.0 109.176 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -165.71 56.9 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.572 1.686 . . . . 10.0 109.977 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.6 66.54 1.55 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -157.59 68.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 113.383 0.882 . . . . 10.0 113.383 -177.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -29.75 -71.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.997 1.11 . . . . 10.0 113.997 172.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 167.95 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.775 1.63 . . . . 10.0 113.338 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -68.53 132.99 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -71.18 81.0 0.71 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.387 0.675 . . . . 10.0 110.536 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.36 141.11 8.8 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.33 -1.508 . . . . 10.0 109.33 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 116.906 -1.521 . . . . 10.0 109.577 -169.536 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtp . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.691 0.281 . . . . 10.0 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -130.99 111.7 12.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.807 1.643 . . . . 10.0 106.921 169.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.92 106.81 4.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.965 -1.124 . . . . 10.0 107.965 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -128.8 161.93 28.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.781 0.801 . . . . 10.0 111.126 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 m -112.02 93.76 4.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.216 1.406 . . . . 10.0 108.067 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.7 tt -78.02 94.23 4.61 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.81 1.244 . . . . 10.0 108.309 177.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 117.84 6.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.09 124.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.725 2.01 . . . . 10.0 111.004 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -85.34 69.15 10.69 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.82 108.82 1.88 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.057 -0.857 . . . . 10.0 112.093 -171.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 tpp -120.18 -152.92 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.071 0.935 . . . . 10.0 111.846 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m 56.26 15.94 2.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.888 1.675 . . . . 10.0 113.861 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 t 45.36 37.16 2.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.379 1.471 . . . . 10.0 111.844 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -164.31 -157.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.5 m170 55.71 31.83 18.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.538 1.135 . . . . 10.0 112.257 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.8 m -29.12 -55.5 0.14 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.255 2.222 . . . . 10.0 113.28 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.74 92.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.937 -1.505 . . . . 10.0 106.937 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.11 -167.09 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.074 1.35 . . . . 10.0 109.231 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.87 -69.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.662 2.785 . . . . 10.0 110.027 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t -47.08 -42.82 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.763 1.625 . . . . 10.0 109.16 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -61.94 -57.43 11.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.231 1.812 . . . . 10.0 108.364 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 m -48.15 -53.95 15.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.181 0.992 . . . . 10.0 110.172 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 m -67.62 -54.13 22.28 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.76 0.314 . . . . 10.0 111.726 -168.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 76.1 t -58.54 -44.14 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.771 -0.825 . . . . 10.0 108.771 176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.28 -2.46 7.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.015 -1.436 . . . . 10.0 114.817 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -81.5 -31.32 32.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 120.123 1.962 . . . . 10.0 108.5 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 123.37 21.28 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 122.095 -0.378 . . . . 10.0 111.002 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.78 -35.14 56.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.2 1.0 . . . . 10.0 111.787 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.64 -12.7 59.7 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.393 -1.276 . . . . 10.0 113.673 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.81 161.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.73 1.765 . . . . 10.0 112.027 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.1 t -138.7 -46.78 0.49 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.44 1.096 . . . . 10.0 110.929 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.42 44.23 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.9 m -141.31 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.268 1.027 . . . . 10.0 110.631 -178.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -83.0 77.1 9.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 120.976 -1.077 . . . . 10.0 108.22 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.71 112.63 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 123.494 0.718 . . . . 10.0 110.113 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -136.23 56.83 1.8 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.246 -1.761 . . . . 10.0 106.246 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.88 -23.43 63.44 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.34 -0.85 . . . . 10.0 111.344 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.24 -31.14 72.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.567 0.621 . . . . 10.0 111.034 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.03 -4.62 53.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.617 0.767 . . . . 10.0 111.586 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.83 19.62 79.74 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.339 1.447 . . . . 10.0 111.131 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -156.06 133.22 10.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.855 0.827 . . . . 10.0 109.274 -168.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.2 m -121.23 120.62 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.04 94.85 9.34 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 m -108.16 109.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -177.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -96.31 120.81 37.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.222 -1.769 . . . . 10.0 106.222 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -146.95 171.99 14.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.767 0.427 . . . . 10.0 111.272 -177.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.4 82.52 2.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.22 -43.26 10.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.755 -1.566 . . . . 10.0 112.233 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -53.96 19.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.812 0.845 . . . . 10.0 111.505 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -38.3 20.53 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.141 -0.349 . . . . 10.0 110.614 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 101.9 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.678 1.591 . . . . 10.0 108.216 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 148.36 38.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.272 0.629 . . . . 10.0 110.234 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.44 -41.21 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.065 -1.022 . . . . 10.0 113.616 172.583 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.24 -52.62 64.58 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 10.0 110.653 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -52.01 -45.65 64.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.459 1.104 . . . . 10.0 110.08 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 24.9 mm -61.6 -48.94 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.17 84.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.03 -33.4 75.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.666 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.66 69.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.321 -0.862 . . . . 10.0 111.721 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.8 mp -68.87 -47.87 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.92 -1.511 . . . . 10.0 106.92 168.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.76 -30.71 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.04 0.836 . . . . 10.0 111.529 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.95 -37.59 77.1 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.984 -0.447 . . . . 10.0 112.007 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 -66.89 0.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.062 1.345 . . . . 10.0 112.043 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.48 -152.14 12.17 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 126.426 1.965 . . . . 10.0 109.224 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -165.67 55.63 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.378 1.089 . . . . 10.0 110.357 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.91 61.65 1.67 Allowed 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 86.5 t -141.63 97.94 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 C-N-CA 123.82 0.848 . . . . 10.0 108.841 179.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.03 -73.11 0.06 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.865 -1.061 . . . . 10.0 108.929 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.69 172.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.506 1.522 . . . . 10.0 111.457 169.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.4 mp -68.34 129.87 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 122.128 -0.358 . . . . 10.0 111.124 171.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -76.98 144.64 38.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 169.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.68 -35.4 1.62 Allowed Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.524 -0.598 . . . . 10.0 111.862 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.483 0 CA-C-O 116.199 -1.857 . . . . 10.0 106.541 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptm . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -109.88 102.33 11.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.84 97.93 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.04 0.936 . . . . 10.0 109.53 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 48.6 mttm -131.85 173.27 11.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.039 0.447 . . . . 10.0 110.415 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -112.56 104.31 12.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.045 0.938 . . . . 10.0 109.251 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.77 86.24 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 176.278 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.8 123.09 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.874 0.87 . . . . 10.0 108.882 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 131.38 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 128.353 2.661 . . . . 10.0 108.33 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -98.16 106.66 18.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.69 93.89 0.57 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.13 -0.788 . . . . 10.0 111.13 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.58 -157.7 0.75 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.35 1.86 . . . . 10.0 107.491 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 48.05 40.88 14.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.401 1.48 . . . . 10.0 114.024 169.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p 42.25 -138.1 0.21 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.38 1.472 . . . . 10.0 113.546 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.08 167.72 20.56 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 120.759 -1.213 . . . . 10.0 110.722 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 80.11 8.15 1.52 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 125.218 1.407 . . . . 10.0 110.48 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.7 p -74.38 -57.63 3.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.431 -0.793 . . . . 10.0 112.028 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -50.26 -46.36 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -44.17 69.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.707 -0.663 . . . . 10.0 111.54 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.23 -53.75 39.7 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.237 1.38 . . . . 10.0 110.11 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.28 -22.6 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.891 -0.505 . . . . 10.0 111.503 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -76.83 -74.9 0.22 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 m -40.94 -53.26 2.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.713 2.405 . . . . 10.0 111.903 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -65.76 -52.36 51.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.182 0.438 . . . . 10.0 112.182 -167.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.3 t -56.94 -44.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.699 -1.223 . . . . 10.0 107.699 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -9.61 17.24 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.32 1.914 . . . . 10.0 116.136 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.68 -24.91 49.19 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.938 1.869 . . . . 10.0 108.687 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.82 122.49 20.81 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.375 0.67 . . . . 10.0 110.753 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.37 -41.8 20.4 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.453 1.121 . . . . 10.0 112.091 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.2 -21.76 68.47 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.047 -1.433 . . . . 10.0 113.793 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.27 150.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.567 1.684 . . . . 10.0 112.258 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.2 t -131.14 -42.6 1.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.493 1.117 . . . . 10.0 110.941 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.57 153.11 40.72 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.82 0.848 . . . . 10.0 108.917 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -145.75 57.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.89 1.676 . . . . 10.0 111.349 -173.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -83.51 72.16 10.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.719 -1.238 . . . . 10.0 110.563 -169.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.74 129.32 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 123.421 0.688 . . . . 10.0 111.43 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -150.32 56.22 0.93 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.995 -1.483 . . . . 10.0 106.995 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.63 -29.05 67.74 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.737 -0.602 . . . . 10.0 111.334 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -63.33 -30.87 71.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.245 1.018 . . . . 10.0 110.811 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.22 -7.16 59.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.09 0.956 . . . . 10.0 111.587 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 25.65 42.08 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 124.952 1.263 . . . . 10.0 110.834 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -156.22 171.8 19.57 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.4 1.095 . . . . 10.0 110.86 -174.174 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.3 p -154.92 141.79 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 102.712 -3.07 . . . . 10.0 102.712 173.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.57 91.4 3.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -110.83 108.15 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -169.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 106.6 18.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -139.43 170.35 16.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.939 0.399 . . . . 10.0 111.852 -172.48 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 0.8 OUTLIER -91.04 73.23 6.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 113.016 0.747 . . . . 10.0 113.016 -168.969 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.94 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.922 1.289 . . . . 10.0 112.792 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.1 t70 -53.88 -57.27 11.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.697 0.799 . . . . 10.0 111.417 173.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -80.52 -39.04 28.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.105 -0.372 . . . . 10.0 110.52 -172.336 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.8 m -139.79 104.31 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 127.021 2.128 . . . . 10.0 106.638 -175.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -64.46 157.9 25.35 Favored 'General case' 0 C--O 1.226 -0.175 0 O-C-N 121.51 -0.744 . . . . 10.0 110.383 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.25 -45.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.833 0.853 . . . . 10.0 113.207 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -61.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 175.514 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.77 -36.45 36.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.483 1.513 . . . . 10.0 111.449 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.8 mm -66.09 -55.07 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 174.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -54.62 -42.77 71.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -171.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -60.78 -37.21 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.171 0.988 . . . . 10.0 110.531 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.239 -0.913 . . . . 10.0 111.373 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.9 mp -64.44 -34.5 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.841 -1.162 . . . . 10.0 109.335 170.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -45.69 76.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.281 0.946 . . . . 10.0 110.05 173.784 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -60.25 -38.3 83.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -126.08 79.16 1.82 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.95 0.9 . . . . 10.0 111.537 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.74 81.12 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.449 -0.66 . . . . 10.0 111.449 169.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -67.23 89.4 0.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.981 1.312 . . . . 10.0 112.142 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -134.36 58.41 1.77 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.99 97.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 O-C-N 120.821 -1.174 . . . . 10.0 110.763 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.13 -68.92 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.351 -0.841 . . . . 10.0 110.222 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.25 171.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.624 1.17 . . . . 10.0 113.925 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -67.3 133.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.461 -0.774 . . . . 10.0 110.582 172.231 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 41' ' ' LYS . 2.0 mt-10 -58.35 119.99 7.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 170.805 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.71 34.16 35.73 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.211 -0.772 . . . . 10.0 114.381 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 118.855 1.328 . . . . 10.0 108.196 170.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.172 -0.442 . . . . 10.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.78 163.52 35.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.964 1.705 . . . . 10.0 106.541 170.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -101.12 111.52 23.75 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 117.453 -1.26 . . . . 10.0 108.599 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 82.4 mttt -136.4 172.74 12.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.07 1.305 . . . . 10.0 112.668 177.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -113.38 97.38 6.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.194 1.398 . . . . 10.0 109.226 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -80.59 87.8 5.74 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -177.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 119.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.276 1.03 . . . . 10.0 109.684 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.7 t -109.85 148.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.182 1.793 . . . . 10.0 111.177 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -131.65 84.95 2.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.567 1.147 . . . . 10.0 108.316 172.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.38 -32.47 72.68 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 121.446 0.47 . . . . 10.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' MET . . . . . 0.403 ' O ' ' CB ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 51.93 63.19 2.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 10.0 114.18 167.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 11' ' ' MET . 14.4 t 120.73 -159.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.963 2.905 . . . . 10.0 109.598 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.9 m -66.3 162.19 20.69 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.262 1.025 . . . . 10.0 109.566 170.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 60.86 -177.88 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.896 0.878 . . . . 10.0 109.761 -168.358 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 57.58 31.07 19.77 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.033 0.445 . . . . 10.0 110.666 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -87.25 -174.03 4.68 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.325 1.05 . . . . 10.0 109.368 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 86.7 t -60.45 73.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.951 2.1 . . . . 10.0 110.176 178.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.55 -47.42 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.934 2.494 . . . . 10.0 110.602 173.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -54.69 44.0 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.822 -1.174 . . . . 10.0 111.027 -172.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.2 t -60.95 -29.6 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.103 1.361 . . . . 10.0 110.567 175.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -57.66 5.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -44.67 -55.31 5.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.869 1.267 . . . . 10.0 111.324 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 m -63.46 -58.59 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.103 0.411 . . . . 10.0 111.71 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.1 t -59.08 -40.0 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 175.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.87 -6.53 24.78 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 118.082 -1.399 . . . . 10.0 114.802 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.48 -20.16 44.32 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 120.365 2.083 . . . . 10.0 108.878 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.7 mt -66.22 117.71 8.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.448 0.642 . . . . 10.0 112.191 -175.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -40.82 -43.55 2.05 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.0 2.12 . . . . 10.0 111.186 167.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.22 6.27 83.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.685 1.612 . . . . 10.0 115.405 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.02 160.54 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 120.883 2.342 . . . . 10.0 111.092 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -132.34 -42.28 0.96 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.42 1.088 . . . . 10.0 111.964 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.32 149.76 29.73 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.311 -1.366 . . . . 10.0 107.311 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.1 m -141.62 60.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 122.079 0.942 . . . . 10.0 110.301 -173.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.39 61.41 5.56 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.311 -0.868 . . . . 10.0 110.398 -169.435 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.24 121.69 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.242 1.417 . . . . 10.0 110.102 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -142.13 54.57 1.46 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 173.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.65 -26.8 67.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.548 -0.72 . . . . 10.0 111.007 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -69.03 -30.84 69.29 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.398 1.079 . . . . 10.0 110.489 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.21 -28.92 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.126 0.571 . . . . 10.0 110.116 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.45 5.4 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.906 1.241 . . . . 10.0 110.949 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -155.91 158.08 37.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.416 1.486 . . . . 10.0 107.43 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.43 94.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.029 -2.952 . . . . 10.0 103.029 -168.35 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.83 94.15 8.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.651 -1.611 . . . . 10.0 106.651 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -109.68 112.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 125.808 1.643 . . . . 10.0 108.038 -171.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.19 115.37 27.33 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 125.985 1.714 . . . . 10.0 106.558 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -149.13 155.76 41.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 113.248 0.833 . . . . 10.0 113.248 -173.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -77.04 82.05 3.56 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.555 0.946 . . . . 10.0 113.555 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.79 -25.63 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.128 -1.396 . . . . 10.0 113.666 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.03 -60.14 2.47 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.081 0.855 . . . . 10.0 110.479 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.83 -0.544 . . . . 10.0 110.083 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.43 103.1 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -72.02 157.66 37.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.661 -1.274 . . . . 10.0 109.065 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 74.5 t -32.15 -48.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 126.315 1.846 . . . . 10.0 112.301 168.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -62.42 1.55 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.78 -41.18 61.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.419 1.488 . . . . 10.0 109.356 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.1 mm -66.12 -52.6 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 119.502 -0.879 . . . . 10.0 108.886 -177.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.37 87.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -58.06 -39.33 78.21 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.627 1.171 . . . . 10.0 109.452 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.81 71.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.916 -0.49 . . . . 10.0 112.183 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.8 mp -70.46 -40.34 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 O-C-N 120.786 -1.196 . . . . 10.0 108.368 169.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -60.34 -28.38 68.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.329 1.422 . . . . 10.0 112.669 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.79 -23.9 67.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 10.0 112.001 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -108.64 -68.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.299 1.84 . . . . 10.0 111.148 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 -144.58 8.42 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.9 2.19 . . . . 10.0 108.806 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -162.5 58.9 0.22 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.666 1.233 . . . . 10.0 108.275 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -137.97 54.2 1.81 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 120.91 0.386 . . . . 10.0 110.398 -166.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 92.1 t -145.86 84.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.306 -1.368 . . . . 10.0 107.306 -172.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.55 -72.77 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.709 -1.132 . . . . 10.0 110.698 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 173.39 174.37 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.256 1.022 . . . . 10.0 113.549 169.762 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 8.9 mm -65.78 111.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.752 -2.684 . . . . 10.0 103.752 168.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -3.78 -89.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.412 2.285 . . . . 10.0 114.189 -168.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.37 36.53 3.37 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.399 1.0 . . . . 10.0 111.002 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 . . . . . 0 C--O 1.256 1.403 0 C-N-CA 126.771 2.028 . . . . 10.0 111.661 -173.461 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 117.965 -1.017 . . . . 10.0 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -126.16 106.76 9.79 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.007 1.723 . . . . 10.0 107.582 167.299 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -61.3 97.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.414 1.486 . . . . 10.0 111.018 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -134.54 171.37 14.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.905 0.859 . . . . 10.0 112.543 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 m -108.29 101.03 10.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.435 ' HG ' ' CG2' ' A' ' 67' ' ' VAL . 12.3 tp -84.34 72.71 10.56 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.079 1.351 . . . . 10.0 107.537 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.3 123.23 0.62 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.919 1.688 . . . . 10.0 111.497 -169.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.85 122.68 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 128.248 2.619 . . . . 10.0 109.182 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -88.17 173.77 8.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.961 -1.496 . . . . 10.0 106.961 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.93 110.45 1.9 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 107.706 -2.158 . . . . 10.0 107.706 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.6 ttt -45.82 -64.95 0.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.146 0.973 . . . . 10.0 111.744 -171.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.8 p 174.51 -65.57 0.01 OUTLIER 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.823 1.249 . . . . 10.0 109.097 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -53.94 147.8 11.66 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.499 1.12 . . . . 10.0 110.226 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -79.62 -155.2 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.781 0.832 . . . . 10.0 111.057 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 58.83 27.11 15.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.618 1.167 . . . . 10.0 111.205 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -80.43 -169.7 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.402 1.081 . . . . 10.0 108.873 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.303 7.3 p 52.42 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.245 1.418 . . . . 10.0 112.248 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.98 -47.66 0.14 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.863 1.665 . . . . 10.0 110.189 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -48.99 46.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.462 1.028 . . . . 10.0 112.332 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.46 -13.34 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.959 1.304 . . . . 10.0 111.496 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.92 -62.7 1.6 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.448 1.099 . . . . 10.0 108.471 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -50.47 -44.45 55.77 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.642 1.577 . . . . 10.0 111.99 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -54.11 -65.57 0.55 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.069 1.347 . . . . 10.0 110.627 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.2 t -55.43 -43.37 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 123.777 0.831 . . . . 10.0 108.787 173.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.43 -19.37 6.05 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.58 1.562 . . . . 10.0 115.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.26 -23.53 32.65 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 120.041 1.92 . . . . 10.0 108.873 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 58.6 mt -66.42 121.38 15.16 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.092 0.473 . . . . 10.0 111.151 -173.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -44.9 -37.79 4.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.204 1.402 . . . . 10.0 112.397 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.12 -5.9 89.29 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.103 1.335 . . . . 10.0 114.684 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.63 166.52 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.245 2.023 . . . . 10.0 111.782 175.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -140.93 -49.26 0.43 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.857 0.863 . . . . 10.0 111.134 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.62 144.73 51.05 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -143.57 56.86 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.253 1.021 . . . . 10.0 111.224 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -86.11 70.29 10.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.524 -1.36 . . . . 10.0 109.017 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.15 130.98 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.402 0.681 . . . . 10.0 110.088 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.26 67.74 0.73 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.61 -21.17 65.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.581 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.27 -35.33 73.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.969 0.508 . . . . 10.0 109.651 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.27 45.68 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.0 25.81 30.72 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.954 1.264 . . . . 10.0 109.969 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -149.71 109.74 4.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.439 0.62 . . . . 10.0 109.569 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 5.0 p -84.46 148.05 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 165.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -119.12 95.79 4.96 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -112.63 109.59 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.177 1.391 . . . . 10.0 107.944 -172.895 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.0 t -99.6 109.93 22.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.408 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.7 OUTLIER -140.76 150.67 43.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 124.411 1.07 . . . . 10.0 111.701 -174.406 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.24 83.35 7.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.244 -0.889 . . . . 10.0 112.958 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.54 -36.22 1.29 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.931 -1.486 . . . . 10.0 112.99 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -61.39 -53.34 57.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.343 0.657 . . . . 10.0 110.134 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.87 -40.26 28.77 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.816 -0.553 . . . . 10.0 110.792 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -138.15 102.74 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.081 1.352 . . . . 10.0 108.598 -173.176 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.16 148.33 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.636 -0.665 . . . . 10.0 111.054 -170.948 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.4 m -39.09 -45.74 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.556 1.142 . . . . 10.0 113.803 173.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -58.36 -52.39 65.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.99 -43.46 50.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.713 1.205 . . . . 10.0 109.83 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.4 mm -64.3 -46.22 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 121.561 -0.712 . . . . 10.0 110.711 179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.17 90.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.863 0.84 . . . . 10.0 109.446 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -66.27 -37.49 85.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.32 82.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.949 -1.094 . . . . 10.0 111.753 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 5.1 mt -58.69 -41.26 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.876 -1.14 . . . . 10.0 109.265 169.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -44.28 90.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.86 -53.95 34.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.778 0.323 . . . . 10.0 111.288 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -48.08 12.39 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.406 0.891 . . . . 10.0 113.406 -169.353 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.35 90.79 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 10.0 108.828 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -65.98 108.22 2.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.009 1.323 . . . . 10.0 111.156 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -166.56 78.71 0.23 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 104.091 -2.559 . . . . 10.0 104.091 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.435 ' CG2' ' HG ' ' A' ' 6' ' ' LEU . 13.9 p -155.5 83.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.16 -50.31 0.71 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.961 2.104 . . . . 10.0 113.361 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 128.16 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.338 3.055 . . . . 10.0 113.308 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.0 mm -65.25 126.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.211 -0.931 . . . . 10.0 108.999 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.5 -48.38 27.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.707 0.803 . . . . 10.0 112.468 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.15 -68.57 1.4 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.927 0.775 . . . . 10.0 112.698 -172.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 . . . . . 0 C--O 1.249 1.049 0 N-CA-C 105.135 -2.172 . . . . 10.0 105.135 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.472 -0.566 . . . . 10.0 109.472 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.42 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 44.6 mt-10 -149.18 148.94 30.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.518 0.599 . . . . 10.0 110.781 -174.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.33 107.49 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.234 1.413 . . . . 10.0 109.918 169.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.42 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 64.6 mttt -136.69 119.72 16.5 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.8 m -78.77 121.5 24.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.859 0.464 . . . . 10.0 110.34 -172.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 pp -78.2 114.47 17.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 169.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 125.92 28.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.88 130.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 127.811 2.444 . . . . 10.0 108.817 -175.207 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -85.85 77.36 9.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.74 101.54 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.307 -0.718 . . . . 10.0 111.399 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 56.62 2.84 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.563 1.182 . . . . 10.0 112.073 -170.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m 21.32 64.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.368 2.667 . . . . 10.0 115.293 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -149.88 135.18 18.13 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.88 -19.9 60.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.972 0.909 . . . . 10.0 113.306 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -35.01 72.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.8 1.24 . . . . 10.0 110.351 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.96 -170.52 0.59 Allowed 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.2 t 72.68 -66.82 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -169.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -66.22 -45.83 79.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.52 -46.23 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.593 0.633 . . . . 10.0 111.538 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 46.0 t -70.93 -28.16 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.963 1.305 . . . . 10.0 110.933 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 -73.03 0.42 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.81 1.244 . . . . 10.0 109.337 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -49.62 -44.6 47.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.5 2.32 . . . . 10.0 111.267 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 t -47.04 -64.08 0.87 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.866 1.317 . . . . 10.0 109.776 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.5 t -66.66 -38.0 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.729 -1.123 . . . . 10.0 108.013 -176.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.56 -15.29 8.3 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 117.99 -1.45 . . . . 10.0 114.81 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.32 -22.02 38.82 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.45 2.125 . . . . 10.0 109.103 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 52.0 mt -70.07 120.58 15.99 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.076 0.465 . . . . 10.0 110.893 -173.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.37 -39.25 10.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.374 1.083 . . . . 10.0 111.874 169.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.15 0.88 86.79 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 114.213 -1.358 . . . . 10.0 114.753 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.72 157.86 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.334 2.067 . . . . 10.0 111.725 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -127.31 -42.92 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.666 1.186 . . . . 10.0 111.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.34 150.08 34.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -141.53 58.18 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.758 0.823 . . . . 10.0 111.495 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 72.39 7.18 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.67 -1.269 . . . . 10.0 110.667 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.01 124.77 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.168 0.987 . . . . 10.0 110.787 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.93 56.81 1.26 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.6 pp -62.46 -23.93 67.17 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.525 -0.734 . . . . 10.0 112.244 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.02 -31.37 72.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.287 0.494 . . . . 10.0 111.19 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.39 -7.52 58.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.397 0.679 . . . . 10.0 111.101 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.96 57.87 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.396 1.474 . . . . 10.0 109.97 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -150.96 162.07 41.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.21 1.005 . . . . 10.0 111.137 -168.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 55.0 t -153.37 111.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.078 -2.564 . . . . 10.0 104.078 -177.524 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.45 85.08 6.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -100.91 126.99 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 178.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.3 t -116.08 120.81 40.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -152.34 158.48 42.79 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 123.776 0.673 . . . . 10.0 112.451 -175.047 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -85.56 88.99 7.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -171.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.69 -25.18 0.67 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.485 -1.689 . . . . 10.0 113.75 168.848 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.04 -61.86 2.32 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.655 1.116 . . . . 10.0 111.086 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -80.12 -50.92 9.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.17 95.06 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.44 -1.689 . . . . 10.0 106.44 -170.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 153.03 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.869 0.842 . . . . 10.0 109.596 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 17.8 t -34.99 -48.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 125.988 1.715 . . . . 10.0 112.009 169.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -55.17 -58.55 7.21 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -48.02 -42.88 29.29 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.601 0.76 . . . . 10.0 110.054 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . 0.433 HG21 ' CE2' ' A' ' 46' ' ' PHE . 2.1 mm -64.63 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.057 -0.657 . . . . 10.0 110.381 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.66 80.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -52.01 -40.86 61.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.527 0.731 . . . . 10.0 109.403 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.87 -40.04 72.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -61.85 -45.85 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 171.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.4 -24.78 67.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.743 0.701 . . . . 10.0 111.944 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.54 -33.89 74.61 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.984 -0.448 . . . . 10.0 111.568 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.73 -70.25 0.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.867 1.267 . . . . 10.0 112.112 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.85 -147.38 18.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.831 -1.708 . . . . 10.0 108.831 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -163.03 53.01 0.18 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 174.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.56 59.13 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -144.75 85.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.92 -62.54 1.36 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.784 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.06 177.13 0.06 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.21 2.204 . . . . 10.0 109.717 169.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 mm -67.15 130.89 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.473 0.709 . . . . 10.0 110.267 169.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -95.02 118.01 31.12 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 106.963 -1.495 . . . . 10.0 106.963 167.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.29 -164.42 24.24 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.536 -2.226 . . . . 10.0 107.536 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.855 -1.545 . . . . 10.0 110.731 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttm . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 118.505 -0.759 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -129.58 102.87 6.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.889 0.876 . . . . 10.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 102.96 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.194 1.798 . . . . 10.0 111.001 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -144.66 176.24 9.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.936 0.789 . . . . 10.0 111.953 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 m -111.38 108.22 17.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.594 1.158 . . . . 10.0 108.745 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -79.22 83.23 5.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 173.545 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.55 126.54 2.35 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 10.0 110.796 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.71 134.88 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.537 2.735 . . . . 10.0 111.437 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.13 94.51 4.97 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.021 -1.103 . . . . 10.0 108.021 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.08 102.76 0.44 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.47 1.033 . . . . 10.0 111.533 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 ttm -119.06 36.2 4.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.458 1.103 . . . . 10.0 111.694 -169.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 p -156.33 176.75 12.28 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.399 -0.813 . . . . 10.0 109.298 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -87.59 -31.95 19.58 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.651 0.78 . . . . 10.0 111.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.7 174.91 13.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.627 -0.671 . . . . 10.0 110.81 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 63.96 22.25 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.322 1.449 . . . . 10.0 112.352 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -108.9 -54.54 2.51 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.672 1.189 . . . . 10.0 109.885 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -35.82 -60.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 125.275 1.43 . . . . 10.0 110.294 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -69.01 -35.11 76.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.816 -0.354 . . . . 10.0 111.686 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 -53.19 61.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.146 -0.972 . . . . 10.0 109.758 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.75 -22.06 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.52 1.928 . . . . 10.0 110.639 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -71.79 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 10.0 109.119 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -49.41 -42.16 41.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.933 2.093 . . . . 10.0 112.884 -174.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.6 p -50.35 -61.41 2.19 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.648 1.179 . . . . 10.0 110.201 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.457 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 89.7 t -61.9 -47.9 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 124.063 0.945 . . . . 10.0 108.524 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.92 -1.57 0.26 Allowed Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.991 -1.449 . . . . 10.0 115.828 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.92 -31.42 19.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.133 1.967 . . . . 10.0 108.688 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.6 125.01 25.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 121.403 -0.811 . . . . 10.0 111.02 -171.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.32 -36.57 32.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 122.45 1.119 . . . . 10.0 111.85 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.88 -12.99 75.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 114.23 -1.35 . . . . 10.0 114.153 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 2.3 t -79.24 146.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 120.085 1.943 . . . . 10.0 111.177 177.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -123.0 -47.11 2.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.891 1.676 . . . . 10.0 111.016 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.64 147.56 51.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 118.237 -0.887 . . . . 10.0 108.771 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.1 58.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.584 1.154 . . . . 10.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -79.39 75.04 5.99 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.221 -1.549 . . . . 10.0 109.501 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.59 122.73 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.362 0.665 . . . . 10.0 110.1 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -147.63 59.74 1.14 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.71 -21.38 65.73 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.695 -0.628 . . . . 10.0 111.946 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -66.47 -32.85 74.47 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.556 0.742 . . . . 10.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.87 -34.57 33.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.81 -1.96 41.72 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.26 1.886 . . . . 10.0 110.611 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -129.9 100.08 5.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.046 0.938 . . . . 10.0 108.746 -170.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 2.4 p -78.02 137.95 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.534 -2.024 . . . . 10.0 105.534 168.423 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -104.79 97.85 7.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.983 1.265 . . . . 10.0 107.812 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -117.81 106.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.12 1.368 . . . . 10.0 108.94 -169.733 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -96.55 114.27 25.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -133.15 152.28 51.95 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.015 1.326 . . . . 10.0 111.649 -178.476 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -82.95 84.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 122.425 1.107 . . . . 10.0 112.353 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.95 1.21 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.239 -1.801 . . . . 10.0 113.801 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.3 -49.56 76.72 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.524 0.602 . . . . 10.0 110.594 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -87.09 -48.62 7.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.86 102.63 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.39 154.55 38.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.402 0.62 . . . . 10.0 109.805 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.51 -42.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.184 1.394 . . . . 10.0 112.601 175.178 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -57.01 -54.44 46.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.246 0.618 . . . . 10.0 109.776 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.35 -40.68 49.91 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.907 0.883 . . . . 10.0 111.178 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.9 mm -66.68 -49.49 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 -179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.23 -39.69 95.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 -174.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -62.28 -41.68 98.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.51 79.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.385 -0.822 . . . . 10.0 110.977 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.457 ' CD1' ' CG2' ' A' ' 24' ' ' VAL . 1.9 mp -61.0 -44.2 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 O-C-N 120.981 -1.074 . . . . 10.0 108.789 168.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.91 -33.56 67.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.013 1.279 . . . . 10.0 112.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.89 -39.35 81.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.997 0.369 . . . . 10.0 111.997 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -133.93 84.4 2.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.623 1.569 . . . . 10.0 108.903 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.28 76.5 1.21 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.495 0.569 . . . . 10.0 112.116 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -68.0 55.22 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.71 2.404 . . . . 10.0 114.739 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.5 56.19 0.63 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.718 -1.238 . . . . 10.0 107.707 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.6 m -133.38 94.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.319 1.448 . . . . 10.0 111.398 -176.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.65 -66.38 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.263 168.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt 160.38 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.53 1.932 . . . . 10.0 113.086 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 6.3 mm -64.12 130.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -72.24 122.08 20.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.14 171.02 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.903 -1.279 . . . . 10.0 109.903 -171.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.409 ' HE ' ' C ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.398 -1.705 . . . . 10.0 106.398 179.088 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 118.973 -0.537 . . . . 10.0 109.843 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -78.98 99.38 6.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.822 -1.547 . . . . 10.0 106.822 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.36 89.21 1.22 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.452 1.101 . . . . 10.0 110.14 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.9 mmtp -139.18 175.18 9.78 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.843 0.682 . . . . 10.0 112.843 -172.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -115.63 117.06 29.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.544 1.538 . . . . 10.0 108.885 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.5 mt -86.57 97.34 10.47 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 171.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -45.8 118.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 t -124.06 124.27 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.76 1.224 . . . . 10.0 108.438 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -97.3 115.69 28.13 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.098 1.759 . . . . 10.0 108.268 173.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 117.63 10.94 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.795 -1.003 . . . . 10.0 111.123 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -80.47 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.304 1.052 . . . . 10.0 110.372 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -168.35 165.28 12.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.111 1.764 . . . . 10.0 108.06 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.4 m 68.36 159.05 0.16 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.278 1.831 . . . . 10.0 111.824 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.52 53.32 1.29 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.019 -1.051 . . . . 10.0 110.258 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -145.32 29.55 1.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.582 0.753 . . . . 10.0 110.453 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p -111.56 -52.68 2.77 Favored 'General case' 0 C--O 1.23 0.031 0 C-N-CA 124.801 1.24 . . . . 10.0 109.993 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -47.56 -56.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.867 1.267 . . . . 10.0 107.858 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -45.53 70.88 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.691 -175.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.74 -49.05 58.79 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.12 0.418 . . . . 10.0 110.302 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 99.4 t -71.43 -25.23 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.357 1.063 . . . . 10.0 111.276 178.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -77.01 -66.11 0.86 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.827 0.851 . . . . 10.0 109.048 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -51.7 -47.91 63.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.307 1.843 . . . . 10.0 111.289 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -53.04 -67.83 0.22 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 10.0 110.753 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 84.8 t -55.46 -42.33 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 124.512 1.125 . . . . 10.0 108.996 175.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.6 -14.04 13.53 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.07 -1.406 . . . . 10.0 115.085 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.01 -22.13 36.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 120.301 2.051 . . . . 10.0 108.697 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 60.3 mt -67.69 117.68 9.94 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.44 0.638 . . . . 10.0 111.498 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -40.79 -40.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.594 1.958 . . . . 10.0 112.251 168.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.14 -8.5 87.56 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.285 1.421 . . . . 10.0 115.2 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.83 158.35 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.022 1.911 . . . . 10.0 111.855 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -132.27 -48.72 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.221 1.009 . . . . 10.0 110.662 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.62 146.09 51.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.099 -1.075 . . . . 10.0 108.099 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.0 m -139.99 57.37 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.328 1.051 . . . . 10.0 110.59 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -82.44 66.15 7.9 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.968 -1.083 . . . . 10.0 110.367 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.09 126.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.038 1.335 . . . . 10.0 110.976 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -144.27 56.14 1.3 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.12 -28.74 66.82 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.551 -0.718 . . . . 10.0 110.986 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -61.85 -31.37 71.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.921 1.289 . . . . 10.0 110.749 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.0 -4.68 56.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.769 1.228 . . . . 10.0 111.771 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.74 40.05 65.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.913 0.768 . . . . 10.0 111.233 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -155.74 160.13 40.06 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 117.901 0.851 . . . . 10.0 109.981 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.31 101.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.45 103.16 11.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -116.38 96.55 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.714 1.206 . . . . 10.0 107.785 -173.683 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 t -88.15 105.76 17.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -135.86 152.39 50.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.696 0.999 . . . . 10.0 113.696 -175.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.38 84.24 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.61 -0.723 . . . . 10.0 112.824 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.87 -30.87 10.81 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.75 -51.87 65.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.012 0.525 . . . . 10.0 110.503 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -78.82 -42.62 27.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.8 98.63 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.179 0.992 . . . . 10.0 109.426 -169.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.69 152.48 26.52 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.48 -0.762 . . . . 10.0 110.617 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -36.81 -44.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.788 1.033 . . . . 10.0 113.788 171.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -55.25 -58.21 8.65 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.36 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -46.79 -44.38 19.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.993 0.917 . . . . 10.0 110.232 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.9 mm -66.99 -45.19 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.542 -0.724 . . . . 10.0 110.669 -178.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.49 99.71 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.383 -0.969 . . . . 10.0 108.383 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.29 -38.95 88.62 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.33 71.88 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.526 -0.733 . . . . 10.0 111.653 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -63.3 -49.8 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 168.233 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.19 -30.4 68.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.563 1.074 . . . . 10.0 112.446 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.94 -29.86 69.87 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.81 -0.556 . . . . 10.0 111.342 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.51 -62.95 1.21 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.109 1.764 . . . . 10.0 111.786 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.54 -143.59 6.66 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.382 1.944 . . . . 10.0 109.18 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.28 57.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.775 1.287 . . . . 10.0 109.978 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.22 70.3 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.725 -1.954 . . . . 10.0 105.725 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -156.23 92.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 121.647 -0.658 . . . . 10.0 112.159 177.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.17 -71.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.512 168.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 13.1 mttt 171.03 176.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.527 1.531 . . . . 10.0 113.959 173.959 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -68.94 130.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.589 -0.523 . . . . 10.0 109.589 177.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -68.44 119.78 13.47 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.84 74.35 0.93 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.576 -0.61 . . . . 10.0 111.576 174.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 C-N-CA 128.351 2.661 . . . . 10.0 104.583 167.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -132.71 134.44 44.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -78.17 106.67 10.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.82 1.648 . . . . 10.0 109.945 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 3.6 mtpm? -128.07 174.72 8.98 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 176.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -120.75 114.99 22.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.658 -0.651 . . . . 10.0 109.593 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.09 82.07 3.6 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.76 -1.57 . . . . 10.0 106.76 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -40.34 120.27 1.19 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -107.48 152.91 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 126.172 1.789 . . . . 10.0 107.717 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.81 56.66 0.94 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.636 . . . . 10.0 107.95 -172.175 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.67 100.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.773 1.654 . . . . 10.0 114.037 -169.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -77.67 6.38 7.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.408 1.083 . . . . 10.0 112.782 -170.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 t 75.36 -39.6 0.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.402 1.481 . . . . 10.0 112.644 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.2 p -49.5 163.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.265 1.426 . . . . 10.0 112.802 173.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -66.64 167.68 10.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.932 0.872 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.76 39.01 0.71 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.571 -1.195 . . . . 10.0 110.42 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -78.91 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.607 0.763 . . . . 10.0 110.353 -174.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.89 57.98 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.169 1.387 . . . . 10.0 108.475 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 -51.47 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 125.661 1.584 . . . . 10.0 111.353 -176.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.91 37.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 121.075 1.761 . . . . 10.0 110.633 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.62 -19.53 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.866 -1.061 . . . . 10.0 110.909 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -78.68 -76.18 0.21 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.167 -1.419 . . . . 10.0 107.167 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -42.09 -49.96 4.75 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.573 2.749 . . . . 10.0 112.152 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -54.33 -58.24 8.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 122.253 1.025 . . . . 10.0 110.63 -177.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.45 -38.66 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.29 -1.004 . . . . 10.0 108.29 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.47 -11.32 40.63 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.181 1.372 . . . . 10.0 114.531 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.94 -21.7 40.23 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.923 1.861 . . . . 10.0 108.123 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 41.4 mt -67.37 117.25 9.1 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.45 0.643 . . . . 10.0 111.525 -175.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -46.96 -35.27 6.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.984 1.313 . . . . 10.0 111.716 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.77 5.69 84.4 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 125.338 1.447 . . . . 10.0 114.93 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.24 159.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 120.532 2.166 . . . . 10.0 111.939 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -126.81 -44.64 1.64 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.07 1.348 . . . . 10.0 112.004 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.65 146.81 34.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.66 -1.162 . . . . 10.0 108.862 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.2 m -145.12 56.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.224 1.01 . . . . 10.0 112.469 -174.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -82.6 70.85 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.158 -1.589 . . . . 10.0 111.147 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.57 126.29 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.541 0.736 . . . . 10.0 111.383 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -144.41 56.97 1.3 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.61 -24.52 67.62 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.659 -0.65 . . . . 10.0 111.529 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.1 -32.27 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.348 0.659 . . . . 10.0 110.518 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.12 44.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.33 9.35 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.118 1.342 . . . . 10.0 111.078 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -141.62 174.41 10.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 122.325 1.06 . . . . 10.0 109.276 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -156.1 115.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 102.996 -2.964 . . . . 10.0 102.996 174.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -91.95 101.24 13.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 120.337 1.426 . . . . 10.0 108.092 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.6 OUTLIER -116.64 107.97 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.637 1.175 . . . . 10.0 109.045 -172.101 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -98.71 116.56 31.22 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -148.06 161.1 42.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 -176.071 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.33 81.8 5.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.302 -0.863 . . . . 10.0 112.97 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.47 -40.87 0.9 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.687 1.595 . . . . 10.0 112.87 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -54.88 18.82 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.31 1.044 . . . . 10.0 111.806 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -83.38 -40.72 19.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -135.43 105.2 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 -177.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 148.67 49.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.588 -0.695 . . . . 10.0 110.222 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 40.1 t -29.31 -52.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 126.871 2.068 . . . . 10.0 112.242 167.454 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -50.32 -60.78 2.64 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.423 0.689 . . . . 10.0 109.331 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -44.76 -44.64 9.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.858 1.663 . . . . 10.0 110.192 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.0 mm -67.15 -45.56 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.098 -1.001 . . . . 10.0 110.904 -177.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.45 94.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -54.69 -39.69 68.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.234 1.014 . . . . 10.0 108.681 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.32 69.83 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.1 0.778 . . . . 10.0 113.1 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mp -66.26 -47.61 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 168.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.32 -26.39 68.4 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -61.97 -33.94 75.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.652 -0.655 . . . . 10.0 111.577 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -98.6 -54.29 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.316 1.446 . . . . 10.0 111.819 -169.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.12 -140.36 3.82 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.155 -1.978 . . . . 10.0 108.155 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -164.83 53.38 0.12 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.685 1.242 . . . . 10.0 110.604 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 78.4 1.48 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.918 -1.512 . . . . 10.0 106.918 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.05 108.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.33 0.14 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.5 tttt 177.75 176.85 0.4 Allowed 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 113.863 1.061 . . . . 10.0 113.863 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.3 mm -67.63 125.03 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.871 -0.518 . . . . 10.0 110.76 174.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 169.58 12.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.37 2.268 . . . . 10.0 109.047 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 54.6 65.19 3.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.936 1.255 . . . . 10.0 111.252 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 105.022 -2.214 . . . . 10.0 105.022 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.097 0.475 . . . . 10.0 112.214 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -128.11 103.36 7.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.848 . . . . 10.0 106.012 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.34 89.7 1.61 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.529 1.132 . . . . 10.0 109.691 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -131.77 173.58 11.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.513 0.673 . . . . 10.0 111.751 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -111.91 112.92 24.92 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.542 1.537 . . . . 10.0 108.148 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 mt -80.64 95.0 6.43 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.611 -1.996 . . . . 10.0 105.611 172.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.4 121.56 5.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.378 -1.341 . . . . 10.0 107.378 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.97 135.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 128.431 2.692 . . . . 10.0 108.192 -169.214 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.67 114.97 25.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.404 -1.702 . . . . 10.0 106.404 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 96.24 1.32 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.155 -1.178 . . . . 10.0 110.155 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.9 57.0 1.15 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.952 0.882 . . . . 10.0 110.983 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -138.39 -104.42 0.18 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.99 . . . . 10.0 108.772 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.27 -163.94 1.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.07 -1.456 . . . . 10.0 107.07 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -43.26 36.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 121.16 1.8 . . . . 10.0 111.197 174.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -75.08 70.64 2.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.03 0.532 . . . . 10.0 109.644 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.92 -63.41 0.65 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.333 1.453 . . . . 10.0 109.277 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.9 t -45.45 -58.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 C-N-CA 124.87 1.268 . . . . 10.0 108.442 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -8.78 57.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.28 -49.16 11.96 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 120.461 -1.399 . . . . 10.0 108.349 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.32 -28.67 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.746 1.218 . . . . 10.0 110.304 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -55.73 4.19 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.4 m -50.06 -53.07 29.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.753 0.821 . . . . 10.0 110.159 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -60.62 -59.95 4.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 122.583 1.183 . . . . 10.0 111.1 -168.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.3 t -60.82 -41.47 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.351 -0.84 . . . . 10.0 108.831 179.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.67 -13.28 7.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.598 1.57 . . . . 10.0 114.546 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.89 -23.0 33.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.984 1.892 . . . . 10.0 108.575 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 73.6 mt -68.9 123.16 20.24 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.733 -0.604 . . . . 10.0 111.085 -174.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -43.4 -43.06 5.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.1 1.36 . . . . 10.0 112.297 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.2 -17.61 74.17 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 113.961 -1.472 . . . . 10.0 114.016 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.4 147.84 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.732 1.766 . . . . 10.0 111.616 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -123.88 -43.23 2.13 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 10.0 110.795 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.6 154.56 44.51 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.794 0.837 . . . . 10.0 109.358 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.3 m -145.64 57.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.079 1.752 . . . . 10.0 111.101 -174.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.17 66.14 7.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.919 -1.113 . . . . 10.0 111.522 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.47 132.4 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 124.618 1.167 . . . . 10.0 111.871 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -152.97 58.17 0.79 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.6 pp -60.79 -26.12 67.05 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.179 -0.951 . . . . 10.0 111.248 -176.399 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -58.9 -34.54 71.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.571 1.148 . . . . 10.0 110.433 173.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.71 -4.19 58.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.104 . . . . 10.0 111.583 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.98 34.74 55.22 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.601 1.096 . . . . 10.0 111.274 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -156.98 160.56 39.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.274 1.037 . . . . 10.0 111.134 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -156.69 104.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.417 -2.438 . . . . 10.0 104.417 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.15 95.26 9.9 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.677 -1.601 . . . . 10.0 106.677 -175.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -110.9 91.84 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.336 1.065 . . . . 10.0 109.93 -169.056 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 m -77.83 84.51 4.14 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.933 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -106.26 178.36 4.58 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.457 0.703 . . . . 10.0 111.372 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.05 83.78 2.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 114.246 1.202 . . . . 10.0 114.246 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -36.0 4.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.904 -1.498 . . . . 10.0 113.036 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -65.72 -54.9 21.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.267 0.485 . . . . 10.0 110.74 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -82.02 -28.08 32.71 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.83 -0.544 . . . . 10.0 111.125 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.63 105.85 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.37 1.468 . . . . 10.0 108.948 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.34 152.28 29.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.404 -0.81 . . . . 10.0 109.663 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.4 -42.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.959 0.903 . . . . 10.0 112.496 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -47.93 83.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.607 0.763 . . . . 10.0 110.567 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.66 -44.57 73.41 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.078 0.951 . . . . 10.0 109.709 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 10.9 mm -62.64 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 122.177 0.989 . . . . 10.0 109.587 -178.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.29 77.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.157 -0.929 . . . . 10.0 108.677 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.54 -43.44 97.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.676 -0.64 . . . . 10.0 109.711 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.94 83.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.725 -0.609 . . . . 10.0 110.451 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.4 mt -51.13 -46.41 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.489 -0.757 . . . . 10.0 109.157 170.177 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.11 -42.74 60.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.963 0.801 . . . . 10.0 111.762 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.37 -41.56 93.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.192 0.52 . . . . 10.0 111.13 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -114.11 66.44 0.67 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.204 1.402 . . . . 10.0 110.606 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 103.5 0.63 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.45 -1.06 . . . . 10.0 110.45 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -74.33 54.3 0.56 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.496 1.518 . . . . 10.0 113.723 -169.365 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -106.04 79.31 1.4 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.441 -1.318 . . . . 10.0 107.441 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.9 p -156.18 104.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.711 -0.618 . . . . 10.0 110.653 172.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.18 -67.63 0.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.027 -0.987 . . . . 10.0 110.514 167.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt 160.03 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.162 2.185 . . . . 10.0 114.098 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.82 133.65 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.23 -0.919 . . . . 10.0 111.178 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.52 109.98 2.15 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.96 78.55 0.64 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.007 -0.837 . . . . 10.0 111.007 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.225 -1.369 . . . . 10.0 110.447 169.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -116.34 125.87 52.72 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.27 99.92 12.61 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.818 0.847 . . . . 10.0 109.493 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -134.35 175.62 9.35 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.963 0.347 . . . . 10.0 110.111 -175.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -117.69 119.38 34.78 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -75.95 111.83 11.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.857 -2.275 . . . . 10.0 104.857 169.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.32 121.62 14.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.84 143.35 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 127.156 2.182 . . . . 10.0 108.5 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.47 117.13 29.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.844 1.657 . . . . 10.0 107.125 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 134.01 38.24 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.534 -1.026 . . . . 10.0 110.534 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -140.23 155.65 46.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.82 0.848 . . . . 10.0 109.19 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 77.96 -175.51 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.525 1.93 . . . . 10.0 112.038 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.1 m -60.91 -41.53 96.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.326 1.05 . . . . 10.0 110.668 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -142.22 -77.4 0.26 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.843 -0.599 . . . . 10.0 109.43 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 70.65 -52.21 0.67 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.811 1.645 . . . . 10.0 111.732 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.5 m 53.45 31.74 12.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.622 1.969 . . . . 10.0 108.373 -168.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 27.7 m 32.57 39.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 128.151 2.581 . . . . 10.0 112.251 -171.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -62.95 -21.65 66.23 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 119.367 -0.933 . . . . 10.0 112.876 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.32 -46.76 36.77 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.039 -1.038 . . . . 10.0 110.96 167.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 41.9 t -59.5 -30.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.251 1.42 . . . . 10.0 111.258 -179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -89.63 -56.95 3.05 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.9 m -60.48 -59.91 4.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.706 1.202 . . . . 10.0 111.48 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -53.91 50.61 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.68 0.673 . . . . 10.0 110.435 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.6 t -59.35 -44.26 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.06 -14.79 3.05 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.034 -1.426 . . . . 10.0 114.876 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -87.22 -20.2 27.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.095 1.947 . . . . 10.0 109.293 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.27 128.59 37.13 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.706 -0.622 . . . . 10.0 111.004 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -46.99 -39.41 12.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.912 1.285 . . . . 10.0 111.901 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.37 -9.24 86.94 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 113.857 -1.519 . . . . 10.0 114.556 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.47 161.32 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 120.385 2.093 . . . . 10.0 112.048 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -140.96 -45.22 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.626 1.17 . . . . 10.0 111.421 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.49 42.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.4 58.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.138 . . . . 10.0 110.516 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -80.05 79.77 6.55 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.757 -1.214 . . . . 10.0 110.44 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.79 118.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.61 0.764 . . . . 10.0 110.584 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -144.65 64.67 1.29 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.054 -1.461 . . . . 10.0 107.054 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.04 -26.82 50.65 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.185 -0.947 . . . . 10.0 111.874 178.401 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -63.34 -31.55 72.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.815 0.846 . . . . 10.0 110.195 177.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.26 -10.9 59.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.25 0.62 . . . . 10.0 111.351 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.44 20.72 79.51 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.743 -1.343 . . . . 10.0 109.743 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -151.63 117.79 5.58 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.703 0.801 . . . . 10.0 109.708 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 p -96.27 126.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 104.604 -2.369 . . . . 10.0 104.604 167.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.84 93.52 8.88 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.427 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -109.43 108.07 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.759 1.266 . . . . 10.0 109.013 -173.019 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 m -99.5 112.92 25.05 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.426 1.49 . . . . 10.0 107.379 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.427 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p90 -148.87 159.26 44.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.277 1.037 . . . . 10.0 113.558 -171.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.82 79.77 9.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.234 1.016 . . . . 10.0 112.337 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.09 -27.98 1.58 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.321 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.24 -56.6 10.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.346 0.521 . . . . 10.0 110.618 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -79.95 -39.23 30.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.798 -0.564 . . . . 10.0 110.639 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 107.67 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -68.16 152.81 44.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.49 0.662 . . . . 10.0 109.809 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 5.7 t -41.18 -44.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.103 1.361 . . . . 10.0 112.539 175.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -49.78 67.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -58.84 -41.03 85.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.217 1.007 . . . . 10.0 109.972 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 15.3 mm -63.3 -45.09 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 121.684 -0.635 . . . . 10.0 109.636 178.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.92 97.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.602 -0.888 . . . . 10.0 108.602 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.06 -38.52 79.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.51 63.44 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.27 -48.83 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.59 -29.82 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.208 0.913 . . . . 10.0 111.91 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.95 -35.64 69.34 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.005 0.431 . . . . 10.0 110.689 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -100.0 -69.67 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.802 1.241 . . . . 10.0 112.732 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.26 -143.27 8.27 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.123 1.821 . . . . 10.0 109.314 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.9 51.99 0.11 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.085 1.443 . . . . 10.0 109.995 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.8 68.15 1.32 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 -172.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.54 78.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.428 0.558 . . . . 10.0 112.18 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.48 -66.55 0.24 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.637 0.775 . . . . 10.0 112.875 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt 162.04 171.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.907 2.083 . . . . 10.0 113.023 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -67.04 129.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.194 -0.316 . . . . 10.0 110.647 -179.199 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.66 179.87 4.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.059 0.943 . . . . 10.0 109.469 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.62 -54.76 3.73 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.497 -0.613 . . . . 10.0 112.04 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 126.976 2.111 . . . . 10.0 111.191 -168.967 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 106.201 -1.778 . . . . 10.0 106.201 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.76 113.43 24.97 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -62.04 108.18 1.0 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 17.7 mtpp -127.59 173.13 10.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.852 0.751 . . . . 10.0 110.129 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -119.01 116.52 26.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.074 0.55 . . . . 10.0 109.932 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.8 mt -78.34 110.83 13.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 170.082 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 116.82 3.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.211 -1.774 . . . . 10.0 106.211 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.4 t -122.87 146.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 125.328 1.451 . . . . 10.0 107.77 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.01 5.19 5.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.635 0.976 . . . . 10.0 113.635 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.45 -155.26 5.03 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.218 0.913 . . . . 10.0 111.875 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.2 mtm -117.93 -84.25 0.65 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.79 0.836 . . . . 10.0 109.859 171.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -162.73 67.5 0.22 Allowed 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.716 -0.615 . . . . 10.0 110.133 -173.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.8 t 70.88 135.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.898 1.679 . . . . 10.0 112.125 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 69.1 162.89 0.22 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.838 1.255 . . . . 10.0 110.764 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 53.48 32.32 13.86 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.636 0.774 . . . . 10.0 111.441 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.44 -93.25 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.183 1.393 . . . . 10.0 109.692 -168.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -60.23 162.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER 72.38 -53.19 0.7 Allowed 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.419 -0.8 . . . . 10.0 112.078 -169.847 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.6 -39.68 81.12 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.163 0.892 . . . . 10.0 110.741 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 31.1 t -90.5 -28.31 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 10.0 110.224 176.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.14 -65.92 0.91 Allowed 'General case' 0 C--N 1.338 0.087 0 C-N-CA 122.912 0.485 . . . . 10.0 110.106 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m -52.84 -40.3 63.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.963 1.305 . . . . 10.0 110.134 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 m -59.51 -51.73 68.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.442 1.097 . . . . 10.0 110.671 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -65.76 -42.52 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.28 -11.8 3.76 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.666 1.603 . . . . 10.0 115.307 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.96 -23.63 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.711 1.756 . . . . 10.0 108.269 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.55 119.07 16.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 121.604 -0.685 . . . . 10.0 110.394 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -48.94 -36.37 17.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.169 0.985 . . . . 10.0 112.18 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 -9.26 77.0 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.934 1.254 . . . . 10.0 114.364 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.57 167.64 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.58 1.69 . . . . 10.0 111.957 174.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -138.26 -50.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.622 1.169 . . . . 10.0 110.847 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.55 145.03 51.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.163 -0.922 . . . . 10.0 108.643 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 56.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.511 1.124 . . . . 10.0 110.778 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.28 78.79 9.71 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 120.27 -1.519 . . . . 10.0 108.717 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.95 123.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.727 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -145.75 59.78 1.26 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.593 -1.632 . . . . 10.0 106.593 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.79 -21.56 64.69 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.567 -0.708 . . . . 10.0 111.586 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.06 -37.61 83.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.74 0.816 . . . . 10.0 109.563 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.83 -16.81 37.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.514 0.726 . . . . 10.0 110.845 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.52 39.26 61.28 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -158.1 95.71 1.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -86.85 120.09 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.899 -1.519 . . . . 10.0 106.899 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -86.32 99.92 11.93 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.714 1.143 . . . . 10.0 108.266 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.449 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.5 m -115.39 106.77 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.102 0.953 . . . . 10.0 108.753 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -99.73 114.72 28.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.449 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -146.8 154.01 40.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 124.034 0.834 . . . . 10.0 113.152 -174.39 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.91 94.43 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.894 0.854 . . . . 10.0 112.095 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.02 22.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.695 -1.139 . . . . 10.0 113.73 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.91 -52.18 61.08 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.229 1.377 . . . . 10.0 110.2 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -87.04 -48.83 7.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 -173.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.83 99.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.55 148.66 32.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.288 -0.634 . . . . 10.0 109.288 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 14.7 t -36.7 -46.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.104 1.362 . . . . 10.0 113.866 173.111 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -51.32 -58.58 5.82 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -44.72 -44.8 9.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.486 1.514 . . . . 10.0 109.824 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 12.0 mm -65.43 -47.41 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.251 -0.906 . . . . 10.0 110.772 179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.83 84.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -55.87 -39.47 71.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.128 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -35.57 70.15 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.1 mp -66.01 -46.21 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 120.398 1.454 . . . . 10.0 107.616 169.318 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.02 -26.19 65.9 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.585 0.63 . . . . 10.0 112.011 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.54 -33.44 68.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.37 0.668 . . . . 10.0 110.766 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -110.39 -63.79 1.34 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.168 1.387 . . . . 10.0 112.086 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.8 -159.16 21.64 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.411 1.482 . . . . 10.0 109.412 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -151.76 57.16 0.86 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.182 1.491 . . . . 10.0 108.196 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.34 61.82 1.6 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.816 -1.179 . . . . 10.0 107.816 -167.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.1 p -158.02 64.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 121.81 -0.556 . . . . 10.0 111.177 -177.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -25.75 -67.89 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.37 1.068 . . . . 10.0 113.224 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 171.65 170.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.373 1.869 . . . . 10.0 111.909 167.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.3 tp -68.41 140.42 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.847 -0.533 . . . . 10.0 111.103 174.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.36 156.72 30.76 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.494 1.118 . . . . 10.0 109.249 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 137.06 0.43 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.091 -1.204 . . . . 10.0 110.091 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 CA-C-O 116.005 -1.95 . . . . 10.0 107.105 -175.527 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.89 112.7 16.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.654 0.264 . . . . 10.0 110.65 -169.253 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -64.07 108.7 1.6 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 172.864 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -134.62 168.47 18.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.601 0.715 . . . . 10.0 110.509 174.863 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -113.54 107.64 16.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.931 -0.577 . . . . 10.0 109.638 178.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -77.27 79.26 3.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 170.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.74 124.14 0.69 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.855 1.262 . . . . 10.0 110.042 173.539 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.5 p -126.3 133.87 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 126.389 1.875 . . . . 10.0 108.011 -178.795 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -97.85 1.55 48.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.488 0.922 . . . . 10.0 113.488 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 58.34 -157.02 19.7 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.429 1.014 . . . . 10.0 111.504 -173.992 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.36 -84.75 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.94 1.696 . . . . 10.0 108.213 176.376 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -163.71 -53.6 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 123.846 0.858 . . . . 10.0 109.815 -173.704 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.3 m -53.74 87.78 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.628 1.571 . . . . 10.0 111.677 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 52.34 46.9 25.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 10.0 109.024 -172.1 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.2 t-160 -68.03 69.65 0.13 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.898 1.279 . . . . 10.0 108.527 170.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -153.76 172.79 16.75 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.797 1.639 . . . . 10.0 107.195 -175.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.8 79.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.835 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -40.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.175 1.39 . . . . 10.0 113.907 168.873 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.82 29.63 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.898 -1.126 . . . . 10.0 110.654 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 94.8 t -70.43 -10.28 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.357 1.063 . . . . 10.0 110.49 -179.597 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.89 -71.54 0.46 Allowed 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 173.269 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -36.39 -47.81 0.62 Allowed 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.44 1.896 . . . . 10.0 112.474 -174.521 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -56.57 -57.81 10.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.18 0.992 . . . . 10.0 111.561 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 49.4 t -66.28 -40.74 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.75 0.71 1.48 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.788 1.661 . . . . 10.0 115.197 173.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.1 -32.46 26.73 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.199 1.999 . . . . 10.0 108.608 173.028 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 66.5 mt -72.73 119.22 16.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.992 -0.442 . . . . 10.0 110.753 -171.231 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.49 -34.47 36.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 122.112 0.958 . . . . 10.0 112.121 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -6.1 71.8 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.828 1.204 . . . . 10.0 114.27 178.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.25 162.75 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.566 1.683 . . . . 10.0 111.771 169.883 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -134.67 -44.96 0.74 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 10.0 111.563 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.37 148.68 44.8 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.43 1.092 . . . . 10.0 108.289 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.16 55.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.122 0.963 . . . . 10.0 111.504 -174.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 70.55 10.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.383 -1.448 . . . . 10.0 108.948 -177.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -61.57 124.61 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.742 -0.599 . . . . 10.0 110.078 173.167 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -141.01 62.18 1.48 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.47 -1.678 . . . . 10.0 106.47 169.772 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -57.34 -25.35 59.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.699 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -60.39 -36.51 78.28 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.463 1.105 . . . . 10.0 109.66 175.328 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.96 19.9 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.213 1.005 . . . . 10.0 110.729 177.13 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.03 39.48 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.862 1.22 . . . . 10.0 111.851 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.09 123.61 26.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.641 -1.614 . . . . 10.0 106.641 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.46 105.38 18.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 126.159 1.783 . . . . 10.0 107.909 173.355 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.16 93.8 4.62 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.38 -0.97 . . . . 10.0 108.38 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.423 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 0.5 OUTLIER -109.96 109.31 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.426 1.09 . . . . 10.0 109.396 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -100.4 123.29 44.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 174.782 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.423 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -150.08 160.97 43.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.686 -173.923 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.77 86.82 5.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.381 1.086 . . . . 10.0 112.484 -172.401 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.01 -27.01 6.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.977 -1.465 . . . . 10.0 113.392 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -43.22 -55.68 3.85 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 10.0 111.377 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -99.01 -39.59 8.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.991 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.26 101.64 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.43 149.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.504 -0.748 . . . . 10.0 109.654 -177.104 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.0 m -36.67 -44.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.082 1.353 . . . . 10.0 114.042 172.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -50.87 72.0 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.645 -0.693 . . . . 10.0 109.663 174.961 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.54 -43.58 25.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.334 1.053 . . . . 10.0 110.151 175.504 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.1 mm -65.61 -43.55 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.227 -0.921 . . . . 10.0 111.025 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.27 90.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -59.22 -41.73 89.32 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.97 63.93 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.994 0.738 . . . . 10.0 112.994 172.628 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -64.84 -46.02 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 120.647 1.567 . . . . 10.0 108.693 169.092 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.85 -28.57 69.58 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.202 0.445 . . . . 10.0 112.202 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -31.77 61.63 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.96 -0.462 . . . . 10.0 111.878 171.932 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.45 -65.81 1.1 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.781 0.832 . . . . 10.0 111.447 -176.473 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.19 -155.63 15.12 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 108.438 -1.865 . . . . 10.0 108.438 -175.619 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -148.72 54.52 1.0 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 119.286 1.543 . . . . 10.0 107.33 172.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.16 65.44 1.56 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.038 -1.468 . . . . 10.0 107.038 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.5 p -150.62 96.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.76 -0.654 . . . . 10.0 109.362 167.755 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tttt 171.7 -174.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.369 1.068 . . . . 10.0 112.801 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 mm -68.3 120.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 O-C-N 121.801 -0.562 . . . . 10.0 109.722 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.98 96.53 4.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 176.774 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.73 165.6 38.82 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 122.239 0.911 . . . . 10.0 112.677 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 . . . . . 0 C--O 1.253 1.287 0 N-CA-C 106.679 -1.6 . . . . 10.0 106.679 168.548 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 121.133 0.492 . . . . 10.0 111.841 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.494 ' CD ' ' HZ3' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -137.8 97.12 3.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.991 1.716 . . . . 10.0 107.983 178.299 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -70.07 98.63 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.746 1.218 . . . . 10.0 109.854 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.494 ' HZ3' ' CD ' ' A' ' 2' ' ' GLU . 39.7 mttt -135.7 166.51 23.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.193 0.597 . . . . 10.0 109.733 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -114.21 117.24 30.61 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.093 0.957 . . . . 10.0 108.827 175.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 12.2 mt -78.59 104.37 9.15 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 170.102 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.53 118.41 3.86 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.035 1.289 . . . . 10.0 108.564 175.942 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 38.4 t -104.39 131.65 52.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 124.974 1.31 . . . . 10.0 109.869 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.75 74.04 0.85 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.23 125.02 7.46 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.856 -0.497 . . . . 10.0 111.856 -172.037 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 ttt -80.88 49.5 1.23 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.341 0.657 . . . . 10.0 112.442 -169.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t 42.68 67.39 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.048 1.339 . . . . 10.0 112.804 172.403 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.2 t -143.68 124.96 14.6 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.713 -0.617 . . . . 10.0 109.91 -176.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -63.78 -16.97 62.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -172.883 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -72.68 -27.84 62.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.844 0.457 . . . . 10.0 111.303 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.02 -155.58 0.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t 73.62 -68.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 127.123 2.169 . . . . 10.0 105.952 -173.082 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -63.61 -44.79 92.94 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.348 -0.842 . . . . 10.0 112.781 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.46 -52.7 44.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.296 0.953 . . . . 10.0 109.574 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 16.9 t -60.21 -31.38 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.15 1.38 . . . . 10.0 110.873 178.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -72.85 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.31 1.044 . . . . 10.0 108.513 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 m -43.0 -44.8 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.991 2.116 . . . . 10.0 111.487 -175.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.7 m -54.1 -51.34 64.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.523 0.678 . . . . 10.0 111.063 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 75.1 t -72.38 -44.04 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 176.074 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -12.73 4.32 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.268 1.413 . . . . 10.0 115.163 176.405 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 -25.63 31.24 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.989 1.394 . . . . 10.0 108.465 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 78.4 mt -62.47 122.71 16.44 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.383 0.611 . . . . 10.0 111.801 -176.073 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.27 -35.99 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.647 1.579 . . . . 10.0 112.286 169.344 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.92 -2.18 81.48 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.273 1.416 . . . . 10.0 114.891 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.04 156.99 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 120.55 2.175 . . . . 10.0 111.466 175.523 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.0 t -130.35 -47.04 1.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 110.912 176.496 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.6 146.04 35.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 178.296 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -143.33 58.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.658 1.183 . . . . 10.0 110.91 -176.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -79.28 76.03 5.84 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.589 -1.319 . . . . 10.0 108.87 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 120.7 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.214 1.005 . . . . 10.0 109.732 173.917 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 57.55 1.36 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 172.086 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -56.49 -28.55 60.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.83 75.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.737 1.215 . . . . 10.0 110.083 176.327 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -7.77 58.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.413 1.085 . . . . 10.0 111.523 178.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.82 38.78 60.46 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 -176.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -158.35 155.57 28.98 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.514 0.725 . . . . 10.0 109.263 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.474 ' CG1' ' O ' ' A' ' 6' ' ' LEU . 1.3 p -146.38 118.68 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 103.617 -2.734 . . . . 10.0 103.617 172.373 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -88.34 108.39 19.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.422 -1.695 . . . . 10.0 106.422 172.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.415 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -121.09 90.21 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 -176.737 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -83.73 108.66 16.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.982 -1.858 . . . . 10.0 105.982 174.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.415 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 1.0 OUTLIER -129.37 178.21 6.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.05 -0.977 . . . . 10.0 110.431 -176.261 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.14 89.88 3.19 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.135 -0.978 . . . . 10.0 113.481 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.88 -33.04 34.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.772 -1.558 . . . . 10.0 112.38 177.13 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.13 -50.41 64.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.802 0.441 . . . . 10.0 110.602 -178.306 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -78.23 -37.86 44.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -142.59 111.08 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.697 1.199 . . . . 10.0 108.104 -177.228 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -70.84 149.84 46.4 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.115 -0.991 . . . . 10.0 110.516 -172.16 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 4.3 t -31.11 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.8 1.64 . . . . 10.0 114.022 172.727 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -50.86 -62.32 1.68 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -42.65 -42.26 3.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.104 0.962 . . . . 10.0 110.609 177.894 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.7 mm -70.29 -44.22 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.588 -0.695 . . . . 10.0 110.628 -177.436 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.74 71.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.78 -38.78 70.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.902 1.281 . . . . 10.0 108.997 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.41 71.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.91 -0.493 . . . . 10.0 112.271 175.139 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.19 -44.35 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.798 1.181 . . . . 10.0 108.141 170.244 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.82 -30.14 68.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.453 0.569 . . . . 10.0 112.425 -178.473 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.5 -26.2 68.41 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.529 -0.732 . . . . 10.0 111.971 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -58.19 1.92 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.297 1.439 . . . . 10.0 111.685 -170.646 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.31 -156.78 8.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.033 -2.027 . . . . 10.0 108.033 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -146.88 56.08 1.13 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.468 1.634 . . . . 10.0 109.812 175.924 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.64 65.65 1.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -150.07 98.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 171.227 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.14 -73.01 0.05 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.303 169.298 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 174.08 173.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.606 1.562 . . . . 10.0 110.795 169.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -66.97 132.55 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 O-C-N 121.59 -0.694 . . . . 10.0 109.793 175.069 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.06 157.04 24.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 170.692 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.16 56.27 3.99 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.653 -0.979 . . . . 10.0 110.653 176.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtt-85 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.661 -167.58 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ttt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 118.521 -0.752 . . . . 10.0 109.901 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.99 104.17 6.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.379 1.072 . . . . 10.0 111.725 -170.113 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -73.69 104.25 4.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.999 1.319 . . . . 10.0 109.902 169.484 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 175.45 9.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.641 0.776 . . . . 10.0 110.556 172.352 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -113.83 108.16 16.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.824 1.25 . . . . 10.0 110.029 175.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 tp -85.63 73.63 10.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.497 1.119 . . . . 10.0 109.054 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.2 119.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.268 1.427 . . . . 10.0 111.88 -173.048 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 65.3 t -99.82 123.04 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.637 1.975 . . . . 10.0 109.987 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -84.78 133.05 34.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.399 -1.704 . . . . 10.0 106.399 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.41 99.17 2.04 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.267 0.939 . . . . 10.0 111.692 -179.058 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -178.5 3.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.407 1.083 . . . . 10.0 108.874 169.962 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 m 67.61 -58.78 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.173 2.189 . . . . 10.0 113.872 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.9 t 78.6 124.53 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 127.473 2.309 . . . . 10.0 110.539 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 69.88 -52.63 0.63 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.378 1.871 . . . . 10.0 112.323 -175.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -77.72 51.58 0.93 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 10.0 110.667 -178.687 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p -161.78 -167.34 1.67 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 127.02 2.128 . . . . 10.0 107.118 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t 72.69 -70.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 C-N-CA 126.828 2.051 . . . . 10.0 106.32 -171.876 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.26 -38.03 87.71 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.762 -1.108 . . . . 10.0 112.483 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.2 -53.41 57.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.817 0.818 . . . . 10.0 109.733 -175.512 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 35.7 t -54.19 -47.85 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.939 1.295 . . . . 10.0 109.222 173.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -61.12 2.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.26 -169.293 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -48.21 -51.12 26.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.25 1.42 . . . . 10.0 111.056 171.883 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -59.17 -59.62 5.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.649 1.113 . . . . 10.0 110.481 -169.201 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 78.9 t -62.46 -36.78 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.335 -0.848 . . . . 10.0 108.899 178.024 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.65 -12.0 25.14 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.141 -1.366 . . . . 10.0 115.113 172.578 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -81.74 -18.1 45.45 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.434 2.117 . . . . 10.0 109.114 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 37.7 mt -70.41 112.07 6.43 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.228 0.537 . . . . 10.0 110.195 -175.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -41.2 -40.76 1.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.795 1.638 . . . . 10.0 113.152 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.93 -15.79 79.6 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.546 -1.206 . . . . 10.0 114.147 -178.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.09 149.96 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.561 1.681 . . . . 10.0 112.133 -174.919 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -111.92 -51.12 2.87 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 10.0 110.878 177.306 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -140.7 146.79 38.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.443 0.697 . . . . 10.0 109.2 179.281 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -146.65 88.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 128.072 2.549 . . . . 10.0 105.108 -173.491 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -114.54 71.74 0.77 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.011 1.324 . . . . 10.0 110.662 -176.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.5 132.06 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.298 -0.876 . . . . 10.0 111.091 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -143.65 57.1 1.36 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 174.139 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.16 -28.97 69.5 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.567 -0.708 . . . . 10.0 111.552 -171.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.631 0.772 . . . . 10.0 111.043 174.521 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 -3.7 58.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.8 0.84 . . . . 10.0 111.5 176.254 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.39 36.91 78.95 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -175.839 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.91 161.42 41.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.823 0.82 . . . . 10.0 109.687 -177.099 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -155.03 121.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 101.665 -3.457 . . . . 10.0 101.665 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -99.6 103.37 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 120.71 1.595 . . . . 10.0 106.754 177.262 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -122.46 99.19 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.641 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.2 p -87.84 95.67 10.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 172.979 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -121.32 155.85 33.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.982 -1.008 . . . . 10.0 110.69 -176.997 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 10.6 t0 -91.61 90.84 7.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.036 0.754 . . . . 10.0 113.036 -172.292 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.81 -30.22 2.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.009 -1.45 . . . . 10.0 113.756 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -64.37 -52.83 56.34 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.13 0.877 . . . . 10.0 110.035 -178.396 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -37.9 35.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 -174.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -144.19 104.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.49 1.116 . . . . 10.0 107.996 -175.513 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.15 150.17 26.05 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 123.453 0.701 . . . . 10.0 111.098 -173.456 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.6 m -40.95 -44.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.446 1.099 . . . . 10.0 113.67 173.409 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -54.5 -56.26 20.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 171.917 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.69 -42.79 46.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.241 1.416 . . . . 10.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 3.0 mm -63.32 -47.65 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.411 -0.806 . . . . 10.0 110.522 178.191 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.89 81.22 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -63.7 -40.37 96.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.721 -0.612 . . . . 10.0 109.468 175.421 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.14 88.64 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.384 -0.823 . . . . 10.0 111.146 177.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.2 mt -55.33 -40.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 120.905 -1.122 . . . . 10.0 109.0 170.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -47.42 72.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.922 0.783 . . . . 10.0 110.282 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.83 -56.7 18.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.478 0.656 . . . . 10.0 109.858 175.468 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -94.53 67.54 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.353 0.661 . . . . 10.0 110.47 -177.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.99 97.06 0.26 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.023 -0.99 . . . . 10.0 111.38 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -65.95 105.11 1.24 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.728 0.775 . . . . 10.0 110.334 -175.729 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -148.94 76.63 1.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 169.14 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.92 105.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 O-C-N 121.152 -0.967 . . . . 10.0 111.129 175.124 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -60.46 -67.61 0.38 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.965 170.569 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttt 157.25 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.746 2.418 . . . . 10.0 112.949 173.889 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.53 107.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.147 0.979 . . . . 10.0 109.576 -173.363 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 81.34 2.8 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.12 110.89 2.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.258 -1.537 . . . . 10.0 109.258 -175.563 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 C--O 1.254 1.294 0 CA-C-O 115.992 -1.956 . . . . 10.0 105.971 171.458 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 ttp . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pm0 -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -78.16 117.07 19.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 2.8 mtpt -130.35 166.13 21.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.482 -1.303 . . . . 10.0 107.482 174.325 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 86.0 m -129.78 108.85 10.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.573 -0.529 . . . . 10.0 109.573 -174.121 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 mt -76.86 92.75 3.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 179.999 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.39 111.79 0.46 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.068 -1.086 . . . . 10.0 108.068 172.573 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.6 m -113.02 144.69 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.949 1.7 . . . . 10.0 109.493 -178.316 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.53 80.02 1.43 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.509 -1.664 . . . . 10.0 106.509 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.15 94.43 0.05 OUTLIER Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.999 1.285 . . . . 10.0 112.457 -171.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.8 ttt -114.53 67.74 0.69 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.846 0.823 . . . . 10.0 110.362 -169.63 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -163.68 -170.74 2.29 Favored 'General case' 0 CA--C 1.527 0.076 0 O-C-N 121.618 -0.676 . . . . 10.0 109.327 -178.26 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.9 m -93.04 -132.17 0.14 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 105.707 -1.96 . . . . 10.0 105.707 168.315 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -64.1 -39.56 94.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.144 -0.973 . . . . 10.0 111.944 178.707 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.62 82.93 6.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.524 -0.735 . . . . 10.0 110.603 -171.025 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -159.45 -39.65 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.72 0.808 . . . . 10.0 111.617 168.755 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -45.18 -53.84 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.428 0.632 . . . . 10.0 110.107 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -29.9 70.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.547 0.573 . . . . 10.0 112.547 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -58.66 6.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.3 t -54.86 -34.15 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.409 0.684 . . . . 10.0 110.174 178.439 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.92 -73.77 0.16 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.809 0.844 . . . . 10.0 109.704 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.1 m -44.92 -45.1 10.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.926 1.69 . . . . 10.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 m -53.48 -55.14 27.81 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.817 0.818 . . . . 10.0 110.709 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -72.15 -25.0 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 123.65 0.78 . . . . 10.0 110.701 179.437 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 4.2 69.38 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.061 1.315 . . . . 10.0 112.688 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.66 -45.1 17.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.087 1.444 . . . . 10.0 107.447 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -55.71 118.82 4.89 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -176.39 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.66 -35.66 14.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.692 1.197 . . . . 10.0 111.963 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.72 -3.54 83.79 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.883 1.23 . . . . 10.0 114.326 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 158.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.902 1.851 . . . . 10.0 111.527 170.1 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -133.93 -46.3 0.79 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.253 . . . . 10.0 110.897 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.33 46.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.291 -1.003 . . . . 10.0 108.291 173.519 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -142.9 58.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 110.255 -174.506 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.92 67.7 5.79 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.355 -0.841 . . . . 10.0 109.964 -172.89 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.5 129.77 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.579 1.152 . . . . 10.0 109.907 178.661 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -155.61 55.51 0.62 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.69 -18.47 65.39 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.715 -0.615 . . . . 10.0 110.493 -175.342 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -36.17 82.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.498 1.119 . . . . 10.0 109.711 171.28 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 -29.02 43.68 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.032 -0.359 . . . . 10.0 110.032 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.94 22.9 7.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 10.0 111.464 174.925 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 4.3 mtpt -148.67 174.65 11.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.407 1.083 . . . . 10.0 108.255 -178.291 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.99 99.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -177.941 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -80.94 90.88 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.737 -1.209 . . . . 10.0 107.737 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.42 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.2 OUTLIER -103.22 101.19 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.135 1.374 . . . . 10.0 108.733 -174.749 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -89.11 107.61 19.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.42 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -141.89 156.59 45.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.313 0.578 . . . . 10.0 112.447 -176.15 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -81.93 90.7 6.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.869 1.063 . . . . 10.0 113.869 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.72 -27.08 1.79 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.92 -1.491 . . . . 10.0 113.353 169.071 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.49 -55.22 9.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.607 1.094 . . . . 10.0 110.342 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -77.22 -38.75 50.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 -175.006 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.99 98.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -176.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.45 148.2 46.32 Favored 'General case' 0 C--O 1.219 -0.52 0 O-C-N 121.497 -0.752 . . . . 10.0 109.091 -175.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.7 t -28.65 -52.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 125.986 1.714 . . . . 10.0 112.843 168.262 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -48.29 -54.01 15.24 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 123.364 0.665 . . . . 10.0 109.443 177.633 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.34 -46.63 62.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.01 2.124 . . . . 10.0 109.132 177.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 8.8 mm -67.3 -45.15 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.752 -0.592 . . . . 10.0 110.88 -176.353 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.66 90.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.877 -0.786 . . . . 10.0 108.877 -178.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.82 -38.88 76.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 175.87 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.51 73.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.767 -0.635 . . . . 10.0 112.285 172.812 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.7 mp -62.51 -47.29 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 120.203 1.365 . . . . 10.0 107.825 169.642 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.38 -34.5 66.75 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.607 1.094 . . . . 10.0 111.614 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.48 -30.01 66.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.503 -0.748 . . . . 10.0 112.022 176.29 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.27 -62.23 1.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.992 1.717 . . . . 10.0 112.108 -169.524 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.07 -147.03 6.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.437 1.97 . . . . 10.0 108.551 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.48 54.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.152 1.476 . . . . 10.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -124.47 58.17 1.22 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 -177.139 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -139.77 100.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 121.221 -0.924 . . . . 10.0 110.766 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.87 -77.24 0.06 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.252 -0.885 . . . . 10.0 109.77 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.61 175.04 0.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.752 1.39 . . . . 10.0 114.752 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 7.7 mm -68.98 113.12 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.674 0.79 . . . . 10.0 109.168 178.139 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.8 115.17 0.98 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.896 0.879 . . . . 10.0 109.479 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.42 -20.49 18.44 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.758 -1.023 . . . . 10.0 113.562 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.853 -1.546 . . . . 10.0 109.873 174.036 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 118.123 -0.941 . . . . 10.0 109.164 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -120.6 114.52 21.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.22 1.408 . . . . 10.0 108.49 174.276 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -79.53 88.86 5.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.259 1.024 . . . . 10.0 110.282 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.477 ' HZ1' ' C ' ' A' ' 73' ' ' ARG . 60.8 mttt -125.21 175.87 7.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.505 0.593 . . . . 10.0 111.965 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -119.78 109.65 15.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.658 0.783 . . . . 10.0 109.205 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.3 tt -82.87 101.8 11.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 177.625 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 124.11 20.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.44 -0.948 . . . . 10.0 108.44 -175.318 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.2 t -127.59 145.34 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.827 2.451 . . . . 10.0 107.275 -175.528 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -136.63 112.81 9.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.736 1.214 . . . . 10.0 107.917 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.15 -37.0 92.21 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.086 -0.841 . . . . 10.0 113.969 -169.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mtt 23.24 60.99 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.142 2.177 . . . . 10.0 113.877 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 t -148.48 -94.52 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 -173.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -161.14 -53.41 0.05 OUTLIER 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.613 0.365 . . . . 10.0 110.431 175.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -160.6 -47.59 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.183 0.593 . . . . 10.0 110.119 176.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -72.66 72.84 1.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.494 0.717 . . . . 10.0 111.53 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.78 -44.26 0.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.548 1.139 . . . . 10.0 110.76 170.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -38.87 -50.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 10.0 112.086 178.777 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -31.67 66.62 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.08 69.73 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 120.869 -1.145 . . . . 10.0 109.28 -178.632 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.9 t -54.98 -40.79 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.133 -0.94 . . . . 10.0 109.615 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -58.51 6.77 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.935 0.894 . . . . 10.0 108.695 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 m -48.35 -49.74 33.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.683 0.793 . . . . 10.0 110.879 173.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -59.57 -58.76 7.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.451 0.643 . . . . 10.0 109.51 -170.437 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . 0.42 ' CG2' ' CD1' ' A' ' 60' ' ' ILE . 95.1 t -71.15 -18.12 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.809 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.44 82.58 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.702 1.144 . . . . 10.0 112.907 178.567 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.25 -44.34 16.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.131 1.466 . . . . 10.0 107.654 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.94 122.22 11.77 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.04 -0.527 . . . . 10.0 112.409 -174.368 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.91 -36.46 38.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.271 1.034 . . . . 10.0 111.538 169.972 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.35 -3.05 64.69 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.224 -1.353 . . . . 10.0 114.038 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -67.82 157.85 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 120.165 1.983 . . . . 10.0 111.772 169.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 m -129.84 -44.28 1.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.152 1.381 . . . . 10.0 111.649 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.03 146.57 33.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.777 -1.106 . . . . 10.0 108.328 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.27 58.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.483 1.113 . . . . 10.0 111.172 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.73 74.57 6.42 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.4 -1.437 . . . . 10.0 109.723 -176.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.53 118.05 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 124.517 1.127 . . . . 10.0 111.507 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -142.27 63.35 1.41 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 174.131 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.51 -22.78 65.43 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.653 -0.655 . . . . 10.0 111.627 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.48 -34.43 77.13 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.028 0.931 . . . . 10.0 110.386 172.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.69 41.88 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 10.0 110.264 171.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.09 21.99 43.57 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.946 1.26 . . . . 10.0 110.667 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -153.63 105.64 2.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 -174.644 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.9 m -89.08 128.67 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.006 -1.849 . . . . 10.0 106.006 170.451 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.24 97.84 10.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 177.722 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -119.99 99.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 -168.399 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -92.63 116.45 29.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.426 -1.694 . . . . 10.0 106.426 176.613 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.1 p90 -147.05 151.78 37.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.699 1.25 . . . . 10.0 112.103 -176.863 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -86.97 88.09 7.62 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.063 0.935 . . . . 10.0 112.655 -169.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.13 -30.34 2.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.496 1.518 . . . . 10.0 112.739 175.95 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.63 -56.94 7.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.122 0.969 . . . . 10.0 111.56 174.903 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -50.34 6.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -172.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.03 99.04 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.53 148.11 34.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.742 -0.836 . . . . 10.0 108.742 -176.821 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -32.66 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.823 1.649 . . . . 10.0 111.553 168.521 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -55.85 -55.61 30.49 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 119.072 -0.489 . . . . 10.0 110.47 175.944 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -46.78 -46.28 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.464 0.706 . . . . 10.0 110.124 173.088 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 14.7 mm -64.04 -51.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 121.85 -0.531 . . . . 10.0 110.128 -177.535 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.58 87.37 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -62.5 -35.86 80.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.543 0.737 . . . . 10.0 109.279 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.6 67.3 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.197 -0.939 . . . . 10.0 112.271 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.42 ' CD1' ' CG2' ' A' ' 24' ' ' VAL . 3.5 mp -70.97 -44.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 168.971 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.92 -36.28 67.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.355 1.434 . . . . 10.0 111.549 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -55.59 -30.79 61.47 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.132 0.424 . . . . 10.0 112.116 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.05 83.48 1.74 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.448 1.099 . . . . 10.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 96.37 109.36 2.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.899 -0.88 . . . . 10.0 110.899 172.615 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -77.32 57.51 1.49 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.307 1.043 . . . . 10.0 112.878 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -120.77 65.7 0.85 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 10.0 109.765 -168.174 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.273 0.9 OUTLIER -142.42 92.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 122.363 1.078 . . . . 10.0 110.337 -174.086 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.59 -23.74 66.24 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.702 -1.135 . . . . 10.0 111.561 169.811 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.0 tttt 107.15 165.75 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.4 2.28 . . . . 10.0 112.16 168.39 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -64.86 128.19 27.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 O-C-N 121.119 -0.988 . . . . 10.0 110.455 -178.494 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.39 165.35 16.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.604 -0.725 . . . . 10.0 110.999 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.34 100.15 0.14 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.298 -1.121 . . . . 10.0 110.298 175.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . 0.477 ' C ' ' HZ1' ' A' ' 4' ' ' LYS . 7.2 ttt-85 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 105.287 -2.116 . . . . 10.0 105.287 -173.458 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.1 ttt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 111.839 0.311 . . . . 10.0 111.839 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.06 154.72 42.16 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 122.674 0.39 . . . . 10.0 111.364 176.643 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.37 114.46 21.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.18 1.792 . . . . 10.0 107.864 169.352 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 23.9 mttp -137.91 175.34 9.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.13 0.877 . . . . 10.0 110.083 176.616 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.7 m -123.83 109.55 13.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.514 -0.755 . . . . 10.0 109.162 -179.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.2 mt -82.61 90.78 6.84 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 179.359 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 121.77 6.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.2 t -102.72 130.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.256 2.222 . . . . 10.0 108.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -82.41 -17.09 46.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.022 1.392 . . . . 10.0 113.483 178.34 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.36 -153.97 38.65 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 109.242 -1.543 . . . . 10.0 109.242 -168.059 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mtp 65.52 80.58 0.22 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.366 1.066 . . . . 10.0 111.626 176.717 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 t -140.9 -69.85 0.38 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.827 -0.546 . . . . 10.0 110.003 175.439 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t -154.72 -77.65 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.688 0.676 . . . . 10.0 111.023 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.25 132.97 6.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.542 -1.281 . . . . 10.0 107.542 179.11 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -177.69 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.974 1.31 . . . . 10.0 108.098 -175.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.1 m 69.97 -68.6 0.19 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.329 1.452 . . . . 10.0 109.07 -176.491 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -149.16 82.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 -178.633 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.44 -47.75 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 174.493 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.68 -63.35 1.15 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.969 1.259 . . . . 10.0 111.254 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 91.4 t -50.09 -36.33 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.784 1.633 . . . . 10.0 110.758 174.478 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.75 -57.24 11.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.92 0.888 . . . . 10.0 108.662 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -50.37 -51.89 41.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.163 0.985 . . . . 10.0 110.093 177.903 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -57.28 -54.26 48.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.091 0.948 . . . . 10.0 111.165 -168.357 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 74.0 t -70.85 -41.6 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.189 178.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.58 -7.93 12.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.152 1.358 . . . . 10.0 114.286 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.73 -24.06 36.35 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.184 1.492 . . . . 10.0 107.823 176.817 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -66.18 121.55 15.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.623 -0.673 . . . . 10.0 111.547 -176.644 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -47.71 -34.32 8.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.077 1.351 . . . . 10.0 112.125 169.735 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 0.88 87.39 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.317 1.437 . . . . 10.0 114.729 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.46 157.15 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 120.578 2.189 . . . . 10.0 111.768 173.881 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -126.48 -44.47 1.7 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.714 1.205 . . . . 10.0 111.968 174.039 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.96 146.87 32.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.041 -0.98 . . . . 10.0 108.439 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.4 m -143.22 59.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 10.0 111.866 -177.344 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.62 73.84 6.31 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 120.431 -1.418 . . . . 10.0 110.29 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.96 124.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 123.858 0.863 . . . . 10.0 111.298 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -146.74 58.24 1.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 171.25 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -56.21 -28.33 57.94 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.717 -0.615 . . . . 10.0 111.173 178.758 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.62 -27.16 69.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.169 1.388 . . . . 10.0 111.144 177.179 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.03 -1.76 51.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.201 1.4 . . . . 10.0 111.852 173.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.29 71.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.906 1.241 . . . . 10.0 111.291 -177.074 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.18 153.39 27.57 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 117.991 0.896 . . . . 10.0 109.387 -177.813 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.04 101.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.846 -2.279 . . . . 10.0 104.846 -175.491 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.27 102.09 12.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 -174.815 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 m -118.89 106.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 124.879 1.272 . . . . 10.0 108.386 -172.317 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -96.56 119.42 35.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.442 -1.688 . . . . 10.0 106.442 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -150.0 157.34 43.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.065 0.936 . . . . 10.0 113.074 -174.317 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.13 82.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.711 -1.132 . . . . 10.0 113.706 -172.182 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.49 -28.57 0.59 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.925 -1.489 . . . . 10.0 113.501 168.307 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.49 -43.63 26.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.063 0.847 . . . . 10.0 110.266 -172.598 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -78.96 -47.63 15.99 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.151 0.887 . . . . 10.0 109.169 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 108.86 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 -174.977 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.91 154.38 41.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -175.368 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 70.9 t -27.34 -55.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 126.662 1.985 . . . . 10.0 113.288 168.926 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.74 -48.39 50.2 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 118.437 0.562 . . . . 10.0 110.002 179.713 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -57.19 -42.6 81.52 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.922 1.289 . . . . 10.0 108.46 -179.051 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 5.4 mm -67.31 -43.99 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 120.365 -0.534 . . . . 10.0 109.734 -178.345 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.28 84.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 -176.08 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -54.48 -41.66 69.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.528 1.131 . . . . 10.0 108.848 177.463 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.911 -0.493 . . . . 10.0 112.029 175.708 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mp -62.55 -43.69 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.773 1.169 . . . . 10.0 108.572 170.647 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.21 -34.76 68.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.668 1.576 . . . . 10.0 111.693 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.33 69.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.773 0.715 . . . . 10.0 112.447 172.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -133.18 65.44 1.59 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.959 1.704 . . . . 10.0 111.342 -176.045 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 117.93 4.13 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.424 1.011 . . . . 10.0 110.843 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.24 55.92 2.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.381 1.091 . . . . 10.0 111.47 -169.973 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.99 64.19 0.86 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.739 1.216 . . . . 10.0 108.406 -170.611 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . 0.266 0.4 OUTLIER -149.62 93.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 120.593 -1.317 . . . . 10.0 110.694 -178.225 . . . . . . . . 3 3 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.68 -73.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.654 169.821 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . 0.402 ' CG ' ' H ' ' A' ' 70' ' ' ILE . 1.5 ttmm 172.28 176.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.67 2.388 . . . . 10.0 108.894 171.559 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.402 ' H ' ' CG ' ' A' ' 69' ' ' LYS . 8.0 mm -64.2 133.14 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 123.909 0.884 . . . . 10.0 109.803 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -59.3 112.54 1.77 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 170.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.8 -11.5 64.43 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 117.848 -1.529 . . . . 10.0 115.966 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 120.562 2.181 . . . . 10.0 108.934 -172.251 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . 0.402 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 1.3 mm-40 -119.64 111.35 17.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.261 0.625 . . . . 10.0 110.017 -172.399 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -69.13 102.74 1.72 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.124 0.969 . . . . 10.0 109.639 169.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . 0.402 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 70.9 mttt -128.33 169.4 14.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 121.466 0.651 . . . . 10.0 110.387 176.465 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -110.4 115.26 29.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.1 tp -83.38 107.3 15.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.118 -1.808 . . . . 10.0 106.118 169.347 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.39 117.1 3.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.482 -1.673 . . . . 10.0 106.482 173.531 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.32 119.09 59.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 176.927 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -83.76 -23.93 31.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.785 1.234 . . . . 10.0 113.84 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.21 -176.19 3.89 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.477 1.513 . . . . 10.0 111.564 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.8 mtp -108.03 -83.12 0.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.691 0.796 . . . . 10.0 108.932 169.204 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -169.94 -178.47 2.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 -176.868 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t 54.65 -161.44 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.972 1.709 . . . . 10.0 111.784 177.574 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -103.05 179.87 4.15 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 10.0 108.823 177.668 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 m170 69.92 24.69 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.417 1.487 . . . . 10.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.51 -64.8 1.05 Allowed 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.785 1.234 . . . . 10.0 108.958 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.5 t -32.49 -62.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.661 1.984 . . . . 10.0 110.511 177.382 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.23 -34.53 78.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.07 -0.49 . . . . 10.0 112.093 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.12 74.76 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.832 1.196 . . . . 10.0 109.875 -178.628 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.24 -41.79 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 174.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -63.11 -65.86 0.62 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.977 1.311 . . . . 10.0 109.494 -175.461 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 m -43.6 -47.02 7.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.082 1.753 . . . . 10.0 110.195 174.695 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 m -67.6 -45.12 76.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 119.029 0.831 . . . . 10.0 111.162 -173.999 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 98.6 t -65.22 -20.45 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 121.31 -0.869 . . . . 10.0 110.38 169.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.87 15.42 60.76 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.034 1.302 . . . . 10.0 112.677 -172.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.51 -44.69 11.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 178.392 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.412 ' CD1' ' H ' ' A' ' 27' ' ' LEU . 0.0 OUTLIER -60.39 126.0 25.81 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.193 -0.912 . . . . 10.0 112.352 -174.686 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.01 -35.81 36.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.24 1.416 . . . . 10.0 111.282 172.247 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.92 -9.14 75.13 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.526 -1.215 . . . . 10.0 113.738 179.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.24 158.93 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 120.115 1.957 . . . . 10.0 112.674 172.461 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.7 t -133.7 -45.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.832 1.253 . . . . 10.0 111.588 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.31 37.43 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.452 1.101 . . . . 10.0 108.473 177.104 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.53 55.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.841 0.856 . . . . 10.0 111.042 -173.812 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -85.91 68.89 10.48 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.702 -1.248 . . . . 10.0 109.257 -170.387 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.32 118.59 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 10.0 110.221 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -136.02 59.21 1.72 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.93 -28.47 51.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.003 -0.544 . . . . 10.0 111.284 -179.419 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -62.76 -36.35 82.79 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.951 0.9 . . . . 10.0 110.946 174.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -8.09 59.28 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.048 0.939 . . . . 10.0 111.236 174.167 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.33 30.27 57.09 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.441 1.02 . . . . 10.0 110.63 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -158.21 161.85 37.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.921 0.867 . . . . 10.0 110.581 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 42.8 t -150.03 125.98 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.367 -3.197 . . . . 10.0 102.367 -172.47 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -105.48 93.44 4.67 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 120.056 1.298 . . . . 10.0 107.749 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.406 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.2 m -105.15 107.56 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -178.634 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -97.84 114.91 27.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 172.918 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . 0.406 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -144.8 153.53 41.73 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.379 0.609 . . . . 10.0 110.929 -177.463 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.19 77.12 6.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.822 -168.486 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.23 -37.35 0.63 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.168 1.787 . . . . 10.0 113.605 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.88 -55.42 26.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.436 1.095 . . . . 10.0 111.272 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -84.21 -42.52 15.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.501 0.72 . . . . 10.0 109.969 -173.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.7 99.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 143.82 57.17 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 121.47 -0.769 . . . . 10.0 109.15 -175.38 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 m -38.88 -45.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.973 1.309 . . . . 10.0 113.562 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -55.67 29.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.612 0.765 . . . . 10.0 110.692 172.379 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -47.95 -38.71 17.32 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.25 1.02 . . . . 10.0 111.044 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.9 mm -68.05 -53.15 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.326 -0.99 . . . . 10.0 108.326 179.96 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -50.02 -47.29 53.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 -179.512 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.43 -38.44 87.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.153 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.73 82.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.645 -0.66 . . . . 10.0 111.004 176.923 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.0 mp -65.07 -42.71 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 117.766 -1.111 . . . . 10.0 108.965 169.537 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -61.15 -21.54 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.201 1.364 . . . . 10.0 113.032 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.44 -33.7 76.57 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 10.0 111.644 169.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 -61.78 1.33 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.987 1.715 . . . . 10.0 112.086 -170.781 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.22 -151.69 10.04 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 127.104 2.288 . . . . 10.0 109.082 176.947 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -159.19 66.54 0.41 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.067 1.434 . . . . 10.0 108.981 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -146.47 55.64 1.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 -168.309 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -153.6 58.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.698 -0.626 . . . . 10.0 110.543 -172.874 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -26.33 -70.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.789 1.236 . . . . 10.0 112.544 176.998 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.92 173.0 0.61 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.438 1.095 . . . . 10.0 111.804 169.821 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 1.2 mp -77.26 128.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 122.972 0.509 . . . . 10.0 111.456 178.455 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -60.85 93.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 170.313 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 0.32 23.39 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.106 -1.386 . . . . 10.0 115.204 169.662 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.275 -1.345 . . . . 10.0 113.133 176.297 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -145.0 156.06 43.73 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 -171.574 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -91.26 123.86 35.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.746 1.218 . . . . 10.0 109.995 173.489 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.52 173.03 12.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.834 0.309 . . . . 10.0 111.834 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 9.9 m -116.53 107.83 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.431 0.693 . . . . 10.0 110.326 -179.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.6 mt -81.68 88.48 6.25 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 174.927 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.19 115.72 1.07 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.434 1.094 . . . . 10.0 109.553 -177.729 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -82.5 129.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.709 1.604 . . . . 10.0 112.258 178.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.74 94.96 9.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 169.215 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.51 100.42 0.54 Allowed Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.384 -0.676 . . . . 10.0 111.6 -174.416 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.8 mtt -144.53 80.06 1.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.703 1.201 . . . . 10.0 111.597 -173.931 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.411 ' HG ' ' CG ' ' A' ' 15' ' ' HIS . 54.7 p -147.43 -63.91 0.27 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.224 -0.922 . . . . 10.0 109.518 168.532 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t 113.63 102.11 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 130.066 3.346 . . . . 10.0 108.693 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.82 56.3 0.1 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.971 1.708 . . . . 10.0 113.126 175.454 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.411 ' CG ' ' HG ' ' A' ' 12' ' ' SER . 0.3 OUTLIER -126.82 129.79 48.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 106.893 -1.521 . . . . 10.0 106.893 168.558 . . . . . . . . 3 3 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.8 m -82.31 66.45 7.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.992 -2.225 . . . . 10.0 104.992 166.998 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER 53.97 15.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 171.66 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -57.42 -32.38 66.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.353 -0.842 . . . . 10.0 112.585 -168.82 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.27 -64.74 0.72 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.827 0.851 . . . . 10.0 110.567 168.935 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -54.19 -46.11 67.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.098 1.759 . . . . 10.0 109.176 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.22 -63.85 1.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.137 1.375 . . . . 10.0 109.644 -173.717 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.5 m -50.87 -48.2 60.27 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.401 1.081 . . . . 10.0 109.526 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 t -58.19 -64.81 0.79 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 122.245 1.021 . . . . 10.0 109.867 -169.746 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 92.2 t -63.64 -36.91 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 -177.404 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.54 -15.61 18.42 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.066 -1.408 . . . . 10.0 115.496 171.497 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -23.7 37.98 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.511 2.156 . . . . 10.0 109.165 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 39.3 mt -67.68 121.79 16.67 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 122.926 0.491 . . . . 10.0 110.443 -173.006 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.01 -41.67 16.86 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 122.659 1.219 . . . . 10.0 111.544 170.015 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.27 -4.6 74.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 113.689 -1.596 . . . . 10.0 114.441 -179.018 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.79 159.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 120.69 2.245 . . . . 10.0 111.168 173.433 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -138.29 -45.06 0.5 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 10.0 110.713 -178.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.19 149.07 39.22 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 173.737 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.6 m -142.9 57.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.64 0.776 . . . . 10.0 111.134 -179.311 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -81.55 74.49 8.55 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.504 -1.373 . . . . 10.0 109.568 -175.793 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.27 131.26 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 123.902 0.881 . . . . 10.0 111.158 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -155.19 66.85 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.171 0.986 . . . . 10.0 109.004 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.44 -23.53 50.22 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.858 176.539 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -63.37 -41.91 98.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.716 1.606 . . . . 10.0 108.96 175.484 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.47 -26.7 46.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 173.726 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.18 5.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -153.9 175.01 13.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 173.792 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -151.61 125.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 101.578 -3.49 . . . . 10.0 101.578 169.113 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -99.78 97.47 8.39 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.43 106.98 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 114.075 -1.42 . . . . 10.0 107.594 -172.38 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 20.3 t -96.7 113.61 25.18 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 175.095 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -146.72 152.9 39.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 124.588 1.18 . . . . 10.0 111.965 -173.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.274 32.8 t0 -83.48 82.0 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.417 1.103 . . . . 10.0 113.303 -170.523 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.87 -25.25 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.452 -2.158 . . . . 10.0 114.005 169.659 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -63.28 -57.25 11.03 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.382 0.992 . . . . 10.0 109.581 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -87.14 -39.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.272 -0.268 . . . . 10.0 110.89 -172.002 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.6 m -124.65 100.44 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 177.538 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -63.97 156.97 26.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.889 0.852 . . . . 10.0 110.186 -177.946 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.1 t -33.69 -49.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 125.573 1.549 . . . . 10.0 111.739 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -52.14 -59.24 4.61 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 175.902 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -43.41 59.17 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.088 0.955 . . . . 10.0 109.565 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 2.3 mm -63.59 -51.12 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.535 -0.913 . . . . 10.0 108.535 -177.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.13 87.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 -174.028 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.65 -37.63 68.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.852 0.861 . . . . 10.0 109.673 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.23 -40.92 74.84 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.622 -0.674 . . . . 10.0 111.187 175.063 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.9 mp -63.26 -38.9 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.029 -1.044 . . . . 10.0 108.269 175.114 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.89 -38.8 79.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.64 1.109 . . . . 10.0 110.727 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -56.31 22.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.467 0.576 . . . . 10.0 110.064 170.758 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -99.07 62.03 1.27 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.418 1.487 . . . . 10.0 111.136 -175.066 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.41 99.67 0.39 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.97 0.795 . . . . 10.0 113.26 169.868 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.01 103.19 1.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.306 1.042 . . . . 10.0 112.553 -171.959 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -149.54 66.09 1.0 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.32 1.048 . . . . 10.0 108.549 173.625 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.9 p -154.49 75.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 120.406 -1.433 . . . . 10.0 112.565 -172.706 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -31.19 -69.1 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.574 1.15 . . . . 10.0 112.751 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 166.25 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.095 1.758 . . . . 10.0 113.91 168.035 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.56 122.72 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.741 -0.599 . . . . 10.0 110.511 176.391 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -105.76 82.06 1.74 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 170.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 164.25 -150.19 18.16 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 105.462 -3.055 . . . . 10.0 105.462 -170.872 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.285 -1.817 . . . . 10.0 106.296 170.908 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttp . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.044 -0.724 . . . . 10.0 109.044 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -123.18 133.67 54.22 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 10.0 109.296 176.392 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -80.37 104.51 10.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.572 1.149 . . . . 10.0 109.272 169.434 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -139.26 177.04 8.2 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.591 0.632 . . . . 10.0 110.399 174.517 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -121.19 110.62 16.4 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.771 1.229 . . . . 10.0 108.112 -173.35 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.87 89.6 4.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.161 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . 0.4 ' NE2' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -46.3 127.31 8.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -178.69 . . . . . . . . 3 3 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.4 ' H ' ' NE2' ' A' ' 7' ' ' GLN . 2.1 p -124.53 136.04 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 128.189 2.595 . . . . 10.0 108.321 -175.476 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.98 -7.84 16.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.517 1.127 . . . . 10.0 113.957 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.61 -173.82 1.15 Allowed Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.949 1.738 . . . . 10.0 112.657 -174.446 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 60.5 mtm -140.07 26.96 2.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.403 0.681 . . . . 10.0 112.022 171.955 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 t 52.86 59.24 4.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.451 0.7 . . . . 10.0 110.956 171.741 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.7 p -157.85 159.56 36.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.17 0.988 . . . . 10.0 108.777 -169.477 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -77.54 167.71 21.18 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 121.549 0.69 . . . . 10.0 110.663 174.173 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 55.67 52.29 11.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.021 1.329 . . . . 10.0 109.995 -177.13 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p -119.02 -49.17 2.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.191 0.996 . . . . 10.0 110.728 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -56.55 -54.73 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.395 -0.816 . . . . 10.0 108.921 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -28.52 69.96 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.403 -0.811 . . . . 10.0 112.017 178.239 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.65 -37.2 84.3 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 121.425 -0.797 . . . . 10.0 111.053 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.97 -18.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.274 0.63 . . . . 10.0 110.446 176.511 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.02 -68.86 0.74 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.086 0.555 . . . . 10.0 111.018 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 m -55.25 -39.5 69.83 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.543 1.537 . . . . 10.0 111.262 -170.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -48.16 -68.74 0.16 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.486 1.914 . . . . 10.0 110.491 177.497 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 124.319 1.048 . . . . 10.0 108.931 175.727 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.59 -18.98 5.86 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.299 1.428 . . . . 10.0 115.034 173.402 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.09 -21.24 29.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.867 1.834 . . . . 10.0 108.72 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.68 121.24 19.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.87 -0.519 . . . . 10.0 109.861 -173.519 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -47.12 -37.12 9.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.009 1.324 . . . . 10.0 112.416 173.847 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.67 81.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 114.519 -1.219 . . . . 10.0 114.35 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.32 163.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.86 1.83 . . . . 10.0 112.755 176.107 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -136.82 -49.17 0.63 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.677 1.191 . . . . 10.0 111.032 174.792 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.81 147.67 51.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.733 -0.839 . . . . 10.0 108.733 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.91 59.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.926 1.29 . . . . 10.0 110.655 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 79.81 5.79 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.329 -1.482 . . . . 10.0 108.54 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 135.03 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 174.15 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.05 58.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 172.374 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.61 -26.98 68.89 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.771 -0.581 . . . . 10.0 111.12 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.43 -30.41 71.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.353 0.661 . . . . 10.0 110.147 174.134 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.43 -19.57 24.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.018 0.527 . . . . 10.0 111.21 172.398 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.52 14.76 55.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.82 1.676 . . . . 10.0 111.542 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -144.38 97.83 3.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.025 0.93 . . . . 10.0 109.35 -169.633 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.5 p -88.97 109.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 N-CA-C 106.699 -1.593 . . . . 10.0 106.699 168.928 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.65 102.92 15.08 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -119.33 106.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 125.233 1.413 . . . . 10.0 108.384 -172.308 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.3 t -92.86 120.95 33.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.667 -1.605 . . . . 10.0 106.667 174.831 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -153.14 157.24 40.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.145 0.974 . . . . 10.0 113.355 -173.254 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.36 80.85 7.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.057 . . . . 10.0 112.497 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.15 -30.19 1.1 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.308 170.844 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.45 -53.55 27.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.084 0.553 . . . . 10.0 110.925 -177.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.17 -36.23 24.88 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.068 0.547 . . . . 10.0 109.868 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.58 101.63 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.762 1.225 . . . . 10.0 109.106 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 152.31 27.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.538 -0.726 . . . . 10.0 110.35 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.07 -39.84 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.884 0.874 . . . . 10.0 112.777 171.771 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -59.15 -53.97 52.25 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 118.581 -0.724 . . . . 10.0 109.935 174.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -47.52 -46.84 27.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.521 0.729 . . . . 10.0 109.898 175.595 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 9.5 mm -62.72 -49.64 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 O-C-N 122.07 -0.394 . . . . 10.0 110.394 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.25 -46.52 88.27 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.088 -1.079 . . . . 10.0 108.088 -175.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -59.99 -38.32 82.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.4 0.68 . . . . 10.0 109.221 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.34 70.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.569 -0.707 . . . . 10.0 112.499 172.661 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.3 mp -66.91 -45.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 168.391 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.21 -24.79 66.6 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.799 0.727 . . . . 10.0 112.864 -176.858 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.54 -36.07 77.54 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.677 -0.64 . . . . 10.0 111.301 171.344 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.55 -55.06 2.85 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.93 1.692 . . . . 10.0 112.164 -169.543 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.54 -152.2 8.01 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.029 1.776 . . . . 10.0 108.874 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -151.27 59.32 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.925 1.363 . . . . 10.0 107.475 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.02 63.39 1.63 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.155 -1.424 . . . . 10.0 107.155 -167.967 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 3.8 p -155.92 70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.871 0.367 . . . . 10.0 111.642 -176.977 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -27.65 -71.37 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.319 1.047 . . . . 10.0 113.541 170.843 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt 165.8 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.28 2.232 . . . . 10.0 112.436 169.303 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 130.5 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 120.721 -1.237 . . . . 10.0 111.844 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.38 149.06 43.44 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.029 0.442 . . . . 10.0 110.579 177.376 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.37 48.02 2.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.047 0.832 . . . . 10.0 112.685 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.104 -1.903 . . . . 10.0 109.185 -169.967 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 4.1 ttp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 . . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.75 158.68 44.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.25 1.42 . . . . 10.0 109.49 173.562 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -93.54 115.12 27.61 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.849 1.66 . . . . 10.0 109.453 170.558 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -135.55 176.96 8.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.993 0.815 . . . . 10.0 112.02 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -123.14 114.17 19.95 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 174.881 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.5 pp -80.15 125.92 30.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.298 -1.741 . . . . 10.0 106.298 166.654 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 130.27 40.78 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.56 130.71 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 128.133 2.573 . . . . 10.0 110.22 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -98.24 57.26 1.23 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.199 -1.037 . . . . 10.0 108.199 174.631 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.76 123.4 13.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.296 -0.722 . . . . 10.0 111.296 -172.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 ttt -89.57 165.82 14.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.415 0.686 . . . . 10.0 111.215 -175.678 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t -67.04 78.55 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.297 1.039 . . . . 10.0 110.337 176.948 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 152.61 34.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 174.898 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -83.25 170.48 14.61 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.145 0.578 . . . . 10.0 110.21 175.87 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.3 m170 61.54 17.71 8.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.127 1.371 . . . . 10.0 112.885 -173.333 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -84.28 -38.91 19.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.383 1.073 . . . . 10.0 111.196 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -74.27 52.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.471 1.508 . . . . 10.0 111.271 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.41 -43.1 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.067 1.747 . . . . 10.0 109.752 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.33 -51.77 51.41 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.22 -0.925 . . . . 10.0 110.664 176.79 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.22 -21.09 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.221 1.408 . . . . 10.0 111.239 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -79.37 -71.42 0.45 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.128 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -49.82 -39.4 38.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.269 1.827 . . . . 10.0 112.365 -167.842 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m -49.82 -55.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.259 1.028 . . . . 10.0 110.24 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -72.43 -41.82 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 124.136 0.975 . . . . 10.0 108.79 -179.78 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.36 -9.27 3.13 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.892 1.234 . . . . 10.0 114.603 173.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.86 -27.51 40.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 119.65 1.725 . . . . 10.0 108.622 177.334 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 75.5 mt -69.76 118.99 13.31 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.344 -173.097 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -45.38 -41.19 8.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.472 1.13 . . . . 10.0 111.925 170.105 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -3.38 81.13 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 114.04 -1.436 . . . . 10.0 114.674 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.09 163.38 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.411 2.105 . . . . 10.0 112.02 174.36 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -136.61 -43.62 0.6 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.841 1.257 . . . . 10.0 111.612 179.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.49 37.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.438 1.095 . . . . 10.0 108.233 176.11 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 57.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.14 1.376 . . . . 10.0 110.774 -173.632 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -81.52 88.87 6.16 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.768 -1.208 . . . . 10.0 109.847 -170.896 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -71.63 110.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.687 0.795 . . . . 10.0 111.231 179.46 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -142.07 57.55 1.47 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 175.043 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.1 -22.51 62.85 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.505 -0.747 . . . . 10.0 112.068 -177.956 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -61.97 -32.83 73.31 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.631 0.772 . . . . 10.0 110.876 172.39 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.93 -6.07 56.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.686 0.794 . . . . 10.0 111.554 173.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 15.44 81.56 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.825 1.679 . . . . 10.0 110.794 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -148.82 135.81 19.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.363 1.065 . . . . 10.0 108.296 -167.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -116.63 131.28 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 102.96 -2.978 . . . . 10.0 102.96 175.547 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.61 96.37 6.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.33 1.423 . . . . 10.0 108.326 177.527 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -111.5 110.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.341 1.456 . . . . 10.0 109.541 -174.289 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.8 t -98.22 123.82 42.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 10.0 106.173 169.743 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -154.59 154.26 32.75 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.605 0.717 . . . . 10.0 112.55 -174.626 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.52 83.04 4.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.339 -0.846 . . . . 10.0 113.223 -170.153 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.14 -32.61 0.49 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.031 -1.441 . . . . 10.0 113.411 168.904 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.0 m-20 -72.1 -40.15 68.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.854 0.752 . . . . 10.0 110.113 -172.889 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -91.48 -42.42 10.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.634 0.652 . . . . 10.0 111.145 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.39 109.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 146.81 50.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.477 -0.765 . . . . 10.0 109.569 -175.177 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.4 m -38.51 -40.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.306 1.042 . . . . 10.0 113.615 170.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -62.63 -48.87 77.49 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.648 -0.691 . . . . 10.0 111.198 174.084 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -48.32 -45.11 34.77 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.819 0.736 . . . . 10.0 109.279 175.429 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' ILE . . . . . . . . . . . . . 1.1 mm -66.26 -43.73 91.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 122.071 -0.393 . . . . 10.0 111.015 178.779 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.84 68.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.42 -34.52 72.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.287 0.635 . . . . 10.0 109.867 -178.432 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.58 -31.69 66.42 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.947 -1.096 . . . . 10.0 113.188 173.377 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 3.4 mp -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 120.477 1.49 . . . . 10.0 108.152 169.837 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.41 -29.72 67.95 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.646 1.112 . . . . 10.0 111.635 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -59.55 -29.49 67.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.697 0.399 . . . . 10.0 111.647 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -111.02 -64.37 1.29 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.518 1.127 . . . . 10.0 111.228 -177.355 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.98 -156.46 24.05 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.557 1.551 . . . . 10.0 109.261 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -152.35 56.13 0.82 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.592 1.196 . . . . 10.0 108.174 173.676 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.04 57.84 1.77 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -168.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.2 p -146.86 79.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 122.172 0.987 . . . . 10.0 109.815 -174.991 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.75 -61.83 1.97 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.63 -1.176 . . . . 10.0 111.727 170.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt 154.53 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.843 2.057 . . . . 10.0 115.122 170.66 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.16 123.37 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.986 1.714 . . . . 10.0 110.988 -177.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -94.05 152.78 18.54 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 124.718 1.262 . . . . 10.0 109.917 178.521 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.96 81.43 0.12 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.749 -1.341 . . . . 10.0 109.749 -176.019 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.547 -1.692 . . . . 10.0 107.218 -169.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.209 0.052 . . . . 10.0 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.59 91.21 4.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.405 1.882 . . . . 10.0 111.016 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB3' HD12 ' A' ' 70' ' ' ILE . 20.2 mttp -117.78 175.37 5.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.488 0.661 . . . . 10.0 112.024 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -118.76 102.33 8.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.362 1.065 . . . . 10.0 110.516 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.54 74.57 3.26 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -34.38 110.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.749 1.619 . . . . 10.0 111.24 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 42' ' ' VAL . 90.9 t . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 125.712 1.605 . . . . 10.0 110.221 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 119.804 -0.141 . . . . 10.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -79.79 -69.67 0.57 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 m -43.52 -44.55 6.1 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 126.668 1.987 . . . . 10.0 111.44 -173.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -49.23 -55.33 12.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.037 0.922 . . . . 10.0 111.186 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 56' ' ' ILE . 72.7 t -70.4 -41.87 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.83 -14.06 5.02 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.389 1.471 . . . . 10.0 114.911 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -81.77 -23.95 36.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.712 1.756 . . . . 10.0 108.442 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 56' ' ' ILE . 65.6 mt -71.05 120.09 16.12 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 122.013 -0.429 . . . . 10.0 110.728 -174.042 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.1 -34.67 14.42 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 10.0 112.168 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.45 -0.84 90.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.121 1.343 . . . . 10.0 114.627 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.66 160.29 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 120.327 2.063 . . . . 10.0 111.682 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -131.0 -42.56 1.1 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.214 1.006 . . . . 10.0 112.377 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.41 147.25 35.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.826 0.85 . . . . 10.0 108.966 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.3 59.12 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.784 1.234 . . . . 10.0 111.128 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 71.47 5.55 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.675 -1.266 . . . . 10.0 109.856 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.24 123.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.936 0.895 . . . . 10.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -150.01 58.69 0.98 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.7 pp -56.54 -29.53 62.04 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.572 -0.705 . . . . 10.0 111.004 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.0 mt-10 -60.08 -35.67 75.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.313 1.045 . . . . 10.0 110.698 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.02 59.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.939 0.896 . . . . 10.0 111.393 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.83 55.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.092 0.853 . . . . 10.0 111.535 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -154.53 154.31 32.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.501 1.151 . . . . 10.0 110.154 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -142.42 102.66 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.73 93.35 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.555 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -105.89 114.03 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.187 1.395 . . . . 10.0 108.609 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -102.27 120.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.42 160.47 43.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 123.981 0.801 . . . . 10.0 111.804 -175.375 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -90.96 80.32 5.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.002 0.906 . . . . 10.0 112.659 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -36.95 -39.13 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.813 2.045 . . . . 10.0 113.684 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.62 -57.19 9.85 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.608 1.163 . . . . 10.0 111.76 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -41.74 15.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 -171.072 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.5 110.97 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -69.66 155.46 40.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.495 0.664 . . . . 10.0 109.746 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -37.91 -40.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.076 1.35 . . . . 10.0 113.095 171.74 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -57.62 -58.33 8.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -47.44 -46.17 26.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.767 0.827 . . . . 10.0 110.096 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -63.94 -45.35 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 O-C-N 121.691 -0.631 . . . . 10.0 111.019 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.23 91.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.674 0.749 . . . . 10.0 108.987 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -60.44 -36.44 78.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.86 -0.793 . . . . 10.0 108.86 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.61 70.13 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.468 -0.77 . . . . 10.0 112.398 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.4 mp -64.59 -48.44 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.288 -1.375 . . . . 10.0 107.288 168.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.52 -26.95 67.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.043 0.838 . . . . 10.0 112.464 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -26.56 59.69 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.303 0.483 . . . . 10.0 112.303 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -120.13 -63.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.766 1.226 . . . . 10.0 111.183 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.51 -153.72 25.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.185 -1.566 . . . . 10.0 109.185 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -162.79 52.98 0.19 Allowed 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.476 -1.305 . . . . 10.0 107.476 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.91 62.19 1.66 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.165 -1.791 . . . . 10.0 106.165 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.74 88.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.56 1.172 . . . . 10.0 108.663 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.74 -70.44 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.43 -1.259 . . . . 10.0 109.397 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 163.07 -174.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.344 1.858 . . . . 10.0 113.53 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 53' ' ' VAL . 18.2 mm . . . . . 0 N--CA 1.438 -1.051 0 C-N-CA 123.674 0.79 . . . . 10.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.9 pm0 -72.64 100.45 2.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.608 1.563 . . . . 10.0 109.686 169.584 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -128.82 178.93 6.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.562 0.345 . . . . 10.0 110.179 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -118.17 114.22 22.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.064 0.546 . . . . 10.0 110.505 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.2 mt -79.54 92.76 5.33 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 106.689 -1.597 . . . . 10.0 106.689 174.291 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 119.89 5.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.451 -0.421 0 C-N-CA 126.818 2.047 . . . . 10.0 110.837 178.606 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -70.39 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.718 1.207 . . . . 10.0 108.764 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -48.11 -44.46 31.9 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.692 1.197 . . . . 10.0 110.941 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -59.8 -58.95 6.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.586 0.708 . . . . 10.0 110.57 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 56' ' ' ILE . 76.8 t -61.16 -41.41 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -13.81 7.77 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.171 -1.349 . . . . 10.0 115.289 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.8 -21.39 34.54 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.289 2.045 . . . . 10.0 108.87 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.748 HD13 HD12 ' A' ' 56' ' ' ILE . 61.7 mt -66.23 121.81 16.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.455 0.645 . . . . 10.0 111.834 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -45.17 -39.61 6.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.266 1.427 . . . . 10.0 111.776 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.58 7.62 81.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.249 1.404 . . . . 10.0 114.69 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.81 160.59 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 120.599 2.199 . . . . 10.0 111.202 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 t -133.24 -44.57 0.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.63 1.172 . . . . 10.0 111.095 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.9 148.34 35.28 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.786 0.834 . . . . 10.0 108.768 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.3 m -141.11 58.31 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.157 0.983 . . . . 10.0 111.292 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.02 67.36 7.99 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.787 -1.196 . . . . 10.0 111.508 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.29 134.9 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.85 1.26 . . . . 10.0 111.576 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.55 55.86 0.69 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -63.41 -23.53 67.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.792 -1.193 . . . . 10.0 111.755 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.32 -32.37 72.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.672 0.789 . . . . 10.0 110.45 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.87 -23.98 44.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.1 29.59 9.55 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.876 1.227 . . . . 10.0 110.275 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -146.34 169.4 18.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.424 1.107 . . . . 10.0 109.964 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -155.23 118.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.856 -3.016 . . . . 10.0 102.856 169.045 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.88 99.27 10.84 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -111.87 112.38 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 125.818 1.647 . . . . 10.0 108.803 -171.403 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.1 t -94.81 114.96 26.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.693 -1.225 . . . . 10.0 107.693 170.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.3 p90 -144.7 154.79 43.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.01 79.31 8.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.242 1.02 . . . . 10.0 111.354 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -35.98 -44.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 112.941 -1.936 . . . . 10.0 112.284 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -44.84 -54.14 6.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.213 1.405 . . . . 10.0 112.299 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.22 -40.42 14.56 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.97 -0.381 . . . . 10.0 109.97 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -134.69 104.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.4 150.05 48.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.591 -0.693 . . . . 10.0 110.248 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 70' ' ' ILE . 3.6 t -33.85 -51.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 125.569 1.548 . . . . 10.0 113.485 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -49.04 -59.98 3.17 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.53 -42.62 33.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.411 1.485 . . . . 10.0 110.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.748 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -65.81 -45.38 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.514 -0.742 . . . . 10.0 110.459 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.78 96.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.23 -39.25 75.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.07 69.96 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.2 mp -64.5 -46.83 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -59.27 -30.19 68.12 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.716 0.689 . . . . 10.0 111.675 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.86 -24.5 67.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.568 -0.707 . . . . 10.0 112.211 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -112.87 -66.84 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.092 1.757 . . . . 10.0 111.362 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 -148.55 9.99 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.096 1.807 . . . . 10.0 108.754 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -161.98 55.16 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.989 1.394 . . . . 10.0 108.266 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.51 61.91 1.67 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 -168.519 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.4 p -149.69 85.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.779 0.799 . . . . 10.0 109.518 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.59 -66.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.382 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt 168.74 172.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.962 2.505 . . . . 10.0 110.266 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.706 HG21 HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 O-C-N 121.598 -0.689 . . . . 10.0 111.645 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 104.332 -2.47 . . . . 10.0 104.332 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -71.0 107.07 3.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.543 ' CB ' HD11 ' A' ' 70' ' ' ILE . 70.1 mttt -131.25 176.2 8.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.732 0.777 . . . . 10.0 111.471 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -112.06 102.5 10.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.585 1.554 . . . . 10.0 110.54 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB2' HG21 ' A' ' 44' ' ' VAL . 3.3 tt -82.09 94.67 7.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.07 1.348 . . . . 10.0 107.856 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -60.43 119.39 7.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.591 -0.892 . . . . 10.0 108.591 -175.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 126.799 2.04 . . . . 10.0 109.178 177.437 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.722 HG21 ' HB2' ' A' ' 66' ' ' ASP . 1.5 t . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 119.204 -0.427 . . . . 10.0 111.437 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -50.41 12.82 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 m -54.93 -36.86 65.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.728 1.211 . . . . 10.0 111.76 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -56.7 -49.91 73.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.232 0.924 . . . . 10.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.659 ' CG2' HD11 ' A' ' 60' ' ' ILE . 72.1 t -68.04 -43.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.5 8.57 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.014 1.292 . . . . 10.0 115.167 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.56 -21.49 28.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.343 1.572 . . . . 10.0 109.094 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD13 HD12 ' A' ' 56' ' ' ILE . 45.2 mt -67.05 125.32 25.64 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 122.024 -0.422 . . . . 10.0 110.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -48.18 -38.15 17.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.303 1.049 . . . . 10.0 111.783 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.92 -1.43 87.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.018 1.294 . . . . 10.0 114.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 166.09 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.753 2.276 . . . . 10.0 112.273 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 t -141.0 -45.43 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.923 1.289 . . . . 10.0 111.385 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.4 147.59 34.86 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.507 1.123 . . . . 10.0 108.483 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -144.48 58.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.618 1.167 . . . . 10.0 112.193 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 87.11 5.49 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.123 -1.611 . . . . 10.0 109.874 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.52 115.28 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 10.0 111.259 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.58 62.95 1.44 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -57.24 -21.24 32.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.614 -0.679 . . . . 10.0 111.839 172.174 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.4 tt0 -64.68 -37.99 89.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.009 0.924 . . . . 10.0 109.001 176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.03 -24.7 43.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 23.45 43.23 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.151 -1.579 . . . . 10.0 109.151 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -155.7 116.15 3.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 44' ' ' VAL . 2.7 m -86.42 146.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.301 -2.111 . . . . 10.0 105.301 167.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.27 96.31 6.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.938 -1.505 . . . . 10.0 106.938 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.6 m -119.76 106.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 122.316 1.055 . . . . 10.0 108.849 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 t -99.62 121.22 40.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.275 -1.379 . . . . 10.0 107.275 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.5 p90 -148.87 172.06 15.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.033 0.933 . . . . 10.0 111.013 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.41 83.32 2.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.547 1.165 . . . . 10.0 113.301 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.2 -31.73 9.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.011 -1.904 . . . . 10.0 112.607 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -51.36 -60.7 2.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.269 1.028 . . . . 10.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -82.55 -46.57 13.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.368 -0.604 . . . . 10.0 109.368 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.17 94.18 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -60.81 153.36 24.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.116 0.484 . . . . 10.0 110.395 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 70' ' ' ILE . 3.7 t -42.56 -42.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 121.353 -0.842 . . . . 10.0 112.749 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -50.57 -61.83 1.95 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -47.15 -39.61 14.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.111 0.964 . . . . 10.0 111.063 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -70.28 -48.53 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.82 89.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.951 0.9 . . . . 10.0 109.826 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.05 -26.48 67.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.786 -0.571 . . . . 10.0 112.077 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.659 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.0 mp -67.59 -49.08 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.886 -1.524 . . . . 10.0 106.886 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -36.14 62.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.05 0.54 . . . . 10.0 110.778 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -51.56 -37.77 51.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.071 0.549 . . . . 10.0 112.327 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.45 -62.11 1.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.91 1.284 . . . . 10.0 111.785 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.95 -152.36 9.16 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.692 1.615 . . . . 10.0 109.631 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.15 51.43 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 10.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' VAL . 1.5 m-20 -120.46 68.39 0.85 Allowed 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 107.234 -1.395 . . . . 10.0 107.234 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 6' ' ' LEU . 2.5 t -139.22 100.34 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.168 0.987 . . . . 10.0 108.873 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -66.8 -34.35 77.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 10.0 109.677 168.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 tttm 117.87 169.79 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 129.186 2.995 . . . . 10.0 110.501 171.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 O-C-N 121.347 -0.846 . . . . 10.0 109.254 175.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.417 0.525 . . . . 10.0 112.417 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.4 pm0 -83.34 99.72 10.21 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.346 2.258 . . . . 10.0 110.053 169.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' CB ' HD11 ' A' ' 70' ' ' ILE . 79.2 mttt -136.96 177.26 8.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.217 0.462 . . . . 10.0 111.504 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.4 m -114.05 110.37 19.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.035 1.334 . . . . 10.0 109.302 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 67' ' ' VAL . 2.1 mt -83.44 93.12 7.72 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.57 118.37 2.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.015 0.926 . . . . 10.0 109.443 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 20' ' ' VAL . 37.7 t . . . . . 0 C--O 1.231 0.107 0 C-N-CA 124.62 1.168 . . . . 10.0 111.523 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 8' ' ' VAL . 11.3 t . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.405 0.621 . . . . 10.0 109.981 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.71 -68.41 0.41 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.749 1.619 . . . . 10.0 109.114 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 m -48.51 -43.78 35.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.943 1.697 . . . . 10.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -56.94 -60.89 2.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 10.0 110.147 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 56' ' ' ILE . 86.7 t -60.48 -40.23 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.65 -17.66 28.09 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.641 1.591 . . . . 10.0 114.789 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.03 -21.73 36.82 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.645 1.723 . . . . 10.0 108.416 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD13 HD12 ' A' ' 56' ' ' ILE . 57.1 mt -66.97 122.1 16.98 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.108 0.48 . . . . 10.0 111.373 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.5 -37.54 5.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.985 1.314 . . . . 10.0 112.107 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.07 90.44 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.086 1.327 . . . . 10.0 114.692 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.21 163.49 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 120.555 2.178 . . . . 10.0 111.909 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 t -133.82 -47.34 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.336 1.455 . . . . 10.0 110.633 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.03 148.46 35.25 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.5 m -141.54 59.1 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.32 1.048 . . . . 10.0 110.991 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.54 69.47 8.2 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.079 -1.013 . . . . 10.0 110.408 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.12 124.81 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.009 0.924 . . . . 10.0 110.939 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.8 58.03 1.23 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.32 -1.363 . . . . 10.0 107.32 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -57.76 -26.71 62.25 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.562 -0.711 . . . . 10.0 111.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.16 -38.65 73.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.165 1.386 . . . . 10.0 110.746 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.49 2.77 46.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.769 1.228 . . . . 10.0 111.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.24 98.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.8 -1.32 . . . . 10.0 109.8 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 157.91 35.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.821 0.81 . . . . 10.0 109.21 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -157.21 102.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.1 97.82 10.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -111.01 110.61 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.372 1.069 . . . . 10.0 109.042 -173.838 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -95.02 117.12 29.62 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.4 p90 -148.96 154.06 38.84 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.256 1.027 . . . . 10.0 113.712 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -82.55 81.0 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.879 -1.055 . . . . 10.0 112.411 -170.422 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.31 -44.73 0.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.002 1.321 . . . . 10.0 111.519 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -52.12 64.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.762 2.025 . . . . 10.0 111.369 -174.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.79 -41.78 25.81 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.731 0.696 . . . . 10.0 109.937 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.91 107.7 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.141 0.976 . . . . 10.0 108.63 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.48 152.01 39.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.788 -0.57 . . . . 10.0 110.354 -171.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 70' ' ' ILE . 4.7 t -39.72 -45.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.489 1.116 . . . . 10.0 112.553 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -52.23 -58.15 7.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.393 -0.337 . . . . 10.0 110.386 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.98 -41.09 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.568 0.747 . . . . 10.0 109.625 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 27' ' ' LEU . 2.2 mm -64.3 -53.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.79 79.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.18 -1.045 . . . . 10.0 108.18 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.67 -32.58 73.67 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.751 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.31 74.41 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.899 -1.126 . . . . 10.0 112.605 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.0 mp -60.57 -36.19 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.275 -1.516 . . . . 10.0 108.412 171.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.62 -49.31 68.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.994 0.815 . . . . 10.0 109.896 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -51.3 -49.5 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.089 0.471 . . . . 10.0 111.819 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.47 -19.9 27.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 -171.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.79 99.79 0.22 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.534 -1.426 . . . . 10.0 109.534 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -67.89 54.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.109 2.263 . . . . 10.0 117.109 -167.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.81 74.41 2.67 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 120.145 -1.597 . . . . 10.0 108.027 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.654 ' CG2' HD22 ' A' ' 6' ' ' LEU . 8.3 p -151.54 110.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.366 -0.834 . . . . 10.0 108.913 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.45 -73.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.942 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 175.8 174.91 0.28 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.467 1.907 . . . . 10.0 110.643 169.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.547 HG21 HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 O-C-N 121.778 -0.576 . . . . 10.0 111.041 174.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 3.3 pm0 -88.63 106.53 18.38 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 125.449 1.5 . . . . 10.0 110.608 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.463 ' CB ' HD12 ' A' ' 70' ' ' ILE . 58.4 mttt -136.39 176.29 8.83 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.1 0.864 . . . . 10.0 112.475 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 42' ' ' VAL . 21.5 m -116.0 108.34 16.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.879 0.872 . . . . 10.0 109.189 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.87 79.8 3.45 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.43 122.12 0.89 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.013 1.325 . . . . 10.0 109.003 172.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 C-N-CA 127.773 2.429 . . . . 10.0 107.74 -170.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 119.705 -0.188 . . . . 10.0 110.999 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -91.01 -69.82 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.36 1.064 . . . . 10.0 109.274 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.3 m -36.45 -53.36 0.86 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.181 2.192 . . . . 10.0 111.495 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -51.2 -55.61 17.13 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.301 1.441 . . . . 10.0 110.959 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.565 ' CG2' HD11 ' A' ' 60' ' ' ILE . 60.1 t -72.0 -19.8 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.559 1.144 . . . . 10.0 110.326 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.47 73.11 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.777 1.18 . . . . 10.0 112.169 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -89.13 -40.24 13.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.023 1.411 . . . . 10.0 108.136 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -59.69 123.78 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.471 0.545 . . . . 10.0 112.471 -177.191 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -51.74 -34.86 41.0 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.896 1.278 . . . . 10.0 111.779 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.5 0.64 87.63 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.328 1.442 . . . . 10.0 114.234 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.37 156.26 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 119.849 -1.971 . . . . 10.0 111.54 169.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 t -128.59 -44.3 1.37 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 10.0 110.902 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.06 149.1 33.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.792 -1.099 . . . . 10.0 108.457 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 44' ' ' VAL . 30.8 m -143.4 58.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.859 0.864 . . . . 10.0 112.062 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.73 74.06 7.68 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.306 -1.496 . . . . 10.0 111.432 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.23 121.81 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.584 1.153 . . . . 10.0 111.578 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.29 56.61 1.0 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.882 -1.155 . . . . 10.0 107.882 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.4 pp -59.65 -21.88 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.631 -0.668 . . . . 10.0 111.338 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' N ' HD12 ' A' ' 37' ' ' LEU . 2.5 tm-20 -63.98 -39.69 94.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.358 1.463 . . . . 10.0 108.865 175.202 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.41 -27.17 41.77 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.79 0.436 . . . . 10.0 110.42 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.32 22.8 9.47 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.128 1.347 . . . . 10.0 111.081 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -147.16 168.52 21.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.634 1.174 . . . . 10.0 108.123 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 HG13 ' A' ' 44' ' ' VAL . 1.1 p -157.18 102.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.011 -2.218 . . . . 10.0 105.011 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.23 95.76 6.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.642 HG13 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -112.86 108.75 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 122.5 1.143 . . . . 10.0 109.133 -174.815 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 25.4 t -103.18 120.92 41.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -152.36 155.63 37.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.412 1.264 . . . . 10.0 114.412 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.13 84.0 5.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.944 -1.025 . . . . 10.0 111.735 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.46 1.53 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.022 1.329 . . . . 10.0 110.142 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.75 -44.75 9.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.505 2.722 . . . . 10.0 112.595 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -46.76 10.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.041 0.382 . . . . 10.0 110.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.21 115.37 18.12 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.079 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.04 144.67 50.32 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 -170.074 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG13 ' CG1' ' A' ' 70' ' ' ILE . 17.1 t -25.53 -55.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.16 2.184 . . . . 10.0 113.661 168.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -47.95 -62.47 1.45 Allowed 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 173.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.6 -39.08 72.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.515 1.526 . . . . 10.0 110.27 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.452 HG21 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mm -61.45 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 119.152 0.887 . . . . 10.0 108.802 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.46 85.75 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -58.46 -34.09 70.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 122.926 0.49 . . . . 10.0 109.978 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -33.13 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.565 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.6 mp -64.47 -49.77 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -31.71 64.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.248 0.477 . . . . 10.0 111.245 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.12 -23.14 66.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.226 0.61 . . . . 10.0 112.099 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -113.39 -63.64 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.452 1.501 . . . . 10.0 111.306 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.16 -146.09 9.56 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.219 1.866 . . . . 10.0 109.344 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -164.8 51.22 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.023 1.411 . . . . 10.0 109.554 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.98 66.11 1.36 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.424 -1.695 . . . . 10.0 106.424 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -147.35 99.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.8 -66.51 0.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.64 -0.695 . . . . 10.0 109.663 168.813 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt 165.86 179.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.31 1.444 . . . . 10.0 113.507 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.49 ' CG1' HG13 ' A' ' 53' ' ' VAL . 6.3 mm . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 119.678 -0.201 . . . . 10.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -78.3 103.88 8.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.095 0.958 . . . . 10.0 109.383 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.618 ' HB3' HD12 ' A' ' 70' ' ' ILE . 31.8 mttm -127.03 176.57 7.25 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -118.14 119.4 34.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.995 -0.742 . . . . 10.0 108.995 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 13.1 mt -77.55 107.67 10.18 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -54.66 116.75 2.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.342 -1.725 . . . . 10.0 106.342 168.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 126.967 2.107 . . . . 10.0 106.867 177.345 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 119.619 -0.229 . . . . 10.0 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -58.46 3.21 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -46.65 -50.54 17.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.829 1.651 . . . . 10.0 111.793 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -52.39 -60.94 2.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 122.594 1.188 . . . . 10.0 110.501 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 56' ' ' ILE . 54.1 t -65.79 -40.42 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.41 -17.46 1.91 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.416 1.484 . . . . 10.0 114.495 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -24.37 30.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.952 1.876 . . . . 10.0 108.757 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.28 125.7 27.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.67 -0.644 . . . . 10.0 110.602 -172.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -48.51 -38.53 20.44 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.446 1.098 . . . . 10.0 112.019 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.06 75.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 114.132 -1.395 . . . . 10.0 114.042 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.35 158.27 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.02 1.91 . . . . 10.0 111.76 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.4 t -133.41 -47.66 0.83 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.907 0.883 . . . . 10.0 110.887 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.41 145.5 41.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.251 -0.88 . . . . 10.0 108.873 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 44' ' ' VAL . 29.7 m -142.96 59.27 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.861 1.264 . . . . 10.0 110.918 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -78.41 76.3 4.92 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.36 -1.463 . . . . 10.0 109.263 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.55 133.34 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.393 1.077 . . . . 10.0 111.132 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -154.9 58.2 0.67 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -61.53 -19.8 62.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.131 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -69.42 -36.13 76.4 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.037 0.935 . . . . 10.0 110.372 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.01 50.46 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 109.673 -0.492 . . . . 10.0 109.673 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.72 32.35 8.12 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.489 -1.445 . . . . 10.0 109.489 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -152.31 171.09 18.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.557 1.143 . . . . 10.0 107.937 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -156.34 125.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 103.062 -2.94 . . . . 10.0 103.062 175.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.67 104.08 15.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.486 -1.302 . . . . 10.0 107.486 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -116.58 107.46 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 124.462 1.105 . . . . 10.0 109.16 -172.81 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.6 t -95.68 113.67 25.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.6 p90 -138.36 154.07 48.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.866 -1.061 . . . . 10.0 112.089 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -80.49 77.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.959 -1.019 . . . . 10.0 112.506 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.65 -38.59 0.41 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.937 1.695 . . . . 10.0 112.902 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.23 -39.02 78.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.793 0.837 . . . . 10.0 110.641 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -80.87 -50.13 10.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.87 0.868 . . . . 10.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.72 137.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.337 0.04 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.77 142.16 34.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 122.0 -0.437 . . . . 10.0 110.479 -168.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.8 t -35.36 -48.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 126.222 1.809 . . . . 10.0 112.458 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -51.7 -65.83 0.49 Allowed 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.429 -0.952 . . . . 10.0 108.429 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -42.56 -41.88 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.693 1.197 . . . . 10.0 111.682 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.486 HG22 HG22 ' A' ' 24' ' ' VAL . 8.2 mm -66.0 -43.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.037 0.835 . . . . 10.0 111.153 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.06 -50.68 69.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.1 -37.22 74.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.823 0.849 . . . . 10.0 109.368 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.68 -29.8 64.95 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.647 0.98 . . . . 10.0 113.647 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -42.85 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.598 -1.314 . . . . 10.0 108.423 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.86 -30.63 71.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.461 0.573 . . . . 10.0 111.115 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.7 -50.97 64.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.992 0.425 . . . . 10.0 110.957 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -49.64 6.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.558 0.947 . . . . 10.0 113.558 -168.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.53 94.23 0.11 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -66.61 102.01 0.86 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.818 1.247 . . . . 10.0 111.711 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.22 74.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 p -156.79 77.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -33.88 -61.8 0.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.38 1.072 . . . . 10.0 112.99 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mttt 157.0 176.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.523 2.329 . . . . 10.0 113.092 169.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.618 HD12 ' HB3' ' A' ' 4' ' ' LYS . 2.8 mm . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.3 pm0 -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.843 2.057 . . . . 10.0 110.408 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' CG1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -114.04 176.63 4.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.169 0.509 . . . . 10.0 110.023 176.091 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.9 m -114.59 109.39 18.18 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.312 1.045 . . . . 10.0 109.297 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.35 83.42 3.8 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.959 0.903 . . . . 10.0 109.267 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.98 116.46 0.45 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.461 1.104 . . . . 10.0 109.76 169.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 C-N-CA 128.77 2.828 . . . . 10.0 109.241 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 119.877 -0.106 . . . . 10.0 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -79.31 -72.31 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.336 1.054 . . . . 10.0 109.404 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -44.35 -49.97 9.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.103 2.161 . . . . 10.0 111.63 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.0 m -54.56 -56.18 21.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.771 0.829 . . . . 10.0 110.47 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.726 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.2 t -67.77 -39.85 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -14.46 17.74 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.964 1.269 . . . . 10.0 114.612 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -81.55 -21.47 38.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.599 1.7 . . . . 10.0 108.935 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD13 HD12 ' A' ' 56' ' ' ILE . 57.9 mt -69.14 120.74 15.45 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 123.185 0.594 . . . . 10.0 111.31 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.97 -39.93 4.37 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.99 1.316 . . . . 10.0 111.94 169.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.63 -4.72 90.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.031 1.301 . . . . 10.0 114.617 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.85 162.55 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.286 2.043 . . . . 10.0 112.103 175.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -135.33 -45.22 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 10.0 111.038 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.73 146.94 29.42 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.265 1.026 . . . . 10.0 108.437 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.8 m -142.5 57.47 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.744 0.818 . . . . 10.0 111.381 -175.453 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -80.79 75.13 7.72 Favored 'General case' 0 N--CA 1.46 0.057 0 O-C-N 120.726 -1.234 . . . . 10.0 110.254 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.78 127.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.16 0.984 . . . . 10.0 110.742 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -146.81 58.45 1.18 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.31 -24.2 64.81 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.006 -0.434 . . . . 10.0 110.961 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.4 tt0 -60.44 -33.5 72.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.571 1.548 . . . . 10.0 110.151 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.23 -3.24 55.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.209 1.403 . . . . 10.0 111.728 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.62 41.07 25.42 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -156.35 165.68 35.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.028 0.918 . . . . 10.0 110.885 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -157.42 107.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 104.726 -2.324 . . . . 10.0 104.726 172.523 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.1 98.71 11.69 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.215 -1.402 . . . . 10.0 107.215 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -114.08 110.18 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.962 -170.557 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.0 t -93.78 114.35 26.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 169.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -145.48 158.93 43.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.833 0.825 . . . . 10.0 112.366 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -79.75 83.05 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.145 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.12 -29.74 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.936 -1.484 . . . . 10.0 113.549 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.82 -52.34 21.08 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.365 0.984 . . . . 10.0 110.402 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -78.38 -38.02 42.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.86 102.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.505 1.122 . . . . 10.0 108.425 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -64.33 152.77 40.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.198 -0.939 . . . . 10.0 110.638 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.408 HG21 HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -43.42 -39.35 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.867 0.867 . . . . 10.0 112.794 173.201 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -56.44 21.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.917 0.887 . . . . 10.0 109.469 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.88 -44.11 66.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.039 0.936 . . . . 10.0 110.624 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -60.58 -51.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.307 -0.998 . . . . 10.0 108.307 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.4 88.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.58 -42.02 77.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.124 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -33.33 67.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.143 -0.456 . . . . 10.0 112.208 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -66.48 -45.26 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 119.864 1.211 . . . . 10.0 108.806 169.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -61.07 -22.9 65.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.388 0.994 . . . . 10.0 112.075 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.05 -39.95 79.72 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 10.0 110.689 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.85 -65.94 1.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.428 1.491 . . . . 10.0 112.222 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.41 -159.05 28.98 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.247 -1.541 . . . . 10.0 109.247 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -151.76 56.78 0.86 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.888 1.344 . . . . 10.0 108.567 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.87 53.03 1.38 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 60' ' ' ILE . 54.1 t -142.25 92.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.93 -62.88 1.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.878 -1.056 . . . . 10.0 109.581 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tttp 169.54 179.79 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.005 1.322 . . . . 10.0 112.53 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.441 ' CG1' ' HB3' ' A' ' 4' ' ' LYS . 1.4 tp . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 40.4 mt-10 . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 111.607 0.225 . . . . 10.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -91.84 107.85 19.5 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.521 2.329 . . . . 10.0 110.407 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 17.8 mttt -128.89 173.74 10.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.399 0.619 . . . . 10.0 111.126 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -112.42 111.56 22.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.9 mt -78.51 99.86 6.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 121.46 9.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.208 -0.932 . . . . 10.0 108.918 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 20' ' ' VAL . 3.5 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 127.719 2.407 . . . . 10.0 108.698 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 8' ' ' VAL . 78.5 t . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 110.739 -0.097 . . . . 10.0 110.739 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -70.32 -66.22 0.63 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.098 1.359 . . . . 10.0 108.775 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.1 m -46.44 -51.16 15.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.481 1.912 . . . . 10.0 111.8 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -55.83 -54.9 38.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.41 1.005 . . . . 10.0 110.957 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 53.3 t -66.37 -40.87 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.03 -13.15 8.2 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.366 -1.241 . . . . 10.0 115.513 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.22 -24.93 46.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.006 1.903 . . . . 10.0 108.534 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 56' ' ' ILE . 65.3 mt -69.33 119.21 13.24 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.458 -172.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.13 -42.78 3.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.263 1.425 . . . . 10.0 111.7 169.124 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.1 -4.29 89.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.109 -1.405 . . . . 10.0 115.138 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 162.01 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.526 2.163 . . . . 10.0 111.713 174.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -133.08 -46.56 0.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.717 1.207 . . . . 10.0 111.108 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.81 38.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 118.172 -0.918 . . . . 10.0 108.724 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.77 57.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.642 1.177 . . . . 10.0 111.504 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 69.16 4.57 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.691 -1.256 . . . . 10.0 111.499 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.2 126.78 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.815 1.246 . . . . 10.0 112.151 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -148.44 58.18 1.07 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.78 -21.53 66.51 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.751 -1.218 . . . . 10.0 111.869 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -61.32 -37.84 84.73 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.378 1.071 . . . . 10.0 109.642 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.51 -28.32 41.38 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.34 12.58 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.752 1.644 . . . . 10.0 110.827 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -142.11 167.08 22.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.996 0.918 . . . . 10.0 109.503 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -158.47 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.617 -1.994 . . . . 10.0 105.617 -178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.57 99.43 6.52 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.368 0.985 . . . . 10.0 108.514 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 42' ' ' VAL . 1.3 m -108.49 109.48 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 125.09 1.356 . . . . 10.0 109.461 -175.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -95.96 115.05 26.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -145.23 154.7 42.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -76.75 82.0 3.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.055 -0.975 . . . . 10.0 112.525 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.04 -28.07 0.65 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.709 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.62 -48.75 18.13 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.949 1.249 . . . . 10.0 110.188 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -82.26 -34.28 28.85 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.056 -0.402 . . . . 10.0 110.276 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.15 104.1 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 10.0 108.556 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 150.35 48.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.195 -0.94 . . . . 10.0 110.24 -171.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 70' ' ' ILE . 1.2 m -40.64 -40.14 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.921 0.889 . . . . 10.0 113.148 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 3.7 ttpp -58.14 -54.86 42.17 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 123.002 0.521 . . . . 10.0 109.773 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.87 -44.78 63.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.145 0.978 . . . . 10.0 110.17 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 27' ' ' LEU . 2.0 mm -62.57 -43.41 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 121.534 -0.729 . . . . 10.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.81 93.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 54' ' ' LYS . 10.0 m-20 -53.36 -42.23 66.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.315 -0.624 . . . . 10.0 109.315 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.61 -36.92 74.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.5 -49.11 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 168.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.41 -22.36 66.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.59 -39.26 88.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.223 0.535 . . . . 10.0 110.552 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.34 -57.65 2.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.442 1.497 . . . . 10.0 111.136 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.09 -152.42 8.65 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.506 2.003 . . . . 10.0 108.59 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -150.36 55.71 0.92 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.388 1.094 . . . . 10.0 108.449 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.66 57.35 1.77 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.212 -1.033 . . . . 10.0 108.212 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.647 ' CG2' HD22 ' A' ' 6' ' ' LEU 0.266 14.5 p -147.81 82.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.596 1.189 . . . . 10.0 111.57 177.303 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.21 -60.31 1.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.321 -1.763 . . . . 10.0 110.574 168.527 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.383 24.0 mttp 140.96 -176.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.39 3.076 . . . . 10.0 114.026 169.16 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 53' ' ' VAL . 12.4 mm . . . . . 0 N--CA 1.442 -0.861 0 O-C-N 121.839 -0.538 . . . . 10.0 110.136 -167.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.0 tt0 -88.81 101.99 14.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 125.441 1.497 . . . . 10.0 110.26 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 70' ' ' ILE . 76.0 mttt -137.08 176.62 8.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.325 0.511 . . . . 10.0 111.136 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 3.0 m -116.39 116.57 27.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.526 0.73 . . . . 10.0 109.64 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 67' ' ' VAL . 4.1 mt -78.41 109.82 12.92 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.038 -1.838 . . . . 10.0 106.038 169.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -52.06 119.32 4.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.963 1.256 . . . . 10.0 107.904 174.061 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 20' ' ' VAL . 16.0 t . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 125.24 1.416 . . . . 10.0 108.164 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 HG12 ' A' ' 60' ' ' ILE . 59.3 t . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 110.078 -0.341 . . . . 10.0 110.078 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -68.83 0.32 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.266 1.426 . . . . 10.0 107.555 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 m -48.18 -45.44 33.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.548 1.539 . . . . 10.0 111.194 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 m -52.4 -58.41 6.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 122.106 0.955 . . . . 10.0 110.808 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 56' ' ' ILE . 64.4 t -66.68 -42.76 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.09 -11.9 10.17 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.429 1.49 . . . . 10.0 115.321 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.73 -26.35 37.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.804 1.802 . . . . 10.0 108.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.625 HD13 HD12 ' A' ' 56' ' ' ILE . 64.0 mt -66.72 122.35 17.45 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.005 -0.434 . . . . 10.0 111.037 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -50.35 -35.23 26.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.29 1.043 . . . . 10.0 111.853 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.73 -3.78 89.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.196 1.379 . . . . 10.0 114.617 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.36 163.39 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.435 2.117 . . . . 10.0 111.312 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -137.7 -44.75 0.53 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.776 1.231 . . . . 10.0 111.313 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.6 149.82 36.41 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.927 . . . . 10.0 108.501 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.09 57.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 10.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.22 67.82 5.04 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.67 -1.269 . . . . 10.0 110.478 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.87 123.5 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.435 1.094 . . . . 10.0 110.913 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -144.52 57.86 1.31 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.485 -0.759 . . . . 10.0 111.099 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -61.55 -39.0 89.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.797 1.239 . . . . 10.0 109.804 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.71 -26.97 44.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.221 0.608 . . . . 10.0 109.59 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.43 32.36 7.02 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.78 -1.328 . . . . 10.0 109.78 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -149.55 162.62 39.8 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -144.0 120.3 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 102.649 -3.093 . . . . 10.0 102.649 169.84 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -96.24 96.24 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -111.43 104.84 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -170.084 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 22.8 t -92.06 117.55 29.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.411 -1.7 . . . . 10.0 106.411 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -146.63 154.75 41.83 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.675 -177.477 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.7 89.0 7.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.866 0.841 . . . . 10.0 112.681 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.12 -24.91 1.25 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.661 -1.609 . . . . 10.0 114.074 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.48 -56.17 25.41 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.898 1.227 . . . . 10.0 110.278 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -86.16 -40.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.184 -0.916 . . . . 10.0 109.827 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' HD11 ' A' ' 56' ' ' ILE . 3.3 m -135.48 99.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 p -64.97 154.69 36.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.429 -0.795 . . . . 10.0 110.521 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -40.92 -40.22 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.273 1.029 . . . . 10.0 113.152 174.552 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -53.88 -65.58 0.54 Allowed 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 108.697 -0.853 . . . . 10.0 108.697 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -43.58 -43.83 5.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.84 0.856 . . . . 10.0 110.613 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 24' ' ' VAL . 1.3 mm -66.82 -44.51 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.517 -0.739 . . . . 10.0 111.156 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.65 92.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.97 -38.67 79.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.53 -0.915 . . . . 10.0 108.53 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.15 69.47 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.753 -0.592 . . . . 10.0 112.311 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 67' ' ' VAL . 1.6 mp -64.41 -48.37 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.6 -29.77 68.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.122 0.874 . . . . 10.0 112.737 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.28 -36.46 61.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.671 0.669 . . . . 10.0 111.86 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -56.39 2.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.535 1.134 . . . . 10.0 112.752 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.33 -145.95 6.31 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.206 1.86 . . . . 10.0 109.176 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -165.71 56.9 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.572 1.686 . . . . 10.0 109.977 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.6 66.54 1.55 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 8.2 p -157.59 68.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 113.383 0.882 . . . . 10.0 113.383 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -29.75 -71.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.997 1.11 . . . . 10.0 113.997 172.412 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 167.95 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.775 1.63 . . . . 10.0 113.338 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 106.921 -1.511 . . . . 10.0 106.921 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.92 106.81 4.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.965 -1.124 . . . . 10.0 107.965 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -128.8 161.93 28.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.781 0.801 . . . . 10.0 111.126 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 m -112.02 93.76 4.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.216 1.406 . . . . 10.0 108.067 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.605 HD21 HG22 ' A' ' 67' ' ' VAL . 9.7 tt -78.02 94.23 4.61 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.81 1.244 . . . . 10.0 108.309 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 117.84 6.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.452 -0.35 0 C-N-CA 126.725 2.01 . . . . 10.0 111.004 175.494 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.598 0.713 . . . . 10.0 109.16 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -61.94 -57.43 11.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.231 1.812 . . . . 10.0 108.364 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 m -48.15 -53.95 15.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.181 0.992 . . . . 10.0 110.172 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 m -67.62 -54.13 22.28 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.76 0.314 . . . . 10.0 111.726 -168.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.81 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.1 t -58.54 -44.14 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.771 -0.825 . . . . 10.0 108.771 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.28 -2.46 7.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.015 -1.436 . . . . 10.0 114.817 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -81.5 -31.32 32.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 120.123 1.962 . . . . 10.0 108.5 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 123.37 21.28 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 122.095 -0.378 . . . . 10.0 111.002 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.78 -35.14 56.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.2 1.0 . . . . 10.0 111.787 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.64 -12.7 59.7 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.393 -1.276 . . . . 10.0 113.673 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.81 161.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.73 1.765 . . . . 10.0 112.027 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.1 t -138.7 -46.78 0.49 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.44 1.096 . . . . 10.0 110.929 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.42 44.23 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.9 m -141.31 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.268 1.027 . . . . 10.0 110.631 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -83.0 77.1 9.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 120.976 -1.077 . . . . 10.0 108.22 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.71 112.63 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 123.494 0.718 . . . . 10.0 110.113 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -136.23 56.83 1.8 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.246 -1.761 . . . . 10.0 106.246 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.88 -23.43 63.44 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.34 -0.85 . . . . 10.0 111.344 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.24 -31.14 72.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.567 0.621 . . . . 10.0 111.034 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.03 -4.62 53.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.617 0.767 . . . . 10.0 111.586 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.83 19.62 79.74 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.339 1.447 . . . . 10.0 111.131 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -156.06 133.22 10.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.855 0.827 . . . . 10.0 109.274 -168.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 6' ' ' LEU . 3.2 m -121.23 120.62 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.04 94.85 9.34 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 33' ' ' VAL . 2.5 m -108.16 109.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -96.31 120.81 37.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.222 -1.769 . . . . 10.0 106.222 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -146.95 171.99 14.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.767 0.427 . . . . 10.0 111.272 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.4 82.52 2.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.22 -43.26 10.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.755 -1.566 . . . . 10.0 112.233 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -53.96 19.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.812 0.845 . . . . 10.0 111.505 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -38.3 20.53 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.141 -0.349 . . . . 10.0 110.614 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 101.9 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.678 1.591 . . . . 10.0 108.216 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 148.36 38.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.272 0.629 . . . . 10.0 110.234 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -40.44 -41.21 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.065 -1.022 . . . . 10.0 113.616 172.583 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.24 -52.62 64.58 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 10.0 110.653 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -52.01 -45.65 64.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.459 1.104 . . . . 10.0 110.08 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.525 HG21 ' CE2' ' A' ' 46' ' ' PHE . 24.9 mm -61.6 -48.94 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.17 84.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.03 -33.4 75.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.666 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.66 69.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.321 -0.862 . . . . 10.0 111.721 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.81 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.8 mp -68.87 -47.87 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.92 -1.511 . . . . 10.0 106.92 168.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.76 -30.71 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.04 0.836 . . . . 10.0 111.529 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.95 -37.59 77.1 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.984 -0.447 . . . . 10.0 112.007 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 -66.89 0.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.062 1.345 . . . . 10.0 112.043 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.48 -152.14 12.17 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 126.426 1.965 . . . . 10.0 109.224 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -165.67 55.63 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.378 1.089 . . . . 10.0 110.357 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.91 61.65 1.67 Allowed 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.605 HG22 HD21 ' A' ' 6' ' ' LEU . 86.5 t -141.63 97.94 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 C-N-CA 123.82 0.848 . . . . 10.0 108.841 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.03 -73.11 0.06 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.865 -1.061 . . . . 10.0 108.929 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.69 172.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.506 1.522 . . . . 10.0 111.457 169.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 6' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.445 -0.698 0 O-C-N 122.128 -0.358 . . . . 10.0 111.124 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.84 97.93 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.04 0.936 . . . . 10.0 109.53 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' CB ' HD11 ' A' ' 70' ' ' ILE . 48.6 mttm -131.85 173.27 11.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.039 0.447 . . . . 10.0 110.415 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -112.56 104.31 12.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.045 0.938 . . . . 10.0 109.251 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -81.77 86.24 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.8 123.09 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.874 0.87 . . . . 10.0 108.882 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.723 0 C-N-CA 128.353 2.661 . . . . 10.0 108.33 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 CA--C 1.542 0.656 0 CA-C-O 119.205 -0.426 . . . . 10.0 111.503 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -76.83 -74.9 0.22 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 m -40.94 -53.26 2.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.713 2.405 . . . . 10.0 111.903 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -65.76 -52.36 51.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.182 0.438 . . . . 10.0 112.182 -167.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 60' ' ' ILE . 74.3 t -56.94 -44.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.699 -1.223 . . . . 10.0 107.699 169.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -9.61 17.24 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.32 1.914 . . . . 10.0 116.136 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.68 -24.91 49.19 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.938 1.869 . . . . 10.0 108.687 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.82 122.49 20.81 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.375 0.67 . . . . 10.0 110.753 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.37 -41.8 20.4 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.453 1.121 . . . . 10.0 112.091 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.2 -21.76 68.47 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.047 -1.433 . . . . 10.0 113.793 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.27 150.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.567 1.684 . . . . 10.0 112.258 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.2 t -131.14 -42.6 1.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.493 1.117 . . . . 10.0 110.941 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.57 153.11 40.72 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.82 0.848 . . . . 10.0 108.917 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -145.75 57.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.89 1.676 . . . . 10.0 111.349 -173.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -83.51 72.16 10.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.719 -1.238 . . . . 10.0 110.563 -169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.74 129.32 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 123.421 0.688 . . . . 10.0 111.43 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -150.32 56.22 0.93 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.995 -1.483 . . . . 10.0 106.995 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.63 -29.05 67.74 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.737 -0.602 . . . . 10.0 111.334 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -63.33 -30.87 71.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.245 1.018 . . . . 10.0 110.811 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.22 -7.16 59.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.09 0.956 . . . . 10.0 111.587 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 25.65 42.08 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 124.952 1.263 . . . . 10.0 110.834 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.22 171.8 19.57 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.4 1.095 . . . . 10.0 110.86 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.488 HG22 HG13 ' A' ' 44' ' ' VAL . 2.3 p -154.92 141.79 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 102.712 -3.07 . . . . 10.0 102.712 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.57 91.4 3.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.83 108.15 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -169.182 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 106.6 18.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -139.43 170.35 16.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.939 0.399 . . . . 10.0 111.852 -172.48 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 0.8 OUTLIER -91.04 73.23 6.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 113.016 0.747 . . . . 10.0 113.016 -168.969 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.94 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.922 1.289 . . . . 10.0 112.792 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.1 t70 -53.88 -57.27 11.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.697 0.799 . . . . 10.0 111.417 173.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -80.52 -39.04 28.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.105 -0.372 . . . . 10.0 110.52 -172.336 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.8 m -139.79 104.31 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 127.021 2.128 . . . . 10.0 106.638 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -64.46 157.9 25.35 Favored 'General case' 0 C--O 1.226 -0.175 0 O-C-N 121.51 -0.744 . . . . 10.0 110.383 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.25 -45.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.833 0.853 . . . . 10.0 113.207 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -61.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 175.514 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.77 -36.45 36.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.483 1.513 . . . . 10.0 111.449 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.8 mm -66.09 -55.07 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.62 -42.77 71.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -171.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -60.78 -37.21 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.171 0.988 . . . . 10.0 110.531 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.239 -0.913 . . . . 10.0 111.373 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.851 HD11 HG22 ' A' ' 24' ' ' VAL . 4.9 mp -64.44 -34.5 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.841 -1.162 . . . . 10.0 109.335 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -45.69 76.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.281 0.946 . . . . 10.0 110.05 173.784 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -60.25 -38.3 83.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -126.08 79.16 1.82 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.95 0.9 . . . . 10.0 111.537 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.74 81.12 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.449 -0.66 . . . . 10.0 111.449 169.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -67.23 89.4 0.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.981 1.312 . . . . 10.0 112.142 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -134.36 58.41 1.77 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.99 97.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 O-C-N 120.821 -1.174 . . . . 10.0 110.763 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.13 -68.92 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.351 -0.841 . . . . 10.0 110.222 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.25 171.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.624 1.17 . . . . 10.0 113.925 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.222 0 O-C-N 121.461 -0.774 . . . . 10.0 110.582 172.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 106.541 -1.652 . . . . 10.0 106.541 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -101.12 111.52 23.75 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 117.453 -1.26 . . . . 10.0 108.599 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.497 ' CB ' HD12 ' A' ' 70' ' ' ILE . 82.4 mttt -136.4 172.74 12.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.07 1.305 . . . . 10.0 112.668 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -113.38 97.38 6.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.194 1.398 . . . . 10.0 109.226 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.685 HD22 HG13 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -80.59 87.8 5.74 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -177.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 119.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.276 1.03 . . . . 10.0 109.684 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HG11 ' A' ' 20' ' ' VAL . 5.7 t . . . . . 0 C--O 1.232 0.183 0 C-N-CA 126.182 1.793 . . . . 10.0 111.177 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.781 HG11 HG21 ' A' ' 8' ' ' VAL . 94.2 t . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 110.567 -0.161 . . . . 10.0 110.567 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -57.66 5.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -44.67 -55.31 5.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.869 1.267 . . . . 10.0 111.324 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 m -63.46 -58.59 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.103 0.411 . . . . 10.0 111.71 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 60' ' ' ILE . 70.1 t -59.08 -40.0 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.87 -6.53 24.78 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 118.082 -1.399 . . . . 10.0 114.802 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.48 -20.16 44.32 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 120.365 2.083 . . . . 10.0 108.878 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.671 HD13 HD12 ' A' ' 56' ' ' ILE . 52.7 mt -66.22 117.71 8.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.448 0.642 . . . . 10.0 112.191 -175.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -40.82 -43.55 2.05 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.0 2.12 . . . . 10.0 111.186 167.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.22 6.27 83.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.685 1.612 . . . . 10.0 115.405 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.02 160.54 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 120.883 2.342 . . . . 10.0 111.092 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -132.34 -42.28 0.96 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.42 1.088 . . . . 10.0 111.964 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.32 149.76 29.73 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.311 -1.366 . . . . 10.0 107.311 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.1 m -141.62 60.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 122.079 0.942 . . . . 10.0 110.301 -173.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.39 61.41 5.56 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.311 -0.868 . . . . 10.0 110.398 -169.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.24 121.69 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.242 1.417 . . . . 10.0 110.102 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -142.13 54.57 1.46 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 173.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.65 -26.8 67.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.548 -0.72 . . . . 10.0 111.007 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -69.03 -30.84 69.29 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.398 1.079 . . . . 10.0 110.489 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.21 -28.92 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.126 0.571 . . . . 10.0 110.116 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.45 5.4 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.906 1.241 . . . . 10.0 110.949 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -155.91 158.08 37.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.416 1.486 . . . . 10.0 107.43 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.43 94.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.029 -2.952 . . . . 10.0 103.029 -168.35 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.83 94.15 8.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.651 -1.611 . . . . 10.0 106.651 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -109.68 112.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 125.808 1.643 . . . . 10.0 108.038 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.19 115.37 27.33 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 125.985 1.714 . . . . 10.0 106.558 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -149.13 155.76 41.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 113.248 0.833 . . . . 10.0 113.248 -173.709 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -77.04 82.05 3.56 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.555 0.946 . . . . 10.0 113.555 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.79 -25.63 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.128 -1.396 . . . . 10.0 113.666 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.03 -60.14 2.47 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.081 0.855 . . . . 10.0 110.479 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.83 -0.544 . . . . 10.0 110.083 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.43 103.1 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -72.02 157.66 37.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.661 -1.274 . . . . 10.0 109.065 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.409 HG13 ' CG1' ' A' ' 70' ' ' ILE . 74.5 t -32.15 -48.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 126.315 1.846 . . . . 10.0 112.301 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -62.42 1.55 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.78 -41.18 61.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.419 1.488 . . . . 10.0 109.356 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.671 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -66.12 -52.6 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 119.502 -0.879 . . . . 10.0 108.886 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.37 87.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -58.06 -39.33 78.21 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.627 1.171 . . . . 10.0 109.452 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.81 71.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.916 -0.49 . . . . 10.0 112.183 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.84 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.8 mp -70.46 -40.34 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 O-C-N 120.786 -1.196 . . . . 10.0 108.368 169.444 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -60.34 -28.38 68.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.329 1.422 . . . . 10.0 112.669 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.79 -23.9 67.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 10.0 112.001 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -108.64 -68.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.299 1.84 . . . . 10.0 111.148 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 -144.58 8.42 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.9 2.19 . . . . 10.0 108.806 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -162.5 58.9 0.22 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.666 1.233 . . . . 10.0 108.275 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -137.97 54.2 1.81 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 120.91 0.386 . . . . 10.0 110.398 -166.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 6' ' ' LEU . 92.1 t -145.86 84.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.306 -1.368 . . . . 10.0 107.306 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.55 -72.77 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.709 -1.132 . . . . 10.0 110.698 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 173.39 174.37 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.256 1.022 . . . . 10.0 113.549 169.762 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CB ' ' A' ' 4' ' ' LYS . 8.9 mm . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 103.752 -2.684 . . . . 10.0 103.752 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -61.3 97.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.414 1.486 . . . . 10.0 111.018 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -134.54 171.37 14.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.905 0.859 . . . . 10.0 112.543 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 m -108.29 101.03 10.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 67' ' ' VAL . 12.3 tp -84.34 72.71 10.56 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.079 1.351 . . . . 10.0 107.537 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.3 123.23 0.62 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.919 1.688 . . . . 10.0 111.497 -169.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 128.248 2.619 . . . . 10.0 109.182 -177.078 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 111.496 0.184 . . . . 10.0 111.496 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.92 -62.7 1.6 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.448 1.099 . . . . 10.0 108.471 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -50.47 -44.45 55.77 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.642 1.577 . . . . 10.0 111.99 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -54.11 -65.57 0.55 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.069 1.347 . . . . 10.0 110.627 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG22 HG22 ' A' ' 56' ' ' ILE . 84.2 t -55.43 -43.37 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 123.777 0.831 . . . . 10.0 108.787 173.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.43 -19.37 6.05 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.58 1.562 . . . . 10.0 115.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.26 -23.53 32.65 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 120.041 1.92 . . . . 10.0 108.873 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.683 HD13 HD12 ' A' ' 56' ' ' ILE . 58.6 mt -66.42 121.38 15.16 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.092 0.473 . . . . 10.0 111.151 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -44.9 -37.79 4.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.204 1.402 . . . . 10.0 112.397 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.12 -5.9 89.29 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.103 1.335 . . . . 10.0 114.684 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.63 166.52 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.245 2.023 . . . . 10.0 111.782 175.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -140.93 -49.26 0.43 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.857 0.863 . . . . 10.0 111.134 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.62 144.73 51.05 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -143.57 56.86 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.253 1.021 . . . . 10.0 111.224 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -86.11 70.29 10.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.524 -1.36 . . . . 10.0 109.017 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.15 130.98 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.402 0.681 . . . . 10.0 110.088 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.26 67.74 0.73 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.61 -21.17 65.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.581 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.27 -35.33 73.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.969 0.508 . . . . 10.0 109.651 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.27 45.68 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.0 25.81 30.72 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.954 1.264 . . . . 10.0 109.969 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -149.71 109.74 4.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.439 0.62 . . . . 10.0 109.569 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 44' ' ' VAL . 5.0 p -84.46 148.05 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 165.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -119.12 95.79 4.96 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -112.63 109.59 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.177 1.391 . . . . 10.0 107.944 -172.895 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.0 t -99.6 109.93 22.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -140.76 150.67 43.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 124.411 1.07 . . . . 10.0 111.701 -174.406 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.24 83.35 7.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.244 -0.889 . . . . 10.0 112.958 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.54 -36.22 1.29 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.931 -1.486 . . . . 10.0 112.99 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -61.39 -53.34 57.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.343 0.657 . . . . 10.0 110.134 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.87 -40.26 28.77 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.816 -0.553 . . . . 10.0 110.792 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.424 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -138.15 102.74 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.081 1.352 . . . . 10.0 108.598 -173.176 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.16 148.33 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.636 -0.665 . . . . 10.0 111.054 -170.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.4 m -39.09 -45.74 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.556 1.142 . . . . 10.0 113.803 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -58.36 -52.39 65.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.99 -43.46 50.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.713 1.205 . . . . 10.0 109.83 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.683 HD12 HD13 ' A' ' 27' ' ' LEU . 2.4 mm -64.3 -46.22 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 121.561 -0.712 . . . . 10.0 110.711 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.17 90.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.863 0.84 . . . . 10.0 109.446 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -66.27 -37.49 85.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.32 82.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.949 -1.094 . . . . 10.0 111.753 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 24' ' ' VAL . 5.1 mt -58.69 -41.26 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.876 -1.14 . . . . 10.0 109.265 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -44.28 90.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.86 -53.95 34.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.778 0.323 . . . . 10.0 111.288 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -48.08 12.39 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.406 0.891 . . . . 10.0 113.406 -169.353 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.35 90.79 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 10.0 108.828 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -65.98 108.22 2.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.009 1.323 . . . . 10.0 111.156 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -166.56 78.71 0.23 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 104.091 -2.559 . . . . 10.0 104.091 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 6' ' ' LEU . 13.9 p -155.5 83.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.16 -50.31 0.71 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.961 2.104 . . . . 10.0 113.361 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 128.16 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.338 3.055 . . . . 10.0 113.308 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.0 mm . . . . . 0 N--CA 1.441 -0.923 0 O-C-N 121.211 -0.931 . . . . 10.0 108.999 -171.588 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 119.717 -0.182 . . . . 10.0 110.781 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.33 107.49 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.234 1.413 . . . . 10.0 109.918 169.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.579 ' HB3' HD12 ' A' ' 70' ' ' ILE . 64.6 mttt -136.69 119.72 16.5 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 1.8 m -78.77 121.5 24.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.859 0.464 . . . . 10.0 110.34 -172.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.434 HD11 ' CG1' ' A' ' 20' ' ' VAL . 1.6 pp -78.2 114.47 17.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 169.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 125.92 28.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 C-N-CA 127.811 2.444 . . . . 10.0 108.817 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 6' ' ' LEU . 46.0 t . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.182 0.039 . . . . 10.0 110.933 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 -73.03 0.42 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.81 1.244 . . . . 10.0 109.337 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -49.62 -44.6 47.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.5 2.32 . . . . 10.0 111.267 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 t -47.04 -64.08 0.87 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.866 1.317 . . . . 10.0 109.776 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 56' ' ' ILE . 82.5 t -66.66 -38.0 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.729 -1.123 . . . . 10.0 108.013 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.56 -15.29 8.3 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 117.99 -1.45 . . . . 10.0 114.81 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.32 -22.02 38.82 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.45 2.125 . . . . 10.0 109.103 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.619 HD13 HD12 ' A' ' 56' ' ' ILE . 52.0 mt -70.07 120.58 15.99 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.076 0.465 . . . . 10.0 110.893 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.37 -39.25 10.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.374 1.083 . . . . 10.0 111.874 169.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.15 0.88 86.79 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 114.213 -1.358 . . . . 10.0 114.753 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.72 157.86 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.334 2.067 . . . . 10.0 111.725 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -127.31 -42.92 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.666 1.186 . . . . 10.0 111.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.34 150.08 34.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.554 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.9 m -141.53 58.18 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.758 0.823 . . . . 10.0 111.495 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 72.39 7.18 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.67 -1.269 . . . . 10.0 110.667 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.01 124.77 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.168 0.987 . . . . 10.0 110.787 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.93 56.81 1.26 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.6 pp -62.46 -23.93 67.17 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.525 -0.734 . . . . 10.0 112.244 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.02 -31.37 72.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.287 0.494 . . . . 10.0 111.19 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.39 -7.52 58.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.397 0.679 . . . . 10.0 111.101 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.96 57.87 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.396 1.474 . . . . 10.0 109.97 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -150.96 162.07 41.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.21 1.005 . . . . 10.0 111.137 -168.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 44' ' ' VAL . 55.0 t -153.37 111.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.078 -2.564 . . . . 10.0 104.078 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.45 85.08 6.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.569 HG13 HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -100.91 126.99 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.3 t -116.08 120.81 40.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -152.34 158.48 42.79 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 123.776 0.673 . . . . 10.0 112.451 -175.047 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -85.56 88.99 7.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.69 -25.18 0.67 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.485 -1.689 . . . . 10.0 113.75 168.848 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.04 -61.86 2.32 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.655 1.116 . . . . 10.0 111.086 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -80.12 -50.92 9.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.17 95.06 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.44 -1.689 . . . . 10.0 106.44 -170.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 153.03 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.869 0.842 . . . . 10.0 109.596 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 70' ' ' ILE . 17.8 t -34.99 -48.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 125.988 1.715 . . . . 10.0 112.009 169.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -55.17 -58.55 7.21 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -48.02 -42.88 29.29 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.601 0.76 . . . . 10.0 110.054 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -64.63 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.057 -0.657 . . . . 10.0 110.381 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.66 80.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -52.01 -40.86 61.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.527 0.731 . . . . 10.0 109.403 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.87 -40.04 72.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.7 mp -61.85 -45.85 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.4 -24.78 67.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.743 0.701 . . . . 10.0 111.944 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.54 -33.89 74.61 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.984 -0.448 . . . . 10.0 111.568 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.73 -70.25 0.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.867 1.267 . . . . 10.0 112.112 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.85 -147.38 18.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.831 -1.708 . . . . 10.0 108.831 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -163.03 53.01 0.18 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 174.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.56 59.13 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -144.75 85.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.92 -62.54 1.36 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.784 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.06 177.13 0.06 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.21 2.204 . . . . 10.0 109.717 169.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 4' ' ' LYS . 12.0 mm . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 123.473 0.709 . . . . 10.0 110.267 169.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 102.96 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.194 1.798 . . . . 10.0 111.001 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -144.66 176.24 9.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.936 0.789 . . . . 10.0 111.953 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 m -111.38 108.22 17.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.594 1.158 . . . . 10.0 108.745 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -79.22 83.23 5.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.55 126.54 2.35 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 10.0 110.796 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 128.537 2.735 . . . . 10.0 111.437 -171.721 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 119.765 -0.16 . . . . 10.0 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -71.79 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 10.0 109.119 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -49.41 -42.16 41.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.933 2.093 . . . . 10.0 112.884 -174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.6 p -50.35 -61.41 2.19 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.648 1.179 . . . . 10.0 110.201 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 60' ' ' ILE . 89.7 t -61.9 -47.9 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 124.063 0.945 . . . . 10.0 108.524 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.92 -1.57 0.26 Allowed Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.991 -1.449 . . . . 10.0 115.828 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.92 -31.42 19.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.133 1.967 . . . . 10.0 108.688 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.6 125.01 25.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 121.403 -0.811 . . . . 10.0 111.02 -171.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.32 -36.57 32.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 122.45 1.119 . . . . 10.0 111.85 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.88 -12.99 75.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 114.23 -1.35 . . . . 10.0 114.153 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 46' ' ' PHE . 2.3 t -79.24 146.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 120.085 1.943 . . . . 10.0 111.177 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -123.0 -47.11 2.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.891 1.676 . . . . 10.0 111.016 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.64 147.56 51.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 118.237 -0.887 . . . . 10.0 108.771 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.1 58.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.584 1.154 . . . . 10.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -79.39 75.04 5.99 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.221 -1.549 . . . . 10.0 109.501 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.59 122.73 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.362 0.665 . . . . 10.0 110.1 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -147.63 59.74 1.14 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.71 -21.38 65.73 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.695 -0.628 . . . . 10.0 111.946 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -66.47 -32.85 74.47 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.556 0.742 . . . . 10.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.87 -34.57 33.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.81 -1.96 41.72 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.26 1.886 . . . . 10.0 110.611 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -129.9 100.08 5.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.046 0.938 . . . . 10.0 108.746 -170.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 44' ' ' VAL . 2.4 p -78.02 137.95 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.534 -2.024 . . . . 10.0 105.534 168.423 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -104.79 97.85 7.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.983 1.265 . . . . 10.0 107.812 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -117.81 106.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.12 1.368 . . . . 10.0 108.94 -169.733 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -96.55 114.27 25.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -133.15 152.28 51.95 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.015 1.326 . . . . 10.0 111.649 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -82.95 84.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 122.425 1.107 . . . . 10.0 112.353 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.95 1.21 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.239 -1.801 . . . . 10.0 113.801 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.3 -49.56 76.72 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.524 0.602 . . . . 10.0 110.594 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -87.09 -48.62 7.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.86 102.63 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.39 154.55 38.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.402 0.62 . . . . 10.0 109.805 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -38.51 -42.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.184 1.394 . . . . 10.0 112.601 175.178 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -57.01 -54.44 46.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.246 0.618 . . . . 10.0 109.776 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.35 -40.68 49.91 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.907 0.883 . . . . 10.0 111.178 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 24' ' ' VAL . 12.9 mm -66.68 -49.49 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -63.23 -39.69 95.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 -174.141 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -62.28 -41.68 98.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.51 79.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.385 -0.822 . . . . 10.0 110.977 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 67' ' ' VAL . 1.9 mp -61.0 -44.2 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 O-C-N 120.981 -1.074 . . . . 10.0 108.789 168.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.91 -33.56 67.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.013 1.279 . . . . 10.0 112.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.89 -39.35 81.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.997 0.369 . . . . 10.0 111.997 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -133.93 84.4 2.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.623 1.569 . . . . 10.0 108.903 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.28 76.5 1.21 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.495 0.569 . . . . 10.0 112.116 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -68.0 55.22 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.71 2.404 . . . . 10.0 114.739 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.5 56.19 0.63 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.718 -1.238 . . . . 10.0 107.707 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 60' ' ' ILE . 3.6 m -133.38 94.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.319 1.448 . . . . 10.0 111.398 -176.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.65 -66.38 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.263 168.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt 160.38 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.53 1.932 . . . . 10.0 113.086 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.423 HG13 HG21 ' A' ' 53' ' ' VAL . 6.3 mm . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 106.822 -1.547 . . . . 10.0 106.822 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.36 89.21 1.22 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.452 1.101 . . . . 10.0 110.14 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HB3' HD11 ' A' ' 70' ' ' ILE . 7.9 mmtp -139.18 175.18 9.78 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.843 0.682 . . . . 10.0 112.843 -172.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -115.63 117.06 29.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.544 1.538 . . . . 10.0 108.885 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.5 mt -86.57 97.34 10.47 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 171.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 2.7 tm0? -45.8 118.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HG11 ' A' ' 20' ' ' VAL . 8.4 t . . . . . 0 N--CA 1.454 -0.233 0 C-N-CA 124.76 1.224 . . . . 10.0 108.438 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 8' ' ' VAL . 99.4 t . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 111.276 0.102 . . . . 10.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -77.01 -66.11 0.86 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.827 0.851 . . . . 10.0 109.048 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -51.7 -47.91 63.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.307 1.843 . . . . 10.0 111.289 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -53.04 -67.83 0.22 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 10.0 110.753 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.767 HG22 HG22 ' A' ' 56' ' ' ILE . 84.8 t -55.46 -42.33 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 124.512 1.125 . . . . 10.0 108.996 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.6 -14.04 13.53 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.07 -1.406 . . . . 10.0 115.085 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.01 -22.13 36.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 120.301 2.051 . . . . 10.0 108.697 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.7 HD13 HD12 ' A' ' 56' ' ' ILE . 60.3 mt -67.69 117.68 9.94 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.44 0.638 . . . . 10.0 111.498 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -40.79 -40.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.594 1.958 . . . . 10.0 112.251 168.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.14 -8.5 87.56 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.285 1.421 . . . . 10.0 115.2 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.83 158.35 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.022 1.911 . . . . 10.0 111.855 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -132.27 -48.72 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.221 1.009 . . . . 10.0 110.662 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.62 146.09 51.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.099 -1.075 . . . . 10.0 108.099 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.0 m -139.99 57.37 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.328 1.051 . . . . 10.0 110.59 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -82.44 66.15 7.9 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.968 -1.083 . . . . 10.0 110.367 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.09 126.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.038 1.335 . . . . 10.0 110.976 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -144.27 56.14 1.3 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.12 -28.74 66.82 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.551 -0.718 . . . . 10.0 110.986 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -61.85 -31.37 71.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.921 1.289 . . . . 10.0 110.749 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.0 -4.68 56.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.769 1.228 . . . . 10.0 111.771 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.74 40.05 65.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.913 0.768 . . . . 10.0 111.233 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -155.74 160.13 40.06 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 117.901 0.851 . . . . 10.0 109.981 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.31 101.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.45 103.16 11.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.38 96.55 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.714 1.206 . . . . 10.0 107.785 -173.683 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 t -88.15 105.76 17.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.86 152.39 50.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.696 0.999 . . . . 10.0 113.696 -175.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.38 84.24 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.61 -0.723 . . . . 10.0 112.824 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.87 -30.87 10.81 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.75 -51.87 65.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.012 0.525 . . . . 10.0 110.503 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -78.82 -42.62 27.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.8 m -135.8 98.63 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.179 0.992 . . . . 10.0 109.426 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.69 152.48 26.52 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.48 -0.762 . . . . 10.0 110.617 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -36.81 -44.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.788 1.033 . . . . 10.0 113.788 171.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -55.25 -58.21 8.65 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.36 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -46.79 -44.38 19.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.993 0.917 . . . . 10.0 110.232 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.767 HG22 HG22 ' A' ' 24' ' ' VAL . 1.9 mm -66.99 -45.19 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.542 -0.724 . . . . 10.0 110.669 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.49 99.71 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.383 -0.969 . . . . 10.0 108.383 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.29 -38.95 88.62 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.33 71.88 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.526 -0.733 . . . . 10.0 111.653 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.406 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.5 mp -63.3 -49.8 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 168.233 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.19 -30.4 68.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.563 1.074 . . . . 10.0 112.446 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.94 -29.86 69.87 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.81 -0.556 . . . . 10.0 111.342 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.51 -62.95 1.21 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.109 1.764 . . . . 10.0 111.786 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.54 -143.59 6.66 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.382 1.944 . . . . 10.0 109.18 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.28 57.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.775 1.287 . . . . 10.0 109.978 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.22 70.3 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.725 -1.954 . . . . 10.0 105.725 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.704 ' CG2' HD22 ' A' ' 6' ' ' LEU . 9.9 p -156.23 92.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 121.647 -0.658 . . . . 10.0 112.159 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -49.17 -71.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.512 168.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' C ' HD23 ' A' ' 6' ' ' LEU . 13.1 mttt 171.03 176.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.527 1.531 . . . . 10.0 113.959 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 4' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.589 -0.523 . . . . 10.0 109.589 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -78.17 106.67 10.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.82 1.648 . . . . 10.0 109.945 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.47 ' CB ' HD12 ' A' ' 70' ' ' ILE . 3.6 mtpm? -128.07 174.72 8.98 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -120.75 114.99 22.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.658 -0.651 . . . . 10.0 109.593 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.09 82.07 3.6 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.76 -1.57 . . . . 10.0 106.76 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -40.34 120.27 1.19 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.439 -1.01 0 C-N-CA 126.172 1.789 . . . . 10.0 107.717 -169.451 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 t . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 119.647 -0.216 . . . . 10.0 110.909 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -78.68 -76.18 0.21 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.167 -1.419 . . . . 10.0 107.167 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -42.09 -49.96 4.75 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.573 2.749 . . . . 10.0 112.152 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -54.33 -58.24 8.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 122.253 1.025 . . . . 10.0 110.63 -177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 56' ' ' ILE . 91.6 t -64.45 -38.66 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.29 -1.004 . . . . 10.0 108.29 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.47 -11.32 40.63 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.181 1.372 . . . . 10.0 114.531 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.94 -21.7 40.23 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.923 1.861 . . . . 10.0 108.123 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.746 HD11 HG23 ' A' ' 56' ' ' ILE . 41.4 mt -67.37 117.25 9.1 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.45 0.643 . . . . 10.0 111.525 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -46.96 -35.27 6.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.984 1.313 . . . . 10.0 111.716 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.77 5.69 84.4 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 125.338 1.447 . . . . 10.0 114.93 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.24 159.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 120.532 2.166 . . . . 10.0 111.939 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -126.81 -44.64 1.64 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.07 1.348 . . . . 10.0 112.004 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.65 146.81 34.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.66 -1.162 . . . . 10.0 108.862 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.2 m -145.12 56.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.224 1.01 . . . . 10.0 112.469 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -82.6 70.85 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.158 -1.589 . . . . 10.0 111.147 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.57 126.29 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.541 0.736 . . . . 10.0 111.383 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -144.41 56.97 1.3 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.61 -24.52 67.62 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.659 -0.65 . . . . 10.0 111.529 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.1 -32.27 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.348 0.659 . . . . 10.0 110.518 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.12 44.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.33 9.35 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.118 1.342 . . . . 10.0 111.078 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -141.62 174.41 10.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 122.325 1.06 . . . . 10.0 109.276 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -156.1 115.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 102.996 -2.964 . . . . 10.0 102.996 174.98 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -91.95 101.24 13.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 120.337 1.426 . . . . 10.0 108.092 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -116.64 107.97 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.637 1.175 . . . . 10.0 109.045 -172.101 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -98.71 116.56 31.22 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.06 161.1 42.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 -176.071 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.33 81.8 5.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.302 -0.863 . . . . 10.0 112.97 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.47 -40.87 0.9 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.687 1.595 . . . . 10.0 112.87 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -54.88 18.82 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.31 1.044 . . . . 10.0 111.806 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -83.38 -40.72 19.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -135.43 105.2 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 148.67 49.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.588 -0.695 . . . . 10.0 110.222 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.514 HG13 ' CG1' ' A' ' 70' ' ' ILE . 40.1 t -29.31 -52.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 126.871 2.068 . . . . 10.0 112.242 167.454 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -50.32 -60.78 2.64 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.423 0.689 . . . . 10.0 109.331 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -44.76 -44.64 9.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.858 1.663 . . . . 10.0 110.192 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 HD11 ' A' ' 27' ' ' LEU . 2.0 mm -67.15 -45.56 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.098 -1.001 . . . . 10.0 110.904 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.45 94.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -54.69 -39.69 68.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.234 1.014 . . . . 10.0 108.681 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.32 69.83 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.1 0.778 . . . . 10.0 113.1 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.422 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.4 mp -66.26 -47.61 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 168.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.32 -26.39 68.4 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -61.97 -33.94 75.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.652 -0.655 . . . . 10.0 111.577 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -98.6 -54.29 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.316 1.446 . . . . 10.0 111.819 -169.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.12 -140.36 3.82 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.155 -1.978 . . . . 10.0 108.155 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -164.83 53.38 0.12 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.685 1.242 . . . . 10.0 110.604 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 78.4 1.48 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.918 -1.512 . . . . 10.0 106.918 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.05 108.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.33 0.14 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.5 tttt 177.75 176.85 0.4 Allowed 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 113.863 1.061 . . . . 10.0 113.863 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.514 ' CG1' HG13 ' A' ' 53' ' ' VAL . 3.3 mm . . . . . 0 CA--C 1.533 0.305 0 O-C-N 121.871 -0.518 . . . . 10.0 110.76 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.848 . . . . 10.0 106.012 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.34 89.7 1.61 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.529 1.132 . . . . 10.0 109.691 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -131.77 173.58 11.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.513 0.673 . . . . 10.0 111.751 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -111.91 112.92 24.92 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.542 1.537 . . . . 10.0 108.148 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.76 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.3 mt -80.64 95.0 6.43 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.611 -1.996 . . . . 10.0 105.611 172.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.4 121.56 5.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.378 -1.341 . . . . 10.0 107.378 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.438 -1.074 0 C-N-CA 128.431 2.692 . . . . 10.0 108.192 -169.214 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.5 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 119.544 -0.265 . . . . 10.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -55.73 4.19 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.4 m -50.06 -53.07 29.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.753 0.821 . . . . 10.0 110.159 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -60.62 -59.95 4.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 122.583 1.183 . . . . 10.0 111.1 -168.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 56' ' ' ILE . 69.3 t -60.82 -41.47 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.351 -0.84 . . . . 10.0 108.831 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.67 -13.28 7.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.598 1.57 . . . . 10.0 114.546 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.89 -23.0 33.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.984 1.892 . . . . 10.0 108.575 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' CD1' HD12 ' A' ' 56' ' ' ILE . 73.6 mt -68.9 123.16 20.24 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.733 -0.604 . . . . 10.0 111.085 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -43.4 -43.06 5.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.1 1.36 . . . . 10.0 112.297 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.2 -17.61 74.17 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 113.961 -1.472 . . . . 10.0 114.016 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.4 147.84 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.732 1.766 . . . . 10.0 111.616 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -123.88 -43.23 2.13 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 10.0 110.795 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.6 154.56 44.51 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.794 0.837 . . . . 10.0 109.358 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.3 m -145.64 57.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.079 1.752 . . . . 10.0 111.101 -174.417 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.17 66.14 7.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.919 -1.113 . . . . 10.0 111.522 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.47 132.4 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 124.618 1.167 . . . . 10.0 111.871 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -152.97 58.17 0.79 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.79 -26.12 67.05 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.179 -0.951 . . . . 10.0 111.248 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -58.9 -34.54 71.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.571 1.148 . . . . 10.0 110.433 173.846 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.71 -4.19 58.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.104 . . . . 10.0 111.583 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.98 34.74 55.22 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.601 1.096 . . . . 10.0 111.274 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -156.98 160.56 39.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.274 1.037 . . . . 10.0 111.134 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -156.69 104.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.417 -2.438 . . . . 10.0 104.417 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.15 95.26 9.9 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.677 -1.601 . . . . 10.0 106.677 -175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.9 91.84 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.336 1.065 . . . . 10.0 109.93 -169.056 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 m -77.83 84.51 4.14 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.933 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -106.26 178.36 4.58 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.457 0.703 . . . . 10.0 111.372 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.05 83.78 2.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 114.246 1.202 . . . . 10.0 114.246 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -36.0 4.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.904 -1.498 . . . . 10.0 113.036 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -65.72 -54.9 21.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.267 0.485 . . . . 10.0 110.74 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -82.02 -28.08 32.71 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.83 -0.544 . . . . 10.0 111.125 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.63 105.85 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.37 1.468 . . . . 10.0 108.948 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.34 152.28 29.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.404 -0.81 . . . . 10.0 109.663 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.4 -42.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.959 0.903 . . . . 10.0 112.496 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -47.93 83.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.607 0.763 . . . . 10.0 110.567 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.66 -44.57 73.41 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.078 0.951 . . . . 10.0 109.709 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.693 HG22 HG22 ' A' ' 24' ' ' VAL . 10.9 mm -62.64 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 122.177 0.989 . . . . 10.0 109.587 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.29 77.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.157 -0.929 . . . . 10.0 108.677 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.54 -43.44 97.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.676 -0.64 . . . . 10.0 109.711 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.94 83.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.725 -0.609 . . . . 10.0 110.451 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 24' ' ' VAL . 1.4 mt -51.13 -46.41 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.489 -0.757 . . . . 10.0 109.157 170.177 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.11 -42.74 60.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.963 0.801 . . . . 10.0 111.762 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.37 -41.56 93.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.192 0.52 . . . . 10.0 111.13 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -114.11 66.44 0.67 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.204 1.402 . . . . 10.0 110.606 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 103.5 0.63 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.45 -1.06 . . . . 10.0 110.45 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -74.33 54.3 0.56 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.496 1.518 . . . . 10.0 113.723 -169.365 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -106.04 79.31 1.4 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.441 -1.318 . . . . 10.0 107.441 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.76 ' CG2' HD22 ' A' ' 6' ' ' LEU . 13.9 p -156.18 104.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.711 -0.618 . . . . 10.0 110.653 172.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.18 -67.63 0.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.027 -0.987 . . . . 10.0 110.514 167.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt 160.03 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.162 2.185 . . . . 10.0 114.098 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.243 0 O-C-N 121.23 -0.919 . . . . 10.0 111.178 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.27 99.92 12.61 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.818 0.847 . . . . 10.0 109.493 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 70' ' ' ILE . 1.4 mtpt -134.35 175.62 9.35 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.963 0.347 . . . . 10.0 110.111 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -117.69 119.38 34.78 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -75.95 111.83 11.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.857 -2.275 . . . . 10.0 104.857 169.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.32 121.62 14.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.727 HG21 HG11 ' A' ' 20' ' ' VAL . 24.8 t . . . . . 0 N--CA 1.446 -0.643 0 C-N-CA 127.156 2.182 . . . . 10.0 108.5 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.727 HG11 HG21 ' A' ' 8' ' ' VAL . 41.9 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 118.924 -0.56 . . . . 10.0 111.258 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -89.63 -56.95 3.05 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.9 m -60.48 -59.91 4.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.706 1.202 . . . . 10.0 111.48 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -53.91 50.61 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.68 0.673 . . . . 10.0 110.435 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 56' ' ' ILE . 74.6 t -59.35 -44.26 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.06 -14.79 3.05 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.034 -1.426 . . . . 10.0 114.876 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -87.22 -20.2 27.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.095 1.947 . . . . 10.0 109.293 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.27 128.59 37.13 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.706 -0.622 . . . . 10.0 111.004 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -46.99 -39.41 12.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.912 1.285 . . . . 10.0 111.901 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.37 -9.24 86.94 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 113.857 -1.519 . . . . 10.0 114.556 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.47 161.32 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 120.385 2.093 . . . . 10.0 112.048 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -140.96 -45.22 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.626 1.17 . . . . 10.0 111.421 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.49 42.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.4 58.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.138 . . . . 10.0 110.516 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -80.05 79.77 6.55 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.757 -1.214 . . . . 10.0 110.44 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.79 118.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.61 0.764 . . . . 10.0 110.584 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -144.65 64.67 1.29 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.054 -1.461 . . . . 10.0 107.054 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -56.04 -26.82 50.65 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.185 -0.947 . . . . 10.0 111.874 178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 37' ' ' LEU . 38.8 mt-10 -63.34 -31.55 72.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.815 0.846 . . . . 10.0 110.195 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.26 -10.9 59.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.25 0.62 . . . . 10.0 111.351 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.44 20.72 79.51 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.743 -1.343 . . . . 10.0 109.743 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -151.63 117.79 5.58 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.703 0.801 . . . . 10.0 109.708 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG22 HG13 ' A' ' 44' ' ' VAL . 1.9 p -96.27 126.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 104.604 -2.369 . . . . 10.0 104.604 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.84 93.52 8.88 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -109.43 108.07 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.759 1.266 . . . . 10.0 109.013 -173.019 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 m -99.5 112.92 25.05 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.426 1.49 . . . . 10.0 107.379 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.476 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p90 -148.87 159.26 44.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.277 1.037 . . . . 10.0 113.558 -171.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.82 79.77 9.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.234 1.016 . . . . 10.0 112.337 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.09 -27.98 1.58 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.321 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.24 -56.6 10.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.346 0.521 . . . . 10.0 110.618 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -79.95 -39.23 30.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.798 -0.564 . . . . 10.0 110.639 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 107.67 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -68.16 152.81 44.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.49 0.662 . . . . 10.0 109.809 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 70' ' ' ILE . 5.7 t -41.18 -44.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.103 1.361 . . . . 10.0 112.539 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -49.78 67.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -58.84 -41.03 85.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.217 1.007 . . . . 10.0 109.972 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.504 HG22 HG22 ' A' ' 24' ' ' VAL . 15.3 mm -63.3 -45.09 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 121.684 -0.635 . . . . 10.0 109.636 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.92 97.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.602 -0.888 . . . . 10.0 108.602 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.06 -38.52 79.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.51 63.44 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.27 -48.83 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.59 -29.82 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.208 0.913 . . . . 10.0 111.91 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.95 -35.64 69.34 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.005 0.431 . . . . 10.0 110.689 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -100.0 -69.67 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.802 1.241 . . . . 10.0 112.732 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.26 -143.27 8.27 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.123 1.821 . . . . 10.0 109.314 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.9 51.99 0.11 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.085 1.443 . . . . 10.0 109.995 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.8 68.15 1.32 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 -172.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.54 78.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.428 0.558 . . . . 10.0 112.18 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.48 -66.55 0.24 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.637 0.775 . . . . 10.0 112.875 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt 162.04 171.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.907 2.083 . . . . 10.0 113.023 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 O-C-N 122.194 -0.316 . . . . 10.0 110.647 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -62.04 108.18 1.0 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.498 ' CB ' HD11 ' A' ' 70' ' ' ILE . 17.7 mtpp -127.59 173.13 10.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.852 0.751 . . . . 10.0 110.129 172.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -119.01 116.52 26.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.074 0.55 . . . . 10.0 109.932 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 70' ' ' ILE . 9.8 mt -78.34 110.83 13.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 170.082 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 116.82 3.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.211 -1.774 . . . . 10.0 106.211 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.677 HG21 HG11 ' A' ' 20' ' ' VAL . 26.4 t . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 125.328 1.451 . . . . 10.0 107.77 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 8' ' ' VAL . 31.1 t . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.14 -65.92 0.91 Allowed 'General case' 0 C--N 1.338 0.087 0 C-N-CA 122.912 0.485 . . . . 10.0 110.106 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m -52.84 -40.3 63.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.963 1.305 . . . . 10.0 110.134 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 m -59.51 -51.73 68.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.442 1.097 . . . . 10.0 110.671 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.594 ' CG2' HD11 ' A' ' 60' ' ' ILE . 78.9 t -65.76 -42.52 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.28 -11.8 3.76 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.666 1.603 . . . . 10.0 115.307 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.96 -23.63 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.711 1.756 . . . . 10.0 108.269 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.55 119.07 16.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 121.604 -0.685 . . . . 10.0 110.394 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -48.94 -36.37 17.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.169 0.985 . . . . 10.0 112.18 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 -9.26 77.0 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.934 1.254 . . . . 10.0 114.364 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -68.57 167.64 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.58 1.69 . . . . 10.0 111.957 174.089 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -138.26 -50.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.622 1.169 . . . . 10.0 110.847 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.55 145.03 51.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.163 -0.922 . . . . 10.0 108.643 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 56.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.511 1.124 . . . . 10.0 110.778 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.28 78.79 9.71 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 120.27 -1.519 . . . . 10.0 108.717 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.95 123.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.727 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -145.75 59.78 1.26 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.593 -1.632 . . . . 10.0 106.593 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.79 -21.56 64.69 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.567 -0.708 . . . . 10.0 111.586 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.06 -37.61 83.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.74 0.816 . . . . 10.0 109.563 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.83 -16.81 37.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.514 0.726 . . . . 10.0 110.845 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.52 39.26 61.28 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -158.1 95.71 1.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -86.85 120.09 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.899 -1.519 . . . . 10.0 106.899 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -86.32 99.92 11.93 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.714 1.143 . . . . 10.0 108.266 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.5 m -115.39 106.77 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.102 0.953 . . . . 10.0 108.753 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -99.73 114.72 28.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.687 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -146.8 154.01 40.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 124.034 0.834 . . . . 10.0 113.152 -174.39 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.91 94.43 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.894 0.854 . . . . 10.0 112.095 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.02 22.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.695 -1.139 . . . . 10.0 113.73 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.91 -52.18 61.08 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.229 1.377 . . . . 10.0 110.2 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -87.04 -48.83 7.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 -173.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.83 99.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.55 148.66 32.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.288 -0.634 . . . . 10.0 109.288 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 70' ' ' ILE . 14.7 t -36.7 -46.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.104 1.362 . . . . 10.0 113.866 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -51.32 -58.58 5.82 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -44.72 -44.8 9.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.486 1.514 . . . . 10.0 109.824 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.687 HG21 ' CE2' ' A' ' 46' ' ' PHE . 12.0 mm -65.43 -47.41 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.251 -0.906 . . . . 10.0 110.772 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.83 84.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -55.87 -39.47 71.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.128 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -35.57 70.15 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 67' ' ' VAL . 3.1 mp -66.01 -46.21 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 120.398 1.454 . . . . 10.0 107.616 169.318 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.02 -26.19 65.9 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.585 0.63 . . . . 10.0 112.011 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.54 -33.44 68.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.37 0.668 . . . . 10.0 110.766 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -110.39 -63.79 1.34 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.168 1.387 . . . . 10.0 112.086 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.8 -159.16 21.64 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.411 1.482 . . . . 10.0 109.412 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -151.76 57.16 0.86 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.182 1.491 . . . . 10.0 108.196 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.34 61.82 1.6 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.816 -1.179 . . . . 10.0 107.816 -167.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 60' ' ' ILE . 8.1 p -158.02 64.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 121.81 -0.556 . . . . 10.0 111.177 -177.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -25.75 -67.89 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.37 1.068 . . . . 10.0 113.224 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 171.65 170.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.373 1.869 . . . . 10.0 111.909 167.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.621 HG21 HG11 ' A' ' 53' ' ' VAL . 1.3 tp . . . . . 0 N--CA 1.454 -0.234 0 O-C-N 121.847 -0.533 . . . . 10.0 111.103 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.654 0.264 . . . . 10.0 110.65 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.07 108.7 1.6 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 172.864 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -134.62 168.47 18.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.601 0.715 . . . . 10.0 110.509 174.863 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 42' ' ' VAL . 22.9 m -113.54 107.64 16.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.931 -0.577 . . . . 10.0 109.638 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -77.27 79.26 3.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 170.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.74 124.14 0.69 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.855 1.262 . . . . 10.0 110.042 173.539 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 126.389 1.875 . . . . 10.0 108.011 -178.795 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 35' ' ' VAL . 94.8 t . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 119.647 -0.216 . . . . 10.0 110.49 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.89 -71.54 0.46 Allowed 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 173.269 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -36.39 -47.81 0.62 Allowed 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.44 1.896 . . . . 10.0 112.474 -174.521 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -56.57 -57.81 10.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.18 0.992 . . . . 10.0 111.561 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 56' ' ' ILE . 49.4 t -66.28 -40.74 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.75 0.71 1.48 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.788 1.661 . . . . 10.0 115.197 173.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.1 -32.46 26.73 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.199 1.999 . . . . 10.0 108.608 173.028 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 56' ' ' ILE . 66.5 mt -72.73 119.22 16.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.992 -0.442 . . . . 10.0 110.753 -171.231 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.49 -34.47 36.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 122.112 0.958 . . . . 10.0 112.121 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -6.1 71.8 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.828 1.204 . . . . 10.0 114.27 178.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -67.25 162.75 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.566 1.683 . . . . 10.0 111.771 169.883 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -134.67 -44.96 0.74 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 10.0 111.563 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.37 148.68 44.8 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.43 1.092 . . . . 10.0 108.289 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.16 55.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.122 0.963 . . . . 10.0 111.504 -174.355 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 70.55 10.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.383 -1.448 . . . . 10.0 108.948 -177.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -61.57 124.61 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.742 -0.599 . . . . 10.0 110.078 173.167 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -141.01 62.18 1.48 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.47 -1.678 . . . . 10.0 106.47 169.772 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 38' ' ' GLU . 2.8 pp -57.34 -25.35 59.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.699 176.614 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.5 tt0 -60.39 -36.51 78.28 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.463 1.105 . . . . 10.0 109.66 175.328 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.96 19.9 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.213 1.005 . . . . 10.0 110.729 177.13 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.03 39.48 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.862 1.22 . . . . 10.0 111.851 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.09 123.61 26.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.641 -1.614 . . . . 10.0 106.641 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -112.46 105.38 18.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 126.159 1.783 . . . . 10.0 107.909 173.355 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.16 93.8 4.62 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.38 -0.97 . . . . 10.0 108.38 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -109.96 109.31 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.426 1.09 . . . . 10.0 109.396 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -100.4 123.29 44.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 174.782 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -150.08 160.97 43.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.686 -173.923 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.77 86.82 5.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.381 1.086 . . . . 10.0 112.484 -172.401 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.01 -27.01 6.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.977 -1.465 . . . . 10.0 113.392 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -43.22 -55.68 3.85 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 10.0 111.377 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -99.01 -39.59 8.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.991 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.26 101.64 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.43 149.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.504 -0.748 . . . . 10.0 109.654 -177.104 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 53' ' ' VAL . 2.0 m -36.67 -44.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.082 1.353 . . . . 10.0 114.042 172.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -50.87 72.0 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.645 -0.693 . . . . 10.0 109.663 174.961 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.54 -43.58 25.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.334 1.053 . . . . 10.0 110.151 175.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -65.61 -43.55 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.227 -0.921 . . . . 10.0 111.025 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.27 90.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -59.22 -41.73 89.32 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.97 63.93 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.994 0.738 . . . . 10.0 112.994 172.628 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.1 mp -64.84 -46.02 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 120.647 1.567 . . . . 10.0 108.693 169.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.85 -28.57 69.58 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.202 0.445 . . . . 10.0 112.202 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -31.77 61.63 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.96 -0.462 . . . . 10.0 111.878 171.932 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.45 -65.81 1.1 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.781 0.832 . . . . 10.0 111.447 -176.473 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.19 -155.63 15.12 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 108.438 -1.865 . . . . 10.0 108.438 -175.619 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -148.72 54.52 1.0 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 119.286 1.543 . . . . 10.0 107.33 172.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.16 65.44 1.56 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.038 -1.468 . . . . 10.0 107.038 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.5 p -150.62 96.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.126 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.76 -0.654 . . . . 10.0 109.362 167.755 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tttt 171.7 -174.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.369 1.068 . . . . 10.0 112.801 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 mm . . . . . 0 N--CA 1.435 -1.193 0 O-C-N 121.801 -0.562 . . . . 10.0 109.722 179.17 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -70.07 98.63 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.746 1.218 . . . . 10.0 109.854 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 70' ' ' ILE . 39.7 mttt -135.7 166.51 23.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.193 0.597 . . . . 10.0 109.733 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -114.21 117.24 30.61 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.093 0.957 . . . . 10.0 108.827 175.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 12.2 mt -78.59 104.37 9.15 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 170.102 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -53.53 118.41 3.86 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.035 1.289 . . . . 10.0 108.564 175.942 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 20' ' ' VAL . 38.4 t . . . . . 0 C--O 1.231 0.114 0 C-N-CA 124.974 1.31 . . . . 10.0 109.869 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 8' ' ' VAL . 16.9 t . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 119.975 -0.06 . . . . 10.0 110.873 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -72.85 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.31 1.044 . . . . 10.0 108.513 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 m -43.0 -44.8 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.991 2.116 . . . . 10.0 111.487 -175.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.7 m -54.1 -51.34 64.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.523 0.678 . . . . 10.0 111.063 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 56' ' ' ILE . 75.1 t -72.38 -44.04 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 176.074 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -12.73 4.32 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.268 1.413 . . . . 10.0 115.163 176.405 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 -25.63 31.24 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.989 1.394 . . . . 10.0 108.465 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.747 HD13 HD12 ' A' ' 56' ' ' ILE . 78.4 mt -62.47 122.71 16.44 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.383 0.611 . . . . 10.0 111.801 -176.073 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.27 -35.99 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.647 1.579 . . . . 10.0 112.286 169.344 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.92 -2.18 81.48 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.273 1.416 . . . . 10.0 114.891 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.04 156.99 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 120.55 2.175 . . . . 10.0 111.466 175.523 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.0 t -130.35 -47.04 1.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 110.912 176.496 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.6 146.04 35.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 178.296 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -143.33 58.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.658 1.183 . . . . 10.0 110.91 -176.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -79.28 76.03 5.84 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.589 -1.319 . . . . 10.0 108.87 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 120.7 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.214 1.005 . . . . 10.0 109.732 173.917 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 57.55 1.36 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 172.086 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -56.49 -28.55 60.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.83 75.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.737 1.215 . . . . 10.0 110.083 176.327 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -7.77 58.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.413 1.085 . . . . 10.0 111.523 178.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.82 38.78 60.46 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 -176.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -158.35 155.57 28.98 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.514 0.725 . . . . 10.0 109.263 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -146.38 118.68 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 103.617 -2.734 . . . . 10.0 103.617 172.373 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -88.34 108.39 19.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.422 -1.695 . . . . 10.0 106.422 172.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.09 90.21 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 -176.737 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -83.73 108.66 16.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.982 -1.858 . . . . 10.0 105.982 174.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -129.37 178.21 6.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.05 -0.977 . . . . 10.0 110.431 -176.261 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.14 89.88 3.19 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.135 -0.978 . . . . 10.0 113.481 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.88 -33.04 34.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.772 -1.558 . . . . 10.0 112.38 177.13 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.13 -50.41 64.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.802 0.441 . . . . 10.0 110.602 -178.306 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -78.23 -37.86 44.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -142.59 111.08 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.697 1.199 . . . . 10.0 108.104 -177.228 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -70.84 149.84 46.4 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.115 -0.991 . . . . 10.0 110.516 -172.16 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 70' ' ' ILE . 4.3 t -31.11 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.8 1.64 . . . . 10.0 114.022 172.727 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -50.86 -62.32 1.68 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -42.65 -42.26 3.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.104 0.962 . . . . 10.0 110.609 177.894 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 27' ' ' LEU . 1.7 mm -70.29 -44.22 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.588 -0.695 . . . . 10.0 110.628 -177.436 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.74 71.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.78 -38.78 70.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.902 1.281 . . . . 10.0 108.997 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.41 71.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.91 -0.493 . . . . 10.0 112.271 175.139 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.19 -44.35 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.798 1.181 . . . . 10.0 108.141 170.244 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.82 -30.14 68.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.453 0.569 . . . . 10.0 112.425 -178.473 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.5 -26.2 68.41 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.529 -0.732 . . . . 10.0 111.971 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -58.19 1.92 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.297 1.439 . . . . 10.0 111.685 -170.646 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.31 -156.78 8.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.033 -2.027 . . . . 10.0 108.033 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -146.88 56.08 1.13 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.468 1.634 . . . . 10.0 109.812 175.924 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.64 65.65 1.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -150.07 98.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 171.227 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -54.14 -73.01 0.05 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.303 169.298 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 174.08 173.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.606 1.562 . . . . 10.0 110.795 169.372 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.284 0 O-C-N 121.59 -0.694 . . . . 10.0 109.793 175.069 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 120.846 0.355 . . . . 10.0 111.725 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -73.69 104.25 4.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.999 1.319 . . . . 10.0 109.902 169.484 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 175.45 9.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.641 0.776 . . . . 10.0 110.556 172.352 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -113.83 108.16 16.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.824 1.25 . . . . 10.0 110.029 175.308 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 tp -85.63 73.63 10.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.497 1.119 . . . . 10.0 109.054 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -35.2 119.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.268 1.427 . . . . 10.0 111.88 -173.048 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 HG11 ' A' ' 20' ' ' VAL . 65.3 t . . . . . 0 N--CA 1.448 -0.564 0 C-N-CA 126.637 1.975 . . . . 10.0 109.987 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 8' ' ' VAL . 35.7 t . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -61.12 2.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.26 -169.293 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -48.21 -51.12 26.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.25 1.42 . . . . 10.0 111.056 171.883 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -59.17 -59.62 5.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.649 1.113 . . . . 10.0 110.481 -169.201 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 56' ' ' ILE . 78.9 t -62.46 -36.78 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.335 -0.848 . . . . 10.0 108.899 178.024 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.65 -12.0 25.14 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.141 -1.366 . . . . 10.0 115.113 172.578 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -81.74 -18.1 45.45 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.434 2.117 . . . . 10.0 109.114 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 56' ' ' ILE . 37.7 mt -70.41 112.07 6.43 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.228 0.537 . . . . 10.0 110.195 -175.115 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -41.2 -40.76 1.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.795 1.638 . . . . 10.0 113.152 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.93 -15.79 79.6 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.546 -1.206 . . . . 10.0 114.147 -178.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -67.09 149.96 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.561 1.681 . . . . 10.0 112.133 -174.919 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -111.92 -51.12 2.87 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 10.0 110.878 177.306 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ALA . . . . . 0.533 ' HB3' ' OG ' ' A' ' 45' ' ' SER . . . -140.7 146.79 38.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.443 0.697 . . . . 10.0 109.2 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -146.65 88.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 128.072 2.549 . . . . 10.0 105.108 -173.491 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -114.54 71.74 0.77 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.011 1.324 . . . . 10.0 110.662 -176.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.5 132.06 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.298 -0.876 . . . . 10.0 111.091 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -143.65 57.1 1.36 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 174.139 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.16 -28.97 69.5 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.567 -0.708 . . . . 10.0 111.552 -171.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.631 0.772 . . . . 10.0 111.043 174.521 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 -3.7 58.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.8 0.84 . . . . 10.0 111.5 176.254 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.39 36.91 78.95 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -175.839 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.91 161.42 41.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.823 0.82 . . . . 10.0 109.687 -177.099 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -155.03 121.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 101.665 -3.457 . . . . 10.0 101.665 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -99.6 103.37 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 120.71 1.595 . . . . 10.0 106.754 177.262 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -122.46 99.19 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.641 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -87.84 95.67 10.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 172.979 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -121.32 155.85 33.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.982 -1.008 . . . . 10.0 110.69 -176.997 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 10.6 t0 -91.61 90.84 7.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.036 0.754 . . . . 10.0 113.036 -172.292 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.81 -30.22 2.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.009 -1.45 . . . . 10.0 113.756 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -64.37 -52.83 56.34 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.13 0.877 . . . . 10.0 110.035 -178.396 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -37.9 35.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 -174.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -144.19 104.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.49 1.116 . . . . 10.0 107.996 -175.513 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.15 150.17 26.05 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 123.453 0.701 . . . . 10.0 111.098 -173.456 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.6 m -40.95 -44.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.446 1.099 . . . . 10.0 113.67 173.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -54.5 -56.26 20.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 171.917 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.69 -42.79 46.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.241 1.416 . . . . 10.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 24' ' ' VAL . 3.0 mm -63.32 -47.65 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.411 -0.806 . . . . 10.0 110.522 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.89 81.22 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -63.7 -40.37 96.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.721 -0.612 . . . . 10.0 109.468 175.421 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.14 88.64 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.384 -0.823 . . . . 10.0 111.146 177.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 24' ' ' VAL . 2.2 mt -55.33 -40.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 120.905 -1.122 . . . . 10.0 109.0 170.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -47.42 72.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.922 0.783 . . . . 10.0 110.282 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.83 -56.7 18.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.478 0.656 . . . . 10.0 109.858 175.468 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -94.53 67.54 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.353 0.661 . . . . 10.0 110.47 -177.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.99 97.06 0.26 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.023 -0.99 . . . . 10.0 111.38 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -65.95 105.11 1.24 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.728 0.775 . . . . 10.0 110.334 -175.729 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -148.94 76.63 1.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 169.14 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.92 105.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 O-C-N 121.152 -0.967 . . . . 10.0 111.129 175.124 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -60.46 -67.61 0.38 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.965 170.569 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttt 157.25 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.746 2.418 . . . . 10.0 112.949 173.889 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 N--CA 1.443 -0.793 0 C-N-CA 124.147 0.979 . . . . 10.0 109.576 -173.363 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pm0 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -78.16 117.07 19.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.503 ' CB ' HD12 ' A' ' 70' ' ' ILE . 2.8 mtpt -130.35 166.13 21.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.482 -1.303 . . . . 10.0 107.482 174.325 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 42' ' ' VAL . 86.0 m -129.78 108.85 10.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.573 -0.529 . . . . 10.0 109.573 -174.121 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.2 mt -76.86 92.75 3.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.39 111.79 0.46 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.068 -1.086 . . . . 10.0 108.068 172.573 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 6' ' ' LEU . 6.6 m . . . . . 0 N--CA 1.441 -0.89 0 C-N-CA 125.949 1.7 . . . . 10.0 109.493 -178.316 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 8' ' ' VAL . 70.3 t . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 110.174 -0.306 . . . . 10.0 110.174 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.92 -73.77 0.16 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.809 0.844 . . . . 10.0 109.704 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.1 m -44.92 -45.1 10.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.926 1.69 . . . . 10.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 m -53.48 -55.14 27.81 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.817 0.818 . . . . 10.0 110.709 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 56' ' ' ILE . 72.5 t -72.15 -25.0 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 123.65 0.78 . . . . 10.0 110.701 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 4.2 69.38 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.061 1.315 . . . . 10.0 112.688 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.66 -45.1 17.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.087 1.444 . . . . 10.0 107.447 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.473 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 118.82 4.89 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -176.39 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.66 -35.66 14.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.692 1.197 . . . . 10.0 111.963 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.72 -3.54 83.79 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.883 1.23 . . . . 10.0 114.326 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 158.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.902 1.851 . . . . 10.0 111.527 170.1 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -133.93 -46.3 0.79 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.253 . . . . 10.0 110.897 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.33 46.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.291 -1.003 . . . . 10.0 108.291 173.519 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -142.9 58.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 110.255 -174.506 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.92 67.7 5.79 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.355 -0.841 . . . . 10.0 109.964 -172.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.5 129.77 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.579 1.152 . . . . 10.0 109.907 178.661 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -155.61 55.51 0.62 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.69 -18.47 65.39 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.715 -0.615 . . . . 10.0 110.493 -175.342 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -36.17 82.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.498 1.119 . . . . 10.0 109.711 171.28 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 -29.02 43.68 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.032 -0.359 . . . . 10.0 110.032 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.94 22.9 7.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 10.0 111.464 174.925 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 5' ' ' THR . 4.3 mtpt -148.67 174.65 11.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.407 1.083 . . . . 10.0 108.255 -178.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -158.99 99.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -177.941 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -80.94 90.88 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.737 -1.209 . . . . 10.0 107.737 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -103.22 101.19 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.135 1.374 . . . . 10.0 108.733 -174.749 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -89.11 107.61 19.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.791 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -141.89 156.59 45.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.313 0.578 . . . . 10.0 112.447 -176.15 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -81.93 90.7 6.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.869 1.063 . . . . 10.0 113.869 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.72 -27.08 1.79 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.92 -1.491 . . . . 10.0 113.353 169.071 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.49 -55.22 9.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.607 1.094 . . . . 10.0 110.342 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -77.22 -38.75 50.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 -175.006 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.99 98.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -176.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.45 148.2 46.32 Favored 'General case' 0 C--O 1.219 -0.52 0 O-C-N 121.497 -0.752 . . . . 10.0 109.091 -175.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 70' ' ' ILE . 70.7 t -28.65 -52.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 125.986 1.714 . . . . 10.0 112.843 168.262 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -48.29 -54.01 15.24 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 123.364 0.665 . . . . 10.0 109.443 177.633 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.34 -46.63 62.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.01 2.124 . . . . 10.0 109.132 177.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 46' ' ' PHE . 8.8 mm -67.3 -45.15 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.752 -0.592 . . . . 10.0 110.88 -176.353 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.66 90.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.877 -0.786 . . . . 10.0 108.877 -178.945 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.82 -38.88 76.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 175.87 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.51 73.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.767 -0.635 . . . . 10.0 112.285 172.812 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.51 -47.29 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 120.203 1.365 . . . . 10.0 107.825 169.642 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.38 -34.5 66.75 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.607 1.094 . . . . 10.0 111.614 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.48 -30.01 66.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.503 -0.748 . . . . 10.0 112.022 176.29 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.27 -62.23 1.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.992 1.717 . . . . 10.0 112.108 -169.524 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.07 -147.03 6.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.437 1.97 . . . . 10.0 108.551 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.48 54.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.152 1.476 . . . . 10.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -124.47 58.17 1.22 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 -177.139 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -139.77 100.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 121.221 -0.924 . . . . 10.0 110.766 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.87 -77.24 0.06 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.252 -0.885 . . . . 10.0 109.77 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.61 175.04 0.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.752 1.39 . . . . 10.0 114.752 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.503 HD12 ' CB ' ' A' ' 4' ' ' LYS . 7.7 mm . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 123.674 0.79 . . . . 10.0 109.168 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.49 -0.929 . . . . 10.0 108.49 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -79.53 88.86 5.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.259 1.024 . . . . 10.0 110.282 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -125.21 175.87 7.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.505 0.593 . . . . 10.0 111.965 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -119.78 109.65 15.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.658 0.783 . . . . 10.0 109.205 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -82.87 101.8 11.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 177.625 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 124.11 20.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.44 -0.948 . . . . 10.0 108.44 -175.318 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.517 HG21 HG11 ' A' ' 20' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 127.827 2.451 . . . . 10.0 107.275 -175.528 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 8' ' ' VAL . 64.9 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -58.51 6.77 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.935 0.894 . . . . 10.0 108.695 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 m -48.35 -49.74 33.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.683 0.793 . . . . 10.0 110.879 173.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -59.57 -58.76 7.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.451 0.643 . . . . 10.0 109.51 -170.437 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.883 ' CG2' HD11 ' A' ' 60' ' ' ILE . 95.1 t -71.15 -18.12 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.809 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.44 82.58 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.702 1.144 . . . . 10.0 112.907 178.567 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.25 -44.34 16.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.131 1.466 . . . . 10.0 107.654 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -56.94 122.22 11.77 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.04 -0.527 . . . . 10.0 112.409 -174.368 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.91 -36.46 38.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.271 1.034 . . . . 10.0 111.538 169.972 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.35 -3.05 64.69 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.224 -1.353 . . . . 10.0 114.038 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -67.82 157.85 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 120.165 1.983 . . . . 10.0 111.772 169.904 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 m -129.84 -44.28 1.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.152 1.381 . . . . 10.0 111.649 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.03 146.57 33.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.777 -1.106 . . . . 10.0 108.328 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.27 58.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.483 1.113 . . . . 10.0 111.172 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.73 74.57 6.42 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.4 -1.437 . . . . 10.0 109.723 -176.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.53 118.05 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 124.517 1.127 . . . . 10.0 111.507 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -142.27 63.35 1.41 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 174.131 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.51 -22.78 65.43 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.653 -0.655 . . . . 10.0 111.627 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.48 -34.43 77.13 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.028 0.931 . . . . 10.0 110.386 172.675 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.69 41.88 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 10.0 110.264 171.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.09 21.99 43.57 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.946 1.26 . . . . 10.0 110.667 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -153.63 105.64 2.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 -174.644 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 44' ' ' VAL . 1.9 m -89.08 128.67 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.006 -1.849 . . . . 10.0 106.006 170.451 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.24 97.84 10.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 177.722 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 42' ' ' VAL . 1.4 m -119.99 99.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 -168.399 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -92.63 116.45 29.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.426 -1.694 . . . . 10.0 106.426 176.613 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.1 p90 -147.05 151.78 37.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.699 1.25 . . . . 10.0 112.103 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -86.97 88.09 7.62 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.063 0.935 . . . . 10.0 112.655 -169.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.13 -30.34 2.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.496 1.518 . . . . 10.0 112.739 175.95 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.63 -56.94 7.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.122 0.969 . . . . 10.0 111.56 174.903 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -50.34 6.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -172.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.03 99.04 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.53 148.11 34.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.742 -0.836 . . . . 10.0 108.742 -176.821 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -32.66 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.823 1.649 . . . . 10.0 111.553 168.521 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -55.85 -55.61 30.49 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 119.072 -0.489 . . . . 10.0 110.47 175.944 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -46.78 -46.28 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.464 0.706 . . . . 10.0 110.124 173.088 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 24' ' ' VAL . 14.7 mm -64.04 -51.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 121.85 -0.531 . . . . 10.0 110.128 -177.535 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.58 87.37 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -62.5 -35.86 80.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.543 0.737 . . . . 10.0 109.279 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.6 67.3 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.197 -0.939 . . . . 10.0 112.271 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.883 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.5 mp -70.97 -44.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 168.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.92 -36.28 67.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.355 1.434 . . . . 10.0 111.549 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -55.59 -30.79 61.47 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.132 0.424 . . . . 10.0 112.116 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.05 83.48 1.74 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.448 1.099 . . . . 10.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 60' ' ' ILE . . . 96.37 109.36 2.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.899 -0.88 . . . . 10.0 110.899 172.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -77.32 57.51 1.49 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.307 1.043 . . . . 10.0 112.878 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -120.77 65.7 0.85 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 10.0 109.765 -168.174 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 6' ' ' LEU 0.273 0.9 OUTLIER -142.42 92.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 122.363 1.078 . . . . 10.0 110.337 -174.086 . . . . . . . . 4 4 . 1 . 025 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.59 -23.74 66.24 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.702 -1.135 . . . . 10.0 111.561 169.811 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.0 tttt 107.15 165.75 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.4 2.28 . . . . 10.0 112.16 168.39 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.165 0 O-C-N 121.119 -0.988 . . . . 10.0 110.455 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.364 0.135 . . . . 10.0 111.364 . . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.37 114.46 21.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.18 1.792 . . . . 10.0 107.864 169.352 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' LYS . . . . . 0.758 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.9 mttp -137.91 175.34 9.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.13 0.877 . . . . 10.0 110.083 176.616 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 42' ' ' VAL . 5.7 m -123.83 109.55 13.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.514 -0.755 . . . . 10.0 109.162 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 67' ' ' VAL . 1.2 mt -82.61 90.78 6.84 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 121.77 6.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 20' ' ' VAL . 27.2 t . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 127.256 2.222 . . . . 10.0 108.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 8' ' ' VAL . 91.4 t . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.359 0.123 . . . . 10.0 110.758 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.75 -57.24 11.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.92 0.888 . . . . 10.0 108.662 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -50.37 -51.89 41.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.163 0.985 . . . . 10.0 110.093 177.903 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -57.28 -54.26 48.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.091 0.948 . . . . 10.0 111.165 -168.357 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.749 HG22 HG22 ' A' ' 56' ' ' ILE . 74.0 t -70.85 -41.6 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.189 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.58 -7.93 12.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.152 1.358 . . . . 10.0 114.286 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.73 -24.06 36.35 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.184 1.492 . . . . 10.0 107.823 176.817 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' CD1' HD12 ' A' ' 56' ' ' ILE . 71.9 mt -66.18 121.55 15.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.623 -0.673 . . . . 10.0 111.547 -176.644 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -47.71 -34.32 8.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.077 1.351 . . . . 10.0 112.125 169.735 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 0.88 87.39 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.317 1.437 . . . . 10.0 114.729 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.46 157.15 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 120.578 2.189 . . . . 10.0 111.768 173.881 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -126.48 -44.47 1.7 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.714 1.205 . . . . 10.0 111.968 174.039 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.96 146.87 32.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.041 -0.98 . . . . 10.0 108.439 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -143.22 59.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 10.0 111.866 -177.344 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.62 73.84 6.31 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 120.431 -1.418 . . . . 10.0 110.29 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.96 124.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 123.858 0.863 . . . . 10.0 111.298 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -146.74 58.24 1.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 171.25 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 38' ' ' GLU . 4.4 pp -56.21 -28.33 57.94 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.717 -0.615 . . . . 10.0 111.173 178.758 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.8 tt0 -63.62 -27.16 69.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.169 1.388 . . . . 10.0 111.144 177.179 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.03 -1.76 51.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.201 1.4 . . . . 10.0 111.852 173.041 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.29 71.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.906 1.241 . . . . 10.0 111.291 -177.074 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.18 153.39 27.57 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 117.991 0.896 . . . . 10.0 109.387 -177.813 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.04 101.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.846 -2.279 . . . . 10.0 104.846 -175.491 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.27 102.09 12.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 -174.815 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.9 m -118.89 106.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 124.879 1.272 . . . . 10.0 108.386 -172.317 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -96.56 119.42 35.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.442 -1.688 . . . . 10.0 106.442 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -150.0 157.34 43.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.065 0.936 . . . . 10.0 113.074 -174.317 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.13 82.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.711 -1.132 . . . . 10.0 113.706 -172.182 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.49 -28.57 0.59 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.925 -1.489 . . . . 10.0 113.501 168.307 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.49 -43.63 26.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.063 0.847 . . . . 10.0 110.266 -172.598 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -78.96 -47.63 15.99 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.151 0.887 . . . . 10.0 109.169 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 108.86 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 -174.977 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.91 154.38 41.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -175.368 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 70' ' ' ILE . 70.9 t -27.34 -55.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 126.662 1.985 . . . . 10.0 113.288 168.926 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HE3' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -49.74 -48.39 50.2 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 118.437 0.562 . . . . 10.0 110.002 179.713 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -57.19 -42.6 81.52 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.922 1.289 . . . . 10.0 108.46 -179.051 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.749 HG22 HG22 ' A' ' 24' ' ' VAL . 5.4 mm -67.31 -43.99 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 120.365 -0.534 . . . . 10.0 109.734 -178.345 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.28 84.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 -176.08 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -54.48 -41.66 69.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.528 1.131 . . . . 10.0 108.848 177.463 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.911 -0.493 . . . . 10.0 112.029 175.708 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.71 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -62.55 -43.69 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.773 1.169 . . . . 10.0 108.572 170.647 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.21 -34.76 68.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.668 1.576 . . . . 10.0 111.693 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.33 69.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.773 0.715 . . . . 10.0 112.447 172.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -133.18 65.44 1.59 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.959 1.704 . . . . 10.0 111.342 -176.045 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 117.93 4.13 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.424 1.011 . . . . 10.0 110.843 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.24 55.92 2.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.381 1.091 . . . . 10.0 111.47 -169.973 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.99 64.19 0.86 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.739 1.216 . . . . 10.0 108.406 -170.611 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 HD22 ' A' ' 6' ' ' LEU 0.266 0.4 OUTLIER -149.62 93.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 120.593 -1.317 . . . . 10.0 110.694 -178.225 . . . . . . . . 4 4 . 1 . 026 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.68 -73.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.654 169.821 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm 172.28 176.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.67 2.388 . . . . 10.0 108.894 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.758 HD12 ' HB3' ' A' ' 4' ' ' LYS . 8.0 mm . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 123.909 0.884 . . . . 10.0 109.803 172.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 119.312 -0.375 . . . . 10.0 110.017 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -69.13 102.74 1.72 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.124 0.969 . . . . 10.0 109.639 169.459 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -128.33 169.4 14.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 121.466 0.651 . . . . 10.0 110.387 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -110.4 115.26 29.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.631 HD11 ' HB ' ' A' ' 67' ' ' VAL . 17.1 tp -83.38 107.3 15.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.118 -1.808 . . . . 10.0 106.118 169.347 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -56.39 117.1 3.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.482 -1.673 . . . . 10.0 106.482 173.531 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.329 -0.295 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 176.927 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -63.11 -65.86 0.62 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.977 1.311 . . . . 10.0 109.494 -175.461 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 m -43.6 -47.02 7.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.082 1.753 . . . . 10.0 110.195 174.695 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 m -67.6 -45.12 76.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 119.029 0.831 . . . . 10.0 111.162 -173.999 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.865 HG22 HD11 ' A' ' 60' ' ' ILE . 98.6 t -65.22 -20.45 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 121.31 -0.869 . . . . 10.0 110.38 169.511 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.87 15.42 60.76 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.034 1.302 . . . . 10.0 112.677 -172.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.51 -44.69 11.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 178.392 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -60.39 126.0 25.81 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.193 -0.912 . . . . 10.0 112.352 -174.686 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.01 -35.81 36.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.24 1.416 . . . . 10.0 111.282 172.247 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.92 -9.14 75.13 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.526 -1.215 . . . . 10.0 113.738 179.155 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.24 158.93 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 120.115 1.957 . . . . 10.0 112.674 172.461 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.7 t -133.7 -45.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.832 1.253 . . . . 10.0 111.588 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.31 37.43 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.452 1.101 . . . . 10.0 108.473 177.104 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.53 55.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.841 0.856 . . . . 10.0 111.042 -173.812 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -85.91 68.89 10.48 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.702 -1.248 . . . . 10.0 109.257 -170.387 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.32 118.59 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 10.0 110.221 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -136.02 59.21 1.72 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.93 -28.47 51.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.003 -0.544 . . . . 10.0 111.284 -179.419 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -62.76 -36.35 82.79 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.951 0.9 . . . . 10.0 110.946 174.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -8.09 59.28 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.048 0.939 . . . . 10.0 111.236 174.167 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.33 30.27 57.09 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.441 1.02 . . . . 10.0 110.63 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -158.21 161.85 37.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.921 0.867 . . . . 10.0 110.581 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 44' ' ' VAL . 42.8 t -150.03 125.98 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.367 -3.197 . . . . 10.0 102.367 -172.47 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -105.48 93.44 4.67 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 120.056 1.298 . . . . 10.0 107.749 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 42' ' ' VAL . 2.2 m -105.15 107.56 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -178.634 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -97.84 114.91 27.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 172.918 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -144.8 153.53 41.73 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.379 0.609 . . . . 10.0 110.929 -177.463 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.19 77.12 6.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.822 -168.486 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.23 -37.35 0.63 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.168 1.787 . . . . 10.0 113.605 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.88 -55.42 26.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.436 1.095 . . . . 10.0 111.272 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -84.21 -42.52 15.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.501 0.72 . . . . 10.0 109.969 -173.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.7 99.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 143.82 57.17 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 121.47 -0.769 . . . . 10.0 109.15 -175.38 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 m -38.88 -45.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.973 1.309 . . . . 10.0 113.562 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -55.67 29.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.612 0.765 . . . . 10.0 110.692 172.379 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -47.95 -38.71 17.32 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.25 1.02 . . . . 10.0 111.044 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.9 mm -68.05 -53.15 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.326 -0.99 . . . . 10.0 108.326 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -50.02 -47.29 53.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.43 -38.44 87.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.153 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.73 82.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.645 -0.66 . . . . 10.0 111.004 176.923 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.865 HD11 HG22 ' A' ' 24' ' ' VAL . 4.0 mp -65.07 -42.71 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 117.766 -1.111 . . . . 10.0 108.965 169.537 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -61.15 -21.54 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.201 1.364 . . . . 10.0 113.032 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.44 -33.7 76.57 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 10.0 111.644 169.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 -61.78 1.33 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.987 1.715 . . . . 10.0 112.086 -170.781 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.22 -151.69 10.04 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 127.104 2.288 . . . . 10.0 109.082 176.947 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -159.19 66.54 0.41 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.067 1.434 . . . . 10.0 108.981 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -146.47 55.64 1.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 -168.309 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 6' ' ' LEU . 17.0 m -153.6 58.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.698 -0.626 . . . . 10.0 110.543 -172.874 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -26.33 -70.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.789 1.236 . . . . 10.0 112.544 176.998 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.92 173.0 0.61 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.438 1.095 . . . . 10.0 111.804 169.821 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 HD13 ' A' ' 6' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 122.972 0.509 . . . . 10.0 111.456 178.455 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 50.9 tt0 -91.26 123.86 35.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.746 1.218 . . . . 10.0 109.995 173.489 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.52 173.03 12.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.834 0.309 . . . . 10.0 111.834 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 42' ' ' VAL . 9.9 m -116.53 107.83 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.431 0.693 . . . . 10.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.648 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.6 mt -81.68 88.48 6.25 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 174.927 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.19 115.72 1.07 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.434 1.094 . . . . 10.0 109.553 -177.729 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 125.709 1.604 . . . . 10.0 112.258 178.224 . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.176 -0.675 . . . . 10.0 109.176 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.22 -63.85 1.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.137 1.375 . . . . 10.0 109.644 -173.717 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.5 m -50.87 -48.2 60.27 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.401 1.081 . . . . 10.0 109.526 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 t -58.19 -64.81 0.79 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 122.245 1.021 . . . . 10.0 109.867 -169.746 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 92.2 t -63.64 -36.91 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 -177.404 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.54 -15.61 18.42 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.066 -1.408 . . . . 10.0 115.496 171.497 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -23.7 37.98 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.511 2.156 . . . . 10.0 109.165 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.722 HD13 HD12 ' A' ' 56' ' ' ILE . 39.3 mt -67.68 121.79 16.67 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 122.926 0.491 . . . . 10.0 110.443 -173.006 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.01 -41.67 16.86 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 122.659 1.219 . . . . 10.0 111.544 170.015 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.27 -4.6 74.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 113.689 -1.596 . . . . 10.0 114.441 -179.018 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.79 159.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 120.69 2.245 . . . . 10.0 111.168 173.433 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -138.29 -45.06 0.5 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 10.0 110.713 -178.239 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.19 149.07 39.22 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 173.737 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.6 m -142.9 57.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.64 0.776 . . . . 10.0 111.134 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -81.55 74.49 8.55 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.504 -1.373 . . . . 10.0 109.568 -175.793 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.27 131.26 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 123.902 0.881 . . . . 10.0 111.158 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -155.19 66.85 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.171 0.986 . . . . 10.0 109.004 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -57.44 -23.53 50.22 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.858 176.539 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLU . . . . . 0.484 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.0 mm-40 -63.37 -41.91 98.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.716 1.606 . . . . 10.0 108.96 175.484 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.47 -26.7 46.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 173.726 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.18 5.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -153.9 175.01 13.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 173.792 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -151.61 125.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 101.578 -3.49 . . . . 10.0 101.578 169.113 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -99.78 97.47 8.39 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.549 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -112.43 106.98 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 114.075 -1.42 . . . . 10.0 107.594 -172.38 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -96.7 113.61 25.18 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 175.095 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 1.7 p90 -146.72 152.9 39.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 124.588 1.18 . . . . 10.0 111.965 -173.959 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.274 32.8 t0 -83.48 82.0 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.417 1.103 . . . . 10.0 113.303 -170.523 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.87 -25.25 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.452 -2.158 . . . . 10.0 114.005 169.659 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -63.28 -57.25 11.03 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.382 0.992 . . . . 10.0 109.581 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -87.14 -39.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.272 -0.268 . . . . 10.0 110.89 -172.002 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.6 m -124.65 100.44 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 177.538 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -63.97 156.97 26.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.889 0.852 . . . . 10.0 110.186 -177.946 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.1 t -33.69 -49.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 125.573 1.549 . . . . 10.0 111.739 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -52.14 -59.24 4.61 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 175.902 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -43.41 59.17 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.088 0.955 . . . . 10.0 109.565 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 27' ' ' LEU . 2.3 mm -63.59 -51.12 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.535 -0.913 . . . . 10.0 108.535 -177.794 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.13 87.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 -174.028 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.65 -37.63 68.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.852 0.861 . . . . 10.0 109.673 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 56' ' ' ILE . . . -56.23 -40.92 74.84 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.622 -0.674 . . . . 10.0 111.187 175.063 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 67' ' ' VAL . 2.9 mp -63.26 -38.9 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.029 -1.044 . . . . 10.0 108.269 175.114 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.89 -38.8 79.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.64 1.109 . . . . 10.0 110.727 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -56.31 22.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.467 0.576 . . . . 10.0 110.064 170.758 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -99.07 62.03 1.27 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.418 1.487 . . . . 10.0 111.136 -175.066 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.41 99.67 0.39 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.97 0.795 . . . . 10.0 113.26 169.868 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.01 103.19 1.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.306 1.042 . . . . 10.0 112.553 -171.959 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -149.54 66.09 1.0 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.32 1.048 . . . . 10.0 108.549 173.625 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.648 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.9 p -154.49 75.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 120.406 -1.433 . . . . 10.0 112.565 -172.706 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -31.19 -69.1 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.574 1.15 . . . . 10.0 112.751 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 166.25 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.095 1.758 . . . . 10.0 113.91 168.035 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 O-C-N 121.741 -0.599 . . . . 10.0 110.511 176.391 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -80.37 104.51 10.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.572 1.149 . . . . 10.0 109.272 169.434 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -139.26 177.04 8.2 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.591 0.632 . . . . 10.0 110.399 174.517 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -121.19 110.62 16.4 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.771 1.229 . . . . 10.0 108.112 -173.35 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.87 89.6 4.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 7' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -46.3 127.31 8.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -178.69 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' H ' ' NE2' ' A' ' 7' ' ' GLN . 2.1 p . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 128.189 2.595 . . . . 10.0 108.321 -175.476 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 110.446 -0.205 . . . . 10.0 110.446 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.02 -68.86 0.74 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.086 0.555 . . . . 10.0 111.018 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 m -55.25 -39.5 69.83 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.543 1.537 . . . . 10.0 111.262 -170.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -48.16 -68.74 0.16 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.486 1.914 . . . . 10.0 110.491 177.497 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 56' ' ' ILE . 97.4 t -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 124.319 1.048 . . . . 10.0 108.931 175.727 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.59 -18.98 5.86 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.299 1.428 . . . . 10.0 115.034 173.402 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.09 -21.24 29.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.867 1.834 . . . . 10.0 108.72 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.68 121.24 19.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.87 -0.519 . . . . 10.0 109.861 -173.519 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -47.12 -37.12 9.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.009 1.324 . . . . 10.0 112.416 173.847 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.67 81.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 114.519 -1.219 . . . . 10.0 114.35 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.32 163.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.86 1.83 . . . . 10.0 112.755 176.107 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -136.82 -49.17 0.63 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.677 1.191 . . . . 10.0 111.032 174.792 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.81 147.67 51.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.733 -0.839 . . . . 10.0 108.733 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.91 59.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.926 1.29 . . . . 10.0 110.655 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 79.81 5.79 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.329 -1.482 . . . . 10.0 108.54 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 135.03 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 174.15 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.05 58.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 172.374 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.61 -26.98 68.89 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.771 -0.581 . . . . 10.0 111.12 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.43 -30.41 71.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.353 0.661 . . . . 10.0 110.147 174.134 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.43 -19.57 24.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.018 0.527 . . . . 10.0 111.21 172.398 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.52 14.76 55.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.82 1.676 . . . . 10.0 111.542 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -144.38 97.83 3.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.025 0.93 . . . . 10.0 109.35 -169.633 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -88.97 109.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 N-CA-C 106.699 -1.593 . . . . 10.0 106.699 168.928 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.65 102.92 15.08 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -119.33 106.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 125.233 1.413 . . . . 10.0 108.384 -172.308 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.3 t -92.86 120.95 33.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.667 -1.605 . . . . 10.0 106.667 174.831 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -153.14 157.24 40.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.145 0.974 . . . . 10.0 113.355 -173.254 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.36 80.85 7.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.057 . . . . 10.0 112.497 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.15 -30.19 1.1 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.308 170.844 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.45 -53.55 27.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.084 0.553 . . . . 10.0 110.925 -177.085 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.17 -36.23 24.88 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.068 0.547 . . . . 10.0 109.868 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.58 101.63 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.762 1.225 . . . . 10.0 109.106 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 152.31 27.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.538 -0.726 . . . . 10.0 110.35 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.07 -39.84 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.884 0.874 . . . . 10.0 112.777 171.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -59.15 -53.97 52.25 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 118.581 -0.724 . . . . 10.0 109.935 174.59 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -47.52 -46.84 27.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.521 0.729 . . . . 10.0 109.898 175.595 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 24' ' ' VAL . 9.5 mm -62.72 -49.64 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 O-C-N 122.07 -0.394 . . . . 10.0 110.394 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.25 -46.52 88.27 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.088 -1.079 . . . . 10.0 108.088 -175.834 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -59.99 -38.32 82.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.4 0.68 . . . . 10.0 109.221 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.34 70.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.569 -0.707 . . . . 10.0 112.499 172.661 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.636 HD13 HG21 ' A' ' 67' ' ' VAL . 2.3 mp -66.91 -45.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 168.391 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.21 -24.79 66.6 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.799 0.727 . . . . 10.0 112.864 -176.858 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.54 -36.07 77.54 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.677 -0.64 . . . . 10.0 111.301 171.344 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.55 -55.06 2.85 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.93 1.692 . . . . 10.0 112.164 -169.543 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.54 -152.2 8.01 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.029 1.776 . . . . 10.0 108.874 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -151.27 59.32 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.925 1.363 . . . . 10.0 107.475 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.02 63.39 1.63 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.155 -1.424 . . . . 10.0 107.155 -167.967 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.636 HG21 HD13 ' A' ' 60' ' ' ILE . 3.8 p -155.92 70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.871 0.367 . . . . 10.0 111.642 -176.977 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -27.65 -71.37 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.319 1.047 . . . . 10.0 113.541 170.843 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt 165.8 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.28 2.232 . . . . 10.0 112.436 169.303 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 O-C-N 120.721 -1.237 . . . . 10.0 111.844 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.49 -0.559 . . . . 10.0 109.49 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 30.0 tt0 -93.54 115.12 27.61 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.849 1.66 . . . . 10.0 109.453 170.558 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -135.55 176.96 8.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.993 0.815 . . . . 10.0 112.02 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -123.14 114.17 19.95 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 174.881 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.711 HD13 HG23 ' A' ' 67' ' ' VAL . 4.5 pp -80.15 125.92 30.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.298 -1.741 . . . . 10.0 106.298 166.654 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 130.27 40.78 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.442 -0.874 0 C-N-CA 128.133 2.573 . . . . 10.0 110.22 -174.949 . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 119.805 -0.141 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -79.37 -71.42 0.45 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.128 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -49.82 -39.4 38.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.269 1.827 . . . . 10.0 112.365 -167.842 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m -49.82 -55.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.259 1.028 . . . . 10.0 110.24 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 24' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 56' ' ' ILE . 72.6 t -72.43 -41.82 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 124.136 0.975 . . . . 10.0 108.79 -179.78 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.36 -9.27 3.13 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.892 1.234 . . . . 10.0 114.603 173.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.86 -27.51 40.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 119.65 1.725 . . . . 10.0 108.622 177.334 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD1' HG23 ' A' ' 56' ' ' ILE . 75.5 mt -69.76 118.99 13.31 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.344 -173.097 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -45.38 -41.19 8.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.472 1.13 . . . . 10.0 111.925 170.105 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -3.38 81.13 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 114.04 -1.436 . . . . 10.0 114.674 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.09 163.38 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.411 2.105 . . . . 10.0 112.02 174.36 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -136.61 -43.62 0.6 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.841 1.257 . . . . 10.0 111.612 179.135 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.49 37.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.438 1.095 . . . . 10.0 108.233 176.11 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 57.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.14 1.376 . . . . 10.0 110.774 -173.632 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -81.52 88.87 6.16 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.768 -1.208 . . . . 10.0 109.847 -170.896 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -71.63 110.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.687 0.795 . . . . 10.0 111.231 179.46 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -142.07 57.55 1.47 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 175.043 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.1 -22.51 62.85 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.505 -0.747 . . . . 10.0 112.068 -177.956 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -61.97 -32.83 73.31 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.631 0.772 . . . . 10.0 110.876 172.39 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.93 -6.07 56.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.686 0.794 . . . . 10.0 111.554 173.837 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 15.44 81.56 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.825 1.679 . . . . 10.0 110.794 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -148.82 135.81 19.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.363 1.065 . . . . 10.0 108.296 -167.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -116.63 131.28 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 102.96 -2.978 . . . . 10.0 102.96 175.547 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.61 96.37 6.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.33 1.423 . . . . 10.0 108.326 177.527 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -111.5 110.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.341 1.456 . . . . 10.0 109.541 -174.289 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 26.8 t -98.22 123.82 42.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 10.0 106.173 169.743 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' PHE . . . . . 0.638 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -154.59 154.26 32.75 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.605 0.717 . . . . 10.0 112.55 -174.626 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.52 83.04 4.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.339 -0.846 . . . . 10.0 113.223 -170.153 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.14 -32.61 0.49 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.031 -1.441 . . . . 10.0 113.411 168.904 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.1 -40.15 68.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.854 0.752 . . . . 10.0 110.113 -172.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -91.48 -42.42 10.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.634 0.652 . . . . 10.0 111.145 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.39 109.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 146.81 50.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.477 -0.765 . . . . 10.0 109.569 -175.177 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 56' ' ' ILE . 2.4 m -38.51 -40.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.306 1.042 . . . . 10.0 113.615 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -62.63 -48.87 77.49 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.648 -0.691 . . . . 10.0 111.198 174.084 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -48.32 -45.11 34.77 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.819 0.736 . . . . 10.0 109.279 175.429 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 24' ' ' VAL . 1.1 mm -66.26 -43.73 91.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 122.071 -0.393 . . . . 10.0 111.015 178.779 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.84 68.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.42 -34.52 72.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.287 0.635 . . . . 10.0 109.867 -178.432 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.58 -31.69 66.42 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.947 -1.096 . . . . 10.0 113.188 173.377 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 120.477 1.49 . . . . 10.0 108.152 169.837 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.41 -29.72 67.95 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.646 1.112 . . . . 10.0 111.635 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -59.55 -29.49 67.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.697 0.399 . . . . 10.0 111.647 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -111.02 -64.37 1.29 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.518 1.127 . . . . 10.0 111.228 -177.355 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.98 -156.46 24.05 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.557 1.551 . . . . 10.0 109.261 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -152.35 56.13 0.82 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.592 1.196 . . . . 10.0 108.174 173.676 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.04 57.84 1.77 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -168.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.711 HG23 HD13 ' A' ' 6' ' ' LEU . 13.2 p -146.86 79.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 122.172 0.987 . . . . 10.0 109.815 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.75 -61.83 1.97 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.63 -1.176 . . . . 10.0 111.727 170.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt 154.53 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.843 2.057 . . . . 10.0 115.122 170.66 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mm . . . . . 0 N--CA 1.446 -0.628 0 C-N-CA 125.986 1.714 . . . . 10.0 110.988 -177.63 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tmt? . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.137 -1.431 . . . . 10.0 107.137 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.21 114.13 13.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.071 0.149 . . . . 10.0 111.022 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.59 91.21 4.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.405 1.882 . . . . 10.0 111.016 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB3' HD12 ' A' ' 70' ' ' ILE . 20.2 mttp -117.78 175.37 5.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.488 0.661 . . . . 10.0 112.024 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -118.76 102.33 8.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.362 1.065 . . . . 10.0 110.516 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.54 74.57 3.26 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -34.38 110.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.749 1.619 . . . . 10.0 111.24 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 42' ' ' VAL . 90.9 t -96.29 137.27 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.712 1.605 . . . . 10.0 110.221 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.302 -1.37 . . . . 10.0 107.302 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.71 0.97 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.13 -0.817 . . . . 10.0 111.523 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.62 94.55 3.78 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.526 1.163 . . . . 10.0 111.376 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -175.71 -132.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 105.469 -2.048 . . . . 10.0 105.469 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 t -143.27 -51.5 0.35 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.996 0.816 . . . . 10.0 112.25 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -158.8 -46.86 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.657 0.741 . . . . 10.0 110.489 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -75.09 82.69 2.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 -47.04 0.17 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.537 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -42.48 -53.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.812 . . . . 10.0 110.192 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.98 75.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.91 0.484 . . . . 10.0 112.244 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.4 65.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.944 1.247 . . . . 10.0 110.341 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.86 -26.44 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.371 1.469 . . . . 10.0 111.162 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -79.79 -69.67 0.57 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 m -43.52 -44.55 6.1 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 126.668 1.987 . . . . 10.0 111.44 -173.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -49.23 -55.33 12.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.037 0.922 . . . . 10.0 111.186 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 56' ' ' ILE . 72.7 t -70.4 -41.87 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.83 -14.06 5.02 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.389 1.471 . . . . 10.0 114.911 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -81.77 -23.95 36.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.712 1.756 . . . . 10.0 108.442 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 56' ' ' ILE . 65.6 mt -71.05 120.09 16.12 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 122.013 -0.429 . . . . 10.0 110.728 -174.042 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.1 -34.67 14.42 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 10.0 112.168 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.45 -0.84 90.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.121 1.343 . . . . 10.0 114.627 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.66 160.29 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 120.327 2.063 . . . . 10.0 111.682 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -131.0 -42.56 1.1 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.214 1.006 . . . . 10.0 112.377 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.41 147.25 35.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.826 0.85 . . . . 10.0 108.966 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.3 59.12 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.784 1.234 . . . . 10.0 111.128 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 71.47 5.55 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.675 -1.266 . . . . 10.0 109.856 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.24 123.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.936 0.895 . . . . 10.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -150.01 58.69 0.98 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.7 pp -56.54 -29.53 62.04 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.572 -0.705 . . . . 10.0 111.004 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.0 mt-10 -60.08 -35.67 75.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.313 1.045 . . . . 10.0 110.698 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.02 59.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.939 0.896 . . . . 10.0 111.393 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.83 55.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.092 0.853 . . . . 10.0 111.535 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -154.53 154.31 32.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.501 1.151 . . . . 10.0 110.154 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -142.42 102.66 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.73 93.35 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.555 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -105.89 114.03 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.187 1.395 . . . . 10.0 108.609 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -102.27 120.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.42 160.47 43.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 123.981 0.801 . . . . 10.0 111.804 -175.375 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -90.96 80.32 5.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.002 0.906 . . . . 10.0 112.659 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -36.95 -39.13 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.813 2.045 . . . . 10.0 113.684 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.62 -57.19 9.85 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.608 1.163 . . . . 10.0 111.76 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -41.74 15.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 -171.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.5 110.97 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -69.66 155.46 40.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.495 0.664 . . . . 10.0 109.746 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -37.91 -40.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.076 1.35 . . . . 10.0 113.095 171.74 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -57.62 -58.33 8.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -47.44 -46.17 26.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.767 0.827 . . . . 10.0 110.096 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -63.94 -45.35 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 O-C-N 121.691 -0.631 . . . . 10.0 111.019 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.23 91.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.674 0.749 . . . . 10.0 108.987 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -60.44 -36.44 78.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.86 -0.793 . . . . 10.0 108.86 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.61 70.13 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.468 -0.77 . . . . 10.0 112.398 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.4 mp -64.59 -48.44 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.288 -1.375 . . . . 10.0 107.288 168.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.52 -26.95 67.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.043 0.838 . . . . 10.0 112.464 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -26.56 59.69 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.303 0.483 . . . . 10.0 112.303 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -120.13 -63.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.766 1.226 . . . . 10.0 111.183 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.51 -153.72 25.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.185 -1.566 . . . . 10.0 109.185 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -162.79 52.98 0.19 Allowed 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.476 -1.305 . . . . 10.0 107.476 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.91 62.19 1.66 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.165 -1.791 . . . . 10.0 106.165 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.74 88.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.56 1.172 . . . . 10.0 108.663 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.74 -70.44 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.43 -1.259 . . . . 10.0 109.397 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 163.07 -174.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.344 1.858 . . . . 10.0 113.53 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 53' ' ' VAL . 18.2 mm -68.29 106.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 123.674 0.79 . . . . 10.0 109.784 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -90.1 99.89 12.82 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.25 158.72 33.84 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.748 0.69 . . . . 10.0 112.171 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 mtm105 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 117.941 -1.028 . . . . 10.0 111.368 -179.204 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 ttp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -104.97 112.77 26.02 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -170.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.9 pm0 -72.64 100.45 2.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.608 1.563 . . . . 10.0 109.686 169.584 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -128.82 178.93 6.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.562 0.345 . . . . 10.0 110.179 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -118.17 114.22 22.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.064 0.546 . . . . 10.0 110.505 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.2 mt -79.54 92.76 5.33 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 106.689 -1.597 . . . . 10.0 106.689 174.291 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 119.89 5.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -94.65 128.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.818 2.047 . . . . 10.0 110.837 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.46 104.34 16.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.292 -2.484 . . . . 10.0 104.292 166.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.76 102.82 0.87 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.192 -0.763 . . . . 10.0 111.192 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -115.81 -173.19 2.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.425 1.09 . . . . 10.0 110.552 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t 65.64 -170.22 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.126 1.37 . . . . 10.0 111.692 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.5 t -96.14 -49.15 5.36 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.325 1.45 . . . . 10.0 109.96 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.46 178.1 10.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 56.22 34.47 24.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.116 1.366 . . . . 10.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.07 -51.39 2.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.195 0.598 . . . . 10.0 110.196 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.88 -50.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.062 0.945 . . . . 10.0 110.665 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -23.17 61.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.47 -56.13 12.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 10.0 108.33 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t -48.79 -41.45 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.342 0.657 . . . . 10.0 109.791 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -70.39 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.718 1.207 . . . . 10.0 108.764 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -48.11 -44.46 31.9 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.692 1.197 . . . . 10.0 110.941 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -59.8 -58.95 6.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.586 0.708 . . . . 10.0 110.57 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 56' ' ' ILE . 76.8 t -61.16 -41.41 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -13.81 7.77 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.171 -1.349 . . . . 10.0 115.289 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.8 -21.39 34.54 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.289 2.045 . . . . 10.0 108.87 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.748 HD13 HD12 ' A' ' 56' ' ' ILE . 61.7 mt -66.23 121.81 16.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.455 0.645 . . . . 10.0 111.834 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -45.17 -39.61 6.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.266 1.427 . . . . 10.0 111.776 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.58 7.62 81.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.249 1.404 . . . . 10.0 114.69 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.81 160.59 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 120.599 2.199 . . . . 10.0 111.202 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 t -133.24 -44.57 0.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.63 1.172 . . . . 10.0 111.095 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.9 148.34 35.28 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.786 0.834 . . . . 10.0 108.768 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.3 m -141.11 58.31 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.157 0.983 . . . . 10.0 111.292 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.02 67.36 7.99 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.787 -1.196 . . . . 10.0 111.508 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.29 134.9 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.85 1.26 . . . . 10.0 111.576 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.55 55.86 0.69 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -63.41 -23.53 67.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.792 -1.193 . . . . 10.0 111.755 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.32 -32.37 72.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.672 0.789 . . . . 10.0 110.45 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.87 -23.98 44.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.1 29.59 9.55 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.876 1.227 . . . . 10.0 110.275 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -146.34 169.4 18.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.424 1.107 . . . . 10.0 109.964 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -155.23 118.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.856 -3.016 . . . . 10.0 102.856 169.045 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.88 99.27 10.84 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -111.87 112.38 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 125.818 1.647 . . . . 10.0 108.803 -171.403 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.1 t -94.81 114.96 26.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.693 -1.225 . . . . 10.0 107.693 170.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.3 p90 -144.7 154.79 43.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.01 79.31 8.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.242 1.02 . . . . 10.0 111.354 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -35.98 -44.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 112.941 -1.936 . . . . 10.0 112.284 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -44.84 -54.14 6.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.213 1.405 . . . . 10.0 112.299 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.22 -40.42 14.56 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.97 -0.381 . . . . 10.0 109.97 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -134.69 104.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.4 150.05 48.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.591 -0.693 . . . . 10.0 110.248 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 70' ' ' ILE . 3.6 t -33.85 -51.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 125.569 1.548 . . . . 10.0 113.485 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -49.04 -59.98 3.17 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.53 -42.62 33.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.411 1.485 . . . . 10.0 110.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.748 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -65.81 -45.38 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.514 -0.742 . . . . 10.0 110.459 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.78 96.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.23 -39.25 75.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.07 69.96 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.2 mp -64.5 -46.83 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -59.27 -30.19 68.12 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.716 0.689 . . . . 10.0 111.675 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.86 -24.5 67.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.568 -0.707 . . . . 10.0 112.211 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -112.87 -66.84 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.092 1.757 . . . . 10.0 111.362 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 -148.55 9.99 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.096 1.807 . . . . 10.0 108.754 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -161.98 55.16 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.989 1.394 . . . . 10.0 108.266 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.51 61.91 1.67 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 -168.519 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.4 p -149.69 85.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.779 0.799 . . . . 10.0 109.518 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.59 -66.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.382 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt 168.74 172.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.962 2.505 . . . . 10.0 110.266 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.706 HG21 HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -67.91 133.46 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.598 -0.689 . . . . 10.0 111.645 173.61 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.19 117.43 6.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.38 73.53 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.251 -0.74 . . . . 10.0 111.251 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.234 0 CA-C-O 117.761 -1.114 . . . . 10.0 111.006 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.423 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 62.0 mtt . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.156 0.503 . . . . 10.0 111.714 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.66 107.75 11.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.332 -2.47 . . . . 10.0 104.332 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -71.0 107.07 3.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.543 ' CB ' HD11 ' A' ' 70' ' ' ILE . 70.1 mttt -131.25 176.2 8.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.732 0.777 . . . . 10.0 111.471 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -112.06 102.5 10.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.585 1.554 . . . . 10.0 110.54 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB2' HG21 ' A' ' 44' ' ' VAL . 3.3 tt -82.09 94.67 7.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.07 1.348 . . . . 10.0 107.856 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -60.43 119.39 7.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.591 -0.892 . . . . 10.0 108.591 -175.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 17' ' ' VAL . 4.5 t -94.31 117.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.799 2.04 . . . . 10.0 109.178 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.69 90.2 5.78 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.41 111.97 2.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.581 -0.566 . . . . 10.0 112.529 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.47 -152.36 0.41 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.314 1.046 . . . . 10.0 110.081 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -71.4 71.64 0.66 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.327 1.451 . . . . 10.0 111.537 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.2 t -135.74 -48.25 0.68 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.92 1.688 . . . . 10.0 109.929 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.14 -155.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.316 1.046 . . . . 10.0 110.974 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.2 m80 49.09 43.67 22.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.247 0.931 . . . . 10.0 112.53 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.03 38.83 10.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.318 1.047 . . . . 10.0 110.756 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG22 ' HB ' ' A' ' 20' ' ' VAL 0.255 9.8 p 51.89 18.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.237 2.215 . . . . 10.0 113.48 -175.589 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -65.74 -30.62 71.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 120.73 -1.231 . . . . 10.0 110.974 -171.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.7 -36.36 11.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.922 -1.111 . . . . 10.0 112.447 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.722 HG21 ' HB2' ' A' ' 66' ' ' ASP . 1.5 t -84.09 -20.65 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.245 1.418 . . . . 10.0 111.437 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -50.41 12.82 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 m -54.93 -36.86 65.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.728 1.211 . . . . 10.0 111.76 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -56.7 -49.91 73.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.232 0.924 . . . . 10.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.659 ' CG2' HD11 ' A' ' 60' ' ' ILE . 72.1 t -68.04 -43.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.5 8.57 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.014 1.292 . . . . 10.0 115.167 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.56 -21.49 28.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.343 1.572 . . . . 10.0 109.094 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD13 HD12 ' A' ' 56' ' ' ILE . 45.2 mt -67.05 125.32 25.64 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 122.024 -0.422 . . . . 10.0 110.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -48.18 -38.15 17.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.303 1.049 . . . . 10.0 111.783 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.92 -1.43 87.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.018 1.294 . . . . 10.0 114.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 166.09 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.753 2.276 . . . . 10.0 112.273 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 t -141.0 -45.43 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.923 1.289 . . . . 10.0 111.385 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.4 147.59 34.86 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.507 1.123 . . . . 10.0 108.483 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -144.48 58.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.618 1.167 . . . . 10.0 112.193 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 87.11 5.49 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.123 -1.611 . . . . 10.0 109.874 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.52 115.28 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 10.0 111.259 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.58 62.95 1.44 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -57.24 -21.24 32.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.614 -0.679 . . . . 10.0 111.839 172.174 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.4 tt0 -64.68 -37.99 89.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.009 0.924 . . . . 10.0 109.001 176.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.03 -24.7 43.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 23.45 43.23 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.151 -1.579 . . . . 10.0 109.151 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -155.7 116.15 3.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 44' ' ' VAL . 2.7 m -86.42 146.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.301 -2.111 . . . . 10.0 105.301 167.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.27 96.31 6.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.938 -1.505 . . . . 10.0 106.938 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.6 m -119.76 106.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 122.316 1.055 . . . . 10.0 108.849 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 t -99.62 121.22 40.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.275 -1.379 . . . . 10.0 107.275 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.5 p90 -148.87 172.06 15.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.033 0.933 . . . . 10.0 111.013 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 1' ' ' MET . 7.4 t70 -102.41 83.32 2.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.547 1.165 . . . . 10.0 113.301 -171.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.2 -31.73 9.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.011 -1.904 . . . . 10.0 112.607 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -51.36 -60.7 2.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.269 1.028 . . . . 10.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -82.55 -46.57 13.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.368 -0.604 . . . . 10.0 109.368 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.17 94.18 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -60.81 153.36 24.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.116 0.484 . . . . 10.0 110.395 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 70' ' ' ILE . 3.7 t -42.56 -42.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 121.353 -0.842 . . . . 10.0 112.749 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -50.57 -61.83 1.95 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -47.15 -39.61 14.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.111 0.964 . . . . 10.0 111.063 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -70.28 -48.53 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.82 89.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.951 0.9 . . . . 10.0 109.826 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.05 -26.48 67.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.786 -0.571 . . . . 10.0 112.077 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.659 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.0 mp -67.59 -49.08 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.886 -1.524 . . . . 10.0 106.886 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -36.14 62.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.05 0.54 . . . . 10.0 110.778 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -51.56 -37.77 51.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.071 0.549 . . . . 10.0 112.327 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.45 -62.11 1.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.91 1.284 . . . . 10.0 111.785 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.95 -152.36 9.16 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.692 1.615 . . . . 10.0 109.631 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.15 51.43 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 10.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' VAL . 1.5 m-20 -120.46 68.39 0.85 Allowed 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 107.234 -1.395 . . . . 10.0 107.234 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 6' ' ' LEU . 2.5 t -139.22 100.34 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.168 0.987 . . . . 10.0 108.873 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -66.8 -34.35 77.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 10.0 109.677 168.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 tttm 117.87 169.79 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 129.186 2.995 . . . . 10.0 110.501 171.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -66.19 128.53 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.347 -0.846 . . . . 10.0 109.254 175.303 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -136.18 144.37 44.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.264 0.978 . . . . 10.0 109.819 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.95 -100.79 0.11 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 . . . . . 0 C--O 1.252 1.222 0 N-CA-C 103.384 -2.821 . . . . 10.0 103.384 173.168 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 21.4 ttt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.079 -0.486 . . . . 10.0 112.031 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -126.65 125.83 42.54 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.109 0.963 . . . . 10.0 112.417 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.4 pm0 -83.34 99.72 10.21 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.346 2.258 . . . . 10.0 110.053 169.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' CB ' HD11 ' A' ' 70' ' ' ILE . 79.2 mttt -136.96 177.26 8.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.217 0.462 . . . . 10.0 111.504 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.4 m -114.05 110.37 19.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.035 1.334 . . . . 10.0 109.302 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 67' ' ' VAL . 2.1 mt -83.44 93.12 7.72 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -47.57 118.37 2.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.015 0.926 . . . . 10.0 109.443 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 20' ' ' VAL . 37.7 t -93.6 133.59 34.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 124.62 1.168 . . . . 10.0 111.523 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.07 96.23 7.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.352 -1.722 . . . . 10.0 106.352 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.44 100.15 0.25 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.337 -0.705 . . . . 10.0 111.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -77.68 167.47 21.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.332 1.053 . . . . 10.0 109.642 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -68.1 74.38 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.332 1.053 . . . . 10.0 110.25 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.75 114.7 3.8 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -59.08 -42.69 91.03 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.547 -0.721 . . . . 10.0 111.072 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -82.64 46.41 1.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.765 -0.584 . . . . 10.0 110.862 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.88 -35.87 23.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.302 1.041 . . . . 10.0 110.566 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.06 60.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.877 1.322 . . . . 10.0 109.848 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.85 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.189 2.596 . . . . 10.0 110.055 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.23 -52.03 54.79 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.165 0.893 . . . . 10.0 110.961 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 8' ' ' VAL . 11.3 t -62.8 -41.76 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.981 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.71 -68.41 0.41 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.749 1.619 . . . . 10.0 109.114 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 m -48.51 -43.78 35.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.943 1.697 . . . . 10.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -56.94 -60.89 2.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 10.0 110.147 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 56' ' ' ILE . 86.7 t -60.48 -40.23 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.65 -17.66 28.09 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.641 1.591 . . . . 10.0 114.789 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.03 -21.73 36.82 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.645 1.723 . . . . 10.0 108.416 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD13 HD12 ' A' ' 56' ' ' ILE . 57.1 mt -66.97 122.1 16.98 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.108 0.48 . . . . 10.0 111.373 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.5 -37.54 5.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.985 1.314 . . . . 10.0 112.107 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.07 90.44 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.086 1.327 . . . . 10.0 114.692 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.21 163.49 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 120.555 2.178 . . . . 10.0 111.909 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 t -133.82 -47.34 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.336 1.455 . . . . 10.0 110.633 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.03 148.46 35.25 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.5 m -141.54 59.1 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.32 1.048 . . . . 10.0 110.991 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.54 69.47 8.2 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.079 -1.013 . . . . 10.0 110.408 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.12 124.81 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.009 0.924 . . . . 10.0 110.939 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.8 58.03 1.23 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.32 -1.363 . . . . 10.0 107.32 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -57.76 -26.71 62.25 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.562 -0.711 . . . . 10.0 111.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.16 -38.65 73.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.165 1.386 . . . . 10.0 110.746 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.49 2.77 46.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.769 1.228 . . . . 10.0 111.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.24 98.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.8 -1.32 . . . . 10.0 109.8 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 157.91 35.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.821 0.81 . . . . 10.0 109.21 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -157.21 102.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.1 97.82 10.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -111.01 110.61 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.372 1.069 . . . . 10.0 109.042 -173.838 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -95.02 117.12 29.62 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.4 p90 -148.96 154.06 38.84 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.256 1.027 . . . . 10.0 113.712 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -82.55 81.0 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.879 -1.055 . . . . 10.0 112.411 -170.422 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.31 -44.73 0.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.002 1.321 . . . . 10.0 111.519 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -55.11 -52.12 64.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.762 2.025 . . . . 10.0 111.369 -174.374 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.79 -41.78 25.81 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.731 0.696 . . . . 10.0 109.937 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.91 107.7 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.141 0.976 . . . . 10.0 108.63 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.48 152.01 39.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.788 -0.57 . . . . 10.0 110.354 -171.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 70' ' ' ILE . 4.7 t -39.72 -45.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.489 1.116 . . . . 10.0 112.553 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -52.23 -58.15 7.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.393 -0.337 . . . . 10.0 110.386 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.98 -41.09 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.568 0.747 . . . . 10.0 109.625 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 27' ' ' LEU . 2.2 mm -64.3 -53.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.79 79.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.18 -1.045 . . . . 10.0 108.18 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.67 -32.58 73.67 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.751 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.31 74.41 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.899 -1.126 . . . . 10.0 112.605 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.0 mp -60.57 -36.19 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.275 -1.516 . . . . 10.0 108.412 171.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.62 -49.31 68.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.994 0.815 . . . . 10.0 109.896 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -51.3 -49.5 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.089 0.471 . . . . 10.0 111.819 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.47 -19.9 27.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 -171.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.79 99.79 0.22 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.534 -1.426 . . . . 10.0 109.534 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -67.89 54.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.109 2.263 . . . . 10.0 117.109 -167.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.81 74.41 2.67 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 120.145 -1.597 . . . . 10.0 108.027 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.654 ' CG2' HD22 ' A' ' 6' ' ' LEU . 8.3 p -151.54 110.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.366 -0.834 . . . . 10.0 108.913 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.45 -73.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.942 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 175.8 174.91 0.28 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.467 1.907 . . . . 10.0 110.643 169.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.547 HG21 HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -68.48 130.64 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.778 -0.576 . . . . 10.0 111.041 174.685 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -84.04 -84.52 0.14 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.349 -1.352 . . . . 10.0 107.349 169.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.11 75.9 0.04 OUTLIER Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.687 -1.765 . . . . 10.0 108.687 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.986 1.715 . . . . 10.0 112.258 -171.207 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 24.5 ttm . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.324 -0.846 . . . . 10.0 110.379 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -155.66 144.75 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.318 0.963 . . . . 10.0 111.861 170.148 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 3.3 pm0 -88.63 106.53 18.38 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 125.449 1.5 . . . . 10.0 110.608 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' CB ' HD12 ' A' ' 70' ' ' ILE . 58.4 mttt -136.39 176.29 8.83 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.1 0.864 . . . . 10.0 112.475 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 42' ' ' VAL . 21.5 m -116.0 108.34 16.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.879 0.872 . . . . 10.0 109.189 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.87 79.8 3.45 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.43 122.12 0.89 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.013 1.325 . . . . 10.0 109.003 172.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.62 140.16 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 127.773 2.429 . . . . 10.0 107.74 -170.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -102.61 112.06 24.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.89 107.58 1.73 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.398 -0.668 . . . . 10.0 111.893 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.45 -69.32 0.76 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.859 0.83 . . . . 10.0 110.196 173.367 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.2 t -83.92 156.04 22.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.382 0.61 . . . . 10.0 111.714 -170.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.1 t -76.15 -41.92 48.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.797 1.239 . . . . 10.0 112.045 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -146.4 170.26 17.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.801 0.841 . . . . 10.0 109.148 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.3 t60 59.0 20.1 7.88 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.622 1.569 . . . . 10.0 112.321 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.6 p -104.88 -36.36 7.39 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.83 1.652 . . . . 10.0 111.072 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -69.09 62.17 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.127 1.771 . . . . 10.0 110.029 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.09 -40.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.143 2.177 . . . . 10.0 109.165 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.28 -48.15 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.029 -1.045 . . . . 10.0 110.153 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 t -67.58 -13.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.715 1.206 . . . . 10.0 110.999 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -91.01 -69.82 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.36 1.064 . . . . 10.0 109.274 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.3 m -36.45 -53.36 0.86 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.181 2.192 . . . . 10.0 111.495 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -51.2 -55.61 17.13 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.301 1.441 . . . . 10.0 110.959 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.565 ' CG2' HD11 ' A' ' 60' ' ' ILE . 60.1 t -72.0 -19.8 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.559 1.144 . . . . 10.0 110.326 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.47 73.11 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.777 1.18 . . . . 10.0 112.169 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -89.13 -40.24 13.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.023 1.411 . . . . 10.0 108.136 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -59.69 123.78 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.471 0.545 . . . . 10.0 112.471 -177.191 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -51.74 -34.86 41.0 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.896 1.278 . . . . 10.0 111.779 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.5 0.64 87.63 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.328 1.442 . . . . 10.0 114.234 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.37 156.26 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 119.849 -1.971 . . . . 10.0 111.54 169.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 t -128.59 -44.3 1.37 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 10.0 110.902 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.06 149.1 33.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.792 -1.099 . . . . 10.0 108.457 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 44' ' ' VAL . 30.8 m -143.4 58.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.859 0.864 . . . . 10.0 112.062 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.73 74.06 7.68 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.306 -1.496 . . . . 10.0 111.432 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.23 121.81 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.584 1.153 . . . . 10.0 111.578 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.29 56.61 1.0 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.882 -1.155 . . . . 10.0 107.882 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.4 pp -59.65 -21.88 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.631 -0.668 . . . . 10.0 111.338 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' N ' HD12 ' A' ' 37' ' ' LEU . 2.5 tm-20 -63.98 -39.69 94.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.358 1.463 . . . . 10.0 108.865 175.202 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.41 -27.17 41.77 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.79 0.436 . . . . 10.0 110.42 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.32 22.8 9.47 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.128 1.347 . . . . 10.0 111.081 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -147.16 168.52 21.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.634 1.174 . . . . 10.0 108.123 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 HG13 ' A' ' 44' ' ' VAL . 1.1 p -157.18 102.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.011 -2.218 . . . . 10.0 105.011 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.23 95.76 6.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.642 HG13 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -112.86 108.75 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 122.5 1.143 . . . . 10.0 109.133 -174.815 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 25.4 t -103.18 120.92 41.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -152.36 155.63 37.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.412 1.264 . . . . 10.0 114.412 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.13 84.0 5.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.944 -1.025 . . . . 10.0 111.735 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.46 1.53 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.022 1.329 . . . . 10.0 110.142 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -44.75 -44.75 9.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.505 2.722 . . . . 10.0 112.595 176.45 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -46.76 10.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.041 0.382 . . . . 10.0 110.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.21 115.37 18.12 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.079 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.04 144.67 50.32 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 -170.074 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG13 ' CG1' ' A' ' 70' ' ' ILE . 17.1 t -25.53 -55.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.16 2.184 . . . . 10.0 113.661 168.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -47.95 -62.47 1.45 Allowed 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 173.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.6 -39.08 72.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.515 1.526 . . . . 10.0 110.27 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.452 HG21 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mm -61.45 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 119.152 0.887 . . . . 10.0 108.802 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.46 85.75 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -58.46 -34.09 70.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 122.926 0.49 . . . . 10.0 109.978 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -33.13 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.565 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.6 mp -64.47 -49.77 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -31.71 64.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.248 0.477 . . . . 10.0 111.245 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.12 -23.14 66.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.226 0.61 . . . . 10.0 112.099 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -113.39 -63.64 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.452 1.501 . . . . 10.0 111.306 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.16 -146.09 9.56 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.219 1.866 . . . . 10.0 109.344 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -164.8 51.22 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.023 1.411 . . . . 10.0 109.554 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.98 66.11 1.36 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.424 -1.695 . . . . 10.0 106.424 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -147.35 99.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.8 -66.51 0.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.64 -0.695 . . . . 10.0 109.663 168.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt 165.86 179.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.31 1.444 . . . . 10.0 113.507 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.49 ' CG1' HG13 ' A' ' 53' ' ' VAL . 6.3 mm -66.11 114.57 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.99 -43.46 73.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.149 1.379 . . . . 10.0 109.311 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.23 -116.11 1.67 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 104.893 -3.283 . . . . 10.0 104.893 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 116.022 -1.942 . . . . 10.0 111.038 -174.163 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.401 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.56 119.99 29.63 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.374 0.669 . . . . 10.0 110.46 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -78.3 103.88 8.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.095 0.958 . . . . 10.0 109.383 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.618 ' HB3' HD12 ' A' ' 70' ' ' ILE . 31.8 mttm -127.03 176.57 7.25 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -118.14 119.4 34.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.995 -0.742 . . . . 10.0 108.995 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 13.1 mt -77.55 107.67 10.18 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -54.66 116.75 2.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.342 -1.725 . . . . 10.0 106.342 168.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.28 130.93 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.967 2.107 . . . . 10.0 106.867 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.257 1.4 pm0 -86.93 -46.32 9.99 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 122.38 1.086 . . . . 10.0 113.386 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.99 118.2 1.37 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.102 2.287 . . . . 10.0 112.508 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.1 ttt -120.5 170.25 9.57 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.431 1.493 . . . . 10.0 111.217 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p 61.78 -137.8 0.5 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.028 1.731 . . . . 10.0 111.819 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.2 m -153.56 128.1 9.31 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 125.245 1.418 . . . . 10.0 107.475 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 54.17 29.61 10.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.459 1.103 . . . . 10.0 112.021 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.71 177.64 7.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.381 1.872 . . . . 10.0 106.09 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.5 m 74.63 -50.05 0.67 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.909 1.284 . . . . 10.0 111.83 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -35.32 -51.42 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 C-N-CA 126.607 1.963 . . . . 10.0 110.142 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -42.42 8.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.78 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.502 1.501 . . . . 10.0 111.615 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -61.21 -25.38 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.501 1.12 . . . . 10.0 110.99 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -58.46 3.21 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -46.65 -50.54 17.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.829 1.651 . . . . 10.0 111.793 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -52.39 -60.94 2.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 122.594 1.188 . . . . 10.0 110.501 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 56' ' ' ILE . 54.1 t -65.79 -40.42 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.41 -17.46 1.91 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.416 1.484 . . . . 10.0 114.495 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -24.37 30.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.952 1.876 . . . . 10.0 108.757 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.28 125.7 27.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.67 -0.644 . . . . 10.0 110.602 -172.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -48.51 -38.53 20.44 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.446 1.098 . . . . 10.0 112.019 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.06 75.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 114.132 -1.395 . . . . 10.0 114.042 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.35 158.27 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.02 1.91 . . . . 10.0 111.76 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.4 t -133.41 -47.66 0.83 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.907 0.883 . . . . 10.0 110.887 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.41 145.5 41.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.251 -0.88 . . . . 10.0 108.873 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 44' ' ' VAL . 29.7 m -142.96 59.27 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.861 1.264 . . . . 10.0 110.918 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -78.41 76.3 4.92 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.36 -1.463 . . . . 10.0 109.263 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.55 133.34 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.393 1.077 . . . . 10.0 111.132 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -154.9 58.2 0.67 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -61.53 -19.8 62.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.131 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -69.42 -36.13 76.4 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.037 0.935 . . . . 10.0 110.372 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.01 50.46 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 109.673 -0.492 . . . . 10.0 109.673 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.72 32.35 8.12 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.489 -1.445 . . . . 10.0 109.489 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -152.31 171.09 18.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.557 1.143 . . . . 10.0 107.937 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -156.34 125.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 103.062 -2.94 . . . . 10.0 103.062 175.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.67 104.08 15.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.486 -1.302 . . . . 10.0 107.486 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -116.58 107.46 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 124.462 1.105 . . . . 10.0 109.16 -172.81 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.6 t -95.68 113.67 25.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.6 p90 -138.36 154.07 48.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.866 -1.061 . . . . 10.0 112.089 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -80.49 77.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.959 -1.019 . . . . 10.0 112.506 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.65 -38.59 0.41 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.937 1.695 . . . . 10.0 112.902 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 1' ' ' MET . 4.6 m-20 -69.23 -39.02 78.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.793 0.837 . . . . 10.0 110.641 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -80.87 -50.13 10.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.87 0.868 . . . . 10.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.72 137.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.337 0.04 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.77 142.16 34.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 122.0 -0.437 . . . . 10.0 110.479 -168.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.8 t -35.36 -48.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 126.222 1.809 . . . . 10.0 112.458 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -51.7 -65.83 0.49 Allowed 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.429 -0.952 . . . . 10.0 108.429 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -42.56 -41.88 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.693 1.197 . . . . 10.0 111.682 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.486 HG22 HG22 ' A' ' 24' ' ' VAL . 8.2 mm -66.0 -43.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.037 0.835 . . . . 10.0 111.153 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.06 -50.68 69.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.1 -37.22 74.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.823 0.849 . . . . 10.0 109.368 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.68 -29.8 64.95 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.647 0.98 . . . . 10.0 113.647 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -42.85 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.598 -1.314 . . . . 10.0 108.423 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.86 -30.63 71.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.461 0.573 . . . . 10.0 111.115 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.7 -50.97 64.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.992 0.425 . . . . 10.0 110.957 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -49.64 6.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.558 0.947 . . . . 10.0 113.558 -168.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.53 94.23 0.11 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -66.61 102.01 0.86 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.818 1.247 . . . . 10.0 111.711 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.22 74.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 p -156.79 77.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -33.88 -61.8 0.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.38 1.072 . . . . 10.0 112.99 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mttt 157.0 176.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.523 2.329 . . . . 10.0 113.092 169.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.618 HD12 ' HB3' ' A' ' 4' ' ' LYS . 2.8 mm -64.71 123.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.74 -56.01 27.48 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 121.42 0.629 . . . . 10.0 109.591 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.09 -172.58 30.69 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.83 -1.308 . . . . 10.0 109.83 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 128.019 2.528 . . . . 10.0 104.406 167.736 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.297 0.639 . . . . 10.0 109.642 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.3 pm0 -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.843 2.057 . . . . 10.0 110.408 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' CG1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -114.04 176.63 4.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.169 0.509 . . . . 10.0 110.023 176.091 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.9 m -114.59 109.39 18.18 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.312 1.045 . . . . 10.0 109.297 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.35 83.42 3.8 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.959 0.903 . . . . 10.0 109.267 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.98 116.46 0.45 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.461 1.104 . . . . 10.0 109.76 169.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.33 131.26 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 128.77 2.828 . . . . 10.0 109.241 -171.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -101.88 56.79 0.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.856 1.262 . . . . 10.0 107.807 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 118.69 6.51 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.239 -1.144 . . . . 10.0 110.239 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ttt -90.15 147.76 23.39 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.331 0.565 . . . . 10.0 110.622 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -64.48 69.54 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.775 1.63 . . . . 10.0 112.129 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.7 t -149.34 -57.19 0.2 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.153 0.581 . . . . 10.0 110.931 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' CG ' ' H ' ' A' ' 15' ' ' HIS . 0.2 OUTLIER -162.37 -148.63 0.14 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 173.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.411 ' H ' ' CG ' ' A' ' 14' ' ' GLN . 44.5 m170 64.89 1.42 1.44 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.178 1.791 . . . . 10.0 114.567 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.3 m -21.22 -70.74 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 128.48 2.712 . . . . 10.0 114.628 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.96 80.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.74 -57.26 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.057 0.762 . . . . 10.0 113.057 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.57 65.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.104 1.32 . . . . 10.0 110.755 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.92 -25.16 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.579 1.551 . . . . 10.0 110.87 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -79.31 -72.31 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.336 1.054 . . . . 10.0 109.404 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -44.35 -49.97 9.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.103 2.161 . . . . 10.0 111.63 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.0 m -54.56 -56.18 21.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.771 0.829 . . . . 10.0 110.47 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.726 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.2 t -67.77 -39.85 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -14.46 17.74 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.964 1.269 . . . . 10.0 114.612 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -81.55 -21.47 38.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.599 1.7 . . . . 10.0 108.935 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD13 HD12 ' A' ' 56' ' ' ILE . 57.9 mt -69.14 120.74 15.45 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 123.185 0.594 . . . . 10.0 111.31 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.97 -39.93 4.37 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.99 1.316 . . . . 10.0 111.94 169.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.63 -4.72 90.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.031 1.301 . . . . 10.0 114.617 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.85 162.55 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.286 2.043 . . . . 10.0 112.103 175.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -135.33 -45.22 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 10.0 111.038 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.73 146.94 29.42 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.265 1.026 . . . . 10.0 108.437 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.8 m -142.5 57.47 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.744 0.818 . . . . 10.0 111.381 -175.453 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -80.79 75.13 7.72 Favored 'General case' 0 N--CA 1.46 0.057 0 O-C-N 120.726 -1.234 . . . . 10.0 110.254 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.78 127.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.16 0.984 . . . . 10.0 110.742 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -146.81 58.45 1.18 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.31 -24.2 64.81 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.006 -0.434 . . . . 10.0 110.961 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.4 tt0 -60.44 -33.5 72.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.571 1.548 . . . . 10.0 110.151 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.23 -3.24 55.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.209 1.403 . . . . 10.0 111.728 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.62 41.07 25.42 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -156.35 165.68 35.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.028 0.918 . . . . 10.0 110.885 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -157.42 107.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 104.726 -2.324 . . . . 10.0 104.726 172.523 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.1 98.71 11.69 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.215 -1.402 . . . . 10.0 107.215 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -114.08 110.18 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.962 -170.557 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.0 t -93.78 114.35 26.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 169.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -145.48 158.93 43.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.833 0.825 . . . . 10.0 112.366 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -79.75 83.05 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.145 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.12 -29.74 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.936 -1.484 . . . . 10.0 113.549 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.82 -52.34 21.08 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.365 0.984 . . . . 10.0 110.402 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -78.38 -38.02 42.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.86 102.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.505 1.122 . . . . 10.0 108.425 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -64.33 152.77 40.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.198 -0.939 . . . . 10.0 110.638 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.408 HG21 HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -43.42 -39.35 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.867 0.867 . . . . 10.0 112.794 173.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -56.44 21.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.917 0.887 . . . . 10.0 109.469 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.88 -44.11 66.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.039 0.936 . . . . 10.0 110.624 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -60.58 -51.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.307 -0.998 . . . . 10.0 108.307 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.4 88.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.58 -42.02 77.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.124 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -33.33 67.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.143 -0.456 . . . . 10.0 112.208 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -66.48 -45.26 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 119.864 1.211 . . . . 10.0 108.806 169.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -61.07 -22.9 65.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.388 0.994 . . . . 10.0 112.075 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.05 -39.95 79.72 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 10.0 110.689 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.85 -65.94 1.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.428 1.491 . . . . 10.0 112.222 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.41 -159.05 28.98 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.247 -1.541 . . . . 10.0 109.247 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -151.76 56.78 0.86 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.888 1.344 . . . . 10.0 108.567 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.87 53.03 1.38 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 60' ' ' ILE . 54.1 t -142.25 92.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.93 -62.88 1.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.878 -1.056 . . . . 10.0 109.581 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tttp 169.54 179.79 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.005 1.322 . . . . 10.0 112.53 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.441 ' CG1' ' HB3' ' A' ' 4' ' ' LYS . 1.4 tp -67.04 140.83 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 169.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.09 158.98 34.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.199 0.904 . . . . 10.0 111.71 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptt85 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.013 -1.47 . . . . 10.0 108.338 168.76 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 117.791 -1.1 . . . . 10.0 108.244 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 40.4 mt-10 -152.4 160.33 43.3 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.835 0.743 . . . . 10.0 111.607 -169.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -91.84 107.85 19.5 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.521 2.329 . . . . 10.0 110.407 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 17.8 mttt -128.89 173.74 10.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.399 0.619 . . . . 10.0 111.126 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -112.42 111.56 22.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.9 mt -78.51 99.86 6.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 121.46 9.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.208 -0.932 . . . . 10.0 108.918 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 20' ' ' VAL . 3.5 t -112.38 129.75 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.719 2.407 . . . . 10.0 108.698 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.92 82.85 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.66 -23.41 68.86 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.849 -0.614 . . . . 10.0 113.316 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.1 ttt 61.01 -69.45 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.231 2.213 . . . . 10.0 113.524 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -64.75 -28.54 69.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.221 1.409 . . . . 10.0 111.988 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.3 m 71.04 -58.9 0.56 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.469 1.907 . . . . 10.0 111.063 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -58.07 138.38 56.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.783 -0.573 . . . . 10.0 110.801 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.7 m170 53.95 -147.75 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.322 1.049 . . . . 10.0 108.331 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t 68.49 -50.98 0.56 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.889 1.44 . . . . 10.0 114.889 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.59 -49.77 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 10.0 110.643 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -35.63 80.41 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.658 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -54.15 48.56 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.366 0.984 . . . . 10.0 108.795 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 8' ' ' VAL . 78.5 t -51.42 -36.15 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.975 0.91 . . . . 10.0 110.739 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -70.32 -66.22 0.63 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.098 1.359 . . . . 10.0 108.775 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.1 m -46.44 -51.16 15.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.481 1.912 . . . . 10.0 111.8 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -55.83 -54.9 38.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.41 1.005 . . . . 10.0 110.957 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 53.3 t -66.37 -40.87 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.03 -13.15 8.2 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.366 -1.241 . . . . 10.0 115.513 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.22 -24.93 46.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.006 1.903 . . . . 10.0 108.534 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 56' ' ' ILE . 65.3 mt -69.33 119.21 13.24 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.458 -172.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.13 -42.78 3.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.263 1.425 . . . . 10.0 111.7 169.124 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.1 -4.29 89.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.109 -1.405 . . . . 10.0 115.138 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 162.01 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.526 2.163 . . . . 10.0 111.713 174.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -133.08 -46.56 0.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.717 1.207 . . . . 10.0 111.108 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.81 38.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 118.172 -0.918 . . . . 10.0 108.724 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.77 57.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.642 1.177 . . . . 10.0 111.504 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 69.16 4.57 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.691 -1.256 . . . . 10.0 111.499 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.2 126.78 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.815 1.246 . . . . 10.0 112.151 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -148.44 58.18 1.07 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.78 -21.53 66.51 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.751 -1.218 . . . . 10.0 111.869 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -61.32 -37.84 84.73 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.378 1.071 . . . . 10.0 109.642 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.51 -28.32 41.38 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.34 12.58 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.752 1.644 . . . . 10.0 110.827 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -142.11 167.08 22.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.996 0.918 . . . . 10.0 109.503 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -158.47 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.617 -1.994 . . . . 10.0 105.617 -178.392 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.57 99.43 6.52 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.368 0.985 . . . . 10.0 108.514 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 42' ' ' VAL . 1.3 m -108.49 109.48 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 125.09 1.356 . . . . 10.0 109.461 -175.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -95.96 115.05 26.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -145.23 154.7 42.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -76.75 82.0 3.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.055 -0.975 . . . . 10.0 112.525 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.04 -28.07 0.65 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.709 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.62 -48.75 18.13 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.949 1.249 . . . . 10.0 110.188 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -82.26 -34.28 28.85 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.056 -0.402 . . . . 10.0 110.276 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.15 104.1 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 10.0 108.556 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 150.35 48.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.195 -0.94 . . . . 10.0 110.24 -171.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 70' ' ' ILE . 1.2 m -40.64 -40.14 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.921 0.889 . . . . 10.0 113.148 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 3.7 ttpp -58.14 -54.86 42.17 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 123.002 0.521 . . . . 10.0 109.773 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.87 -44.78 63.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.145 0.978 . . . . 10.0 110.17 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 27' ' ' LEU . 2.0 mm -62.57 -43.41 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 121.534 -0.729 . . . . 10.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.81 93.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 54' ' ' LYS . 10.0 m-20 -53.36 -42.23 66.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.315 -0.624 . . . . 10.0 109.315 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.61 -36.92 74.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.5 -49.11 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 168.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.41 -22.36 66.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.59 -39.26 88.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.223 0.535 . . . . 10.0 110.552 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.34 -57.65 2.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.442 1.497 . . . . 10.0 111.136 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.09 -152.42 8.65 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.506 2.003 . . . . 10.0 108.59 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -150.36 55.71 0.92 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.388 1.094 . . . . 10.0 108.449 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.66 57.35 1.77 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.212 -1.033 . . . . 10.0 108.212 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.647 ' CG2' HD22 ' A' ' 6' ' ' LEU 0.266 14.5 p -147.81 82.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.596 1.189 . . . . 10.0 111.57 177.303 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.21 -60.31 1.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.321 -1.763 . . . . 10.0 110.574 168.527 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.383 24.0 mttp 140.96 -176.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.39 3.076 . . . . 10.0 114.026 169.16 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 53' ' ' VAL . 12.4 mm -64.74 129.3 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 121.839 -0.538 . . . . 10.0 110.136 -167.288 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.77 -51.48 63.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.348 1.059 . . . . 10.0 111.011 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.12 173.18 44.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.666 -2.574 . . . . 10.0 106.666 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.714 -1.612 . . . . 10.0 110.283 179.513 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 117.925 -1.036 . . . . 10.0 108.661 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -134.9 122.39 21.9 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.147 0.979 . . . . 10.0 110.074 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.0 tt0 -88.81 101.99 14.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 125.441 1.497 . . . . 10.0 110.26 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 70' ' ' ILE . 76.0 mttt -137.08 176.62 8.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.325 0.511 . . . . 10.0 111.136 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 3.0 m -116.39 116.57 27.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.526 0.73 . . . . 10.0 109.64 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 67' ' ' VAL . 4.1 mt -78.41 109.82 12.92 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.038 -1.838 . . . . 10.0 106.038 169.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -52.06 119.32 4.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.963 1.256 . . . . 10.0 107.904 174.061 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 20' ' ' VAL . 16.0 t -123.28 115.84 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 125.24 1.416 . . . . 10.0 108.164 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -92.87 125.11 37.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.416 1.486 . . . . 10.0 107.956 173.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.16 90.54 0.52 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.064 -1.214 . . . . 10.0 110.064 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mtt -143.87 73.27 1.38 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.552 1.176 . . . . 10.0 110.923 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -149.3 -74.33 0.17 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.1 t -167.97 -167.51 0.85 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.8 164.01 3.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.883 0.765 . . . . 10.0 109.91 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 76.44 -3.67 2.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.764 1.226 . . . . 10.0 112.773 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -46.07 76.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.702 0.683 . . . . 10.0 112.051 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.32 -2.2 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.843 1.257 . . . . 10.0 112.588 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -114.98 -43.08 3.13 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.152 -0.967 . . . . 10.0 110.039 167.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.33 -56.27 8.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.586 1.085 . . . . 10.0 111.117 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 HG12 ' A' ' 60' ' ' ILE . 59.3 t -57.09 -34.75 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.792 0.837 . . . . 10.0 110.078 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -68.83 0.32 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.266 1.426 . . . . 10.0 107.555 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 m -48.18 -45.44 33.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.548 1.539 . . . . 10.0 111.194 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 m -52.4 -58.41 6.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 122.106 0.955 . . . . 10.0 110.808 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 56' ' ' ILE . 64.4 t -66.68 -42.76 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.09 -11.9 10.17 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.429 1.49 . . . . 10.0 115.321 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.73 -26.35 37.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.804 1.802 . . . . 10.0 108.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.625 HD13 HD12 ' A' ' 56' ' ' ILE . 64.0 mt -66.72 122.35 17.45 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.005 -0.434 . . . . 10.0 111.037 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -50.35 -35.23 26.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.29 1.043 . . . . 10.0 111.853 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.73 -3.78 89.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.196 1.379 . . . . 10.0 114.617 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.36 163.39 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.435 2.117 . . . . 10.0 111.312 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -137.7 -44.75 0.53 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.776 1.231 . . . . 10.0 111.313 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.6 149.82 36.41 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.927 . . . . 10.0 108.501 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.09 57.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 10.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.22 67.82 5.04 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.67 -1.269 . . . . 10.0 110.478 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.87 123.5 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.435 1.094 . . . . 10.0 110.913 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -144.52 57.86 1.31 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.485 -0.759 . . . . 10.0 111.099 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -61.55 -39.0 89.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.797 1.239 . . . . 10.0 109.804 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.71 -26.97 44.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.221 0.608 . . . . 10.0 109.59 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.43 32.36 7.02 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.78 -1.328 . . . . 10.0 109.78 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -149.55 162.62 39.8 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -144.0 120.3 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 102.649 -3.093 . . . . 10.0 102.649 169.84 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -96.24 96.24 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -111.43 104.84 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -170.084 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 22.8 t -92.06 117.55 29.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.411 -1.7 . . . . 10.0 106.411 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -146.63 154.75 41.83 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.675 -177.477 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.7 89.0 7.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.866 0.841 . . . . 10.0 112.681 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.12 -24.91 1.25 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.661 -1.609 . . . . 10.0 114.074 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.48 -56.17 25.41 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.898 1.227 . . . . 10.0 110.278 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -86.16 -40.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.184 -0.916 . . . . 10.0 109.827 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' HD11 ' A' ' 56' ' ' ILE . 3.3 m -135.48 99.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 p -64.97 154.69 36.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.429 -0.795 . . . . 10.0 110.521 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -40.92 -40.22 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.273 1.029 . . . . 10.0 113.152 174.552 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -53.88 -65.58 0.54 Allowed 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 108.697 -0.853 . . . . 10.0 108.697 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -43.58 -43.83 5.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.84 0.856 . . . . 10.0 110.613 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 24' ' ' VAL . 1.3 mm -66.82 -44.51 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.517 -0.739 . . . . 10.0 111.156 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.65 92.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.97 -38.67 79.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.53 -0.915 . . . . 10.0 108.53 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.15 69.47 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.753 -0.592 . . . . 10.0 112.311 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 67' ' ' VAL . 1.6 mp -64.41 -48.37 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.6 -29.77 68.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.122 0.874 . . . . 10.0 112.737 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.28 -36.46 61.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.671 0.669 . . . . 10.0 111.86 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -56.39 2.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.535 1.134 . . . . 10.0 112.752 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.33 -145.95 6.31 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.206 1.86 . . . . 10.0 109.176 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -165.71 56.9 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.572 1.686 . . . . 10.0 109.977 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.6 66.54 1.55 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 8.2 p -157.59 68.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 113.383 0.882 . . . . 10.0 113.383 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -29.75 -71.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.997 1.11 . . . . 10.0 113.997 172.412 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 167.95 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.775 1.63 . . . . 10.0 113.338 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -68.53 132.99 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -71.18 81.0 0.71 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.387 0.675 . . . . 10.0 110.536 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.36 141.11 8.8 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.33 -1.508 . . . . 10.0 109.33 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.414 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 4.1 ttt180 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 116.906 -1.521 . . . . 10.0 109.577 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtp . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.691 0.281 . . . . 10.0 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -130.99 111.7 12.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.807 1.643 . . . . 10.0 106.921 169.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.92 106.81 4.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.965 -1.124 . . . . 10.0 107.965 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -128.8 161.93 28.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.781 0.801 . . . . 10.0 111.126 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 m -112.02 93.76 4.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.216 1.406 . . . . 10.0 108.067 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.605 HD21 HG22 ' A' ' 67' ' ' VAL . 9.7 tt -78.02 94.23 4.61 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.81 1.244 . . . . 10.0 108.309 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 117.84 6.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.09 124.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.725 2.01 . . . . 10.0 111.004 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -85.34 69.15 10.69 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.82 108.82 1.88 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.057 -0.857 . . . . 10.0 112.093 -171.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 tpp -120.18 -152.92 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.071 0.935 . . . . 10.0 111.846 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m 56.26 15.94 2.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.888 1.675 . . . . 10.0 113.861 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 t 45.36 37.16 2.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.379 1.471 . . . . 10.0 111.844 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -164.31 -157.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.5 m170 55.71 31.83 18.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.538 1.135 . . . . 10.0 112.257 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.8 m -29.12 -55.5 0.14 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.255 2.222 . . . . 10.0 113.28 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.74 92.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.937 -1.505 . . . . 10.0 106.937 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.11 -167.09 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.074 1.35 . . . . 10.0 109.231 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.87 -69.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.662 2.785 . . . . 10.0 110.027 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t -47.08 -42.82 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.763 1.625 . . . . 10.0 109.16 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -61.94 -57.43 11.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.231 1.812 . . . . 10.0 108.364 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 m -48.15 -53.95 15.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.181 0.992 . . . . 10.0 110.172 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 m -67.62 -54.13 22.28 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.76 0.314 . . . . 10.0 111.726 -168.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.81 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.1 t -58.54 -44.14 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.771 -0.825 . . . . 10.0 108.771 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.28 -2.46 7.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.015 -1.436 . . . . 10.0 114.817 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -81.5 -31.32 32.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 120.123 1.962 . . . . 10.0 108.5 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 123.37 21.28 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 122.095 -0.378 . . . . 10.0 111.002 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.78 -35.14 56.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.2 1.0 . . . . 10.0 111.787 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.64 -12.7 59.7 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.393 -1.276 . . . . 10.0 113.673 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.81 161.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.73 1.765 . . . . 10.0 112.027 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.1 t -138.7 -46.78 0.49 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.44 1.096 . . . . 10.0 110.929 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.42 44.23 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.9 m -141.31 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.268 1.027 . . . . 10.0 110.631 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -83.0 77.1 9.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 120.976 -1.077 . . . . 10.0 108.22 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.71 112.63 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 123.494 0.718 . . . . 10.0 110.113 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -136.23 56.83 1.8 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.246 -1.761 . . . . 10.0 106.246 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.88 -23.43 63.44 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.34 -0.85 . . . . 10.0 111.344 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.24 -31.14 72.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.567 0.621 . . . . 10.0 111.034 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.03 -4.62 53.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.617 0.767 . . . . 10.0 111.586 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.83 19.62 79.74 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.339 1.447 . . . . 10.0 111.131 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -156.06 133.22 10.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.855 0.827 . . . . 10.0 109.274 -168.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 6' ' ' LEU . 3.2 m -121.23 120.62 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.04 94.85 9.34 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 33' ' ' VAL . 2.5 m -108.16 109.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -96.31 120.81 37.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.222 -1.769 . . . . 10.0 106.222 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -146.95 171.99 14.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.767 0.427 . . . . 10.0 111.272 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.4 82.52 2.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.22 -43.26 10.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.755 -1.566 . . . . 10.0 112.233 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -53.96 19.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.812 0.845 . . . . 10.0 111.505 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -38.3 20.53 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.141 -0.349 . . . . 10.0 110.614 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 101.9 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.678 1.591 . . . . 10.0 108.216 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 148.36 38.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.272 0.629 . . . . 10.0 110.234 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -40.44 -41.21 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.065 -1.022 . . . . 10.0 113.616 172.583 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.24 -52.62 64.58 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 10.0 110.653 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -52.01 -45.65 64.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.459 1.104 . . . . 10.0 110.08 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.525 HG21 ' CE2' ' A' ' 46' ' ' PHE . 24.9 mm -61.6 -48.94 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.17 84.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.03 -33.4 75.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.666 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.66 69.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.321 -0.862 . . . . 10.0 111.721 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.81 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.8 mp -68.87 -47.87 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.92 -1.511 . . . . 10.0 106.92 168.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.76 -30.71 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.04 0.836 . . . . 10.0 111.529 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.95 -37.59 77.1 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.984 -0.447 . . . . 10.0 112.007 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 -66.89 0.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.062 1.345 . . . . 10.0 112.043 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.48 -152.14 12.17 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 126.426 1.965 . . . . 10.0 109.224 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -165.67 55.63 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.378 1.089 . . . . 10.0 110.357 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.91 61.65 1.67 Allowed 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.605 HG22 HD21 ' A' ' 6' ' ' LEU . 86.5 t -141.63 97.94 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 C-N-CA 123.82 0.848 . . . . 10.0 108.841 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.03 -73.11 0.06 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.865 -1.061 . . . . 10.0 108.929 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.69 172.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.506 1.522 . . . . 10.0 111.457 169.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 6' ' ' LEU . 1.4 mp -68.34 129.87 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 122.128 -0.358 . . . . 10.0 111.124 171.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -76.98 144.64 38.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 169.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.68 -35.4 1.62 Allowed Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.524 -0.598 . . . . 10.0 111.862 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.483 0 CA-C-O 116.199 -1.857 . . . . 10.0 106.541 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptm . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -109.88 102.33 11.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.84 97.93 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.04 0.936 . . . . 10.0 109.53 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' CB ' HD11 ' A' ' 70' ' ' ILE . 48.6 mttm -131.85 173.27 11.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.039 0.447 . . . . 10.0 110.415 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -112.56 104.31 12.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.045 0.938 . . . . 10.0 109.251 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -81.77 86.24 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.8 123.09 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.874 0.87 . . . . 10.0 108.882 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 131.38 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 128.353 2.661 . . . . 10.0 108.33 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -98.16 106.66 18.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.69 93.89 0.57 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.13 -0.788 . . . . 10.0 111.13 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.58 -157.7 0.75 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.35 1.86 . . . . 10.0 107.491 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 48.05 40.88 14.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.401 1.48 . . . . 10.0 114.024 169.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p 42.25 -138.1 0.21 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.38 1.472 . . . . 10.0 113.546 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.08 167.72 20.56 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 120.759 -1.213 . . . . 10.0 110.722 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 80.11 8.15 1.52 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 125.218 1.407 . . . . 10.0 110.48 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.7 p -74.38 -57.63 3.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.431 -0.793 . . . . 10.0 112.028 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -50.26 -46.36 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -44.17 69.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.707 -0.663 . . . . 10.0 111.54 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.23 -53.75 39.7 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.237 1.38 . . . . 10.0 110.11 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.28 -22.6 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.891 -0.505 . . . . 10.0 111.503 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -76.83 -74.9 0.22 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 m -40.94 -53.26 2.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.713 2.405 . . . . 10.0 111.903 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -65.76 -52.36 51.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.182 0.438 . . . . 10.0 112.182 -167.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 60' ' ' ILE . 74.3 t -56.94 -44.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.699 -1.223 . . . . 10.0 107.699 169.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -9.61 17.24 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.32 1.914 . . . . 10.0 116.136 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.68 -24.91 49.19 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.938 1.869 . . . . 10.0 108.687 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.82 122.49 20.81 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.375 0.67 . . . . 10.0 110.753 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.37 -41.8 20.4 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.453 1.121 . . . . 10.0 112.091 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.2 -21.76 68.47 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.047 -1.433 . . . . 10.0 113.793 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.27 150.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.567 1.684 . . . . 10.0 112.258 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.2 t -131.14 -42.6 1.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.493 1.117 . . . . 10.0 110.941 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.57 153.11 40.72 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.82 0.848 . . . . 10.0 108.917 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -145.75 57.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.89 1.676 . . . . 10.0 111.349 -173.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -83.51 72.16 10.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.719 -1.238 . . . . 10.0 110.563 -169.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.74 129.32 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 123.421 0.688 . . . . 10.0 111.43 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -150.32 56.22 0.93 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.995 -1.483 . . . . 10.0 106.995 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.63 -29.05 67.74 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.737 -0.602 . . . . 10.0 111.334 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -63.33 -30.87 71.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.245 1.018 . . . . 10.0 110.811 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.22 -7.16 59.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.09 0.956 . . . . 10.0 111.587 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 25.65 42.08 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 124.952 1.263 . . . . 10.0 110.834 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -156.22 171.8 19.57 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.4 1.095 . . . . 10.0 110.86 -174.174 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.488 HG22 HG13 ' A' ' 44' ' ' VAL . 2.3 p -154.92 141.79 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 102.712 -3.07 . . . . 10.0 102.712 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.57 91.4 3.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.83 108.15 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -169.182 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 106.6 18.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -139.43 170.35 16.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.939 0.399 . . . . 10.0 111.852 -172.48 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 0.8 OUTLIER -91.04 73.23 6.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 113.016 0.747 . . . . 10.0 113.016 -168.969 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.94 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.922 1.289 . . . . 10.0 112.792 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.1 t70 -53.88 -57.27 11.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.697 0.799 . . . . 10.0 111.417 173.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -80.52 -39.04 28.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.105 -0.372 . . . . 10.0 110.52 -172.336 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.8 m -139.79 104.31 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 127.021 2.128 . . . . 10.0 106.638 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -64.46 157.9 25.35 Favored 'General case' 0 C--O 1.226 -0.175 0 O-C-N 121.51 -0.744 . . . . 10.0 110.383 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.25 -45.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.833 0.853 . . . . 10.0 113.207 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -61.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 175.514 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.77 -36.45 36.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.483 1.513 . . . . 10.0 111.449 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.8 mm -66.09 -55.07 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.62 -42.77 71.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -171.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -60.78 -37.21 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.171 0.988 . . . . 10.0 110.531 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.239 -0.913 . . . . 10.0 111.373 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.851 HD11 HG22 ' A' ' 24' ' ' VAL . 4.9 mp -64.44 -34.5 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.841 -1.162 . . . . 10.0 109.335 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -45.69 76.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.281 0.946 . . . . 10.0 110.05 173.784 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -60.25 -38.3 83.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -126.08 79.16 1.82 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.95 0.9 . . . . 10.0 111.537 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.74 81.12 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.449 -0.66 . . . . 10.0 111.449 169.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -67.23 89.4 0.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.981 1.312 . . . . 10.0 112.142 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -134.36 58.41 1.77 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.99 97.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 O-C-N 120.821 -1.174 . . . . 10.0 110.763 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.13 -68.92 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.351 -0.841 . . . . 10.0 110.222 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.25 171.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.624 1.17 . . . . 10.0 113.925 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER -67.3 133.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.461 -0.774 . . . . 10.0 110.582 172.231 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLU . . . . . 0.414 ' OE2' ' NZ ' ' A' ' 41' ' ' LYS . 2.0 mt-10 -58.35 119.99 7.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 170.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.71 34.16 35.73 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.211 -0.772 . . . . 10.0 114.381 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 118.855 1.328 . . . . 10.0 108.196 170.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.172 -0.442 . . . . 10.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.78 163.52 35.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.964 1.705 . . . . 10.0 106.541 170.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -101.12 111.52 23.75 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 117.453 -1.26 . . . . 10.0 108.599 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.497 ' CB ' HD12 ' A' ' 70' ' ' ILE . 82.4 mttt -136.4 172.74 12.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.07 1.305 . . . . 10.0 112.668 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -113.38 97.38 6.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.194 1.398 . . . . 10.0 109.226 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.685 HD22 HG13 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -80.59 87.8 5.74 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -177.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -47.74 119.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.276 1.03 . . . . 10.0 109.684 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HG11 ' A' ' 20' ' ' VAL . 5.7 t -109.85 148.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.182 1.793 . . . . 10.0 111.177 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -131.65 84.95 2.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.567 1.147 . . . . 10.0 108.316 172.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.38 -32.47 72.68 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 121.446 0.47 . . . . 10.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' MET . . . . . 0.403 ' O ' ' CB ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 51.93 63.19 2.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 10.0 114.18 167.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 11' ' ' MET . 14.4 t 120.73 -159.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.963 2.905 . . . . 10.0 109.598 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.9 m -66.3 162.19 20.69 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.262 1.025 . . . . 10.0 109.566 170.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 60.86 -177.88 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.896 0.878 . . . . 10.0 109.761 -168.358 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 57.58 31.07 19.77 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.033 0.445 . . . . 10.0 110.666 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -87.25 -174.03 4.68 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.325 1.05 . . . . 10.0 109.368 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.473 HG13 HG13 ' A' ' 35' ' ' VAL . 86.7 t -60.45 73.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.951 2.1 . . . . 10.0 110.176 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.55 -47.42 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.934 2.494 . . . . 10.0 110.602 173.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -54.69 44.0 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.822 -1.174 . . . . 10.0 111.027 -172.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.781 HG11 HG21 ' A' ' 8' ' ' VAL . 94.2 t -60.95 -29.6 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.103 1.361 . . . . 10.0 110.567 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -57.66 5.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -44.67 -55.31 5.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.869 1.267 . . . . 10.0 111.324 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 m -63.46 -58.59 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.103 0.411 . . . . 10.0 111.71 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 60' ' ' ILE . 70.1 t -59.08 -40.0 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.87 -6.53 24.78 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 118.082 -1.399 . . . . 10.0 114.802 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.48 -20.16 44.32 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 120.365 2.083 . . . . 10.0 108.878 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.671 HD13 HD12 ' A' ' 56' ' ' ILE . 52.7 mt -66.22 117.71 8.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.448 0.642 . . . . 10.0 112.191 -175.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -40.82 -43.55 2.05 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.0 2.12 . . . . 10.0 111.186 167.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.22 6.27 83.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.685 1.612 . . . . 10.0 115.405 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.02 160.54 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 120.883 2.342 . . . . 10.0 111.092 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -132.34 -42.28 0.96 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.42 1.088 . . . . 10.0 111.964 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.32 149.76 29.73 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.311 -1.366 . . . . 10.0 107.311 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.1 m -141.62 60.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 122.079 0.942 . . . . 10.0 110.301 -173.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.39 61.41 5.56 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.311 -0.868 . . . . 10.0 110.398 -169.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -62.24 121.69 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.242 1.417 . . . . 10.0 110.102 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -142.13 54.57 1.46 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 173.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.65 -26.8 67.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.548 -0.72 . . . . 10.0 111.007 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -69.03 -30.84 69.29 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.398 1.079 . . . . 10.0 110.489 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.21 -28.92 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.126 0.571 . . . . 10.0 110.116 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.45 5.4 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.906 1.241 . . . . 10.0 110.949 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -155.91 158.08 37.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.416 1.486 . . . . 10.0 107.43 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.43 94.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.029 -2.952 . . . . 10.0 103.029 -168.35 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.83 94.15 8.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.651 -1.611 . . . . 10.0 106.651 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -109.68 112.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 125.808 1.643 . . . . 10.0 108.038 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.19 115.37 27.33 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 125.985 1.714 . . . . 10.0 106.558 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -149.13 155.76 41.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 113.248 0.833 . . . . 10.0 113.248 -173.709 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -77.04 82.05 3.56 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.555 0.946 . . . . 10.0 113.555 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.79 -25.63 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.128 -1.396 . . . . 10.0 113.666 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.03 -60.14 2.47 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.081 0.855 . . . . 10.0 110.479 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.83 -0.544 . . . . 10.0 110.083 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.43 103.1 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -72.02 157.66 37.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.661 -1.274 . . . . 10.0 109.065 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.409 HG13 ' CG1' ' A' ' 70' ' ' ILE . 74.5 t -32.15 -48.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 126.315 1.846 . . . . 10.0 112.301 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -62.42 1.55 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.78 -41.18 61.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.419 1.488 . . . . 10.0 109.356 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.671 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -66.12 -52.6 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 119.502 -0.879 . . . . 10.0 108.886 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.37 87.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -58.06 -39.33 78.21 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.627 1.171 . . . . 10.0 109.452 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.81 71.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.916 -0.49 . . . . 10.0 112.183 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.84 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.8 mp -70.46 -40.34 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 O-C-N 120.786 -1.196 . . . . 10.0 108.368 169.444 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -60.34 -28.38 68.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.329 1.422 . . . . 10.0 112.669 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.79 -23.9 67.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 10.0 112.001 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -108.64 -68.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.299 1.84 . . . . 10.0 111.148 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 -144.58 8.42 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.9 2.19 . . . . 10.0 108.806 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -162.5 58.9 0.22 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.666 1.233 . . . . 10.0 108.275 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -137.97 54.2 1.81 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 120.91 0.386 . . . . 10.0 110.398 -166.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 6' ' ' LEU . 92.1 t -145.86 84.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.306 -1.368 . . . . 10.0 107.306 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.55 -72.77 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.709 -1.132 . . . . 10.0 110.698 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 173.39 174.37 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.256 1.022 . . . . 10.0 113.549 169.762 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CB ' ' A' ' 4' ' ' LYS . 8.9 mm -65.78 111.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.752 -2.684 . . . . 10.0 103.752 168.209 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -3.78 -89.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.412 2.285 . . . . 10.0 114.189 -168.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.37 36.53 3.37 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.399 1.0 . . . . 10.0 111.002 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 . . . . . 0 C--O 1.256 1.403 0 C-N-CA 126.771 2.028 . . . . 10.0 111.661 -173.461 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 117.965 -1.017 . . . . 10.0 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -126.16 106.76 9.79 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.007 1.723 . . . . 10.0 107.582 167.299 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -61.3 97.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.414 1.486 . . . . 10.0 111.018 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -134.54 171.37 14.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.905 0.859 . . . . 10.0 112.543 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 m -108.29 101.03 10.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 67' ' ' VAL . 12.3 tp -84.34 72.71 10.56 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.079 1.351 . . . . 10.0 107.537 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.3 123.23 0.62 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.919 1.688 . . . . 10.0 111.497 -169.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.85 122.68 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 128.248 2.619 . . . . 10.0 109.182 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -88.17 173.77 8.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.961 -1.496 . . . . 10.0 106.961 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.93 110.45 1.9 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 107.706 -2.158 . . . . 10.0 107.706 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.6 ttt -45.82 -64.95 0.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.146 0.973 . . . . 10.0 111.744 -171.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.8 p 174.51 -65.57 0.01 OUTLIER 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.823 1.249 . . . . 10.0 109.097 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -53.94 147.8 11.66 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.499 1.12 . . . . 10.0 110.226 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -79.62 -155.2 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.781 0.832 . . . . 10.0 111.057 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 58.83 27.11 15.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.618 1.167 . . . . 10.0 111.205 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -80.43 -169.7 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.402 1.081 . . . . 10.0 108.873 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.303 7.3 p 52.42 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.245 1.418 . . . . 10.0 112.248 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.98 -47.66 0.14 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.863 1.665 . . . . 10.0 110.189 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -48.99 46.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.462 1.028 . . . . 10.0 112.332 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.46 -13.34 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.959 1.304 . . . . 10.0 111.496 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.92 -62.7 1.6 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.448 1.099 . . . . 10.0 108.471 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -50.47 -44.45 55.77 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.642 1.577 . . . . 10.0 111.99 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -54.11 -65.57 0.55 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.069 1.347 . . . . 10.0 110.627 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG22 HG22 ' A' ' 56' ' ' ILE . 84.2 t -55.43 -43.37 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 123.777 0.831 . . . . 10.0 108.787 173.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.43 -19.37 6.05 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.58 1.562 . . . . 10.0 115.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.26 -23.53 32.65 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 120.041 1.92 . . . . 10.0 108.873 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD13 HD12 ' A' ' 56' ' ' ILE . 58.6 mt -66.42 121.38 15.16 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.092 0.473 . . . . 10.0 111.151 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -44.9 -37.79 4.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.204 1.402 . . . . 10.0 112.397 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.12 -5.9 89.29 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.103 1.335 . . . . 10.0 114.684 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.63 166.52 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.245 2.023 . . . . 10.0 111.782 175.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -140.93 -49.26 0.43 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.857 0.863 . . . . 10.0 111.134 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.62 144.73 51.05 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -143.57 56.86 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.253 1.021 . . . . 10.0 111.224 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -86.11 70.29 10.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.524 -1.36 . . . . 10.0 109.017 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.15 130.98 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.402 0.681 . . . . 10.0 110.088 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.26 67.74 0.73 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.61 -21.17 65.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.581 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.27 -35.33 73.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.969 0.508 . . . . 10.0 109.651 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.27 45.68 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.0 25.81 30.72 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.954 1.264 . . . . 10.0 109.969 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -149.71 109.74 4.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.439 0.62 . . . . 10.0 109.569 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 44' ' ' VAL . 5.0 p -84.46 148.05 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 165.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -119.12 95.79 4.96 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -112.63 109.59 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.177 1.391 . . . . 10.0 107.944 -172.895 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.0 t -99.6 109.93 22.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -140.76 150.67 43.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 124.411 1.07 . . . . 10.0 111.701 -174.406 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.24 83.35 7.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.244 -0.889 . . . . 10.0 112.958 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.54 -36.22 1.29 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.931 -1.486 . . . . 10.0 112.99 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -61.39 -53.34 57.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.343 0.657 . . . . 10.0 110.134 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.87 -40.26 28.77 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.816 -0.553 . . . . 10.0 110.792 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.424 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -138.15 102.74 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.081 1.352 . . . . 10.0 108.598 -173.176 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.16 148.33 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.636 -0.665 . . . . 10.0 111.054 -170.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.4 m -39.09 -45.74 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.556 1.142 . . . . 10.0 113.803 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -58.36 -52.39 65.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.99 -43.46 50.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.713 1.205 . . . . 10.0 109.83 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.683 HD12 HD13 ' A' ' 27' ' ' LEU . 2.4 mm -64.3 -46.22 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 121.561 -0.712 . . . . 10.0 110.711 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.17 90.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.863 0.84 . . . . 10.0 109.446 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -66.27 -37.49 85.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.32 82.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.949 -1.094 . . . . 10.0 111.753 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 24' ' ' VAL . 5.1 mt -58.69 -41.26 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.876 -1.14 . . . . 10.0 109.265 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -44.28 90.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.86 -53.95 34.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.778 0.323 . . . . 10.0 111.288 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -48.08 12.39 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.406 0.891 . . . . 10.0 113.406 -169.353 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.35 90.79 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 10.0 108.828 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -65.98 108.22 2.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.009 1.323 . . . . 10.0 111.156 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -166.56 78.71 0.23 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 104.091 -2.559 . . . . 10.0 104.091 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 6' ' ' LEU . 13.9 p -155.5 83.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.16 -50.31 0.71 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.961 2.104 . . . . 10.0 113.361 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 128.16 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.338 3.055 . . . . 10.0 113.308 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.0 mm -65.25 126.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.211 -0.931 . . . . 10.0 108.999 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.5 -48.38 27.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.707 0.803 . . . . 10.0 112.468 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.15 -68.57 1.4 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.927 0.775 . . . . 10.0 112.698 -172.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 . . . . . 0 C--O 1.249 1.049 0 N-CA-C 105.135 -2.172 . . . . 10.0 105.135 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.472 -0.566 . . . . 10.0 109.472 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.18 148.94 30.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.518 0.599 . . . . 10.0 110.781 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.33 107.49 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.234 1.413 . . . . 10.0 109.918 169.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.579 ' HB3' HD12 ' A' ' 70' ' ' ILE . 64.6 mttt -136.69 119.72 16.5 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 1.8 m -78.77 121.5 24.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.859 0.464 . . . . 10.0 110.34 -172.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.434 HD11 ' CG1' ' A' ' 20' ' ' VAL . 1.6 pp -78.2 114.47 17.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 169.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 125.92 28.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.88 130.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 127.811 2.444 . . . . 10.0 108.817 -175.207 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -85.85 77.36 9.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.74 101.54 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.307 -0.718 . . . . 10.0 111.399 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 56.62 2.84 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.563 1.182 . . . . 10.0 112.073 -170.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m 21.32 64.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.368 2.667 . . . . 10.0 115.293 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -149.88 135.18 18.13 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.88 -19.9 60.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.972 0.909 . . . . 10.0 113.306 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -35.01 72.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.8 1.24 . . . . 10.0 110.351 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.96 -170.52 0.59 Allowed 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.2 t 72.68 -66.82 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -169.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 9.6 mptt -66.22 -45.83 79.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.52 -46.23 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.593 0.633 . . . . 10.0 111.538 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 6' ' ' LEU . 46.0 t -70.93 -28.16 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.963 1.305 . . . . 10.0 110.933 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 -73.03 0.42 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.81 1.244 . . . . 10.0 109.337 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -49.62 -44.6 47.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.5 2.32 . . . . 10.0 111.267 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 t -47.04 -64.08 0.87 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.866 1.317 . . . . 10.0 109.776 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 56' ' ' ILE . 82.5 t -66.66 -38.0 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.729 -1.123 . . . . 10.0 108.013 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.56 -15.29 8.3 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 117.99 -1.45 . . . . 10.0 114.81 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.32 -22.02 38.82 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.45 2.125 . . . . 10.0 109.103 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.619 HD13 HD12 ' A' ' 56' ' ' ILE . 52.0 mt -70.07 120.58 15.99 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.076 0.465 . . . . 10.0 110.893 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.37 -39.25 10.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.374 1.083 . . . . 10.0 111.874 169.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.15 0.88 86.79 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 114.213 -1.358 . . . . 10.0 114.753 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.72 157.86 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.334 2.067 . . . . 10.0 111.725 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -127.31 -42.92 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.666 1.186 . . . . 10.0 111.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.34 150.08 34.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.554 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.9 m -141.53 58.18 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.758 0.823 . . . . 10.0 111.495 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 72.39 7.18 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.67 -1.269 . . . . 10.0 110.667 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.01 124.77 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.168 0.987 . . . . 10.0 110.787 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.93 56.81 1.26 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.6 pp -62.46 -23.93 67.17 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.525 -0.734 . . . . 10.0 112.244 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.02 -31.37 72.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.287 0.494 . . . . 10.0 111.19 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.39 -7.52 58.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.397 0.679 . . . . 10.0 111.101 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.96 57.87 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.396 1.474 . . . . 10.0 109.97 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -150.96 162.07 41.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.21 1.005 . . . . 10.0 111.137 -168.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 44' ' ' VAL . 55.0 t -153.37 111.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.078 -2.564 . . . . 10.0 104.078 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.45 85.08 6.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.569 HG13 HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -100.91 126.99 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 178.889 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.3 t -116.08 120.81 40.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -152.34 158.48 42.79 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 123.776 0.673 . . . . 10.0 112.451 -175.047 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -85.56 88.99 7.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -171.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.69 -25.18 0.67 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.485 -1.689 . . . . 10.0 113.75 168.848 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.04 -61.86 2.32 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.655 1.116 . . . . 10.0 111.086 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -80.12 -50.92 9.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.17 95.06 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.44 -1.689 . . . . 10.0 106.44 -170.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 153.03 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.869 0.842 . . . . 10.0 109.596 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 70' ' ' ILE . 17.8 t -34.99 -48.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 125.988 1.715 . . . . 10.0 112.009 169.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -55.17 -58.55 7.21 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -48.02 -42.88 29.29 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.601 0.76 . . . . 10.0 110.054 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -64.63 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.057 -0.657 . . . . 10.0 110.381 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.66 80.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -52.01 -40.86 61.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.527 0.731 . . . . 10.0 109.403 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.87 -40.04 72.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.7 mp -61.85 -45.85 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.4 -24.78 67.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.743 0.701 . . . . 10.0 111.944 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.54 -33.89 74.61 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.984 -0.448 . . . . 10.0 111.568 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.73 -70.25 0.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.867 1.267 . . . . 10.0 112.112 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.85 -147.38 18.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.831 -1.708 . . . . 10.0 108.831 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -163.03 53.01 0.18 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 174.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.56 59.13 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -144.75 85.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.92 -62.54 1.36 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.784 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.06 177.13 0.06 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.21 2.204 . . . . 10.0 109.717 169.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 4' ' ' LYS . 12.0 mm -67.15 130.89 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.473 0.709 . . . . 10.0 110.267 169.096 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -95.02 118.01 31.12 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 106.963 -1.495 . . . . 10.0 106.963 167.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.29 -164.42 24.24 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.536 -2.226 . . . . 10.0 107.536 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.855 -1.545 . . . . 10.0 110.731 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttm . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 118.505 -0.759 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -129.58 102.87 6.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.889 0.876 . . . . 10.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 102.96 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.194 1.798 . . . . 10.0 111.001 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -144.66 176.24 9.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.936 0.789 . . . . 10.0 111.953 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 m -111.38 108.22 17.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.594 1.158 . . . . 10.0 108.745 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -79.22 83.23 5.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.55 126.54 2.35 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 10.0 110.796 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.71 134.88 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.537 2.735 . . . . 10.0 111.437 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.13 94.51 4.97 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.021 -1.103 . . . . 10.0 108.021 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.08 102.76 0.44 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.47 1.033 . . . . 10.0 111.533 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 ttm -119.06 36.2 4.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.458 1.103 . . . . 10.0 111.694 -169.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 p -156.33 176.75 12.28 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.399 -0.813 . . . . 10.0 109.298 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -87.59 -31.95 19.58 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.651 0.78 . . . . 10.0 111.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.7 174.91 13.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.627 -0.671 . . . . 10.0 110.81 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 63.96 22.25 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.322 1.449 . . . . 10.0 112.352 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -108.9 -54.54 2.51 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.672 1.189 . . . . 10.0 109.885 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -35.82 -60.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 125.275 1.43 . . . . 10.0 110.294 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -69.01 -35.11 76.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.816 -0.354 . . . . 10.0 111.686 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 -53.19 61.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.146 -0.972 . . . . 10.0 109.758 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.75 -22.06 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.52 1.928 . . . . 10.0 110.639 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -71.79 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 10.0 109.119 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -49.41 -42.16 41.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.933 2.093 . . . . 10.0 112.884 -174.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.6 p -50.35 -61.41 2.19 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.648 1.179 . . . . 10.0 110.201 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 60' ' ' ILE . 89.7 t -61.9 -47.9 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 124.063 0.945 . . . . 10.0 108.524 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.92 -1.57 0.26 Allowed Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.991 -1.449 . . . . 10.0 115.828 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.92 -31.42 19.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.133 1.967 . . . . 10.0 108.688 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.6 125.01 25.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 121.403 -0.811 . . . . 10.0 111.02 -171.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.32 -36.57 32.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 122.45 1.119 . . . . 10.0 111.85 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.88 -12.99 75.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 114.23 -1.35 . . . . 10.0 114.153 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 46' ' ' PHE . 2.3 t -79.24 146.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 120.085 1.943 . . . . 10.0 111.177 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -123.0 -47.11 2.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.891 1.676 . . . . 10.0 111.016 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.64 147.56 51.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 118.237 -0.887 . . . . 10.0 108.771 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.1 58.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.584 1.154 . . . . 10.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -79.39 75.04 5.99 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.221 -1.549 . . . . 10.0 109.501 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.59 122.73 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.362 0.665 . . . . 10.0 110.1 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -147.63 59.74 1.14 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.71 -21.38 65.73 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.695 -0.628 . . . . 10.0 111.946 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -66.47 -32.85 74.47 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.556 0.742 . . . . 10.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.87 -34.57 33.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.81 -1.96 41.72 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.26 1.886 . . . . 10.0 110.611 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -129.9 100.08 5.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.046 0.938 . . . . 10.0 108.746 -170.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 44' ' ' VAL . 2.4 p -78.02 137.95 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.534 -2.024 . . . . 10.0 105.534 168.423 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -104.79 97.85 7.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.983 1.265 . . . . 10.0 107.812 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -117.81 106.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.12 1.368 . . . . 10.0 108.94 -169.733 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -96.55 114.27 25.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -133.15 152.28 51.95 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.015 1.326 . . . . 10.0 111.649 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -82.95 84.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 122.425 1.107 . . . . 10.0 112.353 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.95 1.21 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.239 -1.801 . . . . 10.0 113.801 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.3 -49.56 76.72 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.524 0.602 . . . . 10.0 110.594 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -87.09 -48.62 7.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.86 102.63 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.39 154.55 38.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.402 0.62 . . . . 10.0 109.805 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -38.51 -42.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.184 1.394 . . . . 10.0 112.601 175.178 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -57.01 -54.44 46.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.246 0.618 . . . . 10.0 109.776 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.35 -40.68 49.91 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.907 0.883 . . . . 10.0 111.178 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 24' ' ' VAL . 12.9 mm -66.68 -49.49 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -63.23 -39.69 95.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 -174.141 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -62.28 -41.68 98.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.51 79.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.385 -0.822 . . . . 10.0 110.977 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 67' ' ' VAL . 1.9 mp -61.0 -44.2 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 O-C-N 120.981 -1.074 . . . . 10.0 108.789 168.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.91 -33.56 67.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.013 1.279 . . . . 10.0 112.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.89 -39.35 81.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.997 0.369 . . . . 10.0 111.997 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -133.93 84.4 2.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.623 1.569 . . . . 10.0 108.903 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.28 76.5 1.21 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.495 0.569 . . . . 10.0 112.116 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -68.0 55.22 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.71 2.404 . . . . 10.0 114.739 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.5 56.19 0.63 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.718 -1.238 . . . . 10.0 107.707 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 60' ' ' ILE . 3.6 m -133.38 94.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.319 1.448 . . . . 10.0 111.398 -176.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.65 -66.38 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.263 168.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt 160.38 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.53 1.932 . . . . 10.0 113.086 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.423 HG13 HG21 ' A' ' 53' ' ' VAL . 6.3 mm -64.12 130.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -72.24 122.08 20.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.14 171.02 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.903 -1.279 . . . . 10.0 109.903 -171.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.398 -1.705 . . . . 10.0 106.398 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 118.973 -0.537 . . . . 10.0 109.843 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -78.98 99.38 6.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.822 -1.547 . . . . 10.0 106.822 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.36 89.21 1.22 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.452 1.101 . . . . 10.0 110.14 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HB3' HD11 ' A' ' 70' ' ' ILE . 7.9 mmtp -139.18 175.18 9.78 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.843 0.682 . . . . 10.0 112.843 -172.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -115.63 117.06 29.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.544 1.538 . . . . 10.0 108.885 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.5 mt -86.57 97.34 10.47 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 171.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 2.7 tm0? -45.8 118.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 177.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HG11 ' A' ' 20' ' ' VAL . 8.4 t -124.06 124.27 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.76 1.224 . . . . 10.0 108.438 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -97.3 115.69 28.13 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.098 1.759 . . . . 10.0 108.268 173.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 117.63 10.94 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.795 -1.003 . . . . 10.0 111.123 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -80.47 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.304 1.052 . . . . 10.0 110.372 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -168.35 165.28 12.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.111 1.764 . . . . 10.0 108.06 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.4 m 68.36 159.05 0.16 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.278 1.831 . . . . 10.0 111.824 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.52 53.32 1.29 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.019 -1.051 . . . . 10.0 110.258 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -145.32 29.55 1.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.582 0.753 . . . . 10.0 110.453 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p -111.56 -52.68 2.77 Favored 'General case' 0 C--O 1.23 0.031 0 C-N-CA 124.801 1.24 . . . . 10.0 109.993 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -47.56 -56.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.867 1.267 . . . . 10.0 107.858 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -45.53 70.88 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.691 -175.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.74 -49.05 58.79 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.12 0.418 . . . . 10.0 110.302 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 8' ' ' VAL . 99.4 t -71.43 -25.23 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.357 1.063 . . . . 10.0 111.276 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -77.01 -66.11 0.86 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.827 0.851 . . . . 10.0 109.048 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -51.7 -47.91 63.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.307 1.843 . . . . 10.0 111.289 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -53.04 -67.83 0.22 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 10.0 110.753 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.767 HG22 HG22 ' A' ' 56' ' ' ILE . 84.8 t -55.46 -42.33 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 124.512 1.125 . . . . 10.0 108.996 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.6 -14.04 13.53 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.07 -1.406 . . . . 10.0 115.085 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.01 -22.13 36.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 120.301 2.051 . . . . 10.0 108.697 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.7 HD13 HD12 ' A' ' 56' ' ' ILE . 60.3 mt -67.69 117.68 9.94 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.44 0.638 . . . . 10.0 111.498 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -40.79 -40.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.594 1.958 . . . . 10.0 112.251 168.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.14 -8.5 87.56 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.285 1.421 . . . . 10.0 115.2 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.83 158.35 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.022 1.911 . . . . 10.0 111.855 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -132.27 -48.72 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.221 1.009 . . . . 10.0 110.662 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.62 146.09 51.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.099 -1.075 . . . . 10.0 108.099 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.0 m -139.99 57.37 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.328 1.051 . . . . 10.0 110.59 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -82.44 66.15 7.9 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.968 -1.083 . . . . 10.0 110.367 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.09 126.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.038 1.335 . . . . 10.0 110.976 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -144.27 56.14 1.3 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.12 -28.74 66.82 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.551 -0.718 . . . . 10.0 110.986 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -61.85 -31.37 71.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.921 1.289 . . . . 10.0 110.749 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.0 -4.68 56.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.769 1.228 . . . . 10.0 111.771 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.74 40.05 65.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.913 0.768 . . . . 10.0 111.233 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -155.74 160.13 40.06 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 117.901 0.851 . . . . 10.0 109.981 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.31 101.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.45 103.16 11.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.38 96.55 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.714 1.206 . . . . 10.0 107.785 -173.683 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 t -88.15 105.76 17.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.86 152.39 50.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.696 0.999 . . . . 10.0 113.696 -175.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.38 84.24 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.61 -0.723 . . . . 10.0 112.824 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.87 -30.87 10.81 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.75 -51.87 65.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.012 0.525 . . . . 10.0 110.503 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -78.82 -42.62 27.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.8 m -135.8 98.63 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.179 0.992 . . . . 10.0 109.426 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.69 152.48 26.52 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.48 -0.762 . . . . 10.0 110.617 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -36.81 -44.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.788 1.033 . . . . 10.0 113.788 171.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -55.25 -58.21 8.65 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.36 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -46.79 -44.38 19.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.993 0.917 . . . . 10.0 110.232 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.767 HG22 HG22 ' A' ' 24' ' ' VAL . 1.9 mm -66.99 -45.19 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.542 -0.724 . . . . 10.0 110.669 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.49 99.71 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.383 -0.969 . . . . 10.0 108.383 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.29 -38.95 88.62 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.33 71.88 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.526 -0.733 . . . . 10.0 111.653 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.406 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.5 mp -63.3 -49.8 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 168.233 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.19 -30.4 68.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.563 1.074 . . . . 10.0 112.446 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.94 -29.86 69.87 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.81 -0.556 . . . . 10.0 111.342 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.51 -62.95 1.21 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.109 1.764 . . . . 10.0 111.786 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.54 -143.59 6.66 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.382 1.944 . . . . 10.0 109.18 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.28 57.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.775 1.287 . . . . 10.0 109.978 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.22 70.3 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.725 -1.954 . . . . 10.0 105.725 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.704 ' CG2' HD22 ' A' ' 6' ' ' LEU . 9.9 p -156.23 92.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 121.647 -0.658 . . . . 10.0 112.159 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -49.17 -71.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.512 168.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' C ' HD23 ' A' ' 6' ' ' LEU . 13.1 mttt 171.03 176.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.527 1.531 . . . . 10.0 113.959 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -68.94 130.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.589 -0.523 . . . . 10.0 109.589 177.468 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -68.44 119.78 13.47 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.84 74.35 0.93 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.576 -0.61 . . . . 10.0 111.576 174.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 C-N-CA 128.351 2.661 . . . . 10.0 104.583 167.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -132.71 134.44 44.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -78.17 106.67 10.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.82 1.648 . . . . 10.0 109.945 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' CB ' HD12 ' A' ' 70' ' ' ILE . 3.6 mtpm? -128.07 174.72 8.98 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -120.75 114.99 22.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.658 -0.651 . . . . 10.0 109.593 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.09 82.07 3.6 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.76 -1.57 . . . . 10.0 106.76 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -40.34 120.27 1.19 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -107.48 152.91 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 126.172 1.789 . . . . 10.0 107.717 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.81 56.66 0.94 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.636 . . . . 10.0 107.95 -172.175 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.67 100.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.773 1.654 . . . . 10.0 114.037 -169.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -77.67 6.38 7.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.408 1.083 . . . . 10.0 112.782 -170.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 t 75.36 -39.6 0.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.402 1.481 . . . . 10.0 112.644 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.2 p -49.5 163.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.265 1.426 . . . . 10.0 112.802 173.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -66.64 167.68 10.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.932 0.872 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.76 39.01 0.71 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.571 -1.195 . . . . 10.0 110.42 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -78.91 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.607 0.763 . . . . 10.0 110.353 -174.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.89 57.98 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.169 1.387 . . . . 10.0 108.475 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 -51.47 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 125.661 1.584 . . . . 10.0 111.353 -176.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.91 37.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 121.075 1.761 . . . . 10.0 110.633 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.62 -19.53 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.866 -1.061 . . . . 10.0 110.909 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -78.68 -76.18 0.21 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.167 -1.419 . . . . 10.0 107.167 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -42.09 -49.96 4.75 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.573 2.749 . . . . 10.0 112.152 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -54.33 -58.24 8.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 122.253 1.025 . . . . 10.0 110.63 -177.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 56' ' ' ILE . 91.6 t -64.45 -38.66 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.29 -1.004 . . . . 10.0 108.29 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.47 -11.32 40.63 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.181 1.372 . . . . 10.0 114.531 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.94 -21.7 40.23 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.923 1.861 . . . . 10.0 108.123 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.746 HD11 HG23 ' A' ' 56' ' ' ILE . 41.4 mt -67.37 117.25 9.1 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.45 0.643 . . . . 10.0 111.525 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -46.96 -35.27 6.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.984 1.313 . . . . 10.0 111.716 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.77 5.69 84.4 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 125.338 1.447 . . . . 10.0 114.93 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.24 159.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 120.532 2.166 . . . . 10.0 111.939 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -126.81 -44.64 1.64 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.07 1.348 . . . . 10.0 112.004 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.65 146.81 34.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.66 -1.162 . . . . 10.0 108.862 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.2 m -145.12 56.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.224 1.01 . . . . 10.0 112.469 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -82.6 70.85 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.158 -1.589 . . . . 10.0 111.147 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.57 126.29 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.541 0.736 . . . . 10.0 111.383 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -144.41 56.97 1.3 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.61 -24.52 67.62 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.659 -0.65 . . . . 10.0 111.529 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.1 -32.27 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.348 0.659 . . . . 10.0 110.518 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.12 44.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.33 9.35 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.118 1.342 . . . . 10.0 111.078 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -141.62 174.41 10.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 122.325 1.06 . . . . 10.0 109.276 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -156.1 115.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 102.996 -2.964 . . . . 10.0 102.996 174.98 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -91.95 101.24 13.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 120.337 1.426 . . . . 10.0 108.092 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -116.64 107.97 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.637 1.175 . . . . 10.0 109.045 -172.101 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -98.71 116.56 31.22 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.06 161.1 42.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 -176.071 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.33 81.8 5.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.302 -0.863 . . . . 10.0 112.97 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.47 -40.87 0.9 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.687 1.595 . . . . 10.0 112.87 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -54.88 18.82 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.31 1.044 . . . . 10.0 111.806 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -83.38 -40.72 19.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -135.43 105.2 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 148.67 49.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.588 -0.695 . . . . 10.0 110.222 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.514 HG13 ' CG1' ' A' ' 70' ' ' ILE . 40.1 t -29.31 -52.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 126.871 2.068 . . . . 10.0 112.242 167.454 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -50.32 -60.78 2.64 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.423 0.689 . . . . 10.0 109.331 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -44.76 -44.64 9.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.858 1.663 . . . . 10.0 110.192 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 HD11 ' A' ' 27' ' ' LEU . 2.0 mm -67.15 -45.56 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.098 -1.001 . . . . 10.0 110.904 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.45 94.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -54.69 -39.69 68.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.234 1.014 . . . . 10.0 108.681 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.32 69.83 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.1 0.778 . . . . 10.0 113.1 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.422 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.4 mp -66.26 -47.61 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 168.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.32 -26.39 68.4 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -61.97 -33.94 75.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.652 -0.655 . . . . 10.0 111.577 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -98.6 -54.29 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.316 1.446 . . . . 10.0 111.819 -169.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.12 -140.36 3.82 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.155 -1.978 . . . . 10.0 108.155 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -164.83 53.38 0.12 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.685 1.242 . . . . 10.0 110.604 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 78.4 1.48 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.918 -1.512 . . . . 10.0 106.918 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.05 108.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.33 0.14 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.5 tttt 177.75 176.85 0.4 Allowed 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 113.863 1.061 . . . . 10.0 113.863 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.514 ' CG1' HG13 ' A' ' 53' ' ' VAL . 3.3 mm -67.63 125.03 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.871 -0.518 . . . . 10.0 110.76 174.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 169.58 12.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.37 2.268 . . . . 10.0 109.047 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 54.6 65.19 3.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.936 1.255 . . . . 10.0 111.252 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 105.022 -2.214 . . . . 10.0 105.022 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.097 0.475 . . . . 10.0 112.214 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -128.11 103.36 7.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.848 . . . . 10.0 106.012 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.34 89.7 1.61 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.529 1.132 . . . . 10.0 109.691 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -131.77 173.58 11.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.513 0.673 . . . . 10.0 111.751 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -111.91 112.92 24.92 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.542 1.537 . . . . 10.0 108.148 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.76 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.3 mt -80.64 95.0 6.43 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.611 -1.996 . . . . 10.0 105.611 172.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.4 121.56 5.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.378 -1.341 . . . . 10.0 107.378 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.97 135.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 128.431 2.692 . . . . 10.0 108.192 -169.214 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.67 114.97 25.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.404 -1.702 . . . . 10.0 106.404 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 96.24 1.32 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.155 -1.178 . . . . 10.0 110.155 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.9 57.0 1.15 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.952 0.882 . . . . 10.0 110.983 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -138.39 -104.42 0.18 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.99 . . . . 10.0 108.772 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.27 -163.94 1.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.07 -1.456 . . . . 10.0 107.07 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -43.26 36.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 121.16 1.8 . . . . 10.0 111.197 174.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -75.08 70.64 2.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.03 0.532 . . . . 10.0 109.644 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.92 -63.41 0.65 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.333 1.453 . . . . 10.0 109.277 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.9 t -45.45 -58.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 C-N-CA 124.87 1.268 . . . . 10.0 108.442 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -8.78 57.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.28 -49.16 11.96 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 120.461 -1.399 . . . . 10.0 108.349 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.32 -28.67 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.746 1.218 . . . . 10.0 110.304 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -55.73 4.19 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.4 m -50.06 -53.07 29.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.753 0.821 . . . . 10.0 110.159 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -60.62 -59.95 4.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 122.583 1.183 . . . . 10.0 111.1 -168.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 56' ' ' ILE . 69.3 t -60.82 -41.47 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.351 -0.84 . . . . 10.0 108.831 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.67 -13.28 7.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.598 1.57 . . . . 10.0 114.546 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.89 -23.0 33.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.984 1.892 . . . . 10.0 108.575 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' CD1' HD12 ' A' ' 56' ' ' ILE . 73.6 mt -68.9 123.16 20.24 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.733 -0.604 . . . . 10.0 111.085 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -43.4 -43.06 5.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.1 1.36 . . . . 10.0 112.297 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.2 -17.61 74.17 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 113.961 -1.472 . . . . 10.0 114.016 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.4 147.84 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.732 1.766 . . . . 10.0 111.616 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -123.88 -43.23 2.13 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 10.0 110.795 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.6 154.56 44.51 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.794 0.837 . . . . 10.0 109.358 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.3 m -145.64 57.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.079 1.752 . . . . 10.0 111.101 -174.417 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.17 66.14 7.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.919 -1.113 . . . . 10.0 111.522 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.47 132.4 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 124.618 1.167 . . . . 10.0 111.871 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -152.97 58.17 0.79 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.79 -26.12 67.05 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.179 -0.951 . . . . 10.0 111.248 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -58.9 -34.54 71.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.571 1.148 . . . . 10.0 110.433 173.846 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.71 -4.19 58.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.104 . . . . 10.0 111.583 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.98 34.74 55.22 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.601 1.096 . . . . 10.0 111.274 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -156.98 160.56 39.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.274 1.037 . . . . 10.0 111.134 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -156.69 104.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.417 -2.438 . . . . 10.0 104.417 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.15 95.26 9.9 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.677 -1.601 . . . . 10.0 106.677 -175.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.9 91.84 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.336 1.065 . . . . 10.0 109.93 -169.056 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 m -77.83 84.51 4.14 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.933 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -106.26 178.36 4.58 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.457 0.703 . . . . 10.0 111.372 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.05 83.78 2.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 114.246 1.202 . . . . 10.0 114.246 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -36.0 4.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.904 -1.498 . . . . 10.0 113.036 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -65.72 -54.9 21.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.267 0.485 . . . . 10.0 110.74 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -82.02 -28.08 32.71 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.83 -0.544 . . . . 10.0 111.125 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.63 105.85 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.37 1.468 . . . . 10.0 108.948 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.34 152.28 29.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.404 -0.81 . . . . 10.0 109.663 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.4 -42.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.959 0.903 . . . . 10.0 112.496 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -47.93 83.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.607 0.763 . . . . 10.0 110.567 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.66 -44.57 73.41 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.078 0.951 . . . . 10.0 109.709 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.693 HG22 HG22 ' A' ' 24' ' ' VAL . 10.9 mm -62.64 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 122.177 0.989 . . . . 10.0 109.587 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.29 77.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.157 -0.929 . . . . 10.0 108.677 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.54 -43.44 97.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.676 -0.64 . . . . 10.0 109.711 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.94 83.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.725 -0.609 . . . . 10.0 110.451 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 24' ' ' VAL . 1.4 mt -51.13 -46.41 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.489 -0.757 . . . . 10.0 109.157 170.177 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.11 -42.74 60.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.963 0.801 . . . . 10.0 111.762 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.37 -41.56 93.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.192 0.52 . . . . 10.0 111.13 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -114.11 66.44 0.67 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.204 1.402 . . . . 10.0 110.606 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 103.5 0.63 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.45 -1.06 . . . . 10.0 110.45 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -74.33 54.3 0.56 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.496 1.518 . . . . 10.0 113.723 -169.365 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -106.04 79.31 1.4 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.441 -1.318 . . . . 10.0 107.441 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.76 ' CG2' HD22 ' A' ' 6' ' ' LEU . 13.9 p -156.18 104.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.711 -0.618 . . . . 10.0 110.653 172.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.18 -67.63 0.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.027 -0.987 . . . . 10.0 110.514 167.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt 160.03 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.162 2.185 . . . . 10.0 114.098 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.82 133.65 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.23 -0.919 . . . . 10.0 111.178 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.52 109.98 2.15 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.96 78.55 0.64 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.007 -0.837 . . . . 10.0 111.007 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.225 -1.369 . . . . 10.0 110.447 169.348 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -116.34 125.87 52.72 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.27 99.92 12.61 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.818 0.847 . . . . 10.0 109.493 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 70' ' ' ILE . 1.4 mtpt -134.35 175.62 9.35 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.963 0.347 . . . . 10.0 110.111 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -117.69 119.38 34.78 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -75.95 111.83 11.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.857 -2.275 . . . . 10.0 104.857 169.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.32 121.62 14.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.727 HG21 HG11 ' A' ' 20' ' ' VAL . 24.8 t -122.84 143.35 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 127.156 2.182 . . . . 10.0 108.5 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.47 117.13 29.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.844 1.657 . . . . 10.0 107.125 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 134.01 38.24 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.534 -1.026 . . . . 10.0 110.534 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -140.23 155.65 46.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.82 0.848 . . . . 10.0 109.19 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 77.96 -175.51 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.525 1.93 . . . . 10.0 112.038 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.1 m -60.91 -41.53 96.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.326 1.05 . . . . 10.0 110.668 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -142.22 -77.4 0.26 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.843 -0.599 . . . . 10.0 109.43 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 70.65 -52.21 0.67 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.811 1.645 . . . . 10.0 111.732 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.5 m 53.45 31.74 12.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.622 1.969 . . . . 10.0 108.373 -168.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 HD23 ' A' ' 37' ' ' LEU . 27.7 m 32.57 39.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 128.151 2.581 . . . . 10.0 112.251 -171.83 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -62.95 -21.65 66.23 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 119.367 -0.933 . . . . 10.0 112.876 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.32 -46.76 36.77 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.039 -1.038 . . . . 10.0 110.96 167.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.727 HG11 HG21 ' A' ' 8' ' ' VAL . 41.9 t -59.5 -30.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.251 1.42 . . . . 10.0 111.258 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -89.63 -56.95 3.05 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.9 m -60.48 -59.91 4.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.706 1.202 . . . . 10.0 111.48 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -53.91 50.61 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.68 0.673 . . . . 10.0 110.435 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 56' ' ' ILE . 74.6 t -59.35 -44.26 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.06 -14.79 3.05 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.034 -1.426 . . . . 10.0 114.876 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -87.22 -20.2 27.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.095 1.947 . . . . 10.0 109.293 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.27 128.59 37.13 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.706 -0.622 . . . . 10.0 111.004 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -46.99 -39.41 12.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.912 1.285 . . . . 10.0 111.901 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.37 -9.24 86.94 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 113.857 -1.519 . . . . 10.0 114.556 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.47 161.32 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 120.385 2.093 . . . . 10.0 112.048 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -140.96 -45.22 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.626 1.17 . . . . 10.0 111.421 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.49 42.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.4 58.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.138 . . . . 10.0 110.516 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -80.05 79.77 6.55 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.757 -1.214 . . . . 10.0 110.44 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.79 118.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.61 0.764 . . . . 10.0 110.584 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -144.65 64.67 1.29 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.054 -1.461 . . . . 10.0 107.054 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -56.04 -26.82 50.65 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.185 -0.947 . . . . 10.0 111.874 178.401 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 37' ' ' LEU . 38.8 mt-10 -63.34 -31.55 72.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.815 0.846 . . . . 10.0 110.195 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.26 -10.9 59.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.25 0.62 . . . . 10.0 111.351 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.44 20.72 79.51 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.743 -1.343 . . . . 10.0 109.743 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -151.63 117.79 5.58 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.703 0.801 . . . . 10.0 109.708 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG22 HG13 ' A' ' 44' ' ' VAL . 1.9 p -96.27 126.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 104.604 -2.369 . . . . 10.0 104.604 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.84 93.52 8.88 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -109.43 108.07 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.759 1.266 . . . . 10.0 109.013 -173.019 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 m -99.5 112.92 25.05 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.426 1.49 . . . . 10.0 107.379 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.476 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p90 -148.87 159.26 44.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.277 1.037 . . . . 10.0 113.558 -171.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.82 79.77 9.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.234 1.016 . . . . 10.0 112.337 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.09 -27.98 1.58 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.321 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.24 -56.6 10.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.346 0.521 . . . . 10.0 110.618 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -79.95 -39.23 30.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.798 -0.564 . . . . 10.0 110.639 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 107.67 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -68.16 152.81 44.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.49 0.662 . . . . 10.0 109.809 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 70' ' ' ILE . 5.7 t -41.18 -44.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.103 1.361 . . . . 10.0 112.539 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -49.78 67.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -58.84 -41.03 85.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.217 1.007 . . . . 10.0 109.972 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.504 HG22 HG22 ' A' ' 24' ' ' VAL . 15.3 mm -63.3 -45.09 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 121.684 -0.635 . . . . 10.0 109.636 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.92 97.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.602 -0.888 . . . . 10.0 108.602 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.06 -38.52 79.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.51 63.44 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.27 -48.83 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.59 -29.82 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.208 0.913 . . . . 10.0 111.91 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.95 -35.64 69.34 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.005 0.431 . . . . 10.0 110.689 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -100.0 -69.67 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.802 1.241 . . . . 10.0 112.732 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.26 -143.27 8.27 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.123 1.821 . . . . 10.0 109.314 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.9 51.99 0.11 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.085 1.443 . . . . 10.0 109.995 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.8 68.15 1.32 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 -172.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.54 78.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.428 0.558 . . . . 10.0 112.18 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.48 -66.55 0.24 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.637 0.775 . . . . 10.0 112.875 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt 162.04 171.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.907 2.083 . . . . 10.0 113.023 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -67.04 129.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.194 -0.316 . . . . 10.0 110.647 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.66 179.87 4.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.059 0.943 . . . . 10.0 109.469 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.62 -54.76 3.73 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.497 -0.613 . . . . 10.0 112.04 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 126.976 2.111 . . . . 10.0 111.191 -168.967 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 106.201 -1.778 . . . . 10.0 106.201 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.76 113.43 24.97 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -62.04 108.18 1.0 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.498 ' CB ' HD11 ' A' ' 70' ' ' ILE . 17.7 mtpp -127.59 173.13 10.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.852 0.751 . . . . 10.0 110.129 172.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -119.01 116.52 26.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.074 0.55 . . . . 10.0 109.932 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 70' ' ' ILE . 9.8 mt -78.34 110.83 13.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 170.082 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 116.82 3.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.211 -1.774 . . . . 10.0 106.211 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.677 HG21 HG11 ' A' ' 20' ' ' VAL . 26.4 t -122.87 146.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 125.328 1.451 . . . . 10.0 107.77 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.01 5.19 5.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.635 0.976 . . . . 10.0 113.635 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.45 -155.26 5.03 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.218 0.913 . . . . 10.0 111.875 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.2 mtm -117.93 -84.25 0.65 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.79 0.836 . . . . 10.0 109.859 171.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -162.73 67.5 0.22 Allowed 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.716 -0.615 . . . . 10.0 110.133 -173.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.8 t 70.88 135.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.898 1.679 . . . . 10.0 112.125 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 69.1 162.89 0.22 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.838 1.255 . . . . 10.0 110.764 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 53.48 32.32 13.86 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.636 0.774 . . . . 10.0 111.441 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.44 -93.25 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.183 1.393 . . . . 10.0 109.692 -168.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -60.23 162.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER 72.38 -53.19 0.7 Allowed 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.419 -0.8 . . . . 10.0 112.078 -169.847 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.6 -39.68 81.12 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.163 0.892 . . . . 10.0 110.741 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 8' ' ' VAL . 31.1 t -90.5 -28.31 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 10.0 110.224 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.14 -65.92 0.91 Allowed 'General case' 0 C--N 1.338 0.087 0 C-N-CA 122.912 0.485 . . . . 10.0 110.106 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m -52.84 -40.3 63.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.963 1.305 . . . . 10.0 110.134 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 m -59.51 -51.73 68.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.442 1.097 . . . . 10.0 110.671 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.594 ' CG2' HD11 ' A' ' 60' ' ' ILE . 78.9 t -65.76 -42.52 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.28 -11.8 3.76 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.666 1.603 . . . . 10.0 115.307 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.96 -23.63 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.711 1.756 . . . . 10.0 108.269 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.55 119.07 16.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 121.604 -0.685 . . . . 10.0 110.394 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -48.94 -36.37 17.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.169 0.985 . . . . 10.0 112.18 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 -9.26 77.0 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.934 1.254 . . . . 10.0 114.364 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -68.57 167.64 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.58 1.69 . . . . 10.0 111.957 174.089 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -138.26 -50.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.622 1.169 . . . . 10.0 110.847 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.55 145.03 51.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.163 -0.922 . . . . 10.0 108.643 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 56.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.511 1.124 . . . . 10.0 110.778 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.28 78.79 9.71 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 120.27 -1.519 . . . . 10.0 108.717 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.95 123.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.727 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -145.75 59.78 1.26 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.593 -1.632 . . . . 10.0 106.593 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.79 -21.56 64.69 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.567 -0.708 . . . . 10.0 111.586 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.06 -37.61 83.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.74 0.816 . . . . 10.0 109.563 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.83 -16.81 37.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.514 0.726 . . . . 10.0 110.845 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.52 39.26 61.28 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -158.1 95.71 1.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -86.85 120.09 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.899 -1.519 . . . . 10.0 106.899 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -86.32 99.92 11.93 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.714 1.143 . . . . 10.0 108.266 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.5 m -115.39 106.77 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.102 0.953 . . . . 10.0 108.753 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -99.73 114.72 28.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.687 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -146.8 154.01 40.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 124.034 0.834 . . . . 10.0 113.152 -174.39 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.91 94.43 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.894 0.854 . . . . 10.0 112.095 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.02 22.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.695 -1.139 . . . . 10.0 113.73 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.91 -52.18 61.08 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.229 1.377 . . . . 10.0 110.2 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -87.04 -48.83 7.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 -173.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.83 99.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.55 148.66 32.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.288 -0.634 . . . . 10.0 109.288 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 70' ' ' ILE . 14.7 t -36.7 -46.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.104 1.362 . . . . 10.0 113.866 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -51.32 -58.58 5.82 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -44.72 -44.8 9.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.486 1.514 . . . . 10.0 109.824 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.687 HG21 ' CE2' ' A' ' 46' ' ' PHE . 12.0 mm -65.43 -47.41 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.251 -0.906 . . . . 10.0 110.772 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.83 84.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -55.87 -39.47 71.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.128 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -35.57 70.15 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 67' ' ' VAL . 3.1 mp -66.01 -46.21 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 120.398 1.454 . . . . 10.0 107.616 169.318 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.02 -26.19 65.9 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.585 0.63 . . . . 10.0 112.011 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.54 -33.44 68.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.37 0.668 . . . . 10.0 110.766 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -110.39 -63.79 1.34 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.168 1.387 . . . . 10.0 112.086 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.8 -159.16 21.64 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.411 1.482 . . . . 10.0 109.412 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -151.76 57.16 0.86 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.182 1.491 . . . . 10.0 108.196 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.34 61.82 1.6 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.816 -1.179 . . . . 10.0 107.816 -167.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 60' ' ' ILE . 8.1 p -158.02 64.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 121.81 -0.556 . . . . 10.0 111.177 -177.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -25.75 -67.89 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.37 1.068 . . . . 10.0 113.224 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 171.65 170.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.373 1.869 . . . . 10.0 111.909 167.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.621 HG21 HG11 ' A' ' 53' ' ' VAL . 1.3 tp -68.41 140.42 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.847 -0.533 . . . . 10.0 111.103 174.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.36 156.72 30.76 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.494 1.118 . . . . 10.0 109.249 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 137.06 0.43 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.091 -1.204 . . . . 10.0 110.091 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CA ' ' HE ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 CA-C-O 116.005 -1.95 . . . . 10.0 107.105 -175.527 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.89 112.7 16.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.654 0.264 . . . . 10.0 110.65 -169.253 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.5 tt0 -64.07 108.7 1.6 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 172.864 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -134.62 168.47 18.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.601 0.715 . . . . 10.0 110.509 174.863 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 42' ' ' VAL . 22.9 m -113.54 107.64 16.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.931 -0.577 . . . . 10.0 109.638 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -77.27 79.26 3.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 170.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.74 124.14 0.69 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.855 1.262 . . . . 10.0 110.042 173.539 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 10' ' ' GLY . 1.5 p -126.3 133.87 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 126.389 1.875 . . . . 10.0 108.011 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -97.85 1.55 48.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.488 0.922 . . . . 10.0 113.488 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 8' ' ' VAL . . . 58.34 -157.02 19.7 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.429 1.014 . . . . 10.0 111.504 -173.992 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.36 -84.75 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.94 1.696 . . . . 10.0 108.213 176.376 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -163.71 -53.6 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 123.846 0.858 . . . . 10.0 109.815 -173.704 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.3 m -53.74 87.78 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.628 1.571 . . . . 10.0 111.677 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 52.34 46.9 25.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 10.0 109.024 -172.1 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 4.6 t60 -68.03 69.65 0.13 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.898 1.279 . . . . 10.0 108.527 170.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -153.76 172.79 16.75 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.797 1.639 . . . . 10.0 107.195 -175.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.8 79.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.835 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -40.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.175 1.39 . . . . 10.0 113.907 168.873 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.82 29.63 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.898 -1.126 . . . . 10.0 110.654 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 35' ' ' VAL . 94.8 t -70.43 -10.28 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.357 1.063 . . . . 10.0 110.49 -179.597 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.89 -71.54 0.46 Allowed 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 173.269 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -36.39 -47.81 0.62 Allowed 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.44 1.896 . . . . 10.0 112.474 -174.521 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -56.57 -57.81 10.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.18 0.992 . . . . 10.0 111.561 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 56' ' ' ILE . 49.4 t -66.28 -40.74 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.75 0.71 1.48 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.788 1.661 . . . . 10.0 115.197 173.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.1 -32.46 26.73 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.199 1.999 . . . . 10.0 108.608 173.028 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 56' ' ' ILE . 66.5 mt -72.73 119.22 16.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.992 -0.442 . . . . 10.0 110.753 -171.231 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.49 -34.47 36.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 122.112 0.958 . . . . 10.0 112.121 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -6.1 71.8 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.828 1.204 . . . . 10.0 114.27 178.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -67.25 162.75 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.566 1.683 . . . . 10.0 111.771 169.883 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -134.67 -44.96 0.74 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 10.0 111.563 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.37 148.68 44.8 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.43 1.092 . . . . 10.0 108.289 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.16 55.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.122 0.963 . . . . 10.0 111.504 -174.355 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 70.55 10.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.383 -1.448 . . . . 10.0 108.948 -177.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -61.57 124.61 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.742 -0.599 . . . . 10.0 110.078 173.167 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -141.01 62.18 1.48 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.47 -1.678 . . . . 10.0 106.47 169.772 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 38' ' ' GLU . 2.8 pp -57.34 -25.35 59.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.699 176.614 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.5 tt0 -60.39 -36.51 78.28 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.463 1.105 . . . . 10.0 109.66 175.328 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.96 19.9 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.213 1.005 . . . . 10.0 110.729 177.13 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.03 39.48 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.862 1.22 . . . . 10.0 111.851 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.09 123.61 26.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.641 -1.614 . . . . 10.0 106.641 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -112.46 105.38 18.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 126.159 1.783 . . . . 10.0 107.909 173.355 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.16 93.8 4.62 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.38 -0.97 . . . . 10.0 108.38 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -109.96 109.31 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.426 1.09 . . . . 10.0 109.396 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -100.4 123.29 44.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 174.782 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -150.08 160.97 43.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.686 -173.923 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.77 86.82 5.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.381 1.086 . . . . 10.0 112.484 -172.401 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.01 -27.01 6.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.977 -1.465 . . . . 10.0 113.392 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -43.22 -55.68 3.85 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 10.0 111.377 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -99.01 -39.59 8.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.991 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.26 101.64 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.43 149.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.504 -0.748 . . . . 10.0 109.654 -177.104 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 53' ' ' VAL . 2.0 m -36.67 -44.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.082 1.353 . . . . 10.0 114.042 172.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -50.87 72.0 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.645 -0.693 . . . . 10.0 109.663 174.961 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.54 -43.58 25.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.334 1.053 . . . . 10.0 110.151 175.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -65.61 -43.55 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.227 -0.921 . . . . 10.0 111.025 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.27 90.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -59.22 -41.73 89.32 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.97 63.93 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.994 0.738 . . . . 10.0 112.994 172.628 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.1 mp -64.84 -46.02 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 120.647 1.567 . . . . 10.0 108.693 169.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.85 -28.57 69.58 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.202 0.445 . . . . 10.0 112.202 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -31.77 61.63 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.96 -0.462 . . . . 10.0 111.878 171.932 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.45 -65.81 1.1 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.781 0.832 . . . . 10.0 111.447 -176.473 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.19 -155.63 15.12 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 108.438 -1.865 . . . . 10.0 108.438 -175.619 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -148.72 54.52 1.0 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 119.286 1.543 . . . . 10.0 107.33 172.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.16 65.44 1.56 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.038 -1.468 . . . . 10.0 107.038 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.5 p -150.62 96.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.126 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.76 -0.654 . . . . 10.0 109.362 167.755 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tttt 171.7 -174.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.369 1.068 . . . . 10.0 112.801 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 mm -68.3 120.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 O-C-N 121.801 -0.562 . . . . 10.0 109.722 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.98 96.53 4.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 176.774 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.73 165.6 38.82 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 122.239 0.911 . . . . 10.0 112.677 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 . . . . . 0 C--O 1.253 1.287 0 N-CA-C 106.679 -1.6 . . . . 10.0 106.679 168.548 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 121.133 0.492 . . . . 10.0 111.841 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 97.12 3.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.991 1.716 . . . . 10.0 107.983 178.299 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -70.07 98.63 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.746 1.218 . . . . 10.0 109.854 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 70' ' ' ILE . 39.7 mttt -135.7 166.51 23.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.193 0.597 . . . . 10.0 109.733 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -114.21 117.24 30.61 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.093 0.957 . . . . 10.0 108.827 175.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 12.2 mt -78.59 104.37 9.15 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 170.102 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -53.53 118.41 3.86 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.035 1.289 . . . . 10.0 108.564 175.942 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 20' ' ' VAL . 38.4 t -104.39 131.65 52.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 124.974 1.31 . . . . 10.0 109.869 177.192 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.75 74.04 0.85 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.23 125.02 7.46 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.856 -0.497 . . . . 10.0 111.856 -172.037 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 ttt -80.88 49.5 1.23 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.341 0.657 . . . . 10.0 112.442 -169.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t 42.68 67.39 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.048 1.339 . . . . 10.0 112.804 172.403 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.2 t -143.68 124.96 14.6 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.713 -0.617 . . . . 10.0 109.91 -176.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -63.78 -16.97 62.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -172.883 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -72.68 -27.84 62.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.844 0.457 . . . . 10.0 111.303 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.02 -155.58 0.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t 73.62 -68.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 127.123 2.169 . . . . 10.0 105.952 -173.082 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -63.61 -44.79 92.94 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.348 -0.842 . . . . 10.0 112.781 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.46 -52.7 44.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.296 0.953 . . . . 10.0 109.574 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 8' ' ' VAL . 16.9 t -60.21 -31.38 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.15 1.38 . . . . 10.0 110.873 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -72.85 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.31 1.044 . . . . 10.0 108.513 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 m -43.0 -44.8 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.991 2.116 . . . . 10.0 111.487 -175.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.7 m -54.1 -51.34 64.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.523 0.678 . . . . 10.0 111.063 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 56' ' ' ILE . 75.1 t -72.38 -44.04 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 176.074 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -12.73 4.32 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.268 1.413 . . . . 10.0 115.163 176.405 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 -25.63 31.24 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.989 1.394 . . . . 10.0 108.465 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.747 HD13 HD12 ' A' ' 56' ' ' ILE . 78.4 mt -62.47 122.71 16.44 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.383 0.611 . . . . 10.0 111.801 -176.073 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.27 -35.99 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.647 1.579 . . . . 10.0 112.286 169.344 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.92 -2.18 81.48 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.273 1.416 . . . . 10.0 114.891 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.04 156.99 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 120.55 2.175 . . . . 10.0 111.466 175.523 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.0 t -130.35 -47.04 1.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 110.912 176.496 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.6 146.04 35.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 178.296 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -143.33 58.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.658 1.183 . . . . 10.0 110.91 -176.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -79.28 76.03 5.84 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.589 -1.319 . . . . 10.0 108.87 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 120.7 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.214 1.005 . . . . 10.0 109.732 173.917 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 57.55 1.36 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 172.086 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -56.49 -28.55 60.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.83 75.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.737 1.215 . . . . 10.0 110.083 176.327 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -7.77 58.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.413 1.085 . . . . 10.0 111.523 178.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.82 38.78 60.46 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 -176.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -158.35 155.57 28.98 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.514 0.725 . . . . 10.0 109.263 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -146.38 118.68 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 103.617 -2.734 . . . . 10.0 103.617 172.373 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -88.34 108.39 19.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.422 -1.695 . . . . 10.0 106.422 172.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.09 90.21 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 -176.737 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -83.73 108.66 16.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.982 -1.858 . . . . 10.0 105.982 174.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -129.37 178.21 6.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.05 -0.977 . . . . 10.0 110.431 -176.261 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.14 89.88 3.19 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.135 -0.978 . . . . 10.0 113.481 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.88 -33.04 34.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.772 -1.558 . . . . 10.0 112.38 177.13 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.13 -50.41 64.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.802 0.441 . . . . 10.0 110.602 -178.306 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -78.23 -37.86 44.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -142.59 111.08 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.697 1.199 . . . . 10.0 108.104 -177.228 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -70.84 149.84 46.4 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.115 -0.991 . . . . 10.0 110.516 -172.16 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 70' ' ' ILE . 4.3 t -31.11 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.8 1.64 . . . . 10.0 114.022 172.727 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -50.86 -62.32 1.68 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -42.65 -42.26 3.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.104 0.962 . . . . 10.0 110.609 177.894 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 27' ' ' LEU . 1.7 mm -70.29 -44.22 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.588 -0.695 . . . . 10.0 110.628 -177.436 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.74 71.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.78 -38.78 70.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.902 1.281 . . . . 10.0 108.997 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.41 71.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.91 -0.493 . . . . 10.0 112.271 175.139 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.19 -44.35 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.798 1.181 . . . . 10.0 108.141 170.244 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.82 -30.14 68.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.453 0.569 . . . . 10.0 112.425 -178.473 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.5 -26.2 68.41 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.529 -0.732 . . . . 10.0 111.971 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -58.19 1.92 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.297 1.439 . . . . 10.0 111.685 -170.646 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.31 -156.78 8.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.033 -2.027 . . . . 10.0 108.033 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -146.88 56.08 1.13 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.468 1.634 . . . . 10.0 109.812 175.924 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.64 65.65 1.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -150.07 98.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 171.227 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -54.14 -73.01 0.05 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.303 169.298 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 174.08 173.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.606 1.562 . . . . 10.0 110.795 169.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -66.97 132.55 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 O-C-N 121.59 -0.694 . . . . 10.0 109.793 175.069 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.06 157.04 24.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 170.692 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.16 56.27 3.99 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.653 -0.979 . . . . 10.0 110.653 176.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtt-85 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.661 -167.58 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ttt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 118.521 -0.752 . . . . 10.0 109.901 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.99 104.17 6.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.379 1.072 . . . . 10.0 111.725 -170.113 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -73.69 104.25 4.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.999 1.319 . . . . 10.0 109.902 169.484 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 175.45 9.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.641 0.776 . . . . 10.0 110.556 172.352 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -113.83 108.16 16.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.824 1.25 . . . . 10.0 110.029 175.308 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 tp -85.63 73.63 10.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.497 1.119 . . . . 10.0 109.054 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -35.2 119.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.268 1.427 . . . . 10.0 111.88 -173.048 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 HG11 ' A' ' 20' ' ' VAL . 65.3 t -99.82 123.04 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.637 1.975 . . . . 10.0 109.987 177.429 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -84.78 133.05 34.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.399 -1.704 . . . . 10.0 106.399 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.41 99.17 2.04 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.267 0.939 . . . . 10.0 111.692 -179.058 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -178.5 3.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.407 1.083 . . . . 10.0 108.874 169.962 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 m 67.61 -58.78 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.173 2.189 . . . . 10.0 113.872 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.9 t 78.6 124.53 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 127.473 2.309 . . . . 10.0 110.539 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 69.88 -52.63 0.63 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.378 1.871 . . . . 10.0 112.323 -175.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -77.72 51.58 0.93 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 10.0 110.667 -178.687 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p -161.78 -167.34 1.67 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 127.02 2.128 . . . . 10.0 107.118 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t 72.69 -70.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 C-N-CA 126.828 2.051 . . . . 10.0 106.32 -171.876 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.26 -38.03 87.71 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.762 -1.108 . . . . 10.0 112.483 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 63' ' ' GLN . . . -56.2 -53.41 57.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.817 0.818 . . . . 10.0 109.733 -175.512 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 8' ' ' VAL . 35.7 t -54.19 -47.85 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.939 1.295 . . . . 10.0 109.222 173.743 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -61.12 2.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.26 -169.293 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -48.21 -51.12 26.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.25 1.42 . . . . 10.0 111.056 171.883 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -59.17 -59.62 5.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.649 1.113 . . . . 10.0 110.481 -169.201 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 56' ' ' ILE . 78.9 t -62.46 -36.78 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.335 -0.848 . . . . 10.0 108.899 178.024 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.65 -12.0 25.14 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.141 -1.366 . . . . 10.0 115.113 172.578 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -81.74 -18.1 45.45 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.434 2.117 . . . . 10.0 109.114 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 56' ' ' ILE . 37.7 mt -70.41 112.07 6.43 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.228 0.537 . . . . 10.0 110.195 -175.115 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -41.2 -40.76 1.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.795 1.638 . . . . 10.0 113.152 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.93 -15.79 79.6 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.546 -1.206 . . . . 10.0 114.147 -178.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -67.09 149.96 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.561 1.681 . . . . 10.0 112.133 -174.919 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -111.92 -51.12 2.87 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 10.0 110.878 177.306 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ALA . . . . . 0.533 ' HB3' ' OG ' ' A' ' 45' ' ' SER . . . -140.7 146.79 38.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.443 0.697 . . . . 10.0 109.2 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -146.65 88.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 128.072 2.549 . . . . 10.0 105.108 -173.491 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -114.54 71.74 0.77 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.011 1.324 . . . . 10.0 110.662 -176.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.5 132.06 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.298 -0.876 . . . . 10.0 111.091 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -143.65 57.1 1.36 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 174.139 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.16 -28.97 69.5 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.567 -0.708 . . . . 10.0 111.552 -171.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.631 0.772 . . . . 10.0 111.043 174.521 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 -3.7 58.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.8 0.84 . . . . 10.0 111.5 176.254 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.39 36.91 78.95 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -175.839 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.91 161.42 41.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.823 0.82 . . . . 10.0 109.687 -177.099 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -155.03 121.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 101.665 -3.457 . . . . 10.0 101.665 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -99.6 103.37 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 120.71 1.595 . . . . 10.0 106.754 177.262 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -122.46 99.19 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.641 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -87.84 95.67 10.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 172.979 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -121.32 155.85 33.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.982 -1.008 . . . . 10.0 110.69 -176.997 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 10.6 t0 -91.61 90.84 7.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.036 0.754 . . . . 10.0 113.036 -172.292 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.81 -30.22 2.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.009 -1.45 . . . . 10.0 113.756 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -64.37 -52.83 56.34 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.13 0.877 . . . . 10.0 110.035 -178.396 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -37.9 35.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 -174.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -144.19 104.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.49 1.116 . . . . 10.0 107.996 -175.513 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.15 150.17 26.05 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 123.453 0.701 . . . . 10.0 111.098 -173.456 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.6 m -40.95 -44.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.446 1.099 . . . . 10.0 113.67 173.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -54.5 -56.26 20.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 171.917 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.69 -42.79 46.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.241 1.416 . . . . 10.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 24' ' ' VAL . 3.0 mm -63.32 -47.65 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.411 -0.806 . . . . 10.0 110.522 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.89 81.22 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -63.7 -40.37 96.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.721 -0.612 . . . . 10.0 109.468 175.421 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.14 88.64 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.384 -0.823 . . . . 10.0 111.146 177.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 24' ' ' VAL . 2.2 mt -55.33 -40.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 120.905 -1.122 . . . . 10.0 109.0 170.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -47.42 72.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.922 0.783 . . . . 10.0 110.282 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.83 -56.7 18.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.478 0.656 . . . . 10.0 109.858 175.468 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 20.6 mt-30 -94.53 67.54 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.353 0.661 . . . . 10.0 110.47 -177.301 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.99 97.06 0.26 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.023 -0.99 . . . . 10.0 111.38 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -65.95 105.11 1.24 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.728 0.775 . . . . 10.0 110.334 -175.729 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -148.94 76.63 1.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 169.14 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.92 105.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 O-C-N 121.152 -0.967 . . . . 10.0 111.129 175.124 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -60.46 -67.61 0.38 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.965 170.569 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttt 157.25 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.746 2.418 . . . . 10.0 112.949 173.889 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.53 107.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.147 0.979 . . . . 10.0 109.576 -173.363 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 81.34 2.8 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.12 110.89 2.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.258 -1.537 . . . . 10.0 109.258 -175.563 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 C--O 1.254 1.294 0 CA-C-O 115.992 -1.956 . . . . 10.0 105.971 171.458 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 ttp . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pm0 -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -78.16 117.07 19.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' CB ' HD12 ' A' ' 70' ' ' ILE . 2.8 mtpt -130.35 166.13 21.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.482 -1.303 . . . . 10.0 107.482 174.325 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 42' ' ' VAL . 86.0 m -129.78 108.85 10.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.573 -0.529 . . . . 10.0 109.573 -174.121 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.2 mt -76.86 92.75 3.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.39 111.79 0.46 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.068 -1.086 . . . . 10.0 108.068 172.573 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 6' ' ' LEU . 6.6 m -113.02 144.69 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.949 1.7 . . . . 10.0 109.493 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.53 80.02 1.43 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.509 -1.664 . . . . 10.0 106.509 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.15 94.43 0.05 OUTLIER Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.999 1.285 . . . . 10.0 112.457 -171.169 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.8 ttt -114.53 67.74 0.69 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.846 0.823 . . . . 10.0 110.362 -169.63 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -163.68 -170.74 2.29 Favored 'General case' 0 CA--C 1.527 0.076 0 O-C-N 121.618 -0.676 . . . . 10.0 109.327 -178.26 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.9 m -93.04 -132.17 0.14 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 105.707 -1.96 . . . . 10.0 105.707 168.315 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -64.1 -39.56 94.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.144 -0.973 . . . . 10.0 111.944 178.707 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.62 82.93 6.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.524 -0.735 . . . . 10.0 110.603 -171.025 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -159.45 -39.65 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.72 0.808 . . . . 10.0 111.617 168.755 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -45.18 -53.84 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.428 0.632 . . . . 10.0 110.107 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -29.9 70.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.547 0.573 . . . . 10.0 112.547 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -58.66 6.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 8' ' ' VAL . 70.3 t -54.86 -34.15 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.409 0.684 . . . . 10.0 110.174 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.92 -73.77 0.16 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.809 0.844 . . . . 10.0 109.704 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.1 m -44.92 -45.1 10.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.926 1.69 . . . . 10.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 m -53.48 -55.14 27.81 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.817 0.818 . . . . 10.0 110.709 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 56' ' ' ILE . 72.5 t -72.15 -25.0 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 123.65 0.78 . . . . 10.0 110.701 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 4.2 69.38 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.061 1.315 . . . . 10.0 112.688 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.66 -45.1 17.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.087 1.444 . . . . 10.0 107.447 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.473 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 118.82 4.89 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -176.39 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.66 -35.66 14.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.692 1.197 . . . . 10.0 111.963 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.72 -3.54 83.79 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.883 1.23 . . . . 10.0 114.326 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 158.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.902 1.851 . . . . 10.0 111.527 170.1 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -133.93 -46.3 0.79 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.253 . . . . 10.0 110.897 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.33 46.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.291 -1.003 . . . . 10.0 108.291 173.519 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -142.9 58.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 110.255 -174.506 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.92 67.7 5.79 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.355 -0.841 . . . . 10.0 109.964 -172.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.5 129.77 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.579 1.152 . . . . 10.0 109.907 178.661 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -155.61 55.51 0.62 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.69 -18.47 65.39 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.715 -0.615 . . . . 10.0 110.493 -175.342 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -36.17 82.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.498 1.119 . . . . 10.0 109.711 171.28 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 -29.02 43.68 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.032 -0.359 . . . . 10.0 110.032 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.94 22.9 7.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 10.0 111.464 174.925 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 5' ' ' THR . 4.3 mtpt -148.67 174.65 11.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.407 1.083 . . . . 10.0 108.255 -178.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -158.99 99.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -177.941 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -80.94 90.88 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.737 -1.209 . . . . 10.0 107.737 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -103.22 101.19 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.135 1.374 . . . . 10.0 108.733 -174.749 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -89.11 107.61 19.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.791 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -141.89 156.59 45.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.313 0.578 . . . . 10.0 112.447 -176.15 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -81.93 90.7 6.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.869 1.063 . . . . 10.0 113.869 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.72 -27.08 1.79 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.92 -1.491 . . . . 10.0 113.353 169.071 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.49 -55.22 9.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.607 1.094 . . . . 10.0 110.342 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -77.22 -38.75 50.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 -175.006 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.99 98.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -176.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.45 148.2 46.32 Favored 'General case' 0 C--O 1.219 -0.52 0 O-C-N 121.497 -0.752 . . . . 10.0 109.091 -175.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 70' ' ' ILE . 70.7 t -28.65 -52.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 125.986 1.714 . . . . 10.0 112.843 168.262 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -48.29 -54.01 15.24 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 123.364 0.665 . . . . 10.0 109.443 177.633 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.34 -46.63 62.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.01 2.124 . . . . 10.0 109.132 177.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 46' ' ' PHE . 8.8 mm -67.3 -45.15 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.752 -0.592 . . . . 10.0 110.88 -176.353 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.66 90.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.877 -0.786 . . . . 10.0 108.877 -178.945 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.82 -38.88 76.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 175.87 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.51 73.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.767 -0.635 . . . . 10.0 112.285 172.812 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.51 -47.29 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 120.203 1.365 . . . . 10.0 107.825 169.642 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.38 -34.5 66.75 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.607 1.094 . . . . 10.0 111.614 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.48 -30.01 66.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.503 -0.748 . . . . 10.0 112.022 176.29 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.27 -62.23 1.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.992 1.717 . . . . 10.0 112.108 -169.524 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.07 -147.03 6.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.437 1.97 . . . . 10.0 108.551 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.48 54.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.152 1.476 . . . . 10.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -124.47 58.17 1.22 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 -177.139 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -139.77 100.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 121.221 -0.924 . . . . 10.0 110.766 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.87 -77.24 0.06 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.252 -0.885 . . . . 10.0 109.77 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.61 175.04 0.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.752 1.39 . . . . 10.0 114.752 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.503 HD12 ' CB ' ' A' ' 4' ' ' LYS . 7.7 mm -68.98 113.12 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.674 0.79 . . . . 10.0 109.168 178.139 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.8 115.17 0.98 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.896 0.879 . . . . 10.0 109.479 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.42 -20.49 18.44 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.758 -1.023 . . . . 10.0 113.562 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.853 -1.546 . . . . 10.0 109.873 174.036 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 118.123 -0.941 . . . . 10.0 109.164 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -120.6 114.52 21.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.22 1.408 . . . . 10.0 108.49 174.276 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -79.53 88.86 5.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.259 1.024 . . . . 10.0 110.282 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -125.21 175.87 7.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.505 0.593 . . . . 10.0 111.965 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -119.78 109.65 15.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.658 0.783 . . . . 10.0 109.205 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -82.87 101.8 11.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 177.625 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 124.11 20.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.44 -0.948 . . . . 10.0 108.44 -175.318 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.517 HG21 HG11 ' A' ' 20' ' ' VAL . 9.2 t -127.59 145.34 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.827 2.451 . . . . 10.0 107.275 -175.528 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -136.63 112.81 9.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.736 1.214 . . . . 10.0 107.917 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.15 -37.0 92.21 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.086 -0.841 . . . . 10.0 113.969 -169.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mtt 23.24 60.99 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.142 2.177 . . . . 10.0 113.877 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 t -148.48 -94.52 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 -173.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -161.14 -53.41 0.05 OUTLIER 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.613 0.365 . . . . 10.0 110.431 175.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -160.6 -47.59 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.183 0.593 . . . . 10.0 110.119 176.714 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -72.66 72.84 1.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.494 0.717 . . . . 10.0 111.53 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.78 -44.26 0.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.548 1.139 . . . . 10.0 110.76 170.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -38.87 -50.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 10.0 112.086 178.777 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -31.67 66.62 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.08 69.73 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 120.869 -1.145 . . . . 10.0 109.28 -178.632 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 8' ' ' VAL . 64.9 t -54.98 -40.79 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.133 -0.94 . . . . 10.0 109.615 176.571 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -58.51 6.77 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.935 0.894 . . . . 10.0 108.695 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 m -48.35 -49.74 33.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.683 0.793 . . . . 10.0 110.879 173.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -59.57 -58.76 7.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.451 0.643 . . . . 10.0 109.51 -170.437 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.883 ' CG2' HD11 ' A' ' 60' ' ' ILE . 95.1 t -71.15 -18.12 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.809 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.44 82.58 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.702 1.144 . . . . 10.0 112.907 178.567 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.25 -44.34 16.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.131 1.466 . . . . 10.0 107.654 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -56.94 122.22 11.77 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.04 -0.527 . . . . 10.0 112.409 -174.368 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.91 -36.46 38.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.271 1.034 . . . . 10.0 111.538 169.972 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.35 -3.05 64.69 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.224 -1.353 . . . . 10.0 114.038 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -67.82 157.85 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 120.165 1.983 . . . . 10.0 111.772 169.904 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 m -129.84 -44.28 1.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.152 1.381 . . . . 10.0 111.649 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.03 146.57 33.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.777 -1.106 . . . . 10.0 108.328 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.27 58.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.483 1.113 . . . . 10.0 111.172 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.73 74.57 6.42 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.4 -1.437 . . . . 10.0 109.723 -176.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.53 118.05 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 124.517 1.127 . . . . 10.0 111.507 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -142.27 63.35 1.41 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 174.131 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.51 -22.78 65.43 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.653 -0.655 . . . . 10.0 111.627 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.48 -34.43 77.13 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.028 0.931 . . . . 10.0 110.386 172.675 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.69 41.88 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 10.0 110.264 171.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.09 21.99 43.57 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.946 1.26 . . . . 10.0 110.667 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -153.63 105.64 2.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 -174.644 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 44' ' ' VAL . 1.9 m -89.08 128.67 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.006 -1.849 . . . . 10.0 106.006 170.451 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.24 97.84 10.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 177.722 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 42' ' ' VAL . 1.4 m -119.99 99.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 -168.399 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -92.63 116.45 29.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.426 -1.694 . . . . 10.0 106.426 176.613 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.1 p90 -147.05 151.78 37.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.699 1.25 . . . . 10.0 112.103 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -86.97 88.09 7.62 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.063 0.935 . . . . 10.0 112.655 -169.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.13 -30.34 2.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.496 1.518 . . . . 10.0 112.739 175.95 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.63 -56.94 7.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.122 0.969 . . . . 10.0 111.56 174.903 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -50.34 6.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -172.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.03 99.04 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.53 148.11 34.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.742 -0.836 . . . . 10.0 108.742 -176.821 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -32.66 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.823 1.649 . . . . 10.0 111.553 168.521 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -55.85 -55.61 30.49 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 119.072 -0.489 . . . . 10.0 110.47 175.944 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -46.78 -46.28 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.464 0.706 . . . . 10.0 110.124 173.088 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 24' ' ' VAL . 14.7 mm -64.04 -51.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 121.85 -0.531 . . . . 10.0 110.128 -177.535 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.58 87.37 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -62.5 -35.86 80.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.543 0.737 . . . . 10.0 109.279 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.6 67.3 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.197 -0.939 . . . . 10.0 112.271 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.883 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.5 mp -70.97 -44.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 168.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.92 -36.28 67.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.355 1.434 . . . . 10.0 111.549 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -55.59 -30.79 61.47 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.132 0.424 . . . . 10.0 112.116 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.05 83.48 1.74 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.448 1.099 . . . . 10.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 60' ' ' ILE . . . 96.37 109.36 2.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.899 -0.88 . . . . 10.0 110.899 172.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -77.32 57.51 1.49 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.307 1.043 . . . . 10.0 112.878 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -120.77 65.7 0.85 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 10.0 109.765 -168.174 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 6' ' ' LEU 0.273 0.9 OUTLIER -142.42 92.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 122.363 1.078 . . . . 10.0 110.337 -174.086 . . . . . . . . 4 4 . 1 . 025 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.59 -23.74 66.24 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.702 -1.135 . . . . 10.0 111.561 169.811 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.0 tttt 107.15 165.75 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.4 2.28 . . . . 10.0 112.16 168.39 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -64.86 128.19 27.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 O-C-N 121.119 -0.988 . . . . 10.0 110.455 -178.494 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.39 165.35 16.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.604 -0.725 . . . . 10.0 110.999 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.34 100.15 0.14 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.298 -1.121 . . . . 10.0 110.298 175.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 105.287 -2.116 . . . . 10.0 105.287 -173.458 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 6.1 ttt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 111.839 0.311 . . . . 10.0 111.839 . . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.06 154.72 42.16 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 122.674 0.39 . . . . 10.0 111.364 176.643 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.37 114.46 21.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.18 1.792 . . . . 10.0 107.864 169.352 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LYS . . . . . 0.758 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.9 mttp -137.91 175.34 9.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.13 0.877 . . . . 10.0 110.083 176.616 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 42' ' ' VAL . 5.7 m -123.83 109.55 13.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.514 -0.755 . . . . 10.0 109.162 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 67' ' ' VAL . 1.2 mt -82.61 90.78 6.84 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 121.77 6.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 20' ' ' VAL . 27.2 t -102.72 130.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.256 2.222 . . . . 10.0 108.867 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -82.41 -17.09 46.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.022 1.392 . . . . 10.0 113.483 178.34 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.36 -153.97 38.65 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 109.242 -1.543 . . . . 10.0 109.242 -168.059 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mtp 65.52 80.58 0.22 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.366 1.066 . . . . 10.0 111.626 176.717 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 t -140.9 -69.85 0.38 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.827 -0.546 . . . . 10.0 110.003 175.439 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t -154.72 -77.65 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.688 0.676 . . . . 10.0 111.023 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.25 132.97 6.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.542 -1.281 . . . . 10.0 107.542 179.11 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -177.69 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.974 1.31 . . . . 10.0 108.098 -175.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.1 m 69.97 -68.6 0.19 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.329 1.452 . . . . 10.0 109.07 -176.491 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -149.16 82.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 -178.633 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.44 -47.75 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 174.493 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.68 -63.35 1.15 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.969 1.259 . . . . 10.0 111.254 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 8' ' ' VAL . 91.4 t -50.09 -36.33 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.784 1.633 . . . . 10.0 110.758 174.478 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.75 -57.24 11.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.92 0.888 . . . . 10.0 108.662 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -50.37 -51.89 41.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.163 0.985 . . . . 10.0 110.093 177.903 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -57.28 -54.26 48.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.091 0.948 . . . . 10.0 111.165 -168.357 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.749 HG22 HG22 ' A' ' 56' ' ' ILE . 74.0 t -70.85 -41.6 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.189 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.58 -7.93 12.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.152 1.358 . . . . 10.0 114.286 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.73 -24.06 36.35 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.184 1.492 . . . . 10.0 107.823 176.817 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' CD1' HD12 ' A' ' 56' ' ' ILE . 71.9 mt -66.18 121.55 15.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.623 -0.673 . . . . 10.0 111.547 -176.644 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -47.71 -34.32 8.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.077 1.351 . . . . 10.0 112.125 169.735 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 0.88 87.39 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.317 1.437 . . . . 10.0 114.729 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.46 157.15 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 120.578 2.189 . . . . 10.0 111.768 173.881 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -126.48 -44.47 1.7 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.714 1.205 . . . . 10.0 111.968 174.039 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.96 146.87 32.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.041 -0.98 . . . . 10.0 108.439 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -143.22 59.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 10.0 111.866 -177.344 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.62 73.84 6.31 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 120.431 -1.418 . . . . 10.0 110.29 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.96 124.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 123.858 0.863 . . . . 10.0 111.298 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -146.74 58.24 1.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 171.25 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 38' ' ' GLU . 4.4 pp -56.21 -28.33 57.94 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.717 -0.615 . . . . 10.0 111.173 178.758 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.8 tt0 -63.62 -27.16 69.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.169 1.388 . . . . 10.0 111.144 177.179 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.03 -1.76 51.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.201 1.4 . . . . 10.0 111.852 173.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.29 71.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.906 1.241 . . . . 10.0 111.291 -177.074 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.18 153.39 27.57 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 117.991 0.896 . . . . 10.0 109.387 -177.813 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.04 101.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.846 -2.279 . . . . 10.0 104.846 -175.491 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.27 102.09 12.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 -174.815 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.9 m -118.89 106.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 124.879 1.272 . . . . 10.0 108.386 -172.317 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -96.56 119.42 35.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.442 -1.688 . . . . 10.0 106.442 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -150.0 157.34 43.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.065 0.936 . . . . 10.0 113.074 -174.317 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.13 82.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.711 -1.132 . . . . 10.0 113.706 -172.182 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.49 -28.57 0.59 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.925 -1.489 . . . . 10.0 113.501 168.307 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.6 m-20 -78.49 -43.63 26.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.063 0.847 . . . . 10.0 110.266 -172.598 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -78.96 -47.63 15.99 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.151 0.887 . . . . 10.0 109.169 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 108.86 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 -174.977 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.91 154.38 41.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -175.368 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 70' ' ' ILE . 70.9 t -27.34 -55.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 126.662 1.985 . . . . 10.0 113.288 168.926 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HE3' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -49.74 -48.39 50.2 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 118.437 0.562 . . . . 10.0 110.002 179.713 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -57.19 -42.6 81.52 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.922 1.289 . . . . 10.0 108.46 -179.051 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.749 HG22 HG22 ' A' ' 24' ' ' VAL . 5.4 mm -67.31 -43.99 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 120.365 -0.534 . . . . 10.0 109.734 -178.345 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.28 84.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 -176.08 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -54.48 -41.66 69.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.528 1.131 . . . . 10.0 108.848 177.463 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.911 -0.493 . . . . 10.0 112.029 175.708 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.71 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -62.55 -43.69 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.773 1.169 . . . . 10.0 108.572 170.647 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.21 -34.76 68.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.668 1.576 . . . . 10.0 111.693 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.33 69.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.773 0.715 . . . . 10.0 112.447 172.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -133.18 65.44 1.59 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.959 1.704 . . . . 10.0 111.342 -176.045 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 117.93 4.13 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.424 1.011 . . . . 10.0 110.843 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.24 55.92 2.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.381 1.091 . . . . 10.0 111.47 -169.973 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.99 64.19 0.86 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.739 1.216 . . . . 10.0 108.406 -170.611 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 HD22 ' A' ' 6' ' ' LEU 0.266 0.4 OUTLIER -149.62 93.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 120.593 -1.317 . . . . 10.0 110.694 -178.225 . . . . . . . . 4 4 . 1 . 026 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.68 -73.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.654 169.821 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm 172.28 176.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.67 2.388 . . . . 10.0 108.894 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.758 HD12 ' HB3' ' A' ' 4' ' ' LYS . 8.0 mm -64.2 133.14 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 123.909 0.884 . . . . 10.0 109.803 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -59.3 112.54 1.77 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 170.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.8 -11.5 64.43 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 117.848 -1.529 . . . . 10.0 115.966 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 120.562 2.181 . . . . 10.0 108.934 -172.251 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -119.64 111.35 17.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.261 0.625 . . . . 10.0 110.017 -172.399 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -69.13 102.74 1.72 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.124 0.969 . . . . 10.0 109.639 169.459 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -128.33 169.4 14.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 121.466 0.651 . . . . 10.0 110.387 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -110.4 115.26 29.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.631 HD11 ' HB ' ' A' ' 67' ' ' VAL . 17.1 tp -83.38 107.3 15.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.118 -1.808 . . . . 10.0 106.118 169.347 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 4.4 tm0? -56.39 117.1 3.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.482 -1.673 . . . . 10.0 106.482 173.531 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.32 119.09 59.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 176.927 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -83.76 -23.93 31.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.785 1.234 . . . . 10.0 113.84 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.21 -176.19 3.89 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.477 1.513 . . . . 10.0 111.564 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.8 mtp -108.03 -83.12 0.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.691 0.796 . . . . 10.0 108.932 169.204 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -169.94 -178.47 2.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 -176.868 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t 54.65 -161.44 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.972 1.709 . . . . 10.0 111.784 177.574 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -103.05 179.87 4.15 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 10.0 108.823 177.668 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 m170 69.92 24.69 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.417 1.487 . . . . 10.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.51 -64.8 1.05 Allowed 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.785 1.234 . . . . 10.0 108.958 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.5 t -32.49 -62.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.661 1.984 . . . . 10.0 110.511 177.382 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.23 -34.53 78.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.07 -0.49 . . . . 10.0 112.093 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.12 74.76 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.832 1.196 . . . . 10.0 109.875 -178.628 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.24 -41.79 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 174.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -63.11 -65.86 0.62 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.977 1.311 . . . . 10.0 109.494 -175.461 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 m -43.6 -47.02 7.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.082 1.753 . . . . 10.0 110.195 174.695 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 m -67.6 -45.12 76.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 119.029 0.831 . . . . 10.0 111.162 -173.999 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.865 HG22 HD11 ' A' ' 60' ' ' ILE . 98.6 t -65.22 -20.45 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 121.31 -0.869 . . . . 10.0 110.38 169.511 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.87 15.42 60.76 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.034 1.302 . . . . 10.0 112.677 -172.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.51 -44.69 11.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 178.392 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -60.39 126.0 25.81 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.193 -0.912 . . . . 10.0 112.352 -174.686 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.01 -35.81 36.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.24 1.416 . . . . 10.0 111.282 172.247 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.92 -9.14 75.13 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.526 -1.215 . . . . 10.0 113.738 179.155 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.24 158.93 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 120.115 1.957 . . . . 10.0 112.674 172.461 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.7 t -133.7 -45.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.832 1.253 . . . . 10.0 111.588 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.31 37.43 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.452 1.101 . . . . 10.0 108.473 177.104 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.53 55.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.841 0.856 . . . . 10.0 111.042 -173.812 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -85.91 68.89 10.48 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.702 -1.248 . . . . 10.0 109.257 -170.387 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.32 118.59 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 10.0 110.221 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -136.02 59.21 1.72 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.93 -28.47 51.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.003 -0.544 . . . . 10.0 111.284 -179.419 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -62.76 -36.35 82.79 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.951 0.9 . . . . 10.0 110.946 174.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -8.09 59.28 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.048 0.939 . . . . 10.0 111.236 174.167 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.33 30.27 57.09 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.441 1.02 . . . . 10.0 110.63 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -158.21 161.85 37.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.921 0.867 . . . . 10.0 110.581 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 44' ' ' VAL . 42.8 t -150.03 125.98 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.367 -3.197 . . . . 10.0 102.367 -172.47 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -105.48 93.44 4.67 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 120.056 1.298 . . . . 10.0 107.749 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 42' ' ' VAL . 2.2 m -105.15 107.56 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -178.634 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -97.84 114.91 27.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 172.918 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -144.8 153.53 41.73 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.379 0.609 . . . . 10.0 110.929 -177.463 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.19 77.12 6.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.822 -168.486 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.23 -37.35 0.63 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.168 1.787 . . . . 10.0 113.605 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.88 -55.42 26.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.436 1.095 . . . . 10.0 111.272 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -84.21 -42.52 15.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.501 0.72 . . . . 10.0 109.969 -173.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.7 99.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 143.82 57.17 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 121.47 -0.769 . . . . 10.0 109.15 -175.38 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 m -38.88 -45.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.973 1.309 . . . . 10.0 113.562 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -55.67 29.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.612 0.765 . . . . 10.0 110.692 172.379 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -47.95 -38.71 17.32 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.25 1.02 . . . . 10.0 111.044 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.9 mm -68.05 -53.15 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.326 -0.99 . . . . 10.0 108.326 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -50.02 -47.29 53.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.43 -38.44 87.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.153 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.73 82.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.645 -0.66 . . . . 10.0 111.004 176.923 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.865 HD11 HG22 ' A' ' 24' ' ' VAL . 4.0 mp -65.07 -42.71 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 117.766 -1.111 . . . . 10.0 108.965 169.537 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -61.15 -21.54 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.201 1.364 . . . . 10.0 113.032 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.44 -33.7 76.57 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 10.0 111.644 169.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 -61.78 1.33 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.987 1.715 . . . . 10.0 112.086 -170.781 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.22 -151.69 10.04 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 127.104 2.288 . . . . 10.0 109.082 176.947 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -159.19 66.54 0.41 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.067 1.434 . . . . 10.0 108.981 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -146.47 55.64 1.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 -168.309 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 6' ' ' LEU . 17.0 m -153.6 58.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.698 -0.626 . . . . 10.0 110.543 -172.874 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -26.33 -70.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.789 1.236 . . . . 10.0 112.544 176.998 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.92 173.0 0.61 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.438 1.095 . . . . 10.0 111.804 169.821 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 HD13 ' A' ' 6' ' ' LEU . 1.2 mp -77.26 128.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 122.972 0.509 . . . . 10.0 111.456 178.455 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -60.85 93.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 170.313 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 0.32 23.39 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.106 -1.386 . . . . 10.0 115.204 169.662 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.275 -1.345 . . . . 10.0 113.133 176.297 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -145.0 156.06 43.73 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 -171.574 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 50.9 tt0 -91.26 123.86 35.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.746 1.218 . . . . 10.0 109.995 173.489 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.52 173.03 12.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.834 0.309 . . . . 10.0 111.834 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 42' ' ' VAL . 9.9 m -116.53 107.83 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.431 0.693 . . . . 10.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.648 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.6 mt -81.68 88.48 6.25 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 174.927 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.19 115.72 1.07 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.434 1.094 . . . . 10.0 109.553 -177.729 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -82.5 129.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.709 1.604 . . . . 10.0 112.258 178.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.74 94.96 9.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 169.215 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.51 100.42 0.54 Allowed Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.384 -0.676 . . . . 10.0 111.6 -174.416 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.8 mtt -144.53 80.06 1.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.703 1.201 . . . . 10.0 111.597 -173.931 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.7 p -147.43 -63.91 0.27 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.224 -0.922 . . . . 10.0 109.518 168.532 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t 113.63 102.11 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 130.066 3.346 . . . . 10.0 108.693 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.82 56.3 0.1 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.971 1.708 . . . . 10.0 113.126 175.454 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -126.82 129.79 48.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 106.893 -1.521 . . . . 10.0 106.893 168.558 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.8 m -82.31 66.45 7.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.992 -2.225 . . . . 10.0 104.992 166.998 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER 53.97 15.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 171.66 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -57.42 -32.38 66.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.353 -0.842 . . . . 10.0 112.585 -168.82 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.27 -64.74 0.72 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.827 0.851 . . . . 10.0 110.567 168.935 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -54.19 -46.11 67.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.098 1.759 . . . . 10.0 109.176 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.22 -63.85 1.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.137 1.375 . . . . 10.0 109.644 -173.717 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.5 m -50.87 -48.2 60.27 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.401 1.081 . . . . 10.0 109.526 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 t -58.19 -64.81 0.79 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 122.245 1.021 . . . . 10.0 109.867 -169.746 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 92.2 t -63.64 -36.91 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 -177.404 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.54 -15.61 18.42 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.066 -1.408 . . . . 10.0 115.496 171.497 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -23.7 37.98 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.511 2.156 . . . . 10.0 109.165 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.722 HD13 HD12 ' A' ' 56' ' ' ILE . 39.3 mt -67.68 121.79 16.67 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 122.926 0.491 . . . . 10.0 110.443 -173.006 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.01 -41.67 16.86 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 122.659 1.219 . . . . 10.0 111.544 170.015 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.27 -4.6 74.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 113.689 -1.596 . . . . 10.0 114.441 -179.018 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.79 159.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 120.69 2.245 . . . . 10.0 111.168 173.433 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -138.29 -45.06 0.5 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 10.0 110.713 -178.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.19 149.07 39.22 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 173.737 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.6 m -142.9 57.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.64 0.776 . . . . 10.0 111.134 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -81.55 74.49 8.55 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.504 -1.373 . . . . 10.0 109.568 -175.793 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.27 131.26 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 123.902 0.881 . . . . 10.0 111.158 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -155.19 66.85 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.171 0.986 . . . . 10.0 109.004 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -57.44 -23.53 50.22 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.858 176.539 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLU . . . . . 0.484 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.0 mm-40 -63.37 -41.91 98.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.716 1.606 . . . . 10.0 108.96 175.484 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.47 -26.7 46.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 173.726 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.18 5.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -153.9 175.01 13.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 173.792 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -151.61 125.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 101.578 -3.49 . . . . 10.0 101.578 169.113 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -99.78 97.47 8.39 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.549 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -112.43 106.98 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 114.075 -1.42 . . . . 10.0 107.594 -172.38 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -96.7 113.61 25.18 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 175.095 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 1.7 p90 -146.72 152.9 39.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 124.588 1.18 . . . . 10.0 111.965 -173.959 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.274 32.8 t0 -83.48 82.0 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.417 1.103 . . . . 10.0 113.303 -170.523 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.87 -25.25 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.452 -2.158 . . . . 10.0 114.005 169.659 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -63.28 -57.25 11.03 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.382 0.992 . . . . 10.0 109.581 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -87.14 -39.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.272 -0.268 . . . . 10.0 110.89 -172.002 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.6 m -124.65 100.44 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 177.538 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -63.97 156.97 26.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.889 0.852 . . . . 10.0 110.186 -177.946 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.1 t -33.69 -49.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 125.573 1.549 . . . . 10.0 111.739 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -52.14 -59.24 4.61 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 175.902 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -43.41 59.17 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.088 0.955 . . . . 10.0 109.565 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 27' ' ' LEU . 2.3 mm -63.59 -51.12 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.535 -0.913 . . . . 10.0 108.535 -177.794 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.13 87.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 -174.028 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.65 -37.63 68.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.852 0.861 . . . . 10.0 109.673 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 56' ' ' ILE . . . -56.23 -40.92 74.84 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.622 -0.674 . . . . 10.0 111.187 175.063 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 67' ' ' VAL . 2.9 mp -63.26 -38.9 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.029 -1.044 . . . . 10.0 108.269 175.114 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.89 -38.8 79.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.64 1.109 . . . . 10.0 110.727 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -56.31 22.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.467 0.576 . . . . 10.0 110.064 170.758 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -99.07 62.03 1.27 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.418 1.487 . . . . 10.0 111.136 -175.066 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.41 99.67 0.39 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.97 0.795 . . . . 10.0 113.26 169.868 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.01 103.19 1.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.306 1.042 . . . . 10.0 112.553 -171.959 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -149.54 66.09 1.0 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.32 1.048 . . . . 10.0 108.549 173.625 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.648 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.9 p -154.49 75.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 120.406 -1.433 . . . . 10.0 112.565 -172.706 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -31.19 -69.1 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.574 1.15 . . . . 10.0 112.751 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 166.25 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.095 1.758 . . . . 10.0 113.91 168.035 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -69.56 122.72 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.741 -0.599 . . . . 10.0 110.511 176.391 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -105.76 82.06 1.74 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 170.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 164.25 -150.19 18.16 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 105.462 -3.055 . . . . 10.0 105.462 -170.872 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.285 -1.817 . . . . 10.0 106.296 170.908 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttp . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.044 -0.724 . . . . 10.0 109.044 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -123.18 133.67 54.22 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 10.0 109.296 176.392 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -80.37 104.51 10.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.572 1.149 . . . . 10.0 109.272 169.434 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -139.26 177.04 8.2 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.591 0.632 . . . . 10.0 110.399 174.517 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -121.19 110.62 16.4 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.771 1.229 . . . . 10.0 108.112 -173.35 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.87 89.6 4.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 7' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -46.3 127.31 8.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -178.69 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' H ' ' NE2' ' A' ' 7' ' ' GLN . 2.1 p -124.53 136.04 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 128.189 2.595 . . . . 10.0 108.321 -175.476 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.98 -7.84 16.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.517 1.127 . . . . 10.0 113.957 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.61 -173.82 1.15 Allowed Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.949 1.738 . . . . 10.0 112.657 -174.446 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 60.5 mtm -140.07 26.96 2.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.403 0.681 . . . . 10.0 112.022 171.955 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 t 52.86 59.24 4.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.451 0.7 . . . . 10.0 110.956 171.741 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.7 p -157.85 159.56 36.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.17 0.988 . . . . 10.0 108.777 -169.477 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -77.54 167.71 21.18 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 121.549 0.69 . . . . 10.0 110.663 174.173 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 55.67 52.29 11.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.021 1.329 . . . . 10.0 109.995 -177.13 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p -119.02 -49.17 2.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.191 0.996 . . . . 10.0 110.728 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -56.55 -54.73 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.395 -0.816 . . . . 10.0 108.921 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -28.52 69.96 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.403 -0.811 . . . . 10.0 112.017 178.239 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.65 -37.2 84.3 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 121.425 -0.797 . . . . 10.0 111.053 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.97 -18.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.274 0.63 . . . . 10.0 110.446 176.511 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.02 -68.86 0.74 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.086 0.555 . . . . 10.0 111.018 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 m -55.25 -39.5 69.83 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.543 1.537 . . . . 10.0 111.262 -170.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -48.16 -68.74 0.16 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.486 1.914 . . . . 10.0 110.491 177.497 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 56' ' ' ILE . 97.4 t -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 124.319 1.048 . . . . 10.0 108.931 175.727 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.59 -18.98 5.86 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.299 1.428 . . . . 10.0 115.034 173.402 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.09 -21.24 29.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.867 1.834 . . . . 10.0 108.72 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.68 121.24 19.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.87 -0.519 . . . . 10.0 109.861 -173.519 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -47.12 -37.12 9.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.009 1.324 . . . . 10.0 112.416 173.847 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.67 81.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 114.519 -1.219 . . . . 10.0 114.35 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.32 163.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.86 1.83 . . . . 10.0 112.755 176.107 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -136.82 -49.17 0.63 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.677 1.191 . . . . 10.0 111.032 174.792 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.81 147.67 51.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.733 -0.839 . . . . 10.0 108.733 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.91 59.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.926 1.29 . . . . 10.0 110.655 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 79.81 5.79 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.329 -1.482 . . . . 10.0 108.54 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 135.03 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 174.15 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.05 58.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 172.374 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.61 -26.98 68.89 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.771 -0.581 . . . . 10.0 111.12 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.43 -30.41 71.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.353 0.661 . . . . 10.0 110.147 174.134 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.43 -19.57 24.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.018 0.527 . . . . 10.0 111.21 172.398 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.52 14.76 55.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.82 1.676 . . . . 10.0 111.542 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -144.38 97.83 3.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.025 0.93 . . . . 10.0 109.35 -169.633 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -88.97 109.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 N-CA-C 106.699 -1.593 . . . . 10.0 106.699 168.928 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.65 102.92 15.08 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -119.33 106.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 125.233 1.413 . . . . 10.0 108.384 -172.308 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.3 t -92.86 120.95 33.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.667 -1.605 . . . . 10.0 106.667 174.831 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -153.14 157.24 40.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.145 0.974 . . . . 10.0 113.355 -173.254 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.36 80.85 7.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.057 . . . . 10.0 112.497 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.15 -30.19 1.1 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.308 170.844 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.45 -53.55 27.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.084 0.553 . . . . 10.0 110.925 -177.085 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.17 -36.23 24.88 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.068 0.547 . . . . 10.0 109.868 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.58 101.63 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.762 1.225 . . . . 10.0 109.106 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 152.31 27.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.538 -0.726 . . . . 10.0 110.35 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.07 -39.84 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.884 0.874 . . . . 10.0 112.777 171.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -59.15 -53.97 52.25 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 118.581 -0.724 . . . . 10.0 109.935 174.59 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -47.52 -46.84 27.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.521 0.729 . . . . 10.0 109.898 175.595 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 24' ' ' VAL . 9.5 mm -62.72 -49.64 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 O-C-N 122.07 -0.394 . . . . 10.0 110.394 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.25 -46.52 88.27 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.088 -1.079 . . . . 10.0 108.088 -175.834 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -59.99 -38.32 82.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.4 0.68 . . . . 10.0 109.221 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.34 70.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.569 -0.707 . . . . 10.0 112.499 172.661 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.636 HD13 HG21 ' A' ' 67' ' ' VAL . 2.3 mp -66.91 -45.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 168.391 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.21 -24.79 66.6 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.799 0.727 . . . . 10.0 112.864 -176.858 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.54 -36.07 77.54 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.677 -0.64 . . . . 10.0 111.301 171.344 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.55 -55.06 2.85 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.93 1.692 . . . . 10.0 112.164 -169.543 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.54 -152.2 8.01 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.029 1.776 . . . . 10.0 108.874 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -151.27 59.32 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.925 1.363 . . . . 10.0 107.475 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.02 63.39 1.63 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.155 -1.424 . . . . 10.0 107.155 -167.967 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.636 HG21 HD13 ' A' ' 60' ' ' ILE . 3.8 p -155.92 70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.871 0.367 . . . . 10.0 111.642 -176.977 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -27.65 -71.37 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.319 1.047 . . . . 10.0 113.541 170.843 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt 165.8 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.28 2.232 . . . . 10.0 112.436 169.303 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 130.5 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 120.721 -1.237 . . . . 10.0 111.844 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.38 149.06 43.44 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.029 0.442 . . . . 10.0 110.579 177.376 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.37 48.02 2.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.047 0.832 . . . . 10.0 112.685 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.104 -1.903 . . . . 10.0 109.185 -169.967 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 4.1 ttp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.75 158.68 44.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.25 1.42 . . . . 10.0 109.49 173.562 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 30.0 tt0 -93.54 115.12 27.61 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.849 1.66 . . . . 10.0 109.453 170.558 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -135.55 176.96 8.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.993 0.815 . . . . 10.0 112.02 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -123.14 114.17 19.95 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 174.881 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.711 HD13 HG23 ' A' ' 67' ' ' VAL . 4.5 pp -80.15 125.92 30.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.298 -1.741 . . . . 10.0 106.298 166.654 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 130.27 40.78 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.56 130.71 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 128.133 2.573 . . . . 10.0 110.22 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -98.24 57.26 1.23 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.199 -1.037 . . . . 10.0 108.199 174.631 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.76 123.4 13.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.296 -0.722 . . . . 10.0 111.296 -172.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 ttt -89.57 165.82 14.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.415 0.686 . . . . 10.0 111.215 -175.678 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t -67.04 78.55 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.297 1.039 . . . . 10.0 110.337 176.948 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 152.61 34.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 174.898 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -83.25 170.48 14.61 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.145 0.578 . . . . 10.0 110.21 175.87 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.3 m170 61.54 17.71 8.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.127 1.371 . . . . 10.0 112.885 -173.333 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -84.28 -38.91 19.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.383 1.073 . . . . 10.0 111.196 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -74.27 52.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.471 1.508 . . . . 10.0 111.271 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.41 -43.1 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.067 1.747 . . . . 10.0 109.752 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.33 -51.77 51.41 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.22 -0.925 . . . . 10.0 110.664 176.79 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.22 -21.09 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.221 1.408 . . . . 10.0 111.239 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -79.37 -71.42 0.45 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.128 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -49.82 -39.4 38.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.269 1.827 . . . . 10.0 112.365 -167.842 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m -49.82 -55.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.259 1.028 . . . . 10.0 110.24 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 24' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 56' ' ' ILE . 72.6 t -72.43 -41.82 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 124.136 0.975 . . . . 10.0 108.79 -179.78 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.36 -9.27 3.13 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.892 1.234 . . . . 10.0 114.603 173.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.86 -27.51 40.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 119.65 1.725 . . . . 10.0 108.622 177.334 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD1' HG23 ' A' ' 56' ' ' ILE . 75.5 mt -69.76 118.99 13.31 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.344 -173.097 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -45.38 -41.19 8.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.472 1.13 . . . . 10.0 111.925 170.105 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -3.38 81.13 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 114.04 -1.436 . . . . 10.0 114.674 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.09 163.38 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.411 2.105 . . . . 10.0 112.02 174.36 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -136.61 -43.62 0.6 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.841 1.257 . . . . 10.0 111.612 179.135 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.49 37.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.438 1.095 . . . . 10.0 108.233 176.11 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 57.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.14 1.376 . . . . 10.0 110.774 -173.632 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -81.52 88.87 6.16 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.768 -1.208 . . . . 10.0 109.847 -170.896 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -71.63 110.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.687 0.795 . . . . 10.0 111.231 179.46 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -142.07 57.55 1.47 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 175.043 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.1 -22.51 62.85 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.505 -0.747 . . . . 10.0 112.068 -177.956 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -61.97 -32.83 73.31 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.631 0.772 . . . . 10.0 110.876 172.39 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.93 -6.07 56.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.686 0.794 . . . . 10.0 111.554 173.837 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 15.44 81.56 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.825 1.679 . . . . 10.0 110.794 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -148.82 135.81 19.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.363 1.065 . . . . 10.0 108.296 -167.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -116.63 131.28 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 102.96 -2.978 . . . . 10.0 102.96 175.547 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.61 96.37 6.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.33 1.423 . . . . 10.0 108.326 177.527 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -111.5 110.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.341 1.456 . . . . 10.0 109.541 -174.289 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 26.8 t -98.22 123.82 42.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 10.0 106.173 169.743 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' PHE . . . . . 0.638 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -154.59 154.26 32.75 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.605 0.717 . . . . 10.0 112.55 -174.626 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.52 83.04 4.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.339 -0.846 . . . . 10.0 113.223 -170.153 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.14 -32.61 0.49 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.031 -1.441 . . . . 10.0 113.411 168.904 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.0 m-20 -72.1 -40.15 68.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.854 0.752 . . . . 10.0 110.113 -172.889 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -91.48 -42.42 10.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.634 0.652 . . . . 10.0 111.145 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.39 109.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 146.81 50.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.477 -0.765 . . . . 10.0 109.569 -175.177 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 56' ' ' ILE . 2.4 m -38.51 -40.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.306 1.042 . . . . 10.0 113.615 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -62.63 -48.87 77.49 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.648 -0.691 . . . . 10.0 111.198 174.084 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -48.32 -45.11 34.77 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.819 0.736 . . . . 10.0 109.279 175.429 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 24' ' ' VAL . 1.1 mm -66.26 -43.73 91.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 122.071 -0.393 . . . . 10.0 111.015 178.779 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.84 68.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.42 -34.52 72.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.287 0.635 . . . . 10.0 109.867 -178.432 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.58 -31.69 66.42 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.947 -1.096 . . . . 10.0 113.188 173.377 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 120.477 1.49 . . . . 10.0 108.152 169.837 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.41 -29.72 67.95 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.646 1.112 . . . . 10.0 111.635 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -59.55 -29.49 67.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.697 0.399 . . . . 10.0 111.647 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -111.02 -64.37 1.29 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.518 1.127 . . . . 10.0 111.228 -177.355 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.98 -156.46 24.05 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.557 1.551 . . . . 10.0 109.261 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -152.35 56.13 0.82 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.592 1.196 . . . . 10.0 108.174 173.676 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.04 57.84 1.77 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -168.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.711 HG23 HD13 ' A' ' 6' ' ' LEU . 13.2 p -146.86 79.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 122.172 0.987 . . . . 10.0 109.815 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.75 -61.83 1.97 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.63 -1.176 . . . . 10.0 111.727 170.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt 154.53 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.843 2.057 . . . . 10.0 115.122 170.66 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.16 123.37 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.986 1.714 . . . . 10.0 110.988 -177.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -94.05 152.78 18.54 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 124.718 1.262 . . . . 10.0 109.917 178.521 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.96 81.43 0.12 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.749 -1.341 . . . . 10.0 109.749 -176.019 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.547 -1.692 . . . . 10.0 107.218 -169.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 . . . . . 0 CA--C 1.53 0.178 0 CA-C-O 120.209 0.052 . . . . 10.0 111.022 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.59 91.21 4.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.405 1.882 . . . . 10.0 111.016 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB3' HD12 ' A' ' 70' ' ' ILE . 20.2 mttp -117.78 175.37 5.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.488 0.661 . . . . 10.0 112.024 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -118.76 102.33 8.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.362 1.065 . . . . 10.0 110.516 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.54 74.57 3.26 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -34.38 110.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.749 1.619 . . . . 10.0 111.24 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 42' ' ' VAL . 90.9 t . . . . . 0 N--CA 1.45 -0.446 0 C-N-CA 125.712 1.605 . . . . 10.0 110.221 -179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t . . . . . 0 CA--C 1.536 0.433 0 CA-C-O 119.804 -0.141 . . . . 10.0 111.162 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -79.79 -69.67 0.57 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 m -43.52 -44.55 6.1 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 126.668 1.987 . . . . 10.0 111.44 -173.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -49.23 -55.33 12.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.037 0.922 . . . . 10.0 111.186 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 56' ' ' ILE . 72.7 t -70.4 -41.87 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.83 -14.06 5.02 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.389 1.471 . . . . 10.0 114.911 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -81.77 -23.95 36.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.712 1.756 . . . . 10.0 108.442 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 56' ' ' ILE . 65.6 mt -71.05 120.09 16.12 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 122.013 -0.429 . . . . 10.0 110.728 -174.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.1 -34.67 14.42 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 10.0 112.168 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.45 -0.84 90.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.121 1.343 . . . . 10.0 114.627 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.66 160.29 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 120.327 2.063 . . . . 10.0 111.682 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -131.0 -42.56 1.1 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.214 1.006 . . . . 10.0 112.377 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.41 147.25 35.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.826 0.85 . . . . 10.0 108.966 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.3 59.12 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.784 1.234 . . . . 10.0 111.128 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 71.47 5.55 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.675 -1.266 . . . . 10.0 109.856 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.24 123.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.936 0.895 . . . . 10.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -150.01 58.69 0.98 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.7 pp -56.54 -29.53 62.04 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.572 -0.705 . . . . 10.0 111.004 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.0 mt-10 -60.08 -35.67 75.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.313 1.045 . . . . 10.0 110.698 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.02 59.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.939 0.896 . . . . 10.0 111.393 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.83 55.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.092 0.853 . . . . 10.0 111.535 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -154.53 154.31 32.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.501 1.151 . . . . 10.0 110.154 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -142.42 102.66 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.73 93.35 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.555 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -105.89 114.03 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.187 1.395 . . . . 10.0 108.609 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -102.27 120.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.42 160.47 43.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 123.981 0.801 . . . . 10.0 111.804 -175.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -90.96 80.32 5.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.002 0.906 . . . . 10.0 112.659 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -36.95 -39.13 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.813 2.045 . . . . 10.0 113.684 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.62 -57.19 9.85 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.608 1.163 . . . . 10.0 111.76 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -41.74 15.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 -171.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.5 110.97 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -69.66 155.46 40.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.495 0.664 . . . . 10.0 109.746 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -37.91 -40.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.076 1.35 . . . . 10.0 113.095 171.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -57.62 -58.33 8.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -47.44 -46.17 26.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.767 0.827 . . . . 10.0 110.096 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -63.94 -45.35 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 O-C-N 121.691 -0.631 . . . . 10.0 111.019 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.23 91.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.674 0.749 . . . . 10.0 108.987 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -60.44 -36.44 78.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.86 -0.793 . . . . 10.0 108.86 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.61 70.13 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.468 -0.77 . . . . 10.0 112.398 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.4 mp -64.59 -48.44 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.288 -1.375 . . . . 10.0 107.288 168.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.52 -26.95 67.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.043 0.838 . . . . 10.0 112.464 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -26.56 59.69 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.303 0.483 . . . . 10.0 112.303 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -120.13 -63.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.766 1.226 . . . . 10.0 111.183 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.51 -153.72 25.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.185 -1.566 . . . . 10.0 109.185 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -162.79 52.98 0.19 Allowed 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.476 -1.305 . . . . 10.0 107.476 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.91 62.19 1.66 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.165 -1.791 . . . . 10.0 106.165 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.74 88.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.56 1.172 . . . . 10.0 108.663 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.74 -70.44 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.43 -1.259 . . . . 10.0 109.397 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 163.07 -174.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.344 1.858 . . . . 10.0 113.53 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 53' ' ' VAL . 18.2 mm . . . . . 0 N--CA 1.438 -1.051 0 C-N-CA 123.674 0.79 . . . . 10.0 109.784 -176.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 . . . . . 0 CA--C 1.531 0.227 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.9 pm0 -72.64 100.45 2.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.608 1.563 . . . . 10.0 109.686 169.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -128.82 178.93 6.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.562 0.345 . . . . 10.0 110.179 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -118.17 114.22 22.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.064 0.546 . . . . 10.0 110.505 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.2 mt -79.54 92.76 5.33 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 106.689 -1.597 . . . . 10.0 106.689 174.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 119.89 5.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t . . . . . 0 N--CA 1.451 -0.421 0 C-N-CA 126.818 2.047 . . . . 10.0 110.837 178.606 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t . . . . . 0 CA--C 1.536 0.408 0 N-CA-C 109.791 -0.448 . . . . 10.0 109.791 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -70.39 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.718 1.207 . . . . 10.0 108.764 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -48.11 -44.46 31.9 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.692 1.197 . . . . 10.0 110.941 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -59.8 -58.95 6.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.586 0.708 . . . . 10.0 110.57 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 56' ' ' ILE . 76.8 t -61.16 -41.41 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -13.81 7.77 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.171 -1.349 . . . . 10.0 115.289 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.8 -21.39 34.54 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.289 2.045 . . . . 10.0 108.87 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.748 HD13 HD12 ' A' ' 56' ' ' ILE . 61.7 mt -66.23 121.81 16.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.455 0.645 . . . . 10.0 111.834 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -45.17 -39.61 6.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.266 1.427 . . . . 10.0 111.776 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.58 7.62 81.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.249 1.404 . . . . 10.0 114.69 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.81 160.59 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 120.599 2.199 . . . . 10.0 111.202 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 t -133.24 -44.57 0.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.63 1.172 . . . . 10.0 111.095 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.9 148.34 35.28 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.786 0.834 . . . . 10.0 108.768 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.3 m -141.11 58.31 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.157 0.983 . . . . 10.0 111.292 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.02 67.36 7.99 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.787 -1.196 . . . . 10.0 111.508 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.29 134.9 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.85 1.26 . . . . 10.0 111.576 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.55 55.86 0.69 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -63.41 -23.53 67.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.792 -1.193 . . . . 10.0 111.755 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.32 -32.37 72.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.672 0.789 . . . . 10.0 110.45 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.87 -23.98 44.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.1 29.59 9.55 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.876 1.227 . . . . 10.0 110.275 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -146.34 169.4 18.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.424 1.107 . . . . 10.0 109.964 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -155.23 118.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.856 -3.016 . . . . 10.0 102.856 169.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.88 99.27 10.84 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -111.87 112.38 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 125.818 1.647 . . . . 10.0 108.803 -171.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.1 t -94.81 114.96 26.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.693 -1.225 . . . . 10.0 107.693 170.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.3 p90 -144.7 154.79 43.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.01 79.31 8.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.242 1.02 . . . . 10.0 111.354 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -35.98 -44.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 112.941 -1.936 . . . . 10.0 112.284 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -44.84 -54.14 6.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.213 1.405 . . . . 10.0 112.299 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.22 -40.42 14.56 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.97 -0.381 . . . . 10.0 109.97 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -134.69 104.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.4 150.05 48.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.591 -0.693 . . . . 10.0 110.248 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 70' ' ' ILE . 3.6 t -33.85 -51.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 125.569 1.548 . . . . 10.0 113.485 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -49.04 -59.98 3.17 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.53 -42.62 33.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.411 1.485 . . . . 10.0 110.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.748 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -65.81 -45.38 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.514 -0.742 . . . . 10.0 110.459 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.78 96.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.23 -39.25 75.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.07 69.96 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.2 mp -64.5 -46.83 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -59.27 -30.19 68.12 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.716 0.689 . . . . 10.0 111.675 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.86 -24.5 67.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.568 -0.707 . . . . 10.0 112.211 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -112.87 -66.84 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.092 1.757 . . . . 10.0 111.362 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 -148.55 9.99 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.096 1.807 . . . . 10.0 108.754 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -161.98 55.16 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.989 1.394 . . . . 10.0 108.266 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.51 61.91 1.67 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 -168.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.4 p -149.69 85.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.779 0.799 . . . . 10.0 109.518 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.59 -66.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.382 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt 168.74 172.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.962 2.505 . . . . 10.0 110.266 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.706 HG21 HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.47 0 O-C-N 121.598 -0.689 . . . . 10.0 111.645 173.61 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 . . . . . 0 N--CA 1.448 -0.555 0 N-CA-C 104.332 -2.47 . . . . 10.0 104.332 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -71.0 107.07 3.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.543 ' CB ' HD11 ' A' ' 70' ' ' ILE . 70.1 mttt -131.25 176.2 8.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.732 0.777 . . . . 10.0 111.471 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -112.06 102.5 10.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.585 1.554 . . . . 10.0 110.54 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB2' HG21 ' A' ' 44' ' ' VAL . 3.3 tt -82.09 94.67 7.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.07 1.348 . . . . 10.0 107.856 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -60.43 119.39 7.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.591 -0.892 . . . . 10.0 108.591 -175.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.451 -0.418 0 C-N-CA 126.799 2.04 . . . . 10.0 109.178 177.437 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.722 HG21 ' HB2' ' A' ' 66' ' ' ASP . 1.5 t . . . . . 0 CA--C 1.535 0.403 0 CA-C-O 119.204 -0.427 . . . . 10.0 111.437 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -50.41 12.82 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 m -54.93 -36.86 65.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.728 1.211 . . . . 10.0 111.76 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -56.7 -49.91 73.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.232 0.924 . . . . 10.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.659 ' CG2' HD11 ' A' ' 60' ' ' ILE . 72.1 t -68.04 -43.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.5 8.57 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.014 1.292 . . . . 10.0 115.167 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.56 -21.49 28.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.343 1.572 . . . . 10.0 109.094 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD13 HD12 ' A' ' 56' ' ' ILE . 45.2 mt -67.05 125.32 25.64 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 122.024 -0.422 . . . . 10.0 110.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -48.18 -38.15 17.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.303 1.049 . . . . 10.0 111.783 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.92 -1.43 87.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.018 1.294 . . . . 10.0 114.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 166.09 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.753 2.276 . . . . 10.0 112.273 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 t -141.0 -45.43 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.923 1.289 . . . . 10.0 111.385 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.4 147.59 34.86 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.507 1.123 . . . . 10.0 108.483 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -144.48 58.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.618 1.167 . . . . 10.0 112.193 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 87.11 5.49 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.123 -1.611 . . . . 10.0 109.874 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.52 115.28 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 10.0 111.259 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.58 62.95 1.44 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -57.24 -21.24 32.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.614 -0.679 . . . . 10.0 111.839 172.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.4 tt0 -64.68 -37.99 89.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.009 0.924 . . . . 10.0 109.001 176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.03 -24.7 43.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 23.45 43.23 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.151 -1.579 . . . . 10.0 109.151 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -155.7 116.15 3.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 44' ' ' VAL . 2.7 m -86.42 146.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.301 -2.111 . . . . 10.0 105.301 167.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.27 96.31 6.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.938 -1.505 . . . . 10.0 106.938 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.6 m -119.76 106.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 122.316 1.055 . . . . 10.0 108.849 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 t -99.62 121.22 40.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.275 -1.379 . . . . 10.0 107.275 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.5 p90 -148.87 172.06 15.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.033 0.933 . . . . 10.0 111.013 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -102.41 83.32 2.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.547 1.165 . . . . 10.0 113.301 -171.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.2 -31.73 9.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.011 -1.904 . . . . 10.0 112.607 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -51.36 -60.7 2.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.269 1.028 . . . . 10.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -82.55 -46.57 13.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.368 -0.604 . . . . 10.0 109.368 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.17 94.18 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -60.81 153.36 24.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.116 0.484 . . . . 10.0 110.395 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 70' ' ' ILE . 3.7 t -42.56 -42.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 121.353 -0.842 . . . . 10.0 112.749 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -50.57 -61.83 1.95 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -47.15 -39.61 14.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.111 0.964 . . . . 10.0 111.063 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -70.28 -48.53 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.82 89.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.951 0.9 . . . . 10.0 109.826 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.05 -26.48 67.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.786 -0.571 . . . . 10.0 112.077 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.659 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.0 mp -67.59 -49.08 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.886 -1.524 . . . . 10.0 106.886 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -36.14 62.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.05 0.54 . . . . 10.0 110.778 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -51.56 -37.77 51.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.071 0.549 . . . . 10.0 112.327 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.45 -62.11 1.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.91 1.284 . . . . 10.0 111.785 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.95 -152.36 9.16 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.692 1.615 . . . . 10.0 109.631 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.15 51.43 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 10.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' VAL . 1.5 m-20 -120.46 68.39 0.85 Allowed 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 107.234 -1.395 . . . . 10.0 107.234 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 6' ' ' LEU . 2.5 t -139.22 100.34 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.168 0.987 . . . . 10.0 108.873 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -66.8 -34.35 77.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 10.0 109.677 168.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 tttm 117.87 169.79 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 129.186 2.995 . . . . 10.0 110.501 171.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.381 0 O-C-N 121.347 -0.846 . . . . 10.0 109.254 175.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 CA--C 1.531 0.232 0 N-CA-C 112.417 0.525 . . . . 10.0 112.417 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.4 pm0 -83.34 99.72 10.21 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.346 2.258 . . . . 10.0 110.053 169.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.431 ' CB ' HD11 ' A' ' 70' ' ' ILE . 79.2 mttt -136.96 177.26 8.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.217 0.462 . . . . 10.0 111.504 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.4 m -114.05 110.37 19.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.035 1.334 . . . . 10.0 109.302 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 67' ' ' VAL . 2.1 mt -83.44 93.12 7.72 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.57 118.37 2.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.015 0.926 . . . . 10.0 109.443 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 20' ' ' VAL . 37.7 t . . . . . 0 C--O 1.231 0.107 0 C-N-CA 124.62 1.168 . . . . 10.0 111.523 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 8' ' ' VAL . 11.3 t . . . . . 0 CA--C 1.533 0.322 0 CA-C-O 121.405 0.621 . . . . 10.0 109.981 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.71 -68.41 0.41 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.749 1.619 . . . . 10.0 109.114 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 m -48.51 -43.78 35.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.943 1.697 . . . . 10.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -56.94 -60.89 2.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 10.0 110.147 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 56' ' ' ILE . 86.7 t -60.48 -40.23 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.65 -17.66 28.09 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.641 1.591 . . . . 10.0 114.789 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.03 -21.73 36.82 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.645 1.723 . . . . 10.0 108.416 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.553 HD13 HD12 ' A' ' 56' ' ' ILE . 57.1 mt -66.97 122.1 16.98 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.108 0.48 . . . . 10.0 111.373 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.5 -37.54 5.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.985 1.314 . . . . 10.0 112.107 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.07 90.44 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.086 1.327 . . . . 10.0 114.692 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.21 163.49 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 120.555 2.178 . . . . 10.0 111.909 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 t -133.82 -47.34 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.336 1.455 . . . . 10.0 110.633 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.03 148.46 35.25 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.5 m -141.54 59.1 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.32 1.048 . . . . 10.0 110.991 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.54 69.47 8.2 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.079 -1.013 . . . . 10.0 110.408 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.12 124.81 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.009 0.924 . . . . 10.0 110.939 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.8 58.03 1.23 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.32 -1.363 . . . . 10.0 107.32 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -57.76 -26.71 62.25 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.562 -0.711 . . . . 10.0 111.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.16 -38.65 73.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.165 1.386 . . . . 10.0 110.746 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.49 2.77 46.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.769 1.228 . . . . 10.0 111.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.24 98.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.8 -1.32 . . . . 10.0 109.8 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 157.91 35.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.821 0.81 . . . . 10.0 109.21 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -157.21 102.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.1 97.82 10.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -111.01 110.61 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.372 1.069 . . . . 10.0 109.042 -173.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -95.02 117.12 29.62 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.4 p90 -148.96 154.06 38.84 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.256 1.027 . . . . 10.0 113.712 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -82.55 81.0 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.879 -1.055 . . . . 10.0 112.411 -170.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.31 -44.73 0.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.002 1.321 . . . . 10.0 111.519 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -55.11 -52.12 64.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.762 2.025 . . . . 10.0 111.369 -174.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.79 -41.78 25.81 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.731 0.696 . . . . 10.0 109.937 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.91 107.7 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.141 0.976 . . . . 10.0 108.63 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.48 152.01 39.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.788 -0.57 . . . . 10.0 110.354 -171.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 70' ' ' ILE . 4.7 t -39.72 -45.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.489 1.116 . . . . 10.0 112.553 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -52.23 -58.15 7.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.393 -0.337 . . . . 10.0 110.386 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.98 -41.09 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.568 0.747 . . . . 10.0 109.625 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 27' ' ' LEU . 2.2 mm -64.3 -53.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.79 79.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.18 -1.045 . . . . 10.0 108.18 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.67 -32.58 73.67 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.751 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.31 74.41 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.899 -1.126 . . . . 10.0 112.605 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.0 mp -60.57 -36.19 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.275 -1.516 . . . . 10.0 108.412 171.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.62 -49.31 68.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.994 0.815 . . . . 10.0 109.896 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -51.3 -49.5 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.089 0.471 . . . . 10.0 111.819 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.47 -19.9 27.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 -171.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.79 99.79 0.22 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.534 -1.426 . . . . 10.0 109.534 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -67.89 54.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.109 2.263 . . . . 10.0 117.109 -167.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.81 74.41 2.67 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 120.145 -1.597 . . . . 10.0 108.027 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.654 ' CG2' HD22 ' A' ' 6' ' ' LEU . 8.3 p -151.54 110.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.366 -0.834 . . . . 10.0 108.913 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.45 -73.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.942 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 175.8 174.91 0.28 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.467 1.907 . . . . 10.0 110.643 169.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.547 HG21 HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER . . . . . 0 N--CA 1.449 -0.507 0 O-C-N 121.778 -0.576 . . . . 10.0 111.041 174.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 . . . . . 0 CA--C 1.537 0.47 0 N-CA-C 111.861 0.319 . . . . 10.0 111.861 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 3.3 pm0 -88.63 106.53 18.38 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 125.449 1.5 . . . . 10.0 110.608 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.463 ' CB ' HD12 ' A' ' 70' ' ' ILE . 58.4 mttt -136.39 176.29 8.83 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.1 0.864 . . . . 10.0 112.475 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 42' ' ' VAL . 21.5 m -116.0 108.34 16.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.879 0.872 . . . . 10.0 109.189 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.87 79.8 3.45 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.43 122.12 0.89 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.013 1.325 . . . . 10.0 109.003 172.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.441 -0.905 0 C-N-CA 127.773 2.429 . . . . 10.0 107.74 -170.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 t . . . . . 0 CA--C 1.541 0.617 0 CA-C-O 119.705 -0.188 . . . . 10.0 110.999 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -91.01 -69.82 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.36 1.064 . . . . 10.0 109.274 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.3 m -36.45 -53.36 0.86 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.181 2.192 . . . . 10.0 111.495 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -51.2 -55.61 17.13 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.301 1.441 . . . . 10.0 110.959 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.565 ' CG2' HD11 ' A' ' 60' ' ' ILE . 60.1 t -72.0 -19.8 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.559 1.144 . . . . 10.0 110.326 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.47 73.11 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.777 1.18 . . . . 10.0 112.169 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -89.13 -40.24 13.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.023 1.411 . . . . 10.0 108.136 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.502 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -59.69 123.78 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.471 0.545 . . . . 10.0 112.471 -177.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -51.74 -34.86 41.0 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.896 1.278 . . . . 10.0 111.779 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.5 0.64 87.63 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.328 1.442 . . . . 10.0 114.234 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.37 156.26 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 119.849 -1.971 . . . . 10.0 111.54 169.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 t -128.59 -44.3 1.37 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 10.0 110.902 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.06 149.1 33.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.792 -1.099 . . . . 10.0 108.457 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 44' ' ' VAL . 30.8 m -143.4 58.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.859 0.864 . . . . 10.0 112.062 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.73 74.06 7.68 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.306 -1.496 . . . . 10.0 111.432 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.23 121.81 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.584 1.153 . . . . 10.0 111.578 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.29 56.61 1.0 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.882 -1.155 . . . . 10.0 107.882 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.4 pp -59.65 -21.88 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.631 -0.668 . . . . 10.0 111.338 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.462 ' N ' HD12 ' A' ' 37' ' ' LEU . 2.5 tm-20 -63.98 -39.69 94.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.358 1.463 . . . . 10.0 108.865 175.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.41 -27.17 41.77 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.79 0.436 . . . . 10.0 110.42 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.32 22.8 9.47 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.128 1.347 . . . . 10.0 111.081 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -147.16 168.52 21.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.634 1.174 . . . . 10.0 108.123 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 HG13 ' A' ' 44' ' ' VAL . 1.1 p -157.18 102.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.011 -2.218 . . . . 10.0 105.011 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.23 95.76 6.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.642 HG13 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -112.86 108.75 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 122.5 1.143 . . . . 10.0 109.133 -174.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 25.4 t -103.18 120.92 41.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -152.36 155.63 37.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.412 1.264 . . . . 10.0 114.412 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.13 84.0 5.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.944 -1.025 . . . . 10.0 111.735 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.46 1.53 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.022 1.329 . . . . 10.0 110.142 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -44.75 -44.75 9.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.505 2.722 . . . . 10.0 112.595 176.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -46.76 10.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.041 0.382 . . . . 10.0 110.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.21 115.37 18.12 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.079 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.04 144.67 50.32 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 -170.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.49 HG13 ' CG1' ' A' ' 70' ' ' ILE . 17.1 t -25.53 -55.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.16 2.184 . . . . 10.0 113.661 168.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -47.95 -62.47 1.45 Allowed 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 173.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.6 -39.08 72.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.515 1.526 . . . . 10.0 110.27 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.452 HG21 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mm -61.45 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 119.152 0.887 . . . . 10.0 108.802 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.46 85.75 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -58.46 -34.09 70.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 122.926 0.49 . . . . 10.0 109.978 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -33.13 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.565 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.6 mp -64.47 -49.77 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -31.71 64.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.248 0.477 . . . . 10.0 111.245 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.12 -23.14 66.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.226 0.61 . . . . 10.0 112.099 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -113.39 -63.64 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.452 1.501 . . . . 10.0 111.306 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.16 -146.09 9.56 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.219 1.866 . . . . 10.0 109.344 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -164.8 51.22 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.023 1.411 . . . . 10.0 109.554 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.98 66.11 1.36 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.424 -1.695 . . . . 10.0 106.424 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -147.35 99.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.8 -66.51 0.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.64 -0.695 . . . . 10.0 109.663 168.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt 165.86 179.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.31 1.444 . . . . 10.0 113.507 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.49 ' CG1' HG13 ' A' ' 53' ' ' VAL . 6.3 mm . . . . . 0 N--CA 1.45 -0.446 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 . . . . . 0 C--O 1.231 0.089 0 CA-C-O 119.678 -0.201 . . . . 10.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -78.3 103.88 8.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.095 0.958 . . . . 10.0 109.383 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.618 ' HB3' HD12 ' A' ' 70' ' ' ILE . 31.8 mttm -127.03 176.57 7.25 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -118.14 119.4 34.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.995 -0.742 . . . . 10.0 108.995 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 13.1 mt -77.55 107.67 10.18 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -54.66 116.75 2.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.342 -1.725 . . . . 10.0 106.342 168.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t . . . . . 0 N--CA 1.454 -0.27 0 C-N-CA 126.967 2.107 . . . . 10.0 106.867 177.345 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t . . . . . 0 CA--C 1.537 0.476 0 CA-C-O 119.619 -0.229 . . . . 10.0 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -58.46 3.21 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -46.65 -50.54 17.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.829 1.651 . . . . 10.0 111.793 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -52.39 -60.94 2.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 122.594 1.188 . . . . 10.0 110.501 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 56' ' ' ILE . 54.1 t -65.79 -40.42 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.41 -17.46 1.91 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.416 1.484 . . . . 10.0 114.495 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -24.37 30.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.952 1.876 . . . . 10.0 108.757 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.28 125.7 27.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.67 -0.644 . . . . 10.0 110.602 -172.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -48.51 -38.53 20.44 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.446 1.098 . . . . 10.0 112.019 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.06 75.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 114.132 -1.395 . . . . 10.0 114.042 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.35 158.27 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.02 1.91 . . . . 10.0 111.76 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.4 t -133.41 -47.66 0.83 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.907 0.883 . . . . 10.0 110.887 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.41 145.5 41.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.251 -0.88 . . . . 10.0 108.873 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 44' ' ' VAL . 29.7 m -142.96 59.27 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.861 1.264 . . . . 10.0 110.918 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -78.41 76.3 4.92 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.36 -1.463 . . . . 10.0 109.263 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.55 133.34 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.393 1.077 . . . . 10.0 111.132 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -154.9 58.2 0.67 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -61.53 -19.8 62.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.131 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -69.42 -36.13 76.4 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.037 0.935 . . . . 10.0 110.372 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.01 50.46 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 109.673 -0.492 . . . . 10.0 109.673 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.72 32.35 8.12 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.489 -1.445 . . . . 10.0 109.489 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -152.31 171.09 18.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.557 1.143 . . . . 10.0 107.937 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -156.34 125.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 103.062 -2.94 . . . . 10.0 103.062 175.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.67 104.08 15.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.486 -1.302 . . . . 10.0 107.486 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -116.58 107.46 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 124.462 1.105 . . . . 10.0 109.16 -172.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.6 t -95.68 113.67 25.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.6 p90 -138.36 154.07 48.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.866 -1.061 . . . . 10.0 112.089 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -80.49 77.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.959 -1.019 . . . . 10.0 112.506 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.65 -38.59 0.41 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.937 1.695 . . . . 10.0 112.902 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -69.23 -39.02 78.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.793 0.837 . . . . 10.0 110.641 -176.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -80.87 -50.13 10.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.87 0.868 . . . . 10.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.72 137.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.337 0.04 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.77 142.16 34.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 122.0 -0.437 . . . . 10.0 110.479 -168.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.8 t -35.36 -48.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 126.222 1.809 . . . . 10.0 112.458 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -51.7 -65.83 0.49 Allowed 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.429 -0.952 . . . . 10.0 108.429 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -42.56 -41.88 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.693 1.197 . . . . 10.0 111.682 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.486 HG22 HG22 ' A' ' 24' ' ' VAL . 8.2 mm -66.0 -43.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.037 0.835 . . . . 10.0 111.153 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.06 -50.68 69.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.1 -37.22 74.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.823 0.849 . . . . 10.0 109.368 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.68 -29.8 64.95 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.647 0.98 . . . . 10.0 113.647 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -42.85 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.598 -1.314 . . . . 10.0 108.423 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.86 -30.63 71.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.461 0.573 . . . . 10.0 111.115 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.7 -50.97 64.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.992 0.425 . . . . 10.0 110.957 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -49.64 6.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.558 0.947 . . . . 10.0 113.558 -168.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.53 94.23 0.11 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -66.61 102.01 0.86 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.818 1.247 . . . . 10.0 111.711 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.22 74.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 p -156.79 77.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -33.88 -61.8 0.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.38 1.072 . . . . 10.0 112.99 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mttt 157.0 176.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.523 2.329 . . . . 10.0 113.092 169.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.618 HD12 ' HB3' ' A' ' 4' ' ' LYS . 2.8 mm . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 109.642 -0.503 . . . . 10.0 109.642 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.3 pm0 -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.843 2.057 . . . . 10.0 110.408 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' CG1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -114.04 176.63 4.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.169 0.509 . . . . 10.0 110.023 176.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.9 m -114.59 109.39 18.18 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.312 1.045 . . . . 10.0 109.297 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.35 83.42 3.8 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.959 0.903 . . . . 10.0 109.267 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.98 116.46 0.45 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.461 1.104 . . . . 10.0 109.76 169.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.443 -0.79 0 C-N-CA 128.77 2.828 . . . . 10.0 109.241 -171.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.8 t . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 119.877 -0.106 . . . . 10.0 110.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -79.31 -72.31 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.336 1.054 . . . . 10.0 109.404 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -44.35 -49.97 9.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.103 2.161 . . . . 10.0 111.63 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.0 m -54.56 -56.18 21.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.771 0.829 . . . . 10.0 110.47 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.726 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.2 t -67.77 -39.85 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -14.46 17.74 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.964 1.269 . . . . 10.0 114.612 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -81.55 -21.47 38.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.599 1.7 . . . . 10.0 108.935 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.613 HD13 HD12 ' A' ' 56' ' ' ILE . 57.9 mt -69.14 120.74 15.45 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 123.185 0.594 . . . . 10.0 111.31 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.97 -39.93 4.37 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.99 1.316 . . . . 10.0 111.94 169.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.63 -4.72 90.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.031 1.301 . . . . 10.0 114.617 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.85 162.55 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.286 2.043 . . . . 10.0 112.103 175.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -135.33 -45.22 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 10.0 111.038 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.73 146.94 29.42 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.265 1.026 . . . . 10.0 108.437 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.8 m -142.5 57.47 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.744 0.818 . . . . 10.0 111.381 -175.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -80.79 75.13 7.72 Favored 'General case' 0 N--CA 1.46 0.057 0 O-C-N 120.726 -1.234 . . . . 10.0 110.254 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.78 127.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.16 0.984 . . . . 10.0 110.742 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -146.81 58.45 1.18 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.31 -24.2 64.81 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.006 -0.434 . . . . 10.0 110.961 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.418 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.4 tt0 -60.44 -33.5 72.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.571 1.548 . . . . 10.0 110.151 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.23 -3.24 55.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.209 1.403 . . . . 10.0 111.728 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.62 41.07 25.42 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -156.35 165.68 35.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.028 0.918 . . . . 10.0 110.885 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -157.42 107.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 104.726 -2.324 . . . . 10.0 104.726 172.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.1 98.71 11.69 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.215 -1.402 . . . . 10.0 107.215 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -114.08 110.18 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.962 -170.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.0 t -93.78 114.35 26.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 169.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -145.48 158.93 43.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.833 0.825 . . . . 10.0 112.366 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -79.75 83.05 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.145 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.12 -29.74 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.936 -1.484 . . . . 10.0 113.549 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.82 -52.34 21.08 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.365 0.984 . . . . 10.0 110.402 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -78.38 -38.02 42.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.86 102.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.505 1.122 . . . . 10.0 108.425 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -64.33 152.77 40.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.198 -0.939 . . . . 10.0 110.638 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.408 HG21 HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -43.42 -39.35 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.867 0.867 . . . . 10.0 112.794 173.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -56.44 21.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.917 0.887 . . . . 10.0 109.469 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.88 -44.11 66.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.039 0.936 . . . . 10.0 110.624 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -60.58 -51.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.307 -0.998 . . . . 10.0 108.307 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.4 88.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.58 -42.02 77.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.124 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -33.33 67.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.143 -0.456 . . . . 10.0 112.208 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -66.48 -45.26 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 119.864 1.211 . . . . 10.0 108.806 169.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -61.07 -22.9 65.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.388 0.994 . . . . 10.0 112.075 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.05 -39.95 79.72 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 10.0 110.689 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.85 -65.94 1.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.428 1.491 . . . . 10.0 112.222 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.41 -159.05 28.98 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.247 -1.541 . . . . 10.0 109.247 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -151.76 56.78 0.86 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.888 1.344 . . . . 10.0 108.567 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.87 53.03 1.38 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 60' ' ' ILE . 54.1 t -142.25 92.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.93 -62.88 1.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.878 -1.056 . . . . 10.0 109.581 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tttp 169.54 179.79 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.005 1.322 . . . . 10.0 112.53 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.441 ' CG1' ' HB3' ' A' ' 4' ' ' LYS . 1.4 tp . . . . . 0 N--CA 1.453 -0.325 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 169.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 40.4 mt-10 . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 111.607 0.225 . . . . 10.0 111.607 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -91.84 107.85 19.5 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.521 2.329 . . . . 10.0 110.407 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 17.8 mttt -128.89 173.74 10.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.399 0.619 . . . . 10.0 111.126 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -112.42 111.56 22.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.9 mt -78.51 99.86 6.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 121.46 9.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.208 -0.932 . . . . 10.0 108.918 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 20' ' ' VAL . 3.5 t . . . . . 0 N--CA 1.449 -0.507 0 C-N-CA 127.719 2.407 . . . . 10.0 108.698 -177.115 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 8' ' ' VAL . 78.5 t . . . . . 0 CA--C 1.538 0.514 0 N-CA-C 110.739 -0.097 . . . . 10.0 110.739 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -70.32 -66.22 0.63 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.098 1.359 . . . . 10.0 108.775 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.1 m -46.44 -51.16 15.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.481 1.912 . . . . 10.0 111.8 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -55.83 -54.9 38.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.41 1.005 . . . . 10.0 110.957 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 53.3 t -66.37 -40.87 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.03 -13.15 8.2 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.366 -1.241 . . . . 10.0 115.513 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.22 -24.93 46.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.006 1.903 . . . . 10.0 108.534 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 56' ' ' ILE . 65.3 mt -69.33 119.21 13.24 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.458 -172.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.13 -42.78 3.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.263 1.425 . . . . 10.0 111.7 169.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.1 -4.29 89.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.109 -1.405 . . . . 10.0 115.138 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 162.01 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.526 2.163 . . . . 10.0 111.713 174.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -133.08 -46.56 0.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.717 1.207 . . . . 10.0 111.108 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.81 38.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 118.172 -0.918 . . . . 10.0 108.724 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.77 57.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.642 1.177 . . . . 10.0 111.504 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 69.16 4.57 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.691 -1.256 . . . . 10.0 111.499 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.2 126.78 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.815 1.246 . . . . 10.0 112.151 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -148.44 58.18 1.07 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.78 -21.53 66.51 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.751 -1.218 . . . . 10.0 111.869 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -61.32 -37.84 84.73 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.378 1.071 . . . . 10.0 109.642 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.51 -28.32 41.38 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.34 12.58 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.752 1.644 . . . . 10.0 110.827 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -142.11 167.08 22.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.996 0.918 . . . . 10.0 109.503 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -158.47 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.617 -1.994 . . . . 10.0 105.617 -178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.57 99.43 6.52 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.368 0.985 . . . . 10.0 108.514 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 42' ' ' VAL . 1.3 m -108.49 109.48 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 125.09 1.356 . . . . 10.0 109.461 -175.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -95.96 115.05 26.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -145.23 154.7 42.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -76.75 82.0 3.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.055 -0.975 . . . . 10.0 112.525 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.04 -28.07 0.65 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.709 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.62 -48.75 18.13 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.949 1.249 . . . . 10.0 110.188 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -82.26 -34.28 28.85 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.056 -0.402 . . . . 10.0 110.276 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.15 104.1 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 10.0 108.556 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 150.35 48.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.195 -0.94 . . . . 10.0 110.24 -171.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 70' ' ' ILE . 1.2 m -40.64 -40.14 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.921 0.889 . . . . 10.0 113.148 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 3.7 ttpp -58.14 -54.86 42.17 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 123.002 0.521 . . . . 10.0 109.773 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.87 -44.78 63.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.145 0.978 . . . . 10.0 110.17 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 27' ' ' LEU . 2.0 mm -62.57 -43.41 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 121.534 -0.729 . . . . 10.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.81 93.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 54' ' ' LYS . 10.0 m-20 -53.36 -42.23 66.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.315 -0.624 . . . . 10.0 109.315 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.61 -36.92 74.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.5 -49.11 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 168.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.41 -22.36 66.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.59 -39.26 88.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.223 0.535 . . . . 10.0 110.552 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.34 -57.65 2.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.442 1.497 . . . . 10.0 111.136 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.09 -152.42 8.65 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.506 2.003 . . . . 10.0 108.59 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -150.36 55.71 0.92 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.388 1.094 . . . . 10.0 108.449 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.66 57.35 1.77 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.212 -1.033 . . . . 10.0 108.212 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.647 ' CG2' HD22 ' A' ' 6' ' ' LEU 0.266 14.5 p -147.81 82.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.596 1.189 . . . . 10.0 111.57 177.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.21 -60.31 1.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.321 -1.763 . . . . 10.0 110.574 168.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.383 24.0 mttp 140.96 -176.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.39 3.076 . . . . 10.0 114.026 169.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 53' ' ' VAL . 12.4 mm . . . . . 0 N--CA 1.442 -0.861 0 O-C-N 121.839 -0.538 . . . . 10.0 110.136 -167.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 . . . . . 0 CA--C 1.529 0.146 0 N-CA-C 110.074 -0.343 . . . . 10.0 110.074 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.0 tt0 -88.81 101.99 14.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 125.441 1.497 . . . . 10.0 110.26 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 70' ' ' ILE . 76.0 mttt -137.08 176.62 8.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.325 0.511 . . . . 10.0 111.136 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 3.0 m -116.39 116.57 27.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.526 0.73 . . . . 10.0 109.64 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 67' ' ' VAL . 4.1 mt -78.41 109.82 12.92 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.038 -1.838 . . . . 10.0 106.038 169.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -52.06 119.32 4.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.963 1.256 . . . . 10.0 107.904 174.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 20' ' ' VAL . 16.0 t . . . . . 0 N--CA 1.456 -0.152 0 C-N-CA 125.24 1.416 . . . . 10.0 108.164 178.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 HG12 ' A' ' 60' ' ' ILE . 59.3 t . . . . . 0 CA--C 1.539 0.551 0 N-CA-C 110.078 -0.341 . . . . 10.0 110.078 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -68.83 0.32 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.266 1.426 . . . . 10.0 107.555 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 m -48.18 -45.44 33.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.548 1.539 . . . . 10.0 111.194 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 m -52.4 -58.41 6.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 122.106 0.955 . . . . 10.0 110.808 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 56' ' ' ILE . 64.4 t -66.68 -42.76 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.09 -11.9 10.17 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.429 1.49 . . . . 10.0 115.321 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.73 -26.35 37.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.804 1.802 . . . . 10.0 108.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.625 HD13 HD12 ' A' ' 56' ' ' ILE . 64.0 mt -66.72 122.35 17.45 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.005 -0.434 . . . . 10.0 111.037 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -50.35 -35.23 26.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.29 1.043 . . . . 10.0 111.853 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.73 -3.78 89.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.196 1.379 . . . . 10.0 114.617 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.36 163.39 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.435 2.117 . . . . 10.0 111.312 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -137.7 -44.75 0.53 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.776 1.231 . . . . 10.0 111.313 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.6 149.82 36.41 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.927 . . . . 10.0 108.501 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.09 57.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 10.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.22 67.82 5.04 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.67 -1.269 . . . . 10.0 110.478 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.87 123.5 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.435 1.094 . . . . 10.0 110.913 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -144.52 57.86 1.31 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.485 -0.759 . . . . 10.0 111.099 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -61.55 -39.0 89.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.797 1.239 . . . . 10.0 109.804 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.71 -26.97 44.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.221 0.608 . . . . 10.0 109.59 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.43 32.36 7.02 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.78 -1.328 . . . . 10.0 109.78 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -149.55 162.62 39.8 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -144.0 120.3 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 102.649 -3.093 . . . . 10.0 102.649 169.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -96.24 96.24 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -111.43 104.84 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -170.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 22.8 t -92.06 117.55 29.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.411 -1.7 . . . . 10.0 106.411 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -146.63 154.75 41.83 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.675 -177.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.7 89.0 7.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.866 0.841 . . . . 10.0 112.681 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.12 -24.91 1.25 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.661 -1.609 . . . . 10.0 114.074 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.48 -56.17 25.41 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.898 1.227 . . . . 10.0 110.278 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -86.16 -40.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.184 -0.916 . . . . 10.0 109.827 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' HD11 ' A' ' 56' ' ' ILE . 3.3 m -135.48 99.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 p -64.97 154.69 36.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.429 -0.795 . . . . 10.0 110.521 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -40.92 -40.22 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.273 1.029 . . . . 10.0 113.152 174.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -53.88 -65.58 0.54 Allowed 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 108.697 -0.853 . . . . 10.0 108.697 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -43.58 -43.83 5.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.84 0.856 . . . . 10.0 110.613 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 24' ' ' VAL . 1.3 mm -66.82 -44.51 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.517 -0.739 . . . . 10.0 111.156 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.65 92.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.97 -38.67 79.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.53 -0.915 . . . . 10.0 108.53 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.15 69.47 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.753 -0.592 . . . . 10.0 112.311 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 67' ' ' VAL . 1.6 mp -64.41 -48.37 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.6 -29.77 68.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.122 0.874 . . . . 10.0 112.737 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.28 -36.46 61.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.671 0.669 . . . . 10.0 111.86 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -56.39 2.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.535 1.134 . . . . 10.0 112.752 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.33 -145.95 6.31 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.206 1.86 . . . . 10.0 109.176 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -165.71 56.9 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.572 1.686 . . . . 10.0 109.977 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.6 66.54 1.55 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 8.2 p -157.59 68.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 113.383 0.882 . . . . 10.0 113.383 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -29.75 -71.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.997 1.11 . . . . 10.0 113.997 172.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 167.95 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.775 1.63 . . . . 10.0 113.338 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.7 OUTLIER . . . . . 0 CA--C 1.536 0.404 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 . . . . . 0 N--CA 1.452 -0.348 0 N-CA-C 106.921 -1.511 . . . . 10.0 106.921 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.92 106.81 4.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.965 -1.124 . . . . 10.0 107.965 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -128.8 161.93 28.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.781 0.801 . . . . 10.0 111.126 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 m -112.02 93.76 4.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.216 1.406 . . . . 10.0 108.067 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.605 HD21 HG22 ' A' ' 67' ' ' VAL . 9.7 tt -78.02 94.23 4.61 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.81 1.244 . . . . 10.0 108.309 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 117.84 6.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t . . . . . 0 N--CA 1.452 -0.35 0 C-N-CA 126.725 2.01 . . . . 10.0 111.004 175.494 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t . . . . . 0 CA--C 1.535 0.367 0 CA-C-O 121.598 0.713 . . . . 10.0 109.16 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -61.94 -57.43 11.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.231 1.812 . . . . 10.0 108.364 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 m -48.15 -53.95 15.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.181 0.992 . . . . 10.0 110.172 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 m -67.62 -54.13 22.28 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.76 0.314 . . . . 10.0 111.726 -168.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.81 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.1 t -58.54 -44.14 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.771 -0.825 . . . . 10.0 108.771 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.28 -2.46 7.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.015 -1.436 . . . . 10.0 114.817 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -81.5 -31.32 32.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 120.123 1.962 . . . . 10.0 108.5 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 123.37 21.28 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 122.095 -0.378 . . . . 10.0 111.002 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.78 -35.14 56.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.2 1.0 . . . . 10.0 111.787 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.64 -12.7 59.7 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.393 -1.276 . . . . 10.0 113.673 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.81 161.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.73 1.765 . . . . 10.0 112.027 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.1 t -138.7 -46.78 0.49 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.44 1.096 . . . . 10.0 110.929 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.42 44.23 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.9 m -141.31 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.268 1.027 . . . . 10.0 110.631 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -83.0 77.1 9.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 120.976 -1.077 . . . . 10.0 108.22 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.71 112.63 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 123.494 0.718 . . . . 10.0 110.113 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -136.23 56.83 1.8 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.246 -1.761 . . . . 10.0 106.246 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.88 -23.43 63.44 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.34 -0.85 . . . . 10.0 111.344 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.24 -31.14 72.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.567 0.621 . . . . 10.0 111.034 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.03 -4.62 53.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.617 0.767 . . . . 10.0 111.586 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.83 19.62 79.74 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.339 1.447 . . . . 10.0 111.131 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -156.06 133.22 10.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.855 0.827 . . . . 10.0 109.274 -168.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 6' ' ' LEU . 3.2 m -121.23 120.62 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.04 94.85 9.34 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 33' ' ' VAL . 2.5 m -108.16 109.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -96.31 120.81 37.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.222 -1.769 . . . . 10.0 106.222 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -146.95 171.99 14.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.767 0.427 . . . . 10.0 111.272 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.4 82.52 2.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.22 -43.26 10.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.755 -1.566 . . . . 10.0 112.233 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -53.96 19.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.812 0.845 . . . . 10.0 111.505 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -38.3 20.53 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.141 -0.349 . . . . 10.0 110.614 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 101.9 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.678 1.591 . . . . 10.0 108.216 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 148.36 38.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.272 0.629 . . . . 10.0 110.234 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -40.44 -41.21 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.065 -1.022 . . . . 10.0 113.616 172.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.24 -52.62 64.58 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 10.0 110.653 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -52.01 -45.65 64.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.459 1.104 . . . . 10.0 110.08 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.525 HG21 ' CE2' ' A' ' 46' ' ' PHE . 24.9 mm -61.6 -48.94 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.17 84.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.03 -33.4 75.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.666 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.66 69.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.321 -0.862 . . . . 10.0 111.721 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.81 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.8 mp -68.87 -47.87 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.92 -1.511 . . . . 10.0 106.92 168.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.76 -30.71 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.04 0.836 . . . . 10.0 111.529 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.95 -37.59 77.1 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.984 -0.447 . . . . 10.0 112.007 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 -66.89 0.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.062 1.345 . . . . 10.0 112.043 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.48 -152.14 12.17 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 126.426 1.965 . . . . 10.0 109.224 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -165.67 55.63 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.378 1.089 . . . . 10.0 110.357 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.91 61.65 1.67 Allowed 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.605 HG22 HD21 ' A' ' 6' ' ' LEU . 86.5 t -141.63 97.94 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 C-N-CA 123.82 0.848 . . . . 10.0 108.841 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.03 -73.11 0.06 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.865 -1.061 . . . . 10.0 108.929 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.69 172.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.506 1.522 . . . . 10.0 111.457 169.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 6' ' ' LEU . 1.4 mp . . . . . 0 N--CA 1.445 -0.698 0 O-C-N 122.128 -0.358 . . . . 10.0 111.124 171.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 . . . . . 0 N--CA 1.451 -0.378 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.84 97.93 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.04 0.936 . . . . 10.0 109.53 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.44 ' CB ' HD11 ' A' ' 70' ' ' ILE . 48.6 mttm -131.85 173.27 11.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.039 0.447 . . . . 10.0 110.415 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -112.56 104.31 12.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.045 0.938 . . . . 10.0 109.251 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -81.77 86.24 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.8 123.09 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.874 0.87 . . . . 10.0 108.882 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.445 -0.723 0 C-N-CA 128.353 2.661 . . . . 10.0 108.33 -171.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t . . . . . 0 CA--C 1.542 0.656 0 CA-C-O 119.205 -0.426 . . . . 10.0 111.503 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -76.83 -74.9 0.22 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 m -40.94 -53.26 2.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.713 2.405 . . . . 10.0 111.903 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -65.76 -52.36 51.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.182 0.438 . . . . 10.0 112.182 -167.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 60' ' ' ILE . 74.3 t -56.94 -44.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.699 -1.223 . . . . 10.0 107.699 169.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -9.61 17.24 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.32 1.914 . . . . 10.0 116.136 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.68 -24.91 49.19 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.938 1.869 . . . . 10.0 108.687 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.82 122.49 20.81 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.375 0.67 . . . . 10.0 110.753 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.37 -41.8 20.4 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.453 1.121 . . . . 10.0 112.091 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.2 -21.76 68.47 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.047 -1.433 . . . . 10.0 113.793 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.27 150.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.567 1.684 . . . . 10.0 112.258 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.2 t -131.14 -42.6 1.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.493 1.117 . . . . 10.0 110.941 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.57 153.11 40.72 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.82 0.848 . . . . 10.0 108.917 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -145.75 57.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.89 1.676 . . . . 10.0 111.349 -173.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -83.51 72.16 10.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.719 -1.238 . . . . 10.0 110.563 -169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.74 129.32 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 123.421 0.688 . . . . 10.0 111.43 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -150.32 56.22 0.93 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.995 -1.483 . . . . 10.0 106.995 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.63 -29.05 67.74 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.737 -0.602 . . . . 10.0 111.334 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -63.33 -30.87 71.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.245 1.018 . . . . 10.0 110.811 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.22 -7.16 59.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.09 0.956 . . . . 10.0 111.587 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 25.65 42.08 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 124.952 1.263 . . . . 10.0 110.834 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.22 171.8 19.57 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.4 1.095 . . . . 10.0 110.86 -174.174 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.488 HG22 HG13 ' A' ' 44' ' ' VAL . 2.3 p -154.92 141.79 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 102.712 -3.07 . . . . 10.0 102.712 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.57 91.4 3.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.83 108.15 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -169.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 106.6 18.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -139.43 170.35 16.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.939 0.399 . . . . 10.0 111.852 -172.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 0.8 OUTLIER -91.04 73.23 6.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 113.016 0.747 . . . . 10.0 113.016 -168.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.94 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.922 1.289 . . . . 10.0 112.792 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.1 t70 -53.88 -57.27 11.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.697 0.799 . . . . 10.0 111.417 173.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.48 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -80.52 -39.04 28.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.105 -0.372 . . . . 10.0 110.52 -172.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.8 m -139.79 104.31 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 127.021 2.128 . . . . 10.0 106.638 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -64.46 157.9 25.35 Favored 'General case' 0 C--O 1.226 -0.175 0 O-C-N 121.51 -0.744 . . . . 10.0 110.383 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.25 -45.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.833 0.853 . . . . 10.0 113.207 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -61.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 175.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.77 -36.45 36.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.483 1.513 . . . . 10.0 111.449 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.8 mm -66.09 -55.07 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.62 -42.77 71.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -171.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -60.78 -37.21 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.171 0.988 . . . . 10.0 110.531 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.239 -0.913 . . . . 10.0 111.373 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.851 HD11 HG22 ' A' ' 24' ' ' VAL . 4.9 mp -64.44 -34.5 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.841 -1.162 . . . . 10.0 109.335 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -45.69 76.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.281 0.946 . . . . 10.0 110.05 173.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -60.25 -38.3 83.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -126.08 79.16 1.82 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.95 0.9 . . . . 10.0 111.537 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.74 81.12 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.449 -0.66 . . . . 10.0 111.449 169.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -67.23 89.4 0.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.981 1.312 . . . . 10.0 112.142 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -134.36 58.41 1.77 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.99 97.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 O-C-N 120.821 -1.174 . . . . 10.0 110.763 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.13 -68.92 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.351 -0.841 . . . . 10.0 110.222 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.25 171.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.624 1.17 . . . . 10.0 113.925 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER . . . . . 0 N--CA 1.455 -0.222 0 O-C-N 121.461 -0.774 . . . . 10.0 110.582 172.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 . . . . . 0 CA--C 1.534 0.349 0 N-CA-C 106.541 -1.652 . . . . 10.0 106.541 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -101.12 111.52 23.75 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 117.453 -1.26 . . . . 10.0 108.599 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.497 ' CB ' HD12 ' A' ' 70' ' ' ILE . 82.4 mttt -136.4 172.74 12.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.07 1.305 . . . . 10.0 112.668 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -113.38 97.38 6.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.194 1.398 . . . . 10.0 109.226 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.685 HD22 HG13 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -80.59 87.8 5.74 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -177.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 119.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.276 1.03 . . . . 10.0 109.684 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HG11 ' A' ' 20' ' ' VAL . 5.7 t . . . . . 0 C--O 1.232 0.183 0 C-N-CA 126.182 1.793 . . . . 10.0 111.177 -179.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.781 HG11 HG21 ' A' ' 8' ' ' VAL . 94.2 t . . . . . 0 CA--C 1.538 0.507 0 N-CA-C 110.567 -0.161 . . . . 10.0 110.567 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -57.66 5.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -44.67 -55.31 5.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.869 1.267 . . . . 10.0 111.324 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 m -63.46 -58.59 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.103 0.411 . . . . 10.0 111.71 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 60' ' ' ILE . 70.1 t -59.08 -40.0 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.87 -6.53 24.78 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 118.082 -1.399 . . . . 10.0 114.802 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.48 -20.16 44.32 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 120.365 2.083 . . . . 10.0 108.878 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.671 HD13 HD12 ' A' ' 56' ' ' ILE . 52.7 mt -66.22 117.71 8.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.448 0.642 . . . . 10.0 112.191 -175.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -40.82 -43.55 2.05 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.0 2.12 . . . . 10.0 111.186 167.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.22 6.27 83.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.685 1.612 . . . . 10.0 115.405 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.02 160.54 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 120.883 2.342 . . . . 10.0 111.092 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -132.34 -42.28 0.96 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.42 1.088 . . . . 10.0 111.964 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.32 149.76 29.73 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.311 -1.366 . . . . 10.0 107.311 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.1 m -141.62 60.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 122.079 0.942 . . . . 10.0 110.301 -173.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.39 61.41 5.56 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.311 -0.868 . . . . 10.0 110.398 -169.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -62.24 121.69 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.242 1.417 . . . . 10.0 110.102 -178.552 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -142.13 54.57 1.46 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 173.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.65 -26.8 67.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.548 -0.72 . . . . 10.0 111.007 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -69.03 -30.84 69.29 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.398 1.079 . . . . 10.0 110.489 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.21 -28.92 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.126 0.571 . . . . 10.0 110.116 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.45 5.4 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.906 1.241 . . . . 10.0 110.949 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -155.91 158.08 37.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.416 1.486 . . . . 10.0 107.43 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.43 94.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.029 -2.952 . . . . 10.0 103.029 -168.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.83 94.15 8.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.651 -1.611 . . . . 10.0 106.651 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -109.68 112.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 125.808 1.643 . . . . 10.0 108.038 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.19 115.37 27.33 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 125.985 1.714 . . . . 10.0 106.558 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -149.13 155.76 41.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 113.248 0.833 . . . . 10.0 113.248 -173.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -77.04 82.05 3.56 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.555 0.946 . . . . 10.0 113.555 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.79 -25.63 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.128 -1.396 . . . . 10.0 113.666 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.03 -60.14 2.47 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.081 0.855 . . . . 10.0 110.479 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.83 -0.544 . . . . 10.0 110.083 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.43 103.1 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -72.02 157.66 37.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.661 -1.274 . . . . 10.0 109.065 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.409 HG13 ' CG1' ' A' ' 70' ' ' ILE . 74.5 t -32.15 -48.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 126.315 1.846 . . . . 10.0 112.301 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -62.42 1.55 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.78 -41.18 61.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.419 1.488 . . . . 10.0 109.356 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.671 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -66.12 -52.6 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 119.502 -0.879 . . . . 10.0 108.886 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.37 87.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -58.06 -39.33 78.21 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.627 1.171 . . . . 10.0 109.452 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.81 71.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.916 -0.49 . . . . 10.0 112.183 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.84 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.8 mp -70.46 -40.34 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 O-C-N 120.786 -1.196 . . . . 10.0 108.368 169.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -60.34 -28.38 68.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.329 1.422 . . . . 10.0 112.669 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.79 -23.9 67.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 10.0 112.001 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -108.64 -68.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.299 1.84 . . . . 10.0 111.148 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 -144.58 8.42 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.9 2.19 . . . . 10.0 108.806 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -162.5 58.9 0.22 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.666 1.233 . . . . 10.0 108.275 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -137.97 54.2 1.81 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 120.91 0.386 . . . . 10.0 110.398 -166.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 6' ' ' LEU . 92.1 t -145.86 84.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.306 -1.368 . . . . 10.0 107.306 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.55 -72.77 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.709 -1.132 . . . . 10.0 110.698 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 173.39 174.37 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.256 1.022 . . . . 10.0 113.549 169.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CB ' ' A' ' 4' ' ' LYS . 8.9 mm . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 103.752 -2.684 . . . . 10.0 103.752 168.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 . . . . . 0 CA--C 1.533 0.297 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -61.3 97.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.414 1.486 . . . . 10.0 111.018 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -134.54 171.37 14.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.905 0.859 . . . . 10.0 112.543 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 m -108.29 101.03 10.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 67' ' ' VAL . 12.3 tp -84.34 72.71 10.56 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.079 1.351 . . . . 10.0 107.537 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.3 123.23 0.62 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.919 1.688 . . . . 10.0 111.497 -169.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.7 t . . . . . 0 N--CA 1.448 -0.542 0 C-N-CA 128.248 2.619 . . . . 10.0 109.182 -177.078 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.7 t . . . . . 0 CA--C 1.54 0.567 0 N-CA-C 111.496 0.184 . . . . 10.0 111.496 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.92 -62.7 1.6 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.448 1.099 . . . . 10.0 108.471 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -50.47 -44.45 55.77 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.642 1.577 . . . . 10.0 111.99 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -54.11 -65.57 0.55 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.069 1.347 . . . . 10.0 110.627 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.666 HG22 HG22 ' A' ' 56' ' ' ILE . 84.2 t -55.43 -43.37 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 123.777 0.831 . . . . 10.0 108.787 173.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.43 -19.37 6.05 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.58 1.562 . . . . 10.0 115.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.26 -23.53 32.65 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 120.041 1.92 . . . . 10.0 108.873 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.683 HD13 HD12 ' A' ' 56' ' ' ILE . 58.6 mt -66.42 121.38 15.16 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.092 0.473 . . . . 10.0 111.151 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -44.9 -37.79 4.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.204 1.402 . . . . 10.0 112.397 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.12 -5.9 89.29 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.103 1.335 . . . . 10.0 114.684 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.63 166.52 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.245 2.023 . . . . 10.0 111.782 175.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -140.93 -49.26 0.43 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.857 0.863 . . . . 10.0 111.134 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.62 144.73 51.05 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -143.57 56.86 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.253 1.021 . . . . 10.0 111.224 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -86.11 70.29 10.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.524 -1.36 . . . . 10.0 109.017 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.15 130.98 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.402 0.681 . . . . 10.0 110.088 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.26 67.74 0.73 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.61 -21.17 65.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.581 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.27 -35.33 73.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.969 0.508 . . . . 10.0 109.651 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.27 45.68 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.0 25.81 30.72 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.954 1.264 . . . . 10.0 109.969 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -149.71 109.74 4.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.439 0.62 . . . . 10.0 109.569 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 44' ' ' VAL . 5.0 p -84.46 148.05 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 165.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -119.12 95.79 4.96 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -112.63 109.59 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.177 1.391 . . . . 10.0 107.944 -172.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.0 t -99.6 109.93 22.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -140.76 150.67 43.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 124.411 1.07 . . . . 10.0 111.701 -174.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.24 83.35 7.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.244 -0.889 . . . . 10.0 112.958 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.54 -36.22 1.29 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.931 -1.486 . . . . 10.0 112.99 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -61.39 -53.34 57.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.343 0.657 . . . . 10.0 110.134 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.87 -40.26 28.77 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.816 -0.553 . . . . 10.0 110.792 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.424 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -138.15 102.74 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.081 1.352 . . . . 10.0 108.598 -173.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.16 148.33 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.636 -0.665 . . . . 10.0 111.054 -170.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.43 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.4 m -39.09 -45.74 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.556 1.142 . . . . 10.0 113.803 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -58.36 -52.39 65.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.99 -43.46 50.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.713 1.205 . . . . 10.0 109.83 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.683 HD12 HD13 ' A' ' 27' ' ' LEU . 2.4 mm -64.3 -46.22 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 121.561 -0.712 . . . . 10.0 110.711 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.17 90.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.863 0.84 . . . . 10.0 109.446 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -66.27 -37.49 85.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.32 82.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.949 -1.094 . . . . 10.0 111.753 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 24' ' ' VAL . 5.1 mt -58.69 -41.26 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.876 -1.14 . . . . 10.0 109.265 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -44.28 90.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.86 -53.95 34.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.778 0.323 . . . . 10.0 111.288 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -48.08 12.39 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.406 0.891 . . . . 10.0 113.406 -169.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.35 90.79 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 10.0 108.828 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -65.98 108.22 2.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.009 1.323 . . . . 10.0 111.156 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -166.56 78.71 0.23 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 104.091 -2.559 . . . . 10.0 104.091 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 6' ' ' LEU . 13.9 p -155.5 83.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.16 -50.31 0.71 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.961 2.104 . . . . 10.0 113.361 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 128.16 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.338 3.055 . . . . 10.0 113.308 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.0 mm . . . . . 0 N--CA 1.441 -0.923 0 O-C-N 121.211 -0.931 . . . . 10.0 108.999 -171.588 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 . . . . . 0 CA--C 1.531 0.241 0 CA-C-O 119.717 -0.182 . . . . 10.0 110.781 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.33 107.49 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.234 1.413 . . . . 10.0 109.918 169.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.579 ' HB3' HD12 ' A' ' 70' ' ' ILE . 64.6 mttt -136.69 119.72 16.5 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 1.8 m -78.77 121.5 24.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.859 0.464 . . . . 10.0 110.34 -172.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.434 HD11 ' CG1' ' A' ' 20' ' ' VAL . 1.6 pp -78.2 114.47 17.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 169.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 125.92 28.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.442 -0.832 0 C-N-CA 127.811 2.444 . . . . 10.0 108.817 -175.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 6' ' ' LEU . 46.0 t . . . . . 0 CA--C 1.536 0.418 0 CA-C-O 120.182 0.039 . . . . 10.0 110.933 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 -73.03 0.42 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.81 1.244 . . . . 10.0 109.337 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -49.62 -44.6 47.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.5 2.32 . . . . 10.0 111.267 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 t -47.04 -64.08 0.87 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.866 1.317 . . . . 10.0 109.776 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 56' ' ' ILE . 82.5 t -66.66 -38.0 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.729 -1.123 . . . . 10.0 108.013 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.56 -15.29 8.3 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 117.99 -1.45 . . . . 10.0 114.81 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.32 -22.02 38.82 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.45 2.125 . . . . 10.0 109.103 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.619 HD13 HD12 ' A' ' 56' ' ' ILE . 52.0 mt -70.07 120.58 15.99 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.076 0.465 . . . . 10.0 110.893 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.37 -39.25 10.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.374 1.083 . . . . 10.0 111.874 169.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.15 0.88 86.79 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 114.213 -1.358 . . . . 10.0 114.753 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.72 157.86 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.334 2.067 . . . . 10.0 111.725 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -127.31 -42.92 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.666 1.186 . . . . 10.0 111.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.34 150.08 34.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.554 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.9 m -141.53 58.18 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.758 0.823 . . . . 10.0 111.495 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 72.39 7.18 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.67 -1.269 . . . . 10.0 110.667 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.01 124.77 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.168 0.987 . . . . 10.0 110.787 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.93 56.81 1.26 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.6 pp -62.46 -23.93 67.17 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.525 -0.734 . . . . 10.0 112.244 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.02 -31.37 72.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.287 0.494 . . . . 10.0 111.19 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.39 -7.52 58.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.397 0.679 . . . . 10.0 111.101 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.96 57.87 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.396 1.474 . . . . 10.0 109.97 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -150.96 162.07 41.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.21 1.005 . . . . 10.0 111.137 -168.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 44' ' ' VAL . 55.0 t -153.37 111.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.078 -2.564 . . . . 10.0 104.078 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.45 85.08 6.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.569 HG13 HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -100.91 126.99 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.3 t -116.08 120.81 40.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -152.34 158.48 42.79 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 123.776 0.673 . . . . 10.0 112.451 -175.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -85.56 88.99 7.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.69 -25.18 0.67 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.485 -1.689 . . . . 10.0 113.75 168.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.04 -61.86 2.32 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.655 1.116 . . . . 10.0 111.086 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -80.12 -50.92 9.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.17 95.06 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.44 -1.689 . . . . 10.0 106.44 -170.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 153.03 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.869 0.842 . . . . 10.0 109.596 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 70' ' ' ILE . 17.8 t -34.99 -48.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 125.988 1.715 . . . . 10.0 112.009 169.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -55.17 -58.55 7.21 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -48.02 -42.88 29.29 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.601 0.76 . . . . 10.0 110.054 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -64.63 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.057 -0.657 . . . . 10.0 110.381 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.66 80.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -52.01 -40.86 61.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.527 0.731 . . . . 10.0 109.403 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.87 -40.04 72.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.7 mp -61.85 -45.85 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.4 -24.78 67.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.743 0.701 . . . . 10.0 111.944 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.54 -33.89 74.61 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.984 -0.448 . . . . 10.0 111.568 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.73 -70.25 0.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.867 1.267 . . . . 10.0 112.112 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.85 -147.38 18.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.831 -1.708 . . . . 10.0 108.831 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -163.03 53.01 0.18 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 174.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.56 59.13 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -144.75 85.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.92 -62.54 1.36 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.784 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.06 177.13 0.06 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.21 2.204 . . . . 10.0 109.717 169.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 4' ' ' LYS . 12.0 mm . . . . . 0 N--CA 1.453 -0.305 0 C-N-CA 123.473 0.709 . . . . 10.0 110.267 169.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 CA--C 1.541 0.607 0 N-CA-C 109.764 -0.458 . . . . 10.0 109.764 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 102.96 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.194 1.798 . . . . 10.0 111.001 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -144.66 176.24 9.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.936 0.789 . . . . 10.0 111.953 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 m -111.38 108.22 17.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.594 1.158 . . . . 10.0 108.745 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -79.22 83.23 5.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.55 126.54 2.35 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 10.0 110.796 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.447 -0.592 0 C-N-CA 128.537 2.735 . . . . 10.0 111.437 -171.721 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t . . . . . 0 CA--C 1.54 0.589 0 CA-C-O 119.765 -0.16 . . . . 10.0 110.639 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -71.79 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 10.0 109.119 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -49.41 -42.16 41.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.933 2.093 . . . . 10.0 112.884 -174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.6 p -50.35 -61.41 2.19 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.648 1.179 . . . . 10.0 110.201 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 60' ' ' ILE . 89.7 t -61.9 -47.9 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 124.063 0.945 . . . . 10.0 108.524 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.92 -1.57 0.26 Allowed Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.991 -1.449 . . . . 10.0 115.828 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.92 -31.42 19.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.133 1.967 . . . . 10.0 108.688 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.6 125.01 25.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 121.403 -0.811 . . . . 10.0 111.02 -171.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.32 -36.57 32.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 122.45 1.119 . . . . 10.0 111.85 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.88 -12.99 75.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 114.23 -1.35 . . . . 10.0 114.153 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 46' ' ' PHE . 2.3 t -79.24 146.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 120.085 1.943 . . . . 10.0 111.177 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -123.0 -47.11 2.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.891 1.676 . . . . 10.0 111.016 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.64 147.56 51.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 118.237 -0.887 . . . . 10.0 108.771 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.1 58.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.584 1.154 . . . . 10.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -79.39 75.04 5.99 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.221 -1.549 . . . . 10.0 109.501 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.59 122.73 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.362 0.665 . . . . 10.0 110.1 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -147.63 59.74 1.14 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.71 -21.38 65.73 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.695 -0.628 . . . . 10.0 111.946 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -66.47 -32.85 74.47 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.556 0.742 . . . . 10.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.87 -34.57 33.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.81 -1.96 41.72 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.26 1.886 . . . . 10.0 110.611 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -129.9 100.08 5.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.046 0.938 . . . . 10.0 108.746 -170.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 44' ' ' VAL . 2.4 p -78.02 137.95 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.534 -2.024 . . . . 10.0 105.534 168.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -104.79 97.85 7.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.983 1.265 . . . . 10.0 107.812 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -117.81 106.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.12 1.368 . . . . 10.0 108.94 -169.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -96.55 114.27 25.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -133.15 152.28 51.95 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.015 1.326 . . . . 10.0 111.649 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -82.95 84.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 122.425 1.107 . . . . 10.0 112.353 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.95 1.21 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.239 -1.801 . . . . 10.0 113.801 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.3 -49.56 76.72 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.524 0.602 . . . . 10.0 110.594 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -87.09 -48.62 7.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.86 102.63 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.39 154.55 38.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.402 0.62 . . . . 10.0 109.805 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -38.51 -42.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.184 1.394 . . . . 10.0 112.601 175.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -57.01 -54.44 46.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.246 0.618 . . . . 10.0 109.776 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.35 -40.68 49.91 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.907 0.883 . . . . 10.0 111.178 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 24' ' ' VAL . 12.9 mm -66.68 -49.49 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -63.23 -39.69 95.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 -174.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -62.28 -41.68 98.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.51 79.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.385 -0.822 . . . . 10.0 110.977 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 67' ' ' VAL . 1.9 mp -61.0 -44.2 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 O-C-N 120.981 -1.074 . . . . 10.0 108.789 168.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.91 -33.56 67.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.013 1.279 . . . . 10.0 112.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.89 -39.35 81.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.997 0.369 . . . . 10.0 111.997 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -133.93 84.4 2.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.623 1.569 . . . . 10.0 108.903 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.28 76.5 1.21 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.495 0.569 . . . . 10.0 112.116 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -68.0 55.22 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.71 2.404 . . . . 10.0 114.739 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.5 56.19 0.63 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.718 -1.238 . . . . 10.0 107.707 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 60' ' ' ILE . 3.6 m -133.38 94.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.319 1.448 . . . . 10.0 111.398 -176.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.65 -66.38 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.263 168.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt 160.38 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.53 1.932 . . . . 10.0 113.086 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.423 HG13 HG21 ' A' ' 53' ' ' VAL . 6.3 mm . . . . . 0 N--CA 1.441 -0.879 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 . . . . . 0 N--CA 1.448 -0.55 0 N-CA-C 106.822 -1.547 . . . . 10.0 106.822 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.36 89.21 1.22 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.452 1.101 . . . . 10.0 110.14 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HB3' HD11 ' A' ' 70' ' ' ILE . 7.9 mmtp -139.18 175.18 9.78 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.843 0.682 . . . . 10.0 112.843 -172.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -115.63 117.06 29.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.544 1.538 . . . . 10.0 108.885 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.5 mt -86.57 97.34 10.47 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 171.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -45.8 118.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 177.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HG11 ' A' ' 20' ' ' VAL . 8.4 t . . . . . 0 N--CA 1.454 -0.233 0 C-N-CA 124.76 1.224 . . . . 10.0 108.438 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 8' ' ' VAL . 99.4 t . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 111.276 0.102 . . . . 10.0 111.276 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -77.01 -66.11 0.86 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.827 0.851 . . . . 10.0 109.048 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -51.7 -47.91 63.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.307 1.843 . . . . 10.0 111.289 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -53.04 -67.83 0.22 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 10.0 110.753 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.767 HG22 HG22 ' A' ' 56' ' ' ILE . 84.8 t -55.46 -42.33 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 124.512 1.125 . . . . 10.0 108.996 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.6 -14.04 13.53 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.07 -1.406 . . . . 10.0 115.085 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.01 -22.13 36.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 120.301 2.051 . . . . 10.0 108.697 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.7 HD13 HD12 ' A' ' 56' ' ' ILE . 60.3 mt -67.69 117.68 9.94 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.44 0.638 . . . . 10.0 111.498 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -40.79 -40.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.594 1.958 . . . . 10.0 112.251 168.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.14 -8.5 87.56 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.285 1.421 . . . . 10.0 115.2 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.83 158.35 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.022 1.911 . . . . 10.0 111.855 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -132.27 -48.72 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.221 1.009 . . . . 10.0 110.662 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.62 146.09 51.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.099 -1.075 . . . . 10.0 108.099 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.0 m -139.99 57.37 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.328 1.051 . . . . 10.0 110.59 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -82.44 66.15 7.9 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.968 -1.083 . . . . 10.0 110.367 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.09 126.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.038 1.335 . . . . 10.0 110.976 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -144.27 56.14 1.3 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.12 -28.74 66.82 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.551 -0.718 . . . . 10.0 110.986 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -61.85 -31.37 71.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.921 1.289 . . . . 10.0 110.749 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.0 -4.68 56.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.769 1.228 . . . . 10.0 111.771 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.74 40.05 65.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.913 0.768 . . . . 10.0 111.233 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -155.74 160.13 40.06 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 117.901 0.851 . . . . 10.0 109.981 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.31 101.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.45 103.16 11.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.38 96.55 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.714 1.206 . . . . 10.0 107.785 -173.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 t -88.15 105.76 17.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.86 152.39 50.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.696 0.999 . . . . 10.0 113.696 -175.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.38 84.24 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.61 -0.723 . . . . 10.0 112.824 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.87 -30.87 10.81 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.75 -51.87 65.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.012 0.525 . . . . 10.0 110.503 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -78.82 -42.62 27.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.8 m -135.8 98.63 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.179 0.992 . . . . 10.0 109.426 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.69 152.48 26.52 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.48 -0.762 . . . . 10.0 110.617 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -36.81 -44.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.788 1.033 . . . . 10.0 113.788 171.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -55.25 -58.21 8.65 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.36 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -46.79 -44.38 19.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.993 0.917 . . . . 10.0 110.232 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.767 HG22 HG22 ' A' ' 24' ' ' VAL . 1.9 mm -66.99 -45.19 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.542 -0.724 . . . . 10.0 110.669 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.49 99.71 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.383 -0.969 . . . . 10.0 108.383 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.29 -38.95 88.62 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.33 71.88 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.526 -0.733 . . . . 10.0 111.653 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.406 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.5 mp -63.3 -49.8 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 168.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.19 -30.4 68.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.563 1.074 . . . . 10.0 112.446 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.94 -29.86 69.87 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.81 -0.556 . . . . 10.0 111.342 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.51 -62.95 1.21 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.109 1.764 . . . . 10.0 111.786 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.54 -143.59 6.66 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.382 1.944 . . . . 10.0 109.18 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.28 57.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.775 1.287 . . . . 10.0 109.978 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.22 70.3 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.725 -1.954 . . . . 10.0 105.725 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.704 ' CG2' HD22 ' A' ' 6' ' ' LEU . 9.9 p -156.23 92.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 121.647 -0.658 . . . . 10.0 112.159 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -49.17 -71.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.512 168.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . 0.417 ' C ' HD23 ' A' ' 6' ' ' LEU . 13.1 mttt 171.03 176.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.527 1.531 . . . . 10.0 113.959 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 4' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 N-CA-C 109.589 -0.523 . . . . 10.0 109.589 177.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 . . . . . 0 N--CA 1.447 -0.579 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -78.17 106.67 10.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.82 1.648 . . . . 10.0 109.945 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.47 ' CB ' HD12 ' A' ' 70' ' ' ILE . 3.6 mtpm? -128.07 174.72 8.98 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -120.75 114.99 22.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.658 -0.651 . . . . 10.0 109.593 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.09 82.07 3.6 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.76 -1.57 . . . . 10.0 106.76 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -40.34 120.27 1.19 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p . . . . . 0 N--CA 1.439 -1.01 0 C-N-CA 126.172 1.789 . . . . 10.0 107.717 -169.451 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 t . . . . . 0 CA--C 1.538 0.5 0 CA-C-O 119.647 -0.216 . . . . 10.0 110.909 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -78.68 -76.18 0.21 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.167 -1.419 . . . . 10.0 107.167 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -42.09 -49.96 4.75 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.573 2.749 . . . . 10.0 112.152 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -54.33 -58.24 8.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 122.253 1.025 . . . . 10.0 110.63 -177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 56' ' ' ILE . 91.6 t -64.45 -38.66 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.29 -1.004 . . . . 10.0 108.29 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.47 -11.32 40.63 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.181 1.372 . . . . 10.0 114.531 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.94 -21.7 40.23 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.923 1.861 . . . . 10.0 108.123 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.746 HD11 HG23 ' A' ' 56' ' ' ILE . 41.4 mt -67.37 117.25 9.1 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.45 0.643 . . . . 10.0 111.525 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -46.96 -35.27 6.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.984 1.313 . . . . 10.0 111.716 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.77 5.69 84.4 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 125.338 1.447 . . . . 10.0 114.93 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.24 159.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 120.532 2.166 . . . . 10.0 111.939 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -126.81 -44.64 1.64 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.07 1.348 . . . . 10.0 112.004 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.65 146.81 34.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.66 -1.162 . . . . 10.0 108.862 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.2 m -145.12 56.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.224 1.01 . . . . 10.0 112.469 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -82.6 70.85 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.158 -1.589 . . . . 10.0 111.147 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.57 126.29 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.541 0.736 . . . . 10.0 111.383 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -144.41 56.97 1.3 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.61 -24.52 67.62 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.659 -0.65 . . . . 10.0 111.529 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.1 -32.27 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.348 0.659 . . . . 10.0 110.518 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.12 44.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.33 9.35 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.118 1.342 . . . . 10.0 111.078 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -141.62 174.41 10.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 122.325 1.06 . . . . 10.0 109.276 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -156.1 115.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 102.996 -2.964 . . . . 10.0 102.996 174.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -91.95 101.24 13.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 120.337 1.426 . . . . 10.0 108.092 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -116.64 107.97 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.637 1.175 . . . . 10.0 109.045 -172.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -98.71 116.56 31.22 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.06 161.1 42.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 -176.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.33 81.8 5.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.302 -0.863 . . . . 10.0 112.97 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.47 -40.87 0.9 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.687 1.595 . . . . 10.0 112.87 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -54.88 18.82 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.31 1.044 . . . . 10.0 111.806 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -83.38 -40.72 19.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -135.43 105.2 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 148.67 49.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.588 -0.695 . . . . 10.0 110.222 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.514 HG13 ' CG1' ' A' ' 70' ' ' ILE . 40.1 t -29.31 -52.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 126.871 2.068 . . . . 10.0 112.242 167.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -50.32 -60.78 2.64 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.423 0.689 . . . . 10.0 109.331 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -44.76 -44.64 9.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.858 1.663 . . . . 10.0 110.192 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 HD11 ' A' ' 27' ' ' LEU . 2.0 mm -67.15 -45.56 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.098 -1.001 . . . . 10.0 110.904 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.45 94.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -54.69 -39.69 68.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.234 1.014 . . . . 10.0 108.681 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.32 69.83 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.1 0.778 . . . . 10.0 113.1 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.422 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.4 mp -66.26 -47.61 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 168.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.32 -26.39 68.4 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -61.97 -33.94 75.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.652 -0.655 . . . . 10.0 111.577 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -98.6 -54.29 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.316 1.446 . . . . 10.0 111.819 -169.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.12 -140.36 3.82 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.155 -1.978 . . . . 10.0 108.155 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -164.83 53.38 0.12 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.685 1.242 . . . . 10.0 110.604 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 78.4 1.48 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.918 -1.512 . . . . 10.0 106.918 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.05 108.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.33 0.14 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.5 tttt 177.75 176.85 0.4 Allowed 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 113.863 1.061 . . . . 10.0 113.863 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.514 ' CG1' HG13 ' A' ' 53' ' ' VAL . 3.3 mm . . . . . 0 CA--C 1.533 0.305 0 O-C-N 121.871 -0.518 . . . . 10.0 110.76 174.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 . . . . . 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.848 . . . . 10.0 106.012 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.34 89.7 1.61 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.529 1.132 . . . . 10.0 109.691 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -131.77 173.58 11.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.513 0.673 . . . . 10.0 111.751 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -111.91 112.92 24.92 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.542 1.537 . . . . 10.0 108.148 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.76 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.3 mt -80.64 95.0 6.43 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.611 -1.996 . . . . 10.0 105.611 172.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.4 121.56 5.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.378 -1.341 . . . . 10.0 107.378 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p . . . . . 0 N--CA 1.438 -1.074 0 C-N-CA 128.431 2.692 . . . . 10.0 108.192 -169.214 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.5 t . . . . . 0 CA--C 1.537 0.473 0 CA-C-O 119.544 -0.265 . . . . 10.0 110.304 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -55.73 4.19 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.4 m -50.06 -53.07 29.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.753 0.821 . . . . 10.0 110.159 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -60.62 -59.95 4.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 122.583 1.183 . . . . 10.0 111.1 -168.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 56' ' ' ILE . 69.3 t -60.82 -41.47 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.351 -0.84 . . . . 10.0 108.831 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.67 -13.28 7.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.598 1.57 . . . . 10.0 114.546 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.89 -23.0 33.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.984 1.892 . . . . 10.0 108.575 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.41 ' CD1' HD12 ' A' ' 56' ' ' ILE . 73.6 mt -68.9 123.16 20.24 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.733 -0.604 . . . . 10.0 111.085 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -43.4 -43.06 5.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.1 1.36 . . . . 10.0 112.297 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.2 -17.61 74.17 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 113.961 -1.472 . . . . 10.0 114.016 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.4 147.84 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.732 1.766 . . . . 10.0 111.616 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -123.88 -43.23 2.13 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 10.0 110.795 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.6 154.56 44.51 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.794 0.837 . . . . 10.0 109.358 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.3 m -145.64 57.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.079 1.752 . . . . 10.0 111.101 -174.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.17 66.14 7.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.919 -1.113 . . . . 10.0 111.522 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.47 132.4 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 124.618 1.167 . . . . 10.0 111.871 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -152.97 58.17 0.79 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.79 -26.12 67.05 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.179 -0.951 . . . . 10.0 111.248 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -58.9 -34.54 71.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.571 1.148 . . . . 10.0 110.433 173.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.71 -4.19 58.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.104 . . . . 10.0 111.583 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.98 34.74 55.22 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.601 1.096 . . . . 10.0 111.274 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -156.98 160.56 39.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.274 1.037 . . . . 10.0 111.134 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -156.69 104.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.417 -2.438 . . . . 10.0 104.417 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.15 95.26 9.9 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.677 -1.601 . . . . 10.0 106.677 -175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.9 91.84 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.336 1.065 . . . . 10.0 109.93 -169.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 m -77.83 84.51 4.14 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.933 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -106.26 178.36 4.58 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.457 0.703 . . . . 10.0 111.372 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.05 83.78 2.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 114.246 1.202 . . . . 10.0 114.246 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -36.0 4.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.904 -1.498 . . . . 10.0 113.036 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -65.72 -54.9 21.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.267 0.485 . . . . 10.0 110.74 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -82.02 -28.08 32.71 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.83 -0.544 . . . . 10.0 111.125 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.63 105.85 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.37 1.468 . . . . 10.0 108.948 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.34 152.28 29.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.404 -0.81 . . . . 10.0 109.663 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.4 -42.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.959 0.903 . . . . 10.0 112.496 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -47.93 83.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.607 0.763 . . . . 10.0 110.567 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.66 -44.57 73.41 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.078 0.951 . . . . 10.0 109.709 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.693 HG22 HG22 ' A' ' 24' ' ' VAL . 10.9 mm -62.64 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 122.177 0.989 . . . . 10.0 109.587 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.29 77.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.157 -0.929 . . . . 10.0 108.677 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.54 -43.44 97.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.676 -0.64 . . . . 10.0 109.711 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.94 83.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.725 -0.609 . . . . 10.0 110.451 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 24' ' ' VAL . 1.4 mt -51.13 -46.41 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.489 -0.757 . . . . 10.0 109.157 170.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.11 -42.74 60.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.963 0.801 . . . . 10.0 111.762 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.37 -41.56 93.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.192 0.52 . . . . 10.0 111.13 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -114.11 66.44 0.67 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.204 1.402 . . . . 10.0 110.606 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 103.5 0.63 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.45 -1.06 . . . . 10.0 110.45 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -74.33 54.3 0.56 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.496 1.518 . . . . 10.0 113.723 -169.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -106.04 79.31 1.4 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.441 -1.318 . . . . 10.0 107.441 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.76 ' CG2' HD22 ' A' ' 6' ' ' LEU . 13.9 p -156.18 104.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.711 -0.618 . . . . 10.0 110.653 172.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.18 -67.63 0.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.027 -0.987 . . . . 10.0 110.514 167.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt 160.03 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.162 2.185 . . . . 10.0 114.098 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.531 0.243 0 O-C-N 121.23 -0.919 . . . . 10.0 111.178 -177.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 . . . . . 0 CA--C 1.529 0.137 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.27 99.92 12.61 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.818 0.847 . . . . 10.0 109.493 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 70' ' ' ILE . 1.4 mtpt -134.35 175.62 9.35 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.963 0.347 . . . . 10.0 110.111 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -117.69 119.38 34.78 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -75.95 111.83 11.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.857 -2.275 . . . . 10.0 104.857 169.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.32 121.62 14.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.727 HG21 HG11 ' A' ' 20' ' ' VAL . 24.8 t . . . . . 0 N--CA 1.446 -0.643 0 C-N-CA 127.156 2.182 . . . . 10.0 108.5 -177.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.727 HG11 HG21 ' A' ' 8' ' ' VAL . 41.9 t . . . . . 0 CA--C 1.529 0.166 0 CA-C-O 118.924 -0.56 . . . . 10.0 111.258 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -89.63 -56.95 3.05 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.9 m -60.48 -59.91 4.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.706 1.202 . . . . 10.0 111.48 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -53.91 50.61 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.68 0.673 . . . . 10.0 110.435 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 56' ' ' ILE . 74.6 t -59.35 -44.26 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.06 -14.79 3.05 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.034 -1.426 . . . . 10.0 114.876 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -87.22 -20.2 27.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.095 1.947 . . . . 10.0 109.293 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.27 128.59 37.13 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.706 -0.622 . . . . 10.0 111.004 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -46.99 -39.41 12.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.912 1.285 . . . . 10.0 111.901 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.37 -9.24 86.94 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 113.857 -1.519 . . . . 10.0 114.556 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.47 161.32 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 120.385 2.093 . . . . 10.0 112.048 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -140.96 -45.22 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.626 1.17 . . . . 10.0 111.421 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.49 42.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.4 58.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.138 . . . . 10.0 110.516 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -80.05 79.77 6.55 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.757 -1.214 . . . . 10.0 110.44 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.79 118.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.61 0.764 . . . . 10.0 110.584 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -144.65 64.67 1.29 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.054 -1.461 . . . . 10.0 107.054 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -56.04 -26.82 50.65 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.185 -0.947 . . . . 10.0 111.874 178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 37' ' ' LEU . 38.8 mt-10 -63.34 -31.55 72.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.815 0.846 . . . . 10.0 110.195 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.26 -10.9 59.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.25 0.62 . . . . 10.0 111.351 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.44 20.72 79.51 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.743 -1.343 . . . . 10.0 109.743 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -151.63 117.79 5.58 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.703 0.801 . . . . 10.0 109.708 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.606 HG22 HG13 ' A' ' 44' ' ' VAL . 1.9 p -96.27 126.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 104.604 -2.369 . . . . 10.0 104.604 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.84 93.52 8.88 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -109.43 108.07 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.759 1.266 . . . . 10.0 109.013 -173.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 m -99.5 112.92 25.05 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.426 1.49 . . . . 10.0 107.379 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.476 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p90 -148.87 159.26 44.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.277 1.037 . . . . 10.0 113.558 -171.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.82 79.77 9.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.234 1.016 . . . . 10.0 112.337 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.09 -27.98 1.58 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.321 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.24 -56.6 10.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.346 0.521 . . . . 10.0 110.618 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -79.95 -39.23 30.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.798 -0.564 . . . . 10.0 110.639 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 107.67 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -68.16 152.81 44.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.49 0.662 . . . . 10.0 109.809 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 70' ' ' ILE . 5.7 t -41.18 -44.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.103 1.361 . . . . 10.0 112.539 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -49.78 67.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -58.84 -41.03 85.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.217 1.007 . . . . 10.0 109.972 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.504 HG22 HG22 ' A' ' 24' ' ' VAL . 15.3 mm -63.3 -45.09 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 121.684 -0.635 . . . . 10.0 109.636 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.92 97.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.602 -0.888 . . . . 10.0 108.602 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.06 -38.52 79.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.51 63.44 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.27 -48.83 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.59 -29.82 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.208 0.913 . . . . 10.0 111.91 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.95 -35.64 69.34 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.005 0.431 . . . . 10.0 110.689 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -100.0 -69.67 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.802 1.241 . . . . 10.0 112.732 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.26 -143.27 8.27 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.123 1.821 . . . . 10.0 109.314 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.9 51.99 0.11 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.085 1.443 . . . . 10.0 109.995 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.8 68.15 1.32 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 -172.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.54 78.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.428 0.558 . . . . 10.0 112.18 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.48 -66.55 0.24 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.637 0.775 . . . . 10.0 112.875 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt 162.04 171.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.907 2.083 . . . . 10.0 113.023 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.8 OUTLIER . . . . . 0 N--CA 1.45 -0.469 0 O-C-N 122.194 -0.316 . . . . 10.0 110.647 -179.199 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 . . . . . 0 N--CA 1.447 -0.623 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -62.04 108.18 1.0 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.498 ' CB ' HD11 ' A' ' 70' ' ' ILE . 17.7 mtpp -127.59 173.13 10.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.852 0.751 . . . . 10.0 110.129 172.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -119.01 116.52 26.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.074 0.55 . . . . 10.0 109.932 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 70' ' ' ILE . 9.8 mt -78.34 110.83 13.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 170.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 116.82 3.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.211 -1.774 . . . . 10.0 106.211 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.677 HG21 HG11 ' A' ' 20' ' ' VAL . 26.4 t . . . . . 0 N--CA 1.455 -0.182 0 C-N-CA 125.328 1.451 . . . . 10.0 107.77 177.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 8' ' ' VAL . 31.1 t . . . . . 0 CA--C 1.535 0.386 0 N-CA-C 110.224 -0.287 . . . . 10.0 110.224 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.14 -65.92 0.91 Allowed 'General case' 0 C--N 1.338 0.087 0 C-N-CA 122.912 0.485 . . . . 10.0 110.106 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m -52.84 -40.3 63.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.963 1.305 . . . . 10.0 110.134 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 m -59.51 -51.73 68.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.442 1.097 . . . . 10.0 110.671 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.594 ' CG2' HD11 ' A' ' 60' ' ' ILE . 78.9 t -65.76 -42.52 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.28 -11.8 3.76 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.666 1.603 . . . . 10.0 115.307 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.96 -23.63 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.711 1.756 . . . . 10.0 108.269 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.55 119.07 16.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 121.604 -0.685 . . . . 10.0 110.394 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -48.94 -36.37 17.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.169 0.985 . . . . 10.0 112.18 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 -9.26 77.0 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.934 1.254 . . . . 10.0 114.364 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -68.57 167.64 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.58 1.69 . . . . 10.0 111.957 174.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -138.26 -50.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.622 1.169 . . . . 10.0 110.847 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.55 145.03 51.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.163 -0.922 . . . . 10.0 108.643 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 56.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.511 1.124 . . . . 10.0 110.778 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.28 78.79 9.71 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 120.27 -1.519 . . . . 10.0 108.717 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.95 123.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.727 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -145.75 59.78 1.26 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.593 -1.632 . . . . 10.0 106.593 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.79 -21.56 64.69 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.567 -0.708 . . . . 10.0 111.586 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.06 -37.61 83.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.74 0.816 . . . . 10.0 109.563 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.83 -16.81 37.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.514 0.726 . . . . 10.0 110.845 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.52 39.26 61.28 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -158.1 95.71 1.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -86.85 120.09 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.899 -1.519 . . . . 10.0 106.899 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -86.32 99.92 11.93 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.714 1.143 . . . . 10.0 108.266 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.5 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.5 m -115.39 106.77 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.102 0.953 . . . . 10.0 108.753 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -99.73 114.72 28.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.687 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -146.8 154.01 40.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 124.034 0.834 . . . . 10.0 113.152 -174.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.91 94.43 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.894 0.854 . . . . 10.0 112.095 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.02 22.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.695 -1.139 . . . . 10.0 113.73 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.91 -52.18 61.08 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.229 1.377 . . . . 10.0 110.2 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -87.04 -48.83 7.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 -173.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.83 99.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.55 148.66 32.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.288 -0.634 . . . . 10.0 109.288 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 70' ' ' ILE . 14.7 t -36.7 -46.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.104 1.362 . . . . 10.0 113.866 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -51.32 -58.58 5.82 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -44.72 -44.8 9.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.486 1.514 . . . . 10.0 109.824 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.687 HG21 ' CE2' ' A' ' 46' ' ' PHE . 12.0 mm -65.43 -47.41 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.251 -0.906 . . . . 10.0 110.772 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.83 84.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -55.87 -39.47 71.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.128 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -35.57 70.15 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 67' ' ' VAL . 3.1 mp -66.01 -46.21 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 120.398 1.454 . . . . 10.0 107.616 169.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.02 -26.19 65.9 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.585 0.63 . . . . 10.0 112.011 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.54 -33.44 68.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.37 0.668 . . . . 10.0 110.766 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -110.39 -63.79 1.34 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.168 1.387 . . . . 10.0 112.086 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.8 -159.16 21.64 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.411 1.482 . . . . 10.0 109.412 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -151.76 57.16 0.86 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.182 1.491 . . . . 10.0 108.196 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.34 61.82 1.6 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.816 -1.179 . . . . 10.0 107.816 -167.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 60' ' ' ILE . 8.1 p -158.02 64.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 121.81 -0.556 . . . . 10.0 111.177 -177.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -25.75 -67.89 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.37 1.068 . . . . 10.0 113.224 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 171.65 170.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.373 1.869 . . . . 10.0 111.909 167.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.621 HG21 HG11 ' A' ' 53' ' ' VAL . 1.3 tp . . . . . 0 N--CA 1.454 -0.234 0 O-C-N 121.847 -0.533 . . . . 10.0 111.103 174.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 . . . . . 0 N--CA 1.456 -0.158 0 CA-C-O 120.654 0.264 . . . . 10.0 110.65 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -64.07 108.7 1.6 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 172.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -134.62 168.47 18.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.601 0.715 . . . . 10.0 110.509 174.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 42' ' ' VAL . 22.9 m -113.54 107.64 16.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.931 -0.577 . . . . 10.0 109.638 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -77.27 79.26 3.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 170.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.74 124.14 0.69 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.855 1.262 . . . . 10.0 110.042 173.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.441 -0.889 0 C-N-CA 126.389 1.875 . . . . 10.0 108.011 -178.795 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 35' ' ' VAL . 94.8 t . . . . . 0 CA--C 1.543 0.689 0 CA-C-O 119.647 -0.216 . . . . 10.0 110.49 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.89 -71.54 0.46 Allowed 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 173.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -36.39 -47.81 0.62 Allowed 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.44 1.896 . . . . 10.0 112.474 -174.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -56.57 -57.81 10.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.18 0.992 . . . . 10.0 111.561 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 56' ' ' ILE . 49.4 t -66.28 -40.74 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.75 0.71 1.48 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.788 1.661 . . . . 10.0 115.197 173.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.1 -32.46 26.73 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.199 1.999 . . . . 10.0 108.608 173.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 56' ' ' ILE . 66.5 mt -72.73 119.22 16.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.992 -0.442 . . . . 10.0 110.753 -171.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.49 -34.47 36.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 122.112 0.958 . . . . 10.0 112.121 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -6.1 71.8 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.828 1.204 . . . . 10.0 114.27 178.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -67.25 162.75 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.566 1.683 . . . . 10.0 111.771 169.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -134.67 -44.96 0.74 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 10.0 111.563 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.37 148.68 44.8 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.43 1.092 . . . . 10.0 108.289 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.16 55.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.122 0.963 . . . . 10.0 111.504 -174.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 70.55 10.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.383 -1.448 . . . . 10.0 108.948 -177.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -61.57 124.61 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.742 -0.599 . . . . 10.0 110.078 173.167 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -141.01 62.18 1.48 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.47 -1.678 . . . . 10.0 106.47 169.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 38' ' ' GLU . 2.8 pp -57.34 -25.35 59.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.699 176.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.509 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.5 tt0 -60.39 -36.51 78.28 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.463 1.105 . . . . 10.0 109.66 175.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.96 19.9 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.213 1.005 . . . . 10.0 110.729 177.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.03 39.48 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.862 1.22 . . . . 10.0 111.851 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.09 123.61 26.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.641 -1.614 . . . . 10.0 106.641 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -112.46 105.38 18.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 126.159 1.783 . . . . 10.0 107.909 173.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.16 93.8 4.62 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.38 -0.97 . . . . 10.0 108.38 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -109.96 109.31 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.426 1.09 . . . . 10.0 109.396 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -100.4 123.29 44.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 174.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -150.08 160.97 43.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.686 -173.923 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.77 86.82 5.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.381 1.086 . . . . 10.0 112.484 -172.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.01 -27.01 6.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.977 -1.465 . . . . 10.0 113.392 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -43.22 -55.68 3.85 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 10.0 111.377 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -99.01 -39.59 8.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.991 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.26 101.64 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.43 149.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.504 -0.748 . . . . 10.0 109.654 -177.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 53' ' ' VAL . 2.0 m -36.67 -44.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.082 1.353 . . . . 10.0 114.042 172.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -50.87 72.0 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.645 -0.693 . . . . 10.0 109.663 174.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.54 -43.58 25.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.334 1.053 . . . . 10.0 110.151 175.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -65.61 -43.55 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.227 -0.921 . . . . 10.0 111.025 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.27 90.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -59.22 -41.73 89.32 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.97 63.93 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.994 0.738 . . . . 10.0 112.994 172.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.1 mp -64.84 -46.02 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 120.647 1.567 . . . . 10.0 108.693 169.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.85 -28.57 69.58 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.202 0.445 . . . . 10.0 112.202 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -31.77 61.63 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.96 -0.462 . . . . 10.0 111.878 171.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.45 -65.81 1.1 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.781 0.832 . . . . 10.0 111.447 -176.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.19 -155.63 15.12 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 108.438 -1.865 . . . . 10.0 108.438 -175.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -148.72 54.52 1.0 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 119.286 1.543 . . . . 10.0 107.33 172.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.16 65.44 1.56 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.038 -1.468 . . . . 10.0 107.038 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.5 p -150.62 96.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.76 -0.654 . . . . 10.0 109.362 167.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tttt 171.7 -174.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.369 1.068 . . . . 10.0 112.801 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 mm . . . . . 0 N--CA 1.435 -1.193 0 O-C-N 121.801 -0.562 . . . . 10.0 109.722 179.17 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.583 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -70.07 98.63 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.746 1.218 . . . . 10.0 109.854 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 70' ' ' ILE . 39.7 mttt -135.7 166.51 23.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.193 0.597 . . . . 10.0 109.733 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -114.21 117.24 30.61 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.093 0.957 . . . . 10.0 108.827 175.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 12.2 mt -78.59 104.37 9.15 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 170.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -53.53 118.41 3.86 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.035 1.289 . . . . 10.0 108.564 175.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 20' ' ' VAL . 38.4 t . . . . . 0 C--O 1.231 0.114 0 C-N-CA 124.974 1.31 . . . . 10.0 109.869 177.192 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 8' ' ' VAL . 16.9 t . . . . . 0 CA--C 1.535 0.395 0 CA-C-O 119.975 -0.06 . . . . 10.0 110.873 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -72.85 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.31 1.044 . . . . 10.0 108.513 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 m -43.0 -44.8 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.991 2.116 . . . . 10.0 111.487 -175.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.7 m -54.1 -51.34 64.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.523 0.678 . . . . 10.0 111.063 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 56' ' ' ILE . 75.1 t -72.38 -44.04 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 176.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -12.73 4.32 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.268 1.413 . . . . 10.0 115.163 176.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 -25.63 31.24 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.989 1.394 . . . . 10.0 108.465 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.747 HD13 HD12 ' A' ' 56' ' ' ILE . 78.4 mt -62.47 122.71 16.44 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.383 0.611 . . . . 10.0 111.801 -176.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.27 -35.99 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.647 1.579 . . . . 10.0 112.286 169.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.92 -2.18 81.48 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.273 1.416 . . . . 10.0 114.891 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.04 156.99 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 120.55 2.175 . . . . 10.0 111.466 175.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.0 t -130.35 -47.04 1.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 110.912 176.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.6 146.04 35.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 178.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -143.33 58.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.658 1.183 . . . . 10.0 110.91 -176.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -79.28 76.03 5.84 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.589 -1.319 . . . . 10.0 108.87 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 120.7 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.214 1.005 . . . . 10.0 109.732 173.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 57.55 1.36 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 172.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -56.49 -28.55 60.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.83 75.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.737 1.215 . . . . 10.0 110.083 176.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -7.77 58.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.413 1.085 . . . . 10.0 111.523 178.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.82 38.78 60.46 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 -176.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -158.35 155.57 28.98 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.514 0.725 . . . . 10.0 109.263 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -146.38 118.68 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 103.617 -2.734 . . . . 10.0 103.617 172.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -88.34 108.39 19.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.422 -1.695 . . . . 10.0 106.422 172.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.09 90.21 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 -176.737 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -83.73 108.66 16.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.982 -1.858 . . . . 10.0 105.982 174.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -129.37 178.21 6.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.05 -0.977 . . . . 10.0 110.431 -176.261 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.14 89.88 3.19 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.135 -0.978 . . . . 10.0 113.481 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.88 -33.04 34.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.772 -1.558 . . . . 10.0 112.38 177.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.13 -50.41 64.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.802 0.441 . . . . 10.0 110.602 -178.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -78.23 -37.86 44.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -142.59 111.08 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.697 1.199 . . . . 10.0 108.104 -177.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -70.84 149.84 46.4 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.115 -0.991 . . . . 10.0 110.516 -172.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 70' ' ' ILE . 4.3 t -31.11 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.8 1.64 . . . . 10.0 114.022 172.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -50.86 -62.32 1.68 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -42.65 -42.26 3.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.104 0.962 . . . . 10.0 110.609 177.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 27' ' ' LEU . 1.7 mm -70.29 -44.22 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.588 -0.695 . . . . 10.0 110.628 -177.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.74 71.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.78 -38.78 70.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.902 1.281 . . . . 10.0 108.997 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.41 71.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.91 -0.493 . . . . 10.0 112.271 175.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.19 -44.35 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.798 1.181 . . . . 10.0 108.141 170.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.82 -30.14 68.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.453 0.569 . . . . 10.0 112.425 -178.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.5 -26.2 68.41 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.529 -0.732 . . . . 10.0 111.971 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -58.19 1.92 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.297 1.439 . . . . 10.0 111.685 -170.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.31 -156.78 8.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.033 -2.027 . . . . 10.0 108.033 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -146.88 56.08 1.13 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.468 1.634 . . . . 10.0 109.812 175.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.64 65.65 1.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -150.07 98.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 171.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -54.14 -73.01 0.05 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.303 169.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 174.08 173.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.606 1.562 . . . . 10.0 110.795 169.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.234 0.284 0 O-C-N 121.59 -0.694 . . . . 10.0 109.793 175.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 . . . . . 0 CA--C 1.534 0.341 0 CA-C-O 120.846 0.355 . . . . 10.0 111.725 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -73.69 104.25 4.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.999 1.319 . . . . 10.0 109.902 169.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 175.45 9.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.641 0.776 . . . . 10.0 110.556 172.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -113.83 108.16 16.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.824 1.25 . . . . 10.0 110.029 175.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 tp -85.63 73.63 10.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.497 1.119 . . . . 10.0 109.054 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -35.2 119.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.268 1.427 . . . . 10.0 111.88 -173.048 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 HG11 ' A' ' 20' ' ' VAL . 65.3 t . . . . . 0 N--CA 1.448 -0.564 0 C-N-CA 126.637 1.975 . . . . 10.0 109.987 177.429 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 8' ' ' VAL . 35.7 t . . . . . 0 N--CA 1.453 -0.306 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -61.12 2.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.26 -169.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -48.21 -51.12 26.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.25 1.42 . . . . 10.0 111.056 171.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -59.17 -59.62 5.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.649 1.113 . . . . 10.0 110.481 -169.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 56' ' ' ILE . 78.9 t -62.46 -36.78 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.335 -0.848 . . . . 10.0 108.899 178.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.65 -12.0 25.14 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.141 -1.366 . . . . 10.0 115.113 172.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -81.74 -18.1 45.45 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.434 2.117 . . . . 10.0 109.114 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 56' ' ' ILE . 37.7 mt -70.41 112.07 6.43 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.228 0.537 . . . . 10.0 110.195 -175.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -41.2 -40.76 1.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.795 1.638 . . . . 10.0 113.152 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.93 -15.79 79.6 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.546 -1.206 . . . . 10.0 114.147 -178.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -67.09 149.96 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.561 1.681 . . . . 10.0 112.133 -174.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -111.92 -51.12 2.87 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 10.0 110.878 177.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . 0.533 ' HB3' ' OG ' ' A' ' 45' ' ' SER . . . -140.7 146.79 38.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.443 0.697 . . . . 10.0 109.2 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -146.65 88.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 128.072 2.549 . . . . 10.0 105.108 -173.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -114.54 71.74 0.77 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.011 1.324 . . . . 10.0 110.662 -176.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.5 132.06 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.298 -0.876 . . . . 10.0 111.091 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -143.65 57.1 1.36 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 174.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.16 -28.97 69.5 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.567 -0.708 . . . . 10.0 111.552 -171.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.631 0.772 . . . . 10.0 111.043 174.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 -3.7 58.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.8 0.84 . . . . 10.0 111.5 176.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.39 36.91 78.95 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -175.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.91 161.42 41.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.823 0.82 . . . . 10.0 109.687 -177.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -155.03 121.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 101.665 -3.457 . . . . 10.0 101.665 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -99.6 103.37 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 120.71 1.595 . . . . 10.0 106.754 177.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -122.46 99.19 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.641 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -87.84 95.67 10.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 172.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -121.32 155.85 33.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.982 -1.008 . . . . 10.0 110.69 -176.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 10.6 t0 -91.61 90.84 7.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.036 0.754 . . . . 10.0 113.036 -172.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.81 -30.22 2.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.009 -1.45 . . . . 10.0 113.756 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -64.37 -52.83 56.34 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.13 0.877 . . . . 10.0 110.035 -178.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -37.9 35.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 -174.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -144.19 104.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.49 1.116 . . . . 10.0 107.996 -175.513 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.15 150.17 26.05 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 123.453 0.701 . . . . 10.0 111.098 -173.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.6 m -40.95 -44.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.446 1.099 . . . . 10.0 113.67 173.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -54.5 -56.26 20.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 171.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.69 -42.79 46.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.241 1.416 . . . . 10.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 24' ' ' VAL . 3.0 mm -63.32 -47.65 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.411 -0.806 . . . . 10.0 110.522 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.89 81.22 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -63.7 -40.37 96.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.721 -0.612 . . . . 10.0 109.468 175.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.14 88.64 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.384 -0.823 . . . . 10.0 111.146 177.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 24' ' ' VAL . 2.2 mt -55.33 -40.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 120.905 -1.122 . . . . 10.0 109.0 170.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -47.42 72.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.922 0.783 . . . . 10.0 110.282 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.83 -56.7 18.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.478 0.656 . . . . 10.0 109.858 175.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -94.53 67.54 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.353 0.661 . . . . 10.0 110.47 -177.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.99 97.06 0.26 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.023 -0.99 . . . . 10.0 111.38 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -65.95 105.11 1.24 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.728 0.775 . . . . 10.0 110.334 -175.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -148.94 76.63 1.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 169.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.92 105.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 O-C-N 121.152 -0.967 . . . . 10.0 111.129 175.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -60.46 -67.61 0.38 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.965 170.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttt 157.25 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.746 2.418 . . . . 10.0 112.949 173.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mm . . . . . 0 N--CA 1.443 -0.793 0 C-N-CA 124.147 0.979 . . . . 10.0 109.576 -173.363 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pm0 . . . . . 0 N--CA 1.448 -0.538 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -78.16 117.07 19.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.503 ' CB ' HD12 ' A' ' 70' ' ' ILE . 2.8 mtpt -130.35 166.13 21.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.482 -1.303 . . . . 10.0 107.482 174.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 42' ' ' VAL . 86.0 m -129.78 108.85 10.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.573 -0.529 . . . . 10.0 109.573 -174.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.2 mt -76.86 92.75 3.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.39 111.79 0.46 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.068 -1.086 . . . . 10.0 108.068 172.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 6' ' ' LEU . 6.6 m . . . . . 0 N--CA 1.441 -0.89 0 C-N-CA 125.949 1.7 . . . . 10.0 109.493 -178.316 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 8' ' ' VAL . 70.3 t . . . . . 0 CA--C 1.54 0.566 0 N-CA-C 110.174 -0.306 . . . . 10.0 110.174 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.92 -73.77 0.16 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.809 0.844 . . . . 10.0 109.704 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.1 m -44.92 -45.1 10.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.926 1.69 . . . . 10.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 m -53.48 -55.14 27.81 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.817 0.818 . . . . 10.0 110.709 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 56' ' ' ILE . 72.5 t -72.15 -25.0 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 123.65 0.78 . . . . 10.0 110.701 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 4.2 69.38 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.061 1.315 . . . . 10.0 112.688 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.66 -45.1 17.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.087 1.444 . . . . 10.0 107.447 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.473 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 118.82 4.89 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -176.39 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.66 -35.66 14.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.692 1.197 . . . . 10.0 111.963 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.72 -3.54 83.79 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.883 1.23 . . . . 10.0 114.326 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 158.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.902 1.851 . . . . 10.0 111.527 170.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -133.93 -46.3 0.79 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.253 . . . . 10.0 110.897 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.33 46.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.291 -1.003 . . . . 10.0 108.291 173.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -142.9 58.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 110.255 -174.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.92 67.7 5.79 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.355 -0.841 . . . . 10.0 109.964 -172.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.5 129.77 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.579 1.152 . . . . 10.0 109.907 178.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -155.61 55.51 0.62 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.69 -18.47 65.39 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.715 -0.615 . . . . 10.0 110.493 -175.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -36.17 82.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.498 1.119 . . . . 10.0 109.711 171.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 -29.02 43.68 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.032 -0.359 . . . . 10.0 110.032 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.94 22.9 7.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 10.0 111.464 174.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 5' ' ' THR . 4.3 mtpt -148.67 174.65 11.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.407 1.083 . . . . 10.0 108.255 -178.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -158.99 99.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -177.941 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -80.94 90.88 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.737 -1.209 . . . . 10.0 107.737 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -103.22 101.19 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.135 1.374 . . . . 10.0 108.733 -174.749 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -89.11 107.61 19.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.791 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -141.89 156.59 45.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.313 0.578 . . . . 10.0 112.447 -176.15 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -81.93 90.7 6.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.869 1.063 . . . . 10.0 113.869 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.72 -27.08 1.79 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.92 -1.491 . . . . 10.0 113.353 169.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.49 -55.22 9.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.607 1.094 . . . . 10.0 110.342 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -77.22 -38.75 50.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 -175.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.99 98.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -176.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.45 148.2 46.32 Favored 'General case' 0 C--O 1.219 -0.52 0 O-C-N 121.497 -0.752 . . . . 10.0 109.091 -175.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 70' ' ' ILE . 70.7 t -28.65 -52.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 125.986 1.714 . . . . 10.0 112.843 168.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -48.29 -54.01 15.24 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 123.364 0.665 . . . . 10.0 109.443 177.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.34 -46.63 62.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.01 2.124 . . . . 10.0 109.132 177.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 46' ' ' PHE . 8.8 mm -67.3 -45.15 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.752 -0.592 . . . . 10.0 110.88 -176.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.66 90.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.877 -0.786 . . . . 10.0 108.877 -178.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.82 -38.88 76.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 175.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.51 73.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.767 -0.635 . . . . 10.0 112.285 172.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.51 -47.29 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 120.203 1.365 . . . . 10.0 107.825 169.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.38 -34.5 66.75 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.607 1.094 . . . . 10.0 111.614 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.48 -30.01 66.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.503 -0.748 . . . . 10.0 112.022 176.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.27 -62.23 1.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.992 1.717 . . . . 10.0 112.108 -169.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.07 -147.03 6.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.437 1.97 . . . . 10.0 108.551 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.48 54.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.152 1.476 . . . . 10.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -124.47 58.17 1.22 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 -177.139 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -139.77 100.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 121.221 -0.924 . . . . 10.0 110.766 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.87 -77.24 0.06 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.252 -0.885 . . . . 10.0 109.77 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.61 175.04 0.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.752 1.39 . . . . 10.0 114.752 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.503 HD12 ' CB ' ' A' ' 4' ' ' LYS . 7.7 mm . . . . . 0 N--CA 1.449 -0.485 0 C-N-CA 123.674 0.79 . . . . 10.0 109.168 178.139 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 N--CA 1.453 -0.276 0 N-CA-C 108.49 -0.929 . . . . 10.0 108.49 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -79.53 88.86 5.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.259 1.024 . . . . 10.0 110.282 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -125.21 175.87 7.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.505 0.593 . . . . 10.0 111.965 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -119.78 109.65 15.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.658 0.783 . . . . 10.0 109.205 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -82.87 101.8 11.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 177.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 124.11 20.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.44 -0.948 . . . . 10.0 108.44 -175.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.517 HG21 HG11 ' A' ' 20' ' ' VAL . 9.2 t . . . . . 0 N--CA 1.453 -0.288 0 C-N-CA 127.827 2.451 . . . . 10.0 107.275 -175.528 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 8' ' ' VAL . 64.9 t . . . . . 0 CA--C 1.535 0.397 0 N-CA-C 109.615 -0.513 . . . . 10.0 109.615 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -58.51 6.77 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.935 0.894 . . . . 10.0 108.695 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 m -48.35 -49.74 33.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.683 0.793 . . . . 10.0 110.879 173.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -59.57 -58.76 7.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.451 0.643 . . . . 10.0 109.51 -170.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.883 ' CG2' HD11 ' A' ' 60' ' ' ILE . 95.1 t -71.15 -18.12 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.809 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.44 82.58 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.702 1.144 . . . . 10.0 112.907 178.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.25 -44.34 16.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.131 1.466 . . . . 10.0 107.654 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.496 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -56.94 122.22 11.77 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.04 -0.527 . . . . 10.0 112.409 -174.368 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.91 -36.46 38.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.271 1.034 . . . . 10.0 111.538 169.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.35 -3.05 64.69 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.224 -1.353 . . . . 10.0 114.038 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -67.82 157.85 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 120.165 1.983 . . . . 10.0 111.772 169.904 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 m -129.84 -44.28 1.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.152 1.381 . . . . 10.0 111.649 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.03 146.57 33.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.777 -1.106 . . . . 10.0 108.328 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.27 58.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.483 1.113 . . . . 10.0 111.172 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.73 74.57 6.42 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.4 -1.437 . . . . 10.0 109.723 -176.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.53 118.05 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 124.517 1.127 . . . . 10.0 111.507 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -142.27 63.35 1.41 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 174.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.51 -22.78 65.43 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.653 -0.655 . . . . 10.0 111.627 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.48 -34.43 77.13 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.028 0.931 . . . . 10.0 110.386 172.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.69 41.88 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 10.0 110.264 171.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.09 21.99 43.57 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.946 1.26 . . . . 10.0 110.667 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -153.63 105.64 2.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 -174.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 44' ' ' VAL . 1.9 m -89.08 128.67 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.006 -1.849 . . . . 10.0 106.006 170.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.24 97.84 10.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 177.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 42' ' ' VAL . 1.4 m -119.99 99.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 -168.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -92.63 116.45 29.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.426 -1.694 . . . . 10.0 106.426 176.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.1 p90 -147.05 151.78 37.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.699 1.25 . . . . 10.0 112.103 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -86.97 88.09 7.62 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.063 0.935 . . . . 10.0 112.655 -169.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.13 -30.34 2.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.496 1.518 . . . . 10.0 112.739 175.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.63 -56.94 7.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.122 0.969 . . . . 10.0 111.56 174.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -50.34 6.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -172.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.03 99.04 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.53 148.11 34.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.742 -0.836 . . . . 10.0 108.742 -176.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -32.66 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.823 1.649 . . . . 10.0 111.553 168.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -55.85 -55.61 30.49 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 119.072 -0.489 . . . . 10.0 110.47 175.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -46.78 -46.28 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.464 0.706 . . . . 10.0 110.124 173.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 24' ' ' VAL . 14.7 mm -64.04 -51.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 121.85 -0.531 . . . . 10.0 110.128 -177.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.58 87.37 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -62.5 -35.86 80.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.543 0.737 . . . . 10.0 109.279 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.6 67.3 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.197 -0.939 . . . . 10.0 112.271 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.883 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.5 mp -70.97 -44.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 168.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.92 -36.28 67.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.355 1.434 . . . . 10.0 111.549 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -55.59 -30.79 61.47 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.132 0.424 . . . . 10.0 112.116 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.05 83.48 1.74 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.448 1.099 . . . . 10.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 60' ' ' ILE . . . 96.37 109.36 2.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.899 -0.88 . . . . 10.0 110.899 172.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -77.32 57.51 1.49 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.307 1.043 . . . . 10.0 112.878 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -120.77 65.7 0.85 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 10.0 109.765 -168.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 6' ' ' LEU 0.273 0.9 OUTLIER -142.42 92.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 122.363 1.078 . . . . 10.0 110.337 -174.086 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.59 -23.74 66.24 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.702 -1.135 . . . . 10.0 111.561 169.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.0 tttt 107.15 165.75 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.4 2.28 . . . . 10.0 112.16 168.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.165 0 O-C-N 121.119 -0.988 . . . . 10.0 110.455 -178.494 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 111.364 0.135 . . . . 10.0 111.364 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.37 114.46 21.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.18 1.792 . . . . 10.0 107.864 169.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . 0.758 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.9 mttp -137.91 175.34 9.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.13 0.877 . . . . 10.0 110.083 176.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 42' ' ' VAL . 5.7 m -123.83 109.55 13.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.514 -0.755 . . . . 10.0 109.162 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 67' ' ' VAL . 1.2 mt -82.61 90.78 6.84 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 121.77 6.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 20' ' ' VAL . 27.2 t . . . . . 0 N--CA 1.45 -0.442 0 C-N-CA 127.256 2.222 . . . . 10.0 108.867 179.267 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 8' ' ' VAL . 91.4 t . . . . . 0 CA--C 1.542 0.663 0 CA-C-O 120.359 0.123 . . . . 10.0 110.758 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.75 -57.24 11.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.92 0.888 . . . . 10.0 108.662 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -50.37 -51.89 41.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.163 0.985 . . . . 10.0 110.093 177.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -57.28 -54.26 48.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.091 0.948 . . . . 10.0 111.165 -168.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.749 HG22 HG22 ' A' ' 56' ' ' ILE . 74.0 t -70.85 -41.6 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.189 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.58 -7.93 12.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.152 1.358 . . . . 10.0 114.286 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.73 -24.06 36.35 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.184 1.492 . . . . 10.0 107.823 176.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.59 ' CD1' HD12 ' A' ' 56' ' ' ILE . 71.9 mt -66.18 121.55 15.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.623 -0.673 . . . . 10.0 111.547 -176.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -47.71 -34.32 8.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.077 1.351 . . . . 10.0 112.125 169.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 0.88 87.39 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.317 1.437 . . . . 10.0 114.729 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.46 157.15 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 120.578 2.189 . . . . 10.0 111.768 173.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -126.48 -44.47 1.7 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.714 1.205 . . . . 10.0 111.968 174.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.96 146.87 32.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.041 -0.98 . . . . 10.0 108.439 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -143.22 59.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 10.0 111.866 -177.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.62 73.84 6.31 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 120.431 -1.418 . . . . 10.0 110.29 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.96 124.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 123.858 0.863 . . . . 10.0 111.298 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -146.74 58.24 1.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 171.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 38' ' ' GLU . 4.4 pp -56.21 -28.33 57.94 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.717 -0.615 . . . . 10.0 111.173 178.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.8 tt0 -63.62 -27.16 69.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.169 1.388 . . . . 10.0 111.144 177.179 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.03 -1.76 51.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.201 1.4 . . . . 10.0 111.852 173.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.29 71.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.906 1.241 . . . . 10.0 111.291 -177.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.18 153.39 27.57 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 117.991 0.896 . . . . 10.0 109.387 -177.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.04 101.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.846 -2.279 . . . . 10.0 104.846 -175.491 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.27 102.09 12.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 -174.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.9 m -118.89 106.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 124.879 1.272 . . . . 10.0 108.386 -172.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -96.56 119.42 35.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.442 -1.688 . . . . 10.0 106.442 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -150.0 157.34 43.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.065 0.936 . . . . 10.0 113.074 -174.317 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.13 82.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.711 -1.132 . . . . 10.0 113.706 -172.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.49 -28.57 0.59 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.925 -1.489 . . . . 10.0 113.501 168.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -78.49 -43.63 26.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.063 0.847 . . . . 10.0 110.266 -172.598 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -78.96 -47.63 15.99 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.151 0.887 . . . . 10.0 109.169 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 108.86 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 -174.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.91 154.38 41.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -175.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 70' ' ' ILE . 70.9 t -27.34 -55.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 126.662 1.985 . . . . 10.0 113.288 168.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HE3' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -49.74 -48.39 50.2 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 118.437 0.562 . . . . 10.0 110.002 179.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . 0.404 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -57.19 -42.6 81.52 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.922 1.289 . . . . 10.0 108.46 -179.051 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.749 HG22 HG22 ' A' ' 24' ' ' VAL . 5.4 mm -67.31 -43.99 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 120.365 -0.534 . . . . 10.0 109.734 -178.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.28 84.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 -176.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -54.48 -41.66 69.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.528 1.131 . . . . 10.0 108.848 177.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.911 -0.493 . . . . 10.0 112.029 175.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.71 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -62.55 -43.69 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.773 1.169 . . . . 10.0 108.572 170.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.21 -34.76 68.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.668 1.576 . . . . 10.0 111.693 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.33 69.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.773 0.715 . . . . 10.0 112.447 172.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -133.18 65.44 1.59 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.959 1.704 . . . . 10.0 111.342 -176.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 117.93 4.13 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.424 1.011 . . . . 10.0 110.843 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.24 55.92 2.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.381 1.091 . . . . 10.0 111.47 -169.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.99 64.19 0.86 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.739 1.216 . . . . 10.0 108.406 -170.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 HD22 ' A' ' 6' ' ' LEU 0.266 0.4 OUTLIER -149.62 93.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 120.593 -1.317 . . . . 10.0 110.694 -178.225 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.68 -73.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.654 169.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm 172.28 176.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.67 2.388 . . . . 10.0 108.894 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.758 HD12 ' HB3' ' A' ' 4' ' ' LYS . 8.0 mm . . . . . 0 N--CA 1.451 -0.39 0 C-N-CA 123.909 0.884 . . . . 10.0 109.803 172.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 119.312 -0.375 . . . . 10.0 110.017 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -69.13 102.74 1.72 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.124 0.969 . . . . 10.0 109.639 169.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -128.33 169.4 14.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 121.466 0.651 . . . . 10.0 110.387 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -110.4 115.26 29.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.631 HD11 ' HB ' ' A' ' 67' ' ' VAL . 17.1 tp -83.38 107.3 15.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.118 -1.808 . . . . 10.0 106.118 169.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.39 117.1 3.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.482 -1.673 . . . . 10.0 106.482 173.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t . . . . . 0 C--N 1.329 -0.295 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 176.927 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t . . . . . 0 CA--C 1.538 0.5 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -63.11 -65.86 0.62 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.977 1.311 . . . . 10.0 109.494 -175.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 m -43.6 -47.02 7.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.082 1.753 . . . . 10.0 110.195 174.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 m -67.6 -45.12 76.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 119.029 0.831 . . . . 10.0 111.162 -173.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.865 HG22 HD11 ' A' ' 60' ' ' ILE . 98.6 t -65.22 -20.45 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 121.31 -0.869 . . . . 10.0 110.38 169.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.87 15.42 60.76 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.034 1.302 . . . . 10.0 112.677 -172.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.51 -44.69 11.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 178.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -60.39 126.0 25.81 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.193 -0.912 . . . . 10.0 112.352 -174.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.01 -35.81 36.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.24 1.416 . . . . 10.0 111.282 172.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.92 -9.14 75.13 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.526 -1.215 . . . . 10.0 113.738 179.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.24 158.93 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 120.115 1.957 . . . . 10.0 112.674 172.461 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.7 t -133.7 -45.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.832 1.253 . . . . 10.0 111.588 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.31 37.43 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.452 1.101 . . . . 10.0 108.473 177.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.53 55.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.841 0.856 . . . . 10.0 111.042 -173.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -85.91 68.89 10.48 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.702 -1.248 . . . . 10.0 109.257 -170.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.32 118.59 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 10.0 110.221 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -136.02 59.21 1.72 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.93 -28.47 51.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.003 -0.544 . . . . 10.0 111.284 -179.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -62.76 -36.35 82.79 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.951 0.9 . . . . 10.0 110.946 174.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -8.09 59.28 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.048 0.939 . . . . 10.0 111.236 174.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.33 30.27 57.09 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.441 1.02 . . . . 10.0 110.63 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -158.21 161.85 37.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.921 0.867 . . . . 10.0 110.581 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 44' ' ' VAL . 42.8 t -150.03 125.98 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.367 -3.197 . . . . 10.0 102.367 -172.47 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -105.48 93.44 4.67 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 120.056 1.298 . . . . 10.0 107.749 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 42' ' ' VAL . 2.2 m -105.15 107.56 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -178.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -97.84 114.91 27.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 172.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -144.8 153.53 41.73 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.379 0.609 . . . . 10.0 110.929 -177.463 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.19 77.12 6.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.822 -168.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.23 -37.35 0.63 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.168 1.787 . . . . 10.0 113.605 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.88 -55.42 26.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.436 1.095 . . . . 10.0 111.272 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -84.21 -42.52 15.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.501 0.72 . . . . 10.0 109.969 -173.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.7 99.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 143.82 57.17 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 121.47 -0.769 . . . . 10.0 109.15 -175.38 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 m -38.88 -45.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.973 1.309 . . . . 10.0 113.562 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -55.67 29.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.612 0.765 . . . . 10.0 110.692 172.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -47.95 -38.71 17.32 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.25 1.02 . . . . 10.0 111.044 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.9 mm -68.05 -53.15 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.326 -0.99 . . . . 10.0 108.326 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -50.02 -47.29 53.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.43 -38.44 87.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.153 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.73 82.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.645 -0.66 . . . . 10.0 111.004 176.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.865 HD11 HG22 ' A' ' 24' ' ' VAL . 4.0 mp -65.07 -42.71 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 117.766 -1.111 . . . . 10.0 108.965 169.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -61.15 -21.54 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.201 1.364 . . . . 10.0 113.032 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.44 -33.7 76.57 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 10.0 111.644 169.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 -61.78 1.33 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.987 1.715 . . . . 10.0 112.086 -170.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.22 -151.69 10.04 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 127.104 2.288 . . . . 10.0 109.082 176.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -159.19 66.54 0.41 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.067 1.434 . . . . 10.0 108.981 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -146.47 55.64 1.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 -168.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 6' ' ' LEU . 17.0 m -153.6 58.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.698 -0.626 . . . . 10.0 110.543 -172.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -26.33 -70.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.789 1.236 . . . . 10.0 112.544 176.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.92 173.0 0.61 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.438 1.095 . . . . 10.0 111.804 169.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 HD13 ' A' ' 6' ' ' LEU . 1.2 mp . . . . . 0 N--CA 1.45 -0.453 0 C-N-CA 122.972 0.509 . . . . 10.0 111.456 178.455 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 . . . . . 0 C--O 1.232 0.152 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 50.9 tt0 -91.26 123.86 35.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.746 1.218 . . . . 10.0 109.995 173.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.52 173.03 12.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.834 0.309 . . . . 10.0 111.834 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 42' ' ' VAL . 9.9 m -116.53 107.83 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.431 0.693 . . . . 10.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.648 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.6 mt -81.68 88.48 6.25 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 174.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.19 115.72 1.07 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.434 1.094 . . . . 10.0 109.553 -177.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t . . . . . 0 N--CA 1.453 -0.282 0 C-N-CA 125.709 1.604 . . . . 10.0 112.258 178.224 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t . . . . . 0 CA--C 1.535 0.375 0 N-CA-C 109.176 -0.675 . . . . 10.0 109.176 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.22 -63.85 1.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.137 1.375 . . . . 10.0 109.644 -173.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.5 m -50.87 -48.2 60.27 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.401 1.081 . . . . 10.0 109.526 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 t -58.19 -64.81 0.79 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 122.245 1.021 . . . . 10.0 109.867 -169.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 92.2 t -63.64 -36.91 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 -177.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.54 -15.61 18.42 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.066 -1.408 . . . . 10.0 115.496 171.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -23.7 37.98 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.511 2.156 . . . . 10.0 109.165 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.722 HD13 HD12 ' A' ' 56' ' ' ILE . 39.3 mt -67.68 121.79 16.67 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 122.926 0.491 . . . . 10.0 110.443 -173.006 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.01 -41.67 16.86 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 122.659 1.219 . . . . 10.0 111.544 170.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.27 -4.6 74.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 113.689 -1.596 . . . . 10.0 114.441 -179.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.79 159.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 120.69 2.245 . . . . 10.0 111.168 173.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -138.29 -45.06 0.5 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 10.0 110.713 -178.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.19 149.07 39.22 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 173.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.6 m -142.9 57.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.64 0.776 . . . . 10.0 111.134 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -81.55 74.49 8.55 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.504 -1.373 . . . . 10.0 109.568 -175.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.27 131.26 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 123.902 0.881 . . . . 10.0 111.158 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -155.19 66.85 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.171 0.986 . . . . 10.0 109.004 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.484 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -57.44 -23.53 50.22 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.858 176.539 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . 0.484 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.0 mm-40 -63.37 -41.91 98.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.716 1.606 . . . . 10.0 108.96 175.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.47 -26.7 46.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 173.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.18 5.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -153.9 175.01 13.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 173.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -151.61 125.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 101.578 -3.49 . . . . 10.0 101.578 169.113 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -99.78 97.47 8.39 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.549 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -112.43 106.98 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 114.075 -1.42 . . . . 10.0 107.594 -172.38 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -96.7 113.61 25.18 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 175.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 1.7 p90 -146.72 152.9 39.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 124.588 1.18 . . . . 10.0 111.965 -173.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.274 32.8 t0 -83.48 82.0 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.417 1.103 . . . . 10.0 113.303 -170.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.87 -25.25 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.452 -2.158 . . . . 10.0 114.005 169.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -63.28 -57.25 11.03 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.382 0.992 . . . . 10.0 109.581 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -87.14 -39.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.272 -0.268 . . . . 10.0 110.89 -172.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . 0.44 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.6 m -124.65 100.44 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 177.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -63.97 156.97 26.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.889 0.852 . . . . 10.0 110.186 -177.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.1 t -33.69 -49.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 125.573 1.549 . . . . 10.0 111.739 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -52.14 -59.24 4.61 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 175.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -43.41 59.17 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.088 0.955 . . . . 10.0 109.565 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 27' ' ' LEU . 2.3 mm -63.59 -51.12 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.535 -0.913 . . . . 10.0 108.535 -177.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.13 87.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 -174.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.65 -37.63 68.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.852 0.861 . . . . 10.0 109.673 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 56' ' ' ILE . . . -56.23 -40.92 74.84 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.622 -0.674 . . . . 10.0 111.187 175.063 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 67' ' ' VAL . 2.9 mp -63.26 -38.9 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.029 -1.044 . . . . 10.0 108.269 175.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.89 -38.8 79.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.64 1.109 . . . . 10.0 110.727 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -56.31 22.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.467 0.576 . . . . 10.0 110.064 170.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -99.07 62.03 1.27 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.418 1.487 . . . . 10.0 111.136 -175.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.41 99.67 0.39 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.97 0.795 . . . . 10.0 113.26 169.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.01 103.19 1.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.306 1.042 . . . . 10.0 112.553 -171.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -149.54 66.09 1.0 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.32 1.048 . . . . 10.0 108.549 173.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.648 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.9 p -154.49 75.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 120.406 -1.433 . . . . 10.0 112.565 -172.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -31.19 -69.1 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.574 1.15 . . . . 10.0 112.751 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 166.25 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.095 1.758 . . . . 10.0 113.91 168.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.361 0 O-C-N 121.741 -0.599 . . . . 10.0 110.511 176.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 . . . . . 0 N--CA 1.457 -0.077 0 N-CA-C 109.296 -0.631 . . . . 10.0 109.296 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -80.37 104.51 10.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.572 1.149 . . . . 10.0 109.272 169.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -139.26 177.04 8.2 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.591 0.632 . . . . 10.0 110.399 174.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -121.19 110.62 16.4 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.771 1.229 . . . . 10.0 108.112 -173.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.87 89.6 4.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -46.3 127.31 8.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -178.69 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.403 ' H ' ' NE2' ' A' ' 7' ' ' GLN . 2.1 p . . . . . 0 N--CA 1.443 -0.777 0 C-N-CA 128.189 2.595 . . . . 10.0 108.321 -175.476 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.3 t . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 110.446 -0.205 . . . . 10.0 110.446 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.02 -68.86 0.74 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.086 0.555 . . . . 10.0 111.018 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 m -55.25 -39.5 69.83 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.543 1.537 . . . . 10.0 111.262 -170.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -48.16 -68.74 0.16 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.486 1.914 . . . . 10.0 110.491 177.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 56' ' ' ILE . 97.4 t -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 124.319 1.048 . . . . 10.0 108.931 175.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.59 -18.98 5.86 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.299 1.428 . . . . 10.0 115.034 173.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.09 -21.24 29.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.867 1.834 . . . . 10.0 108.72 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.68 121.24 19.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.87 -0.519 . . . . 10.0 109.861 -173.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -47.12 -37.12 9.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.009 1.324 . . . . 10.0 112.416 173.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.67 81.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 114.519 -1.219 . . . . 10.0 114.35 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.32 163.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.86 1.83 . . . . 10.0 112.755 176.107 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -136.82 -49.17 0.63 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.677 1.191 . . . . 10.0 111.032 174.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.81 147.67 51.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.733 -0.839 . . . . 10.0 108.733 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.91 59.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.926 1.29 . . . . 10.0 110.655 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 79.81 5.79 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.329 -1.482 . . . . 10.0 108.54 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 135.03 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 174.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.05 58.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 172.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.61 -26.98 68.89 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.771 -0.581 . . . . 10.0 111.12 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.43 -30.41 71.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.353 0.661 . . . . 10.0 110.147 174.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.43 -19.57 24.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.018 0.527 . . . . 10.0 111.21 172.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.52 14.76 55.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.82 1.676 . . . . 10.0 111.542 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -144.38 97.83 3.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.025 0.93 . . . . 10.0 109.35 -169.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -88.97 109.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 N-CA-C 106.699 -1.593 . . . . 10.0 106.699 168.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.65 102.92 15.08 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -119.33 106.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 125.233 1.413 . . . . 10.0 108.384 -172.308 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.3 t -92.86 120.95 33.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.667 -1.605 . . . . 10.0 106.667 174.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -153.14 157.24 40.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.145 0.974 . . . . 10.0 113.355 -173.254 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.36 80.85 7.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.057 . . . . 10.0 112.497 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.15 -30.19 1.1 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.308 170.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.45 -53.55 27.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.084 0.553 . . . . 10.0 110.925 -177.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.17 -36.23 24.88 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.068 0.547 . . . . 10.0 109.868 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.58 101.63 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.762 1.225 . . . . 10.0 109.106 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 152.31 27.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.538 -0.726 . . . . 10.0 110.35 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.07 -39.84 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.884 0.874 . . . . 10.0 112.777 171.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -59.15 -53.97 52.25 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 118.581 -0.724 . . . . 10.0 109.935 174.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -47.52 -46.84 27.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.521 0.729 . . . . 10.0 109.898 175.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 24' ' ' VAL . 9.5 mm -62.72 -49.64 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 O-C-N 122.07 -0.394 . . . . 10.0 110.394 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.25 -46.52 88.27 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.088 -1.079 . . . . 10.0 108.088 -175.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -59.99 -38.32 82.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.4 0.68 . . . . 10.0 109.221 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.34 70.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.569 -0.707 . . . . 10.0 112.499 172.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.636 HD13 HG21 ' A' ' 67' ' ' VAL . 2.3 mp -66.91 -45.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 168.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.21 -24.79 66.6 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.799 0.727 . . . . 10.0 112.864 -176.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.54 -36.07 77.54 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.677 -0.64 . . . . 10.0 111.301 171.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.55 -55.06 2.85 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.93 1.692 . . . . 10.0 112.164 -169.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.54 -152.2 8.01 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.029 1.776 . . . . 10.0 108.874 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -151.27 59.32 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.925 1.363 . . . . 10.0 107.475 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.02 63.39 1.63 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.155 -1.424 . . . . 10.0 107.155 -167.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.636 HG21 HD13 ' A' ' 60' ' ' ILE . 3.8 p -155.92 70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.871 0.367 . . . . 10.0 111.642 -176.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -27.65 -71.37 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.319 1.047 . . . . 10.0 113.541 170.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt 165.8 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.28 2.232 . . . . 10.0 112.436 169.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.453 -0.282 0 O-C-N 120.721 -1.237 . . . . 10.0 111.844 -179.626 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 CA--C 1.535 0.384 0 N-CA-C 109.49 -0.559 . . . . 10.0 109.49 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 30.0 tt0 -93.54 115.12 27.61 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.849 1.66 . . . . 10.0 109.453 170.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -135.55 176.96 8.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.993 0.815 . . . . 10.0 112.02 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -123.14 114.17 19.95 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 174.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.711 HD13 HG23 ' A' ' 67' ' ' VAL . 4.5 pp -80.15 125.92 30.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.298 -1.741 . . . . 10.0 106.298 166.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 130.27 40.78 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m . . . . . 0 N--CA 1.442 -0.874 0 C-N-CA 128.133 2.573 . . . . 10.0 110.22 -174.949 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 t . . . . . 0 CA--C 1.54 0.592 0 CA-C-O 119.805 -0.141 . . . . 10.0 111.239 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -79.37 -71.42 0.45 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -49.82 -39.4 38.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.269 1.827 . . . . 10.0 112.365 -167.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m -49.82 -55.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.259 1.028 . . . . 10.0 110.24 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 56' ' ' ILE . 72.6 t -72.43 -41.82 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 124.136 0.975 . . . . 10.0 108.79 -179.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.36 -9.27 3.13 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.892 1.234 . . . . 10.0 114.603 173.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.86 -27.51 40.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 119.65 1.725 . . . . 10.0 108.622 177.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD1' HG23 ' A' ' 56' ' ' ILE . 75.5 mt -69.76 118.99 13.31 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.344 -173.097 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -45.38 -41.19 8.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.472 1.13 . . . . 10.0 111.925 170.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -3.38 81.13 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 114.04 -1.436 . . . . 10.0 114.674 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.09 163.38 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.411 2.105 . . . . 10.0 112.02 174.36 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -136.61 -43.62 0.6 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.841 1.257 . . . . 10.0 111.612 179.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.49 37.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.438 1.095 . . . . 10.0 108.233 176.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 57.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.14 1.376 . . . . 10.0 110.774 -173.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -81.52 88.87 6.16 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.768 -1.208 . . . . 10.0 109.847 -170.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -71.63 110.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.687 0.795 . . . . 10.0 111.231 179.46 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -142.07 57.55 1.47 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 175.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.1 -22.51 62.85 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.505 -0.747 . . . . 10.0 112.068 -177.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -61.97 -32.83 73.31 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.631 0.772 . . . . 10.0 110.876 172.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.93 -6.07 56.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.686 0.794 . . . . 10.0 111.554 173.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 15.44 81.56 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.825 1.679 . . . . 10.0 110.794 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -148.82 135.81 19.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.363 1.065 . . . . 10.0 108.296 -167.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -116.63 131.28 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 102.96 -2.978 . . . . 10.0 102.96 175.547 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.61 96.37 6.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.33 1.423 . . . . 10.0 108.326 177.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -111.5 110.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.341 1.456 . . . . 10.0 109.541 -174.289 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 26.8 t -98.22 123.82 42.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 10.0 106.173 169.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' PHE . . . . . 0.638 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -154.59 154.26 32.75 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.605 0.717 . . . . 10.0 112.55 -174.626 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.52 83.04 4.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.339 -0.846 . . . . 10.0 113.223 -170.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.14 -32.61 0.49 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.031 -1.441 . . . . 10.0 113.411 168.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -72.1 -40.15 68.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.854 0.752 . . . . 10.0 110.113 -172.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -91.48 -42.42 10.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.634 0.652 . . . . 10.0 111.145 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.39 109.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 146.81 50.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.477 -0.765 . . . . 10.0 109.569 -175.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 56' ' ' ILE . 2.4 m -38.51 -40.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.306 1.042 . . . . 10.0 113.615 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -62.63 -48.87 77.49 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.648 -0.691 . . . . 10.0 111.198 174.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -48.32 -45.11 34.77 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.819 0.736 . . . . 10.0 109.279 175.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 24' ' ' VAL . 1.1 mm -66.26 -43.73 91.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 122.071 -0.393 . . . . 10.0 111.015 178.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.84 68.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.42 -34.52 72.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.287 0.635 . . . . 10.0 109.867 -178.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.58 -31.69 66.42 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.947 -1.096 . . . . 10.0 113.188 173.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 120.477 1.49 . . . . 10.0 108.152 169.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.41 -29.72 67.95 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.646 1.112 . . . . 10.0 111.635 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -59.55 -29.49 67.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.697 0.399 . . . . 10.0 111.647 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -111.02 -64.37 1.29 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.518 1.127 . . . . 10.0 111.228 -177.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.98 -156.46 24.05 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.557 1.551 . . . . 10.0 109.261 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -152.35 56.13 0.82 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.592 1.196 . . . . 10.0 108.174 173.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.04 57.84 1.77 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -168.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.711 HG23 HD13 ' A' ' 6' ' ' LEU . 13.2 p -146.86 79.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 122.172 0.987 . . . . 10.0 109.815 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.75 -61.83 1.97 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.63 -1.176 . . . . 10.0 111.727 170.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt 154.53 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.843 2.057 . . . . 10.0 115.122 170.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mm . . . . . 0 N--CA 1.446 -0.628 0 C-N-CA 125.986 1.714 . . . . 10.0 110.988 -177.63 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 tmt? . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 107.137 -1.431 . . . . 10.0 107.137 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -133.21 114.13 13.47 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 122.071 0.149 . . . . 10.0 111.022 -169.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -78.59 91.21 4.57 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 126.405 1.882 . . . . 10.0 111.016 -179.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.401 ' HB3' HD12 ' A' ' 70' ' ' ILE . 20.2 mttp -117.78 175.37 5.69 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 121.488 0.661 . . . . 10.0 112.024 -173.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -118.76 102.33 8.75 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.362 1.065 . . . . 10.0 110.516 177.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.9 mt -76.54 74.57 3.26 Favored 'General case' 0 C--O 1.221 -0.411 0 N-CA-C 109.161 -0.681 . . . . 10.0 109.161 174.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -34.38 110.5 0.09 Allowed 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.749 1.619 . . . . 10.0 111.24 -179.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.446 HG23 HG11 ' A' ' 42' ' ' VAL . 90.9 t -96.29 137.27 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 C-N-CA 125.712 1.605 . . . . 10.0 110.221 -179.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -98.22 124.15 42.66 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.302 -1.37 . . . . 10.0 107.302 168.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -76.95 87.71 0.97 Allowed Glycine 0 CA--C 1.529 0.964 0 CA-C-O 119.13 -0.817 . . . . 10.0 111.523 -176.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -129.62 94.55 3.78 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 118.526 1.163 . . . . 10.0 111.376 178.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.6 t -175.71 -132.39 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 105.469 -2.048 . . . . 10.0 105.469 178.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 21.4 t -143.27 -51.5 0.35 Allowed 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.996 0.816 . . . . 10.0 112.25 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -158.8 -46.86 0.06 Allowed 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.657 0.741 . . . . 10.0 110.489 176.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.0 t60 -75.09 82.69 2.29 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 108.055 -1.091 . . . . 10.0 108.055 170.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -147.44 -47.04 0.17 Allowed 'General case' 0 CA--C 1.517 -0.304 0 CA-C-N 116.234 -0.439 . . . . 10.0 111.537 169.224 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 35.7 m -42.48 -53.39 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.352 0 C-N-CA 123.731 0.812 . . . . 10.0 110.192 179.134 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.88 -39.98 75.97 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 122.91 0.484 . . . . 10.0 112.244 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.65 -51.4 65.56 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 119.944 1.247 . . . . 10.0 110.341 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.3 t -58.86 -26.44 32.29 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.433 0 C-N-CA 125.371 1.469 . . . . 10.0 111.162 177.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -79.79 -69.67 0.57 Allowed 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 108.356 -0.979 . . . . 10.0 108.356 176.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.2 m -43.52 -44.55 6.1 Favored 'General case' 0 C--O 1.221 -0.426 0 C-N-CA 126.668 1.987 . . . . 10.0 111.44 -173.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.1 m -49.23 -55.33 12.91 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-O 122.037 0.922 . . . . 10.0 111.186 178.85 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.779 HG22 HG22 ' A' ' 56' ' ' ILE . 72.7 t -70.4 -41.87 78.43 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.14 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -54.83 -14.06 5.02 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.389 1.471 . . . . 10.0 114.911 172.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -81.77 -23.95 36.32 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 119.712 1.756 . . . . 10.0 108.442 -179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.5 HD13 HD12 ' A' ' 56' ' ' ILE . 65.6 mt -71.05 120.09 16.12 Favored 'General case' 0 N--CA 1.433 -1.322 0 O-C-N 122.013 -0.429 . . . . 10.0 110.728 -174.042 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -49.1 -34.67 14.42 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.418 1.087 . . . . 10.0 112.168 171.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.45 -0.84 90.25 Favored Glycine 0 CA--C 1.535 1.321 0 C-N-CA 125.121 1.343 . . . . 10.0 114.627 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.66 160.29 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 CA-C-N 120.327 2.063 . . . . 10.0 111.682 171.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.4 m -131.0 -42.56 1.1 Allowed 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.214 1.006 . . . . 10.0 112.377 173.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.41 147.25 35.87 Favored 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 123.826 0.85 . . . . 10.0 108.966 -179.775 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.3 59.12 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.784 1.234 . . . . 10.0 111.128 -175.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -79.08 71.47 5.55 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 120.675 -1.266 . . . . 10.0 109.856 -175.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.24 123.71 17.57 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.327 0 C-N-CA 123.936 0.895 . . . . 10.0 110.708 178.026 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.4 m120 -150.01 58.69 0.98 Allowed 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.955 -1.128 . . . . 10.0 107.955 171.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.498 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.7 pp -56.54 -29.53 62.04 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.572 -0.705 . . . . 10.0 111.004 178.449 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.498 ' N ' HD12 ' A' ' 37' ' ' LEU . 5.0 mt-10 -60.08 -35.67 75.67 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.313 1.045 . . . . 10.0 110.698 175.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.42 -6.02 59.02 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 123.939 0.896 . . . . 10.0 111.393 176.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.76 34.83 55.8 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 124.092 0.853 . . . . 10.0 111.535 -175.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.8 tttm -154.53 154.31 32.89 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 118.501 1.151 . . . . 10.0 110.154 176.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.555 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -142.42 102.66 0.97 Allowed 'Isoleucine or valine' 0 C--O 1.221 -0.407 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 172.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.73 93.35 8.42 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 107.953 -1.129 . . . . 10.0 107.953 -176.578 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.555 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -105.89 114.03 44.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.719 0 C-N-CA 125.187 1.395 . . . . 10.0 108.609 -177.305 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.6 t -102.27 120.02 39.79 Favored 'General case' 0 N--CA 1.446 -0.653 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 172.147 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.471 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.42 160.47 43.0 Favored 'General case' 0 N--CA 1.449 -0.52 0 O-C-N 123.981 0.801 . . . . 10.0 111.804 -175.375 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -90.96 80.32 5.76 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 122.002 0.906 . . . . 10.0 112.659 -169.624 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -36.95 -39.13 0.21 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 126.813 2.045 . . . . 10.0 113.684 175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -51.62 -57.19 9.85 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 124.608 1.163 . . . . 10.0 111.76 179.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -85.13 -41.74 15.41 Favored 'General case' 0 N--CA 1.457 -0.116 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 -171.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.1 m -130.5 110.97 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.468 0 N-CA-C 106.825 -1.546 . . . . 10.0 106.825 177.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.8 p -69.66 155.46 40.48 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-O 121.495 0.664 . . . . 10.0 109.746 178.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.513 HG21 HG13 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -37.91 -40.72 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 125.076 1.35 . . . . 10.0 113.095 171.74 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 28.7 tttp -57.62 -58.33 8.81 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 108.71 -0.848 . . . . 10.0 108.71 175.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -47.44 -46.17 26.34 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.767 0.827 . . . . 10.0 110.096 175.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.779 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -63.94 -45.35 97.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 O-C-N 121.691 -0.631 . . . . 10.0 111.019 -178.291 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -45.23 91.89 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.674 0.749 . . . . 10.0 108.987 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -60.44 -36.44 78.22 Favored 'General case' 0 N--CA 1.442 -0.848 0 N-CA-C 108.86 -0.793 . . . . 10.0 108.86 179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.04 -31.61 70.13 Favored 'General case' 0 CA--C 1.535 0.394 0 O-C-N 121.468 -0.77 . . . . 10.0 112.398 172.073 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.416 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.4 mp -64.59 -48.44 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 107.288 -1.375 . . . . 10.0 107.288 168.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -60.52 -26.95 67.24 Favored 'General case' 0 CA--C 1.533 0.327 0 CA-C-N 119.043 0.838 . . . . 10.0 112.464 -176.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -56.93 -26.56 59.69 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 112.303 0.483 . . . . 10.0 112.303 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -120.13 -63.71 1.34 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.766 1.226 . . . . 10.0 111.183 -175.521 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -101.51 -153.72 25.94 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 109.185 -1.566 . . . . 10.0 109.185 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -162.79 52.98 0.19 Allowed 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 107.476 -1.305 . . . . 10.0 107.476 174.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -133.91 62.19 1.66 Allowed 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 106.165 -1.791 . . . . 10.0 106.165 -168.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.6 p -147.74 88.29 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.627 0 CA-C-O 122.56 1.172 . . . . 10.0 108.663 177.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -49.74 -70.44 0.09 Allowed 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 114.43 -1.259 . . . . 10.0 109.397 169.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 163.07 -174.46 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 126.344 1.858 . . . . 10.0 113.53 172.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.513 HG13 HG21 ' A' ' 53' ' ' VAL . 18.2 mm -68.29 106.72 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.051 0 C-N-CA 123.674 0.79 . . . . 10.0 109.784 -176.119 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.0 tp10 -90.1 99.89 12.82 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 107.505 -1.294 . . . . 10.0 107.505 173.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 88.25 158.72 33.84 Favored Glycine 0 CA--C 1.53 1.027 0 C-N-CA 123.748 0.69 . . . . 10.0 112.171 179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 3.0 mtm105 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 117.941 -1.028 . . . . 10.0 111.368 -179.204 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 34.4 ttp . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 108.929 -0.767 . . . . 10.0 108.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -104.97 112.77 26.02 Favored 'General case' 0 CA--C 1.531 0.227 0 N-CA-C 109.975 -0.38 . . . . 10.0 109.975 -170.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.432 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.9 pm0 -72.64 100.45 2.8 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.608 1.563 . . . . 10.0 109.686 169.584 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.506 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -128.82 178.93 6.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 122.562 0.345 . . . . 10.0 110.179 172.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.6 m -118.17 114.22 22.72 Favored 'General case' 0 N--CA 1.45 -0.469 0 C-N-CA 123.064 0.546 . . . . 10.0 110.505 175.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.716 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.2 mt -79.54 92.76 5.33 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 106.689 -1.597 . . . . 10.0 106.689 174.291 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -52.7 119.89 5.08 Favored 'General case' 0 N--CA 1.448 -0.557 0 N-CA-C 108.902 -0.777 . . . . 10.0 108.902 -177.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 70.7 t -94.65 128.32 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 C-N-CA 126.818 2.047 . . . . 10.0 110.837 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -91.46 104.34 16.86 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 104.292 -2.484 . . . . 10.0 104.292 166.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -67.76 102.82 0.87 Allowed Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.192 -0.763 . . . . 10.0 111.192 -172.451 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -115.81 -173.19 2.3 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.425 1.09 . . . . 10.0 110.552 -176.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t 65.64 -170.22 0.2 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 125.126 1.37 . . . . 10.0 111.692 -175.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 32.5 t -96.14 -49.15 5.36 Favored 'General case' 0 C--N 1.333 -0.124 0 C-N-CA 125.325 1.45 . . . . 10.0 109.96 176.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -158.46 178.1 10.51 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 -175.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 52.2 t-80 56.22 34.47 24.03 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 125.116 1.366 . . . . 10.0 112.031 177.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -107.07 -51.39 2.93 Favored 'General case' 0 CA--C 1.52 -0.2 0 C-N-CA 123.195 0.598 . . . . 10.0 110.196 -175.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.3 p -43.88 -50.05 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 C-N-CA 124.062 0.945 . . . . 10.0 110.665 172.21 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -72.06 -23.17 61.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 112.499 0.555 . . . . 10.0 112.499 -179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.47 -56.13 12.36 Favored 'General case' 0 N--CA 1.456 -0.172 0 N-CA-C 108.33 -0.989 . . . . 10.0 108.33 173.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 75.5 t -48.79 -41.45 12.72 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.408 0 C-N-CA 123.342 0.657 . . . . 10.0 109.791 175.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -66.13 -70.39 0.24 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.718 1.207 . . . . 10.0 108.764 -176.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.9 m -48.11 -44.46 31.9 Favored 'General case' 0 N--CA 1.447 -0.592 0 C-N-CA 124.692 1.197 . . . . 10.0 110.941 -178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 64.1 m -59.8 -58.95 6.36 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-O 121.586 0.708 . . . . 10.0 110.57 -170.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.575 HG22 HG22 ' A' ' 56' ' ' ILE . 76.8 t -61.16 -41.41 89.32 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.142 0 N-CA-C 108.276 -1.009 . . . . 10.0 108.276 175.829 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.3 -13.81 7.77 Favored Glycine 0 CA--C 1.534 1.257 0 CA-C-O 118.171 -1.349 . . . . 10.0 115.289 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -82.8 -21.39 34.54 Favored 'General case' 0 C--N 1.341 0.203 0 CA-C-N 120.289 2.045 . . . . 10.0 108.87 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.748 HD13 HD12 ' A' ' 56' ' ' ILE . 61.7 mt -66.23 121.81 16.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 CA-C-O 121.455 0.645 . . . . 10.0 111.834 -174.699 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.7 t70 -45.17 -39.61 6.35 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 125.266 1.427 . . . . 10.0 111.776 169.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.58 7.62 81.35 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 125.249 1.404 . . . . 10.0 114.69 -178.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -70.81 160.59 5.09 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 120.599 2.199 . . . . 10.0 111.202 169.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.9 t -133.24 -44.57 0.84 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.63 1.172 . . . . 10.0 111.095 176.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.9 148.34 35.28 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 123.786 0.834 . . . . 10.0 108.768 174.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.497 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.3 m -141.11 58.31 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 C-N-CA 124.157 0.983 . . . . 10.0 111.292 -175.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 55.2 t-80 -82.02 67.36 7.99 Favored 'General case' 0 CA--C 1.535 0.373 0 O-C-N 120.787 -1.196 . . . . 10.0 111.508 -169.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -57.29 134.9 21.62 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.85 1.26 . . . . 10.0 111.576 -179.258 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -154.55 55.86 0.69 Allowed 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 106.648 -1.612 . . . . 10.0 106.648 176.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.8 pp -63.41 -23.53 67.45 Favored 'General case' 0 CA--C 1.533 0.293 0 O-C-N 120.792 -1.193 . . . . 10.0 111.755 -172.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -68.32 -32.37 72.44 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.672 0.789 . . . . 10.0 110.45 175.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.87 -23.98 44.55 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 109.99 -0.374 . . . . 10.0 109.99 172.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 94.1 29.59 9.55 Favored Glycine 0 CA--C 1.525 0.675 0 C-N-CA 124.876 1.227 . . . . 10.0 110.275 -178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 24.5 mtpt -146.34 169.4 18.91 Favored 'General case' 0 N--CA 1.451 -0.394 0 CA-C-O 122.424 1.107 . . . . 10.0 109.964 178.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.58 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -155.23 118.75 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 N-CA-C 102.856 -3.016 . . . . 10.0 102.856 169.045 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -96.88 99.27 10.84 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 106.778 -1.564 . . . . 10.0 106.778 -179.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.58 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -111.87 112.38 40.26 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 C-N-CA 125.818 1.647 . . . . 10.0 108.803 -171.403 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.432 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.1 t -94.81 114.96 26.91 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.693 -1.225 . . . . 10.0 107.693 170.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.574 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.3 p90 -144.7 154.79 43.13 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 113.482 0.919 . . . . 10.0 113.482 179.107 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -88.01 79.31 8.03 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-O 122.242 1.02 . . . . 10.0 111.354 -172.016 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -35.98 -44.86 0.39 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 112.941 -1.936 . . . . 10.0 112.284 169.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -44.84 -54.14 6.72 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.213 1.405 . . . . 10.0 112.299 177.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.5 tttt -87.22 -40.42 14.56 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 109.97 -0.381 . . . . 10.0 109.97 -175.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.502 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -134.69 104.67 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 -178.213 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.4 150.05 48.96 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 121.591 -0.693 . . . . 10.0 110.248 -172.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.706 HG11 HG21 ' A' ' 70' ' ' ILE . 3.6 t -33.85 -51.87 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 C-N-CA 125.569 1.548 . . . . 10.0 113.485 170.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 tttm -49.04 -59.98 3.17 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 173.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -48.53 -42.62 33.78 Favored 'General case' 0 N--CA 1.449 -0.491 0 C-N-CA 125.411 1.485 . . . . 10.0 110.006 179.7 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.748 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -65.81 -45.38 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.578 0 O-C-N 121.514 -0.742 . . . . 10.0 110.459 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.82 -44.78 96.18 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.35 -0.981 . . . . 10.0 108.35 -178.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.8 m-20 -57.23 -39.25 75.14 Favored 'General case' 0 N--CA 1.446 -0.631 0 N-CA-C 109.229 -0.656 . . . . 10.0 109.229 178.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.2 -34.07 69.96 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 112.803 0.668 . . . . 10.0 112.803 174.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.468 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.2 mp -64.5 -46.83 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.007 -1.479 . . . . 10.0 107.007 168.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -59.27 -30.19 68.12 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-N 118.716 0.689 . . . . 10.0 111.675 -175.393 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -62.86 -24.5 67.83 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 121.568 -0.707 . . . . 10.0 112.211 173.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -112.87 -66.84 1.05 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.092 1.757 . . . . 10.0 111.362 -169.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.82 -148.55 9.99 Favored Glycine 0 CA--C 1.527 0.827 0 C-N-CA 126.096 1.807 . . . . 10.0 108.754 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.3 p90 -161.98 55.16 0.25 Allowed 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 118.989 1.394 . . . . 10.0 108.266 177.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -133.51 61.91 1.67 Allowed 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 108.023 -1.103 . . . . 10.0 108.023 -168.519 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.716 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.4 p -149.69 85.36 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.598 0 CA-C-O 121.779 0.799 . . . . 10.0 109.518 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -40.59 -66.99 0.27 Allowed 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 115.494 -0.775 . . . . 10.0 111.382 170.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 ttmt 168.74 172.7 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 127.962 2.505 . . . . 10.0 110.266 168.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.706 HG21 HG11 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -67.91 133.46 31.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 O-C-N 121.598 -0.689 . . . . 10.0 111.645 173.61 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 11.2 mm-40 -62.19 117.43 6.04 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 169.835 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 62.38 73.53 0.51 Allowed Glycine 0 CA--C 1.53 1.02 0 N-CA-C 111.251 -0.74 . . . . 10.0 111.251 179.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.252 1.234 0 CA-C-O 117.761 -1.114 . . . . 10.0 111.006 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.423 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 62.0 mtt . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 121.156 0.503 . . . . 10.0 111.714 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -123.66 107.75 11.83 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 104.332 -2.47 . . . . 10.0 104.332 166.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.2 tt0 -71.0 107.07 3.91 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.543 ' CB ' HD11 ' A' ' 70' ' ' ILE . 70.1 mttt -131.25 176.2 8.48 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-O 121.732 0.777 . . . . 10.0 111.471 171.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.5 m -112.06 102.5 10.7 Favored 'General case' 0 N--CA 1.446 -0.644 0 C-N-CA 125.585 1.554 . . . . 10.0 110.54 177.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB2' HG21 ' A' ' 44' ' ' VAL . 3.3 tt -82.09 94.67 7.26 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.07 1.348 . . . . 10.0 107.856 174.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.447 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -60.43 119.39 7.91 Favored 'General case' 0 N--CA 1.443 -0.797 0 N-CA-C 108.591 -0.892 . . . . 10.0 108.591 -175.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.455 ' CG1' HG21 ' A' ' 17' ' ' VAL . 4.5 t -94.31 117.59 38.33 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 C-N-CA 126.799 2.04 . . . . 10.0 109.178 177.437 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -80.69 90.2 5.78 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.993 -1.114 . . . . 10.0 107.993 177.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -53.41 111.97 2.09 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.581 -0.566 . . . . 10.0 112.529 -176.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -144.47 -152.36 0.41 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.314 1.046 . . . . 10.0 110.081 -174.786 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.7 m -71.4 71.64 0.66 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.327 1.451 . . . . 10.0 111.537 -173.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 29.2 t -135.74 -48.25 0.68 Allowed 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 125.92 1.688 . . . . 10.0 109.929 -175.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 62.14 -155.67 0.34 Allowed 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.316 1.046 . . . . 10.0 110.974 175.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.2 m80 49.09 43.67 22.45 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 119.247 0.931 . . . . 10.0 112.53 -176.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.5 m 48.03 38.83 10.16 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 124.318 1.047 . . . . 10.0 110.756 -173.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.541 HG22 ' HB ' ' A' ' 20' ' ' VAL 0.255 9.8 p 51.89 18.48 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 C-N-CA 127.237 2.215 . . . . 10.0 113.48 -175.589 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 18.7 pttt -65.74 -30.62 71.31 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 120.73 -1.231 . . . . 10.0 110.974 -171.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -47.7 -36.36 11.13 Favored 'General case' 0 CA--C 1.54 0.57 0 O-C-N 120.922 -1.111 . . . . 10.0 112.447 171.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.722 HG21 ' HB2' ' A' ' 66' ' ' ASP . 1.5 t -84.09 -20.65 8.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 C-N-CA 125.245 1.418 . . . . 10.0 111.437 179.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.37 -50.41 12.82 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 108.657 -0.868 . . . . 10.0 108.657 175.341 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 66.8 m -54.93 -36.86 65.7 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.728 1.211 . . . . 10.0 111.76 -175.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -56.7 -49.91 73.73 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.232 0.924 . . . . 10.0 110.332 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.659 ' CG2' HD11 ' A' ' 60' ' ' ILE . 72.1 t -68.04 -43.46 85.38 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.025 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 175.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.51 -15.5 8.57 Favored Glycine 0 CA--C 1.535 1.289 0 C-N-CA 125.014 1.292 . . . . 10.0 115.167 174.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -85.56 -21.49 28.53 Favored 'General case' 0 N--CA 1.455 -0.195 0 CA-C-N 119.343 1.572 . . . . 10.0 109.094 -178.358 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD13 HD12 ' A' ' 56' ' ' ILE . 45.2 mt -67.05 125.32 25.64 Favored 'General case' 0 N--CA 1.435 -1.187 0 O-C-N 122.024 -0.422 . . . . 10.0 110.909 -174.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -48.18 -38.15 17.44 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 122.303 1.049 . . . . 10.0 111.783 169.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.92 -1.43 87.39 Favored Glycine 0 CA--C 1.535 1.332 0 C-N-CA 125.018 1.294 . . . . 10.0 114.497 -179.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -69.49 166.09 2.26 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.753 2.276 . . . . 10.0 112.273 174.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.8 t -141.0 -45.43 0.39 Allowed 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.923 1.289 . . . . 10.0 111.385 176.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.4 147.59 34.86 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 124.507 1.123 . . . . 10.0 108.483 177.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.521 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -144.48 58.45 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.674 0 C-N-CA 124.618 1.167 . . . . 10.0 112.193 -178.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.12 87.11 5.49 Favored 'General case' 0 N--CA 1.461 0.122 0 O-C-N 120.123 -1.611 . . . . 10.0 109.874 -177.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.52 115.28 6.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 122.864 0.466 . . . . 10.0 111.259 177.544 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -141.58 62.95 1.44 Allowed 'General case' 0 C--O 1.234 0.251 0 N-CA-C 107.939 -1.134 . . . . 10.0 107.939 178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.562 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.5 OUTLIER -57.24 -21.24 32.6 Favored 'General case' 0 CA--C 1.534 0.343 0 O-C-N 121.614 -0.679 . . . . 10.0 111.839 172.174 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.4 tt0 -64.68 -37.99 89.48 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.009 0.924 . . . . 10.0 109.001 176.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.03 -24.7 43.45 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 174.253 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 86.51 23.45 43.23 Favored Glycine 0 CA--C 1.523 0.559 0 N-CA-C 109.151 -1.579 . . . . 10.0 109.151 -177.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 28.7 mttt -155.7 116.15 3.78 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 107.513 -1.292 . . . . 10.0 107.513 -177.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG23 HG22 ' A' ' 44' ' ' VAL . 2.7 m -86.42 146.27 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 105.301 -2.111 . . . . 10.0 105.301 167.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -106.27 96.31 6.38 Favored 'General case' 0 CA--C 1.516 -0.363 0 N-CA-C 106.938 -1.505 . . . . 10.0 106.938 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.521 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.6 m -119.76 106.67 19.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.063 0 CA-C-O 122.316 1.055 . . . . 10.0 108.849 -168.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.7 t -99.62 121.22 40.89 Favored 'General case' 0 N--CA 1.443 -0.798 0 N-CA-C 107.275 -1.379 . . . . 10.0 107.275 174.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.431 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.5 p90 -148.87 172.06 15.29 Favored 'General case' 0 N--CA 1.448 -0.571 0 C-N-CA 124.033 0.933 . . . . 10.0 111.013 -175.678 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.423 ' OD1' ' N ' ' A' ' 1' ' ' MET . 7.4 t70 -102.41 83.32 2.29 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 122.547 1.165 . . . . 10.0 113.301 -171.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.2 -31.73 9.05 Favored 'General case' 0 N--CA 1.452 -0.362 0 CA-C-N 113.011 -1.904 . . . . 10.0 112.607 176.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -51.36 -60.7 2.84 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 124.269 1.028 . . . . 10.0 111.101 177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -82.55 -46.57 13.2 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 109.368 -0.604 . . . . 10.0 109.368 -177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.4 m -124.17 94.18 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.423 0 N-CA-C 107.187 -1.412 . . . . 10.0 107.187 -172.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -60.81 153.36 24.68 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.116 0.484 . . . . 10.0 110.395 -172.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.611 HG11 HG21 ' A' ' 70' ' ' ILE . 3.7 t -42.56 -42.82 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.439 -1.021 0 O-C-N 121.353 -0.842 . . . . 10.0 112.749 173.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.8 tttm -50.57 -61.83 1.95 Allowed 'General case' 0 C--O 1.22 -0.472 0 N-CA-C 109.539 -0.541 . . . . 10.0 109.539 169.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -47.15 -39.61 14.0 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.111 0.964 . . . . 10.0 111.063 177.316 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.59 HD12 HD13 ' A' ' 27' ' ' LEU . 2.5 mm -70.28 -48.53 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.709 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -177.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.08 -45.82 89.86 Favored 'General case' 0 N--CA 1.444 -0.742 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 -179.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -60.03 -39.98 87.78 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.951 0.9 . . . . 10.0 109.826 178.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.05 -26.48 67.66 Favored 'General case' 0 N--CA 1.456 -0.171 0 O-C-N 121.786 -0.571 . . . . 10.0 112.077 177.884 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.659 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.0 mp -67.59 -49.08 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.901 0 N-CA-C 106.886 -1.524 . . . . 10.0 106.886 168.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -53.9 -36.14 62.38 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.05 0.54 . . . . 10.0 110.778 -176.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -51.56 -37.77 51.21 Favored 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 123.071 0.549 . . . . 10.0 112.327 175.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -105.45 -62.11 1.4 Allowed 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 124.91 1.284 . . . . 10.0 111.785 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.95 -152.36 9.16 Favored Glycine 0 CA--C 1.526 0.778 0 C-N-CA 125.692 1.615 . . . . 10.0 109.631 -175.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 7.6 p90 -163.15 51.43 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.843 1.321 . . . . 10.0 111.18 -179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.722 ' HB2' HG21 ' A' ' 20' ' ' VAL . 1.5 m-20 -120.46 68.39 0.85 Allowed 'General case' 0 C--O 1.225 -0.237 0 N-CA-C 107.234 -1.395 . . . . 10.0 107.234 176.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.439 HG22 ' CD2' ' A' ' 6' ' ' LEU . 2.5 t -139.22 100.34 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 124.168 0.987 . . . . 10.0 108.873 -178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -66.8 -34.35 77.63 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 114.494 -1.23 . . . . 10.0 109.677 168.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 tttm 117.87 169.79 0.0 OUTLIER 'General case' 0 C--N 1.35 0.596 0 C-N-CA 129.186 2.995 . . . . 10.0 110.501 171.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.611 HG21 HG11 ' A' ' 53' ' ' VAL . 0.3 OUTLIER -66.19 128.53 29.35 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 O-C-N 121.347 -0.846 . . . . 10.0 109.254 175.303 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -136.18 144.37 44.94 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 124.264 0.978 . . . . 10.0 109.819 -176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 55.95 -100.79 0.11 Allowed Glycine 0 CA--C 1.526 0.762 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -174.876 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 19.2 ttm105 . . . . . 0 C--O 1.252 1.222 0 N-CA-C 103.384 -2.821 . . . . 10.0 103.384 173.168 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.417 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 21.4 ttt . . . . . 0 N--CA 1.482 1.145 0 CA-C-O 119.079 -0.486 . . . . 10.0 112.031 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -126.65 125.83 42.54 Favored 'General case' 0 C--N 1.344 0.329 0 C-N-CA 124.109 0.963 . . . . 10.0 112.417 -179.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.417 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 1.4 pm0 -83.34 99.72 10.21 Favored 'General case' 0 N--CA 1.463 0.214 0 C-N-CA 127.346 2.258 . . . . 10.0 110.053 169.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.431 ' CB ' HD11 ' A' ' 70' ' ' ILE . 79.2 mttt -136.96 177.26 8.0 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.217 0.462 . . . . 10.0 111.504 178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 60.4 m -114.05 110.37 19.92 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.035 1.334 . . . . 10.0 109.302 -177.044 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.654 HD22 ' CG2' ' A' ' 67' ' ' VAL . 2.1 mt -83.44 93.12 7.72 Favored 'General case' 0 C--O 1.22 -0.452 0 N-CA-C 108.236 -1.024 . . . . 10.0 108.236 174.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.57 118.37 2.21 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 124.015 0.926 . . . . 10.0 109.443 -178.663 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.444 ' CG2' HG11 ' A' ' 20' ' ' VAL . 37.7 t -93.6 133.59 34.17 Favored 'Isoleucine or valine' 0 C--O 1.231 0.107 0 C-N-CA 124.62 1.168 . . . . 10.0 111.523 178.529 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -98.07 96.23 7.99 Favored 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.352 -1.722 . . . . 10.0 106.352 169.385 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.44 100.15 0.25 Allowed Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.337 -0.705 . . . . 10.0 111.337 -178.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.7 tmt? -77.68 167.47 21.53 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.332 1.053 . . . . 10.0 109.642 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 10.3 t -68.1 74.38 0.21 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.332 1.053 . . . . 10.0 110.25 176.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 4.8 t -154.75 114.7 3.8 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 -179.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.9 pp0? -59.08 -42.69 91.03 Favored 'General case' 0 CA--C 1.53 0.191 0 O-C-N 121.547 -0.721 . . . . 10.0 111.072 -174.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -82.64 46.41 1.07 Allowed 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.765 -0.584 . . . . 10.0 110.862 -179.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 28.9 p -83.88 -35.87 23.82 Favored 'General case' 0 C--O 1.232 0.169 0 C-N-CA 124.302 1.041 . . . . 10.0 110.566 175.791 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.06 60.72 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 122.877 1.322 . . . . 10.0 109.848 177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.85 -43.6 0.01 OUTLIER 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 128.189 2.596 . . . . 10.0 110.055 174.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.23 -52.03 54.79 Favored 'General case' 0 CA--C 1.533 0.314 0 CA-C-N 119.165 0.893 . . . . 10.0 110.961 -176.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.444 HG11 ' CG2' ' A' ' 8' ' ' VAL . 11.3 t -62.8 -41.76 93.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 CA-C-N 115.357 -0.838 . . . . 10.0 109.981 177.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.71 -68.41 0.41 Allowed 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.749 1.619 . . . . 10.0 109.114 -169.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 23.5 m -48.51 -43.78 35.52 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 125.943 1.697 . . . . 10.0 111.233 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 48.0 t -56.94 -60.89 2.91 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-O 121.834 0.826 . . . . 10.0 110.147 -176.356 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.497 HG22 ' CG2' ' A' ' 56' ' ' ILE . 86.7 t -60.48 -40.23 83.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.385 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.65 -17.66 28.09 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.641 1.591 . . . . 10.0 114.789 174.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -82.03 -21.73 36.82 Favored 'General case' 0 C--N 1.341 0.196 0 CA-C-N 119.645 1.723 . . . . 10.0 108.416 -179.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.553 HD13 HD12 ' A' ' 56' ' ' ILE . 57.1 mt -66.97 122.1 16.98 Favored 'General case' 0 N--CA 1.433 -1.285 0 CA-C-O 121.108 0.48 . . . . 10.0 111.373 -175.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -45.5 -37.54 5.4 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.985 1.314 . . . . 10.0 112.107 168.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.75 -4.07 90.44 Favored Glycine 0 CA--C 1.535 1.331 0 C-N-CA 125.086 1.327 . . . . 10.0 114.692 -178.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -67.21 163.49 2.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 120.555 2.178 . . . . 10.0 111.909 175.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 42.3 t -133.82 -47.34 0.8 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.336 1.455 . . . . 10.0 110.633 175.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.03 148.46 35.25 Favored 'General case' 0 N--CA 1.463 0.221 0 N-CA-C 108.435 -0.95 . . . . 10.0 108.435 177.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.547 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.5 m -141.54 59.1 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 C-N-CA 124.32 1.048 . . . . 10.0 110.991 -177.282 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.54 69.47 8.2 Favored 'General case' 0 CA--C 1.533 0.321 0 O-C-N 121.079 -1.013 . . . . 10.0 110.408 -170.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -61.12 124.81 16.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.45 0 C-N-CA 124.009 0.924 . . . . 10.0 110.939 -178.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.6 m120 -145.8 58.03 1.23 Allowed 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.32 -1.363 . . . . 10.0 107.32 172.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -57.76 -26.71 62.25 Favored 'General case' 0 CA--C 1.539 0.526 0 O-C-N 121.562 -0.711 . . . . 10.0 111.297 -177.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -57.16 -38.65 73.89 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 125.165 1.386 . . . . 10.0 110.746 172.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.49 2.77 46.72 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.769 1.228 . . . . 10.0 111.874 176.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 59.94 42.24 98.18 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 109.8 -1.32 . . . . 10.0 109.8 -175.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -157.18 157.91 35.27 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 117.821 0.81 . . . . 10.0 109.21 -178.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.535 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -157.21 102.75 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.471 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -85.1 97.82 10.08 Favored 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 107.088 -1.449 . . . . 10.0 107.088 -171.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.547 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.9 OUTLIER -111.01 110.61 32.84 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 124.372 1.069 . . . . 10.0 109.042 -173.838 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -95.02 117.12 29.62 Favored 'General case' 0 N--CA 1.442 -0.832 0 N-CA-C 107.892 -1.151 . . . . 10.0 107.892 170.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.418 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.4 p90 -148.96 154.06 38.84 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-O 122.256 1.027 . . . . 10.0 113.712 -177.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -82.55 81.0 8.52 Favored 'General case' 0 N--CA 1.45 -0.455 0 CA-C-N 114.879 -1.055 . . . . 10.0 112.411 -170.422 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.31 -44.73 0.92 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.002 1.321 . . . . 10.0 111.519 169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.417 ' OD1' ' N ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -55.11 -52.12 64.24 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 126.762 2.025 . . . . 10.0 111.369 -174.374 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.79 -41.78 25.81 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 118.731 0.696 . . . . 10.0 109.937 177.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -137.91 107.7 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.141 0.976 . . . . 10.0 108.63 -173.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -63.48 152.01 39.62 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 121.788 -0.57 . . . . 10.0 110.354 -171.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.547 HG11 HG21 ' A' ' 70' ' ' ILE . 4.7 t -39.72 -45.42 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.838 0 C-N-CA 124.489 1.116 . . . . 10.0 112.553 170.469 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 8.5 tttm -52.23 -58.15 7.52 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-O 119.393 -0.337 . . . . 10.0 110.386 171.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -50.98 -41.09 59.33 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.568 0.747 . . . . 10.0 109.625 179.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.553 HD12 HD13 ' A' ' 27' ' ' LEU . 2.2 mm -64.3 -53.05 47.97 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.812 0 N-CA-C 108.498 -0.927 . . . . 10.0 108.498 -178.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -56.72 -47.79 79.18 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.18 -1.045 . . . . 10.0 108.18 -176.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.1 m-20 -62.67 -32.58 73.67 Favored 'General case' 0 N--CA 1.44 -0.952 0 CA-C-N 115.711 -0.677 . . . . 10.0 109.751 -177.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.3 -33.31 74.41 Favored 'General case' 0 CA--C 1.533 0.317 0 O-C-N 120.899 -1.126 . . . . 10.0 112.605 172.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.412 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.0 mp -60.57 -36.19 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 O-C-N 120.275 -1.516 . . . . 10.0 108.412 171.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -53.62 -49.31 68.12 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.994 0.815 . . . . 10.0 109.896 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -51.3 -49.5 61.18 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-O 121.089 0.471 . . . . 10.0 111.819 177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.47 -19.9 27.34 Favored 'General case' 0 CA--C 1.538 0.498 0 N-CA-C 113.427 0.899 . . . . 10.0 113.427 -171.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 148.79 99.79 0.22 Allowed Glycine 0 CA--C 1.531 1.082 0 N-CA-C 109.534 -1.426 . . . . 10.0 109.534 -174.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 29.4 p90 -67.89 54.28 0.07 Allowed 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 117.109 2.263 . . . . 10.0 117.109 -167.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.81 74.41 2.67 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 120.145 -1.597 . . . . 10.0 108.027 169.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.654 ' CG2' HD22 ' A' ' 6' ' ' LEU . 8.3 p -151.54 110.05 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.366 -0.834 . . . . 10.0 108.913 173.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -62.45 -73.32 0.11 Allowed 'General case' 0 CA--C 1.539 0.539 0 CA-C-N 115.349 -0.841 . . . . 10.0 109.942 169.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 175.8 174.91 0.28 Allowed 'General case' 0 C--N 1.344 0.363 0 C-N-CA 126.467 1.907 . . . . 10.0 110.643 169.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.547 HG21 HG11 ' A' ' 53' ' ' VAL . 1.0 OUTLIER -68.48 130.64 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 121.778 -0.576 . . . . 10.0 111.041 174.685 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.8 mm-40 -84.04 -84.52 0.14 Allowed 'General case' 0 N--CA 1.457 -0.09 0 N-CA-C 107.349 -1.352 . . . . 10.0 107.349 169.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 171.11 75.9 0.04 OUTLIER Glycine 0 CA--C 1.522 0.479 0 N-CA-C 108.687 -1.765 . . . . 10.0 108.687 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 30.8 ptt180 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 125.986 1.715 . . . . 10.0 112.258 -171.207 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 24.5 ttm . . . . . 0 N--CA 1.471 0.589 0 CA-C-O 118.324 -0.846 . . . . 10.0 110.379 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -155.66 144.75 20.71 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.318 0.963 . . . . 10.0 111.861 170.148 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 3.3 pm0 -88.63 106.53 18.38 Favored 'General case' 0 C--N 1.345 0.37 0 C-N-CA 125.449 1.5 . . . . 10.0 110.608 175.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.463 ' CB ' HD12 ' A' ' 70' ' ' ILE . 58.4 mttt -136.39 176.29 8.83 Favored 'General case' 0 C--N 1.341 0.227 0 CA-C-N 119.1 0.864 . . . . 10.0 112.475 179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.412 HG23 ' H ' ' A' ' 42' ' ' VAL . 21.5 m -116.0 108.34 16.11 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 123.879 0.872 . . . . 10.0 109.189 -175.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -76.87 79.8 3.45 Favored 'General case' 0 C--O 1.225 -0.228 0 N-CA-C 107.887 -1.153 . . . . 10.0 107.887 174.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -37.43 122.12 0.89 Allowed 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.013 1.325 . . . . 10.0 109.003 172.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -122.62 140.16 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 127.773 2.429 . . . . 10.0 107.74 -170.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -102.61 112.06 24.65 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 106.882 -1.525 . . . . 10.0 106.882 178.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -62.89 107.58 1.73 Allowed Glycine 0 CA--C 1.532 1.125 0 CA-C-O 119.398 -0.668 . . . . 10.0 111.893 178.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.45 -69.32 0.76 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-N 117.859 0.83 . . . . 10.0 110.196 173.367 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 27.2 t -83.92 156.04 22.56 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.382 0.61 . . . . 10.0 111.714 -170.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.1 t -76.15 -41.92 48.33 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.797 1.239 . . . . 10.0 112.045 -172.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.6 mm-40 -146.4 170.26 17.19 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.801 0.841 . . . . 10.0 109.148 -176.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.3 t60 59.0 20.1 7.88 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 125.622 1.569 . . . . 10.0 112.321 -175.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.6 p -104.88 -36.36 7.39 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.83 1.652 . . . . 10.0 111.072 -173.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.0 m -69.09 62.17 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.127 1.771 . . . . 10.0 110.029 172.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.09 -40.29 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 127.143 2.177 . . . . 10.0 109.165 -175.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.28 -48.15 82.71 Favored 'General case' 0 N--CA 1.462 0.161 0 O-C-N 121.029 -1.045 . . . . 10.0 110.153 -178.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 32.6 t -67.58 -13.92 17.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.715 1.206 . . . . 10.0 110.999 176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -91.01 -69.82 0.71 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.36 1.064 . . . . 10.0 109.274 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 63.3 m -36.45 -53.36 0.86 Allowed 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 127.181 2.192 . . . . 10.0 111.495 -175.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 16.6 m -51.2 -55.61 17.13 Favored 'General case' 0 N--CA 1.45 -0.475 0 C-N-CA 125.301 1.441 . . . . 10.0 110.959 179.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.565 ' CG2' HD11 ' A' ' 60' ' ' ILE . 60.1 t -72.0 -19.8 20.06 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.412 0 C-N-CA 124.559 1.144 . . . . 10.0 110.326 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.34 10.47 73.11 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 124.777 1.18 . . . . 10.0 112.169 176.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -89.13 -40.24 13.05 Favored 'General case' 0 N--CA 1.453 -0.292 0 CA-C-N 119.023 1.411 . . . . 10.0 108.136 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.502 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.1 OUTLIER -59.69 123.78 18.03 Favored 'General case' 0 N--CA 1.43 -1.466 0 N-CA-C 112.471 0.545 . . . . 10.0 112.471 -177.191 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -51.74 -34.86 41.0 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.896 1.278 . . . . 10.0 111.779 172.221 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.5 0.64 87.63 Favored Glycine 0 CA--C 1.535 1.311 0 C-N-CA 125.328 1.442 . . . . 10.0 114.234 178.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.437 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.37 156.26 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.671 0 O-C-N 119.849 -1.971 . . . . 10.0 111.54 169.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 7.3 t -128.59 -44.3 1.37 Allowed 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.117 1.367 . . . . 10.0 110.902 -177.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -146.06 149.1 33.43 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-O 117.792 -1.099 . . . . 10.0 108.457 175.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.533 ' HA ' HG12 ' A' ' 44' ' ' VAL . 30.8 m -143.4 58.24 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.578 0 C-N-CA 123.859 0.864 . . . . 10.0 112.062 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 t-80 -80.73 74.06 7.68 Favored 'General case' 0 CA--C 1.536 0.404 0 O-C-N 120.306 -1.496 . . . . 10.0 111.432 -171.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.23 121.81 7.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.482 0 C-N-CA 124.584 1.153 . . . . 10.0 111.578 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -149.29 56.61 1.0 Allowed 'General case' 0 C--O 1.234 0.246 0 N-CA-C 107.882 -1.155 . . . . 10.0 107.882 174.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.462 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.4 pp -59.65 -21.88 61.1 Favored 'General case' 0 CA--C 1.534 0.335 0 O-C-N 121.631 -0.668 . . . . 10.0 111.338 177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.462 ' N ' HD12 ' A' ' 37' ' ' LEU . 2.5 tm-20 -63.98 -39.69 94.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.358 1.463 . . . . 10.0 108.865 175.202 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.41 -27.17 41.77 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 122.79 0.436 . . . . 10.0 110.42 173.505 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 102.32 22.8 9.47 Favored Glycine 0 CA--C 1.526 0.723 0 C-N-CA 125.128 1.347 . . . . 10.0 111.081 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -147.16 168.52 21.44 Favored 'General case' 0 N--CA 1.451 -0.415 0 C-N-CA 124.634 1.174 . . . . 10.0 108.123 -179.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.642 HG22 HG13 ' A' ' 44' ' ' VAL . 1.1 p -157.18 102.39 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.584 0 N-CA-C 105.011 -2.218 . . . . 10.0 105.011 -178.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 48.0 t0 -80.23 95.76 6.39 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 108.089 -1.078 . . . . 10.0 108.089 -175.499 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.642 HG13 HG22 ' A' ' 42' ' ' VAL . 0.9 OUTLIER -112.86 108.75 26.33 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.904 0 CA-C-O 122.5 1.143 . . . . 10.0 109.133 -174.815 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.451 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 25.4 t -103.18 120.92 41.6 Favored 'General case' 0 N--CA 1.439 -1.004 0 N-CA-C 107.648 -1.241 . . . . 10.0 107.648 177.379 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.508 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -152.36 155.63 37.99 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 114.412 1.264 . . . . 10.0 114.412 -171.626 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.13 84.0 5.15 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 114.944 -1.025 . . . . 10.0 111.735 177.741 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.46 -45.46 1.53 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.022 1.329 . . . . 10.0 110.142 167.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.424 ' OD1' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER -44.75 -44.75 9.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 128.505 2.722 . . . . 10.0 112.595 176.45 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.21 -46.76 10.76 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 118.041 0.382 . . . . 10.0 110.329 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 79.7 t -135.21 115.37 18.12 Favored 'Isoleucine or valine' 0 C--O 1.228 -0.079 0 N-CA-C 105.666 -1.975 . . . . 10.0 105.666 -177.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.04 144.67 50.32 Favored 'General case' 0 C--O 1.218 -0.6 0 N-CA-C 108.542 -0.91 . . . . 10.0 108.542 -170.074 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.49 HG13 ' CG1' ' A' ' 70' ' ' ILE . 17.1 t -25.53 -55.21 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.16 2.184 . . . . 10.0 113.661 168.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.7 tttm -47.95 -62.47 1.45 Allowed 'General case' 0 C--O 1.22 -0.498 0 N-CA-C 108.858 -0.793 . . . . 10.0 108.858 173.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -56.6 -39.08 72.93 Favored 'General case' 0 N--CA 1.447 -0.611 0 C-N-CA 125.515 1.526 . . . . 10.0 110.27 -178.513 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.452 HG21 ' CE2' ' A' ' 46' ' ' PHE . 3.0 mm -61.45 -46.06 97.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 119.152 0.887 . . . . 10.0 108.802 175.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.38 -47.46 85.75 Favored 'General case' 0 N--CA 1.445 -0.715 0 N-CA-C 107.928 -1.138 . . . . 10.0 107.928 -179.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -58.46 -34.09 70.47 Favored 'General case' 0 N--CA 1.446 -0.63 0 C-N-CA 122.926 0.49 . . . . 10.0 109.978 -177.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.89 -33.13 66.58 Favored 'General case' 0 CA--C 1.535 0.378 0 N-CA-C 112.425 0.528 . . . . 10.0 112.425 174.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.565 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.6 mp -64.47 -49.77 79.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.613 0 N-CA-C 107.548 -1.278 . . . . 10.0 107.548 169.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -56.42 -31.71 64.17 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.248 0.477 . . . . 10.0 111.245 -177.307 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -62.12 -23.14 66.37 Favored 'General case' 0 CA--C 1.541 0.63 0 C-N-CA 123.226 0.61 . . . . 10.0 112.099 177.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 35.6 tt0 -113.39 -63.64 1.42 Allowed 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 125.452 1.501 . . . . 10.0 111.306 -179.407 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -113.16 -146.09 9.56 Favored Glycine 0 CA--C 1.526 0.73 0 C-N-CA 126.219 1.866 . . . . 10.0 109.344 -178.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.3 p90 -164.8 51.22 0.11 Allowed 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 119.023 1.411 . . . . 10.0 109.554 177.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -127.98 66.11 1.36 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 106.424 -1.695 . . . . 10.0 106.424 -175.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 4.0 p -147.35 99.06 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 175.579 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -57.8 -66.51 0.46 Allowed 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 118.64 -0.695 . . . . 10.0 109.663 168.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.0 mtpt 165.86 179.95 0.02 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 125.31 1.444 . . . . 10.0 113.507 174.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.49 ' CG1' HG13 ' A' ' 53' ' ' VAL . 6.3 mm -66.11 114.57 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 108.129 -1.063 . . . . 10.0 108.129 174.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -54.99 -43.46 73.57 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.149 1.379 . . . . 10.0 109.311 176.181 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.23 -116.11 1.67 Allowed Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 104.893 -3.283 . . . . 10.0 104.893 -169.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 22.4 mmm180 . . . . . 0 C--O 1.249 1.045 0 CA-C-O 116.022 -1.942 . . . . 10.0 111.038 -174.163 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.401 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 0.2 OUTLIER . . . . . 0 N--CA 1.478 0.955 0 N-CA-C 109.364 -0.606 . . . . 10.0 109.364 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -125.56 119.99 29.63 Favored 'General case' 0 C--N 1.341 0.238 0 C-N-CA 123.374 0.669 . . . . 10.0 110.46 -173.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.6 tt0 -78.3 103.88 8.53 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.095 0.958 . . . . 10.0 109.383 169.744 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.618 ' HB3' HD12 ' A' ' 70' ' ' ILE . 31.8 mttm -127.03 176.57 7.25 Favored 'General case' 0 C--N 1.334 -0.092 0 N-CA-C 109.757 -0.46 . . . . 10.0 109.757 176.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -118.14 119.4 34.63 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.995 -0.742 . . . . 10.0 108.995 172.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.466 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 13.1 mt -77.55 107.67 10.18 Favored 'General case' 0 C--O 1.219 -0.528 0 N-CA-C 107.157 -1.423 . . . . 10.0 107.157 171.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.462 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -54.66 116.75 2.86 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 106.342 -1.725 . . . . 10.0 106.342 168.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 25.0 t -120.28 130.93 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 C-N-CA 126.967 2.107 . . . . 10.0 106.867 177.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . 0.257 1.4 pm0 -86.93 -46.32 9.99 Favored 'General case' 0 CA--C 1.523 -0.068 0 CA-C-O 122.38 1.086 . . . . 10.0 113.386 -175.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 87.99 118.2 1.37 Allowed Glycine 0 CA--C 1.531 1.06 0 C-N-CA 127.102 2.287 . . . . 10.0 112.508 175.486 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 8.1 ttt -120.5 170.25 9.57 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.431 1.493 . . . . 10.0 111.217 -174.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 24.6 p 61.78 -137.8 0.5 Allowed 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.028 1.731 . . . . 10.0 111.819 -179.45 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.2 m -153.56 128.1 9.31 Favored 'General case' 0 N--CA 1.457 -0.089 0 C-N-CA 125.245 1.418 . . . . 10.0 107.475 -175.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 10.9 mt-30 54.17 29.61 10.78 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.459 1.103 . . . . 10.0 112.021 176.321 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -140.71 177.64 7.89 Favored 'General case' 0 N--CA 1.448 -0.558 0 C-N-CA 126.381 1.872 . . . . 10.0 106.09 174.561 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 85.5 m 74.63 -50.05 0.67 Allowed 'General case' 0 C--O 1.227 -0.123 0 C-N-CA 124.909 1.284 . . . . 10.0 111.83 179.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 77.6 t -35.32 -51.42 0.19 Allowed 'Isoleucine or valine' 0 C--O 1.225 -0.203 0 C-N-CA 126.607 1.963 . . . . 10.0 110.142 173.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -94.17 -42.42 8.98 Favored 'General case' 0 N--CA 1.449 -0.493 0 N-CA-C 113.298 0.851 . . . . 10.0 113.298 178.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.74 -45.78 67.16 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 120.502 1.501 . . . . 10.0 111.615 -177.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 84.5 t -61.21 -25.38 36.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 124.501 1.12 . . . . 10.0 110.99 178.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.17 -58.46 3.21 Favored 'General case' 0 C--N 1.341 0.225 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 174.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 16.5 m -46.65 -50.54 17.52 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.829 1.651 . . . . 10.0 111.793 -177.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.4 m -52.39 -60.94 2.63 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-O 122.594 1.188 . . . . 10.0 110.501 -172.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.486 HG22 HG22 ' A' ' 56' ' ' ILE . 54.1 t -65.79 -40.42 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.139 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -50.41 -17.46 1.91 Allowed Glycine 0 CA--C 1.534 1.232 0 C-N-CA 125.416 1.484 . . . . 10.0 114.495 169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -83.83 -24.37 30.99 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 119.952 1.876 . . . . 10.0 108.757 -178.512 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 71.9 mt -71.28 125.7 27.65 Favored 'General case' 0 N--CA 1.435 -1.21 0 O-C-N 121.67 -0.644 . . . . 10.0 110.602 -172.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -48.51 -38.53 20.44 Favored 'General case' 0 CA--C 1.528 0.122 0 C-N-CA 124.446 1.098 . . . . 10.0 112.019 173.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.97 -14.06 75.93 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-N 114.132 -1.395 . . . . 10.0 114.042 179.385 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.35 158.27 3.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.455 0 CA-C-N 120.02 1.91 . . . . 10.0 111.76 175.095 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.4 t -133.41 -47.66 0.83 Allowed 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 123.907 0.883 . . . . 10.0 110.887 175.333 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.41 145.5 41.06 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-O 118.251 -0.88 . . . . 10.0 108.873 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' HA ' HG12 ' A' ' 44' ' ' VAL . 29.7 m -142.96 59.27 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.617 0 C-N-CA 124.861 1.264 . . . . 10.0 110.918 -178.458 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -78.41 76.3 4.92 Favored 'General case' 0 C--N 1.338 0.073 0 O-C-N 120.36 -1.463 . . . . 10.0 109.263 -176.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -60.55 133.34 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.608 0 C-N-CA 124.393 1.077 . . . . 10.0 111.132 176.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 51.0 t-20 -154.9 58.2 0.67 Allowed 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 108.134 -1.062 . . . . 10.0 108.134 172.107 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -61.53 -19.8 62.52 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-N 115.762 -0.654 . . . . 10.0 111.131 -176.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 66.7 mt-10 -69.42 -36.13 76.4 Favored 'General case' 0 C--N 1.342 0.279 0 C-N-CA 124.037 0.935 . . . . 10.0 110.372 173.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -77.39 -25.01 50.46 Favored 'General case' 0 CA--C 1.529 0.161 0 N-CA-C 109.673 -0.492 . . . . 10.0 109.673 171.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.72 32.35 8.12 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 109.489 -1.445 . . . . 10.0 109.489 177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 23.8 mttp -152.31 171.09 18.54 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.557 1.143 . . . . 10.0 107.937 175.307 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.597 HG22 HG13 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -156.34 125.12 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 N-CA-C 103.062 -2.94 . . . . 10.0 103.062 175.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -95.67 104.08 15.98 Favored 'General case' 0 CA--C 1.519 -0.25 0 N-CA-C 107.486 -1.302 . . . . 10.0 107.486 178.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.597 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -116.58 107.46 22.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.851 0 C-N-CA 124.462 1.105 . . . . 10.0 109.16 -172.81 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 34.6 t -95.68 113.67 25.33 Favored 'General case' 0 CA--C 1.508 -0.664 0 N-CA-C 107.657 -1.238 . . . . 10.0 107.657 169.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.6 p90 -138.36 154.07 48.95 Favored 'General case' 0 N--CA 1.441 -0.901 0 CA-C-N 114.866 -1.061 . . . . 10.0 112.089 177.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 47.0 t0 -80.49 77.46 7.28 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 114.959 -1.019 . . . . 10.0 112.506 -169.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -38.65 -38.59 0.41 Allowed 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 125.937 1.695 . . . . 10.0 112.902 169.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.401 ' OD1' ' N ' ' A' ' 1' ' ' MET . 4.6 m-20 -69.23 -39.02 78.8 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.793 0.837 . . . . 10.0 110.641 -176.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tpmt? -80.87 -50.13 10.17 Favored 'General case' 0 CA--C 1.53 0.208 0 C-N-CA 123.87 0.868 . . . . 10.0 110.655 -179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 45.9 t -134.72 137.3 51.27 Favored 'Isoleucine or valine' 0 C--N 1.337 0.04 0 N-CA-C 107.695 -1.224 . . . . 10.0 107.695 -175.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.77 142.16 34.05 Favored 'General case' 0 N--CA 1.447 -0.585 0 O-C-N 122.0 -0.437 . . . . 10.0 110.479 -168.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 68.8 t -35.36 -48.33 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.818 0 C-N-CA 126.222 1.809 . . . . 10.0 112.458 169.195 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -51.7 -65.83 0.49 Allowed 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 108.429 -0.952 . . . . 10.0 108.429 173.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -42.56 -41.88 3.17 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.693 1.197 . . . . 10.0 111.682 175.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.486 HG22 HG22 ' A' ' 24' ' ' VAL . 8.2 mm -66.0 -43.01 92.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 CA-C-N 119.037 0.835 . . . . 10.0 111.153 178.245 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.06 -50.68 69.65 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 109.168 -0.679 . . . . 10.0 109.168 177.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -58.1 -37.22 74.12 Favored 'General case' 0 N--CA 1.446 -0.628 0 C-N-CA 123.823 0.849 . . . . 10.0 109.368 -176.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.68 -29.8 64.95 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.647 0.98 . . . . 10.0 113.647 173.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.4 mt -69.86 -42.85 79.99 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 120.598 -1.314 . . . . 10.0 108.423 169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 57.0 mt-10 -62.86 -30.63 71.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 118.461 0.573 . . . . 10.0 111.115 -177.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -53.7 -50.97 64.72 Favored 'General case' 0 CA--C 1.536 0.442 0 CA-C-O 120.992 0.425 . . . . 10.0 110.957 171.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -90.29 -49.64 6.43 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 113.558 0.947 . . . . 10.0 113.558 -168.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -168.53 94.23 0.11 Allowed Glycine 0 CA--C 1.527 0.836 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -169.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 22.2 p90 -66.61 102.01 0.86 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.818 1.247 . . . . 10.0 111.711 -169.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -153.22 74.37 1.02 Allowed 'General case' 0 C--N 1.332 -0.163 0 N-CA-C 105.905 -1.887 . . . . 10.0 105.905 172.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.3 p -156.79 77.42 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 N-CA-C 112.911 0.708 . . . . 10.0 112.911 177.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.462 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -33.88 -61.8 0.33 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 124.38 1.072 . . . . 10.0 112.99 169.504 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 23.2 mttt 157.0 176.47 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 127.523 2.329 . . . . 10.0 113.092 169.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.618 HD12 ' HB3' ' A' ' 4' ' ' LYS . 2.8 mm -64.71 123.46 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.578 -0.897 . . . . 10.0 108.578 179.844 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -57.74 -56.01 27.48 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-O 121.42 0.629 . . . . 10.0 109.591 174.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 151.09 -172.58 30.69 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 109.83 -1.308 . . . . 10.0 109.83 179.371 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.335 0 C-N-CA 128.019 2.528 . . . . 10.0 104.406 167.736 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.788 0 N-CA-C 109.616 -0.513 . . . . 10.0 109.616 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 56.5 mt-10 -151.06 152.43 33.44 Favored 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 123.297 0.639 . . . . 10.0 109.642 178.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.3 pm0 -93.73 93.11 7.81 Favored 'General case' 0 C--N 1.34 0.164 0 C-N-CA 126.843 2.057 . . . . 10.0 110.408 174.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.441 ' HB3' ' CG1' ' A' ' 70' ' ' ILE . 0.8 OUTLIER -114.04 176.63 4.95 Favored 'General case' 0 N--CA 1.467 0.394 0 CA-C-O 121.169 0.509 . . . . 10.0 110.023 176.091 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.9 m -114.59 109.39 18.18 Favored 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 124.312 1.045 . . . . 10.0 109.297 -177.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.7 mt -77.35 83.42 3.8 Favored 'General case' 0 C--O 1.224 -0.273 0 C-N-CA 123.959 0.903 . . . . 10.0 109.267 173.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -36.98 116.46 0.45 Allowed 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.461 1.104 . . . . 10.0 109.76 169.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -107.33 131.26 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.79 0 C-N-CA 128.77 2.828 . . . . 10.0 109.241 -171.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -101.88 56.79 0.81 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.856 1.262 . . . . 10.0 107.807 176.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.93 118.69 6.51 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.239 -1.144 . . . . 10.0 110.239 -175.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 22.3 ttt -90.15 147.76 23.39 Favored 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 117.331 0.565 . . . . 10.0 110.622 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.8 m -64.48 69.54 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.775 1.63 . . . . 10.0 112.129 176.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 18.7 t -149.34 -57.19 0.2 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.153 0.581 . . . . 10.0 110.931 -176.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' CG ' ' H ' ' A' ' 15' ' ' HIS . 0.2 OUTLIER -162.37 -148.63 0.14 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 108.166 -1.05 . . . . 10.0 108.166 173.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.411 ' H ' ' CG ' ' A' ' 14' ' ' GLN . 44.5 m170 64.89 1.42 1.44 Allowed 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.178 1.791 . . . . 10.0 114.567 177.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 40.3 m -21.22 -70.74 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.448 0 C-N-CA 128.48 2.712 . . . . 10.0 114.628 -170.732 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.96 80.42 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 N-CA-C 106.736 -1.579 . . . . 10.0 106.736 176.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.74 -57.26 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.487 0 N-CA-C 113.057 0.762 . . . . 10.0 113.057 178.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.95 -51.57 65.72 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 120.104 1.32 . . . . 10.0 110.755 -174.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.8 t -61.92 -25.16 36.46 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.501 0 C-N-CA 125.579 1.551 . . . . 10.0 110.87 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -79.31 -72.31 0.4 Allowed 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.336 1.054 . . . . 10.0 109.404 -179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 25.7 m -44.35 -49.97 9.33 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 127.103 2.161 . . . . 10.0 111.63 -176.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.0 m -54.56 -56.18 21.61 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 123.771 0.829 . . . . 10.0 110.47 -172.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.726 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.2 t -67.77 -39.85 82.72 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 N-CA-C 108.581 -0.896 . . . . 10.0 108.581 177.606 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.05 -14.46 17.74 Favored Glycine 0 CA--C 1.533 1.183 0 C-N-CA 124.964 1.269 . . . . 10.0 114.612 174.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -81.55 -21.47 38.49 Favored 'General case' 0 N--CA 1.455 -0.213 0 CA-C-N 119.599 1.7 . . . . 10.0 108.935 179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.613 HD13 HD12 ' A' ' 56' ' ' ILE . 57.9 mt -69.14 120.74 15.45 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 123.185 0.594 . . . . 10.0 111.31 -174.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -43.97 -39.93 4.37 Favored 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 124.99 1.316 . . . . 10.0 111.94 169.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.63 -4.72 90.2 Favored Glycine 0 CA--C 1.534 1.252 0 C-N-CA 125.031 1.301 . . . . 10.0 114.617 -177.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.85 162.55 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.286 2.043 . . . . 10.0 112.103 175.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 30.6 t -135.33 -45.22 0.69 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 124.998 1.319 . . . . 10.0 111.038 177.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.73 146.94 29.42 Favored 'General case' 0 N--CA 1.464 0.234 0 C-N-CA 124.265 1.026 . . . . 10.0 108.437 178.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.426 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.8 m -142.5 57.47 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.526 0 C-N-CA 123.744 0.818 . . . . 10.0 111.381 -175.453 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 61.6 m-70 -80.79 75.13 7.72 Favored 'General case' 0 N--CA 1.46 0.057 0 O-C-N 120.726 -1.234 . . . . 10.0 110.254 -176.107 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 3.0 p -60.78 127.79 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.957 0 C-N-CA 124.16 0.984 . . . . 10.0 110.742 172.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 21.9 m120 -146.81 58.45 1.18 Allowed 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.381 -1.711 . . . . 10.0 106.381 171.596 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.31 -24.2 64.81 Favored 'General case' 0 CA--C 1.531 0.221 0 O-C-N 122.006 -0.434 . . . . 10.0 110.961 -176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.418 ' N ' HD12 ' A' ' 37' ' ' LEU . 11.4 tt0 -60.44 -33.5 72.63 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.571 1.548 . . . . 10.0 110.151 175.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -92.23 -3.24 55.8 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.209 1.403 . . . . 10.0 111.728 175.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.62 41.07 25.42 Favored Glycine 0 C--N 1.334 0.467 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.4 mttp -156.35 165.68 35.64 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-O 122.028 0.918 . . . . 10.0 110.885 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.576 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -157.42 107.9 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.686 0 N-CA-C 104.726 -2.324 . . . . 10.0 104.726 172.523 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -88.1 98.71 11.69 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.215 -1.402 . . . . 10.0 107.215 -175.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.576 HG13 HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -114.08 110.18 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.892 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.962 -170.557 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.422 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 9.0 t -93.78 114.35 26.6 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 107.331 -1.359 . . . . 10.0 107.331 169.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.429 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 p90 -145.48 158.93 43.76 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 121.833 0.825 . . . . 10.0 112.366 178.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.3 t0 -79.75 83.05 5.76 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-N 114.989 -1.005 . . . . 10.0 113.145 -174.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.12 -29.74 0.66 Allowed 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 113.936 -1.484 . . . . 10.0 113.549 168.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -70.82 -52.34 21.08 Favored 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.365 0.984 . . . . 10.0 110.402 -177.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -78.38 -38.02 42.75 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 109.571 -0.529 . . . . 10.0 109.571 -175.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.6 m -139.86 102.89 1.59 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.532 0 C-N-CA 124.505 1.122 . . . . 10.0 108.425 -175.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.3 m -64.33 152.77 40.34 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.198 -0.939 . . . . 10.0 110.638 -172.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.408 HG21 HG21 ' A' ' 70' ' ' ILE . 0.9 OUTLIER -43.42 -39.35 1.18 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 C-N-CA 123.867 0.867 . . . . 10.0 112.794 173.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -57.35 -56.44 21.81 Favored 'General case' 0 N--CA 1.448 -0.536 0 C-N-CA 123.917 0.887 . . . . 10.0 109.469 173.679 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -52.88 -44.11 66.64 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.039 0.936 . . . . 10.0 110.624 176.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.613 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -60.58 -51.97 66.89 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.756 0 N-CA-C 108.307 -0.998 . . . . 10.0 108.307 178.59 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.43 -45.4 88.53 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 108.299 -1.0 . . . . 10.0 108.299 -172.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -56.58 -42.02 77.93 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.74 -0.664 . . . . 10.0 110.124 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.3 -33.33 67.56 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 119.143 -0.456 . . . . 10.0 112.208 -178.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.726 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.7 mp -66.48 -45.26 89.47 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 119.864 1.211 . . . . 10.0 108.806 169.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -61.07 -22.9 65.05 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.388 0.994 . . . . 10.0 112.075 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.9 t0 -58.05 -39.95 79.72 Favored 'General case' 0 CA--C 1.545 0.765 0 O-C-N 121.534 -0.729 . . . . 10.0 110.689 170.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -106.85 -65.94 1.05 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.428 1.491 . . . . 10.0 112.222 -172.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -99.41 -159.05 28.98 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 109.247 -1.541 . . . . 10.0 109.247 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.1 m-85 -151.76 56.78 0.86 Allowed 'General case' 0 C--N 1.341 0.213 0 CA-C-N 118.888 1.344 . . . . 10.0 108.567 172.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -142.87 53.03 1.38 Allowed 'General case' 0 N--CA 1.45 -0.427 0 N-CA-C 109.245 -0.65 . . . . 10.0 109.245 -169.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.615 HG21 HD13 ' A' ' 60' ' ' ILE . 54.1 t -142.25 92.07 0.51 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.481 0 N-CA-C 107.185 -1.413 . . . . 10.0 107.185 169.579 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -44.93 -62.88 1.06 Allowed 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 114.878 -1.056 . . . . 10.0 109.581 168.283 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.1 tttp 169.54 179.79 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 125.005 1.322 . . . . 10.0 112.53 172.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.441 ' CG1' ' HB3' ' A' ' 4' ' ' LYS . 1.4 tp -67.04 140.83 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.325 0 N-CA-C 109.267 -0.642 . . . . 10.0 109.267 169.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -126.09 158.98 34.05 Favored 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 107.804 -1.184 . . . . 10.0 107.804 171.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.73 55.42 5.42 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 124.199 0.904 . . . . 10.0 111.71 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 1.5 ptt85 . . . . . 0 C--O 1.25 1.121 0 CA-C-O 117.013 -1.47 . . . . 10.0 108.338 168.76 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.0 ttt . . . . . 0 N--CA 1.471 0.613 0 CA-C-O 117.791 -1.1 . . . . 10.0 108.244 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . 0.44 ' OE2' ' NZ ' ' A' ' 4' ' ' LYS . 40.4 mt-10 -152.4 160.33 43.3 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 118.835 0.743 . . . . 10.0 111.607 -169.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 11.5 pt20 -91.84 107.85 19.5 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 127.521 2.329 . . . . 10.0 110.407 177.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' NZ ' ' OE2' ' A' ' 2' ' ' GLU . 17.8 mttt -128.89 173.74 10.12 Favored 'General case' 0 N--CA 1.464 0.25 0 CA-C-O 121.399 0.619 . . . . 10.0 111.126 176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.0 m -112.42 111.56 22.49 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.822 -1.177 . . . . 10.0 107.822 173.103 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.647 HD22 ' CG2' ' A' ' 67' ' ' VAL . 3.9 mt -78.51 99.86 6.65 Favored 'General case' 0 C--O 1.22 -0.459 0 N-CA-C 107.296 -1.372 . . . . 10.0 107.296 170.157 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.74 121.46 9.85 Favored 'General case' 0 N--CA 1.449 -0.491 0 O-C-N 121.208 -0.932 . . . . 10.0 108.918 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.544 HG21 HG11 ' A' ' 20' ' ' VAL . 3.5 t -112.38 129.75 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 C-N-CA 127.719 2.407 . . . . 10.0 108.698 -177.115 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -107.92 82.85 1.7 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 107.211 -1.403 . . . . 10.0 107.211 175.112 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.66 -23.41 68.86 Favored Glycine 0 CA--C 1.532 1.112 0 CA-C-N 115.849 -0.614 . . . . 10.0 113.316 -176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 20.1 ttt 61.01 -69.45 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.231 2.213 . . . . 10.0 113.524 175.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 16.2 m -64.75 -28.54 69.65 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.221 1.409 . . . . 10.0 111.988 179.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 86.3 m 71.04 -58.9 0.56 Allowed 'General case' 0 N--CA 1.466 0.325 0 C-N-CA 126.469 1.907 . . . . 10.0 111.063 -176.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -58.07 138.38 56.08 Favored 'General case' 0 N--CA 1.454 -0.242 0 O-C-N 121.783 -0.573 . . . . 10.0 110.801 174.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 12.7 m170 53.95 -147.75 0.49 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.322 1.049 . . . . 10.0 108.331 -172.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.0 t 68.49 -50.98 0.56 Allowed 'General case' 0 N--CA 1.467 0.378 0 N-CA-C 114.889 1.44 . . . . 10.0 114.889 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 3.5 m -43.59 -49.77 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.62 1.168 . . . . 10.0 110.643 -179.165 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.96 -35.63 80.41 Favored 'General case' 0 C--O 1.219 -0.521 0 C-N-CA 120.83 -0.348 . . . . 10.0 111.658 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.96 -54.15 48.56 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.366 0.984 . . . . 10.0 108.795 178.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.544 HG11 HG21 ' A' ' 8' ' ' VAL . 78.5 t -51.42 -36.15 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 C-N-CA 123.975 0.91 . . . . 10.0 110.739 175.561 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 76.0 tt0 -70.32 -66.22 0.63 Allowed 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.098 1.359 . . . . 10.0 108.775 -178.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 88.1 m -46.44 -51.16 15.67 Favored 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 126.481 1.912 . . . . 10.0 111.8 178.002 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 49.5 m -55.83 -54.9 38.95 Favored 'General case' 0 N--CA 1.448 -0.564 0 CA-C-N 119.41 1.005 . . . . 10.0 110.957 -168.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 53.3 t -66.37 -40.87 87.79 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.215 0 N-CA-C 108.783 -0.821 . . . . 10.0 108.783 175.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.03 -13.15 8.2 Favored Glycine 0 CA--C 1.535 1.334 0 CA-C-O 118.366 -1.241 . . . . 10.0 115.513 174.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -78.22 -24.93 46.84 Favored 'General case' 0 C--N 1.341 0.23 0 CA-C-N 120.006 1.903 . . . . 10.0 108.534 179.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.728 HD13 HD12 ' A' ' 56' ' ' ILE . 65.3 mt -69.33 119.21 13.24 Favored 'General case' 0 N--CA 1.431 -1.38 0 CA-C-N 115.763 -0.653 . . . . 10.0 111.458 -172.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -42.13 -42.78 3.07 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 125.263 1.425 . . . . 10.0 111.7 169.124 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.1 -4.29 89.69 Favored Glycine 0 CA--C 1.535 1.332 0 CA-C-N 114.109 -1.405 . . . . 10.0 115.138 -176.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.45 162.01 2.81 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-N 120.526 2.163 . . . . 10.0 111.713 174.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 t -133.08 -46.56 0.85 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.717 1.207 . . . . 10.0 111.108 176.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.81 38.14 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-O 118.172 -0.918 . . . . 10.0 108.724 177.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.9 m -143.77 57.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 C-N-CA 124.642 1.177 . . . . 10.0 111.504 -175.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -78.42 69.16 4.57 Favored 'General case' 0 CA--C 1.538 0.499 0 O-C-N 120.691 -1.256 . . . . 10.0 111.499 -173.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -59.2 126.78 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 C-N-CA 124.815 1.246 . . . . 10.0 112.151 178.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.6 m-80 -148.44 58.18 1.07 Allowed 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 107.36 -1.348 . . . . 10.0 107.36 175.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -65.78 -21.53 66.51 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 120.751 -1.218 . . . . 10.0 111.869 -174.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 11.1 mp0 -61.32 -37.84 84.73 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 124.378 1.071 . . . . 10.0 109.642 170.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.51 -28.32 41.38 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.603 -0.517 . . . . 10.0 109.603 176.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 103.36 19.34 12.58 Favored Glycine 0 CA--C 1.525 0.684 0 C-N-CA 125.752 1.644 . . . . 10.0 110.827 176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -142.11 167.08 22.98 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.996 0.918 . . . . 10.0 109.503 -174.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG22 HG13 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -158.47 98.02 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.446 -0.663 0 N-CA-C 105.617 -1.994 . . . . 10.0 105.617 -178.392 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -78.57 99.43 6.52 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 119.368 0.985 . . . . 10.0 108.514 -173.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.609 HG13 HG22 ' A' ' 42' ' ' VAL . 1.3 m -108.49 109.48 28.47 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.066 0 C-N-CA 125.09 1.356 . . . . 10.0 109.461 -175.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.7 t -95.96 115.05 26.84 Favored 'General case' 0 N--CA 1.443 -0.816 0 N-CA-C 106.26 -1.756 . . . . 10.0 106.26 169.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.575 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -145.23 154.7 42.67 Favored 'General case' 0 N--CA 1.445 -0.692 0 N-CA-C 113.139 0.792 . . . . 10.0 113.139 -177.114 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -76.75 82.0 3.36 Favored 'General case' 0 N--CA 1.448 -0.562 0 CA-C-N 115.055 -0.975 . . . . 10.0 112.525 -174.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.04 -28.07 0.65 Allowed 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 114.187 -1.37 . . . . 10.0 113.709 169.41 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -76.62 -48.75 18.13 Favored 'General case' 0 C--N 1.342 0.24 0 CA-C-N 119.949 1.249 . . . . 10.0 110.188 -174.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -82.26 -34.28 28.85 Favored 'General case' 0 N--CA 1.457 -0.105 0 O-C-N 122.056 -0.402 . . . . 10.0 110.276 -177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.4 m -140.15 104.1 1.75 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.381 0 C-N-CA 124.228 1.011 . . . . 10.0 108.556 -178.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -65.54 150.35 48.54 Favored 'General case' 0 N--CA 1.45 -0.446 0 O-C-N 121.195 -0.94 . . . . 10.0 110.24 -171.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.465 HG21 HG13 ' A' ' 70' ' ' ILE . 1.2 m -40.64 -40.14 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.921 0.889 . . . . 10.0 113.148 172.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' NZ ' ' OD2' ' A' ' 58' ' ' ASP . 3.7 ttpp -58.14 -54.86 42.17 Favored 'General case' 0 C--O 1.222 -0.391 0 C-N-CA 123.002 0.521 . . . . 10.0 109.773 173.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -51.87 -44.78 63.84 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.145 0.978 . . . . 10.0 110.17 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.728 HD12 HD13 ' A' ' 27' ' ' LEU . 2.0 mm -62.57 -43.41 98.42 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 O-C-N 121.534 -0.729 . . . . 10.0 110.24 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.5 -44.81 93.24 Favored 'General case' 0 N--CA 1.439 -1.018 0 N-CA-C 108.16 -1.052 . . . . 10.0 108.16 -178.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . 0.404 ' OD2' ' NZ ' ' A' ' 54' ' ' LYS . 10.0 m-20 -53.36 -42.23 66.62 Favored 'General case' 0 N--CA 1.449 -0.513 0 N-CA-C 109.315 -0.624 . . . . 10.0 109.315 176.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.61 -36.92 74.8 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 112.445 0.535 . . . . 10.0 112.445 177.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.4 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.5 -49.11 85.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.618 0 N-CA-C 106.838 -1.541 . . . . 10.0 106.838 168.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 52.9 mt-10 -63.41 -22.36 66.84 Favored 'General case' 0 CA--C 1.537 0.454 0 N-CA-C 112.528 0.566 . . . . 10.0 112.528 -172.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -66.59 -39.26 88.33 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-O 121.223 0.535 . . . . 10.0 110.552 172.153 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -91.34 -57.65 2.71 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.442 1.497 . . . . 10.0 111.136 -169.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -122.09 -152.42 8.65 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 126.506 2.003 . . . . 10.0 108.59 176.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 73.8 m-85 -150.36 55.71 0.92 Allowed 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 118.388 1.094 . . . . 10.0 108.449 176.223 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -131.66 57.35 1.77 Allowed 'General case' 0 N--CA 1.444 -0.767 0 N-CA-C 108.212 -1.033 . . . . 10.0 108.212 -167.779 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.647 ' CG2' HD22 ' A' ' 6' ' ' LEU 0.266 14.5 p -147.81 82.99 0.11 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.402 0 CA-C-O 122.596 1.189 . . . . 10.0 111.57 177.303 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -41.21 -60.31 1.28 Allowed 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 113.321 -1.763 . . . . 10.0 110.574 168.527 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . 0.383 24.0 mttp 140.96 -176.2 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 129.39 3.076 . . . . 10.0 114.026 169.16 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.465 HG13 HG21 ' A' ' 53' ' ' VAL . 12.4 mm -64.74 129.3 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.861 0 O-C-N 121.839 -0.538 . . . . 10.0 110.136 -167.288 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 24.3 tt0 -53.77 -51.48 63.28 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.348 1.059 . . . . 10.0 111.011 -178.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -170.12 173.18 44.14 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 106.666 -2.574 . . . . 10.0 106.666 -179.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 70.6 mtt-85 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.714 -1.612 . . . . 10.0 110.283 179.513 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.9 tmt? . . . . . 0 N--CA 1.475 0.796 0 CA-C-O 117.925 -1.036 . . . . 10.0 108.661 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -134.9 122.39 21.9 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.147 0.979 . . . . 10.0 110.074 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.426 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 2.0 tt0 -88.81 101.99 14.58 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 125.441 1.497 . . . . 10.0 110.26 177.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.455 ' HB2' HD11 ' A' ' 70' ' ' ILE . 76.0 mttt -137.08 176.62 8.54 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 118.325 0.511 . . . . 10.0 111.136 176.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 3.0 m -116.39 116.57 27.95 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.526 0.73 . . . . 10.0 109.64 177.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.487 HD22 HG22 ' A' ' 67' ' ' VAL . 4.1 mt -78.41 109.82 12.92 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.038 -1.838 . . . . 10.0 106.038 169.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.499 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -52.06 119.32 4.2 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.963 1.256 . . . . 10.0 107.904 174.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG21 HG11 ' A' ' 20' ' ' VAL . 16.0 t -123.28 115.84 46.73 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.152 0 C-N-CA 125.24 1.416 . . . . 10.0 108.164 178.525 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -92.87 125.11 37.32 Favored 'General case' 0 N--CA 1.446 -0.637 0 C-N-CA 125.416 1.486 . . . . 10.0 107.956 173.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -72.16 90.54 0.52 Allowed Glycine 0 CA--C 1.529 0.919 0 N-CA-C 110.064 -1.214 . . . . 10.0 110.064 177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 30.0 mtt -143.87 73.27 1.38 Allowed 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 118.552 1.176 . . . . 10.0 110.923 -179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 45.0 t -149.3 -74.33 0.17 Allowed 'General case' 0 N--CA 1.453 -0.282 0 N-CA-C 108.962 -0.755 . . . . 10.0 108.962 168.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 3.1 t -167.97 -167.51 0.85 Allowed 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 107.402 -1.333 . . . . 10.0 107.402 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 2.8 tp60 -58.8 164.01 3.05 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 118.883 0.765 . . . . 10.0 109.91 172.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.2 t-80 76.44 -3.67 2.5 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.764 1.226 . . . . 10.0 112.773 176.279 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -55.33 -46.07 76.36 Favored 'General case' 0 C--O 1.231 0.123 0 CA-C-N 118.702 0.683 . . . . 10.0 112.051 -175.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 7.9 p -61.32 -2.2 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.576 0 C-N-CA 124.843 1.257 . . . . 10.0 112.588 177.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 4.0 mptt -114.98 -43.08 3.13 Favored 'General case' 0 C--O 1.22 -0.468 0 O-C-N 121.152 -0.967 . . . . 10.0 110.039 167.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.33 -56.27 8.52 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.586 1.085 . . . . 10.0 111.117 178.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.474 HG13 HG12 ' A' ' 60' ' ' ILE . 59.3 t -57.09 -34.75 45.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 C-N-CA 123.792 0.837 . . . . 10.0 110.078 178.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.49 -68.83 0.32 Allowed 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 125.266 1.426 . . . . 10.0 107.555 -179.433 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.9 m -48.18 -45.44 33.62 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 125.548 1.539 . . . . 10.0 111.194 -177.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 37.9 m -52.4 -58.41 6.79 Favored 'General case' 0 N--CA 1.455 -0.185 0 CA-C-O 122.106 0.955 . . . . 10.0 110.808 -176.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.846 HG22 HG22 ' A' ' 56' ' ' ILE . 64.4 t -66.68 -42.76 90.11 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.183 -1.043 . . . . 10.0 108.183 -179.577 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -58.09 -11.9 10.17 Favored Glycine 0 CA--C 1.533 1.218 0 C-N-CA 125.429 1.49 . . . . 10.0 115.321 175.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -80.73 -26.35 37.43 Favored 'General case' 0 C--N 1.339 0.13 0 CA-C-N 119.804 1.802 . . . . 10.0 108.226 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.625 HD13 HD12 ' A' ' 56' ' ' ILE . 64.0 mt -66.72 122.35 17.45 Favored 'General case' 0 N--CA 1.434 -1.24 0 O-C-N 122.005 -0.434 . . . . 10.0 111.037 -174.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -50.35 -35.23 26.96 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 122.29 1.043 . . . . 10.0 111.853 171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -79.73 -3.78 89.19 Favored Glycine 0 CA--C 1.535 1.296 0 C-N-CA 125.196 1.379 . . . . 10.0 114.617 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.36 163.39 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 CA-C-N 120.435 2.117 . . . . 10.0 111.312 172.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.5 t -137.7 -44.75 0.53 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 124.776 1.231 . . . . 10.0 111.313 178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.6 149.82 36.41 Favored 'General case' 0 N--CA 1.464 0.264 0 C-N-CA 124.016 0.927 . . . . 10.0 108.501 175.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 34.8 m -143.09 57.92 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 C-N-CA 124.237 1.015 . . . . 10.0 111.194 -175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.1 m-70 -79.22 67.82 5.04 Favored 'General case' 0 CA--C 1.532 0.258 0 O-C-N 120.67 -1.269 . . . . 10.0 110.478 -176.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.3 p -62.87 123.5 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.435 1.094 . . . . 10.0 110.913 176.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.6 m-80 -144.52 57.86 1.31 Allowed 'General case' 0 C--O 1.234 0.258 0 N-CA-C 106.754 -1.573 . . . . 10.0 106.754 176.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -62.65 -23.77 67.26 Favored 'General case' 0 CA--C 1.539 0.55 0 O-C-N 121.485 -0.759 . . . . 10.0 111.099 -174.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 31.0 mp0 -61.55 -39.0 89.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.797 1.239 . . . . 10.0 109.804 172.254 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.71 -26.97 44.91 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 123.221 0.608 . . . . 10.0 109.59 177.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 95.43 32.36 7.02 Favored Glycine 0 CA--C 1.522 0.479 0 N-CA-C 109.78 -1.328 . . . . 10.0 109.78 177.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 14.6 mttt -149.55 162.62 39.8 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 173.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.537 HG22 HG13 ' A' ' 44' ' ' VAL . 1.0 OUTLIER -144.0 120.3 4.83 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.742 0 N-CA-C 102.649 -3.093 . . . . 10.0 102.649 169.84 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -96.24 96.24 8.65 Favored 'General case' 0 CA--C 1.519 -0.217 0 N-CA-C 107.236 -1.394 . . . . 10.0 107.236 -179.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.537 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -111.43 104.84 17.7 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.872 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -170.084 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.426 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 22.8 t -92.06 117.55 29.94 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 106.411 -1.7 . . . . 10.0 106.411 171.429 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.542 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -146.63 154.75 41.83 Favored 'General case' 0 N--CA 1.442 -0.871 0 CA-C-N 114.975 -1.012 . . . . 10.0 110.675 -177.477 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -85.7 89.0 7.62 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-O 121.866 0.841 . . . . 10.0 112.681 -170.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -48.12 -24.91 1.25 Allowed 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 113.661 -1.609 . . . . 10.0 114.074 172.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -59.48 -56.17 25.41 Favored 'General case' 0 C--N 1.345 0.4 0 CA-C-N 119.898 1.227 . . . . 10.0 110.278 176.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 tpmt? -86.16 -40.86 15.21 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.184 -0.916 . . . . 10.0 109.827 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.491 ' O ' HD11 ' A' ' 56' ' ' ILE . 3.3 m -135.48 99.89 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 N-CA-C 106.687 -1.597 . . . . 10.0 106.687 -175.199 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.4 p -64.97 154.69 36.89 Favored 'General case' 0 N--CA 1.448 -0.532 0 O-C-N 121.429 -0.795 . . . . 10.0 110.521 -176.997 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.425 HG21 HG21 ' A' ' 70' ' ' ILE . 1.0 OUTLIER -40.92 -40.22 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 124.273 1.029 . . . . 10.0 113.152 174.552 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -53.88 -65.58 0.54 Allowed 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 108.697 -0.853 . . . . 10.0 108.697 170.294 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -43.58 -43.83 5.86 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.84 0.856 . . . . 10.0 110.613 179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.846 HG22 HG22 ' A' ' 24' ' ' VAL . 1.3 mm -66.82 -44.51 89.08 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.465 0 O-C-N 121.517 -0.739 . . . . 10.0 111.156 179.808 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.12 -45.65 92.51 Favored 'General case' 0 N--CA 1.446 -0.655 0 N-CA-C 108.838 -0.801 . . . . 10.0 108.838 -179.185 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 12.0 m-20 -58.97 -38.67 79.63 Favored 'General case' 0 N--CA 1.443 -0.809 0 N-CA-C 108.53 -0.915 . . . . 10.0 108.53 177.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.45 -30.15 69.47 Favored 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.753 -0.592 . . . . 10.0 112.311 174.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.605 HD13 HG21 ' A' ' 67' ' ' VAL . 1.6 mp -64.41 -48.37 85.52 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.599 0 N-CA-C 106.785 -1.561 . . . . 10.0 106.785 167.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 mt-10 -59.6 -29.77 68.21 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 119.122 0.874 . . . . 10.0 112.737 -176.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -53.28 -36.46 61.2 Favored 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 118.671 0.669 . . . . 10.0 111.86 171.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -102.07 -56.39 2.28 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.535 1.134 . . . . 10.0 112.752 -175.025 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.33 -145.95 6.31 Favored Glycine 0 CA--C 1.526 0.774 0 C-N-CA 126.206 1.86 . . . . 10.0 109.176 -173.131 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -165.71 56.9 0.11 Allowed 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 119.572 1.686 . . . . 10.0 109.977 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -133.6 66.54 1.55 Allowed 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.4 -1.704 . . . . 10.0 106.4 -171.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.605 HG21 HD13 ' A' ' 60' ' ' ILE . 8.2 p -157.59 68.59 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.246 0 N-CA-C 113.383 0.882 . . . . 10.0 113.383 -177.521 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.499 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -29.75 -71.99 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 N-CA-C 113.997 1.11 . . . . 10.0 113.997 172.412 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.6 ttpt 167.95 171.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 125.775 1.63 . . . . 10.0 113.338 173.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.455 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.7 OUTLIER -68.53 132.99 32.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.404 0 N-CA-C 112.248 0.462 . . . . 10.0 112.248 -179.805 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -71.18 81.0 0.71 Allowed 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.387 0.675 . . . . 10.0 110.536 -179.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 90.36 141.11 8.8 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 109.33 -1.508 . . . . 10.0 109.33 -177.634 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.414 ' OXT' ' NZ ' ' A' ' 4' ' ' LYS . 4.1 ttt180 . . . . . 0 C--O 1.249 1.063 0 CA-C-O 116.906 -1.521 . . . . 10.0 109.577 -169.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 68.1 mtp . . . . . 0 N--CA 1.47 0.559 0 CA-C-O 120.691 0.281 . . . . 10.0 111.404 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -130.99 111.7 12.27 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 125.807 1.643 . . . . 10.0 106.921 169.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -72.92 106.81 4.99 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 107.965 -1.124 . . . . 10.0 107.965 169.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 13.6 mmtt -128.8 161.93 28.63 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-O 121.781 0.801 . . . . 10.0 111.126 -177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 68.4 m -112.02 93.76 4.61 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 125.216 1.406 . . . . 10.0 108.067 -178.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.605 HD21 HG22 ' A' ' 67' ' ' VAL . 9.7 tt -78.02 94.23 4.61 Favored 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.81 1.244 . . . . 10.0 108.309 177.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.76 117.84 6.37 Favored 'General case' 0 N--CA 1.44 -0.942 0 N-CA-C 108.831 -0.803 . . . . 10.0 108.831 -179.055 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 40.6 t -93.09 124.39 45.5 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 C-N-CA 126.725 2.01 . . . . 10.0 111.004 175.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -85.34 69.15 10.69 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 107.375 -1.343 . . . . 10.0 107.375 169.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.82 108.82 1.88 Allowed Glycine 0 CA--C 1.529 0.937 0 CA-C-O 119.057 -0.857 . . . . 10.0 112.093 -171.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 3.3 tpp -120.18 -152.92 0.52 Allowed 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 118.071 0.935 . . . . 10.0 111.846 -173.089 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 14.8 m 56.26 15.94 2.13 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.888 1.675 . . . . 10.0 113.861 -178.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 5.0 t 45.36 37.16 2.71 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 125.379 1.471 . . . . 10.0 111.844 -173.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -164.31 -157.44 0.38 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.679 -0.86 . . . . 10.0 108.679 -172.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 38.5 m170 55.71 31.83 18.19 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 124.538 1.135 . . . . 10.0 112.257 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 88.8 m -29.12 -55.5 0.14 Allowed 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 127.255 2.222 . . . . 10.0 113.28 -172.085 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -146.74 92.31 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 N-CA-C 106.937 -1.505 . . . . 10.0 106.937 169.561 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -178.11 -167.09 0.13 Allowed 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 125.074 1.35 . . . . 10.0 109.231 174.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 71.87 -69.19 0.19 Allowed 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 128.662 2.785 . . . . 10.0 110.027 176.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 45.5 t -47.08 -42.82 6.79 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 C-N-CA 125.763 1.625 . . . . 10.0 109.16 169.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -61.94 -57.43 11.76 Favored 'General case' 0 N--CA 1.448 -0.546 0 C-N-CA 126.231 1.812 . . . . 10.0 108.364 -175.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 2.5 m -48.15 -53.95 15.01 Favored 'General case' 0 N--CA 1.445 -0.714 0 C-N-CA 124.181 0.992 . . . . 10.0 110.172 175.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.6 m -67.62 -54.13 22.28 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 120.76 0.314 . . . . 10.0 111.726 -168.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.81 ' CG2' HD11 ' A' ' 60' ' ' ILE . 76.1 t -58.54 -44.14 88.6 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 108.771 -0.825 . . . . 10.0 108.771 176.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.28 -2.46 7.11 Favored Glycine 0 CA--C 1.531 1.049 0 CA-C-O 118.015 -1.436 . . . . 10.0 114.817 178.172 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -81.5 -31.32 32.91 Favored 'General case' 0 N--CA 1.456 -0.174 0 CA-C-N 120.123 1.962 . . . . 10.0 108.5 176.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 81.8 mt -69.81 123.37 21.28 Favored 'General case' 0 N--CA 1.437 -1.083 0 O-C-N 122.095 -0.378 . . . . 10.0 111.002 -173.453 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -52.78 -35.14 56.05 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-O 122.2 1.0 . . . . 10.0 111.787 172.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -66.64 -12.7 59.7 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.393 -1.276 . . . . 10.0 113.673 176.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.81 161.61 2.39 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 CA-C-N 119.73 1.765 . . . . 10.0 112.027 171.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.1 t -138.7 -46.78 0.49 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.44 1.096 . . . . 10.0 110.929 179.106 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -137.98 147.42 44.23 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 107.771 -1.196 . . . . 10.0 107.771 174.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.466 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.9 m -141.31 58.5 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.294 0 C-N-CA 124.268 1.027 . . . . 10.0 110.631 -178.269 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 7.8 t-160 -83.0 77.1 9.78 Favored 'General case' 0 N--CA 1.453 -0.309 0 O-C-N 120.976 -1.077 . . . . 10.0 108.22 -171.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.71 112.63 2.37 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 C-N-CA 123.494 0.718 . . . . 10.0 110.113 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -136.23 56.83 1.8 Allowed 'General case' 0 N--CA 1.45 -0.468 0 N-CA-C 106.246 -1.761 . . . . 10.0 106.246 175.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.88 -23.43 63.44 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 121.34 -0.85 . . . . 10.0 111.344 -178.132 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -63.24 -31.14 72.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.567 0.621 . . . . 10.0 111.034 173.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.03 -4.62 53.41 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.617 0.767 . . . . 10.0 111.586 172.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.83 19.62 79.74 Favored Glycine 0 CA--C 1.526 0.726 0 C-N-CA 125.339 1.447 . . . . 10.0 111.131 -175.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.3 mttt -156.06 133.22 10.67 Favored 'General case' 0 N--CA 1.453 -0.309 0 CA-C-N 117.855 0.827 . . . . 10.0 109.274 -168.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.425 HG22 ' O ' ' A' ' 6' ' ' LEU . 3.2 m -121.23 120.62 62.6 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.501 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 175.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 39.6 t0 -86.04 94.85 9.34 Favored 'General case' 0 CA--C 1.518 -0.273 0 N-CA-C 107.263 -1.384 . . . . 10.0 107.263 179.364 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.466 HG12 ' HA ' ' A' ' 33' ' ' VAL . 2.5 m -108.16 109.88 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.017 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -177.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 28.8 t -96.31 120.81 37.3 Favored 'General case' 0 N--CA 1.443 -0.817 0 N-CA-C 106.222 -1.769 . . . . 10.0 106.222 171.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.525 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -146.95 171.99 14.39 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 122.767 0.427 . . . . 10.0 111.272 -177.613 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -98.4 82.52 2.9 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 113.467 0.914 . . . . 10.0 113.467 -172.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.22 -43.26 10.11 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 113.755 -1.566 . . . . 10.0 112.233 176.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -49.42 -53.96 19.99 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.812 0.845 . . . . 10.0 111.505 177.309 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.34 -38.3 20.53 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 122.141 -0.349 . . . . 10.0 110.614 -174.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -139.57 101.9 1.53 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.678 1.591 . . . . 10.0 108.216 -178.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.58 148.36 38.4 Favored 'General case' 0 C--O 1.22 -0.481 0 C-N-CA 123.272 0.629 . . . . 10.0 110.234 -174.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.412 HG13 ' H ' ' A' ' 53' ' ' VAL . 1.0 OUTLIER -40.44 -41.21 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.537 0 O-C-N 121.065 -1.022 . . . . 10.0 113.616 172.583 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -57.24 -52.62 64.58 Favored 'General case' 0 CA--C 1.532 0.257 0 O-C-N 122.015 -0.428 . . . . 10.0 110.653 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -52.01 -45.65 64.64 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.459 1.104 . . . . 10.0 110.08 175.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.525 HG21 ' CE2' ' A' ' 46' ' ' PHE . 24.9 mm -61.6 -48.94 86.42 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.728 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 -179.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.63 -46.17 84.49 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 108.573 -0.899 . . . . 10.0 108.573 -178.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -63.03 -33.4 75.35 Favored 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 115.443 -0.799 . . . . 10.0 110.666 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.24 -28.66 69.86 Favored 'General case' 0 N--CA 1.452 -0.362 0 O-C-N 121.321 -0.862 . . . . 10.0 111.721 175.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.81 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.8 mp -68.87 -47.87 73.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 106.92 -1.511 . . . . 10.0 106.92 168.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -55.76 -30.71 61.71 Favored 'General case' 0 CA--C 1.536 0.422 0 CA-C-N 119.04 0.836 . . . . 10.0 111.529 -176.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -58.95 -37.59 77.1 Favored 'General case' 0 CA--C 1.54 0.588 0 O-C-N 121.984 -0.447 . . . . 10.0 112.007 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.47 -66.89 0.88 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.062 1.345 . . . . 10.0 112.043 -176.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -111.48 -152.14 12.17 Favored Glycine 0 CA--C 1.524 0.645 0 C-N-CA 126.426 1.965 . . . . 10.0 109.224 -176.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -165.67 55.63 0.11 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 118.378 1.089 . . . . 10.0 110.357 -175.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -132.91 61.65 1.67 Allowed 'General case' 0 C--O 1.227 -0.119 0 N-CA-C 108.216 -1.031 . . . . 10.0 108.216 179.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.605 HG22 HD21 ' A' ' 6' ' ' LEU . 86.5 t -141.63 97.94 0.78 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.52 0 C-N-CA 123.82 0.848 . . . . 10.0 108.841 179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.03 -73.11 0.06 Allowed 'General case' 0 N--CA 1.449 -0.521 0 CA-C-N 114.865 -1.061 . . . . 10.0 108.929 167.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 173.69 172.16 0.17 Allowed 'General case' 0 N--CA 1.466 0.366 0 C-N-CA 125.506 1.522 . . . . 10.0 111.457 169.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.43 HD11 HD12 ' A' ' 6' ' ' LEU . 1.4 mp -68.34 129.87 33.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.698 0 O-C-N 122.128 -0.358 . . . . 10.0 111.124 171.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -76.98 144.64 38.6 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 109.628 -0.508 . . . . 10.0 109.628 169.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 143.68 -35.4 1.62 Allowed Glycine 0 CA--C 1.524 0.597 0 CA-C-O 119.524 -0.598 . . . . 10.0 111.862 175.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.483 0 CA-C-O 116.199 -1.857 . . . . 10.0 106.541 179.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptm . . . . . 0 N--CA 1.47 0.561 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -109.88 102.33 11.1 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.659 -1.608 . . . . 10.0 106.659 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -63.84 97.93 0.18 Allowed 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 124.04 0.936 . . . . 10.0 109.53 169.861 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.44 ' CB ' HD11 ' A' ' 70' ' ' ILE . 48.6 mttm -131.85 173.27 11.34 Favored 'General case' 0 CA--C 1.532 0.27 0 CA-C-O 121.039 0.447 . . . . 10.0 110.415 175.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -112.56 104.31 12.4 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 124.045 0.938 . . . . 10.0 109.251 -177.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD21 ' HB2' ' A' ' 57' ' ' ALA . 0.5 OUTLIER -81.77 86.24 6.49 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 107.518 -1.29 . . . . 10.0 107.518 176.278 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -44.8 123.09 3.53 Favored 'General case' 0 N--CA 1.451 -0.404 0 C-N-CA 123.874 0.87 . . . . 10.0 108.882 179.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -112.93 131.38 64.7 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 C-N-CA 128.353 2.661 . . . . 10.0 108.33 -171.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -98.16 106.66 18.98 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 105.811 -1.922 . . . . 10.0 105.811 176.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -71.69 93.89 0.57 Allowed Glycine 0 CA--C 1.528 0.869 0 N-CA-C 111.13 -0.788 . . . . 10.0 111.13 -173.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.58 -157.7 0.75 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 126.35 1.86 . . . . 10.0 107.491 -177.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 48.05 40.88 14.26 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 125.401 1.48 . . . . 10.0 114.024 169.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 16.8 p 42.25 -138.1 0.21 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 125.38 1.472 . . . . 10.0 113.546 178.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 46.4 mt-30 -73.08 167.72 20.56 Favored 'General case' 0 C--O 1.225 -0.219 0 O-C-N 120.759 -1.213 . . . . 10.0 110.722 175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER 80.11 8.15 1.52 Allowed 'General case' 0 C--O 1.222 -0.388 0 C-N-CA 125.218 1.407 . . . . 10.0 110.48 -176.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 10.7 p -74.38 -57.63 3.82 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.431 -0.793 . . . . 10.0 112.028 -176.655 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 17.3 m -50.26 -46.36 25.22 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.148 0 N-CA-C 109.136 -0.69 . . . . 10.0 109.136 175.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.13 -44.17 69.45 Favored 'General case' 0 N--CA 1.445 -0.688 0 CA-C-O 118.707 -0.663 . . . . 10.0 111.54 -177.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -52.23 -53.75 39.7 Favored 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 120.237 1.38 . . . . 10.0 110.11 175.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 55.7 t -61.28 -22.6 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.656 0 O-C-N 121.891 -0.505 . . . . 10.0 111.503 178.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -76.83 -74.9 0.22 Allowed 'General case' 0 CA--C 1.531 0.218 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 173.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.3 m -40.94 -53.26 2.97 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 127.713 2.405 . . . . 10.0 111.903 -178.112 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 40.0 m -65.76 -52.36 51.62 Favored 'General case' 0 N--CA 1.442 -0.856 0 N-CA-C 112.182 0.438 . . . . 10.0 112.182 -167.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 60' ' ' ILE . 74.3 t -56.94 -44.1 81.83 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.845 0 N-CA-C 107.699 -1.223 . . . . 10.0 107.699 169.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.28 -9.61 17.24 Favored Glycine 0 CA--C 1.533 1.165 0 C-N-CA 126.32 1.914 . . . . 10.0 116.136 -178.684 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -77.68 -24.91 49.19 Favored 'General case' 0 C--N 1.338 0.102 0 CA-C-N 119.938 1.869 . . . . 10.0 108.687 -179.596 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 67.4 mt -71.82 122.49 20.81 Favored 'General case' 0 N--CA 1.434 -1.256 0 C-N-CA 123.375 0.67 . . . . 10.0 110.753 -172.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -47.37 -41.8 20.4 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.453 1.121 . . . . 10.0 112.091 173.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -65.2 -21.76 68.47 Favored Glycine 0 CA--C 1.535 1.34 0 CA-C-N 114.047 -1.433 . . . . 10.0 113.793 179.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -56.27 150.86 2.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-N 119.567 1.684 . . . . 10.0 112.258 -178.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.2 t -131.14 -42.6 1.08 Allowed 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.493 1.117 . . . . 10.0 110.941 -176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -145.57 153.11 40.72 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 123.82 0.848 . . . . 10.0 108.917 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.496 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -145.75 57.16 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 C-N-CA 125.89 1.676 . . . . 10.0 111.349 -173.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 5.9 t-80 -83.51 72.16 10.28 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 120.719 -1.238 . . . . 10.0 110.563 -169.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -60.74 129.32 23.24 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.312 0 C-N-CA 123.421 0.688 . . . . 10.0 111.43 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.8 m120 -150.32 56.22 0.93 Allowed 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.995 -1.483 . . . . 10.0 106.995 172.527 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -59.63 -29.05 67.74 Favored 'General case' 0 C--O 1.226 -0.145 0 O-C-N 121.737 -0.602 . . . . 10.0 111.334 -174.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 88.0 mt-10 -63.33 -30.87 71.93 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 124.245 1.018 . . . . 10.0 110.811 176.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -84.22 -7.16 59.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.09 0.956 . . . . 10.0 111.587 173.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 84.51 25.65 42.08 Favored Glycine 0 C--N 1.336 0.535 0 C-N-CA 124.952 1.263 . . . . 10.0 110.834 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.414 ' NZ ' ' OE2' ' A' ' 71' ' ' GLU . 0.0 OUTLIER -156.22 171.8 19.57 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-O 122.4 1.095 . . . . 10.0 110.86 -174.174 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.488 HG22 HG13 ' A' ' 44' ' ' VAL . 2.3 p -154.92 141.79 12.11 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.675 0 N-CA-C 102.712 -3.07 . . . . 10.0 102.712 173.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -113.57 91.4 3.63 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.674 -1.602 . . . . 10.0 106.674 177.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.496 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.83 108.15 24.72 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 107.731 -1.211 . . . . 10.0 107.731 -169.182 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 6.3 m -98.7 106.6 18.89 Favored 'General case' 0 N--CA 1.441 -0.882 0 N-CA-C 106.914 -1.513 . . . . 10.0 106.914 179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.414 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.8 OUTLIER -139.43 170.35 16.09 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-O 120.939 0.399 . . . . 10.0 111.852 -172.48 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 0.8 OUTLIER -91.04 73.23 6.39 Favored 'General case' 0 CA--C 1.513 -0.458 0 N-CA-C 113.016 0.747 . . . . 10.0 113.016 -168.969 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.58 -37.94 1.83 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.922 1.289 . . . . 10.0 112.792 174.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.48 ' OD1' ' NZ ' ' A' ' 50' ' ' LYS . 5.1 t70 -53.88 -57.27 11.55 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 123.697 0.799 . . . . 10.0 111.417 173.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.48 ' NZ ' ' OD1' ' A' ' 49' ' ' ASP . 0.0 OUTLIER -80.52 -39.04 28.6 Favored 'General case' 0 N--CA 1.453 -0.318 0 O-C-N 122.105 -0.372 . . . . 10.0 110.52 -172.336 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.423 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.8 m -139.79 104.31 1.92 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 C-N-CA 127.021 2.128 . . . . 10.0 106.638 -175.153 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.2 m -64.46 157.9 25.35 Favored 'General case' 0 C--O 1.226 -0.175 0 O-C-N 121.51 -0.744 . . . . 10.0 110.383 -176.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -38.25 -45.82 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 123.833 0.853 . . . . 10.0 113.207 171.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -54.82 -61.99 1.95 Allowed 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 175.514 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -50.77 -36.45 36.86 Favored 'General case' 0 N--CA 1.452 -0.36 0 C-N-CA 125.483 1.513 . . . . 10.0 111.449 179.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.638 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.8 mm -66.09 -55.07 20.74 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 N-CA-C 108.106 -1.072 . . . . 10.0 108.106 174.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.477 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -54.62 -42.77 71.59 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -171.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.0 m-20 -60.78 -37.21 81.12 Favored 'General case' 0 N--CA 1.443 -0.778 0 C-N-CA 124.171 0.988 . . . . 10.0 110.531 179.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -61.82 -37.52 84.71 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.239 -0.913 . . . . 10.0 111.373 176.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.851 HD11 HG22 ' A' ' 24' ' ' VAL . 4.9 mp -64.44 -34.5 69.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.773 0 O-C-N 120.841 -1.162 . . . . 10.0 109.335 170.826 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.44 -45.69 76.81 Favored 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 119.281 0.946 . . . . 10.0 110.05 173.784 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -60.25 -38.3 83.05 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 111.877 0.325 . . . . 10.0 111.877 175.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.7 mt-30 -126.08 79.16 1.82 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.95 0.9 . . . . 10.0 111.537 -178.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 83.74 81.12 1.01 Allowed Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.449 -0.66 . . . . 10.0 111.449 169.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 21.3 p90 -67.23 89.4 0.2 Allowed 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 124.981 1.312 . . . . 10.0 112.142 -171.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -134.36 58.41 1.77 Allowed 'General case' 0 N--CA 1.453 -0.277 0 N-CA-C 108.486 -0.931 . . . . 10.0 108.486 174.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -138.99 97.5 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 O-C-N 120.821 -1.174 . . . . 10.0 110.763 177.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.13 -68.92 0.13 Allowed 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 115.351 -0.841 . . . . 10.0 110.222 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 170.25 171.49 0.06 Allowed 'General case' 0 N--CA 1.472 0.655 0 C-N-CA 124.624 1.17 . . . . 10.0 113.925 172.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.44 HD11 ' CB ' ' A' ' 4' ' ' LYS . 0.4 OUTLIER -67.3 133.88 30.92 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 O-C-N 121.461 -0.774 . . . . 10.0 110.582 172.231 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . 0.414 ' OE2' ' NZ ' ' A' ' 41' ' ' LYS . 2.0 mt-10 -58.35 119.99 7.93 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 108.95 -0.759 . . . . 10.0 108.95 170.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 78.71 34.16 35.73 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 119.211 -0.772 . . . . 10.0 114.381 170.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.251 1.157 0 CA-C-N 118.855 1.328 . . . . 10.0 108.196 170.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 mtm . . . . . 0 N--CA 1.476 0.835 0 CA-C-O 119.172 -0.442 . . . . 10.0 110.214 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -146.78 163.52 35.73 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.964 1.705 . . . . 10.0 106.541 170.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -101.12 111.52 23.75 Favored 'General case' 0 C--N 1.338 0.072 0 CA-C-O 117.453 -1.26 . . . . 10.0 108.599 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.497 ' CB ' HD12 ' A' ' 70' ' ' ILE . 82.4 mttt -136.4 172.74 12.57 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 120.07 1.305 . . . . 10.0 112.668 177.446 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 95.7 m -113.38 97.38 6.44 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.194 1.398 . . . . 10.0 109.226 -169.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.685 HD22 HG13 ' A' ' 67' ' ' VAL . 0.4 OUTLIER -80.59 87.8 5.74 Favored 'General case' 0 C--O 1.221 -0.402 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -177.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.74 119.92 3.07 Favored 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 124.276 1.03 . . . . 10.0 109.684 -179.123 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.781 HG21 HG11 ' A' ' 20' ' ' VAL . 5.7 t -109.85 148.46 13.47 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 C-N-CA 126.182 1.793 . . . . 10.0 111.177 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -131.65 84.95 2.21 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 124.567 1.147 . . . . 10.0 108.316 172.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -59.38 -32.47 72.68 Favored Glycine 0 CA--C 1.534 1.269 0 CA-C-O 121.446 0.47 . . . . 10.0 112.121 179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . 0.403 ' O ' ' CB ' ' A' ' 12' ' ' SER . 0.0 OUTLIER 51.93 63.19 2.34 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.844 1.258 . . . . 10.0 114.18 167.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.403 ' CB ' ' O ' ' A' ' 11' ' ' MET . 14.4 t 120.73 -159.71 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 128.963 2.905 . . . . 10.0 109.598 172.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 36.9 m -66.3 162.19 20.69 Favored 'General case' 0 CA--C 1.528 0.117 0 C-N-CA 124.262 1.025 . . . . 10.0 109.566 170.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 38.1 mt-30 60.86 -177.88 0.11 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 123.896 0.878 . . . . 10.0 109.761 -168.358 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 46.6 m-70 57.58 31.07 19.77 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-O 121.033 0.445 . . . . 10.0 110.666 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.2 m -87.25 -174.03 4.68 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.325 1.05 . . . . 10.0 109.368 -175.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.473 HG13 HG13 ' A' ' 35' ' ' VAL . 86.7 t -60.45 73.38 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 126.951 2.1 . . . . 10.0 110.176 178.671 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.55 -47.42 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 127.934 2.494 . . . . 10.0 110.602 173.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.32 -54.69 44.0 Favored 'General case' 0 CA--C 1.535 0.365 0 O-C-N 120.822 -1.174 . . . . 10.0 111.027 -172.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.781 HG11 HG21 ' A' ' 8' ' ' VAL . 94.2 t -60.95 -29.6 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 C-N-CA 125.103 1.361 . . . . 10.0 110.567 175.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -68.54 -57.66 5.44 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.409 -1.33 . . . . 10.0 107.409 -176.491 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.3 m -44.67 -55.31 5.35 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.869 1.267 . . . . 10.0 111.324 176.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 21.2 m -63.46 -58.59 6.55 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-N 118.103 0.411 . . . . 10.0 111.71 -167.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.84 ' CG2' HD11 ' A' ' 60' ' ' ILE . 70.1 t -59.08 -40.0 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.899 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 175.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -64.87 -6.53 24.78 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-O 118.082 -1.399 . . . . 10.0 114.802 177.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -80.48 -20.16 44.32 Favored 'General case' 0 C--N 1.342 0.255 0 CA-C-N 120.365 2.083 . . . . 10.0 108.878 176.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.671 HD13 HD12 ' A' ' 56' ' ' ILE . 52.7 mt -66.22 117.71 8.89 Favored 'General case' 0 N--CA 1.435 -1.179 0 CA-C-O 121.448 0.642 . . . . 10.0 112.191 -175.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -40.82 -43.55 2.05 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 127.0 2.12 . . . . 10.0 111.186 167.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -88.22 6.27 83.75 Favored Glycine 0 CA--C 1.537 1.445 0 C-N-CA 125.685 1.612 . . . . 10.0 115.405 -177.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.02 160.54 3.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 120.883 2.342 . . . . 10.0 111.092 172.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 3.7 m -132.34 -42.28 0.96 Allowed 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.42 1.088 . . . . 10.0 111.964 179.23 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -151.32 149.76 29.73 Favored 'General case' 0 CA--C 1.517 -0.294 0 N-CA-C 107.311 -1.366 . . . . 10.0 107.311 175.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.561 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.1 m -141.62 60.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.323 0 CA-C-O 122.079 0.942 . . . . 10.0 110.301 -173.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -82.39 61.41 5.56 Favored 'General case' 0 CA--C 1.535 0.382 0 O-C-N 121.311 -0.868 . . . . 10.0 110.398 -169.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.473 HG13 HG13 ' A' ' 17' ' ' VAL . 1.0 OUTLIER -62.24 121.69 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.696 0 C-N-CA 125.242 1.417 . . . . 10.0 110.102 -178.552 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.2 m-80 -142.13 54.57 1.46 Allowed 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 106.254 -1.758 . . . . 10.0 106.254 173.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -60.65 -26.8 67.33 Favored 'General case' 0 CA--C 1.532 0.275 0 O-C-N 121.548 -0.72 . . . . 10.0 111.007 -173.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.5 mt-10 -69.03 -30.84 69.29 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.398 1.079 . . . . 10.0 110.489 176.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.21 -28.92 42.6 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.126 0.571 . . . . 10.0 110.116 170.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 101.88 31.45 5.4 Favored Glycine 0 CA--C 1.524 0.643 0 C-N-CA 124.906 1.241 . . . . 10.0 110.949 174.57 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 2.1 mptt -155.91 158.08 37.38 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.416 1.486 . . . . 10.0 107.43 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.43 94.17 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 N-CA-C 103.029 -2.952 . . . . 10.0 103.029 -168.35 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 67.5 m-20 -93.83 94.15 8.35 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 106.651 -1.611 . . . . 10.0 106.651 -169.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.561 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -109.68 112.09 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.999 0 C-N-CA 125.808 1.643 . . . . 10.0 108.038 -171.846 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.8 m -96.19 115.37 27.33 Favored 'General case' 0 N--CA 1.432 -1.338 0 C-N-CA 125.985 1.714 . . . . 10.0 106.558 176.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.592 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -149.13 155.76 41.16 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 113.248 0.833 . . . . 10.0 113.248 -173.709 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -77.04 82.05 3.56 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 113.555 0.946 . . . . 10.0 113.555 -172.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.79 -25.63 0.53 Allowed 'General case' 0 CA--C 1.542 0.648 0 CA-C-N 114.128 -1.396 . . . . 10.0 113.666 169.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -70.03 -60.14 2.47 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 119.081 0.855 . . . . 10.0 110.479 -177.797 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.2 tttt -79.31 -36.11 40.14 Favored 'General case' 0 N--CA 1.457 -0.12 0 O-C-N 121.83 -0.544 . . . . 10.0 110.083 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.5 m -130.43 103.1 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.254 -1.388 . . . . 10.0 107.254 -177.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 13.0 m -72.02 157.66 37.4 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 120.661 -1.274 . . . . 10.0 109.065 -174.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.409 HG13 ' CG1' ' A' ' 70' ' ' ILE . 74.5 t -32.15 -48.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.434 -1.238 0 C-N-CA 126.315 1.846 . . . . 10.0 112.301 168.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -49.22 -62.42 1.55 Allowed 'General case' 0 C--O 1.223 -0.33 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 174.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -51.78 -41.18 61.47 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.419 1.488 . . . . 10.0 109.356 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.671 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -66.12 -52.6 46.38 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.813 0 C-N-CA 119.502 -0.879 . . . . 10.0 108.886 -177.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.75 -46.37 87.6 Favored 'General case' 0 N--CA 1.44 -0.946 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -58.06 -39.33 78.21 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 124.627 1.171 . . . . 10.0 109.452 179.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.85 -32.81 71.04 Favored 'General case' 0 N--CA 1.453 -0.298 0 O-C-N 121.916 -0.49 . . . . 10.0 112.183 177.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.84 HD11 ' CG2' ' A' ' 24' ' ' VAL . 4.8 mp -70.46 -40.34 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 O-C-N 120.786 -1.196 . . . . 10.0 108.368 169.444 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 -60.34 -28.38 68.11 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 120.329 1.422 . . . . 10.0 112.669 178.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -62.79 -23.9 67.47 Favored 'General case' 0 CA--C 1.542 0.65 0 O-C-N 121.489 -0.757 . . . . 10.0 112.001 171.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -108.64 -68.05 0.94 Allowed 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 126.299 1.84 . . . . 10.0 111.148 -169.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.09 -144.58 8.42 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 126.9 2.19 . . . . 10.0 108.806 175.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 32.5 m-85 -162.5 58.9 0.22 Allowed 'General case' 0 N--CA 1.468 0.468 0 CA-C-N 118.666 1.233 . . . . 10.0 108.275 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -137.97 54.2 1.81 Allowed 'General case' 0 CA--C 1.509 -0.6 0 CA-C-O 120.91 0.386 . . . . 10.0 110.398 -166.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.685 HG13 HD22 ' A' ' 6' ' ' LEU . 92.1 t -145.86 84.65 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.711 0 N-CA-C 107.306 -1.368 . . . . 10.0 107.306 -172.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -45.55 -72.77 0.05 Allowed 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 114.709 -1.132 . . . . 10.0 110.698 168.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 173.39 174.37 0.13 Allowed 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.256 1.022 . . . . 10.0 113.549 169.762 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.497 HD12 ' CB ' ' A' ' 4' ' ' LYS . 8.9 mm -65.78 111.06 1.4 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 N-CA-C 103.752 -2.684 . . . . 10.0 103.752 168.209 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 56.2 mt-10 -3.78 -89.36 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 127.412 2.285 . . . . 10.0 114.189 -168.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -120.37 36.53 3.37 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.399 1.0 . . . . 10.0 111.002 176.22 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 . . . . . 0 C--O 1.256 1.403 0 C-N-CA 126.771 2.028 . . . . 10.0 111.661 -173.461 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.474 0.754 0 CA-C-O 117.965 -1.017 . . . . 10.0 110.324 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -126.16 106.76 9.79 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 126.007 1.723 . . . . 10.0 107.582 167.299 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.0 pm0 -61.3 97.84 0.07 Allowed 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 125.414 1.486 . . . . 10.0 111.018 169.785 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 79.5 mttt -134.54 171.37 14.41 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.905 0.859 . . . . 10.0 112.543 174.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.4 m -108.29 101.03 10.26 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 177.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.446 ' HG ' ' CG2' ' A' ' 67' ' ' VAL . 12.3 tp -84.34 72.71 10.56 Favored 'General case' 0 N--CA 1.448 -0.569 0 C-N-CA 125.079 1.351 . . . . 10.0 107.537 178.481 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.3 123.23 0.62 Allowed 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 125.919 1.688 . . . . 10.0 111.497 -169.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 95.7 t -114.85 122.68 69.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.542 0 C-N-CA 128.248 2.619 . . . . 10.0 109.182 -177.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -88.17 173.77 8.62 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 106.961 -1.496 . . . . 10.0 106.961 166.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -118.93 110.45 1.9 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 107.706 -2.158 . . . . 10.0 107.706 174.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.6 ttt -45.82 -64.95 0.62 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-N 118.146 0.973 . . . . 10.0 111.744 -171.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 15.8 p 174.51 -65.57 0.01 OUTLIER 'General case' 0 C--N 1.338 0.102 0 C-N-CA 124.823 1.249 . . . . 10.0 109.097 -176.249 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.9 t -53.94 147.8 11.66 Favored 'General case' 0 CA--C 1.531 0.234 0 C-N-CA 124.499 1.12 . . . . 10.0 110.226 176.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 6.8 tt0 -79.62 -155.2 0.1 Allowed 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 123.781 0.832 . . . . 10.0 111.057 -174.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 60.0 m-70 58.83 27.11 15.64 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.618 1.167 . . . . 10.0 111.205 -168.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 71.0 m -80.43 -169.7 2.23 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 124.402 1.081 . . . . 10.0 108.873 175.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . 0.303 7.3 p 52.42 19.32 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 125.245 1.418 . . . . 10.0 112.248 -178.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.98 -47.66 0.14 Allowed 'General case' 0 C--O 1.222 -0.385 0 C-N-CA 125.863 1.665 . . . . 10.0 110.189 174.516 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -49.33 -48.99 46.09 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 119.462 1.028 . . . . 10.0 112.332 -178.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 90.7 t -76.46 -13.34 14.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.959 1.304 . . . . 10.0 111.496 177.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.92 -62.7 1.6 Allowed 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.448 1.099 . . . . 10.0 108.471 177.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 10.5 m -50.47 -44.45 55.77 Favored 'General case' 0 C--O 1.221 -0.401 0 C-N-CA 125.642 1.577 . . . . 10.0 111.99 -174.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 9.3 p -54.11 -65.57 0.55 Allowed 'General case' 0 N--CA 1.45 -0.465 0 C-N-CA 125.069 1.347 . . . . 10.0 110.627 -175.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.666 HG22 HG22 ' A' ' 56' ' ' ILE . 84.2 t -55.43 -43.37 71.63 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.199 0 C-N-CA 123.777 0.831 . . . . 10.0 108.787 173.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.43 -19.37 6.05 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.58 1.562 . . . . 10.0 115.531 173.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -83.26 -23.53 32.65 Favored 'General case' 0 C--N 1.34 0.172 0 CA-C-N 120.041 1.92 . . . . 10.0 108.873 -177.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.683 HD13 HD12 ' A' ' 56' ' ' ILE . 58.6 mt -66.42 121.38 15.16 Favored 'General case' 0 N--CA 1.432 -1.335 0 CA-C-O 121.092 0.473 . . . . 10.0 111.151 -173.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -44.9 -37.79 4.18 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.204 1.402 . . . . 10.0 112.397 169.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -82.12 -5.9 89.29 Favored Glycine 0 CA--C 1.535 1.338 0 C-N-CA 125.103 1.335 . . . . 10.0 114.684 -178.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -68.63 166.52 1.95 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 CA-C-N 120.245 2.023 . . . . 10.0 111.782 175.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.5 t -140.93 -49.26 0.43 Allowed 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.857 0.863 . . . . 10.0 111.134 170.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -127.62 144.73 51.05 Favored 'General case' 0 CA--C 1.519 -0.22 0 N-CA-C 108.206 -1.035 . . . . 10.0 108.206 178.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.2 m -143.57 56.86 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.399 0 C-N-CA 124.253 1.021 . . . . 10.0 111.224 -176.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 9.1 t-80 -86.11 70.29 10.56 Favored 'General case' 0 N--CA 1.451 -0.391 0 O-C-N 120.524 -1.36 . . . . 10.0 109.017 -170.468 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.15 130.98 24.59 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 123.402 0.681 . . . . 10.0 110.088 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 58.3 t-20 -154.26 67.74 0.73 Allowed 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 170.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.61 -21.17 65.43 Favored 'General case' 0 N--CA 1.454 -0.266 0 CA-C-N 114.845 -1.07 . . . . 10.0 111.581 176.721 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -70.27 -35.33 73.68 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.969 0.508 . . . . 10.0 109.651 174.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.56 -24.27 45.68 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 169.732 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.0 25.81 30.72 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 124.954 1.264 . . . . 10.0 109.969 -178.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -149.71 109.74 4.12 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-N 117.439 0.62 . . . . 10.0 109.569 -175.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.524 ' CG2' HG13 ' A' ' 44' ' ' VAL . 5.0 p -84.46 148.05 5.2 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 N-CA-C 105.671 -1.974 . . . . 10.0 105.671 165.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -119.12 95.79 4.96 Favored 'General case' 0 CA--C 1.518 -0.288 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 167.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.524 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -112.63 109.59 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.002 0 C-N-CA 125.177 1.391 . . . . 10.0 107.944 -172.895 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.0 t -99.6 109.93 22.4 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.486 -1.672 . . . . 10.0 106.486 172.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.43 ' HE1' HG12 ' A' ' 53' ' ' VAL . 0.7 OUTLIER -140.76 150.67 43.67 Favored 'General case' 0 N--CA 1.446 -0.66 0 O-C-N 124.411 1.07 . . . . 10.0 111.701 -174.406 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -82.24 83.35 7.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 115.244 -0.889 . . . . 10.0 112.958 -169.782 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.54 -36.22 1.29 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-N 113.931 -1.486 . . . . 10.0 112.99 171.523 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -61.39 -53.34 57.82 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.343 0.657 . . . . 10.0 110.134 -177.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -79.87 -40.26 28.77 Favored 'General case' 0 CA--C 1.53 0.202 0 O-C-N 121.816 -0.553 . . . . 10.0 110.792 -179.407 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.424 ' O ' HD11 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -138.15 102.74 2.2 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 125.081 1.352 . . . . 10.0 108.598 -173.176 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -63.16 148.33 48.3 Favored 'General case' 0 N--CA 1.45 -0.435 0 O-C-N 121.636 -0.665 . . . . 10.0 111.054 -170.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.43 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.4 m -39.09 -45.74 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.556 1.142 . . . . 10.0 113.803 173.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 46.2 tttt -58.36 -52.39 65.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.408 -0.59 . . . . 10.0 109.408 174.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -49.99 -43.46 50.44 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.713 1.205 . . . . 10.0 109.83 178.176 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.683 HD12 HD13 ' A' ' 27' ' ' LEU . 2.4 mm -64.3 -46.22 93.86 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 O-C-N 121.561 -0.712 . . . . 10.0 110.711 179.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.48 -38.17 90.1 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 121.863 0.84 . . . . 10.0 109.446 -178.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -66.27 -37.49 85.58 Favored 'General case' 0 N--CA 1.441 -0.922 0 N-CA-C 109.157 -0.683 . . . . 10.0 109.157 177.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.51 -36.32 82.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 120.949 -1.094 . . . . 10.0 111.753 173.214 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.618 HD11 ' CG2' ' A' ' 24' ' ' VAL . 5.1 mt -58.69 -41.26 81.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 O-C-N 120.876 -1.14 . . . . 10.0 109.265 169.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.7 -44.28 90.26 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.723 -0.473 . . . . 10.0 109.723 -178.663 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -51.86 -53.95 34.68 Favored 'General case' 0 CA--C 1.535 0.379 0 CA-C-O 120.778 0.323 . . . . 10.0 111.288 174.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -81.39 -48.08 12.39 Favored 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 113.406 0.891 . . . . 10.0 113.406 -169.353 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -171.35 90.79 0.09 OUTLIER Glycine 0 CA--C 1.525 0.66 0 N-CA-C 108.828 -1.709 . . . . 10.0 108.828 -168.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -65.98 108.22 2.12 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 125.009 1.323 . . . . 10.0 111.156 -170.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -166.56 78.71 0.23 Allowed 'General case' 0 CA--C 1.529 0.173 0 N-CA-C 104.091 -2.559 . . . . 10.0 104.091 174.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.446 ' CG2' ' HG ' ' A' ' 6' ' ' LEU . 13.9 p -155.5 83.62 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 113.779 1.029 . . . . 10.0 113.779 174.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -36.16 -50.31 0.71 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 126.961 2.104 . . . . 10.0 113.361 168.243 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 87.3 mttt 128.16 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 C-N-CA 129.338 3.055 . . . . 10.0 113.308 170.026 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 10.0 mm -65.25 126.83 25.1 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.923 0 O-C-N 121.211 -0.931 . . . . 10.0 108.999 -171.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -47.5 -48.38 27.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.707 0.803 . . . . 10.0 112.468 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -84.15 -68.57 1.4 Allowed Glycine 0 CA--C 1.531 1.037 0 C-N-CA 123.927 0.775 . . . . 10.0 112.698 -172.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 52.6 ttt85 . . . . . 0 C--O 1.249 1.049 0 N-CA-C 105.135 -2.172 . . . . 10.0 105.135 -179.915 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.3 ttt . . . . . 0 N--CA 1.475 0.79 0 N-CA-C 109.472 -0.566 . . . . 10.0 109.472 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -149.18 148.94 30.21 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 118.518 0.599 . . . . 10.0 110.781 -174.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.33 107.49 5.67 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 125.234 1.413 . . . . 10.0 109.918 169.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.579 ' HB3' HD12 ' A' ' 70' ' ' ILE . 64.6 mttt -136.69 119.72 16.5 Favored 'General case' 0 C--O 1.22 -0.477 0 N-CA-C 108.357 -0.979 . . . . 10.0 108.357 179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.406 HG23 ' H ' ' A' ' 42' ' ' VAL . 1.8 m -78.77 121.5 24.85 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 122.859 0.464 . . . . 10.0 110.34 -172.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.434 HD11 ' CG1' ' A' ' 20' ' ' VAL . 1.6 pp -78.2 114.47 17.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.095 -1.076 . . . . 10.0 108.095 169.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.7 125.92 28.16 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 105.981 -1.859 . . . . 10.0 105.981 168.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -116.88 130.45 71.75 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 127.811 2.444 . . . . 10.0 108.817 -175.207 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -85.85 77.36 9.74 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 168.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -63.74 101.54 0.48 Allowed Glycine 0 CA--C 1.527 0.789 0 CA-C-O 119.307 -0.718 . . . . 10.0 111.399 -170.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -81.03 56.62 2.84 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 118.563 1.182 . . . . 10.0 112.073 -170.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.1 m 21.32 64.84 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 128.368 2.667 . . . . 10.0 115.293 174.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 54.0 t -149.88 135.18 18.13 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 109.714 -0.476 . . . . 10.0 109.714 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 89.2 mt-30 -60.88 -19.9 60.99 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.972 0.909 . . . . 10.0 113.306 -176.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -70.7 -35.01 72.54 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.8 1.24 . . . . 10.0 110.351 173.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 84.5 m -71.96 -170.52 0.59 Allowed 'General case' 0 C--O 1.233 0.218 0 N-CA-C 108.279 -1.008 . . . . 10.0 108.279 173.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.2 t 72.68 -66.82 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.256 -1.387 . . . . 10.0 107.256 -169.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.436 ' H ' ' HD2' ' A' ' 18' ' ' LYS . 9.6 mptt -66.22 -45.83 79.34 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 109.521 -0.548 . . . . 10.0 109.521 -179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -46.52 -46.23 19.04 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 118.593 0.633 . . . . 10.0 111.538 176.537 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.434 ' CG1' HD11 ' A' ' 6' ' ' LEU . 46.0 t -70.93 -28.16 32.58 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 124.963 1.305 . . . . 10.0 110.933 -179.286 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -82.5 -73.03 0.42 Allowed 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 124.81 1.244 . . . . 10.0 109.337 -179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 20.7 m -49.62 -44.6 47.43 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 127.5 2.32 . . . . 10.0 111.267 -169.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 6.4 t -47.04 -64.08 0.87 Allowed 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 122.866 1.317 . . . . 10.0 109.776 178.568 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.485 HG22 ' CG2' ' A' ' 56' ' ' ILE . 82.5 t -66.66 -38.0 80.7 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.401 0 CA-C-N 114.729 -1.123 . . . . 10.0 108.013 -176.764 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.56 -15.29 8.3 Favored Glycine 0 CA--C 1.534 1.276 0 CA-C-O 117.99 -1.45 . . . . 10.0 114.81 170.104 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -81.32 -22.02 38.82 Favored 'General case' 0 C--N 1.342 0.281 0 CA-C-N 120.45 2.125 . . . . 10.0 109.103 179.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.619 HD13 HD12 ' A' ' 56' ' ' ILE . 52.0 mt -70.07 120.58 15.99 Favored 'General case' 0 N--CA 1.435 -1.223 0 CA-C-O 121.076 0.465 . . . . 10.0 110.893 -173.05 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -46.37 -39.25 10.05 Favored 'General case' 0 CA--C 1.531 0.241 0 CA-C-O 122.374 1.083 . . . . 10.0 111.874 169.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -81.15 0.88 86.79 Favored Glycine 0 CA--C 1.535 1.297 0 CA-C-N 114.213 -1.358 . . . . 10.0 114.753 -178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -68.72 157.86 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-N 120.334 2.067 . . . . 10.0 111.725 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.5 m -127.31 -42.92 1.65 Allowed 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 124.666 1.186 . . . . 10.0 111.716 175.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -147.34 150.08 34.04 Favored 'General case' 0 N--CA 1.463 0.22 0 N-CA-C 108.47 -0.937 . . . . 10.0 108.47 177.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.554 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.9 m -141.53 58.18 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 123.758 0.823 . . . . 10.0 111.495 -178.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -80.33 72.39 7.18 Favored 'General case' 0 CA--C 1.533 0.304 0 O-C-N 120.67 -1.269 . . . . 10.0 110.667 -173.323 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -60.01 124.77 14.96 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 124.168 0.987 . . . . 10.0 110.787 176.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 26.9 m-80 -144.93 56.81 1.26 Allowed 'General case' 0 N--CA 1.455 -0.202 0 N-CA-C 106.434 -1.691 . . . . 10.0 106.434 174.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.6 pp -62.46 -23.93 67.17 Favored 'General case' 0 CA--C 1.532 0.279 0 O-C-N 121.525 -0.734 . . . . 10.0 112.244 -169.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -65.02 -31.37 72.57 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 118.287 0.494 . . . . 10.0 111.19 173.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.39 -7.52 58.44 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 123.397 0.679 . . . . 10.0 111.101 172.739 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 82.34 22.96 57.87 Favored Glycine 0 C--N 1.339 0.736 0 C-N-CA 125.396 1.474 . . . . 10.0 109.97 178.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 87.5 mttt -150.96 162.07 41.52 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-O 122.21 1.005 . . . . 10.0 111.137 -168.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.569 HG12 HG13 ' A' ' 44' ' ' VAL . 55.0 t -153.37 111.36 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 104.078 -2.564 . . . . 10.0 104.078 -177.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -89.45 85.08 6.45 Favored 'General case' 0 CA--C 1.511 -0.542 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 179.331 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.569 HG13 HG12 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -100.91 126.99 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.212 0 N-CA-C 106.544 -1.65 . . . . 10.0 106.544 178.889 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 26.3 t -116.08 120.81 40.26 Favored 'General case' 0 N--CA 1.444 -0.769 0 N-CA-C 106.251 -1.759 . . . . 10.0 106.251 171.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.502 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.9 OUTLIER -152.34 158.48 42.79 Favored 'General case' 0 C--O 1.237 0.447 0 O-C-N 123.776 0.673 . . . . 10.0 112.451 -175.047 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 14.2 t0 -85.56 88.99 7.6 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 113.986 1.106 . . . . 10.0 113.986 -171.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.69 -25.18 0.67 Allowed 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 113.485 -1.689 . . . . 10.0 113.75 168.848 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -59.04 -61.86 2.32 Favored 'General case' 0 C--N 1.346 0.415 0 CA-C-N 119.655 1.116 . . . . 10.0 111.086 -179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 78.7 tttt -80.12 -50.92 9.64 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.483 -0.932 . . . . 10.0 108.483 -176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 m -116.17 95.06 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.679 0 N-CA-C 106.44 -1.689 . . . . 10.0 106.44 -170.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 4.9 p -63.03 153.03 35.27 Favored 'General case' 0 N--CA 1.444 -0.731 0 CA-C-O 121.869 0.842 . . . . 10.0 109.596 -176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.445 HG13 HG13 ' A' ' 70' ' ' ILE . 17.8 t -34.99 -48.31 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.44 -0.928 0 C-N-CA 125.988 1.715 . . . . 10.0 112.009 169.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 10.2 tttm -55.17 -58.55 7.21 Favored 'General case' 0 C--O 1.221 -0.398 0 N-CA-C 109.007 -0.738 . . . . 10.0 109.007 176.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -48.02 -42.88 29.29 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.601 0.76 . . . . 10.0 110.054 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.619 HD12 HD13 ' A' ' 27' ' ' LEU . 2.1 mm -64.63 -47.25 89.74 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 C-N-CA 120.057 -0.657 . . . . 10.0 110.381 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.12 -46.66 80.05 Favored 'General case' 0 N--CA 1.44 -0.959 0 N-CA-C 108.267 -1.012 . . . . 10.0 108.267 -174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 41.7 m-20 -52.01 -40.86 61.64 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.527 0.731 . . . . 10.0 109.403 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -55.87 -40.04 72.37 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 112.393 0.516 . . . . 10.0 112.393 176.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.441 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.7 mp -61.85 -45.85 97.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.479 0 N-CA-C 107.015 -1.476 . . . . 10.0 107.015 171.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 29.1 mt-10 -63.4 -24.78 67.99 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 118.743 0.701 . . . . 10.0 111.944 -174.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.0 t70 -61.54 -33.89 74.61 Favored 'General case' 0 CA--C 1.54 0.561 0 O-C-N 121.984 -0.448 . . . . 10.0 111.568 171.632 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -102.73 -70.25 0.76 Allowed 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 124.867 1.267 . . . . 10.0 112.112 -177.041 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -102.85 -147.38 18.86 Favored Glycine 0 CA--C 1.524 0.633 0 N-CA-C 108.831 -1.708 . . . . 10.0 108.831 -178.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -163.03 53.01 0.18 Allowed 'General case' 0 N--CA 1.461 0.092 0 N-CA-C 107.664 -1.236 . . . . 10.0 107.664 174.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -132.56 59.13 1.73 Allowed 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.944 -1.132 . . . . 10.0 107.944 -168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.5 p -144.75 85.58 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 108.614 -0.884 . . . . 10.0 108.614 178.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -46.92 -62.54 1.36 Allowed 'General case' 0 CA--C 1.538 0.499 0 CA-C-N 116.148 -0.478 . . . . 10.0 110.784 171.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 171.06 177.13 0.06 Allowed 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 127.21 2.204 . . . . 10.0 109.717 169.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.579 HD12 ' HB3' ' A' ' 4' ' ' LYS . 12.0 mm -67.15 130.89 32.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.305 0 C-N-CA 123.473 0.709 . . . . 10.0 110.267 169.096 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -95.02 118.01 31.12 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 106.963 -1.495 . . . . 10.0 106.963 167.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.29 -164.42 24.24 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 107.536 -2.226 . . . . 10.0 107.536 -174.265 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 116.855 -1.545 . . . . 10.0 110.731 178.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.7 ttm . . . . . 0 N--CA 1.474 0.743 0 CA-C-O 118.505 -0.759 . . . . 10.0 109.921 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -129.58 102.87 6.56 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 123.889 0.876 . . . . 10.0 109.764 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -77.77 102.96 7.42 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 126.194 1.798 . . . . 10.0 111.001 172.83 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 88.1 mttt -144.66 176.24 9.56 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 118.936 0.789 . . . . 10.0 111.953 178.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.3 m -111.38 108.22 17.72 Favored 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 124.594 1.158 . . . . 10.0 108.745 178.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.412 ' HB2' HG21 ' A' ' 44' ' ' VAL . 0.5 OUTLIER -79.22 83.23 5.29 Favored 'General case' 0 C--O 1.218 -0.589 0 N-CA-C 106.162 -1.792 . . . . 10.0 106.162 173.545 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.55 126.54 2.35 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.346 1.458 . . . . 10.0 110.796 -177.795 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 2.9 m -110.71 134.88 51.55 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.592 0 C-N-CA 128.537 2.735 . . . . 10.0 111.437 -171.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -112.13 94.51 4.97 Favored 'General case' 0 C--O 1.226 -0.173 0 N-CA-C 108.021 -1.103 . . . . 10.0 108.021 -179.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -61.08 102.76 0.44 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.47 1.033 . . . . 10.0 111.533 -173.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 23.4 ttm -119.06 36.2 4.55 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.458 1.103 . . . . 10.0 111.694 -169.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.5 p -156.33 176.75 12.28 Favored 'General case' 0 CA--C 1.53 0.2 0 O-C-N 121.399 -0.813 . . . . 10.0 109.298 170.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 51.7 t -87.59 -31.95 19.58 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 123.651 0.78 . . . . 10.0 111.13 171.622 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.7 174.91 13.82 Favored 'General case' 0 N--CA 1.454 -0.271 0 O-C-N 121.627 -0.671 . . . . 10.0 110.81 179.689 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 27.6 t-80 63.96 22.25 12.91 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.322 1.449 . . . . 10.0 112.352 177.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -108.9 -54.54 2.51 Favored 'General case' 0 C--O 1.224 -0.237 0 C-N-CA 124.672 1.189 . . . . 10.0 109.885 177.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 55.0 t -35.82 -60.76 0.1 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.24 0 C-N-CA 125.275 1.43 . . . . 10.0 110.294 177.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 5.6 mptt -69.01 -35.11 76.29 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 120.816 -0.354 . . . . 10.0 111.686 -177.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.56 -53.19 61.12 Favored 'General case' 0 CA--C 1.531 0.224 0 O-C-N 121.146 -0.972 . . . . 10.0 109.758 -179.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 64.0 t -59.75 -22.06 22.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 C-N-CA 126.52 1.928 . . . . 10.0 110.639 177.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -80.08 -71.79 0.44 Allowed 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.172 0.989 . . . . 10.0 109.119 173.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 50.5 m -49.41 -42.16 41.68 Favored 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 126.933 2.093 . . . . 10.0 112.884 -174.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 10.6 p -50.35 -61.41 2.19 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.648 1.179 . . . . 10.0 110.201 -178.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.749 ' CG2' HD11 ' A' ' 60' ' ' ILE . 89.7 t -61.9 -47.9 91.07 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.28 0 C-N-CA 124.063 0.945 . . . . 10.0 108.524 174.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.92 -1.57 0.26 Allowed Glycine 0 CA--C 1.537 1.416 0 CA-C-O 117.991 -1.449 . . . . 10.0 115.828 176.026 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -87.92 -31.42 19.45 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-N 120.133 1.967 . . . . 10.0 108.688 173.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 69.4 mt -69.6 125.01 25.43 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 121.403 -0.811 . . . . 10.0 111.02 -171.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -50.32 -36.57 32.54 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-O 122.45 1.119 . . . . 10.0 111.85 172.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -71.88 -12.99 75.36 Favored Glycine 0 CA--C 1.533 1.17 0 CA-C-N 114.23 -1.35 . . . . 10.0 114.153 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.524 HG22 ' HB3' ' A' ' 46' ' ' PHE . 2.3 t -79.24 146.32 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.666 0 CA-C-N 120.085 1.943 . . . . 10.0 111.177 177.826 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.6 t -123.0 -47.11 2.06 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.891 1.676 . . . . 10.0 111.016 -173.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.64 147.56 51.46 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-O 118.237 -0.887 . . . . 10.0 108.771 177.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.3 m -145.1 58.52 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 C-N-CA 124.584 1.154 . . . . 10.0 111.859 -176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -79.39 75.04 5.99 Favored 'General case' 0 C--N 1.333 -0.13 0 O-C-N 120.221 -1.549 . . . . 10.0 109.501 -178.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.59 122.73 10.48 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.362 0.665 . . . . 10.0 110.1 175.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 23.7 m-80 -147.63 59.74 1.14 Allowed 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.139 -1.43 . . . . 10.0 107.139 175.711 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -62.71 -21.38 65.73 Favored 'General case' 0 CA--C 1.533 0.324 0 O-C-N 121.695 -0.628 . . . . 10.0 111.946 179.057 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 54.6 mt-10 -66.47 -32.85 74.47 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.556 0.742 . . . . 10.0 110.094 172.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.87 -34.57 33.55 Favored 'General case' 0 CA--C 1.533 0.291 0 N-CA-C 109.592 -0.522 . . . . 10.0 109.592 171.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 104.81 -1.96 41.72 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 126.26 1.886 . . . . 10.0 110.611 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 20.1 mtpp -129.9 100.08 5.33 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 124.046 0.938 . . . . 10.0 108.746 -170.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.492 HG22 HG13 ' A' ' 44' ' ' VAL . 2.4 p -78.02 137.95 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 N-CA-C 105.534 -2.024 . . . . 10.0 105.534 168.423 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -104.79 97.85 7.67 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 119.983 1.265 . . . . 10.0 107.812 172.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.492 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -117.81 106.53 20.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.828 0 C-N-CA 125.12 1.368 . . . . 10.0 108.94 -169.733 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -96.55 114.27 25.91 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 106.993 -1.484 . . . . 10.0 106.993 175.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.524 ' HB3' HG22 ' A' ' 30' ' ' VAL . 0.3 OUTLIER -133.15 152.28 51.95 Favored 'General case' 0 CA--C 1.518 -0.25 0 C-N-CA 125.015 1.326 . . . . 10.0 111.649 -178.476 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 4.3 t0 -82.95 84.99 7.23 Favored 'General case' 0 N--CA 1.447 -0.59 0 CA-C-O 122.425 1.107 . . . . 10.0 112.353 177.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.85 -28.95 1.21 Allowed 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 113.239 -1.801 . . . . 10.0 113.801 173.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -58.3 -49.56 76.72 Favored 'General case' 0 C--N 1.341 0.217 0 CA-C-N 118.524 0.602 . . . . 10.0 110.594 178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -87.09 -48.62 7.93 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.828 -0.804 . . . . 10.0 108.828 -173.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -127.86 102.63 9.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.582 -1.266 . . . . 10.0 107.582 -178.022 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 3.2 p -65.39 154.55 38.09 Favored 'General case' 0 N--CA 1.446 -0.639 0 CA-C-O 121.402 0.62 . . . . 10.0 109.805 -176.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.442 HG12 ' HE1' ' A' ' 46' ' ' PHE . 0.9 OUTLIER -38.51 -42.91 0.36 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 C-N-CA 125.184 1.394 . . . . 10.0 112.601 175.178 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -57.01 -54.44 46.67 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 123.246 0.618 . . . . 10.0 109.776 175.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -50.35 -40.68 49.91 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.907 0.883 . . . . 10.0 111.178 176.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.621 ' CG2' HG22 ' A' ' 24' ' ' VAL . 12.9 mm -66.68 -49.49 74.21 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.704 0 N-CA-C 107.997 -1.112 . . . . 10.0 107.997 -179.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.402 ' HB2' HD21 ' A' ' 6' ' ' LEU . . . -63.23 -39.69 95.33 Favored 'General case' 0 N--CA 1.436 -1.126 0 N-CA-C 108.684 -0.858 . . . . 10.0 108.684 -174.141 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 45.2 m-20 -62.28 -41.68 98.69 Favored 'General case' 0 N--CA 1.443 -0.784 0 N-CA-C 109.401 -0.592 . . . . 10.0 109.401 175.446 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -37.51 79.97 Favored 'General case' 0 CA--C 1.533 0.294 0 O-C-N 121.385 -0.822 . . . . 10.0 110.977 173.388 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.759 HD13 HG11 ' A' ' 67' ' ' VAL . 1.9 mp -61.0 -44.2 97.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.875 0 O-C-N 120.981 -1.074 . . . . 10.0 108.789 168.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.5 mt-10 -56.91 -33.56 67.06 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.013 1.279 . . . . 10.0 112.155 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -58.89 -39.35 81.17 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 111.997 0.369 . . . . 10.0 111.997 172.636 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 32.3 tt0 -133.93 84.4 2.12 Favored 'General case' 0 N--CA 1.445 -0.679 0 C-N-CA 125.623 1.569 . . . . 10.0 108.903 -176.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 85.28 76.5 1.21 Allowed Glycine 0 CA--C 1.527 0.819 0 C-N-CA 123.495 0.569 . . . . 10.0 112.116 169.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 24.5 p90 -68.0 55.22 0.07 Allowed 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 127.71 2.404 . . . . 10.0 114.739 -169.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -110.5 56.19 0.63 Allowed 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.718 -1.238 . . . . 10.0 107.707 -175.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.759 HG11 HD13 ' A' ' 60' ' ' ILE . 3.6 m -133.38 94.6 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.291 0 C-N-CA 125.319 1.448 . . . . 10.0 111.398 -176.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.65 -66.38 0.41 Allowed 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.311 -0.859 . . . . 10.0 111.263 168.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.6 mtpt 160.38 -179.42 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 126.53 1.932 . . . . 10.0 113.086 176.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.423 HG13 HG21 ' A' ' 53' ' ' VAL . 6.3 mm -64.12 130.58 29.23 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.879 0 N-CA-C 108.774 -0.825 . . . . 10.0 108.774 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -72.24 122.08 20.48 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 108.268 -1.012 . . . . 10.0 108.268 176.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 76.14 171.02 31.3 Favored Glycine 0 CA--C 1.528 0.902 0 N-CA-C 109.903 -1.279 . . . . 10.0 109.903 -171.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.952 0 N-CA-C 106.398 -1.705 . . . . 10.0 106.398 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.471 0.577 0 CA-C-O 118.973 -0.537 . . . . 10.0 109.843 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 17.0 tt0 -78.98 99.38 6.82 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 106.822 -1.547 . . . . 10.0 106.822 173.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -72.36 89.21 1.22 Allowed 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 124.452 1.101 . . . . 10.0 110.14 -179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.409 ' HB3' HD11 ' A' ' 70' ' ' ILE . 7.9 mmtp -139.18 175.18 9.78 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 112.843 0.682 . . . . 10.0 112.843 -172.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 12.7 m -115.63 117.06 29.26 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 125.544 1.538 . . . . 10.0 108.885 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.704 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.5 mt -86.57 97.34 10.47 Favored 'General case' 0 C--O 1.218 -0.553 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 171.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.406 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -45.8 118.53 1.86 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.746 -0.835 . . . . 10.0 108.746 177.287 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.704 HG21 HG11 ' A' ' 20' ' ' VAL . 8.4 t -124.06 124.27 68.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 C-N-CA 124.76 1.224 . . . . 10.0 108.438 179.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 3.0 pm0 -97.3 115.69 28.13 Favored 'General case' 0 N--CA 1.446 -0.658 0 C-N-CA 126.098 1.759 . . . . 10.0 108.268 173.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 117.63 10.94 Favored Glycine 0 CA--C 1.526 0.749 0 CA-C-O 118.795 -1.003 . . . . 10.0 111.123 179.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -65.37 -80.47 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 118.304 1.052 . . . . 10.0 110.372 178.575 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.3 m -168.35 165.28 12.87 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 126.111 1.764 . . . . 10.0 108.06 179.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 84.4 m 68.36 159.05 0.16 Allowed 'General case' 0 C--N 1.341 0.227 0 C-N-CA 126.278 1.831 . . . . 10.0 111.824 174.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -78.52 53.32 1.29 Allowed 'General case' 0 CA--C 1.533 0.311 0 O-C-N 121.019 -1.051 . . . . 10.0 110.258 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 t60 -145.32 29.55 1.16 Allowed 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.582 0.753 . . . . 10.0 110.453 178.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.8 p -111.56 -52.68 2.77 Favored 'General case' 0 C--O 1.23 0.031 0 C-N-CA 124.801 1.24 . . . . 10.0 109.993 177.482 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 70.3 t -47.56 -56.59 1.61 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.219 0 C-N-CA 124.867 1.267 . . . . 10.0 107.858 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -68.84 -45.53 70.88 Favored 'General case' 0 N--CA 1.441 -0.875 0 CA-C-N 115.27 -0.877 . . . . 10.0 110.691 -175.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.74 -49.05 58.79 Favored 'General case' 0 N--CA 1.457 -0.077 0 CA-C-N 118.12 0.418 . . . . 10.0 110.302 -179.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.704 HG11 HG21 ' A' ' 8' ' ' VAL . 99.4 t -71.43 -25.23 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 C-N-CA 124.357 1.063 . . . . 10.0 111.276 178.724 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 57.4 tt0 -77.01 -66.11 0.86 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.827 0.851 . . . . 10.0 109.048 -178.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.6 m -51.7 -47.91 63.75 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 126.307 1.843 . . . . 10.0 111.289 -177.127 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 13.0 p -53.04 -67.83 0.22 Allowed 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 124.437 1.095 . . . . 10.0 110.753 -174.215 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.767 HG22 HG22 ' A' ' 56' ' ' ILE . 84.8 t -55.46 -42.33 67.27 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.261 0 C-N-CA 124.512 1.125 . . . . 10.0 108.996 175.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.6 -14.04 13.53 Favored Glycine 0 CA--C 1.535 1.296 0 CA-C-O 118.07 -1.406 . . . . 10.0 115.085 174.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -82.01 -22.13 36.68 Favored 'General case' 0 N--CA 1.454 -0.235 0 CA-C-N 120.301 2.051 . . . . 10.0 108.697 179.346 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.7 HD13 HD12 ' A' ' 56' ' ' ILE . 60.3 mt -67.69 117.68 9.94 Favored 'General case' 0 N--CA 1.432 -1.375 0 CA-C-O 121.44 0.638 . . . . 10.0 111.498 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -40.79 -40.66 1.39 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.594 1.958 . . . . 10.0 112.251 168.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -80.14 -8.5 87.56 Favored Glycine 0 CA--C 1.538 1.474 0 C-N-CA 125.285 1.421 . . . . 10.0 115.2 -178.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -62.83 158.35 3.49 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 CA-C-N 120.022 1.911 . . . . 10.0 111.855 175.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.5 t -132.27 -48.72 0.92 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.221 1.009 . . . . 10.0 110.662 172.275 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -132.62 146.09 51.61 Favored 'General case' 0 CA--C 1.519 -0.236 0 N-CA-C 108.099 -1.075 . . . . 10.0 108.099 178.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.459 ' HA ' HG12 ' A' ' 44' ' ' VAL . 35.0 m -139.99 57.37 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 124.328 1.051 . . . . 10.0 110.59 179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.2 t60 -82.44 66.15 7.9 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.968 -1.083 . . . . 10.0 110.367 -170.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 p -59.09 126.42 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 C-N-CA 125.038 1.335 . . . . 10.0 110.976 179.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 18.3 m-80 -144.27 56.14 1.3 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 106.724 -1.584 . . . . 10.0 106.724 172.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.4 pp -59.12 -28.74 66.82 Favored 'General case' 0 CA--C 1.531 0.22 0 O-C-N 121.551 -0.718 . . . . 10.0 110.986 -176.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -61.85 -31.37 71.63 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.921 1.289 . . . . 10.0 110.749 176.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -91.0 -4.68 56.24 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.769 1.228 . . . . 10.0 111.771 175.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 70.74 40.05 65.6 Favored Glycine 0 CA--C 1.526 0.763 0 C-N-CA 123.913 0.768 . . . . 10.0 111.233 -175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.9 tttp -155.74 160.13 40.06 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 117.901 0.851 . . . . 10.0 109.981 173.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -157.31 101.29 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 N-CA-C 104.274 -2.491 . . . . 10.0 104.274 178.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -82.45 103.16 11.79 Favored 'General case' 0 C--O 1.232 0.163 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -178.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.459 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -116.38 96.55 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.882 0 C-N-CA 124.714 1.206 . . . . 10.0 107.785 -173.683 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.3 t -88.15 105.76 17.73 Favored 'General case' 0 N--CA 1.443 -0.807 0 N-CA-C 106.054 -1.832 . . . . 10.0 106.054 177.637 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.459 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -135.86 152.39 50.99 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 113.696 0.999 . . . . 10.0 113.696 -175.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -76.38 84.24 3.13 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.61 -0.723 . . . . 10.0 112.824 -170.766 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -49.87 -30.87 10.81 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 113.4 0.889 . . . . 10.0 113.4 173.467 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 10.6 t70 -62.75 -51.87 65.43 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.012 0.525 . . . . 10.0 110.503 -175.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -78.82 -42.62 27.21 Favored 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 109.291 -0.633 . . . . 10.0 109.291 177.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.517 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.8 m -135.8 98.63 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 124.179 0.992 . . . . 10.0 109.426 -169.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -60.69 152.48 26.52 Favored 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.48 -0.762 . . . . 10.0 110.617 -173.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -36.81 -44.34 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 N-CA-C 113.788 1.033 . . . . 10.0 113.788 171.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 35.3 ttmt -55.25 -58.21 8.65 Favored 'General case' 0 C--O 1.219 -0.5 0 CA-C-O 118.723 -0.656 . . . . 10.0 109.36 174.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -46.79 -44.38 19.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.993 0.917 . . . . 10.0 110.232 177.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.767 HG22 HG22 ' A' ' 24' ' ' VAL . 1.9 mm -66.99 -45.19 87.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 O-C-N 121.542 -0.724 . . . . 10.0 110.669 -178.035 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.76 -42.49 99.71 Favored 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 108.383 -0.969 . . . . 10.0 108.383 -178.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 -61.29 -38.95 88.62 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.93 -0.767 . . . . 10.0 108.93 176.647 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.96 -32.33 71.88 Favored 'General case' 0 CA--C 1.533 0.309 0 O-C-N 121.526 -0.733 . . . . 10.0 111.653 173.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.406 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.5 mp -63.3 -49.8 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.579 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 168.233 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -59.19 -30.4 68.18 Favored 'General case' 0 N--CA 1.466 0.33 0 CA-C-N 119.563 1.074 . . . . 10.0 112.446 -176.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -60.94 -29.86 69.87 Favored 'General case' 0 CA--C 1.541 0.607 0 O-C-N 121.81 -0.556 . . . . 10.0 111.342 176.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -102.51 -62.95 1.21 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 126.109 1.764 . . . . 10.0 111.786 -173.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -121.54 -143.59 6.66 Favored Glycine 0 CA--C 1.528 0.867 0 C-N-CA 126.382 1.944 . . . . 10.0 109.18 -179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -167.28 57.03 0.08 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 118.775 1.287 . . . . 10.0 109.978 178.069 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -131.22 70.3 1.47 Allowed 'General case' 0 N--CA 1.45 -0.462 0 N-CA-C 105.725 -1.954 . . . . 10.0 105.725 -176.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.704 ' CG2' HD22 ' A' ' 6' ' ' LEU . 9.9 p -156.23 92.64 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 O-C-N 121.647 -0.658 . . . . 10.0 112.159 177.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.406 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -49.17 -71.42 0.07 Allowed 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.261 -0.427 . . . . 10.0 111.512 168.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . 0.417 ' C ' HD23 ' A' ' 6' ' ' LEU . 13.1 mttt 171.03 176.62 0.06 Allowed 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.527 1.531 . . . . 10.0 113.959 173.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.409 HD11 ' HB3' ' A' ' 4' ' ' LYS . 1.0 OUTLIER -68.94 130.18 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 N-CA-C 109.589 -0.523 . . . . 10.0 109.589 177.468 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 12.0 mm-40 -68.44 119.78 13.47 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 108.965 -0.754 . . . . 10.0 108.965 173.807 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 75.84 74.35 0.93 Allowed Glycine 0 CA--C 1.525 0.683 0 N-CA-C 111.576 -0.61 . . . . 10.0 111.576 174.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 C-N-CA 128.351 2.661 . . . . 10.0 104.583 167.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.1 ttp . . . . . 0 N--CA 1.472 0.664 0 N-CA-C 109.644 -0.502 . . . . 10.0 109.644 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 75.8 tt0 -132.71 134.44 44.79 Favored 'General case' 0 N--CA 1.447 -0.579 0 N-CA-C 109.039 -0.726 . . . . 10.0 109.039 -176.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -78.17 106.67 10.23 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 125.82 1.648 . . . . 10.0 109.945 175.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.47 ' CB ' HD12 ' A' ' 70' ' ' ILE . 3.6 mtpm? -128.07 174.72 8.98 Favored 'General case' 0 N--CA 1.455 -0.215 0 N-CA-C 109.517 -0.549 . . . . 10.0 109.517 176.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.5 m -120.75 114.99 22.44 Favored 'General case' 0 CA--C 1.513 -0.455 0 O-C-N 121.658 -0.651 . . . . 10.0 109.593 178.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.3 mt -77.09 82.07 3.6 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 106.76 -1.57 . . . . 10.0 106.76 175.044 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 36.3 tp60 -40.34 120.27 1.19 Allowed 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 108.156 -1.053 . . . . 10.0 108.156 175.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.0 p -107.48 152.91 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 126.172 1.789 . . . . 10.0 107.717 -169.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -119.81 56.66 0.94 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.791 1.636 . . . . 10.0 107.95 -172.175 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -43.67 100.02 0.02 OUTLIER Glycine 0 CA--C 1.532 1.122 0 C-N-CA 125.773 1.654 . . . . 10.0 114.037 -169.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 1.1 tmt? -77.67 6.38 7.44 Favored 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 124.408 1.083 . . . . 10.0 112.782 -170.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 5.4 t 75.36 -39.6 0.4 Allowed 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 125.402 1.481 . . . . 10.0 112.644 177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 17.2 p -49.5 163.15 0.12 Allowed 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.265 1.426 . . . . 10.0 112.802 173.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -66.64 167.68 10.65 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 121.932 0.872 . . . . 10.0 112.373 -179.119 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER 72.76 39.01 0.71 Allowed 'General case' 0 CA--C 1.533 0.326 0 CA-C-N 114.571 -1.195 . . . . 10.0 110.42 -176.389 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -83.81 -78.91 0.22 Allowed 'General case' 0 C--O 1.232 0.15 0 C-N-CA 123.607 0.763 . . . . 10.0 110.353 -174.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 20.5 t -76.89 57.98 0.1 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.345 0 C-N-CA 125.169 1.387 . . . . 10.0 108.475 -175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -174.62 -51.47 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.565 0 C-N-CA 125.661 1.584 . . . . 10.0 111.353 -176.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.04 -54.91 37.07 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 121.075 1.761 . . . . 10.0 110.633 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 27.9 t -65.62 -19.53 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 114.866 -1.061 . . . . 10.0 110.909 179.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 13.0 tm-20 -78.68 -76.18 0.21 Allowed 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.167 -1.419 . . . . 10.0 107.167 172.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 98.4 m -42.09 -49.96 4.75 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 128.573 2.749 . . . . 10.0 112.152 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 4.3 m -54.33 -58.24 8.17 Favored 'General case' 0 N--CA 1.457 -0.091 0 CA-C-O 122.253 1.025 . . . . 10.0 110.63 -177.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.661 HG22 HG22 ' A' ' 56' ' ' ILE . 91.6 t -64.45 -38.66 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.221 0 N-CA-C 108.29 -1.004 . . . . 10.0 108.29 -179.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -63.47 -11.32 40.63 Favored Glycine 0 CA--C 1.531 1.068 0 C-N-CA 125.181 1.372 . . . . 10.0 114.531 174.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -80.94 -21.7 40.23 Favored 'General case' 0 C--N 1.341 0.197 0 CA-C-N 119.923 1.861 . . . . 10.0 108.123 177.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.746 HD11 HG23 ' A' ' 56' ' ' ILE . 41.4 mt -67.37 117.25 9.1 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-O 121.45 0.643 . . . . 10.0 111.525 -175.827 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -46.96 -35.27 6.36 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.984 1.313 . . . . 10.0 111.716 168.226 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.77 5.69 84.4 Favored Glycine 0 CA--C 1.535 1.344 0 C-N-CA 125.338 1.447 . . . . 10.0 114.93 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -72.24 159.04 5.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-N 120.532 2.166 . . . . 10.0 111.939 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 73.9 m -126.81 -44.64 1.64 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.07 1.348 . . . . 10.0 112.004 171.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.65 146.81 34.85 Favored 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 117.66 -1.162 . . . . 10.0 108.862 -178.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.461 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.2 m -145.12 56.69 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 124.224 1.01 . . . . 10.0 112.469 -174.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -82.6 70.85 9.66 Favored 'General case' 0 C--O 1.234 0.278 0 O-C-N 120.158 -1.589 . . . . 10.0 111.147 -173.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.57 126.29 15.95 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 123.541 0.736 . . . . 10.0 111.383 176.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 25.3 m-80 -144.41 56.97 1.3 Allowed 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 106.967 -1.494 . . . . 10.0 106.967 175.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.5 pp -64.61 -24.52 67.62 Favored 'General case' 0 CA--C 1.531 0.246 0 O-C-N 121.659 -0.65 . . . . 10.0 111.529 -172.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -67.1 -32.27 73.3 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.348 0.659 . . . . 10.0 110.518 173.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.78 -29.12 44.82 Favored 'General case' 0 CA--C 1.531 0.217 0 N-CA-C 109.432 -0.581 . . . . 10.0 109.432 172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 106.09 20.33 9.35 Favored Glycine 0 CA--C 1.524 0.61 0 C-N-CA 125.118 1.342 . . . . 10.0 111.078 175.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.1 mttt -141.62 174.41 10.59 Favored 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 122.325 1.06 . . . . 10.0 109.276 179.012 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.545 HG22 HG13 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -156.1 115.64 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.77 0 N-CA-C 102.996 -2.964 . . . . 10.0 102.996 174.98 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -91.95 101.24 13.81 Favored 'General case' 0 CA--C 1.517 -0.319 0 CA-C-N 120.337 1.426 . . . . 10.0 108.092 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.545 HG13 HG22 ' A' ' 42' ' ' VAL . 0.6 OUTLIER -116.64 107.97 23.84 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.034 0 C-N-CA 124.637 1.175 . . . . 10.0 109.045 -172.101 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.5 t -98.71 116.56 31.22 Favored 'General case' 0 N--CA 1.443 -0.811 0 N-CA-C 106.867 -1.531 . . . . 10.0 106.867 175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.692 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.8 OUTLIER -148.06 161.1 42.08 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 113.319 0.859 . . . . 10.0 113.319 -176.071 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -91.33 81.8 5.45 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.302 -0.863 . . . . 10.0 112.97 -169.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -39.47 -40.87 0.9 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.687 1.595 . . . . 10.0 112.87 172.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.48 -54.88 18.82 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.31 1.044 . . . . 10.0 111.806 177.72 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -83.38 -40.72 19.02 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.878 -0.415 . . . . 10.0 109.878 -174.675 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.5 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.4 m -135.43 105.2 5.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.401 0 N-CA-C 107.59 -1.263 . . . . 10.0 107.59 -177.9 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -64.3 148.67 49.74 Favored 'General case' 0 N--CA 1.448 -0.544 0 O-C-N 121.588 -0.695 . . . . 10.0 110.222 -174.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.514 HG13 ' CG1' ' A' ' 70' ' ' ILE . 40.1 t -29.31 -52.82 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 C-N-CA 126.871 2.068 . . . . 10.0 112.242 167.454 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 18.3 tttt -50.32 -60.78 2.64 Favored 'General case' 0 C--O 1.219 -0.524 0 C-N-CA 123.423 0.689 . . . . 10.0 109.331 175.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -44.76 -44.64 9.44 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.858 1.663 . . . . 10.0 110.192 175.287 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.746 HG23 HD11 ' A' ' 27' ' ' LEU . 2.0 mm -67.15 -45.56 86.25 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 O-C-N 121.098 -1.001 . . . . 10.0 110.904 -177.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -63.43 -44.45 94.51 Favored 'General case' 0 N--CA 1.444 -0.736 0 N-CA-C 108.561 -0.903 . . . . 10.0 108.561 -179.967 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 54.9 m-20 -54.69 -39.69 68.37 Favored 'General case' 0 N--CA 1.445 -0.71 0 C-N-CA 124.234 1.014 . . . . 10.0 108.681 178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.02 -31.32 69.83 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 113.1 0.778 . . . . 10.0 113.1 175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.422 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.4 mp -66.26 -47.61 83.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 168.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -62.32 -26.39 68.4 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 112.201 0.445 . . . . 10.0 112.201 -174.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -61.97 -33.94 75.23 Favored 'General case' 0 CA--C 1.537 0.448 0 O-C-N 121.652 -0.655 . . . . 10.0 111.577 171.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -98.6 -54.29 3.07 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 125.316 1.446 . . . . 10.0 111.819 -169.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -141.12 -140.36 3.82 Favored Glycine 0 CA--C 1.524 0.607 0 N-CA-C 108.155 -1.978 . . . . 10.0 108.155 -177.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -164.83 53.38 0.12 Allowed 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 118.685 1.242 . . . . 10.0 110.604 -179.128 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -122.08 78.4 1.48 Allowed 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 106.918 -1.512 . . . . 10.0 106.918 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.05 108.08 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.867 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 169.723 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -67.26 -73.33 0.14 Allowed 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.675 -1.232 . . . . 10.0 107.675 168.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.5 tttt 177.75 176.85 0.4 Allowed 'General case' 0 C--O 1.221 -0.425 0 N-CA-C 113.863 1.061 . . . . 10.0 113.863 175.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.514 ' CG1' HG13 ' A' ' 53' ' ' VAL . 3.3 mm -67.63 125.03 24.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 O-C-N 121.871 -0.518 . . . . 10.0 110.76 174.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -86.18 169.58 12.94 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 127.37 2.268 . . . . 10.0 109.047 174.185 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 54.6 65.19 3.69 Favored Glycine 0 CA--C 1.525 0.702 0 C-N-CA 124.936 1.255 . . . . 10.0 111.252 176.391 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.25 1.1 0 N-CA-C 105.022 -2.214 . . . . 10.0 105.022 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.7 ptt? . . . . . 0 N--CA 1.473 0.699 0 CA-C-O 121.097 0.475 . . . . 10.0 112.214 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -128.11 103.36 7.17 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 106.012 -1.848 . . . . 10.0 106.012 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.1 mp0 -73.34 89.7 1.61 Allowed 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.529 1.132 . . . . 10.0 109.691 -174.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 83.2 mttt -131.77 173.58 11.01 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 121.513 0.673 . . . . 10.0 111.751 174.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 38.6 m -111.91 112.92 24.92 Favored 'General case' 0 N--CA 1.442 -0.861 0 C-N-CA 125.542 1.537 . . . . 10.0 108.148 -176.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.76 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.3 mt -80.64 95.0 6.43 Favored 'General case' 0 CA--C 1.516 -0.34 0 N-CA-C 105.611 -1.996 . . . . 10.0 105.611 172.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -49.4 121.56 5.16 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.378 -1.341 . . . . 10.0 107.378 177.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 8.4 p -111.97 135.63 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.074 0 C-N-CA 128.431 2.692 . . . . 10.0 108.192 -169.214 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -115.67 114.97 25.58 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.404 -1.702 . . . . 10.0 106.404 179.401 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -78.06 96.24 1.32 Allowed Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.155 -1.178 . . . . 10.0 110.155 -173.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -146.9 57.0 1.15 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 121.952 0.882 . . . . 10.0 110.983 -174.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 11.4 t -138.39 -104.42 0.18 Allowed 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.174 0.99 . . . . 10.0 108.772 176.418 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 6.5 t -160.27 -163.94 1.19 Allowed 'General case' 0 CA--C 1.536 0.42 0 N-CA-C 107.07 -1.456 . . . . 10.0 107.07 -177.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -48.63 -43.26 36.19 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 121.16 1.8 . . . . 10.0 111.197 174.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 66.2 m80 -75.08 70.64 2.08 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 123.03 0.532 . . . . 10.0 109.644 174.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 39.5 t -135.92 -63.41 0.65 Allowed 'General case' 0 N--CA 1.462 0.129 0 C-N-CA 125.333 1.453 . . . . 10.0 109.277 -178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 68.9 t -45.45 -58.22 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.175 0 C-N-CA 124.87 1.268 . . . . 10.0 108.442 175.048 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -76.82 -8.78 57.97 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 113.338 0.866 . . . . 10.0 113.338 -178.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -80.28 -49.16 11.96 Favored 'General case' 0 C--O 1.232 0.154 0 O-C-N 120.461 -1.399 . . . . 10.0 108.349 179.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 77.5 t -56.32 -28.67 26.56 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 124.746 1.218 . . . . 10.0 110.304 172.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -83.12 -55.73 4.19 Favored 'General case' 0 C--N 1.342 0.253 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 177.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 48.4 m -50.06 -53.07 29.51 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 123.753 0.821 . . . . 10.0 110.159 -178.141 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 17.5 t -60.62 -59.95 4.58 Favored 'General case' 0 N--CA 1.447 -0.625 0 CA-C-O 122.583 1.183 . . . . 10.0 111.1 -168.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.693 HG22 HG22 ' A' ' 56' ' ' ILE . 69.3 t -60.82 -41.47 88.74 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.309 0 CA-C-N 115.351 -0.84 . . . . 10.0 108.831 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.67 -13.28 7.68 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 125.598 1.57 . . . . 10.0 114.546 172.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -82.89 -23.0 33.78 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 119.984 1.892 . . . . 10.0 108.575 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.41 ' CD1' HD12 ' A' ' 56' ' ' ILE . 73.6 mt -68.9 123.16 20.24 Favored 'General case' 0 N--CA 1.434 -1.227 0 O-C-N 121.733 -0.604 . . . . 10.0 111.085 -174.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -43.4 -43.06 5.0 Favored 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 125.1 1.36 . . . . 10.0 112.297 171.4 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -70.2 -17.61 74.17 Favored Glycine 0 CA--C 1.534 1.241 0 CA-C-N 113.961 -1.472 . . . . 10.0 114.016 -178.858 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.4 147.84 6.69 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 119.732 1.766 . . . . 10.0 111.616 -178.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.5 t -123.88 -43.23 2.13 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.987 0.915 . . . . 10.0 110.795 177.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.6 154.56 44.51 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.794 0.837 . . . . 10.0 109.358 172.179 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.54 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.3 m -145.64 57.53 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 126.079 1.752 . . . . 10.0 111.101 -174.417 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 58.3 t-80 -82.17 66.14 7.61 Favored 'General case' 0 CA--C 1.535 0.368 0 O-C-N 120.919 -1.113 . . . . 10.0 111.522 -169.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.47 132.4 23.26 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 C-N-CA 124.618 1.167 . . . . 10.0 111.871 -178.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 38.3 m-20 -152.97 58.17 0.79 Allowed 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 107.291 -1.374 . . . . 10.0 107.291 170.238 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.414 HD12 ' N ' ' A' ' 38' ' ' GLU . 3.6 pp -60.79 -26.12 67.05 Favored 'General case' 0 CA--C 1.535 0.398 0 O-C-N 121.179 -0.951 . . . . 10.0 111.248 -176.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.414 ' N ' HD12 ' A' ' 37' ' ' LEU . 0.6 OUTLIER -58.9 -34.54 71.8 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.571 1.148 . . . . 10.0 110.433 173.846 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -87.71 -4.19 58.92 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.459 1.104 . . . . 10.0 111.583 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 73.98 34.74 55.22 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 124.601 1.096 . . . . 10.0 111.274 -176.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -156.98 160.56 39.15 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 118.274 1.037 . . . . 10.0 111.134 -179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.464 HG22 HG13 ' A' ' 44' ' ' VAL . 0.6 OUTLIER -156.69 104.9 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.57 0 N-CA-C 104.417 -2.438 . . . . 10.0 104.417 -179.776 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -87.15 95.26 9.9 Favored 'General case' 0 C--O 1.234 0.25 0 N-CA-C 106.677 -1.601 . . . . 10.0 106.677 -175.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.54 HG12 ' HA ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -110.9 91.84 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.34 0 CA-C-O 122.336 1.065 . . . . 10.0 109.93 -169.056 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.2 m -77.83 84.51 4.14 Favored 'General case' 0 N--CA 1.443 -0.801 0 CA-C-N 115.369 -0.832 . . . . 10.0 108.933 174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.434 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -106.26 178.36 4.58 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.457 0.703 . . . . 10.0 111.372 177.517 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -101.05 83.78 2.56 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 114.246 1.202 . . . . 10.0 114.246 -175.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.51 -36.0 4.23 Favored 'General case' 0 N--CA 1.452 -0.349 0 CA-C-N 113.904 -1.498 . . . . 10.0 113.036 173.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -65.72 -54.9 21.02 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.267 0.485 . . . . 10.0 110.74 -177.154 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.8 tmtt? -82.02 -28.08 32.71 Favored 'General case' 0 CA--C 1.534 0.341 0 O-C-N 121.83 -0.544 . . . . 10.0 111.125 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -144.63 105.85 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.269 0 C-N-CA 125.37 1.468 . . . . 10.0 108.948 179.746 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -61.34 152.28 29.86 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.404 -0.81 . . . . 10.0 109.663 -173.84 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -37.4 -42.23 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.959 0.903 . . . . 10.0 112.496 170.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -59.99 -47.93 83.79 Favored 'General case' 0 N--CA 1.445 -0.721 0 C-N-CA 123.607 0.763 . . . . 10.0 110.567 178.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -54.66 -44.57 73.41 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.078 0.951 . . . . 10.0 109.709 175.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.693 HG22 HG22 ' A' ' 24' ' ' VAL . 10.9 mm -62.64 -45.87 97.76 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 CA-C-O 122.177 0.989 . . . . 10.0 109.587 -178.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -68.05 -35.29 77.99 Favored 'General case' 0 N--CA 1.437 -1.084 0 CA-C-N 115.157 -0.929 . . . . 10.0 108.677 -174.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 59.4 m-20 -63.54 -43.44 97.1 Favored 'General case' 0 N--CA 1.45 -0.466 0 O-C-N 121.676 -0.64 . . . . 10.0 109.711 172.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -59.03 -39.94 83.49 Favored 'General case' 0 N--CA 1.455 -0.192 0 O-C-N 121.725 -0.609 . . . . 10.0 110.451 177.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 24' ' ' VAL . 1.4 mt -51.13 -46.41 31.79 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 O-C-N 121.489 -0.757 . . . . 10.0 109.157 170.177 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.11 -42.74 60.87 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 118.963 0.801 . . . . 10.0 111.762 -178.159 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 14.0 t70 -60.37 -41.56 93.99 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 121.192 0.52 . . . . 10.0 111.13 178.755 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -114.11 66.44 0.67 Allowed 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.204 1.402 . . . . 10.0 110.606 -177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 84.74 103.5 0.63 Allowed Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.45 -1.06 . . . . 10.0 110.45 173.132 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 33.8 p90 -74.33 54.3 0.56 Allowed 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 125.496 1.518 . . . . 10.0 113.723 -169.365 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -106.04 79.31 1.4 Allowed 'General case' 0 N--CA 1.444 -0.745 0 N-CA-C 107.441 -1.318 . . . . 10.0 107.441 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.76 ' CG2' HD22 ' A' ' 6' ' ' LEU . 13.9 p -156.18 104.41 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.612 0 O-C-N 121.711 -0.618 . . . . 10.0 110.653 172.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -56.18 -67.63 0.28 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 118.027 -0.987 . . . . 10.0 110.514 167.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.1 mtpt 160.03 173.41 0.01 OUTLIER 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 127.162 2.185 . . . . 10.0 114.098 172.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -67.82 133.65 31.33 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 O-C-N 121.23 -0.919 . . . . 10.0 111.178 -177.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.6 mm-40 -64.52 109.98 2.15 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 109.739 -0.467 . . . . 10.0 109.739 173.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -71.96 78.55 0.64 Allowed Glycine 0 CA--C 1.526 0.758 0 N-CA-C 111.007 -0.837 . . . . 10.0 111.007 178.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.251 1.137 0 CA-C-O 117.225 -1.369 . . . . 10.0 110.447 169.348 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.794 0 N-CA-C 108.467 -0.938 . . . . 10.0 108.467 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 12.6 mm-40 -116.34 125.87 52.72 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 -178.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -92.27 99.92 12.61 Favored 'General case' 0 C--N 1.339 0.152 0 C-N-CA 123.818 0.847 . . . . 10.0 109.493 176.506 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.472 ' HB2' HD11 ' A' ' 70' ' ' ILE . 1.4 mtpt -134.35 175.62 9.35 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 117.963 0.347 . . . . 10.0 110.111 -175.411 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -117.69 119.38 34.78 Favored 'General case' 0 N--CA 1.445 -0.709 0 N-CA-C 109.37 -0.604 . . . . 10.0 109.37 177.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 13.5 mt -75.95 111.83 11.74 Favored 'General case' 0 N--CA 1.448 -0.553 0 N-CA-C 104.857 -2.275 . . . . 10.0 104.857 169.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.32 121.62 14.2 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 107.134 -1.432 . . . . 10.0 107.134 175.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.727 HG21 HG11 ' A' ' 20' ' ' VAL . 24.8 t -122.84 143.35 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.643 0 C-N-CA 127.156 2.182 . . . . 10.0 108.5 -177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -116.47 117.13 29.06 Favored 'General case' 0 N--CA 1.446 -0.642 0 C-N-CA 125.844 1.657 . . . . 10.0 107.125 179.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -64.62 134.01 38.24 Favored Glycine 0 CA--C 1.529 0.91 0 N-CA-C 110.534 -1.026 . . . . 10.0 110.534 -178.368 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -140.23 155.65 46.8 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.82 0.848 . . . . 10.0 109.19 -175.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.5 t 77.96 -175.51 0.09 Allowed 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 126.525 1.93 . . . . 10.0 112.038 178.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 59.1 m -60.91 -41.53 96.31 Favored 'General case' 0 CA--C 1.522 -0.129 0 C-N-CA 124.326 1.05 . . . . 10.0 110.668 -176.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -142.22 -77.4 0.26 Allowed 'General case' 0 N--CA 1.451 -0.396 0 CA-C-O 118.843 -0.599 . . . . 10.0 109.43 179.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.6 t-160 70.65 -52.21 0.67 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.811 1.645 . . . . 10.0 111.732 -178.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 55.5 m 53.45 31.74 12.71 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 126.622 1.969 . . . . 10.0 108.373 -168.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 HD23 ' A' ' 37' ' ' LEU . 27.7 m 32.57 39.15 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.281 0 C-N-CA 128.151 2.581 . . . . 10.0 112.251 -171.83 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.2 mtmp? -62.95 -21.65 66.23 Favored 'General case' 0 C--O 1.223 -0.319 0 C-N-CA 119.367 -0.933 . . . . 10.0 112.876 -168.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -48.32 -46.76 36.77 Favored 'General case' 0 CA--C 1.54 0.579 0 O-C-N 121.039 -1.038 . . . . 10.0 110.96 167.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.727 HG11 HG21 ' A' ' 8' ' ' VAL . 41.9 t -59.5 -30.47 44.57 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.166 0 C-N-CA 125.251 1.42 . . . . 10.0 111.258 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . 0.252 0.0 OUTLIER -89.63 -56.95 3.05 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 108.931 -0.766 . . . . 10.0 108.931 179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 27.9 m -60.48 -59.91 4.65 Favored 'General case' 0 N--CA 1.444 -0.751 0 C-N-CA 124.706 1.202 . . . . 10.0 111.48 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -61.35 -53.91 50.61 Favored 'General case' 0 C--N 1.339 0.118 0 CA-C-N 118.68 0.673 . . . . 10.0 110.435 -169.674 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.504 HG22 HG22 ' A' ' 56' ' ' ILE . 74.6 t -59.35 -44.26 92.01 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.009 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 176.096 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -53.06 -14.79 3.05 Favored Glycine 0 CA--C 1.53 0.98 0 CA-C-O 118.034 -1.426 . . . . 10.0 114.876 171.626 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -87.22 -20.2 27.26 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 120.095 1.947 . . . . 10.0 109.293 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 74.5 mt -68.27 128.59 37.13 Favored 'General case' 0 N--CA 1.435 -1.175 0 O-C-N 121.706 -0.622 . . . . 10.0 111.004 -175.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -46.99 -39.41 12.45 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 124.912 1.285 . . . . 10.0 111.901 173.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.37 -9.24 86.94 Favored Glycine 0 CA--C 1.533 1.194 0 CA-C-N 113.857 -1.519 . . . . 10.0 114.556 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.47 161.32 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 120.385 2.093 . . . . 10.0 112.048 175.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 t -140.96 -45.22 0.39 Allowed 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 124.626 1.17 . . . . 10.0 111.421 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.99 151.49 42.55 Favored 'General case' 0 N--CA 1.467 0.383 0 N-CA-C 108.354 -0.98 . . . . 10.0 108.354 173.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 22.5 m -144.4 58.04 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 124.546 1.138 . . . . 10.0 110.516 -177.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -80.05 79.77 6.55 Favored 'General case' 0 CA--C 1.529 0.142 0 O-C-N 120.757 -1.214 . . . . 10.0 110.44 -169.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -58.79 118.68 2.66 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 C-N-CA 123.61 0.764 . . . . 10.0 110.584 177.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 53.5 m-20 -144.65 64.67 1.29 Allowed 'General case' 0 C--O 1.233 0.195 0 N-CA-C 107.054 -1.461 . . . . 10.0 107.054 173.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.554 HD12 ' N ' ' A' ' 38' ' ' GLU . 0.3 OUTLIER -56.04 -26.82 50.65 Favored 'General case' 0 CA--C 1.533 0.301 0 O-C-N 121.185 -0.947 . . . . 10.0 111.874 178.401 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.554 ' N ' HD12 ' A' ' 37' ' ' LEU . 38.8 mt-10 -63.34 -31.55 72.74 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.815 0.846 . . . . 10.0 110.195 177.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -81.26 -10.9 59.51 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 123.25 0.62 . . . . 10.0 111.351 174.318 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 74.44 20.72 79.51 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 109.743 -1.343 . . . . 10.0 109.743 -173.514 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 17.6 mttt -151.63 117.79 5.58 Favored 'General case' 0 N--CA 1.441 -0.883 0 C-N-CA 123.703 0.801 . . . . 10.0 109.708 -168.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.606 HG22 HG13 ' A' ' 44' ' ' VAL . 1.9 p -96.27 126.47 48.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.56 0 N-CA-C 104.604 -2.369 . . . . 10.0 104.604 167.186 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -91.84 93.52 8.88 Favored 'General case' 0 N--CA 1.462 0.166 0 N-CA-C 106.879 -1.526 . . . . 10.0 106.879 177.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.606 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -109.43 108.07 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.538 0 CA-C-O 122.759 1.266 . . . . 10.0 109.013 -173.019 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.1 m -99.5 112.92 25.05 Favored 'General case' 0 N--CA 1.432 -1.367 0 C-N-CA 125.426 1.49 . . . . 10.0 107.379 -178.672 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.476 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 1.4 p90 -148.87 159.26 44.34 Favored 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 122.277 1.037 . . . . 10.0 113.558 -171.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -83.82 79.77 9.36 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-O 122.234 1.016 . . . . 10.0 112.337 -173.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.09 -27.98 1.58 Allowed 'General case' 0 CA--C 1.536 0.442 0 CA-C-N 113.796 -1.547 . . . . 10.0 113.321 170.516 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.5 t70 -66.24 -56.6 10.46 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 118.346 0.521 . . . . 10.0 110.618 -178.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 35.7 tttp -79.95 -39.23 30.68 Favored 'General case' 0 N--CA 1.454 -0.252 0 O-C-N 121.798 -0.564 . . . . 10.0 110.639 -175.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -129.3 107.67 15.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.435 0 N-CA-C 107.173 -1.417 . . . . 10.0 107.173 -179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.5 p -68.16 152.81 44.93 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-O 121.49 0.662 . . . . 10.0 109.809 -171.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.446 HG11 HG21 ' A' ' 70' ' ' ILE . 5.7 t -41.18 -44.76 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.103 1.361 . . . . 10.0 112.539 175.782 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.78 -49.78 67.51 Favored 'General case' 0 N--CA 1.446 -0.672 0 N-CA-C 109.681 -0.489 . . . . 10.0 109.681 174.729 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -58.84 -41.03 85.98 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.217 1.007 . . . . 10.0 109.972 178.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.504 HG22 HG22 ' A' ' 24' ' ' VAL . 15.3 mm -63.3 -45.09 99.15 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.624 0 O-C-N 121.684 -0.635 . . . . 10.0 109.636 178.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.87 -43.92 97.74 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 108.602 -0.888 . . . . 10.0 108.602 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -59.06 -38.52 79.59 Favored 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 109.893 -0.41 . . . . 10.0 109.893 179.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.03 -29.51 63.44 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 112.791 0.663 . . . . 10.0 112.791 175.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.27 -48.83 71.62 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.762 0 N-CA-C 107.772 -1.196 . . . . 10.0 107.772 169.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 9.3 mt-10 -57.59 -29.82 64.78 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 119.208 0.913 . . . . 10.0 111.91 -178.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -56.95 -35.64 69.34 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-O 121.005 0.431 . . . . 10.0 110.689 174.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.4 mt-30 -100.0 -69.67 0.76 Allowed 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.802 1.241 . . . . 10.0 112.732 179.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -114.26 -143.27 8.27 Favored Glycine 0 CA--C 1.525 0.686 0 C-N-CA 126.123 1.821 . . . . 10.0 109.314 -173.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 10.4 p90 -164.9 51.99 0.11 Allowed 'General case' 0 N--CA 1.463 0.203 0 CA-C-N 119.085 1.443 . . . . 10.0 109.995 177.423 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -127.8 68.15 1.32 Allowed 'General case' 0 N--CA 1.454 -0.225 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 -172.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.6 p -155.54 78.8 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-N 118.428 0.558 . . . . 10.0 112.18 -178.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -37.48 -66.55 0.24 Allowed 'General case' 0 CA--C 1.545 0.755 0 C-N-CA 123.637 0.775 . . . . 10.0 112.875 172.236 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 17.8 mtpt 162.04 171.04 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.907 2.083 . . . . 10.0 113.023 169.064 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.472 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.8 OUTLIER -67.04 129.12 31.32 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 O-C-N 122.194 -0.316 . . . . 10.0 110.647 -179.199 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -103.66 179.87 4.15 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 124.059 0.943 . . . . 10.0 109.469 175.292 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 77.62 -54.76 3.73 Favored Glycine 0 CA--C 1.532 1.148 0 CA-C-O 119.497 -0.613 . . . . 10.0 112.04 -176.989 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 65.4 mtp180 . . . . . 0 C--O 1.248 0.991 0 C-N-CA 126.976 2.111 . . . . 10.0 111.191 -168.967 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.47 0.553 0 N-CA-C 106.201 -1.778 . . . . 10.0 106.201 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.76 113.43 24.97 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 107.784 -1.191 . . . . 10.0 107.784 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 22.2 mp0 -62.04 108.18 1.0 Allowed 'General case' 0 C--O 1.233 0.205 0 N-CA-C 108.329 -0.989 . . . . 10.0 108.329 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.498 ' CB ' HD11 ' A' ' 70' ' ' ILE . 17.7 mtpp -127.59 173.13 10.13 Favored 'General case' 0 CA--C 1.528 0.123 0 CA-C-N 118.852 0.751 . . . . 10.0 110.129 172.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.5 m -119.01 116.52 26.59 Favored 'General case' 0 N--CA 1.444 -0.755 0 C-N-CA 123.074 0.55 . . . . 10.0 109.932 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.423 HD23 ' N ' ' A' ' 70' ' ' ILE . 9.8 mt -78.34 110.83 13.73 Favored 'General case' 0 N--CA 1.453 -0.281 0 N-CA-C 106.222 -1.77 . . . . 10.0 106.222 170.082 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.97 116.82 3.43 Favored 'General case' 0 N--CA 1.448 -0.546 0 N-CA-C 106.211 -1.774 . . . . 10.0 106.211 172.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.677 HG21 HG11 ' A' ' 20' ' ' VAL . 26.4 t -122.87 146.98 27.29 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 C-N-CA 125.328 1.451 . . . . 10.0 107.77 177.127 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -129.01 5.19 5.35 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 113.635 0.976 . . . . 10.0 113.635 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 52.45 -155.26 5.03 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 124.218 0.913 . . . . 10.0 111.875 -172.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 6.2 mtm -117.93 -84.25 0.65 Allowed 'General case' 0 N--CA 1.456 -0.142 0 C-N-CA 123.79 0.836 . . . . 10.0 109.859 171.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -162.73 67.5 0.22 Allowed 'General case' 0 CA--C 1.53 0.187 0 O-C-N 121.716 -0.615 . . . . 10.0 110.133 -173.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.8 t 70.88 135.88 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.898 1.679 . . . . 10.0 112.125 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 69.1 162.89 0.22 Allowed 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.838 1.255 . . . . 10.0 110.764 -177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.3 t-80 53.48 32.32 13.86 Favored 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.636 0.774 . . . . 10.0 111.441 -177.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 2.0 m -96.44 -93.25 0.21 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 125.183 1.393 . . . . 10.0 109.692 -168.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.7 m -60.23 162.76 1.1 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.416 0 N-CA-C 107.987 -1.116 . . . . 10.0 107.987 171.416 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . 0.304 0.0 OUTLIER 72.38 -53.19 0.7 Allowed 'General case' 0 CA--C 1.532 0.252 0 O-C-N 121.419 -0.8 . . . . 10.0 112.078 -169.847 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.6 -39.68 81.12 Favored 'General case' 0 CA--C 1.529 0.135 0 CA-C-N 119.163 0.892 . . . . 10.0 110.741 -178.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.677 HG11 HG21 ' A' ' 8' ' ' VAL . 31.1 t -90.5 -28.31 4.95 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.386 0 C-N-CA 124.292 1.037 . . . . 10.0 110.224 176.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -78.14 -65.92 0.91 Allowed 'General case' 0 C--N 1.338 0.087 0 C-N-CA 122.912 0.485 . . . . 10.0 110.106 -172.755 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 8.4 m -52.84 -40.3 63.25 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 124.963 1.305 . . . . 10.0 110.134 -172.39 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 15.4 m -59.51 -51.73 68.6 Favored 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 124.442 1.097 . . . . 10.0 110.671 -174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.594 ' CG2' HD11 ' A' ' 60' ' ' ILE . 78.9 t -65.76 -42.52 92.58 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.862 0 N-CA-C 108.597 -0.89 . . . . 10.0 108.597 173.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.28 -11.8 3.76 Favored Glycine 0 CA--C 1.533 1.211 0 C-N-CA 125.666 1.603 . . . . 10.0 115.307 174.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -83.96 -23.63 31.0 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 119.711 1.756 . . . . 10.0 108.269 179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 64.6 mt -72.55 119.07 16.26 Favored 'General case' 0 N--CA 1.434 -1.265 0 O-C-N 121.604 -0.685 . . . . 10.0 110.394 -174.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -48.94 -36.37 17.22 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 122.169 0.985 . . . . 10.0 112.18 171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.31 -9.26 77.0 Favored Glycine 0 CA--C 1.537 1.461 0 C-N-CA 124.934 1.254 . . . . 10.0 114.364 178.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG21 HG12 ' A' ' 24' ' ' VAL . 0.4 OUTLIER -68.57 167.64 1.63 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 CA-C-N 119.58 1.69 . . . . 10.0 111.957 174.089 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 35.1 t -138.26 -50.21 0.57 Allowed 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.622 1.169 . . . . 10.0 110.847 172.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -129.55 145.03 51.51 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 118.163 -0.922 . . . . 10.0 108.643 -179.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.55 56.6 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 C-N-CA 124.511 1.124 . . . . 10.0 110.778 -176.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.3 t-80 -85.28 78.79 9.71 Favored 'General case' 0 N--CA 1.452 -0.325 0 O-C-N 120.27 -1.519 . . . . 10.0 108.717 -172.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -61.95 123.71 15.17 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.869 0 CA-C-N 115.829 -0.623 . . . . 10.0 110.727 178.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -145.75 59.78 1.26 Allowed 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 106.593 -1.632 . . . . 10.0 106.593 174.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.3 pp -61.79 -21.56 64.69 Favored 'General case' 0 CA--C 1.532 0.26 0 O-C-N 121.567 -0.708 . . . . 10.0 111.586 177.066 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -61.06 -37.61 83.28 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 123.74 0.816 . . . . 10.0 109.563 172.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.83 -16.81 37.51 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.514 0.726 . . . . 10.0 110.845 176.178 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.52 39.26 61.28 Favored Glycine 0 CA--C 1.523 0.556 0 N-CA-C 109.12 -1.592 . . . . 10.0 109.12 -176.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -158.1 95.71 1.4 Allowed 'General case' 0 CA--C 1.532 0.258 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 178.798 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -86.85 120.09 35.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 106.899 -1.519 . . . . 10.0 106.899 173.927 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -86.32 99.92 11.93 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 119.714 1.143 . . . . 10.0 108.266 179.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.5 ' HB ' ' CE2' ' A' ' 46' ' ' PHE . 2.5 m -115.39 106.77 21.16 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.011 0 CA-C-O 122.102 0.953 . . . . 10.0 108.753 -175.349 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 10.2 t -99.73 114.72 28.03 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.578 -1.638 . . . . 10.0 106.578 176.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.687 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -146.8 154.01 40.86 Favored 'General case' 0 N--CA 1.448 -0.547 0 O-C-N 124.034 0.834 . . . . 10.0 113.152 -174.39 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.2 t0 -83.91 94.43 8.24 Favored 'General case' 0 C--O 1.237 0.413 0 CA-C-O 121.894 0.854 . . . . 10.0 112.095 -171.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -59.1 -17.02 22.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 CA-C-N 114.695 -1.139 . . . . 10.0 113.73 174.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -63.91 -52.18 61.08 Favored 'General case' 0 C--N 1.342 0.263 0 CA-C-N 120.229 1.377 . . . . 10.0 110.2 179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -87.04 -48.83 7.77 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 109.004 -0.739 . . . . 10.0 109.004 -173.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -125.83 99.4 5.82 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.656 -1.239 . . . . 10.0 107.656 -177.11 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.55 148.66 32.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 N-CA-C 109.288 -0.634 . . . . 10.0 109.288 -176.157 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.621 HG11 HG21 ' A' ' 70' ' ' ILE . 14.7 t -36.7 -46.06 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.104 1.362 . . . . 10.0 113.866 173.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 38.9 tttt -51.32 -58.58 5.82 Favored 'General case' 0 C--O 1.221 -0.399 0 N-CA-C 109.524 -0.547 . . . . 10.0 109.524 172.091 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 5.6 t0 -44.72 -44.8 9.46 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.486 1.514 . . . . 10.0 109.824 175.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.687 HG21 ' CE2' ' A' ' 46' ' ' PHE . 12.0 mm -65.43 -47.41 86.93 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 O-C-N 121.251 -0.906 . . . . 10.0 110.772 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -57.85 -46.83 84.21 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 108.328 -0.99 . . . . 10.0 108.328 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 35.2 m-20 -55.87 -39.47 71.56 Favored 'General case' 0 N--CA 1.442 -0.86 0 CA-C-N 115.46 -0.791 . . . . 10.0 109.128 178.777 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.38 -35.57 70.15 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 113.045 0.757 . . . . 10.0 113.045 174.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.741 HD13 HG21 ' A' ' 67' ' ' VAL . 3.1 mp -66.01 -46.21 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.826 0 CA-C-N 120.398 1.454 . . . . 10.0 107.616 169.318 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -60.02 -26.19 65.9 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-N 118.585 0.63 . . . . 10.0 112.011 -176.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -57.54 -33.44 68.11 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 123.37 0.668 . . . . 10.0 110.766 174.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 31.9 tt0 -110.39 -63.79 1.34 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.168 1.387 . . . . 10.0 112.086 -175.253 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -106.8 -159.16 21.64 Favored Glycine 0 CA--C 1.526 0.76 0 C-N-CA 125.411 1.482 . . . . 10.0 109.412 -178.32 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 90.0 m-85 -151.76 57.16 0.86 Allowed 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 119.182 1.491 . . . . 10.0 108.196 174.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -137.34 61.82 1.6 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 107.816 -1.179 . . . . 10.0 107.816 -167.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.741 HG21 HD13 ' A' ' 60' ' ' ILE . 8.1 p -158.02 64.26 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.453 -0.303 0 O-C-N 121.81 -0.556 . . . . 10.0 111.177 -177.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -25.75 -67.89 0.05 OUTLIER 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.37 1.068 . . . . 10.0 113.224 178.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.4 tttt 171.65 170.33 0.09 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 126.373 1.869 . . . . 10.0 111.909 167.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.621 HG21 HG11 ' A' ' 53' ' ' VAL . 1.3 tp -68.41 140.42 19.05 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 O-C-N 121.847 -0.533 . . . . 10.0 111.103 174.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -120.36 156.72 30.76 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.494 1.118 . . . . 10.0 109.249 173.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 74.4 137.06 0.43 Allowed Glycine 0 CA--C 1.532 1.141 0 N-CA-C 110.091 -1.204 . . . . 10.0 110.091 -169.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . 0.412 ' CA ' ' HE ' ' A' ' 73' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.255 1.352 0 CA-C-O 116.005 -1.95 . . . . 10.0 107.105 -175.527 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.4 ttt . . . . . 0 N--CA 1.472 0.649 0 N-CA-C 107.704 -1.221 . . . . 10.0 107.704 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -124.89 112.7 16.94 Favored 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 120.654 0.264 . . . . 10.0 110.65 -169.253 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -64.07 108.7 1.6 Allowed 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 172.864 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 41.9 mttm -134.62 168.47 18.93 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-O 121.601 0.715 . . . . 10.0 110.509 174.863 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.404 HG23 ' H ' ' A' ' 42' ' ' VAL . 22.9 m -113.54 107.64 16.08 Favored 'General case' 0 N--CA 1.437 -1.124 0 CA-C-N 115.931 -0.577 . . . . 10.0 109.638 178.695 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.7 mt -77.27 79.26 3.79 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 108.973 -0.751 . . . . 10.0 108.973 170.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -35.74 124.14 0.69 Allowed 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.855 1.262 . . . . 10.0 110.042 173.539 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.457 HG22 ' H ' ' A' ' 10' ' ' GLY . 1.5 p -126.3 133.87 67.77 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.889 0 C-N-CA 126.389 1.875 . . . . 10.0 108.011 -178.795 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -97.85 1.55 48.32 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 113.488 0.922 . . . . 10.0 113.488 177.753 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.457 ' H ' HG22 ' A' ' 8' ' ' VAL . . . 58.34 -157.02 19.7 Favored Glycine 0 CA--C 1.53 0.99 0 C-N-CA 124.429 1.014 . . . . 10.0 111.504 -173.992 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 179.36 -84.75 0.0 OUTLIER 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 125.94 1.696 . . . . 10.0 108.213 176.376 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 40.4 t -163.71 -53.6 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.212 0 C-N-CA 123.846 0.858 . . . . 10.0 109.815 -173.704 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 55.3 m -53.74 87.78 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.215 0 C-N-CA 125.628 1.571 . . . . 10.0 111.677 -177.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.5 mp0 52.34 46.9 25.82 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 123.543 0.737 . . . . 10.0 109.024 -172.1 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.416 ' CD2' HD13 ' A' ' 37' ' ' LEU . 9.2 t-160 -68.03 69.65 0.13 Allowed 'General case' 0 N--CA 1.456 -0.14 0 C-N-CA 124.898 1.279 . . . . 10.0 108.527 170.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 74.6 m -153.76 172.79 16.75 Favored 'General case' 0 N--CA 1.443 -0.788 0 C-N-CA 125.797 1.639 . . . . 10.0 107.195 -175.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 52.2 t -75.8 79.4 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.641 0 CA-C-N 114.843 -1.071 . . . . 10.0 109.835 -178.991 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.01 -40.75 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 125.175 1.39 . . . . 10.0 113.907 168.873 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.95 -55.82 29.63 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 120.898 -1.126 . . . . 10.0 110.654 -175.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 ' HB ' HG21 ' A' ' 35' ' ' VAL . 94.8 t -70.43 -10.28 13.61 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 C-N-CA 124.357 1.063 . . . . 10.0 110.49 -179.597 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -80.89 -71.54 0.46 Allowed 'General case' 0 C--N 1.344 0.348 0 N-CA-C 107.382 -1.34 . . . . 10.0 107.382 173.269 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 3.3 p -36.39 -47.81 0.62 Allowed 'General case' 0 C--O 1.224 -0.271 0 C-N-CA 126.44 1.896 . . . . 10.0 112.474 -174.521 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 28.3 m -56.57 -57.81 10.74 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 124.18 0.992 . . . . 10.0 111.561 -177.767 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.848 HG22 HG22 ' A' ' 56' ' ' ILE . 49.4 t -66.28 -40.74 87.61 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.029 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.75 0.71 1.48 Allowed Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.788 1.661 . . . . 10.0 115.197 173.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -83.1 -32.46 26.73 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 120.199 1.999 . . . . 10.0 108.608 173.028 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.429 HD12 HG23 ' A' ' 56' ' ' ILE . 66.5 mt -72.73 119.22 16.65 Favored 'General case' 0 N--CA 1.437 -1.081 0 O-C-N 121.992 -0.442 . . . . 10.0 110.753 -171.231 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -51.49 -34.47 36.01 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-O 122.112 0.958 . . . . 10.0 112.121 172.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.87 -6.1 71.8 Favored Glycine 0 CA--C 1.537 1.412 0 C-N-CA 124.828 1.204 . . . . 10.0 114.27 178.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.522 HG21 HG12 ' A' ' 24' ' ' VAL . 0.3 OUTLIER -67.25 162.75 3.06 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 CA-C-N 119.566 1.683 . . . . 10.0 111.771 169.883 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.9 t -134.67 -44.96 0.74 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.562 1.145 . . . . 10.0 111.563 -178.679 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -138.37 148.68 44.8 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 124.43 1.092 . . . . 10.0 108.289 177.054 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.5 m -146.16 55.85 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 CA-C-O 122.122 0.963 . . . . 10.0 111.504 -174.355 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -83.91 70.55 10.44 Favored 'General case' 0 N--CA 1.456 -0.162 0 O-C-N 120.383 -1.448 . . . . 10.0 108.948 -177.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.413 HG21 ' HB ' ' A' ' 20' ' ' VAL . 0.6 OUTLIER -61.57 124.61 16.36 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 O-C-N 121.742 -0.599 . . . . 10.0 110.078 173.167 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 28.9 m120 -141.01 62.18 1.48 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.47 -1.678 . . . . 10.0 106.47 169.772 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.509 HD12 ' N ' ' A' ' 38' ' ' GLU . 2.8 pp -57.34 -25.35 59.24 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.442 -0.799 . . . . 10.0 111.699 176.614 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.509 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.5 tt0 -60.39 -36.51 78.28 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.463 1.105 . . . . 10.0 109.66 175.328 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.96 -28.96 19.9 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.213 1.005 . . . . 10.0 110.729 177.13 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 99.52 13.03 39.48 Favored Glycine 0 CA--C 1.53 1.017 0 C-N-CA 124.862 1.22 . . . . 10.0 111.851 177.967 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.09 123.61 26.05 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 106.641 -1.614 . . . . 10.0 106.641 178.928 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.546 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -112.46 105.38 18.69 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.521 0 C-N-CA 126.159 1.783 . . . . 10.0 107.909 173.355 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -78.16 93.8 4.62 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 108.38 -0.97 . . . . 10.0 108.38 -178.602 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.546 HG13 HG22 ' A' ' 42' ' ' VAL . 0.5 OUTLIER -109.96 109.31 27.94 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.859 0 C-N-CA 124.426 1.09 . . . . 10.0 109.396 -179.819 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.8 t -100.4 123.29 44.43 Favored 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 105.941 -1.874 . . . . 10.0 105.941 174.782 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.511 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.4 OUTLIER -150.08 160.97 43.24 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 116.044 -0.525 . . . . 10.0 111.686 -173.923 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.77 86.82 5.23 Favored 'General case' 0 C--O 1.236 0.367 0 CA-C-O 122.381 1.086 . . . . 10.0 112.484 -172.401 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.01 -27.01 6.83 Favored 'General case' 0 N--CA 1.453 -0.28 0 CA-C-N 113.977 -1.465 . . . . 10.0 113.392 177.368 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -43.22 -55.68 3.85 Favored 'General case' 0 CA--C 1.529 0.149 0 C-N-CA 124.483 1.113 . . . . 10.0 111.377 171.518 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 72.3 tttt -99.01 -39.59 8.46 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.037 -0.528 . . . . 10.0 110.991 -169.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.2 m -131.26 101.64 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.115 -1.439 . . . . 10.0 107.115 178.662 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -59.43 149.85 28.26 Favored 'General case' 0 N--CA 1.45 -0.474 0 O-C-N 121.504 -0.748 . . . . 10.0 109.654 -177.104 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.418 HG13 ' H ' ' A' ' 53' ' ' VAL . 2.0 m -36.67 -44.82 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 125.082 1.353 . . . . 10.0 114.042 172.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -60.11 -50.87 72.0 Favored 'General case' 0 C--O 1.217 -0.652 0 CA-C-O 118.645 -0.693 . . . . 10.0 109.663 174.961 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -47.54 -43.58 25.12 Favored 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 124.334 1.053 . . . . 10.0 110.151 175.504 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.848 HG22 HG22 ' A' ' 24' ' ' VAL . 3.1 mm -65.61 -43.55 93.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.486 0 O-C-N 121.227 -0.921 . . . . 10.0 111.025 177.753 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.68 -44.27 90.17 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 177.311 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -59.22 -41.73 89.32 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 179.462 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -56.19 -31.97 63.93 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.994 0.738 . . . . 10.0 112.994 172.628 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.519 HD11 ' CG2' ' A' ' 24' ' ' VAL . 2.1 mp -64.84 -46.02 93.2 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 CA-C-N 120.647 1.567 . . . . 10.0 108.693 169.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -61.85 -28.57 69.58 Favored 'General case' 0 CA--C 1.533 0.326 0 N-CA-C 112.202 0.445 . . . . 10.0 112.202 -178.201 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -55.17 -31.77 61.63 Favored 'General case' 0 CA--C 1.537 0.464 0 O-C-N 121.96 -0.462 . . . . 10.0 111.878 171.932 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 17.3 tt0 -108.45 -65.81 1.1 Allowed 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 123.781 0.832 . . . . 10.0 111.447 -176.473 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -110.19 -155.63 15.12 Favored Glycine 0 C--N 1.336 0.583 0 N-CA-C 108.438 -1.865 . . . . 10.0 108.438 -175.619 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 59.9 m-85 -148.72 54.52 1.0 Allowed 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 119.286 1.543 . . . . 10.0 107.33 172.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -131.16 65.44 1.56 Allowed 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 107.038 -1.468 . . . . 10.0 107.038 -168.396 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.401 ' O ' HG13 ' A' ' 67' ' ' VAL . 8.5 p -150.62 96.65 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.126 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -54.69 -75.91 0.03 OUTLIER 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.76 -0.654 . . . . 10.0 109.362 167.755 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 6.3 tttt 171.7 -174.41 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.369 1.068 . . . . 10.0 112.801 177.142 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 mm -68.3 120.0 15.01 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.193 0 O-C-N 121.801 -0.562 . . . . 10.0 109.722 179.17 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.98 96.53 4.37 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 107.403 -1.332 . . . . 10.0 107.403 176.774 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 83.73 165.6 38.82 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 122.239 0.911 . . . . 10.0 112.677 178.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 . . . . . 0 C--O 1.253 1.287 0 N-CA-C 106.679 -1.6 . . . . 10.0 106.679 168.548 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 8.0 ttt . . . . . 0 N--CA 1.472 0.661 0 CA-C-O 121.133 0.492 . . . . 10.0 111.841 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -137.8 97.12 3.35 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 125.991 1.716 . . . . 10.0 107.983 178.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -70.07 98.63 1.34 Allowed 'General case' 0 N--CA 1.45 -0.47 0 C-N-CA 124.746 1.218 . . . . 10.0 109.854 174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.638 ' HB3' HD11 ' A' ' 70' ' ' ILE . 39.7 mttt -135.7 166.51 23.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 123.193 0.597 . . . . 10.0 109.733 177.942 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -114.21 117.24 30.61 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 124.093 0.957 . . . . 10.0 108.827 175.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.474 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 12.2 mt -78.59 104.37 9.15 Favored 'General case' 0 C--O 1.214 -0.775 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 170.102 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.463 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -53.53 118.41 3.86 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 120.035 1.289 . . . . 10.0 108.564 175.942 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.413 HG21 HG11 ' A' ' 20' ' ' VAL . 38.4 t -104.39 131.65 52.8 Favored 'Isoleucine or valine' 0 C--O 1.231 0.114 0 C-N-CA 124.974 1.31 . . . . 10.0 109.869 177.192 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -113.75 74.04 0.85 Allowed 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.594 -1.632 . . . . 10.0 106.594 177.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -88.23 125.02 7.46 Favored Glycine 0 CA--C 1.521 0.452 0 N-CA-C 111.856 -0.497 . . . . 10.0 111.856 -172.037 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 4.2 ttt -80.88 49.5 1.23 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.341 0.657 . . . . 10.0 112.442 -169.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.1 t 42.68 67.39 0.62 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.048 1.339 . . . . 10.0 112.804 172.403 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 39.2 t -143.68 124.96 14.6 Favored 'General case' 0 N--CA 1.457 -0.112 0 O-C-N 121.713 -0.617 . . . . 10.0 109.91 -176.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -63.78 -16.97 62.56 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 112.752 0.649 . . . . 10.0 112.752 -172.883 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 62.3 m80 -72.68 -27.84 62.33 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 122.844 0.457 . . . . 10.0 111.303 172.577 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 92.2 m -78.02 -155.58 0.08 Allowed 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 174.169 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.5 t 73.62 -68.01 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 127.123 2.169 . . . . 10.0 105.952 -173.082 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 6.3 ptmt -63.61 -44.79 92.94 Favored 'General case' 0 N--CA 1.442 -0.861 0 CA-C-N 115.348 -0.842 . . . . 10.0 112.781 178.049 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.46 -52.7 44.21 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 119.296 0.953 . . . . 10.0 109.574 179.874 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.413 HG11 HG21 ' A' ' 8' ' ' VAL . 16.9 t -60.21 -31.38 48.08 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.395 0 C-N-CA 125.15 1.38 . . . . 10.0 110.873 178.889 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -75.39 -72.85 0.28 Allowed 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 124.31 1.044 . . . . 10.0 108.513 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 18.7 m -43.0 -44.8 4.83 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 126.991 2.116 . . . . 10.0 111.487 -175.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 73.7 m -54.1 -51.34 64.47 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.523 0.678 . . . . 10.0 111.063 -175.283 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.716 HG22 HG22 ' A' ' 56' ' ' ILE . 75.1 t -72.38 -44.04 63.35 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.25 0 N-CA-C 108.666 -0.864 . . . . 10.0 108.666 176.074 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -55.17 -12.73 4.32 Favored Glycine 0 CA--C 1.534 1.275 0 C-N-CA 125.268 1.413 . . . . 10.0 115.163 176.405 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -83.36 -25.63 31.24 Favored 'General case' 0 N--CA 1.453 -0.275 0 CA-C-N 118.989 1.394 . . . . 10.0 108.465 -179.394 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.747 HD13 HD12 ' A' ' 56' ' ' ILE . 78.4 mt -62.47 122.71 16.44 Favored 'General case' 0 N--CA 1.433 -1.318 0 CA-C-O 121.383 0.611 . . . . 10.0 111.801 -176.073 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -45.27 -35.99 3.75 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 125.647 1.579 . . . . 10.0 112.286 169.344 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -87.92 -2.18 81.48 Favored Glycine 0 CA--C 1.536 1.363 0 C-N-CA 125.273 1.416 . . . . 10.0 114.891 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -64.04 156.99 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 CA-C-N 120.55 2.175 . . . . 10.0 111.466 175.523 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.0 t -130.35 -47.04 1.09 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.139 0.976 . . . . 10.0 110.912 176.496 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -141.6 146.04 35.77 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 178.296 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 33.7 m -143.33 58.81 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 124.658 1.183 . . . . 10.0 110.91 -176.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 16.9 m-70 -79.28 76.03 5.84 Favored 'General case' 0 N--CA 1.457 -0.124 0 O-C-N 120.589 -1.319 . . . . 10.0 108.87 -177.816 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -61.59 120.7 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 C-N-CA 124.214 1.005 . . . . 10.0 109.732 173.917 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 16.6 m120 -143.71 57.55 1.36 Allowed 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.191 -1.411 . . . . 10.0 107.191 172.086 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -56.49 -28.55 60.11 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.199 -0.455 . . . . 10.0 110.999 -179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -59.57 -35.83 75.03 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.737 1.215 . . . . 10.0 110.083 176.327 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -86.05 -7.77 58.39 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.413 1.085 . . . . 10.0 111.523 178.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 71.82 38.78 60.46 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 109.943 -1.263 . . . . 10.0 109.943 -176.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.2 mttp -158.35 155.57 28.98 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 123.514 0.725 . . . . 10.0 109.263 176.444 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.56 HG22 HG13 ' A' ' 44' ' ' VAL . 1.3 p -146.38 118.68 2.0 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 103.617 -2.734 . . . . 10.0 103.617 172.373 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -88.34 108.39 19.32 Favored 'General case' 0 CA--C 1.516 -0.349 0 N-CA-C 106.422 -1.695 . . . . 10.0 106.422 172.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.56 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -121.09 90.21 1.56 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.067 0 N-CA-C 106.933 -1.506 . . . . 10.0 106.933 -176.737 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.9 t -83.73 108.66 16.93 Favored 'General case' 0 N--CA 1.441 -0.88 0 N-CA-C 105.982 -1.858 . . . . 10.0 105.982 174.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.584 ' CD2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -129.37 178.21 6.62 Favored 'General case' 0 N--CA 1.448 -0.575 0 CA-C-N 115.05 -0.977 . . . . 10.0 110.431 -176.261 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -106.14 89.88 3.19 Favored 'General case' 0 CA--C 1.518 -0.252 0 O-C-N 121.135 -0.978 . . . . 10.0 113.481 -176.408 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -51.88 -33.04 34.83 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 113.772 -1.558 . . . . 10.0 112.38 177.13 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -66.13 -50.41 64.09 Favored 'General case' 0 CA--C 1.531 0.228 0 C-N-CA 122.802 0.441 . . . . 10.0 110.602 -178.306 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -78.23 -37.86 44.33 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 109.534 -0.543 . . . . 10.0 109.534 -176.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.479 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -142.59 111.08 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 124.697 1.199 . . . . 10.0 108.104 -177.228 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 1.1 p -70.84 149.84 46.4 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 121.115 -0.991 . . . . 10.0 110.516 -172.16 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.504 HG13 HD13 ' A' ' 70' ' ' ILE . 4.3 t -31.11 -49.54 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.885 0 C-N-CA 125.8 1.64 . . . . 10.0 114.022 172.727 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 33.3 ttmt -50.86 -62.32 1.68 Allowed 'General case' 0 C--O 1.217 -0.614 0 N-CA-C 108.881 -0.785 . . . . 10.0 108.881 173.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -42.65 -42.26 3.39 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.104 0.962 . . . . 10.0 110.609 177.894 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.747 HD12 HD13 ' A' ' 27' ' ' LEU . 1.7 mm -70.29 -44.22 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.677 0 O-C-N 121.588 -0.695 . . . . 10.0 110.628 -177.436 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -61.57 -50.74 71.41 Favored 'General case' 0 N--CA 1.449 -0.512 0 N-CA-C 108.566 -0.902 . . . . 10.0 108.566 179.029 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -55.78 -38.78 70.37 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.902 1.281 . . . . 10.0 108.997 -178.954 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.12 -37.41 71.94 Favored 'General case' 0 N--CA 1.453 -0.313 0 O-C-N 121.91 -0.493 . . . . 10.0 112.271 175.139 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.7 mp -64.19 -44.35 97.48 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 CA-C-N 119.798 1.181 . . . . 10.0 108.141 170.244 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -59.82 -30.14 68.73 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 118.453 0.569 . . . . 10.0 112.425 -178.473 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 10.8 m-20 -62.5 -26.2 68.41 Favored 'General case' 0 CA--C 1.539 0.552 0 O-C-N 121.529 -0.732 . . . . 10.0 111.971 173.241 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.09 -58.19 1.92 Allowed 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.297 1.439 . . . . 10.0 111.685 -170.646 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -133.31 -156.78 8.17 Favored Glycine 0 CA--C 1.525 0.681 0 N-CA-C 108.033 -2.027 . . . . 10.0 108.033 -179.842 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 82.3 m-85 -146.88 56.08 1.13 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 119.468 1.634 . . . . 10.0 109.812 175.924 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -125.64 65.65 1.17 Allowed 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 106.488 -1.671 . . . . 10.0 106.488 -178.723 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -150.07 98.8 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.548 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 171.227 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.463 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -54.14 -73.01 0.05 Allowed 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 115.712 -0.676 . . . . 10.0 110.303 169.298 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER 174.08 173.9 0.17 Allowed 'General case' 0 N--CA 1.473 0.69 0 C-N-CA 125.606 1.562 . . . . 10.0 110.795 169.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.638 HD11 ' HB3' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -66.97 132.55 32.24 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 O-C-N 121.59 -0.694 . . . . 10.0 109.793 175.069 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -82.06 157.04 24.29 Favored 'General case' 0 CA--C 1.531 0.244 0 N-CA-C 109.149 -0.686 . . . . 10.0 109.149 170.692 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -78.16 56.27 3.99 Favored Glycine 0 CA--C 1.53 0.984 0 N-CA-C 110.653 -0.979 . . . . 10.0 110.653 176.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 24.1 mtt-85 . . . . . 0 C--O 1.251 1.141 0 CA-C-O 117.407 -1.282 . . . . 10.0 109.661 -167.58 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.4 ttt . . . . . 0 N--CA 1.473 0.685 0 CA-C-O 118.521 -0.752 . . . . 10.0 109.901 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -131.99 104.17 6.69 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.379 1.072 . . . . 10.0 111.725 -170.113 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.3 pt20 -73.69 104.25 4.55 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.999 1.319 . . . . 10.0 109.902 169.484 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.44 175.45 9.55 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.641 0.776 . . . . 10.0 110.556 172.352 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.4 m -113.83 108.16 16.7 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 124.824 1.25 . . . . 10.0 110.029 175.308 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.7 tp -85.63 73.63 10.41 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 124.497 1.119 . . . . 10.0 109.054 -178.149 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.403 ' HB3' ' HB3' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -35.2 119.36 0.49 Allowed 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 125.268 1.427 . . . . 10.0 111.88 -173.048 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG21 HG11 ' A' ' 20' ' ' VAL . 65.3 t -99.82 123.04 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.564 0 C-N-CA 126.637 1.975 . . . . 10.0 109.987 177.429 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -84.78 133.05 34.36 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 106.399 -1.704 . . . . 10.0 106.399 167.842 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -82.41 99.17 2.04 Favored Glycine 0 CA--C 1.529 0.95 0 CA-C-N 119.267 0.939 . . . . 10.0 111.692 -179.058 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.91 -178.5 3.49 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.407 1.083 . . . . 10.0 108.874 169.962 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 17.0 m 67.61 -58.78 0.42 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 127.173 2.189 . . . . 10.0 113.872 -178.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.9 t 78.6 124.53 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 127.473 2.309 . . . . 10.0 110.539 -174.4 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 28.2 mt-30 69.88 -52.63 0.63 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 126.378 1.871 . . . . 10.0 112.323 -175.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 3.3 t-80 -77.72 51.58 0.93 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.995 1.318 . . . . 10.0 110.667 -178.687 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 31.7 p -161.78 -167.34 1.67 Allowed 'General case' 0 C--O 1.233 0.196 0 C-N-CA 127.02 2.128 . . . . 10.0 107.118 -171.669 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 21.4 t 72.69 -70.28 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.458 -0.056 0 C-N-CA 126.828 2.051 . . . . 10.0 106.32 -171.876 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 8.5 ptmt -62.26 -38.03 87.71 Favored 'General case' 0 N--CA 1.439 -0.979 0 CA-C-N 114.762 -1.108 . . . . 10.0 112.483 -179.638 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.441 ' HB1' ' O ' ' A' ' 63' ' ' GLN . . . -56.2 -53.41 57.48 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-O 121.817 0.818 . . . . 10.0 109.733 -175.512 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.497 HG11 HG21 ' A' ' 8' ' ' VAL . 35.7 t -54.19 -47.85 67.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.306 0 C-N-CA 124.939 1.295 . . . . 10.0 109.222 173.743 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 3.0 tp10 -66.17 -61.12 2.2 Favored 'General case' 0 N--CA 1.454 -0.261 0 CA-C-N 115.715 -0.675 . . . . 10.0 110.26 -169.293 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 32.6 m -48.21 -51.12 26.68 Favored 'General case' 0 N--CA 1.443 -0.819 0 C-N-CA 125.25 1.42 . . . . 10.0 111.056 171.883 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 22.9 t -59.17 -59.62 5.17 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 119.649 1.113 . . . . 10.0 110.481 -169.201 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.739 HG22 HG22 ' A' ' 56' ' ' ILE . 78.9 t -62.46 -36.78 76.56 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.287 0 CA-C-N 115.335 -0.848 . . . . 10.0 108.899 178.024 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -60.65 -12.0 25.14 Favored Glycine 0 CA--C 1.532 1.118 0 CA-C-O 118.141 -1.366 . . . . 10.0 115.113 172.578 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -81.74 -18.1 45.45 Favored 'General case' 0 C--N 1.342 0.271 0 CA-C-N 120.434 2.117 . . . . 10.0 109.114 -179.891 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.61 HD13 HD12 ' A' ' 56' ' ' ILE . 37.7 mt -70.41 112.07 6.43 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.228 0.537 . . . . 10.0 110.195 -175.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -41.2 -40.76 1.66 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 125.795 1.638 . . . . 10.0 113.152 170.343 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -73.93 -15.79 79.6 Favored Glycine 0 CA--C 1.535 1.318 0 CA-C-N 114.546 -1.206 . . . . 10.0 114.147 -178.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.473 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.4 OUTLIER -67.09 149.96 11.34 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 CA-C-N 119.561 1.681 . . . . 10.0 112.133 -174.919 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 18.5 m -111.92 -51.12 2.87 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.878 1.271 . . . . 10.0 110.878 177.306 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . 0.533 ' HB3' ' OG ' ' A' ' 45' ' ' SER . . . -140.7 146.79 38.28 Favored 'General case' 0 CA--C 1.51 -0.564 0 C-N-CA 123.443 0.697 . . . . 10.0 109.2 179.281 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 29.2 m -146.65 88.55 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.442 -0.839 0 C-N-CA 128.072 2.549 . . . . 10.0 105.108 -173.491 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.4 t-80 -114.54 71.74 0.77 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.011 1.324 . . . . 10.0 110.662 -176.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.2 p -63.5 132.06 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.451 0 O-C-N 121.298 -0.876 . . . . 10.0 111.091 179.283 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 17.2 m-80 -143.65 57.1 1.36 Allowed 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 106.639 -1.615 . . . . 10.0 106.639 174.139 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 pp -61.16 -28.97 69.5 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.567 -0.708 . . . . 10.0 111.552 -171.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 89.2 mt-10 -61.15 -32.03 71.75 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.631 0.772 . . . . 10.0 111.043 174.521 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -85.88 -3.7 58.98 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 123.8 0.84 . . . . 10.0 111.5 176.254 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.39 36.91 78.95 Favored Glycine 0 CA--C 1.524 0.652 0 N-CA-C 110.54 -1.024 . . . . 10.0 110.54 -175.839 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 7.5 mttt -154.91 161.42 41.43 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-O 121.823 0.82 . . . . 10.0 109.687 -177.099 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -155.03 121.42 0.56 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 101.665 -3.457 . . . . 10.0 101.665 178.228 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.9 t0 -99.6 103.37 15.08 Favored 'General case' 0 CA--C 1.519 -0.242 0 CA-C-N 120.71 1.595 . . . . 10.0 106.754 177.262 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.413 ' HB ' ' CD2' ' A' ' 46' ' ' PHE . 0.0 OUTLIER -122.46 99.19 6.53 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.976 0 N-CA-C 107.572 -1.27 . . . . 10.0 107.572 -169.641 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.533 ' OG ' ' HB3' ' A' ' 32' ' ' ALA . 4.2 p -87.84 95.67 10.18 Favored 'General case' 0 N--CA 1.44 -0.932 0 N-CA-C 107.862 -1.162 . . . . 10.0 107.862 172.979 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.473 ' HB3' HG23 ' A' ' 30' ' ' VAL . 0.9 OUTLIER -121.32 155.85 33.83 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 114.982 -1.008 . . . . 10.0 110.69 -176.997 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.26 10.6 t0 -91.61 90.84 7.76 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 113.036 0.754 . . . . 10.0 113.036 -172.292 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -46.81 -30.22 2.35 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-N 114.009 -1.45 . . . . 10.0 113.756 171.436 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -64.37 -52.83 56.34 Favored 'General case' 0 C--N 1.34 0.188 0 CA-C-N 119.13 0.877 . . . . 10.0 110.035 -178.396 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -79.59 -37.9 35.2 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 109.306 -0.627 . . . . 10.0 109.306 -174.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.483 ' O ' HD11 ' A' ' 56' ' ' ILE . 0.7 OUTLIER -144.19 104.63 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.381 0 C-N-CA 124.49 1.116 . . . . 10.0 107.996 -175.513 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.15 150.17 26.05 Favored 'General case' 0 C--O 1.222 -0.345 0 C-N-CA 123.453 0.701 . . . . 10.0 111.098 -173.456 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.439 HG12 ' HE1' ' A' ' 46' ' ' PHE . 1.6 m -40.95 -44.78 0.67 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 C-N-CA 124.446 1.099 . . . . 10.0 113.67 173.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 40.8 tttm -54.5 -56.26 20.63 Favored 'General case' 0 C--O 1.221 -0.421 0 N-CA-C 109.269 -0.641 . . . . 10.0 109.269 171.917 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -49.69 -42.79 46.59 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.241 1.416 . . . . 10.0 110.109 -179.671 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.739 HG22 HG22 ' A' ' 24' ' ' VAL . 3.0 mm -63.32 -47.65 91.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 O-C-N 121.411 -0.806 . . . . 10.0 110.522 178.191 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -62.72 -35.89 81.22 Favored 'General case' 0 N--CA 1.445 -0.699 0 N-CA-C 109.329 -0.619 . . . . 10.0 109.329 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 47.6 m-20 -63.7 -40.37 96.63 Favored 'General case' 0 N--CA 1.444 -0.752 0 O-C-N 121.721 -0.612 . . . . 10.0 109.468 175.421 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.46 -38.14 88.64 Favored 'General case' 0 C--O 1.234 0.261 0 O-C-N 121.384 -0.823 . . . . 10.0 111.146 177.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.482 HD11 HG21 ' A' ' 24' ' ' VAL . 2.2 mt -55.33 -40.58 57.65 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.543 0 O-C-N 120.905 -1.122 . . . . 10.0 109.0 170.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -54.17 -47.42 72.03 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 118.922 0.783 . . . . 10.0 110.282 -179.869 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -56.83 -56.7 18.21 Favored 'General case' 0 C--N 1.343 0.307 0 CA-C-O 121.478 0.656 . . . . 10.0 109.858 175.468 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . 0.441 ' O ' ' HB1' ' A' ' 19' ' ' ALA . 20.6 mt-30 -94.53 67.54 3.39 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 123.353 0.661 . . . . 10.0 110.47 -177.301 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 78.99 97.06 0.26 Allowed Glycine 0 CA--C 1.524 0.655 0 CA-C-N 115.023 -0.99 . . . . 10.0 111.38 169.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 16.6 p90 -65.95 105.11 1.24 Allowed 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 121.728 0.775 . . . . 10.0 110.334 -175.729 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 31.0 m-20 -148.94 76.63 1.34 Allowed 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 105.49 -2.041 . . . . 10.0 105.49 169.14 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.2 p -154.92 105.78 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.286 0 O-C-N 121.152 -0.967 . . . . 10.0 111.129 175.124 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.403 ' HB3' ' HB3' ' A' ' 7' ' ' GLN . . . -60.46 -67.61 0.38 Allowed 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 114.229 -1.35 . . . . 10.0 110.965 170.569 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 42.1 mttt 157.25 -173.02 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 127.746 2.418 . . . . 10.0 112.949 173.889 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 4.8 mm -65.53 107.47 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.793 0 C-N-CA 124.147 0.979 . . . . 10.0 109.576 -173.363 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -75.9 81.34 2.8 Favored 'General case' 0 CA--C 1.531 0.242 0 N-CA-C 108.511 -0.922 . . . . 10.0 108.511 178.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 93.12 110.89 2.02 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 109.258 -1.537 . . . . 10.0 109.258 -175.563 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 31.2 ptt180 . . . . . 0 C--O 1.254 1.294 0 CA-C-O 115.992 -1.956 . . . . 10.0 105.971 171.458 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 30.0 ttp . . . . . 0 N--CA 1.475 0.782 0 N-CA-C 109.846 -0.427 . . . . 10.0 109.846 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 11.5 pm0 -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 108.343 -0.984 . . . . 10.0 108.343 -177.187 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 7.8 tm0? -78.16 117.07 19.09 Favored 'General case' 0 CA--C 1.517 -0.319 0 N-CA-C 109.018 -0.734 . . . . 10.0 109.018 173.608 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.503 ' CB ' HD12 ' A' ' 70' ' ' ILE . 2.8 mtpt -130.35 166.13 21.06 Favored 'General case' 0 N--CA 1.449 -0.491 0 N-CA-C 107.482 -1.303 . . . . 10.0 107.482 174.325 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.572 HG23 ' H ' ' A' ' 42' ' ' VAL . 86.0 m -129.78 108.85 10.48 Favored 'General case' 0 N--CA 1.44 -0.965 0 N-CA-C 109.573 -0.529 . . . . 10.0 109.573 -174.121 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.599 ' O ' HG13 ' A' ' 8' ' ' VAL . 12.2 mt -76.86 92.75 3.66 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -47.39 111.79 0.46 Allowed 'General case' 0 N--CA 1.441 -0.915 0 N-CA-C 108.068 -1.086 . . . . 10.0 108.068 172.573 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.599 HG13 ' O ' ' A' ' 6' ' ' LEU . 6.6 m -113.02 144.69 20.16 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.89 0 C-N-CA 125.949 1.7 . . . . 10.0 109.493 -178.316 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -106.53 80.02 1.43 Allowed 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 106.509 -1.664 . . . . 10.0 106.509 -178.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -58.15 94.43 0.05 OUTLIER Glycine 0 CA--C 1.53 1.018 0 C-N-CA 124.999 1.285 . . . . 10.0 112.457 -171.169 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.8 ttt -114.53 67.74 0.69 Allowed 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 117.846 0.823 . . . . 10.0 110.362 -169.63 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 22.9 t -163.68 -170.74 2.29 Favored 'General case' 0 CA--C 1.527 0.076 0 O-C-N 121.618 -0.676 . . . . 10.0 109.327 -178.26 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 98.9 m -93.04 -132.17 0.14 Allowed 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 105.707 -1.96 . . . . 10.0 105.707 168.315 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -64.1 -39.56 94.32 Favored 'General case' 0 CA--C 1.536 0.416 0 O-C-N 121.144 -0.973 . . . . 10.0 111.944 178.707 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -80.62 82.93 6.51 Favored 'General case' 0 N--CA 1.454 -0.261 0 O-C-N 121.524 -0.735 . . . . 10.0 110.603 -171.025 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 52.0 t -159.45 -39.65 0.06 Allowed 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 123.72 0.808 . . . . 10.0 111.617 168.755 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 16.6 m -45.18 -53.84 1.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.398 0 CA-C-O 121.428 0.632 . . . . 10.0 110.107 177.232 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.53 -29.9 70.1 Favored 'General case' 0 N--CA 1.45 -0.434 0 N-CA-C 112.547 0.573 . . . . 10.0 112.547 179.648 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -63.41 -58.66 6.35 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.237 -1.023 . . . . 10.0 108.237 177.235 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.556 HG11 HG11 ' A' ' 8' ' ' VAL . 70.3 t -54.86 -34.15 30.11 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 C-N-CA 123.409 0.684 . . . . 10.0 110.174 178.439 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 22.6 tt0 -70.92 -73.77 0.16 Allowed 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 123.809 0.844 . . . . 10.0 109.704 179.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 94.1 m -44.92 -45.1 10.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 125.926 1.69 . . . . 10.0 110.496 -176.614 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 69.6 m -53.48 -55.14 27.81 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.817 0.818 . . . . 10.0 110.709 -177.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.656 HG22 HG22 ' A' ' 56' ' ' ILE . 72.5 t -72.15 -25.0 22.93 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.216 0 C-N-CA 123.65 0.78 . . . . 10.0 110.701 179.437 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -80.43 4.2 69.38 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.061 1.315 . . . . 10.0 112.688 177.362 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 11.7 mm-40 -80.66 -45.1 17.76 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-N 119.087 1.444 . . . . 10.0 107.447 176.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.473 HD22 ' H ' ' A' ' 27' ' ' LEU . 0.5 OUTLIER -55.71 118.82 4.89 Favored 'General case' 0 N--CA 1.424 -1.736 0 N-CA-C 113.182 0.808 . . . . 10.0 113.182 -176.39 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -48.66 -35.66 14.29 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.692 1.197 . . . . 10.0 111.963 169.558 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.72 -3.54 83.79 Favored Glycine 0 CA--C 1.535 1.282 0 C-N-CA 124.883 1.23 . . . . 10.0 114.326 179.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.32 158.57 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 119.902 1.851 . . . . 10.0 111.527 170.1 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.3 t -133.93 -46.3 0.79 Allowed 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.834 1.253 . . . . 10.0 110.897 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -139.44 151.33 46.15 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 108.291 -1.003 . . . . 10.0 108.291 173.519 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.457 ' HA ' HG12 ' A' ' 44' ' ' VAL . 33.7 m -142.9 58.85 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.293 0 C-N-CA 124.784 1.234 . . . . 10.0 110.255 -174.506 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -79.92 67.7 5.79 Favored 'General case' 0 CA--C 1.533 0.297 0 O-C-N 121.355 -0.841 . . . . 10.0 109.964 -172.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -57.5 129.77 19.72 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 124.579 1.152 . . . . 10.0 109.907 178.661 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -155.61 55.51 0.62 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.96 -1.126 . . . . 10.0 107.96 175.744 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.2 pp -66.69 -18.47 65.39 Favored 'General case' 0 CA--C 1.535 0.396 0 O-C-N 121.715 -0.615 . . . . 10.0 110.493 -175.342 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -65.88 -36.17 82.69 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 124.498 1.119 . . . . 10.0 109.711 171.28 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.96 -29.02 43.68 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 110.032 -0.359 . . . . 10.0 110.032 171.237 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 107.94 22.9 7.01 Favored Glycine 0 CA--C 1.527 0.788 0 C-N-CA 125.279 1.419 . . . . 10.0 111.464 174.925 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.513 ' HE3' HG21 ' A' ' 5' ' ' THR . 4.3 mtpt -148.67 174.65 11.93 Favored 'General case' 0 N--CA 1.452 -0.331 0 C-N-CA 124.407 1.083 . . . . 10.0 108.255 -178.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.607 HG22 HG13 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -158.99 99.59 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 104.842 -2.281 . . . . 10.0 104.842 -177.941 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -80.94 90.88 5.96 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 107.737 -1.209 . . . . 10.0 107.737 -176.307 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.607 HG13 HG22 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -103.22 101.19 11.85 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 125.135 1.374 . . . . 10.0 108.733 -174.749 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -89.11 107.61 19.14 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 106.763 -1.569 . . . . 10.0 106.763 177.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.791 ' CE2' HG21 ' A' ' 56' ' ' ILE . 0.6 OUTLIER -141.89 156.59 45.51 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 121.313 0.578 . . . . 10.0 112.447 -176.15 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -81.93 90.7 6.48 Favored 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 113.869 1.063 . . . . 10.0 113.869 -176.424 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.72 -27.08 1.79 Allowed 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.92 -1.491 . . . . 10.0 113.353 169.071 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -70.49 -55.22 9.46 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 119.607 1.094 . . . . 10.0 110.342 -178.794 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -77.22 -38.75 50.65 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 109.255 -0.646 . . . . 10.0 109.255 -175.006 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -134.99 98.24 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.568 0 N-CA-C 107.823 -1.177 . . . . 10.0 107.823 -176.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.45 148.2 46.32 Favored 'General case' 0 C--O 1.219 -0.52 0 O-C-N 121.497 -0.752 . . . . 10.0 109.091 -175.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.476 HG13 HG12 ' A' ' 70' ' ' ILE . 70.7 t -28.65 -52.77 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.439 -1.01 0 C-N-CA 125.986 1.714 . . . . 10.0 112.843 168.262 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 9.8 pttm -48.29 -54.01 15.24 Favored 'General case' 0 C--O 1.217 -0.629 0 C-N-CA 123.364 0.665 . . . . 10.0 109.443 177.633 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -51.34 -46.63 62.74 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 127.01 2.124 . . . . 10.0 109.132 177.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.791 HG21 ' CE2' ' A' ' 46' ' ' PHE . 8.8 mm -67.3 -45.15 86.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 O-C-N 121.752 -0.592 . . . . 10.0 110.88 -176.353 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -66.33 -40.66 90.02 Favored 'General case' 0 N--CA 1.444 -0.774 0 N-CA-C 108.877 -0.786 . . . . 10.0 108.877 -178.945 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 74.2 m-20 -57.82 -38.88 76.38 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.949 -0.759 . . . . 10.0 108.949 175.87 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -58.15 -36.51 73.1 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-O 118.767 -0.635 . . . . 10.0 112.285 172.812 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.419 HD11 ' CG2' ' A' ' 24' ' ' VAL . 1.7 mp -62.51 -47.29 93.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 CA-C-N 120.203 1.365 . . . . 10.0 107.825 169.642 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 2.6 mm-40 -56.38 -34.5 66.75 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-N 119.607 1.094 . . . . 10.0 111.614 -178.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -58.48 -30.01 66.66 Favored 'General case' 0 CA--C 1.54 0.582 0 O-C-N 121.503 -0.748 . . . . 10.0 112.022 176.29 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -106.27 -62.23 1.41 Allowed 'General case' 0 CA--C 1.537 0.479 0 C-N-CA 125.992 1.717 . . . . 10.0 112.108 -169.524 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.07 -147.03 6.61 Favored Glycine 0 CA--C 1.525 0.709 0 C-N-CA 126.437 1.97 . . . . 10.0 108.551 179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.2 p90 -163.48 54.46 0.17 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 119.152 1.476 . . . . 10.0 109.551 -179.782 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . 0.518 ' O ' HG12 ' A' ' 8' ' ' VAL . 0.6 OUTLIER -124.47 58.17 1.22 Allowed 'General case' 0 N--CA 1.447 -0.589 0 N-CA-C 106.95 -1.5 . . . . 10.0 106.95 -177.139 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.8 p -139.77 100.76 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.249 0 O-C-N 121.221 -0.924 . . . . 10.0 110.766 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -64.87 -77.24 0.06 Allowed 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.252 -0.885 . . . . 10.0 109.77 168.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER 178.61 175.04 0.61 Allowed 'General case' 0 N--CA 1.47 0.531 0 N-CA-C 114.752 1.39 . . . . 10.0 114.752 177.239 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.503 HD12 ' CB ' ' A' ' 4' ' ' LYS . 7.7 mm -68.98 113.12 4.29 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 C-N-CA 123.674 0.79 . . . . 10.0 109.168 178.139 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -46.8 115.17 0.98 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 123.896 0.879 . . . . 10.0 109.479 179.835 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.42 -20.49 18.44 Favored Glycine 0 CA--C 1.531 1.089 0 CA-C-O 118.758 -1.023 . . . . 10.0 113.562 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 25.0 mtt-85 . . . . . 0 C--O 1.251 1.164 0 CA-C-O 116.853 -1.546 . . . . 10.0 109.873 174.036 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 16.3 ptp . . . . . 0 N--CA 1.473 0.677 0 CA-C-O 118.123 -0.941 . . . . 10.0 109.164 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -120.6 114.52 21.85 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.22 1.408 . . . . 10.0 108.49 174.276 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 44.1 mt-30 -79.53 88.86 5.07 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.259 1.024 . . . . 10.0 110.282 179.481 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.41 ' HB2' HD11 ' A' ' 70' ' ' ILE . 60.8 mttt -125.21 175.87 7.12 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-N 118.505 0.593 . . . . 10.0 111.965 178.561 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.8 m -119.78 109.65 15.85 Favored 'General case' 0 N--CA 1.443 -0.803 0 C-N-CA 123.658 0.783 . . . . 10.0 109.205 179.105 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.576 HD22 HG22 ' A' ' 67' ' ' VAL . 1.3 tt -82.87 101.8 11.23 Favored 'General case' 0 N--CA 1.447 -0.621 0 N-CA-C 107.705 -1.22 . . . . 10.0 107.705 177.625 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -63.37 124.11 20.44 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.44 -0.948 . . . . 10.0 108.44 -175.318 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.517 HG21 HG11 ' A' ' 20' ' ' VAL . 9.2 t -127.59 145.34 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.288 0 C-N-CA 127.827 2.451 . . . . 10.0 107.275 -175.528 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -136.63 112.81 9.79 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.736 1.214 . . . . 10.0 107.917 177.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -60.15 -37.0 92.21 Favored Glycine 0 CA--C 1.528 0.906 0 CA-C-O 119.086 -0.841 . . . . 10.0 113.969 -169.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 11.7 mtt 23.24 60.99 0.04 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.142 2.177 . . . . 10.0 113.877 178.901 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.8 t -148.48 -94.52 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.531 -1.285 . . . . 10.0 107.531 -173.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 44.1 t -161.14 -53.41 0.05 OUTLIER 'General case' 0 N--CA 1.457 -0.096 0 C-N-CA 122.613 0.365 . . . . 10.0 110.431 175.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.9 tt0 -160.6 -47.59 0.05 OUTLIER 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 123.183 0.593 . . . . 10.0 110.119 176.714 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -72.66 72.84 1.05 Allowed 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 123.494 0.717 . . . . 10.0 111.53 179.3 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.3 m -141.78 -44.26 0.35 Allowed 'General case' 0 C--N 1.333 -0.144 0 C-N-CA 124.548 1.139 . . . . 10.0 110.76 170.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 14.7 p -38.87 -50.38 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.389 0 C-N-CA 124.838 1.255 . . . . 10.0 112.086 178.777 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.9 -31.67 66.62 Favored 'General case' 0 CA--C 1.536 0.413 0 N-CA-C 113.122 0.786 . . . . 10.0 113.122 -179.218 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.82 -51.08 69.73 Favored 'General case' 0 CA--C 1.527 0.081 0 O-C-N 120.869 -1.145 . . . . 10.0 109.28 -178.632 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.517 HG11 HG21 ' A' ' 8' ' ' VAL . 64.9 t -54.98 -40.79 55.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.397 0 CA-C-N 115.133 -0.94 . . . . 10.0 109.615 176.571 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.51 -58.51 6.77 Favored 'General case' 0 C--N 1.341 0.222 0 C-N-CA 123.935 0.894 . . . . 10.0 108.695 -177.539 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 24.1 m -48.35 -49.74 33.16 Favored 'General case' 0 N--CA 1.448 -0.565 0 C-N-CA 123.683 0.793 . . . . 10.0 110.879 173.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 3.8 m -59.57 -58.76 7.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 CA-C-O 121.451 0.643 . . . . 10.0 109.51 -170.437 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.883 ' CG2' HD11 ' A' ' 60' ' ' ILE . 95.1 t -71.15 -18.12 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.338 0 CA-C-N 116.008 -0.542 . . . . 10.0 110.809 -179.13 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -90.15 6.44 82.58 Favored Glycine 0 CA--C 1.529 0.926 0 C-N-CA 124.702 1.144 . . . . 10.0 112.907 178.567 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -82.25 -44.34 16.44 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 119.131 1.466 . . . . 10.0 107.654 178.867 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.496 ' H ' HD22 ' A' ' 27' ' ' LEU . 0.3 OUTLIER -56.94 122.22 11.77 Favored 'General case' 0 N--CA 1.423 -1.784 0 CA-C-N 116.04 -0.527 . . . . 10.0 112.409 -174.368 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -50.91 -36.46 38.47 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-O 122.271 1.034 . . . . 10.0 111.538 169.972 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.35 -3.05 64.69 Favored Glycine 0 CA--C 1.533 1.211 0 CA-C-N 114.224 -1.353 . . . . 10.0 114.038 178.339 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.491 HG23 ' HB3' ' A' ' 46' ' ' PHE . 0.3 OUTLIER -67.82 157.85 5.99 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.647 0 CA-C-N 120.165 1.983 . . . . 10.0 111.772 169.904 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.1 m -129.84 -44.28 1.2 Allowed 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.152 1.381 . . . . 10.0 111.649 177.296 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.03 146.57 33.97 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-O 117.777 -1.106 . . . . 10.0 108.328 179.123 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 30.3 m -143.27 58.48 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 C-N-CA 124.483 1.113 . . . . 10.0 111.172 -178.59 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 2.7 m-70 -79.73 74.57 6.42 Favored 'General case' 0 C--O 1.234 0.242 0 O-C-N 120.4 -1.437 . . . . 10.0 109.723 -176.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -62.53 118.05 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.782 0 C-N-CA 124.517 1.127 . . . . 10.0 111.507 -179.82 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 14.5 m-80 -142.27 63.35 1.41 Allowed 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.612 -1.255 . . . . 10.0 107.612 174.131 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.3 pp -61.51 -22.78 65.43 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.653 -0.655 . . . . 10.0 111.627 175.72 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.48 -34.43 77.13 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.028 0.931 . . . . 10.0 110.386 172.675 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.82 -23.69 41.88 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.474 0.31 . . . . 10.0 110.264 171.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 88.09 21.99 43.57 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 124.946 1.26 . . . . 10.0 110.667 -179.251 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.2 mttt -153.63 105.64 2.83 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 -174.644 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 44' ' ' VAL . 1.9 m -89.08 128.67 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 N-CA-C 106.006 -1.849 . . . . 10.0 106.006 170.451 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -94.24 97.84 10.53 Favored 'General case' 0 CA--C 1.521 -0.149 0 N-CA-C 107.026 -1.472 . . . . 10.0 107.026 177.722 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 42' ' ' VAL . 1.4 m -119.99 99.55 7.8 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.672 0 N-CA-C 108.607 -0.886 . . . . 10.0 108.607 -168.399 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 35.1 t -92.63 116.45 29.02 Favored 'General case' 0 N--CA 1.441 -0.881 0 N-CA-C 106.426 -1.694 . . . . 10.0 106.426 176.613 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.523 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.1 p90 -147.05 151.78 37.47 Favored 'General case' 0 N--CA 1.45 -0.437 0 O-C-N 124.699 1.25 . . . . 10.0 112.103 -176.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.9 t0 -86.97 88.09 7.62 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-O 122.063 0.935 . . . . 10.0 112.655 -169.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -47.13 -30.34 2.77 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.496 1.518 . . . . 10.0 112.739 175.95 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t70 -48.63 -56.94 7.08 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.122 0.969 . . . . 10.0 111.56 174.903 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -87.82 -50.34 6.52 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 -172.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -121.03 99.04 6.66 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.168 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 -178.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -59.53 148.11 34.45 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 108.742 -0.836 . . . . 10.0 108.742 -176.821 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 71.2 t -32.66 -46.08 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.442 -0.848 0 C-N-CA 125.823 1.649 . . . . 10.0 111.553 168.521 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -55.85 -55.61 30.49 Favored 'General case' 0 C--O 1.221 -0.439 0 CA-C-O 119.072 -0.489 . . . . 10.0 110.47 175.944 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -46.78 -46.28 20.45 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.464 0.706 . . . . 10.0 110.124 173.088 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.539 HG22 HG22 ' A' ' 24' ' ' VAL . 14.7 mm -64.04 -51.06 73.83 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.657 0 O-C-N 121.85 -0.531 . . . . 10.0 110.128 -177.535 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.84 -46.58 87.37 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 107.906 -1.146 . . . . 10.0 107.906 -175.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -62.5 -35.86 80.72 Favored 'General case' 0 N--CA 1.442 -0.875 0 C-N-CA 123.543 0.737 . . . . 10.0 109.279 -179.753 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -62.19 -24.6 67.3 Favored 'General case' 0 CA--C 1.533 0.32 0 O-C-N 121.197 -0.939 . . . . 10.0 112.271 175.495 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.883 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.5 mp -70.97 -44.38 75.78 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.786 0 N-CA-C 107.685 -1.228 . . . . 10.0 107.685 168.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -55.92 -36.28 67.54 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 120.355 1.434 . . . . 10.0 111.549 177.708 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 34.1 m-20 -55.59 -30.79 61.47 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-N 118.132 0.424 . . . . 10.0 112.116 173.89 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -144.05 83.48 1.74 Allowed 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.448 1.099 . . . . 10.0 109.898 -179.489 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.424 ' O ' HG22 ' A' ' 60' ' ' ILE . . . 96.37 109.36 2.53 Favored Glycine 0 CA--C 1.528 0.875 0 N-CA-C 110.899 -0.88 . . . . 10.0 110.899 172.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.8 m-85 -77.32 57.51 1.49 Allowed 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.307 1.043 . . . . 10.0 112.878 -168.75 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -120.77 65.7 0.85 Allowed 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 123.397 0.679 . . . . 10.0 109.765 -168.174 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.576 HG22 HD22 ' A' ' 6' ' ' LEU 0.273 0.9 OUTLIER -142.42 92.65 0.52 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-O 122.363 1.078 . . . . 10.0 110.337 -174.086 . . . . . . . . 4 4 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -66.59 -23.74 66.24 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-N 114.702 -1.135 . . . . 10.0 111.561 169.811 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 70.0 tttt 107.15 165.75 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.4 2.28 . . . . 10.0 112.16 168.39 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.41 HD11 ' HB2' ' A' ' 4' ' ' LYS . 0.2 OUTLIER -64.86 128.19 27.04 Favored 'Isoleucine or valine' 0 C--O 1.232 0.165 0 O-C-N 121.119 -0.988 . . . . 10.0 110.455 -178.494 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 6.8 mm-40 -67.39 165.35 16.71 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 115.604 -0.725 . . . . 10.0 110.999 178.883 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -58.34 100.15 0.14 Allowed Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.298 -1.121 . . . . 10.0 110.298 175.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 7.2 ttt-85 . . . . . 0 C--O 1.253 1.275 0 N-CA-C 105.287 -2.116 . . . . 10.0 105.287 -173.458 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.439 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 6.1 ttt . . . . . 0 N--CA 1.473 0.681 0 N-CA-C 111.839 0.311 . . . . 10.0 111.839 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -146.06 154.72 42.16 Favored 'General case' 0 C--N 1.343 0.284 0 C-N-CA 122.674 0.39 . . . . 10.0 111.364 176.643 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 34.3 mt-30 -84.37 114.46 21.9 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 126.18 1.792 . . . . 10.0 107.864 169.352 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . 0.758 ' HB3' HD12 ' A' ' 70' ' ' ILE . 23.9 mttp -137.91 175.34 9.67 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 119.13 0.877 . . . . 10.0 110.083 176.616 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.409 HG23 ' H ' ' A' ' 42' ' ' VAL . 5.7 m -123.83 109.55 13.77 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 118.514 -0.755 . . . . 10.0 109.162 -179.708 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.69 HD22 HG22 ' A' ' 67' ' ' VAL . 1.2 mt -82.61 90.78 6.84 Favored 'General case' 0 C--O 1.219 -0.53 0 N-CA-C 106.13 -1.804 . . . . 10.0 106.13 179.359 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -51.15 121.77 6.65 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.983 -0.747 . . . . 10.0 108.983 -179.104 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.615 HG21 HG11 ' A' ' 20' ' ' VAL . 27.2 t -102.72 130.4 52.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 127.256 2.222 . . . . 10.0 108.867 179.267 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -82.41 -17.09 46.66 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-O 123.022 1.392 . . . . 10.0 113.483 178.34 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 61.36 -153.97 38.65 Favored Glycine 0 CA--C 1.533 1.206 0 N-CA-C 109.242 -1.543 . . . . 10.0 109.242 -168.059 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 2.5 mtp 65.52 80.58 0.22 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 124.366 1.066 . . . . 10.0 111.626 176.717 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 28.8 t -140.9 -69.85 0.38 Allowed 'General case' 0 CA--C 1.529 0.147 0 O-C-N 121.827 -0.546 . . . . 10.0 110.003 175.439 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 42.6 t -154.72 -77.65 0.1 Allowed 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 118.688 0.676 . . . . 10.0 111.023 175.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.25 132.97 6.47 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.542 -1.281 . . . . 10.0 107.542 179.11 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -177.69 -49.2 0.01 OUTLIER 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.974 1.31 . . . . 10.0 108.098 -175.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 63.1 m 69.97 -68.6 0.19 Allowed 'General case' 0 C--O 1.222 -0.369 0 C-N-CA 125.329 1.452 . . . . 10.0 109.07 -176.491 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 1.3 m -149.16 82.94 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 N-CA-C 108.196 -1.038 . . . . 10.0 108.196 -178.633 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -170.44 -47.75 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.474 0 N-CA-C 113.092 0.775 . . . . 10.0 113.092 174.493 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.68 -63.35 1.15 Allowed 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 119.969 1.259 . . . . 10.0 111.254 -173.035 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . 0.615 HG11 HG21 ' A' ' 8' ' ' VAL . 91.4 t -50.09 -36.33 12.3 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.663 0 C-N-CA 125.784 1.633 . . . . 10.0 110.758 174.478 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -62.75 -57.24 11.63 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 123.92 0.888 . . . . 10.0 108.662 -178.964 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 12.1 m -50.37 -51.89 41.97 Favored 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 124.163 0.985 . . . . 10.0 110.093 177.903 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 1.4 m -57.28 -54.26 48.86 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-O 122.091 0.948 . . . . 10.0 111.165 -168.357 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.749 HG22 HG22 ' A' ' 56' ' ' ILE . 74.0 t -70.85 -41.6 77.3 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.171 0 CA-C-N 115.442 -0.799 . . . . 10.0 109.189 178.918 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -61.58 -7.93 12.55 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 125.152 1.358 . . . . 10.0 114.286 176.369 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 3.2 mm-40 -81.73 -24.06 36.35 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 119.184 1.492 . . . . 10.0 107.823 176.817 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.59 ' CD1' HD12 ' A' ' 56' ' ' ILE . 71.9 mt -66.18 121.55 15.44 Favored 'General case' 0 N--CA 1.432 -1.338 0 O-C-N 121.623 -0.673 . . . . 10.0 111.547 -176.644 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -47.71 -34.32 8.11 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.077 1.351 . . . . 10.0 112.125 169.735 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -86.32 0.88 87.39 Favored Glycine 0 CA--C 1.535 1.329 0 C-N-CA 125.317 1.437 . . . . 10.0 114.729 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -66.46 157.15 5.98 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-N 120.578 2.189 . . . . 10.0 111.768 173.881 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 49.2 m -126.48 -44.47 1.7 Allowed 'General case' 0 CA--C 1.535 0.365 0 C-N-CA 124.714 1.205 . . . . 10.0 111.968 174.039 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -144.96 146.87 32.14 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-O 118.041 -0.98 . . . . 10.0 108.439 179.869 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.568 ' HA ' HG12 ' A' ' 44' ' ' VAL . 34.4 m -143.22 59.01 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 C-N-CA 124.33 1.052 . . . . 10.0 111.866 -177.344 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 99.3 m-70 -79.62 73.84 6.31 Favored 'General case' 0 N--CA 1.457 -0.091 0 O-C-N 120.431 -1.418 . . . . 10.0 110.29 -176.347 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -62.96 124.8 18.25 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 C-N-CA 123.858 0.863 . . . . 10.0 111.298 178.272 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 15.9 m120 -146.74 58.24 1.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 N-CA-C 107.905 -1.146 . . . . 10.0 107.905 171.25 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 38' ' ' GLU . 4.4 pp -56.21 -28.33 57.94 Favored 'General case' 0 CA--C 1.533 0.3 0 O-C-N 121.717 -0.615 . . . . 10.0 111.173 178.758 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 37' ' ' LEU . 1.8 tt0 -63.62 -27.16 69.04 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.169 1.388 . . . . 10.0 111.144 177.179 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -95.03 -1.76 51.64 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.201 1.4 . . . . 10.0 111.852 173.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 69.83 34.29 71.63 Favored Glycine 0 CA--C 1.526 0.748 0 C-N-CA 124.906 1.241 . . . . 10.0 111.291 -177.074 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -157.18 153.39 27.57 Favored 'General case' 0 C--O 1.223 -0.301 0 CA-C-N 117.991 0.896 . . . . 10.0 109.387 -177.813 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.409 ' H ' HG23 ' A' ' 5' ' ' THR . 0.1 OUTLIER -156.04 101.46 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.444 0 N-CA-C 104.846 -2.279 . . . . 10.0 104.846 -175.491 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -84.27 102.09 12.41 Favored 'General case' 0 CA--C 1.518 -0.287 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 -174.815 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 33' ' ' VAL . 1.9 m -118.89 106.41 19.42 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.102 0 C-N-CA 124.879 1.272 . . . . 10.0 108.386 -172.317 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 30.0 t -96.56 119.42 35.02 Favored 'General case' 0 N--CA 1.44 -0.931 0 N-CA-C 106.442 -1.688 . . . . 10.0 106.442 174.923 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.59 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -150.0 157.34 43.05 Favored 'General case' 0 N--CA 1.445 -0.712 0 CA-C-O 122.065 0.936 . . . . 10.0 113.074 -174.317 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -78.13 82.76 4.44 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-N 114.711 -1.132 . . . . 10.0 113.706 -172.182 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.49 -28.57 0.59 Allowed 'General case' 0 CA--C 1.539 0.535 0 CA-C-N 113.925 -1.489 . . . . 10.0 113.501 168.307 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.439 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.6 m-20 -78.49 -43.63 26.54 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.063 0.847 . . . . 10.0 110.266 -172.598 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 62.3 tttp -78.96 -47.63 15.99 Favored 'General case' 0 C--N 1.34 0.158 0 CA-C-N 119.151 0.887 . . . . 10.0 109.169 176.052 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -127.83 108.86 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 107.534 -1.284 . . . . 10.0 107.534 -174.977 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -70.91 154.38 41.87 Favored 'General case' 0 N--CA 1.449 -0.476 0 N-CA-C 108.224 -1.028 . . . . 10.0 108.224 -175.368 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.415 HG13 ' CG1' ' A' ' 70' ' ' ILE . 70.9 t -27.34 -55.67 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 C-N-CA 126.662 1.985 . . . . 10.0 113.288 168.926 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.404 ' HE3' ' N ' ' A' ' 55' ' ' ASP . 0.0 OUTLIER -49.74 -48.39 50.2 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 118.437 0.562 . . . . 10.0 110.002 179.713 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . 0.404 ' N ' ' HE3' ' A' ' 54' ' ' LYS . 0.2 OUTLIER -57.19 -42.6 81.52 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 124.922 1.289 . . . . 10.0 108.46 -179.051 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.749 HG22 HG22 ' A' ' 24' ' ' VAL . 5.4 mm -67.31 -43.99 87.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.706 0 C-N-CA 120.365 -0.534 . . . . 10.0 109.734 -178.345 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -65.35 -45.28 84.81 Favored 'General case' 0 N--CA 1.44 -0.928 0 N-CA-C 108.394 -0.965 . . . . 10.0 108.394 -176.08 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -54.48 -41.66 69.79 Favored 'General case' 0 N--CA 1.447 -0.609 0 C-N-CA 124.528 1.131 . . . . 10.0 108.848 177.463 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.08 -38.84 73.89 Favored 'General case' 0 N--CA 1.451 -0.381 0 O-C-N 121.911 -0.493 . . . . 10.0 112.029 175.708 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.71 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -62.55 -43.69 98.65 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.683 0 CA-C-N 119.773 1.169 . . . . 10.0 108.572 170.647 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -57.21 -34.76 68.86 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-N 120.668 1.576 . . . . 10.0 111.693 179.445 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.18 -27.33 69.29 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.773 0.715 . . . . 10.0 112.447 172.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -133.18 65.44 1.59 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.959 1.704 . . . . 10.0 111.342 -176.045 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 100.17 117.93 4.13 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 124.424 1.011 . . . . 10.0 110.843 172.683 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.8 m-85 -80.24 55.92 2.34 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 118.381 1.091 . . . . 10.0 111.47 -169.973 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -120.99 64.19 0.86 Allowed 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.739 1.216 . . . . 10.0 108.406 -170.611 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.69 HG22 HD22 ' A' ' 6' ' ' LEU 0.266 0.4 OUTLIER -149.62 93.13 0.17 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 O-C-N 120.593 -1.317 . . . . 10.0 110.694 -178.225 . . . . . . . . 4 4 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -48.68 -73.61 0.04 OUTLIER 'General case' 0 CA--C 1.543 0.686 0 CA-C-N 114.527 -1.215 . . . . 10.0 111.654 169.821 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.5 ttmm 172.28 176.47 0.09 Allowed 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 127.67 2.388 . . . . 10.0 108.894 171.559 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.758 HD12 ' HB3' ' A' ' 4' ' ' LYS . 8.0 mm -64.2 133.14 30.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 C-N-CA 123.909 0.884 . . . . 10.0 109.803 172.033 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -59.3 112.54 1.77 Allowed 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 108.96 -0.755 . . . . 10.0 108.96 170.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 97.8 -11.5 64.43 Favored Glycine 0 CA--C 1.53 1.011 0 CA-C-O 117.848 -1.529 . . . . 10.0 115.966 168.632 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 29.2 ttt180 . . . . . 0 C--O 1.25 1.12 0 CA-C-N 120.562 2.181 . . . . 10.0 108.934 -172.251 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 54.6 ttm . . . . . 0 N--CA 1.473 0.699 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -119.64 111.35 17.94 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.261 0.625 . . . . 10.0 110.017 -172.399 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.0 pm0 -69.13 102.74 1.72 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.124 0.969 . . . . 10.0 109.639 169.459 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 70.9 mttt -128.33 169.4 14.28 Favored 'General case' 0 N--CA 1.457 -0.084 0 CA-C-O 121.466 0.651 . . . . 10.0 110.387 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 3.9 m -110.4 115.26 29.35 Favored 'General case' 0 N--CA 1.44 -0.948 0 N-CA-C 108.359 -0.978 . . . . 10.0 108.359 176.465 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.631 HD11 ' HB ' ' A' ' 67' ' ' VAL . 17.1 tp -83.38 107.3 15.79 Favored 'General case' 0 N--CA 1.448 -0.569 0 N-CA-C 106.118 -1.808 . . . . 10.0 106.118 169.347 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -56.39 117.1 3.49 Favored 'General case' 0 N--CA 1.449 -0.515 0 N-CA-C 106.482 -1.673 . . . . 10.0 106.482 173.531 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.32 119.09 59.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 107.251 -1.389 . . . . 10.0 107.251 176.927 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -83.76 -23.93 31.32 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.785 1.234 . . . . 10.0 113.84 179.184 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 60.21 -176.19 3.89 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.477 1.513 . . . . 10.0 111.564 -169.454 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 35.8 mtp -108.03 -83.12 0.55 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.691 0.796 . . . . 10.0 108.932 169.204 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 33.5 t -169.94 -178.47 2.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 107.569 -1.271 . . . . 10.0 107.569 -176.868 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 1.8 t 54.65 -161.44 0.15 Allowed 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 125.972 1.709 . . . . 10.0 111.784 177.574 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.7 mp0 -103.05 179.87 4.15 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.835 1.254 . . . . 10.0 108.823 177.668 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.4 m170 69.92 24.69 5.11 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 125.417 1.487 . . . . 10.0 111.872 -177.799 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.7 m -103.51 -64.8 1.05 Allowed 'General case' 0 CA--C 1.521 -0.155 0 C-N-CA 124.785 1.234 . . . . 10.0 108.958 -179.654 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 90.5 t -32.49 -62.72 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 126.661 1.984 . . . . 10.0 110.511 177.382 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 9.6 mptt -65.23 -34.53 78.58 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 119.07 -0.49 . . . . 10.0 112.093 -176.133 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.67 -50.12 74.76 Favored 'General case' 0 C--O 1.235 0.293 0 CA-C-N 119.832 1.196 . . . . 10.0 109.875 -178.628 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 21.4 t -55.24 -41.79 62.78 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 109.162 -0.681 . . . . 10.0 109.162 174.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 -63.11 -65.86 0.62 Allowed 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.977 1.311 . . . . 10.0 109.494 -175.461 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 64.1 m -43.6 -47.02 7.45 Favored 'General case' 0 N--CA 1.444 -0.771 0 C-N-CA 126.082 1.753 . . . . 10.0 110.195 174.695 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 31.1 m -67.6 -45.12 76.39 Favored 'General case' 0 N--CA 1.44 -0.965 0 CA-C-N 119.029 0.831 . . . . 10.0 111.162 -173.999 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.865 HG22 HD11 ' A' ' 60' ' ' ILE . 98.6 t -65.22 -20.45 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.854 0 O-C-N 121.31 -0.869 . . . . 10.0 110.38 169.511 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -98.87 15.42 60.76 Favored Glycine 0 CA--C 1.526 0.737 0 C-N-CA 125.034 1.302 . . . . 10.0 112.677 -172.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -87.51 -44.69 11.1 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.604 -1.258 . . . . 10.0 107.604 178.392 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.572 ' H ' HD12 ' A' ' 27' ' ' LEU . 0.0 OUTLIER -60.39 126.0 25.81 Favored 'General case' 0 N--CA 1.443 -0.822 0 CA-C-N 115.193 -0.912 . . . . 10.0 112.352 -174.686 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -51.01 -35.81 36.07 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 125.24 1.416 . . . . 10.0 111.282 172.247 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -72.92 -9.14 75.13 Favored Glycine 0 CA--C 1.532 1.111 0 CA-C-N 114.526 -1.215 . . . . 10.0 113.738 179.155 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 24' ' ' VAL . 0.3 OUTLIER -63.24 158.93 3.37 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 120.115 1.957 . . . . 10.0 112.674 172.461 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.7 t -133.7 -45.27 0.81 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 124.832 1.253 . . . . 10.0 111.588 179.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.44 149.31 37.43 Favored 'General case' 0 N--CA 1.466 0.334 0 C-N-CA 124.452 1.101 . . . . 10.0 108.473 177.104 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 31.3 m -144.53 55.36 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 123.841 0.856 . . . . 10.0 111.042 -173.812 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 3.5 t-80 -85.91 68.89 10.48 Favored 'General case' 0 N--CA 1.453 -0.303 0 O-C-N 120.702 -1.248 . . . . 10.0 109.257 -170.387 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.4 p -68.32 118.59 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 C-N-CA 123.861 0.864 . . . . 10.0 110.221 179.684 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -136.02 59.21 1.72 Allowed 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 107.133 -1.432 . . . . 10.0 107.133 174.688 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -54.93 -28.47 51.3 Favored 'General case' 0 CA--C 1.538 0.493 0 CA-C-N 116.003 -0.544 . . . . 10.0 111.284 -179.419 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 61.4 mt-10 -62.76 -36.35 82.79 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.951 0.9 . . . . 10.0 110.946 174.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.22 -8.09 59.28 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 124.048 0.939 . . . . 10.0 111.236 174.167 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 76.33 30.27 57.09 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.441 1.02 . . . . 10.0 110.63 -178.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 8.1 mttp -158.21 161.85 37.83 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 121.921 0.867 . . . . 10.0 110.581 179.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.455 HG12 HG13 ' A' ' 44' ' ' VAL . 42.8 t -150.03 125.98 2.01 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 102.367 -3.197 . . . . 10.0 102.367 -172.47 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 28.0 t0 -105.48 93.44 4.67 Favored 'General case' 0 CA--C 1.522 -0.131 0 CA-C-N 120.056 1.298 . . . . 10.0 107.749 174.58 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.455 HG13 HG12 ' A' ' 42' ' ' VAL . 2.2 m -105.15 107.56 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.922 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 -178.634 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.4 t -97.84 114.91 27.09 Favored 'General case' 0 N--CA 1.442 -0.839 0 N-CA-C 105.919 -1.882 . . . . 10.0 105.919 172.918 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.433 ' CE2' ' HB ' ' A' ' 44' ' ' VAL . 0.1 OUTLIER -144.8 153.53 41.73 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 121.379 0.609 . . . . 10.0 110.929 -177.463 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -80.19 77.12 6.94 Favored 'General case' 0 N--CA 1.449 -0.476 0 CA-C-N 115.746 -0.661 . . . . 10.0 111.822 -168.486 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -40.23 -37.35 0.63 Allowed 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 126.168 1.787 . . . . 10.0 113.605 -179.86 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -53.88 -55.42 26.95 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 124.436 1.095 . . . . 10.0 111.272 176.579 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -84.21 -42.52 15.85 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.501 0.72 . . . . 10.0 109.969 -173.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.1 m -131.7 99.3 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.244 0 N-CA-C 106.536 -1.654 . . . . 10.0 106.536 -177.615 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.92 143.82 57.17 Favored 'General case' 0 C--O 1.218 -0.568 0 O-C-N 121.47 -0.769 . . . . 10.0 109.15 -175.38 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 2.5 m -38.88 -45.27 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 C-N-CA 124.973 1.309 . . . . 10.0 113.562 178.905 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -55.67 29.17 Favored 'General case' 0 C--O 1.219 -0.501 0 C-N-CA 123.612 0.765 . . . . 10.0 110.692 172.379 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -47.95 -38.71 17.32 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.25 1.02 . . . . 10.0 111.044 176.079 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.732 ' O ' HD12 ' A' ' 60' ' ' ILE . 2.9 mm -68.05 -53.15 31.8 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.965 0 N-CA-C 108.326 -0.99 . . . . 10.0 108.326 179.96 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . 0.462 ' O ' HG21 ' A' ' 67' ' ' VAL . . . -50.02 -47.29 53.22 Favored 'General case' 0 N--CA 1.449 -0.484 0 N-CA-C 107.363 -1.347 . . . . 10.0 107.363 -179.512 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -61.43 -38.44 87.16 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.183 -0.917 . . . . 10.0 110.153 -178.91 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.74 -37.73 82.77 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 121.645 -0.66 . . . . 10.0 111.004 176.923 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.865 HD11 HG22 ' A' ' 24' ' ' VAL . 4.0 mp -65.07 -42.71 95.23 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.028 0 CA-C-O 117.766 -1.111 . . . . 10.0 108.965 169.537 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -61.15 -21.54 63.85 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 120.201 1.364 . . . . 10.0 113.032 179.59 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.44 -33.7 76.57 Favored 'General case' 0 CA--C 1.543 0.686 0 O-C-N 121.378 -0.826 . . . . 10.0 111.644 169.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.14 -61.78 1.33 Allowed 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.987 1.715 . . . . 10.0 112.086 -170.781 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -115.22 -151.69 10.04 Favored Glycine 0 CA--C 1.53 1.021 0 C-N-CA 127.104 2.288 . . . . 10.0 109.082 176.947 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -159.19 66.54 0.41 Allowed 'General case' 0 N--CA 1.466 0.367 0 CA-C-N 119.067 1.434 . . . . 10.0 108.981 177.678 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -146.47 55.64 1.15 Allowed 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 108.562 -0.903 . . . . 10.0 108.562 -168.309 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.631 ' HB ' HD11 ' A' ' 6' ' ' LEU . 17.0 m -153.6 58.68 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 O-C-N 121.698 -0.626 . . . . 10.0 110.543 -172.874 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -26.33 -70.35 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.789 1.236 . . . . 10.0 112.544 176.998 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 177.92 173.0 0.61 Allowed 'General case' 0 C--N 1.342 0.252 0 C-N-CA 124.438 1.095 . . . . 10.0 111.804 169.821 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.555 HD12 HD13 ' A' ' 6' ' ' LEU . 1.2 mp -77.26 128.46 37.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.453 0 C-N-CA 122.972 0.509 . . . . 10.0 111.456 178.455 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 32.0 mt-10 -60.85 93.4 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 N-CA-C 108.989 -0.745 . . . . 10.0 108.989 170.313 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 114.5 0.32 23.39 Favored Glycine 0 CA--C 1.531 1.08 0 CA-C-O 118.106 -1.386 . . . . 10.0 115.204 169.662 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 62.4 ttt180 . . . . . 0 C--O 1.248 0.988 0 CA-C-O 117.275 -1.345 . . . . 10.0 113.133 176.297 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 109.482 -0.562 . . . . 10.0 109.482 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 26.0 mt-10 -145.0 156.06 43.73 Favored 'General case' 0 C--O 1.232 0.152 0 N-CA-C 108.325 -0.991 . . . . 10.0 108.325 -171.574 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 50.9 tt0 -91.26 123.86 35.02 Favored 'General case' 0 CA--C 1.518 -0.27 0 C-N-CA 124.746 1.218 . . . . 10.0 109.995 173.489 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.52 173.03 12.0 Favored 'General case' 0 CA--C 1.53 0.177 0 N-CA-C 111.834 0.309 . . . . 10.0 111.834 174.351 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.466 HG23 ' H ' ' A' ' 42' ' ' VAL . 9.9 m -116.53 107.83 15.24 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 123.431 0.693 . . . . 10.0 110.326 -179.759 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.648 HD22 ' CG2' ' A' ' 67' ' ' VAL . 1.6 mt -81.68 88.48 6.25 Favored 'General case' 0 N--CA 1.467 0.387 0 N-CA-C 107.681 -1.229 . . . . 10.0 107.681 174.927 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.19 115.72 1.07 Allowed 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.434 1.094 . . . . 10.0 109.553 -177.729 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 41.6 t -82.5 129.08 38.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.709 1.604 . . . . 10.0 112.258 178.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -92.74 94.96 9.27 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 106.448 -1.686 . . . . 10.0 106.448 169.215 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -66.51 100.42 0.54 Allowed Glycine 0 CA--C 1.532 1.128 0 CA-C-O 119.384 -0.676 . . . . 10.0 111.6 -174.416 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 5.8 mtt -144.53 80.06 1.62 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.703 1.201 . . . . 10.0 111.597 -173.931 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 54.7 p -147.43 -63.91 0.27 Allowed 'General case' 0 CA--C 1.529 0.172 0 O-C-N 121.224 -0.922 . . . . 10.0 109.518 168.532 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 49.2 t 113.63 102.11 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 130.066 3.346 . . . . 10.0 108.693 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER 73.82 56.3 0.1 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.971 1.708 . . . . 10.0 113.126 175.454 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -126.82 129.79 48.97 Favored 'General case' 0 N--CA 1.456 -0.146 0 N-CA-C 106.893 -1.521 . . . . 10.0 106.893 168.558 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 69.8 m -82.31 66.45 7.91 Favored 'General case' 0 CA--C 1.516 -0.328 0 N-CA-C 104.992 -2.225 . . . . 10.0 104.992 166.998 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.507 HG13 HD23 ' A' ' 37' ' ' LEU . 0.1 OUTLIER 53.97 15.46 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.535 0.39 0 N-CA-C 114.549 1.314 . . . . 10.0 114.549 171.66 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -57.42 -32.38 66.82 Favored 'General case' 0 N--CA 1.456 -0.14 0 O-C-N 121.353 -0.842 . . . . 10.0 112.585 -168.82 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -50.27 -64.74 0.72 Allowed 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 123.827 0.851 . . . . 10.0 110.567 168.935 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 22.0 t -54.19 -46.11 67.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 C-N-CA 126.098 1.759 . . . . 10.0 109.176 179.009 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 20.7 tt0 -61.22 -63.85 1.15 Allowed 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 125.137 1.375 . . . . 10.0 109.644 -173.717 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 51.5 m -50.87 -48.2 60.27 Favored 'General case' 0 N--CA 1.446 -0.651 0 C-N-CA 124.401 1.081 . . . . 10.0 109.526 176.867 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 20.7 t -58.19 -64.81 0.79 Allowed 'General case' 0 N--CA 1.444 -0.761 0 CA-C-O 122.245 1.021 . . . . 10.0 109.867 -169.746 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.617 HG22 HG22 ' A' ' 56' ' ' ILE . 92.2 t -63.64 -36.91 78.17 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.504 0 N-CA-C 107.936 -1.135 . . . . 10.0 107.936 -177.404 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -57.54 -15.61 18.42 Favored Glycine 0 CA--C 1.535 1.319 0 CA-C-O 118.066 -1.408 . . . . 10.0 115.496 171.497 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -81.19 -23.7 37.98 Favored 'General case' 0 C--N 1.342 0.279 0 CA-C-N 120.511 2.156 . . . . 10.0 109.165 -178.331 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.722 HD13 HD12 ' A' ' 56' ' ' ILE . 39.3 mt -67.68 121.79 16.67 Favored 'General case' 0 N--CA 1.436 -1.156 0 C-N-CA 122.926 0.491 . . . . 10.0 110.443 -173.006 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -47.01 -41.67 16.86 Favored 'General case' 0 C--O 1.226 -0.145 0 CA-C-O 122.659 1.219 . . . . 10.0 111.544 170.015 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -75.27 -4.6 74.16 Favored Glycine 0 CA--C 1.532 1.149 0 CA-C-N 113.689 -1.596 . . . . 10.0 114.441 -179.018 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.79 159.8 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 CA-C-N 120.69 2.245 . . . . 10.0 111.168 173.433 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.4 t -138.29 -45.06 0.5 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.65 1.18 . . . . 10.0 110.713 -178.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -142.19 149.07 39.22 Favored 'General case' 0 N--CA 1.464 0.256 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 173.737 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.43 ' HA ' HG12 ' A' ' 44' ' ' VAL . 26.6 m -142.9 57.55 0.15 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 123.64 0.776 . . . . 10.0 111.134 -179.311 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 63.4 m80 -81.55 74.49 8.55 Favored 'General case' 0 N--CA 1.462 0.145 0 O-C-N 120.504 -1.373 . . . . 10.0 109.568 -175.793 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 p -66.27 131.26 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.778 0 C-N-CA 123.902 0.881 . . . . 10.0 111.158 177.734 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 59.6 t-20 -155.19 66.85 0.65 Allowed 'General case' 0 N--CA 1.451 -0.379 0 CA-C-O 122.171 0.986 . . . . 10.0 109.004 178.158 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.507 HD23 HG13 ' A' ' 17' ' ' VAL . 0.3 OUTLIER -57.44 -23.53 50.22 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-N 115.875 -0.602 . . . . 10.0 111.858 176.539 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . 0.484 ' N ' HD12 ' A' ' 37' ' ' LEU . 3.0 mm-40 -63.37 -41.91 98.84 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.716 1.606 . . . . 10.0 108.96 175.484 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -78.47 -26.7 46.14 Favored 'General case' 0 CA--C 1.528 0.112 0 N-CA-C 109.955 -0.387 . . . . 10.0 109.955 173.726 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 91.72 39.18 5.62 Favored Glycine 0 CA--C 1.521 0.435 0 N-CA-C 109.241 -1.544 . . . . 10.0 109.241 179.529 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 18.9 mttp -153.9 175.01 13.86 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 107.696 -1.224 . . . . 10.0 107.696 173.792 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.549 ' CG2' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -151.61 125.02 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.437 -1.108 0 N-CA-C 101.578 -3.49 . . . . 10.0 101.578 169.113 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 40.9 m-20 -99.78 97.47 8.39 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.343 -1.725 . . . . 10.0 106.343 178.352 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.549 HG13 ' CG2' ' A' ' 42' ' ' VAL . 0.1 OUTLIER -112.43 106.98 21.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.069 0 CA-C-N 114.075 -1.42 . . . . 10.0 107.594 -172.38 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.435 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 20.3 t -96.7 113.61 25.18 Favored 'General case' 0 N--CA 1.439 -1.009 0 N-CA-C 106.306 -1.738 . . . . 10.0 106.306 175.095 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.416 ' CD2' ' HB ' ' A' ' 44' ' ' VAL . 1.7 p90 -146.72 152.9 39.57 Favored 'General case' 0 N--CA 1.443 -0.823 0 O-C-N 124.588 1.18 . . . . 10.0 111.965 -173.959 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . 0.274 32.8 t0 -83.48 82.0 8.48 Favored 'General case' 0 N--CA 1.451 -0.377 0 CA-C-O 122.417 1.103 . . . . 10.0 113.303 -170.523 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -44.87 -25.25 0.28 Allowed 'General case' 0 N--CA 1.446 -0.652 0 CA-C-N 112.452 -2.158 . . . . 10.0 114.005 169.659 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 20.4 t0 -63.28 -57.25 11.03 Favored 'General case' 0 C--N 1.343 0.3 0 CA-C-N 119.382 0.992 . . . . 10.0 109.581 179.957 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 46.3 tttt -87.14 -39.51 15.46 Favored 'General case' 0 N--CA 1.454 -0.235 0 O-C-N 122.272 -0.268 . . . . 10.0 110.89 -172.002 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.44 ' O ' HD11 ' A' ' 56' ' ' ILE . 2.6 m -124.65 100.44 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.508 0 N-CA-C 106.303 -1.74 . . . . 10.0 106.303 177.538 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 16.2 p -63.97 156.97 26.23 Favored 'General case' 0 N--CA 1.449 -0.507 0 CA-C-O 121.889 0.852 . . . . 10.0 110.186 -177.946 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 13.1 t -33.69 -49.14 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 125.573 1.549 . . . . 10.0 111.739 168.647 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 1.2 tttt -52.14 -59.24 4.61 Favored 'General case' 0 C--O 1.221 -0.428 0 N-CA-C 108.925 -0.768 . . . . 10.0 108.925 175.902 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.84 -43.41 59.17 Favored 'General case' 0 N--CA 1.456 -0.157 0 C-N-CA 124.088 0.955 . . . . 10.0 109.565 178.901 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.722 HD12 HD13 ' A' ' 27' ' ' LEU . 2.3 mm -63.59 -51.12 74.31 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.535 -0.913 . . . . 10.0 108.535 -177.794 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -60.25 -47.13 87.29 Favored 'General case' 0 N--CA 1.442 -0.838 0 N-CA-C 108.105 -1.072 . . . . 10.0 108.105 -174.028 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 78.3 m-20 -55.65 -37.63 68.49 Favored 'General case' 0 N--CA 1.447 -0.6 0 C-N-CA 123.852 0.861 . . . . 10.0 109.673 178.627 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 56' ' ' ILE . . . -56.23 -40.92 74.84 Favored 'General case' 0 N--CA 1.452 -0.342 0 O-C-N 121.622 -0.674 . . . . 10.0 111.187 175.063 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.483 HD13 HG21 ' A' ' 67' ' ' VAL . 2.9 mp -63.26 -38.9 83.33 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 O-C-N 121.029 -1.044 . . . . 10.0 108.269 175.114 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -58.89 -38.8 79.68 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 119.64 1.109 . . . . 10.0 110.727 176.676 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.11 -56.31 22.29 Favored 'General case' 0 CA--C 1.537 0.463 0 CA-C-N 118.467 0.576 . . . . 10.0 110.064 170.758 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 4.6 mm-40 -99.07 62.03 1.27 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 125.418 1.487 . . . . 10.0 111.136 -175.066 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . 81.41 99.67 0.39 Allowed Glycine 0 CA--C 1.534 1.226 0 C-N-CA 123.97 0.795 . . . . 10.0 113.26 169.868 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 12.1 p90 -67.01 103.19 1.1 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 124.306 1.042 . . . . 10.0 112.553 -171.959 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 12.6 m-20 -149.54 66.09 1.0 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.32 1.048 . . . . 10.0 108.549 173.625 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.648 ' CG2' HD22 ' A' ' 6' ' ' LEU . 14.9 p -154.49 75.1 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 O-C-N 120.406 -1.433 . . . . 10.0 112.565 -172.706 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -31.19 -69.1 0.08 Allowed 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 124.574 1.15 . . . . 10.0 112.751 170.444 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 166.25 176.5 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 126.095 1.758 . . . . 10.0 113.91 168.035 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.401 ' N ' HD23 ' A' ' 6' ' ' LEU . 0.7 OUTLIER -69.56 122.72 21.68 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 O-C-N 121.741 -0.599 . . . . 10.0 110.511 176.391 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -105.76 82.06 1.74 Allowed 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 106.612 -1.625 . . . . 10.0 106.612 170.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 164.25 -150.19 18.16 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 105.462 -3.055 . . . . 10.0 105.462 -170.872 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 . . . . . 0 C--O 1.25 1.125 0 CA-C-O 116.285 -1.817 . . . . 10.0 106.296 170.908 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 ttp . . . . . 0 N--CA 1.475 0.799 0 N-CA-C 109.044 -0.724 . . . . 10.0 109.044 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -123.18 133.67 54.22 Favored 'General case' 0 N--CA 1.457 -0.077 0 C-N-CA 123.83 0.852 . . . . 10.0 109.296 176.392 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 2.7 pt20 -80.37 104.51 10.97 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.572 1.149 . . . . 10.0 109.272 169.434 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 7.2 mtpm? -139.26 177.04 8.2 Favored 'General case' 0 CA--C 1.527 0.082 0 CA-C-N 118.591 0.632 . . . . 10.0 110.399 174.517 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 51.8 m -121.19 110.62 16.4 Favored 'General case' 0 N--CA 1.437 -1.079 0 C-N-CA 124.771 1.229 . . . . 10.0 108.112 -173.35 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.578 HD12 HG22 ' A' ' 67' ' ' VAL . 0.0 OUTLIER -78.87 89.6 4.69 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 106.861 -1.533 . . . . 10.0 106.861 177.161 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . 0.403 ' NE2' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -46.3 127.31 8.8 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.772 -0.825 . . . . 10.0 108.772 -178.69 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.403 ' H ' ' NE2' ' A' ' 7' ' ' GLN . 2.1 p -124.53 136.04 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.777 0 C-N-CA 128.189 2.595 . . . . 10.0 108.321 -175.476 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -106.98 -7.84 16.82 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.517 1.127 . . . . 10.0 113.957 179.901 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 55.61 -173.82 1.15 Allowed Glycine 0 CA--C 1.535 1.322 0 C-N-CA 125.949 1.738 . . . . 10.0 112.657 -174.446 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 60.5 mtm -140.07 26.96 2.2 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 123.403 0.681 . . . . 10.0 112.022 171.955 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.9 t 52.86 59.24 4.61 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 123.451 0.7 . . . . 10.0 110.956 171.741 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 31.7 p -157.85 159.56 36.79 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 124.17 0.988 . . . . 10.0 108.777 -169.477 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 14.0 mt-30 -77.54 167.71 21.18 Favored 'General case' 0 CA--C 1.528 0.135 0 CA-C-O 121.549 0.69 . . . . 10.0 110.663 174.173 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 1.9 t60 55.67 52.29 11.21 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 125.021 1.329 . . . . 10.0 109.995 -177.13 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 25.9 p -119.02 -49.17 2.42 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 124.191 0.996 . . . . 10.0 110.728 -177.074 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 30.2 m -56.55 -54.73 25.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 O-C-N 121.395 -0.816 . . . . 10.0 108.921 179.842 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -63.67 -28.52 69.96 Favored 'General case' 0 CA--C 1.534 0.362 0 O-C-N 121.403 -0.811 . . . . 10.0 112.017 178.239 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -66.65 -37.2 84.3 Favored 'General case' 0 C--O 1.226 -0.181 0 O-C-N 121.425 -0.797 . . . . 10.0 111.053 178.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 52.3 t -82.97 -18.87 10.34 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 C-N-CA 123.274 0.63 . . . . 10.0 110.446 176.511 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -89.02 -68.86 0.74 Allowed 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.086 0.555 . . . . 10.0 111.018 -178.591 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 19.1 m -55.25 -39.5 69.83 Favored 'General case' 0 C--O 1.22 -0.462 0 C-N-CA 125.543 1.537 . . . . 10.0 111.262 -170.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 5.3 p -48.16 -68.74 0.16 Allowed 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 126.486 1.914 . . . . 10.0 110.491 177.497 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.674 HG22 HG22 ' A' ' 56' ' ' ILE . 97.4 t -56.62 -43.05 77.9 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.201 0 C-N-CA 124.319 1.048 . . . . 10.0 108.931 175.727 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -52.59 -18.98 5.86 Favored Glycine 0 CA--C 1.532 1.153 0 C-N-CA 125.299 1.428 . . . . 10.0 115.034 173.402 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -85.09 -21.24 29.41 Favored 'General case' 0 N--CA 1.453 -0.303 0 CA-C-N 119.867 1.834 . . . . 10.0 108.72 -178.322 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . . . . . . . . . 55.9 mt -72.68 121.24 19.48 Favored 'General case' 0 N--CA 1.433 -1.319 0 O-C-N 121.87 -0.519 . . . . 10.0 109.861 -173.519 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -47.12 -37.12 9.28 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 125.009 1.324 . . . . 10.0 112.416 173.847 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -74.19 -12.67 81.64 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-N 114.519 -1.219 . . . . 10.0 114.35 179.194 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -63.32 163.01 1.74 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 119.86 1.83 . . . . 10.0 112.755 176.107 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 47.6 t -136.82 -49.17 0.63 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 124.677 1.191 . . . . 10.0 111.032 174.792 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -133.81 147.67 51.26 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.733 -0.839 . . . . 10.0 108.733 179.367 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.8 m -143.91 59.88 0.14 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 124.926 1.29 . . . . 10.0 110.655 -177.571 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -79.37 79.81 5.79 Favored 'General case' 0 N--CA 1.458 -0.068 0 O-C-N 120.329 -1.482 . . . . 10.0 108.54 177.225 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -60.66 135.03 25.82 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.547 0 N-CA-C 110.272 -0.27 . . . . 10.0 110.272 174.15 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -157.05 58.83 0.52 Allowed 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 172.374 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.6 pp -62.61 -26.98 68.89 Favored 'General case' 0 CA--C 1.53 0.194 0 O-C-N 121.771 -0.581 . . . . 10.0 111.12 179.192 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -64.43 -30.41 71.45 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.353 0.661 . . . . 10.0 110.147 174.134 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -89.43 -19.57 24.99 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.018 0.527 . . . . 10.0 111.21 172.398 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 92.52 14.76 55.03 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 125.82 1.676 . . . . 10.0 111.542 178.769 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 43.5 mttp -144.38 97.83 3.11 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 124.025 0.93 . . . . 10.0 109.35 -169.633 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.507 HG22 HG13 ' A' ' 44' ' ' VAL . 1.5 p -88.97 109.52 20.29 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.37 0 N-CA-C 106.699 -1.593 . . . . 10.0 106.699 168.928 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -87.65 102.92 15.08 Favored 'General case' 0 CA--C 1.519 -0.225 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 178.699 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.507 HG13 HG22 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -119.33 106.82 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.998 0 C-N-CA 125.233 1.413 . . . . 10.0 108.384 -172.308 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 22.3 t -92.86 120.95 33.73 Favored 'General case' 0 N--CA 1.442 -0.868 0 N-CA-C 106.667 -1.605 . . . . 10.0 106.667 174.831 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.537 ' CE2' HG21 ' A' ' 56' ' ' ILE . 1.0 OUTLIER -153.14 157.24 40.04 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-O 122.145 0.974 . . . . 10.0 113.355 -173.254 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -81.36 80.85 7.67 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 114.876 -1.057 . . . . 10.0 112.497 -173.432 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -45.15 -30.19 1.1 Allowed 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 114.173 -1.376 . . . . 10.0 113.308 170.844 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 15.1 t70 -67.45 -53.55 27.98 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 123.084 0.553 . . . . 10.0 110.925 -177.085 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -83.17 -36.23 24.88 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 123.068 0.547 . . . . 10.0 109.868 -176.987 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -136.58 101.63 2.57 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 C-N-CA 124.762 1.225 . . . . 10.0 109.106 -179.554 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -60.93 152.31 27.93 Favored 'General case' 0 N--CA 1.452 -0.326 0 O-C-N 121.538 -0.726 . . . . 10.0 110.35 -174.949 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -40.07 -39.84 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.37 0 C-N-CA 123.884 0.874 . . . . 10.0 112.777 171.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 12.4 tttt -59.15 -53.97 52.25 Favored 'General case' 0 C--O 1.219 -0.545 0 CA-C-O 118.581 -0.724 . . . . 10.0 109.935 174.59 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -47.52 -46.84 27.86 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.521 0.729 . . . . 10.0 109.898 175.595 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.674 HG22 HG22 ' A' ' 24' ' ' VAL . 9.5 mm -62.72 -49.64 82.92 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 O-C-N 122.07 -0.394 . . . . 10.0 110.394 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -59.25 -46.52 88.27 Favored 'General case' 0 N--CA 1.442 -0.825 0 N-CA-C 108.088 -1.079 . . . . 10.0 108.088 -175.834 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 39.2 m-20 -59.99 -38.32 82.23 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.4 0.68 . . . . 10.0 109.221 179.742 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -60.13 -32.34 70.92 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.569 -0.707 . . . . 10.0 112.499 172.661 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.636 HD13 HG21 ' A' ' 67' ' ' VAL . 2.3 mp -66.91 -45.62 86.96 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.814 0 N-CA-C 107.505 -1.295 . . . . 10.0 107.505 168.391 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -61.21 -24.79 66.6 Favored 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 118.799 0.727 . . . . 10.0 112.864 -176.858 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -60.54 -36.07 77.54 Favored 'General case' 0 CA--C 1.54 0.571 0 O-C-N 121.677 -0.64 . . . . 10.0 111.301 171.344 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -98.55 -55.06 2.85 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.93 1.692 . . . . 10.0 112.164 -169.543 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -126.54 -152.2 8.01 Favored Glycine 0 CA--C 1.527 0.832 0 C-N-CA 126.029 1.776 . . . . 10.0 108.874 178.707 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 61.4 m-85 -151.27 59.32 0.9 Allowed 'General case' 0 CA--C 1.517 -0.324 0 CA-C-N 118.925 1.363 . . . . 10.0 107.475 171.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -134.02 63.39 1.63 Allowed 'General case' 0 N--CA 1.443 -0.794 0 N-CA-C 107.155 -1.424 . . . . 10.0 107.155 -167.967 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.636 HG21 HD13 ' A' ' 60' ' ' ILE . 3.8 p -155.92 70.37 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 CA-C-O 120.871 0.367 . . . . 10.0 111.642 -176.977 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -27.65 -71.37 0.04 OUTLIER 'General case' 0 CA--C 1.545 0.787 0 C-N-CA 124.319 1.047 . . . . 10.0 113.541 170.843 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 8.0 ttpt 165.8 172.05 0.02 OUTLIER 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 127.28 2.232 . . . . 10.0 112.436 169.303 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -68.02 130.5 33.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 O-C-N 120.721 -1.237 . . . . 10.0 111.844 -179.626 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -62.38 149.06 43.44 Favored 'General case' 0 C--O 1.237 0.445 0 CA-C-O 121.029 0.442 . . . . 10.0 110.579 177.376 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -77.37 48.02 2.77 Favored Glycine 0 CA--C 1.53 0.985 0 C-N-CA 124.047 0.832 . . . . 10.0 112.685 -179.043 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 74.5 mtt180 . . . . . 0 C--O 1.252 1.199 0 CA-C-O 116.104 -1.903 . . . . 10.0 109.185 -169.967 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.431 ' N ' ' OD1' ' A' ' 49' ' ' ASP . 4.1 ttp . . . . . 0 N--CA 1.476 0.834 0 N-CA-C 113.353 0.871 . . . . 10.0 113.353 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -149.75 158.68 44.4 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 125.25 1.42 . . . . 10.0 109.49 173.562 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 45' ' ' SER . 30.0 tt0 -93.54 115.12 27.61 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.849 1.66 . . . . 10.0 109.453 170.558 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LYS . . . . . . . . . . . . . 73.5 mttt -135.55 176.96 8.2 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 118.993 0.815 . . . . 10.0 112.02 177.049 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 8.0 m -123.14 114.17 19.95 Favored 'General case' 0 N--CA 1.439 -0.992 0 N-CA-C 109.281 -0.637 . . . . 10.0 109.281 174.881 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.711 HD13 HG23 ' A' ' 67' ' ' VAL . 4.5 pp -80.15 125.92 30.43 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 106.298 -1.741 . . . . 10.0 106.298 166.654 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -71.59 130.27 40.78 Favored 'General case' 0 N--CA 1.44 -0.96 0 N-CA-C 107.283 -1.377 . . . . 10.0 107.283 176.832 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 35.6 m -109.56 130.71 62.15 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.874 0 C-N-CA 128.133 2.573 . . . . 10.0 110.22 -174.949 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -98.24 57.26 1.23 Allowed 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 108.199 -1.037 . . . . 10.0 108.199 174.631 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -69.76 123.4 13.21 Favored Glycine 0 CA--C 1.528 0.868 0 N-CA-C 111.296 -0.722 . . . . 10.0 111.296 -172.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' MET . . . . . . . . . . . . . 15.5 ttt -89.57 165.82 14.03 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 123.415 0.686 . . . . 10.0 111.215 -175.678 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 9.9 t -67.04 78.55 0.13 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.297 1.039 . . . . 10.0 110.337 176.948 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.3 152.61 34.75 Favored 'General case' 0 N--CA 1.455 -0.191 0 N-CA-C 108.646 -0.872 . . . . 10.0 108.646 174.898 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -83.25 170.48 14.61 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.145 0.578 . . . . 10.0 110.21 175.87 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 36.3 m170 61.54 17.71 8.78 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.127 1.371 . . . . 10.0 112.885 -173.333 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 29.4 p -84.28 -38.91 19.86 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.383 1.073 . . . . 10.0 111.196 179.618 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 6.2 m -74.27 52.94 0.05 OUTLIER 'Isoleucine or valine' 0 CA--C 1.538 0.508 0 C-N-CA 125.471 1.508 . . . . 10.0 111.271 179.686 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -178.41 -43.1 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.362 0 C-N-CA 126.067 1.747 . . . . 10.0 109.752 -177.273 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.33 -51.77 51.41 Favored 'General case' 0 CA--C 1.536 0.419 0 O-C-N 121.22 -0.925 . . . . 10.0 110.664 176.79 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 12.4 t -65.22 -21.09 28.72 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.221 1.408 . . . . 10.0 111.239 179.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLU . . . . . . . . . . . . . 6.5 tm-20 -79.37 -71.42 0.45 Allowed 'General case' 0 N--CA 1.455 -0.198 0 N-CA-C 108.131 -1.063 . . . . 10.0 108.131 176.128 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' THR . . . . . . . . . . . . . 26.9 m -49.82 -39.4 38.47 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 126.269 1.827 . . . . 10.0 112.365 -167.842 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' SER . . . . . . . . . . . . . 46.8 m -49.82 -55.03 15.73 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.259 1.028 . . . . 10.0 110.24 176.517 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . 0.874 HG22 HG22 ' A' ' 56' ' ' ILE . 72.6 t -72.43 -41.82 64.65 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.152 0 C-N-CA 124.136 0.975 . . . . 10.0 108.79 -179.78 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -56.36 -9.27 3.13 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 124.892 1.234 . . . . 10.0 114.603 173.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -79.86 -27.51 40.08 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 119.65 1.725 . . . . 10.0 108.622 177.334 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.623 ' CD1' HG23 ' A' ' 56' ' ' ILE . 75.5 mt -69.76 118.99 13.31 Favored 'General case' 0 N--CA 1.433 -1.312 0 CA-C-O 120.972 0.415 . . . . 10.0 111.344 -173.097 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 12.4 t70 -45.38 -41.19 8.81 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-O 122.472 1.13 . . . . 10.0 111.925 170.105 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . -77.04 -3.38 81.13 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-N 114.04 -1.436 . . . . 10.0 114.674 -178.62 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -64.09 163.38 1.86 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 120.411 2.105 . . . . 10.0 112.02 174.36 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 t -136.61 -43.62 0.6 Allowed 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 124.841 1.257 . . . . 10.0 111.612 179.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ALA . . . . . . . . . . . . . . . -143.8 149.49 37.11 Favored 'General case' 0 N--CA 1.464 0.25 0 C-N-CA 124.438 1.095 . . . . 10.0 108.233 176.11 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.9 m -146.98 57.92 0.09 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.545 0 C-N-CA 125.14 1.376 . . . . 10.0 110.774 -173.632 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' HIS . . . . . . . . . . . . . 1.1 t-80 -81.52 88.87 6.16 Favored 'General case' 0 CA--C 1.53 0.188 0 O-C-N 120.768 -1.208 . . . . 10.0 109.847 -170.896 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.416 ' HA ' HG22 ' A' ' 42' ' ' VAL . 0.3 OUTLIER -71.63 110.88 5.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.474 0 C-N-CA 123.687 0.795 . . . . 10.0 111.231 179.46 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' ASN . . . . . . . . . . . . . 31.7 m120 -142.07 57.55 1.47 Allowed 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.1 -1.445 . . . . 10.0 107.1 175.043 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 pp -60.1 -22.51 62.85 Favored 'General case' 0 CA--C 1.536 0.426 0 O-C-N 121.505 -0.747 . . . . 10.0 112.068 -177.956 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLU . . . . . . . . . . . . . 50.9 mt-10 -61.97 -32.83 73.31 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.631 0.772 . . . . 10.0 110.876 172.39 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.93 -6.07 56.8 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.686 0.794 . . . . 10.0 111.554 173.837 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 77.22 15.44 81.56 Favored Glycine 0 CA--C 1.525 0.663 0 C-N-CA 125.825 1.679 . . . . 10.0 110.794 -179.488 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 22.5 mtpt -148.82 135.81 19.95 Favored 'General case' 0 N--CA 1.445 -0.696 0 C-N-CA 124.363 1.065 . . . . 10.0 108.296 -167.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -116.63 131.28 69.71 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 102.96 -2.978 . . . . 10.0 102.96 175.547 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -104.61 96.37 6.54 Favored 'General case' 0 CA--C 1.516 -0.33 0 CA-C-N 120.33 1.423 . . . . 10.0 108.326 177.527 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.567 HG13 HG13 ' A' ' 42' ' ' VAL . 0.8 OUTLIER -111.5 110.26 31.53 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 C-N-CA 125.341 1.456 . . . . 10.0 109.541 -174.289 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 3' ' ' GLN . 26.8 t -98.22 123.82 42.49 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.173 -1.788 . . . . 10.0 106.173 169.743 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' PHE . . . . . 0.638 ' CD2' HG21 ' A' ' 56' ' ' ILE . 0.1 OUTLIER -154.59 154.26 32.75 Favored 'General case' 0 N--CA 1.443 -0.798 0 CA-C-O 121.605 0.717 . . . . 10.0 112.55 -174.626 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -78.52 83.04 4.74 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.339 -0.846 . . . . 10.0 113.223 -170.153 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -42.14 -32.61 0.49 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 114.031 -1.441 . . . . 10.0 113.411 168.904 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.431 ' OD1' ' N ' ' A' ' 1' ' ' MET . 3.0 m-20 -72.1 -40.15 68.41 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.854 0.752 . . . . 10.0 110.113 -172.889 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -91.48 -42.42 10.29 Favored 'General case' 0 C--N 1.34 0.17 0 CA-C-N 118.634 0.652 . . . . 10.0 111.145 179.062 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 1.5 m -130.39 109.19 16.83 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.32 0 N-CA-C 106.991 -1.485 . . . . 10.0 106.991 179.273 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -62.43 146.81 50.46 Favored 'General case' 0 N--CA 1.45 -0.467 0 O-C-N 121.477 -0.765 . . . . 10.0 109.569 -175.177 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' VAL . . . . . 0.436 ' HA ' HG12 ' A' ' 56' ' ' ILE . 2.4 m -38.51 -40.83 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.582 0 C-N-CA 124.306 1.042 . . . . 10.0 113.615 170.767 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 44.2 tttm -62.63 -48.87 77.49 Favored 'General case' 0 C--O 1.222 -0.371 0 CA-C-O 118.648 -0.691 . . . . 10.0 111.198 174.084 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -48.32 -45.11 34.77 Favored 'General case' 0 CA--C 1.529 0.148 0 CA-C-N 118.819 0.736 . . . . 10.0 109.279 175.429 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' ILE . . . . . 0.874 HG22 HG22 ' A' ' 24' ' ' VAL . 1.1 mm -66.26 -43.73 91.57 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.783 0 O-C-N 122.071 -0.393 . . . . 10.0 111.015 178.779 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ALA . . . . . . . . . . . . . . . -58.44 -51.84 68.16 Favored 'General case' 0 N--CA 1.437 -1.087 0 N-CA-C 107.076 -1.453 . . . . 10.0 107.076 -178.135 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -59.42 -34.52 72.57 Favored 'General case' 0 N--CA 1.442 -0.848 0 C-N-CA 123.287 0.635 . . . . 10.0 109.867 -178.432 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -57.58 -31.69 66.42 Favored 'General case' 0 CA--C 1.533 0.319 0 O-C-N 120.947 -1.096 . . . . 10.0 113.188 173.377 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.67 HD11 ' CG2' ' A' ' 24' ' ' VAL . 3.4 mp -64.25 -43.49 97.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 120.477 1.49 . . . . 10.0 108.152 169.837 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 55.9 mt-10 -59.41 -29.72 67.95 Favored 'General case' 0 C--N 1.346 0.446 0 CA-C-N 119.646 1.112 . . . . 10.0 111.635 -178.383 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -59.55 -29.49 67.95 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 122.697 0.399 . . . . 10.0 111.647 176.285 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -111.02 -64.37 1.29 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.518 1.127 . . . . 10.0 111.228 -177.355 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -103.98 -156.46 24.05 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 125.557 1.551 . . . . 10.0 109.261 -178.675 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 76.4 m-85 -152.35 56.13 0.82 Allowed 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 118.592 1.196 . . . . 10.0 108.174 173.676 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -136.04 57.84 1.77 Allowed 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 -168.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.711 HG23 HD13 ' A' ' 6' ' ' LEU . 13.2 p -146.86 79.36 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 CA-C-O 122.172 0.987 . . . . 10.0 109.815 -174.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -50.75 -61.83 1.97 Allowed 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 117.63 -1.176 . . . . 10.0 111.727 170.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 20.1 mtpt 154.53 172.26 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 126.843 2.057 . . . . 10.0 115.122 170.66 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 3.0 mm -66.16 123.37 18.98 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 C-N-CA 125.986 1.714 . . . . 10.0 110.988 -177.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLU . . . . . . . . . . . . . 35.4 mm-40 -94.05 152.78 18.54 Favored 'General case' 0 C--N 1.333 -0.117 0 O-C-N 124.718 1.262 . . . . 10.0 109.917 178.521 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 64.96 81.43 0.12 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.749 -1.341 . . . . 10.0 109.749 -176.019 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.251 1.141 0 CA-C-O 116.547 -1.692 . . . . 10.0 107.218 -169.519 . . . . . . . . 1 1 . 1 stop_ save_